id,Pubmed_id,phenotype,origin_of_participants,geographical_region,Ethnicity,mixed_population,p-value,curated_gene_symbol,study_type,gene_symbol_mined,gene_name,chromosome,uniprot,function,data_ac,publication_type,title,publication,publication_year,source,id_in_source,variant_type,drug_name,ID Drug bank,state,Indication,IUPAC_name,Notes
rs2230806,26243156,Obesity,Egypt,North Africa,NS,FALSE,0.014,ABCA1,,ABCA1,ATP binding cassette subfamily A member 1,9,O95477,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. With cholesterol as its substrate, this protein functions as a cholesteral efflux pump in the cellular lipid removal pathway. Mutations in both alleles of this gene cause Tangier disease and familial high-density lipoprotein (HDL) deficiency. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Functional and Structural Impact of ATP-Binding Cassette Transporter A1 R219K and I883M Gene Polymorphisms in Obese Children and Adolescents.,26243156,2016,DisGeNET,rs2230806,SNV,,,,,,Associated with higher suceptibility to obesity.
rs2066714,26243156,Obesity,Egypt,North Africa,NS,FALSE,< 0.05,ABCA1,,ABCA1,ATP binding cassette subfamily A member 1,9,O95477,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. With cholesterol as its substrate, this protein functions as a cholesteral efflux pump in the cellular lipid removal pathway. Mutations in both alleles of this gene cause Tangier disease and familial high-density lipoprotein (HDL) deficiency. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Functional and Structural Impact of ATP-Binding Cassette Transporter A1 R219K and I883M Gene Polymorphisms in Obese Children and Adolescents.,26243156,2016,DisGeNET,rs2066714,SNV,,,,,,Associated with lower suceptibility to obesity.
rs28940268,8845852,"Lamellar Ichthyosis, Type 2","Algeria, Mali, Morocco",North Africa,NS,TRUE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mapping of a second locus for lamellar ichthyosis to chromosome 2q33-35.,8845852,1996,DisGeNET,rs28940268,SNV,,,,,,
rs28940269,8845852,"Lamellar Ichthyosis, Type 2","Algeria, Mali, Morocco",North Africa,NS,TRUE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mapping of a second locus for lamellar ichthyosis to chromosome 2q33-35.,8845852,1996,DisGeNET,rs28940269,SNV,,,,,,
rs28940268,12915478,"Lamellar Ichthyosis, Type 2",Morocco,North Africa,NS,FALSE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.,12915478,2004,DisGeNET,rs28940268,SNV,,,,,,
rs28940269,12915478,"Lamellar Ichthyosis, Type 2",Morocco,North Africa,NS,FALSE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.,12915478,2004,DisGeNET,rs28940269,SNV,,,,,,
rs28940271,12915478,"Lamellar Ichthyosis, Type 2",Morocco,North Africa,NS,FALSE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.,12915478,2004,DisGeNET,rs28940271,SNV,,,,,,
rs28940568,12915478,"Lamellar Ichthyosis, Type 2",Morocco,North Africa,NS,FALSE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.,12915478,2004,DisGeNET,rs28940568,SNV,,,,,,
rs28940270,12915478,"Lamellar Ichthyosis, Type 2","Algeria, Mali, Morocco",West Africa,NS,TRUE,NS,ABCA12,,ABCA12,ATP binding cassette subfamily A member 12,2,Q86UK0,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the transporter ABCA12 are associated with lamellar ichthyosis type 2.,12915478,2004,DisGeNET,rs28940270,SNV,,,,,,
rs149989682,18317237,Idiopathic Pulmonary Fibrosis,South Africa,South Africa,NS,FALSE,NS,ABCA3,,ABCA3,ATP binding cassette subfamily A member 3,16,Q99758,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters.  ABC proteins transport various molecules across extra- and intracellular membranes.  ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White).  This protein is a member of the ABC1 subfamily.  Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes.  The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Population and disease-based prevalence of the common mutations associated with surfactant deficiency.,18317237,2008,DisGeNET,rs149989682,SNV,,,,,,"The data from this study suggest that ATP-binding cassette member A3 (E292V) may increase respiratory distress syndrome (RDS) susceptibility in the context of currently unknown developmental, genetic, or environmental traits. E292V frequency is 0% in South African black population (n=1686)."
rs149989682,18317237,"Respiratory Distress Syndrome, Newborn",South Africa,South Africa,NS,FALSE,NS,ABCA3,,ABCA3,ATP binding cassette subfamily A member 3,16,Q99758,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters.  ABC proteins transport various molecules across extra- and intracellular membranes.  ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White).  This protein is a member of the ABC1 subfamily.  Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes.  The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Population and disease-based prevalence of the common mutations associated with surfactant deficiency.,18317237,2008,DisGeNET,rs149989682,SNV,,,,,,"The data from this study suggest that ATP-binding cassette member A3 (E292V) may increase respiratory distress syndrome (RDS) susceptibility in the context of currently unknown developmental, genetic, or environmental traits. E292V frequency is 0% in South African black population (n=1686)."
rs149989682,18317237,"Surfactant Metabolism Dysfunction, Pulmonary, 3",South Africa,South Africa,NS,FALSE,NS,ABCA3,,ABCA3,ATP binding cassette subfamily A member 3,16,Q99758,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters.  ABC proteins transport various molecules across extra- and intracellular membranes.  ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White).  This protein is a member of the ABC1 subfamily.  Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes.  The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Population and disease-based prevalence of the common mutations associated with surfactant deficiency.,18317237,2008,DisGeNET,rs149989682,SNV,,,,,,"The data from this study suggest that ATP-binding cassette member A3 (E292V) may increase respiratory distress syndrome (RDS) susceptibility in the context of currently unknown developmental, genetic, or environmental traits. E292V frequency is 0% in South African black population (n=1686)."
rs61752361,21940684,Rett Syndrome,Tunisia,North Africa,NS,FALSE,NS,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Novel mutations in the C-terminal region of the MECP2 gene in Tunisian Rett syndrome patients.,21940684,2012,DisGeNET,rs61752361,SNV,,,,,,
rs61751402,23695285,Stargardt Disease 1 (Disorder),South Africa,South Africa,Afrikaner,TRUE,2.71E-10,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs61751402,SNV,,,,,,"The c.4469G4A (p.Cys1490Tyr) mutation, in combination with either itself or another mutation, was the most common, as it was detected in 64 of the 118 patient samples (54%). The median AOO differed significantly between mutation combinations (P=0.003); 0.0460 is the intercept term, 0.0528 is the regression coefficient for this mutation."
rs62645944,23695285,Stargardt Disease 1 (Disorder),South Africa,South Africa,Afrikaner,TRUE,2.06E-08,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs62645944,SNV,,,,,,"For c.768G4T (p.Val256Val), the regression coefficient  is 0.0507."
rs61749409,23695285,Stargardt Disease 1 (Disorder),South Africa,South Africa,Afrikaner,TRUE,2.33E-07,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs61749409,SNV,,,,,,0.0468 is the regression coefficient for c.1804C4T (p.Arg602Trp).
rs1800728,23695285,Cone-Rod Dystrophy 3 (Disorder),South Africa,South Africa,Afrikaner,TRUE,6.59E-07,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs1800728,SNV,,,,,,"c.5461-10T4C, the regression coefficient is 0.0562."
rs1800728,23695285,Stargardt Disease 1 (Disorder),South Africa,South Africa,Afrikaner,TRUE,6.59E-07,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs1800728,SNV,,,,,,"c.5461-10T4C, the regression coefficient is 0.0562."
rs62646861,23695285,Stargardt Disease 1 (Disorder),South Africa,South Africa,Afrikaner,TRUE,0.0013,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs62646861,SNV,,,,,,"For c.454C4T (p.Arg152*), the regression coefficient is 0.0519."
rs61751408,23695285,Stargardt Disease 1 (Disorder),South Africa,South Africa,Afrikaner,TRUE,0.3117,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt disease: towards developing a model to predict phenotype.,23695285,2014,DisGeNET,rs61751408,SNV,,,,,,"For c.6079C4T (p.Leu2027Phe), the regression coefficient  is (- 0.0090)."
rs1800728,22328824,Stargardt Disease 1 (Disorder),South Africa,South Africa,"Afrikaner,Indian,Coloured",TRUE,NS,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt macular dystrophy: common ABCA4 mutations in South Africa--establishment of a rapid genetic test and relating risk to patients.,22328824,2012,DisGeNET,rs1800728,SNV,,,,,,"181 patients affected with AARs revealed that seven ABCA4 mutations (p.Arg152*, c.768G>T, p.Arg602Trp, p.Gly863Ala, p.Cys1490Tyr, c.5461-10T>C, and p.Leu2027Phe) occurred at a relatively high frequency."
rs62646861,22328824,Stargardt Disease 1 (Disorder),South Africa,South Africa,"Afrikaner,Indian,Coloured",TRUE,NS,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt macular dystrophy: common ABCA4 mutations in South Africa--establishment of a rapid genetic test and relating risk to patients.,22328824,2012,DisGeNET,rs62646861,SNV,,,,,,p.Arg152* nucleotide change: c. 454 C>T with frequency 3.31%.
rs1800728,22328824,Cone-Rod Dystrophy 3 (Disorder),South Africa,South Africa,"Caucasians, Black Africans, Indians, Coloured",TRUE,NS,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Stargardt macular dystrophy: common ABCA4 mutations in South Africa--establishment of a rapid genetic test and relating risk to patients.,22328824,2012,DisGeNET,rs1800728,SNV,,,,,,"181 patients affected with AARs revealed that seven ABCA4 mutations (p.Arg152*, c.768G>T, p.Arg602Trp, p.Gly863Ala, p.Cys1490Tyr, c.5461-10T>C, and p.Leu2027Phe) occurred at a relatively high frequency."
rs1800553,11346402,Age Related Macular Degeneration,"Somali, USA, Australia, Switzerland",East Africa / African American/Afro-Caribbean,NS,TRUE,NS,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration.,11346402,2001,DisGeNET,rs1800553,SNV,,,,,,
rs1800555,11346402,Age Related Macular Degeneration,"Somali, USA, Australia, Switzerland",East Africa / African American/Afro-Caribbean,NS,TRUE,NS,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration.,11346402,2001,DisGeNET,rs1800555,SNV,,,,,,
rs61749423,24342785,Stargardt Disease 1 (Disorder),Tunisia,North Africa,NS,FALSE,0.00000075,ABCA4,,ABCA4,ATP binding cassette subfamily A member 4,1,P78363,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,[Clinical characterization of the Stargardt disease and molecular exploration of the c.2041C>T mutation (ABCA4 gene) in Tunisian patients].,24342785,2019,DisGeNET,rs61749423,SNV,,,,,,
rs1045642,29162334,Genotype AG is not associated with concentrations of tacrolimus in people with Kidney Transplantation as compared to genotype GG.,USA,African American/Afro-Caribbean,African American,FALSE,NS,ABCB1,Association,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449171233,SNV,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",Fifty African-Americans receiving stable doses of immediate-release tacrolimus were included in the study.  Neither heterozygous nor homozygous ABCB1 C3435T variant allele carriers had increased tacrolimus dose requirements.
rs2032582,25240575,Genotypes AC + CC is associated with increased dose of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT.,Egypt,North Africa,NS,FALSE,0.004,ABCB1,Association,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.,25240575,2016,PharmGKB,1185012207,SNV,cyclosporine,DB00091,"Approved, Investigational","Cyclosporine is officially approved for different conditions listed below: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. For this indication, it can be used concomitantly with azathioprine and corticosteroids. Treatment of patients with severe active, rheumatoid arthritis when the patient no longer responds to methotrexate. Concomitantly with methotrexate for the treatment of patients with severe active rheumatoid arthritis when patients do not respond to methotrexate treatment alone. Treatment of adult nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. Its ophthalmic solution is indicated to increase tear production in patients with keratoconjunctivitis sicca in patients from 4 years old. Prevention of graft rejection following bone marrow transplantation and in the treatment of graft-versus-host disease (GVHD). Treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis in adults and children. Away from all this approved and reviewed indications, cyclosporine is commonly used on dermatology for the treatment of various inflammatory skin conditions such as atopic dermatitis, blistering disorders, and connective tissue diseases.","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",ABCB1 is also known as MDR1. Fifty Egyptian renal transplant recipients and under cyclosporin therapy were recruited for the study. Patients carrying the G2677T/A variants in either homozygous or heterozygous forms show a significant difference in the daily dose requirement of cyclosporin. The p-value presented in the table was calculated 9 months after the transplantation.
rs2032582,25240575,Genotypes AC + CC is associated with decreased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotypes AA + CT.,Egypt,North Africa,NS,FALSE,0.012,ABCB1,Association,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.,25240575,2016,PharmGKB,1185012234,SNV,cyclosporine,DB00091,"Approved, Investigational","Cyclosporine is officially approved for different conditions listed below: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. For this indication, it can be used concomitantly with azathioprine and corticosteroids. Treatment of patients with severe active, rheumatoid arthritis when the patient no longer responds to methotrexate. Concomitantly with methotrexate for the treatment of patients with severe active rheumatoid arthritis when patients do not respond to methotrexate treatment alone. Treatment of adult nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. Its ophthalmic solution is indicated to increase tear production in patients with keratoconjunctivitis sicca in patients from 4 years old. Prevention of graft rejection following bone marrow transplantation and in the treatment of graft-versus-host disease (GVHD). Treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis in adults and children. Away from all this approved and reviewed indications, cyclosporine is commonly used on dermatology for the treatment of various inflammatory skin conditions such as atopic dermatitis, blistering disorders, and connective tissue diseases.","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",ABCB1 is also known as MDR1. Fifty Egyptian renal transplant recipients and under cyclosporin therapy were recruited for the study. Patients carrying the G2677T/A variants in either homozygous or heterozygous forms show a significant difference in dose-adjusted C0 levels. The p-value presented in the table was calculated 9 months after the transplantation.
rs3842,27045425,Genotypes CC + CT is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to genotype TT.,Uganda,East Africa,NS,FALSE,0.028437,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.,27045425,2017,PharmGKB,1447984401,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",ABCB1 -c.4046A>G(rs3842)
rs3842,25303294,Allele C is associated with concentrations of efavirenz in people with HIV as compared to allele T.,Uganda,East Africa,NS,FALSE,0.0012,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,"CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.",25303294,2015,PharmGKB,1185234940,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one","Patients with CC genotype, and HIV infection, may have increased exposure to efavirenz compared to patients with the TT genotype. Other genetic and clinical factors may also influence metabolism of efavirenz and patient's exposure to the drug."
rs3842,24497997,Allele C is associated with metabolism of efavirenz in people with HIV as compared to allele T.,Uganda,East Africa,NS,FALSE,0.0012,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.,24497997,2014,PharmGKB,1183944307,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",ABCB1 -c.4046A>G(rs3842)
rs1045642,22111602,Genotypes AA + AG are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG.,Malawi,East Africa,NS,FALSE,NS,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823804,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",ABCB1 3435C>T (rs1045642)
rs3842,28673292,Allele C is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T.,Tanzania,East Africa,NS,FALSE,0.462,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003619,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol",
rs3842,28673292,Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.,Tanzania,East Africa,NS,FALSE,0.462,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003680,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol",
rs4148739,23252947,Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotype CT.,USA,African American/Afro-Caribbean,African American,FALSE,0.023,ABCB1,Association,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501801,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",The association is reported for ratio CBZ-diol:CBZ-E measures in epilepsy patients receiving carbamazepine treatment for allele rs4148739 (A>G) in 30 African-Americans.
rs4148740,23252947,Genotype AG is associated with increased metabolism of carbamazepine in people with Epilepsy as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.026,ABCB1,Association,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501809,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",The association is reported for ratio CBZ-diol:CBZ-E measures in epilepsy patients receiving carbamazepine treatment for allele rs4148740 (T>C) in 30 African-Americans.
rs1128503,23252947,Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.,USA,African American/Afro-Caribbean,African American,FALSE,0.036,ABCB1,Association,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501792,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",The association is reported for clearance measures in epilepsy patients receiving carbamazepine treatment for allele rs1128503 (C>T) in 30 African-Americans.
rs1045642,27426203,"Genotypes AA + AG is associated with decreased trough concentration of imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to genotype GG.",Nigeria,West Africa,NS,FALSE,< 0.001,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.,27426203,2017,PharmGKB,1448125824,SNV,imatinib,DB00619,Approved,"For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).",N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide,
rs1045642,28836054,"Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.",Tunisia,North Africa,NS,FALSE,NS,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.,28836054,2017,PharmGKB,1449005441,SNV,imatinib,DB00619,Approved,"For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).",N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide,ABCB1 3435C>T
rs1128503,28836054,"Allele A is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele G.",Tunisia,North Africa,NS,FALSE,NS,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.,28836054,2017,PharmGKB,1449005428,SNV,imatinib,DB00619,Approved,"For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).",N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide,"ABCB1 1236C>T, ABCB1 polymorphisms study and their correlation with IM response in this study showed that the optimal response rate to imatinib did not difer signifcantly between C1236T, G2677T/A or C3435T genotypes"
rs2032582,28836054,"Allele T is not associated with response to imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to allele A.",Tunisia,North Africa,NS,FALSE,NS,ABCB1,,ABCB1,ATP binding cassette subfamily B member 1,7,P08183,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017].",22/11/2021,PubMed,Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia.,28836054,2017,PharmGKB,1449005435,SNV,imatinib,DB00619,Approved,"For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).",N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide,ABCB1 2677G>T/A
rs2287622,30100615,Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.003,ABCB11,,ABCB11,ATP binding cassette subfamily B member 11,2,O95342,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733121,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Variants associated with high rosuvastatin Cmax (Cmaxâ€‰>â€‰20â€‰ng/ml)
rs7579275,30100615,Allele G is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele A.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.03,ABCB11,,ABCB11,ATP binding cassette subfamily B member 11,2,O95342,"The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is the major canalicular bile salt export pump in man. Mutations in this gene cause a form of progressive familial intrahepatic cholestases which are a group of inherited disorders with severe cholestatic liver disease from early infancy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733115,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Variants associated with high rosuvastatin Cmax (Cmaxâ€‰>â€‰20â€‰ng/ml)
rs7910642,27142945,Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,ABCC2,Association,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986105,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs7910642 and lopinavir plasma concentration.
rs8187706,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733184,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs8187710,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733194,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs7899457,30100615,Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733176,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs8187692,30100615,Allele A is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.003,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733103,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Variants associated with high rosuvastatin Cmax (Cmaxâ€‰>â€‰20â€‰ng/ml)
rs17216177,30100615,Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.006,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733189,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs3740066,30100615,Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.01,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733168,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs17216198,30100615,Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.015,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733162,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs2273897,30767719,Genotype TT is associated with increased concentrations of emtricitabine in people with HIV and Pregnancy as compared to genotypes CC + CT.,Nigeria,West Africa,NS,FALSE,0.028,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Impact of pharmacogenetics and pregnancy on tenofovir and emtricitabine pharmacokinetics.,30767719,2020,PharmGKB,1450377018,SNV,emtricitabine,DB00879,"Approved, Investigational","Indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and for postexposure prophylaxis of HIV infection in health care workers and others exposed occupationally or nonoccupationally via percutaneous injury or mucous membrane or nonintact skin contact with blood, tissues, or other body fluids associated with risk for transmission of the virus.","4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one","ABCC2 12:g.154962860T>C T allele, was associated with a significantly increased concentration of FTC by a factor of log10 0.766 in both pregnant and postpartum women irrespective of time postdose"
rs2273697,23252947,Genotypes AA + AG are associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotype GG.,USA,African American/Afro-Caribbean,African American,FALSE,0.047,ABCC2,Association,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501817,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",The p-value measures the association of the rs2273697 (G>A) SNP with the clearance of carbamazepine in 30 African-Americans epilepsy patients receiving carbamazepine treatment. The p-value was reported at 0.002 for the measurement of the ratio CBZ-E:CBZ.
rs72558200,17287630,"Jaundice, Chronic Idiopathic","Morocco, Iran",North Africa,NS,TRUE,6.82E-08,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations.,17287630,2007,DisGeNET,rs72558200,SNV,,,,,,
rs72558200,11477083,"Jaundice, Chronic Idiopathic","Morocco, Iran",North Africa,NS,TRUE,6.82E-08,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.,11477083,2001,DisGeNET,rs72558200,SNV,,,,,,
rs72558201,11477083,"Jaundice, Chronic Idiopathic","Morocco, Iran",North Africa,NS,TRUE,6.82E-08,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome.,11477083,2001,DisGeNET,rs72558201,SNV,,,,,,
rs72558201,17287630,"Jaundice, Chronic Idiopathic","Morocco, Iran",North Africa,NS,TRUE,6.82E-08,ABCC2,,ABCC2,ATP binding cassette subfamily C member 2,10,Q92887,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations.,17287630,2007,DisGeNET,rs72558201,SNV,,,,,,
rs67561842,12384774,"Arterial Calcification, Generalized, Of Infancy, 2",South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs67561842,SNV,,,,,,
rs67561842,12384774,"Arterial Calcification, Generalized, Of Infancy, 2",South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs67561842,SNV,,,,,,
rs63749856,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs63749856,SNV,,,,,,
rs63749856,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs63749856,SNV,,,,,,
rs63751325,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs63751325,SNV,,,,,,
rs63751325,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs63751325,SNV,,,,,,
rs67561842,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs67561842,SNV,,,,,,
rs67561842,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs67561842,SNV,,,,,,
rs72664288,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs72664288,SNV,,,,,,
rs72664288,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs72664288,SNV,,,,,,
rs72664297,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs72664297,SNV,,,,,,
rs72664297,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs72664297,SNV,,,,,,
rs74315139,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs74315139,SNV,,,,,,
rs74315139,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs74315139,SNV,,,,,,
rs63749823,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs63749823,SNV,,,,,,
rs63749823,12384774,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Indian, British descent",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa.,12384774,2002,DisGeNET,rs63749823,SNV,,,,,,
rs28939702,10954200,Pseudoxanthoma Elasticum,South Africa,South Africa,NS,FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum.,10954200,2001,DisGeNET,rs28939702,SNV,,,,,,
rs28939702,10954200,Pseudoxanthoma Elasticum,South Africa,South Africa,NS,FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum.,10954200,2001,DisGeNET,rs28939702,SNV,,,,,,
rs72653744,10954200,Pseudoxanthoma Elasticum,South Africa,South Africa,NS,FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum.,10954200,2001,DisGeNET,rs72653744,SNV,,,,,,
rs72653744,10954200,Pseudoxanthoma Elasticum,South Africa,South Africa,NS,FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum.,10954200,2001,DisGeNET,rs72653744,SNV,,,,,,
rs28939702,10954200,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,NS,FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum.,10954200,2001,DisGeNET,rs28939702,SNV,,,,,,
rs28939702,10954200,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,NS,FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum.,10954200,2001,DisGeNET,rs28939702,SNV,,,,,,
rs2856597,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs2856597,SNV,,,,,,"The Afrikaner founder mutation, R1339C, was present in 0.41 of white ABCC6 PXE alleles, confirming the founder effect and its presence in both Afrikaans- (34/63 PXE alleles) and Englishspeakers (4/28). Eleven mutations were detected in the white patients (of European origin), including two nonsense mutations, 6 missense mutations, two frameshift mutations and a large deletion mutation. The five 'Coloured' patients included three compound heterozygotes with R1339C as one of the mutations. The three black patients were all apparent homozygotes for the R1314W mutation. Blacks showed a trend towards a higher degree of neurtral variation (18 variants) when compared to whites (12 variants)."
rs28939702,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs28939702,SNV,,,,,,
rs60791294,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs60791294,SNV,,,,,,
rs63749856,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63749856,SNV,,,,,,
rs63750414,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63750414,SNV,,,,,,
rs72653772,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653772,SNV,,,,,,
rs72653785,19339160,Gronblad-Strandberg Syndrome,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653785,SNV,,,,,,
rs2856597,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs2856597,SNV,,,,,,
rs28939702,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs28939702,SNV,,,,,,
rs60791294,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs60791294,SNV,,,,,,
rs63749856,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63749856,SNV,,,,,,
rs63750414,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63750414,SNV,,,,,,
rs72653772,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653772,SNV,,,,,,
rs72653785,19339160,Pseudoxanthoma Elasticum,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653785,SNV,,,,,,
rs2856597,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs2856597,SNV,,,,,,
rs28939702,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs28939702,SNV,,,,,,
rs60791294,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs60791294,SNV,,,,,,
rs63749856,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63749856,SNV,,,,,,
rs63750414,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63750414,SNV,,,,,,
rs72653772,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653772,SNV,,,,,,
rs72653785,19339160,"Pseudoxanthoma Elasticum, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653785,SNV,,,,,,
rs2856597,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs2856597,SNV,,,,,,
rs28939702,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs28939702,SNV,,,,,,
rs60791294,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs60791294,SNV,,,,,,
rs63749856,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63749856,SNV,,,,,,
rs63750414,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs63750414,SNV,,,,,,
rs72653772,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653772,SNV,,,,,,
rs72653785,19339160,"Pxe, Modifier Of Severity Of",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ABCC6,,ABCC6,ATP binding cassette subfamily C member 6,16,O95255,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). The encoded protein, a member of the MRP subfamily, is involved in multi-drug resistance. Mutations in this gene cause pseudoxanthoma elasticum. Alternatively spliced transcript variants that encode different proteins have been described for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of genetic variation at the ABCC6 locus in South Africans: Pseudoxanthoma elasticum patients and healthy individuals.,19339160,2009,DisGeNET,rs72653785,SNV,,,,,,
rs2231142,25676789,Allele T is associated with decreased response to allopurinol in people with Gout as compared to allele G.,USA,African American/Afro-Caribbean,African American,TRUE,1.86E-06,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,PharmGKB,1444703466,SNV,allopurinol,DB00437,Approved,"Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.","1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one",rs2231142 is assigned to Q141K in the ABCG2 gene in this study and it's associated with decreased response to allopurinol in people with Gout
rs10011796,25676789,Gout,USA,African American/Afro-Caribbean,African American,TRUE,1.99E-08,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs10011796,SNV,,,,,,rs10011796 is assigned to ABCG2 gene in this study and it's associated with suric acid change in response to allopurinol
rs2725271,25676789,Uric Acid Measurement (Procedure),USA,African American/Afro-Caribbean,African American,TRUE,1.44E-07,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs2725271,SNV,,,,,,Association results in all subjects after imputation
rs2231142,25676789,Gout,USA,African American/Afro-Caribbean,African American,TRUE,1.86E-06,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs2231142,SNV,,,,,,SNPs associating with gout in a previous meta-analysis
rs2199936,25676789,Gout,USA,African American/Afro-Caribbean,African American,TRUE,3.84E-06,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs2199936,SNV,,,,,,rs2199936 is assigned to ABCG2 and PKD2 gene in this study and it's associated with suric acid change in response to allopurinol
rs10011796,25676789,Uric Acid Measurement (Procedure),USA,African American/Afro-Caribbean,African American,TRUE,0.00069,ABCG2,GWAS,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs10011796,SNV,,,,,,The study reports on a GWA study that includes 84 African-Americans from a total cohort of 2027 with a majority of Caucasian ethnicity.
rs2231142,25676789,Uric Acid Measurement (Procedure),USA,African American/Afro-Caribbean,African American,TRUE,0.00000186,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs2231142,SNV,,,,,,"The authors observed that BCRP, the protein encoded by ABCG2, transports allopurinol and that the rs2231142 variant reduces allopurinol transport. "
rs2231142,24718721,Childhood Acute Lymphoblastic Leukemia,Egypt,North Africa,NS,FALSE,> 0.05,ABCG2,,ABCG2,ATP binding cassette subfamily G member 2 (Junior blood group),4,Q9UNQ0,"The membrane-associated protein encoded by this gene is included in the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. Alternatively referred to as a breast cancer resistance protein, this protein functions as a xenobiotic transporter which may play a major role in multi-drug resistance. It likely serves as a cellular defense mechanism in response to mitoxantrone and anthracycline exposure. Significant expression of this protein has been observed in the placenta, which may suggest a potential role for this molecule in placenta tissue. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,"High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?",24718721,2014,DisGeNET,rs2231142,SNV,,,,,,Result was not found to be statistically significant.
rs957176669,28739549,Sitosterolemia,Tunisia,North Africa,NS,FALSE,NS,ABCG8,,ABCG8,ATP binding cassette subfamily G member 8,2,Q9H221,"The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. The protein encoded by this gene functions to exclude non-cholesterol sterol entry at the intestinal level, promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into the intestinal lumen. It is expressed in a tissue-specific manner in the liver, intestine, and gallbladder. This gene is tandemly arrayed on chromosome 2, in a head-to-head orientation with family member ABCG5. Mutations in this gene may contribute to sterol accumulation and atherosclerosis, and have been observed in patients with sitosterolemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the ABCG8 gene are associated with sitosterolaemia in the homozygous form and xanthelasmas in the heterozygous form.,28739549,2018,DisGeNET,rs957176669,SNV,,,,,,
rs8176719,22895189,Malaria,Ghana,West Africa,NS,FALSE,1.10E-20,ABO,Association,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Genome-wide association study indicates two novel resistance loci for severe malaria.,22895189,2012,DisGeNET,rs8176719,SNV,,,,,,"OR=1,73 in Combined Ghanaian groups (Dominant model)."
rs8176703,22895189,Malaria,Ghana,West Africa,NS,FALSE,4.00E-12,ABO,Association,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Genome-wide association study indicates two novel resistance loci for severe malaria.,22895189,2012,DisGeNET,rs8176703,SNV,,,,,,"OR=1,73 in Combined Ghanaian groups (Dominant model)."
rs8176693,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,5.00E-08,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176693,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs8176722,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,5.00E-08,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176722,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs8176743,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,5.00E-08,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176743,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs8176746,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,5.00E-08,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176746,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs8176749,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,5.00E-08,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176749,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs8176751,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,5.00E-08,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176751,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs505922,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 5E-8,ABO,,ABO,"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase",9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs505922,SNV,,,,,,compelling evidence of association with malaria susceptibility
rs8176672,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-6,ABO,,ABO,alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase,9,P16442,"This gene encodes proteins related to the first discovered blood group system, ABO. Variation in the ABO gene (chromosome 9q34.2) is the basis of the ABO blood group, thus the presence of an allele determines the blood group in an individual. The 'O' blood group is caused by a deletion of guanine-258 near the N-terminus of the protein which results in a frameshift and translation of an almost entirely different protein. Individuals with the A, B, and AB alleles express glycosyltransferase activities that convert the H antigen into the A or B antigen. Other minor alleles have been found for this gene. This locus has been identified as a susceptibility locus for severe coronavirus disease 2019 (COVID-19) by genome-wide association study. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs8176672,SNV,,,,,,
rs4359,17885551,Genotypes CC + TT are associated with increased response to ramipril in people with Hypertension as compared to genotype CT.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,ACE,,ACE,angiotensin I converting enzyme,17,P12821,"This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020].",22/11/2021,PubMed,Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.,17885551,2008,PharmGKB,982048078,SNV,ramipril,DB00178,Approved,"For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.","(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid",rs4359 is assigned to C17888T in the ACE gene in this study and it's associated with increased response to ramipril in people with Hypertension
rs4344,17885551,Genotypes AA + GG are associated with increased response to ramipril in people with Hypertension as compared to genotype AG.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,ACE,,ACE,angiotensin I converting enzyme,17,P12821,"This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020].",22/11/2021,PubMed,Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.,17885551,2008,PharmGKB,982048062,SNV,ramipril,DB00178,Approved,"For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.","(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid",rs4344 is assigned to G12269A in the ACE gene in this study and it's associated with increased response to ramipril in people with Hypertension
rs4363,17885551,Genotypes AA + AG are not associated with increased response to ramipril in people with Hypertension as compared to genotype GG.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ACE,,ACE,angiotensin I converting enzyme,17,P12821,"This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020].",22/11/2021,PubMed,Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.,17885551,2008,PharmGKB,982048083,SNV,ramipril,DB00178,Approved,"For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.","(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid",rs4363 is assigned to G20037A in the ACE gene in this study and not associated with increased response to ramipril in people with Hypertension
rs2814778,21507922,Neutrophil Count (Procedure),South Africa,South Africa,NS,TRUE,7.90E-11,ACKR1,,ACKR1,atypical chemokine receptor 1 (Duffy blood group),1,Q16570,"The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women.,21507922,2011,DisGeNET,rs2814778,SNV,,,,,,
rs2814778,10570183,White Blood Cell Count Quantitative Trait Locus 1,USA,African American/Afro-Caribbean,African American,TRUE,< 0.05,ACKR1,,ACKR1,atypical chemokine receptor 1 (Duffy blood group),1,Q16570,"The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea.,10570183,1999,DisGeNET,rs2814778,SNV,,,,,,
rs2814778,18621010,White Blood Cell Count Quantitative Trait Locus 1,USA,African American/Afro-Caribbean,African American,TRUE,< 0.05,ACKR1,,ACKR1,atypical chemokine receptor 1 (Duffy blood group),1,Q16570,"The protein encoded by this gene is a glycosylated membrane protein and a non-specific receptor for several chemokines. The encoded protein is the receptor for the human malarial parasites Plasmodium vivax and Plasmodium knowlesi. Polymorphisms in this gene are the basis of the Duffy blood group system. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility.,18621010,2008,DisGeNET,rs2814778,SNV,,,,,,
rs61732239,8589684,Pancreatic Ductal Adenocarcinoma,Somali,East Africa,NS,FALSE,NS,ADA,,ADA,adenosine deaminase,20,P00813,"This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.,8589684,1995,DisGeNET,rs61732239,SNV,,,,,,
rs780014431,8589684,Severe Combined Immunodeficiency,Somali,East Africa,NS,FALSE,NS,ADA,,ADA,adenosine deaminase,20,P00813,"This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.,8589684,1995,DisGeNET,rs780014431,SNV,,,,,,
rs786205151,25091951,Cone-Rod Dystrophy 9,Egypt,North Africa,NS,FALSE,NS,ADAM9,,ADAM9,ADAM metallopeptidase domain 9,8,Q13443,"This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The protein encoded by this gene interacts with SH3 domain-containing proteins, binds mitotic arrest deficient 2 beta protein, and is also involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. Several alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Jul 2010].",22/11/2021,PubMed,Novel ADAM9 homozygous mutation in a consanguineous Egyptian family with severe cone-rod dystrophy and cataract.,25091951,2015,DisGeNET,rs786205151,SNV,,,,,,
rs373533,24934404,Hyperpyrexia,Cameroon,West Africa,NS,FALSE,0.003,ADGRE1,Association,ADGRE1,adhesion G protein-coupled receptor E1,19,Q14246,"This gene encodes a protein that has a domain resembling seven transmembrane G protein-coupled hormone receptors (7TM receptors) at its C-terminus. The N-terminus of the encoded protein has six EGF-like modules, separated from the transmembrane segments by a serine/threonine-rich domain, a feature reminiscent of mucin-like, single-span, integral membrane glycoproteins with adhesive properties. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012].",22/11/2021,PubMed,Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.,24934404,2015,DisGeNET,rs373533,SNV,,,,,,"A total of 971 cases and 891 controls were enrolled into the study. Study involved malaria diagnosed children (aged 1 month to 13 years) admitted in nine health facilities in the Centre, Littoral and South West regions of Cameroon."
rs461645,24934404,Hyperpyrexia,Cameroon,West Africa,NS,FALSE,0.008,ADGRE1,Association,ADGRE1,adhesion G protein-coupled receptor E1,19,Q14246,"This gene encodes a protein that has a domain resembling seven transmembrane G protein-coupled hormone receptors (7TM receptors) at its C-terminus. The N-terminus of the encoded protein has six EGF-like modules, separated from the transmembrane segments by a serine/threonine-rich domain, a feature reminiscent of mucin-like, single-span, integral membrane glycoproteins with adhesive properties. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012].",22/11/2021,PubMed,Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.,24934404,2015,DisGeNET,rs461645,SNV,,,,,,"A total of 971 cases and 891 controls were enrolled into the study. Study involved malaria diagnosed children (aged 1 month to 13 years) admitted in nine health facilities in the Centre, Littoral and South West regions of Cameroon."
rs121909763,10234513,"Usher Syndrome, Type 2C",Tunisia,North Africa,NS,FALSE,NS,ADGRV1,Linkage,ADGRV1,adhesion G protein-coupled receptor V1,5,Q8WXG9,"This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2.",10234513,1999,DisGeNET,rs121909763,SNV,,,,,,"Through linkage analysis, this study demonstrated that the gene responsible for Usher type II syndrome in a Tunisian consanguineous family maps to chromosome 3 at position p23-24.2, thus providing definitive evidence for the genetic heterogeneity of the syndrome."
rs121909763,18854872,"Usher Syndrome, Type 2C",Tunisia,North Africa,NS,FALSE,NS,ADGRV1,,ADGRV1,adhesion G protein-coupled receptor V1,5,Q8WXG9,"This gene encodes a member of the G-protein coupled receptor superfamily. The encoded protein contains a 7-transmembrane receptor domain, binds calcium and is expressed in the central nervous system. Mutations in this gene are associated with Usher syndrome 2 and familial febrile seizures. Several alternatively spliced transcripts have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family.,18854872,2009,DisGeNET,rs121909763,SNV,,,,,,"Linkage analysis disclosed the cosegregation of the USH2 phenotype with the USH2C locus markers, D5S428 and D5S618, whereas the ARRP perfectly segregates with PDE6B flanking markers D4S3360 and D4S2930."
rs822396,22497971,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.02,ADIPOQ,Association,ADIPOQ,"adiponectin, C1Q and collagen domain containing",3,Q15848,"This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010].",22/11/2021,PubMed,Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs.,22497971,2012,DisGeNET,rs822396,SNV,,,,,,Associated with T2DM under the dominant models only.
rs1063538,22497971,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.026,ADIPOQ,Association,ADIPOQ,"adiponectin, C1Q and collagen domain containing",3,Q15848,"This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010].",22/11/2021,PubMed,Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs.,22497971,2012,DisGeNET,rs1063538,SNV,,,,,,The study includes 917 patients and 748 normoglycemic control. The p-value reports on the difference of the CFH 402H allele frequency between the patient and control groups.
rs2241766,22497971,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,NS,ADIPOQ,Association,ADIPOQ,"adiponectin, C1Q and collagen domain containing",3,Q15848,"This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010].",22/11/2021,PubMed,Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs.,22497971,2012,DisGeNET,rs2241766,SNV,,,,,,The study includes 917 patients and 748 normoglycemic control. Associated with T2DM under the dominant models only.
rs2241767,22497971,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,NS,ADIPOQ,Association,ADIPOQ,"adiponectin, C1Q and collagen domain containing",3,Q15848,"This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010].",22/11/2021,PubMed,Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs.,22497971,2012,DisGeNET,rs2241767,SNV,,,,,,"rs2241767 did not associate significantly with T2DM under any of the genetic models tested, but showed lower magnitude of effect and in the same direction, after adjusting for covariates under the dominant mode."
rs1801252,18797399,"Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",USA,African American/Afro-Caribbean,African American,FALSE,0.134,ADRB1,,ADRB1,adrenoceptor beta 1,10,P08588,"The adrenergic receptors (subtypes alpha 1, alpha 2, beta 1, and beta 2) are a prototypic family of guanine nucleotide binding regulatory protein-coupled receptors that mediate the physiological effects of the hormone epinephrine and the neurotransmitter norepinephrine. Beta-1 adrenoceptors are predominately located in the heart. Specific polymorphisms in this gene have been shown to affect the resting heart rate and can be involved in heart failure. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.,18797399,2008,PharmGKB,1184749202,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",
rs1801253,18797399,"Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",USA,African American/Afro-Caribbean,African American,FALSE,> 0.1,ADRB1,,ADRB1,adrenoceptor beta 1,10,P08588,"The adrenergic receptors (subtypes alpha 1, alpha 2, beta 1, and beta 2) are a prototypic family of guanine nucleotide binding regulatory protein-coupled receptors that mediate the physiological effects of the hormone epinephrine and the neurotransmitter norepinephrine. Beta-1 adrenoceptors are predominately located in the heart. Specific polymorphisms in this gene have been shown to affect the resting heart rate and can be involved in heart failure. [provided by RefSeq, Sep 2019].",22/11/2021,PubMed,Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.,18797399,2008,PharmGKB,1184749213,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",
rs2053044,26111150,Genotypes AA + AG is associated with increased response to ramipril in people with Hypertension as compared to genotype GG.,USA,African American/Afro-Caribbean,NS,FALSE,0.01,ADRB2,,ADRB2,adrenoceptor beta 2,5,P07550,"This gene encodes beta-2-adrenergic receptor which is a member of the G protein-coupled receptor superfamily. This receptor is directly associated with one of its ultimate effectors, the class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A. The assembly of the signaling complex provides a mechanism that ensures specific and rapid signaling by this G protein-coupled receptor. This receptor is also a transcription regulator of the alpha-synuclein gene, and together, both genes are believed to be associated with risk of Parkinson's Disease. This gene is intronless. Different polymorphic forms, point mutations, and/or downregulation of this gene are associated with nocturnal asthma, obesity, type 2 diabetes and cardiovascular disease. [provided by RefSeq, Oct 2019].",22/11/2021,PubMed,Association of the ADRB2 (rs2053044) polymorphism and angiotensin-converting enzyme-inhibitor blood pressure response in the African American Study of Kidney Disease and Hypertension.,26111150,2016,PharmGKB,1444929453,SNV,ramipril,DB00178,Approved,"For the management of mild to severe hypertension. May be used to reduce cardiovascular mortality following myocardial infarction in hemodynamically stable individuals who develop clinical signs of congestive heart failure within a few days following myocardial infarction. To reduce the rate of death, myocardial infarction and stroke in individuals at high risk of cardiovascular events. May be used to slow the progression of renal disease in individuals with hypertension, diabetes mellitus and microalubinuria or overt nephropathy.","(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid",rs2053044 is assigned to ADRB2 gene in this study and it's associated with increased response to ramipril in African-American with Hypertension
rs386833435,8830180,Aspartylglucosaminuria,Mauritius,South Africa,NS,FALSE,NS,AGA,,AGA,aspartylglucosaminidase,4,P20933,"This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015].",22/11/2021,PubMed,Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin.,8830180,2001,DisGeNET,rs386833435,SNV,,,,,,
rs386833437,8830180,Aspartylglucosaminuria,Mauritius,South Africa,NS,FALSE,NS,AGA,,AGA,aspartylglucosaminidase,4,P20933,"This gene encodes a member of the N-terminal nucleophile (Ntn) hydrolase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta chains that comprise the mature enzyme. This enzyme is involved in the catabolism of N-linked oligosaccharides of glycoproteins. It cleaves asparagine from N-acetylglucosamines as one of the final steps in the lysosomal breakdown of glycoproteins. Mutations in this gene are associated with the lysosomal storage disease aspartylglycosaminuria that results in progressive neurodegeneration. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is subject to proteolytic processing. [provided by RefSeq, Nov 2015].",22/11/2021,PubMed,Single base deletion in exon 7 of the glycosylasparaginase gene causes a mild form of aspartylglycosaminuria in a patient of Mauritian origin.,8830180,2001,DisGeNET,rs386833437,SNV,,,,,,
rs771069887,22035446,Glycogen Storage Disease Iiia,Tunisia,North Africa,NS,FALSE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A c.3216_3217delGA mutation in AGL gene in Tunisian patients with a glycogen storage disease type III: evidence of a founder effect.,22035446,2013,DisGeNET,rs771069887,SNV,,,,,,
rs786204616,19754354,Glycogen Storage Disease Type Iii,Egypt,North Africa,NS,FALSE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.",19754354,2009,DisGeNET,rs786204616,SNV,,,,,,
rs267606640,23207808,Glycogen Storage Disease Type Iii,Tunisia,North Africa,NS,FALSE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia.,23207808,2013,DisGeNET,rs267606640,SNV,,,,,,Aimed to determine the frequency of variant among Tunisian patients.
rs369973784,22089644,Glycogen Storage Disease Type Iii,Tunisia,North Africa,NS,FALSE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III.,22089644,2012,DisGeNET,rs369973784,SNV,,,,,,
rs776977863,22089644,Glycogen Storage Disease Type Iii,Tunisia,North Africa,NS,FALSE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular and biochemical characterization of Tunisian patients with glycogen storage disease type III.,22089644,2012,DisGeNET,rs776977863,SNV,,,,,,
rs370792293,12442284,Glycogen Storage Disease Type Iii,Tunisia,North Africa,NS,FALSE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.,12442284,2002,DisGeNET,rs370792293,SNV,,,,,,"The aim of this study was the molecular characterisation of eight unrelated patients from an ethnically heterogeneous population (six Italians, one from India and another one from Tunisia)."
rs267606640,12442284,Glycogen Storage Disease Type Iii,"Tunisia, Italy, India",North Africa,NS,TRUE,NS,AGL,,AGL,"amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase",1,P35573,"This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular characterisation of GSD III subjects and identification of six novel mutations in AGL.,12442284,2002,DisGeNET,rs267606640,SNV,,,,,,"The aim of this study was the molecular characterisation of eight unrelated patients from an ethnically heterogeneous population (six Italians, one from India and another one from Tunisia)."
rs121908525,24012869,"Primary Hyperoxaluria, Type I",Tunisia,North Africa,NS,FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A double mutation in AGXT gene in families with primary hyperoxaluria type 1.,24012869,2013,DisGeNET,rs121908525,SNV,,,,,,"Results from this study provide evidence regarding the potential involvement of c.32C>T (Pro11Leu), originally described as common polymorphism, on the resulting phenotype."
rs34116584,24012869,"Primary Hyperoxaluria, Type I",Tunisia,North Africa,NS,FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A double mutation in AGXT gene in families with primary hyperoxaluria type 1.,24012869,2013,DisGeNET,rs34116584,SNV,,,,,,"Results from this study provide evidence regarding the potential involvement of c.32C>T (Pro11Leu), originally described as common polymorphism, on the resulting phenotype."
rs121908525,26383609,"Primary Hyperoxaluria, Type I",Morocco,North Africa,Arab,FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,AGXT Gene Mutations and Prevalence of Primary Hyperoxaluria Type 1 in Moroccan Population.,26383609,2016,DisGeNET,rs121908525,SNV,,,,,,PH1 is one of the most prevalent genetic diseases in the Moroccon population and is probably underdiagnosed. The prevalence of the PH1 mutation among Moroccons was then estimated to range from 1/7267 to 1/6264.
rs121908530,23810941,"Primary Hyperoxaluria, Type I",Tunisia,North Africa,"Maghrebian,Arab",FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.,23810941,2013,DisGeNET,rs121908530,SNV,,,,,,Confirmation of the relationship between the mutational heterogeneity and Primary hyperoxaluria type 1 (PH1).
rs180177239,23810941,"Primary Hyperoxaluria, Type I",Tunisia,North Africa,"Maghrebian,Arab",FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.,23810941,2013,DisGeNET,rs180177239,SNV,,,,,,Confirmation of the relationship between the mutational heterogeneity and Primary hyperoxaluria type 1 (PH1).
rs121908524,21612638,"Primary Hyperoxaluria, Type I",Tunisia,North Africa,NS,FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.,21612638,2011,DisGeNET,rs121908524,SNV,,,,,,I244T and 33_34insC presented 28.2% of identified mutations causing disease in our cohort.
rs121908525,21612638,"Primary Hyperoxaluria, Type I",Tunisia,North Africa,NS,FALSE,NS,AGXT,Genetic variability study,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Selected AGXT gene mutations analysis provides a genetic diagnosis in 28% of Tunisian patients with primary hyperoxaluria.,21612638,2011,DisGeNET,rs121908525,SNV,,,,,,I244T and 33_34insC presented 28.2% of identified mutations causing disease in our cohort.
rs796052061,12559847,"Primary Hyperoxaluria, Type I",South Africa,South Africa,NS,FALSE,NS,AGXT,,AGXT,alanine--glyoxylate and serine--pyruvate aminotransferase,2,P21549,"This gene is expressed only in the liver and the encoded protein is localized mostly in the peroxisomes, where it is involved in glyoxylate detoxification. Mutations in this gene, some of which alter subcellular targetting, have been associated with type I primary hyperoxaluria. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"The AGT gene in Africa: a distinctive minor allele haplotype, a polymorphism (V326I), and a novel PH1 mutation (A112D) in Black Africans.",12559847,2003,DisGeNET,rs796052061,SNV,,,,,,
rs121434256,16166780,Polyglandular Type I Autoimmune Syndrome,Egypt,North Africa,NS,FALSE,NS,AIRE,Genetic variability study,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy presenting with severe keratopathy in an Egyptian patient with a homozygous R139X mutation.,16166780,2005,DisGeNET,rs121434256,SNV,,,,,,The R139X has been found at homozygous state in an Egyptian patient with an unusual presentation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and severe keratopathy. 
rs121434254,11524733,Polyglandular Type I Autoimmune Syndrome,"Egypt, Europe",North Africa,NS,TRUE,0,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs121434254,SNV,,,,,,
rs179363877,11524733,"Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant","Egypt, Europe",North Africa,NS,TRUE,0.00000065,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs179363877,SNV,,,,,,
rs179363877,11524733,"Polyglandular Deficiency Syndrome, Persian-Jewish Type","Egypt, Europe",North Africa,NS,TRUE,0.00000065,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs179363877,SNV,,,,,,
rs179363877,11524733,Polyglandular Type I Autoimmune Syndrome,"Egypt, Europe",North Africa,NS,TRUE,0.00000065,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs179363877,SNV,,,,,,
rs179363880,11524733,"Autoimmune Polyendocrinopathy Syndrome, Type I, Autosomal Dominant","Egypt, Europe",North Africa,NS,TRUE,0.00000065,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs179363880,SNV,,,,,,
rs179363880,11524733,"Polyglandular Deficiency Syndrome, Persian-Jewish Type","Egypt, Europe",North Africa,NS,TRUE,0.00000065,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs179363880,SNV,,,,,,
rs179363880,11524733,Polyglandular Type I Autoimmune Syndrome,"Egypt, Europe",North Africa,NS,TRUE,0.00000065,AIRE,,AIRE,autoimmune regulator,21,O43918,"This gene encodes a transcriptional regulator that forms nuclear bodies and interacts with the transcriptional coactivator CREB binding protein. The encoded protein plays an important role in immunity by regulating the expression of autoantigens and negative selection of autoreactive T-cells in the thymus. Mutations in this gene cause the rare autosomal-recessive systemic autoimmune disease termed autoimmune polyendocrinopathy with candidiasis and ectodermal dystrophy (APECED). [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,Novel AIRE mutations and P450 cytochrome autoantibodies in Central and Eastern European patients with APECED.,11524733,2001,DisGeNET,rs179363880,SNV,,,,,,
rs767350733,12601111,"Genetic Diseases, Inborn","Algeria, Libya",North Africa,NS,TRUE,NS,ALS2,,ALS2,alsin Rho guanine nucleotide exchange factor ALS2,2,Q96Q42,"The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families.,12601111,2004,DisGeNET,rs767350733,SNV,,,,,,
rs386834170,17285242,Megaloblastic Anemia Due To Inborn Errors Of Metabolism,Tunisia,North Africa,NS,FALSE,NS,AMN,,AMN,amnion associated transmembrane protein,14,Q9BXJ7,"The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of megaloblastic anaemia type 1 in Tunisian patients.,17285242,2007,DisGeNET,rs386834170,SNV,,,,,,
rs2445365,28045923,Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ANGPT1,,ANGPT1,angiopoietin 1,8,Q15389,"This gene encodes a secreted glycoprotein that belongs to the angiopoietin family. Members of this family play important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The protein encoded by this gene is a secreted glycoprotein that activates the receptor by inducing its tyrosine phosphorylation. It plays a critical role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme and inhibits endothelial permeability. The protein also contributes to blood vessel maturation and stability, and may be involved in early development of the heart. Mutations in this gene are associated with hereditary angioedema. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995748,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs2445365 is assigned to ANGPT1 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs2515462,28045923,Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ANGPT2,,ANGPT2,angiopoietin 2,8,O15123,"This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995772,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs2515462 is assigned to ANGPT2 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs2515409,28045923,Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ANGPT2,,ANGPT2,angiopoietin 2,8,O15123,"This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995758,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs2515409 is assigned to ANGPT2 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs10102851,28045923,Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ANGPT2,,ANGPT2,angiopoietin 2,8,O15123,"This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995765,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs10102851 is assigned to ANGPT2 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs1375668,28045923,Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ANGPT2,,ANGPT2,angiopoietin 2,8,O15123,"This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995793,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs1375668 is assigned to ANGPT2 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs13269021,28045923,Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,NS,ANGPT2,,ANGPT2,angiopoietin 2,8,O15123,"This gene belongs to the angiopoietin family of growth factors. The protein encoded by this gene is an antagonist of angiopoietin 1, and both angiopoietin 1 and angiopoietin 2 are ligands for the endothelial TEK receptor tyrosine kinase. Angiopoietin 2 is upregulated in multiple inflammatory diseases and is implicated in the direct control of inflammation-related signaling pathways. The encoded protein affects angiogenesis during embryogenesis and tumorigenesis, disrupts the vascular remodeling ability of angiopoietin 1, and may induce endothelial cell apoptosis. This gene serves a prognostic biomarker for acute respiratory distress syndrome. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995786,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs13269021 is assigned to ANGPT2 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs397514701,9298746,"Growth Retardation, Alopecia, Pseudoanodontia And Optic Atrophy",Egypt,North Africa,Arab,FALSE,NS,ANTXR1,,ANTXR1,ANTXR cell adhesion molecule 1,2,Q9H6X2,"This gene encodes a type I transmembrane protein and is a tumor-specific endothelial marker that has been implicated in colorectal cancer. The encoded protein has been shown to also be a docking protein or receptor for Bacillus anthracis toxin, the causative agent of the disease, anthrax. The binding of the protective antigen (PA) component, of the tripartite anthrax toxin, to this receptor protein mediates delivery of toxin components to the cytosol of cells. Once inside the cell, the other two components of anthrax toxin, edema factor (EF) and lethal factor (LF) disrupt normal cellular processes. Three alternatively spliced variants that encode different protein isoforms have been described. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,GAPO syndrome: first Egyptian case with ultrastructural changes in the gingiva.,9298746,1997,DisGeNET,rs397514701,SNV,,,,,,
rs75995567,27798726,One SNP was associated with a higher xanthine oxidase inhibitors dose.,USA,African American/Afro-Caribbean,African American,TRUE,0.031,AOX1,,AOX1,aldehyde oxidase 1 ,2,Q06278,"Aldehyde oxidase produces hydrogen peroxide and, under certain conditions, can catalyze the formation of superoxide. Aldehyde oxidase is a candidate gene for amyotrophic lateral sclerosis. ",22/11/2021,PubMed,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.,27798726,2017,PharmGKB,TBD,SNV,allopurinol,DB00437,Approved,"Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.","1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one",
rs11678615,27798726,rs11678615 associated with 300 mg daily of allopurinol.,USA,African American/Afro-Caribbean,African American,TRUE,0.022,AOX1,,AOX1,aldehyde oxidase 1 ,2,Q06278,"Aldehyde oxidase produces hydrogen peroxide and, under certain conditions, can catalyze the formation of superoxide. Aldehyde oxidase is a candidate gene for amyotrophic lateral sclerosis. ",22/11/2021,PubMed,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.,27798726,2017,PharmGKB,TBD,SNV,allopurinol,DB00437,Approved,"Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.","1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one",
rs3731722,27798726,rs3731722 associated with 300 mg daily of allopurinol.,USA,African American/Afro-Caribbean,African American,TRUE,0.001,AOX1,,AOX1,aldehyde oxidase 1 ,2,Q06278,"Aldehyde oxidase produces hydrogen peroxide and, under certain conditions, can catalyze the formation of superoxide. Aldehyde oxidase is a candidate gene for amyotrophic lateral sclerosis. ",22/11/2021,PubMed,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.,27798726,2017,PharmGKB,TBD,SNV,allopurinol,DB00437,Approved,"Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.","1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one",
rs75995567,27798726,One SNP was associated with a higher xanthine oxidase inhibitors dose.,USA,African American/Afro-Caribbean,African American,TRUE,0.031,AOX1,,AOX1,aldehyde oxidase 1 ,2,Q06278,"Aldehyde oxidase produces hydrogen peroxide and, under certain conditions, can catalyze the formation of superoxide. Aldehyde oxidase is a candidate gene for amyotrophic lateral sclerosis. ",22/11/2021,PubMed,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.,27798726,2017,PharmGKB,TBD,SNV,febuxostat,DB04854,Approved,"Febuxostat is indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable.13 It is not recommended for the treatment of asymptomatic hyperuricemia 10 or secondary hyperuricemia.","2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid",
rs556450190,26544806,Stuttering,Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs556450190,SNV,,,,,,SNP not found in the specified article
rs760021635,26544806,Stuttering,Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs760021635,SNV,,,,,,SNP not found in the specified article
rs556450190,26544806,"Stuttering, Developmental",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs556450190,SNV,,,,,,SNP not found in the specified article
rs760021635,26544806,"Stuttering, Developmental",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs760021635,SNV,,,,,,SNP not found in the specified article
rs139640763,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs139640763,SNV,,,,,,"c.3314G > A, p.Arg1105Gln (rs139640763)"
rs141278078,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs141278078,SNV,,,,,,"c.2932C > T, p.Pro978Ser (rs141278078)"
rs148499164,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs148499164,SNV,,,,,,c.613C>A p.His205Asn (rs148499164)
rs200678853,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs200678853,SNV,,,,,,c.1424C>T p.Ala475Val (rs200678853)
rs536656846,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs536656846,SNV,,,,,,c.932A>G p.Asn311Ser (rs536656846)
rs542940704,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs542940704,SNV,,,,,,SNP not found in the specified article
rs550237440,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs550237440,SNV,,,,,,SNP not found in the specified article
rs556450190,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs556450190,SNV,,,,,,SNP not found in the specified article
rs566579877,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs566579877,SNV,,,,,,SNP not found in the specified article
rs760021635,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs760021635,SNV,,,,,,SNP not found in the specified article
rs766696884,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs766696884,SNV,,,,,,SNP not found in the specified article
rs767423538,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs767423538,SNV,,,,,,SNP not found in the specified article
rs780520338,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs780520338,SNV,,,,,,SNP not found in the specified article
rs866266998,26544806,"Stuttering, Familial Persistent 1",Cameroon,Central Africa,NS,FALSE,NS,AP4E1,,AP4E1,adaptor related protein complex 4 subunit epsilon 1,15,Q9UPM8,"This gene encodes a member of the adaptor complexes large subunit protein family. These proteins are components of the heterotetrameric adaptor protein complexes, which play important roles in the secretory and endocytic pathways by mediating vesicle formation and sorting of integral membrane proteins. The encoded protein is a large subunit of adaptor protein complex-4, which is associated with both clathrin- and nonclathrin-coated vesicles. Disruption of this gene may be associated with cerebral palsy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011].",22/11/2021,PubMed,"Association between Rare Variants in AP4E1, a Component of Intracellular Trafficking, and Persistent Stuttering.",26544806,2016,DisGeNET,rs866266998,SNV,,,,,,SNP not found in the specified article
rs121913329,18992635,Colorectal Neoplasms,Tunisia,North Africa,NS,FALSE,NS,APC,,APC,APC regulator of WNT signaling pathway,5,P25054,"This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,"Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer.",18992635,2008,DisGeNET,rs121913329,SNV,,,,,,Clinicopathological analyses showed an association between APC point mutations and the earliest occurrence of sporadic colorectal cancer.
rs121913332,18992635,Colorectal Neoplasms,Tunisia,North Africa,NS,FALSE,NS,APC,,APC,APC regulator of WNT signaling pathway,5,P25054,"This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,"Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer.",18992635,2008,DisGeNET,rs121913332,SNV,,,,,,Clinicopathological analyses showed an association between APC point mutations and the earliest occurrence of sporadic colorectal cancer.
rs137854575,16292097,"Polyposis, Adenomatous Intestinal",Algeria,North Africa,NS,FALSE,> 0.05,APC,,APC,APC regulator of WNT signaling pathway,5,P25054,"This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. ",22/11/2021,PubMed,An unexpected Cowden syndrome case found among members of a large familial adenomatous polyposis kindred.,16292097,2005,DisGeNET,rs137854575,SNV,,,,,,
rs2239785,20668430,Focal Glomerulosclerosis,USA,African American/Afro-Caribbean,African American,FALSE,< 10E−7,APOL1,,APOL1,apolipoprotein L1,22,O14791,"This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008].",22/11/2021,PubMed,A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9.,20668430,2011,DisGeNET,rs2239785,SNV,,,,,,
rs73885319,20647424,"Focal Segmental Glomerulosclerosis 4, Susceptibility To",USA,African American/Afro-Caribbean,African American,FALSE,1.10E-39,APOL1,,APOL1,apolipoprotein L1,22,O14791,"This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008].",22/11/2021,PubMed,Association of trypanolytic ApoL1 variants with kidney disease in African Americans.,20647424,2010,DisGeNET,rs73885319,SNV,,,,,,
rs60910145,20647424,"Focal Segmental Glomerulosclerosis 4, Susceptibility To",USA,African American/Afro-Caribbean,African American,FALSE,NS,APOL1,,APOL1,apolipoprotein L1,22,O14791,"This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008].",22/11/2021,PubMed,Association of trypanolytic ApoL1 variants with kidney disease in African Americans.,20647424,2010,DisGeNET,rs60910145,SNV,,,,,,
rs71785313,20647424,"Focal Segmental Glomerulosclerosis 4, Susceptibility To",USA,African American/Afro-Caribbean,African American,FALSE,NS,APOL1,,APOL1,apolipoprotein L1,22,O14791,"This gene encodes a secreted high density lipoprotein which binds to apolipoprotein A-I. Apolipoprotein A-I is a relatively abundant plasma protein and is the major apoprotein of HDL. It is involved in the formation of most cholesteryl esters in plasma and also promotes efflux of cholesterol from cells. This apolipoprotein L family member may play a role in lipid exchange and transport throughout the body, as well as in reverse cholesterol transport from peripheral cells to the liver. Several different transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008].",22/11/2021,PubMed,Association of trypanolytic ApoL1 variants with kidney disease in African Americans.,20647424,2010,DisGeNET,rs71785313,SNV,,,,,,
rs10490924,23362846,Age Related Macular Degeneration,Egypt,North Africa,NS,FALSE,< 0.017,ARMS2,Association,ARMS2,age-related maculopathy susceptibility 2,10,P0C7Q2,"This gene encodes a small secreted protein specific to primates. This protein is a component of the choroidal extracellular matrix of the eye. Mutations in this gene are associated with age-related macular degeneration. [provided by RefSeq, Sep 2017].",22/11/2021,PubMed,"Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients.",23362846,2014,DisGeNET,rs10490924,SNV,,,,,,The OR for the TG genotype was 4.667 (95% CI: 1.2-18.4) and for combined TG + TT genotypes was 7 (95% CI: 1.8-26.5). The study includes 26 Age-related macular degeneration patients and 20 controls.
rs1061170,23362846,Age Related Macular Degeneration,Egypt,North Africa,NS,FALSE,< 0.017,ARMS2,Association,ARMS2,age-related maculopathy susceptibility 2,10,P0C7Q2,"This gene encodes a small secreted protein specific to primates. This protein is a component of the choroidal extracellular matrix of the eye. Mutations in this gene are associated with age-related macular degeneration. [provided by RefSeq, Sep 2017].",22/11/2021,PubMed,"Association of single nucleotide polymorphisms in CFH, ARMS2 and HTRA1 genes with risk of age-related macular degeneration in Egyptian patients.",23362846,2014,DisGeNET,rs1061170,SNV,,,,,,The odds ratio (OR) for the TC genotype was 5.5 (95% CI: 1.1-26.4) and for combined TC + CC  enotypes was 8 (95% CI: 1.7-37.1). The study includes 26 Age-related macular degeneration patients and 20 controls.
rs368345612,28905881,Keloid,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,ASAH1,,ASAH1,N-acylsphingosine amidohydrolase 1,8,Q13510,"This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015].",22/11/2021,PubMed,Identification of ASAH1 as a susceptibility gene for familial keloids.,28905881,2017,DisGeNET,rs368345612,SNV,,,,,,"Had a CADD score of 28.1 and was predicted damaging by LRT, MetaLR/MetaSVM from dbNSFP, MutationAssessor, MutationTaster, Polyphen-2, PROVEAN and SIFT."
rs12405994,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,8.20E-07,ASB17,,ASB17,ankyrin repeat and SOCS box containing 17,1,Q8WXJ9,Predicted to be involved in intracellular signal transduction and protein ubiquitination. Predicted to be located in cytosol.,22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs12405994,SNV,,,,,,
rs765530357,19332161,"Genetic Diseases, Inborn",Algeria,North Africa,NS,FALSE,NS,ASPM,,ASPM,assembly factor for spindle microtubules,1,Q8IZT6,"This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011].",22/11/2021,PubMed,Compound heterozygous ASPM mutations associated with microcephaly and simplified cortical gyration in a consanguineous Algerian family.,19332161,2009,DisGeNET,rs765530357,SNV,,,,,,this rs is described as c.7781_7782delAG  in exon 18 which would cause a frameshift followed by a premature termination codon (p.Gln2594fsX6).
rs145489194,19332161,"Microcephaly, Primary Autosomal Recessive, 5",Algeria,North Africa,NS,FALSE,NS,ASPM,,ASPM,assembly factor for spindle microtubules,1,Q8IZT6,"This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011].",22/11/2021,PubMed,Compound heterozygous ASPM mutations associated with microcephaly and simplified cortical gyration in a consanguineous Algerian family.,19332161,2009,DisGeNET,rs145489194,SNV,,,,,,This rs is described as nonsense mutation (c.2389C > T [p.Arg797X]);
rs121908641,11708871,Citrullinemia,Morocco,North Africa,NS,FALSE,NS,ASS1,"Genetic variability study,Functional Analysis",ASS1,argininosuccinate synthase 1,9,P00966,"The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012].",22/11/2021,PubMed,Phenotype and genotype heterogeneity in Mediterranean citrullinemia.,11708871,2002,DisGeNET,rs121908641,SNV,,,,,,Phenotype variability and genetic heterogeneity are common in classical citrullinemia in Mediterranean patients.
rs35269064,11708871,Citrullinemia,Morocco,North Africa,NS,FALSE,NS,ASS1,"Genetic variability study,Functional Analysis",ASS1,argininosuccinate synthase 1,9,P00966,"The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012].",22/11/2021,PubMed,Phenotype and genotype heterogeneity in Mediterranean citrullinemia.,11708871,2002,DisGeNET,rs35269064,SNV,,,,,,Phenotype variability and genetic heterogeneity are common in classical citrullinemia in Mediterranean patients.
rs771594651,11708871,Citrullinemia,Morocco,North Africa,NS,FALSE,NS,ASS1,"Genetic variability study,Functional Analysis",ASS1,argininosuccinate synthase 1,9,P00966,"The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012].",22/11/2021,PubMed,Phenotype and genotype heterogeneity in Mediterranean citrullinemia.,11708871,2002,DisGeNET,rs771594651,SNV,,,,,,Phenotype variability and genetic heterogeneity are common in classical citrullinemia in Mediterranean patients.
rs775163147,11708871,Citrullinemia,Morocco,North Africa,NS,FALSE,NS,ASS1,"Genetic variability study,Functional Analysis",ASS1,argininosuccinate synthase 1,9,P00966,"The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012].",22/11/2021,PubMed,Phenotype and genotype heterogeneity in Mediterranean citrullinemia.,11708871,2002,DisGeNET,rs775163147,SNV,,,,,,Phenotype variability and genetic heterogeneity are common in classical citrullinemia in Mediterranean patients.
rs55861249,8968760,Ataxia Telangiectasia,"Morocco, Tunisia",North Africa,NS,TRUE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Ataxia-telangiectasia: founder effect among north African Jews.,8968760,1996,DisGeNET,rs55861249,SNV,,,,,,
rs55861249,8968760,"Neoplastic Syndromes, Hereditary","Morocco, Tunisia",North Africa,NS,TRUE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Ataxia-telangiectasia: founder effect among north African Jews.,8968760,1996,DisGeNET,rs55861249,SNV,,,,,,
rs587781347,23322442,Ataxia Telangiectasia,Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs587781347,SNV,,,,,,
rs587781558,23322442,Ataxia Telangiectasia,Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs587781558,SNV,,,,,,
rs770641163,23322442,Ataxia Telangiectasia,Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs770641163,SNV,,,,,,
rs786204433,23322442,Ataxia Telangiectasia,Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs786204433,SNV,,,,,,
rs55861249,23322442,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs55861249,SNV,,,,,,
rs587781558,23322442,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs587781558,SNV,,,,,,
rs770641163,23322442,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs770641163,SNV,,,,,,
rs775036118,23322442,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs775036118,SNV,,,,,,
rs786204433,23322442,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,ATM,,ATM,ATM serine/threonine kinase,11,Q13315,"The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Molecular defects in Moroccan patients with ataxia-telangiectasia.,23322442,2014,DisGeNET,rs786204433,SNV,,,,,,
rs10900585,22895189,Malaria,Ghana,West Africa,NS,FALSE,6.10E-09,ATP2B4,Association,ATP2B4,ATPase plasma membrane Ca2+ transporting 4,1,P23634,"The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide association study indicates two novel resistance loci for severe malaria.,22895189,2012,DisGeNET,rs10900585,SNV,,,,,,SNP rs10900585 showed the strongest association in the joint Ghanaian study groups (odds ratio (OR) =0.65) (recessive model).
rs4951074,22895189,Malaria,Ghana,West Africa,NS,FALSE,3.80E-08,ATP2B4,Association,ATP2B4,ATPase plasma membrane Ca2+ transporting 4,1,P23634,"The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide association study indicates two novel resistance loci for severe malaria.,22895189,2012,DisGeNET,rs4951074,SNV,,,,,,OR=0.62 in Combined Ghanaian groups (Recessive model).
rs1057517233,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs1057517233,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs193922107,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs193922107,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs193922109,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs193922109,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs60431989,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs60431989,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs72552285,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs72552285,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs755709270,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs755709270,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs758355520,18483695,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,Genetic variability study,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Mutational analysis of ATP7B gene in Egyptian children with Wilson disease: 12 novel mutations.,18483695,2008,DisGeNET,rs758355520,SNV,,,,,,P1273L Pathogenic mutation identified in Egyptian children with Wilson disease. Pathogenic/likely pathogenic mutation identified in Egyptian children with Wilson disease. The study consisted of 48 children with Wilson disease from 32 independent families.
rs137853284,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs137853284,SNV,,,,,,SNP not found in the specified article
rs193922109,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs193922109,SNV,,,,,,SNP not found in the specified article
rs28942075,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs28942075,SNV,,,,,,SNP not found in the specified article
rs587783309,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs587783309,SNV,,,,,,SNP not found in the specified article
rs72552255,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs72552255,SNV,,,,,,SNP not found in the specified article
rs72552285,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs72552285,SNV,,,,,,SNP not found in the specified article
rs755709270,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs755709270,SNV,,,,,,SNP not found in the specified article
rs758355520,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs758355520,SNV,,,,,,SNP not found in the specified article
rs76151636,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs76151636,SNV,,,,,,SNP not found in the specified article
rs767218895,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs767218895,SNV,,,,,,SNP not found in the specified article
rs779494870,21682854,Hepatolenticular Degeneration,Egypt,North Africa,NS,FALSE,NS,ATP7B,,ATP7B,ATPase copper transporting beta,13,P35670,"This gene is a member of the P-type cation transport ATPase family and encodes a protein with several membrane-spanning domains, an ATPase consensus sequence, a hinge domain, a phosphorylation site, and at least 2 putative copper-binding sites. This protein is a monomer, and functions as a copper-transporting ATPase which exports copper out of the cells, such as the efflux of hepatic copper into the bile. Alternate transcriptional splice variants, encoding different isoforms with distinct cellular localizations, have been characterized. Mutations in this gene have been associated with Wilson disease which is characterized by copper accumulation. [provided by RefSeq, Dec 2019].",22/11/2021,PubMed,Phenotypic and genetic characterization of a cohort of pediatric Wilson disease patients.,21682854,2011,DisGeNET,rs779494870,SNV,,,,,,SNP not found in the specified article
rs786204444,23432027,Bardet-Biedl Syndrome,Tunisia,North Africa,NS,FALSE,NS,BBS1,,BBS1,Bardet-Biedl syndrome 1,11,Q8NFJ9,"Mutations in this gene have been observed in patients with the major form (type 1) of Bardet-Biedl syndrome. The encoded protein may play a role in eye, limb, cardiac and reproductive system development. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical and genetic characterization of Bardet-Biedl syndrome in Tunisia: defining a strategy for molecular diagnosis.,23432027,2015,DisGeNET,rs786204444,SNV,,,,,,
rs113624356,21642631,Bardet-Biedl Syndrome,"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,0.000000636,BBS1,,BBS1,Bardet-Biedl syndrome 1,11,Q8NFJ9,"Mutations in this gene have been observed in patients with the major form (type 1) of Bardet-Biedl syndrome. The encoded protein may play a role in eye, limb, cardiac and reproductive system development. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs113624356,SNV,,,,,,
rs121917777,21642631,Bardet-Biedl Syndrome,"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,< 0.05,BBS1,,BBS1,Bardet-Biedl syndrome 1,11,Q8NFJ9,"Mutations in this gene have been observed in patients with the major form (type 1) of Bardet-Biedl syndrome. The encoded protein may play a role in eye, limb, cardiac and reproductive system development. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs121917777,SNV,,,,,,
rs786204671,27245532,Bardet-Biedl Syndrome,South Africa,South Africa,NS,FALSE,NS,BBS10,,BBS10,Bardet-Biedl syndrome 10,12,Q8TAM1,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Bardet Biedl syndrome in South Africa: A single founder mutation.,27245532,2017,DisGeNET,rs786204671,SNV,,,,,,Conducted in Black South Africans.
rs549625604,21642631,"Genetic Diseases, Inborn","Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,> 0.05,BBS10,,BBS10,Bardet-Biedl syndrome 10,12,Q8TAM1,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs549625604,SNV,,,,,,
rs727503818,21642631,Bardet-Biedl Syndrome 10,"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,6.82E-08,BBS10,,BBS10,Bardet-Biedl syndrome 10,12,Q8TAM1,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs727503818,SNV,,,,,,
rs768933093,21642631,Bardet-Biedl Syndrome,"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,< 0.05,BBS10,,BBS10,Bardet-Biedl syndrome 10,12,Q8TAM1,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs768933093,SNV,,,,,,
rs770556842,21642631,Bardet-Biedl Syndrome 10,"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,< 0.05,BBS10,,BBS10,Bardet-Biedl syndrome 10,12,Q8TAM1,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs770556842,SNV,,,,,,
rs778431173,21642631,"Genetic Diseases, Inborn","Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,> 0.05,BBS10,,BBS10,Bardet-Biedl syndrome 10,12,Q8TAM1,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by progressive retinal degeneration, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene is likely not a ciliary protein but rather has distant sequence homology to type II chaperonins. As a molecular chaperone, this protein may affect the folding or stability of other ciliary or basal body proteins. Inhibition of this protein's expression impairs ciliogenesis in preadipocytes. Mutations in this gene cause Bardet-Biedl syndrome type 10. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs778431173,SNV,,,,,,
rs752202089,21642631,Bardet-Biedl Syndrome,"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,0.004,BBS12,,BBS12,Bardet-Biedl syndrome 12,4,Q6ZW61,The protein encoded by this gene is part of a complex that is involved in membrane trafficking. The encoded protein is a molecular chaperone that aids in protein folding upon ATP hydrolysis. This protein also plays a role in adipocyte differentiation. Defects in this gene are a cause of Bardet-Biedl syndrome type 12. Two transcript variants encoding the same protein have been found for this gene. ,22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs752202089,SNV,,,,,,
rs121908179,25541840,Bardet-Biedl Syndrome,Morocco,North Africa,NS,TRUE,NS,BBS2,Genetic variability study,BBS2,Bardet-Biedl syndrome 2,16,Q9BXC9,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014].",22/11/2021,PubMed,Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.,25541840,2015,DisGeNET,rs121908179,SNV,,,,,,"Identified 4 BBS2 missense mutations that cause nonsyndromic retinitis pigmentosa. Three siblings of Moroccon Jewish ancestry were compound heterozygotes for p.A33D and p.P134R, and 6 patients belonging to 4 families of Ashkenazi Jewish ancestry were homozygous for either p.D104A or p.R632P, or compound heterozygous for these 2 mutations. The mutations cosegregated with retinitis pigmentosa in the studied families, and the affected amino acid residues are evolutionarily conserved."
rs138043021,25541840,Bardet-Biedl Syndrome,Morocco,North Africa,NS,TRUE,NS,BBS2,Genetic variability study,BBS2,Bardet-Biedl syndrome 2,16,Q9BXC9,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014].",22/11/2021,PubMed,Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.,25541840,2015,DisGeNET,rs138043021,SNV,,,,,,"Identified 4 BBS2 missense mutations that cause nonsyndromic retinitis pigmentosa. Three siblings of Moroccon Jewish ancestry were compound heterozygotes for p.A33D and p.P134R, and 6 patients belonging to 4 families of Ashkenazi Jewish ancestry were homozygous for either p.D104A or p.R632P, or compound heterozygous for these 2 mutations. The mutations cosegregated with retinitis pigmentosa in the studied families, and the affected amino acid residues are evolutionarily conserved."
rs147030232,21642631,Bardet-Biedl Syndrome 2 (Disorder),"Tunisia, Pakistan, USA, Europe",North Africa,NS,TRUE,0.00000135,BBS2,,BBS2,Bardet-Biedl syndrome 2,16,Q9BXC9,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014].",22/11/2021,PubMed,Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.,21642631,2011,DisGeNET,rs147030232,SNV,,,,,,
rs376306240,25541840,Retinitis Pigmentosa 74,Morocco,North Africa,Jewish,FALSE,NS,BBS4,Genetic variability study,BBS4,Bardet-Biedl syndrome 4,15,Q96RK4,"This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse. The similar phenotypes exhibited by mutations in BBS gene family members are likely due to the protein's shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene has sequence similarity to O-linked N-acetylglucosamine (O-GlcNAc) transferases in plants and archaebacteria and in human forms a multi-protein 'BBSome' complex with seven other BBS proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016].",22/11/2021,PubMed,Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.,25541840,2015,DisGeNET,rs376306240,SNV,,,,,,"Identified 4 BBS2 missense mutations that cause nonsyndromic retinitis pigmentosa. Three siblings of Moroccon Jewish ancestry were compound heterozygotes for p.A33D and p.P134R, and 6 patients belonging to 4 families of Ashkenazi Jewish ancestry were homozygous for either p.D104A or p.R632P, or compound heterozygous for these 2 mutations. The mutations cosegregated with retinitis pigmentosa in the studied families, and the affected amino acid residues are evolutionarily conserved."
rs797045155,25541840,Retinitis Pigmentosa 74,Morocco,North Africa,Jewish,FALSE,NS,BBS5,Genetic variability study,BBS5,Bardet-Biedl syndrome 5,2,Q8N3I7,"This gene encodes a protein that has been directly linked to Bardet-Biedl syndrome. The primary features of this syndrome include retinal dystrophy, obesity, polydactyly, renal abnormalities and learning disabilities. Experimentation in non-human eukaryotes suggests that this gene is expressed in ciliated cells and that it is required for the formation of cilia. Alternate transcriptional splice variants have been observed but have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association between missense mutations in the BBS2 gene and nonsyndromic retinitis pigmentosa.,25541840,2015,DisGeNET,rs797045155,SNV,,,,,,"Identified 4 BBS2 missense mutations that cause nonsyndromic retinitis pigmentosa. Three siblings of Moroccon Jewish ancestry were compound heterozygotes for p.A33D and p.P134R, and 6 patients belonging to 4 families of Ashkenazi Jewish ancestry were homozygous for either p.D104A or p.R632P, or compound heterozygous for these 2 mutations. The mutations cosegregated with retinitis pigmentosa in the studied families, and the affected amino acid residues are evolutionarily conserved."
rs1427407,25372704,"Anemia, Sickle Cell",Tanzania,East Africa,NS,FALSE,3.75E-53,BCL11A,,BCL11A,BAF chromatin remodeling complex subunit BCL11A,2,Q9H165,"This gene encodes a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.,25372704,2015,DisGeNET,rs1427407,SNV,,,,,,"This study supports the likely causality of rs1427407 at the BCL11A locus, as recently
reported  as well as the presence of multiple independent risk variants. "
rs6265,22521161,Schizophrenia,Egypt,North Africa,NS,FALSE,< 0.05,BDNF,,BDNF,brain derived neurotrophic factor,11,P23560,"This gene encodes a member of the nerve growth factor family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. Binding of this protein to its cognate receptor promotes neuronal survival in the adult brain. Expression of this gene is reduced in Alzheimer's, Parkinson's, and Huntington's disease patients. This gene may play a role in the regulation of the stress response and in the biology of mood disorders. [provided by RefSeq, Nov 2015].",22/11/2021,PubMed,Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.,22521161,2012,DisGeNET,rs6265,SNV,,,,,,"Multiple rs IDs Merged into rs6265 for same location (rs386602118, rs60760775, rs17855547, rs16917222, rs3829232)"
rs759834365,22521161,Schizophrenia,Egypt,North Africa,NS,FALSE,NS,BDNF,,BDNF,brain derived neurotrophic factor,11,P23560,"This gene encodes a member of the nerve growth factor family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature protein. Binding of this protein to its cognate receptor promotes neuronal survival in the adult brain. Expression of this gene is reduced in Alzheimer's, Parkinson's, and Huntington's disease patients. This gene may play a role in the regulation of the stress response and in the biology of mood disorders. [provided by RefSeq, Nov 2015].",22/11/2021,PubMed,Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.,22521161,2012,DisGeNET,rs759834365,SNV,,,,,,"Multiple rs IDs Merged into rs6265 for same location (rs386602118, rs60760775, rs17855547, rs16917222, rs3829232). This record for rs759834365 is associated with different location."
rs281865207,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865207,SNV,,,,,,
rs281865207,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865207,SNV,,,,,,
rs281865207,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865207,SNV,,,,,,
rs281865224,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865224,SNV,,,,,,
rs281865224,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865224,SNV,,,,,,
rs281865224,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865224,SNV,,,,,,
rs281865226,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865226,SNV,,,,,,
rs281865226,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865226,SNV,,,,,,
rs281865226,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865226,SNV,,,,,,
rs281865234,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865234,SNV,,,,,,
rs281865234,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865234,SNV,,,,,,
rs281865234,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865234,SNV,,,,,,
rs281865238,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865238,SNV,,,,,,
rs281865238,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865238,SNV,,,,,,
rs281865238,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865238,SNV,,,,,,
rs281865250,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865250,SNV,,,,,,
rs281865250,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865250,SNV,,,,,,
rs281865250,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865250,SNV,,,,,,
rs281865530,10394929,"Best Vitelliform Macular Dystrophy, Multifocal (Disorder)","Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865530,SNV,,,,,,
rs281865530,10394929,Juvenile-Onset Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865530,SNV,,,,,,
rs281865530,10394929,Vitelliform Macular Dystrophy,"Morocco, Europe",North Africa,NS,TRUE,< 0.05,BEST1,,BEST1,bestrophin 1,11,O76090,"This gene encodes a member of the bestrophin gene family. This small gene family is characterized by proteins with a highly conserved N-terminus with four to six transmembrane domains. Bestrophins may form chloride ion channels or may regulate voltage-gated L-type calcium-ion channels. Bestrophins are generally believed to form calcium-activated chloride-ion channels in epithelial cells but they have also been shown to be highly permeable to bicarbonate ion transport in retinal tissue. Mutations in this gene are responsible for juvenile-onset vitelliform macular dystrophy (VMD2), also known as Best macular dystrophy, in addition to adult-onset vitelliform macular dystrophy (AVMD) and other retinopathies. Alternative splicing results in multiple variants encoding distinct isoforms.",22/11/2021,PubMed,The mutation spectrum of the bestrophin protein--functional implications.,10394929,1999,DisGeNET,rs281865530,SNV,,,,,,
rs398122891,22052668,"Osteogenesis Imperfecta, Type Xiii",Egypt,North Africa,NS,FALSE,NS,BMP1,,BMP1,bone morphogenetic protein 1,8,P13497,"This gene encodes a protein that is capable of inducing formation of cartilage in vivo. Although other bone morphogenetic proteins are members of the TGF-beta superfamily, this gene encodes a protein that is not closely related to other known growth factors. This gene is expressed as alternatively spliced variants that share an N-terminal protease domain but differ in their C-terminal region. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta.,22052668,2012,DisGeNET,rs398122891,SNV,,,,,,A consanguineous Egyptian family with two children diagnosed with severe autosomal recessive osteogenesis imperfecta (AR-OI) and a large umbilical hernia investigated.
rs80357888,21204799,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.,21204799,2012,DisGeNET,rs80357888,SNV,,,,,,
rs397508988,21204799,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.,21204799,2012,DisGeNET,rs397508988,SNV,,,,,,
rs397509050,22425665,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Morocco,North Africa,Berber/Arab,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs397509050,SNV,,,,,,
rs80357724,22425665,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Morocco,North Africa,Berber/Arab,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs80357724,SNV,,,,,,
rs397509050,22425665,Hereditary Breast And Ovarian Cancer Syndrome,Morocco,North Africa,Berber/Arab,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs397509050,SNV,,,,,,
rs397509050,22425665,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,Berber/Arab,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs397509050,SNV,,,,,,
rs80358344,22425665,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,Berber/Arab,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs80358344,SNV,,,,,,
rs80357724,20683152,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs80357724,SNV,,,,,,
rs80357728,20683152,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs80357728,SNV,,,,,,
rs28897672,20683152,Hereditary Breast And Ovarian Cancer Syndrome,Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs28897672,SNV,,,,,,"Three distinct pathogenic mutations c.83 84delTG, c.181T>G, c.798 799delTT and two large rearrangements involving deletion of exon 2 and exon 8 respectively, were detected in BRCA1 gene. Moreover 17 unclassified variants and polymorphisms were detected in BRCA1 gene (6 described for the first time). Two pathogenic mutations, c.1310 1313delAAGA and c.5722 5723delCT and 40 unclassified variants and polymorphisms (14 never described before) were identified in BRCA2 gene."
rs80357728,20683152,"Neoplastic Syndromes, Hereditary  Breast-Ovarian Cancer",Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs80357728,SNV,,,,,,
rs80357724,18645608,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.",18645608,2008,DisGeNET,rs80357724,SNV,,,,,,
rs80357728,18645608,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.",18645608,2008,DisGeNET,rs80357728,SNV,,,,,,
rs80357724,18645608,Hereditary Breast And Ovarian Cancer Syndrome,Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.",18645608,2008,DisGeNET,rs80357724,SNV,,,,,,
rs80357728,18645608,"Neoplastic Syndromes, Hereditary",Algeria,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases.",18645608,2008,DisGeNET,rs80357728,SNV,,,,,,
rs80358086,24729269,Hereditary Breast And Ovarian Cancer Syndrome,Sudan,East Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan.,24729269,2015,DisGeNET,rs80358086,SNV,,,,,,
rs387906563,12491487,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",USA,African American/Afro-Caribbean,NS,FALSE,< 0.005,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs387906563,SNV,,,,,,
rs387906563,12491487,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs387906563,SNV,,,,,,
rs80356997,12491487,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80356997,SNV,,,,,,
rs80357915,12491487,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357915,SNV,,,,,,
rs879255281,12491487,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs879255281,SNV,,,,,,
rs387906563,12491487,Hereditary Breast And Ovarian Cancer Syndrome,USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs387906563,SNV,,,,,,
rs80357254,12491487,Hereditary Breast And Ovarian Cancer Syndrome,USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357254,SNV,,,,,,
rs80357786,12491487,Hereditary Breast And Ovarian Cancer Syndrome,USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357786,SNV,,,,,,
rs80356997,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80356997,SNV,,,,,,
rs80357391,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357391,SNV,,,,,,
rs80357640,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357640,SNV,,,,,,
rs80357786,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357786,SNV,,,,,,
rs80357915,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80357915,SNV,,,,,,
rs80358041,26997744,"Neoplastic Syndromes, Hereditary",Algeria,North Africa,Kabyle,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer.,26997744,2016,DisGeNET,rs80358041,SNV,,,,,,
rs80357727,17922257,Hereditary Breast And Ovarian Cancer Syndrome,Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia.,17922257,2008,DisGeNET,rs80357727,SNV,,,,,,
rs80356936,18679828,Hereditary Breast And Ovarian Cancer Syndrome,Nigeria,West Africa,Yoruba,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.,18679828,2009,DisGeNET,rs80356936,SNV,,,,,,
rs80356936,18679828,"Neoplastic Syndromes, Hereditary",Nigeria,West Africa,Yoruba,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Evidence for an ancient BRCA1 mutation in breast cancer patients of Yoruban ancestry.,18679828,2009,DisGeNET,rs80356936,SNV,,,,,,
rs80357701,21603858,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.",21603858,2012,DisGeNET,rs80357701,SNV,,,,,,
rs80357724,21603858,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.",21603858,2012,DisGeNET,rs80357724,SNV,,,,,,
rs80357701,21603858,Hereditary Breast And Ovarian Cancer Syndrome,Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.",21603858,2012,DisGeNET,rs80357701,SNV,,,,,,
rs80357724,21603858,Hereditary Breast And Ovarian Cancer Syndrome,Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.",21603858,2012,DisGeNET,rs80357724,SNV,,,,,,
rs80357724,21603858,"Neoplastic Syndromes, Hereditary",Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population.",21603858,2012,DisGeNET,rs80357724,SNV,,,,,,
rs55851803,22034289,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Nigeria,West Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs55851803,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs41293463,22034289,Hereditary Breast And Ovarian Cancer Syndrome,Nigeria,West Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs41293463,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs55851803,22034289,Hereditary Breast And Ovarian Cancer Syndrome,Nigeria,West Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs55851803,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80356936,22034289,Hereditary Breast And Ovarian Cancer Syndrome,Nigeria,West Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs80356936,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80357064,22034289,Hereditary Breast And Ovarian Cancer Syndrome,Nigeria,West Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs80357064,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80356936,22034289,"Neoplastic Syndromes, Hereditary",Nigeria,West Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs80356936,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80357724,26864382,Hereditary Breast And Ovarian Cancer Syndrome,Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Identification of a founder BRCA1 mutation in the Moroccan population.,26864382,2017,DisGeNET,rs80357724,SNV,,,,,,
rs397508988,23885733,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,Xhosa,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Implementation of a breast cancer genetic service in South Africa - lessons learned.,23885733,2013,DisGeNET,rs397508988,SNV,,,,,,
rs397509050,23289006,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs397509050,SNV,,,,,,
rs80357701,23289006,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs80357701,SNV,,,,,,
rs80357724,23289006,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs80357724,SNV,,,,,,
rs80357569,23289006,Hereditary Breast And Ovarian Cancer Syndrome,Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs80357569,SNV,,,,,,
rs80357724,23289006,Hereditary Breast And Ovarian Cancer Syndrome,Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs80357724,SNV,,,,,,
rs80357569,23289006,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs80357569,SNV,,,,,,
rs80357724,23289006,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation screening of the BRCA1 gene in early onset and familial breast/ovarian cancer in Moroccan population.,23289006,2013,DisGeNET,rs80357724,SNV,,,,,,
rs80357888,24372583,Hereditary Breast And Ovarian Cancer Syndrome,Tunisia,North Africa,NS,FALSE,< 0.01,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.,24372583,2015,DisGeNET,rs80357888,SNV,,,,,,Associated with Hereditary Breast And Ovarian Cancer Syndrome
rs80357888,24372583,"Neoplastic Syndromes, Hereditary",Tunisia,North Africa,NS,FALSE,< 0.01,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia.,24372583,2015,DisGeNET,rs80357888,SNV,,,,,,Not specified in this study
rs80357590,20579331,"Neoplastic Syndromes, Hereditary",Egypt,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection.,20579331,2010,DisGeNET,rs80357590,SNV,,,,,,
rs387906563,22739995,Hereditary Breast And Ovarian Cancer Syndrome,"Nigeria, USA, Barbados",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.,22739995,2012,DisGeNET,rs387906563,SNV,,,,,,
rs387906563,22739995,"Neoplastic Syndromes, Hereditary","Nigeria, USA, Barbados",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.,22739995,2012,DisGeNET,rs387906563,SNV,,,,,,
rs80356936,22739995,"Neoplastic Syndromes, Hereditary","Nigeria, USA, Barbados",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.,22739995,2012,DisGeNET,rs80356936,SNV,,,,,,
rs80357727,25418591,Hereditary Breast And Ovarian Cancer Syndrome,Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.,25418591,2015,DisGeNET,rs80357727,SNV,,,,,,
rs80357727,25418591,"Neoplastic Syndromes, Hereditary",Tunisia,North Africa,NS,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.,25418591,2015,DisGeNET,rs80357727,SNV,,,,,,
rs397509050,25885115,"Breast-Ovarian Cancer, Familial, Susceptibility To, 1",Morocco,North Africa,Berber/Arab,FALSE,NS,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients.,25885115,2016,DisGeNET,rs397509050,SNV,,,,,,
rs80357919,21324156,Hereditary Breast And Ovarian Cancer Syndrome,"Morocco, Turkey",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Social and cultural factors underlying generational differences in overweight: a cross-sectional study among ethnic minorities in the Netherlands.,21324156,2011,DisGeNET,rs80357919,SNV,,,,,,
rs80357783,22763381,Hereditary Breast And Ovarian Cancer Syndrome,"Tunisia, Iraq, Malaysia, Spain",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.,22763381,2013,DisGeNET,rs80357783,SNV,,,,,,
rs80357783,22763381,"Neoplastic Syndromes, Hereditary","Tunisia, Iraq, Malaysia, Spain",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations.,22763381,2013,DisGeNET,rs80357783,SNV,,,,,,
rs80356936,23519070,Hereditary Breast And Ovarian Cancer Syndrome,Africa,Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.,23519070,2012,DisGeNET,rs80356936,SNV,,,,,,
rs80356936,23519070,"Neoplastic Syndromes, Hereditary",Africa,Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Seventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.,23519070,2012,DisGeNET,rs80356936,SNV,,,,,,
rs80357727,23697973,Hereditary Breast And Ovarian Cancer Syndrome,"Algeria, Morocco, Tunisia",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries.,23697973,2012,DisGeNET,rs80357727,SNV,,,,,,
rs80357446,25814778,"Neoplastic Syndromes, Hereditary","Algeria, Egypt, Morocco, Tunisia, Asia",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.,25814778,2015,DisGeNET,rs80357446,SNV,,,,,,
rs80357724,25814778,Hereditary Breast And Ovarian Cancer Syndrome,"Algeria, Egypt, Morocco, Tunisia, Asia",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.,25814778,2015,DisGeNET,rs80357724,SNV,,,,,,
rs80358344,25814778,"Neoplastic Syndromes, Hereditary","Algeria, Egypt, Morocco, Tunisia, Asia",North Africa,NS,TRUE,1.45E-10,BRCA1,,BRCA1,BRCA1 DNA repair associated,17,P38398,"This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North African.,25814778,2015,DisGeNET,rs80358344,SNV,,,,,,
rs397507858,21204799,"Breast-Ovarian Cancer, Familial, Susceptibility To, 2",South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.,21204799,2012,DisGeNET,rs397507858,SNV,,,,,,
rs80359688,21204799,Hereditary Breast And Ovarian Cancer Syndrome,South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.,21204799,2012,DisGeNET,rs80359688,SNV,,,,,,
rs80359535,21204799,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.,21204799,2012,DisGeNET,rs80359535,SNV,,,,,,
rs80359688,21204799,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South Africa.,21204799,2012,DisGeNET,rs80359688,SNV,,,,,,
rs81002849,22425665,"Breast-Ovarian Cancer, Familial, Susceptibility To, 2",Morocco,North Africa,Berber/Arab,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs81002849,SNV,,,,,,
rs81002849,22425665,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,Berber/Arab,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.,22425665,2012,DisGeNET,rs81002849,SNV,,,,,,
rs80359277,20683152,Hereditary Breast And Ovarian Cancer Syndrome,Algeria,North Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs80359277,SNV,,,,,,
rs80359530,20683152,Hereditary Breast And Ovarian Cancer Syndrome,Algeria,North Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs80359530,SNV,,,,,,
rs80359277,20683152,"Neoplastic Syndromes, Hereditary",Algeria,North Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families.,20683152,2010,DisGeNET,rs80359277,SNV,,,,,,
rs80359375,17333343,Hereditary Breast And Ovarian Cancer Syndrome,Sudan,East Africa,"Ja-alia,Kawahla,Arakeia,Hawsa,Danagla",FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,"BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors.",17333343,2007,DisGeNET,rs80359375,SNV,,,,,,
rs80358928,12491487,"Breast-Ovarian Cancer, Familial, Susceptibility To, 2",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80358928,SNV,,,,,,
rs80359297,12491487,Hereditary Breast And Ovarian Cancer Syndrome,USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80359297,SNV,,,,,,
rs80358928,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs80358928,SNV,,,,,,
rs81002823,12491487,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer genetics in African Americans.,12491487,2003,DisGeNET,rs81002823,SNV,,,,,,
rs80359688,26915939,Hereditary Breast And Ovarian Cancer Syndrome,South Africa,South Africa,Afrikaner,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?,26915939,2016,DisGeNET,rs80359688,SNV,,,,,,
rs397508988,26915939,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,Afrikaner,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?,26915939,2016,DisGeNET,rs397508988,SNV,,,,,,"The most common mutation detected in this studied cohort was the BRCA2 c.7934delG (rs397508988) Afrikaner founder mutation, which was identified in 12 counsellees (22.2% of those tested)."
rs80359624,26915939,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,Afrikaner,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Breast cancer in high-risk Afrikaner families: Is BRCA founder mutation testing sufficient?,26915939,2016,DisGeNET,rs80359624,SNV,,,,,,"The Afrikaner BRCA2 c.7943delG (rs80359624) founder mutation was the most common mutation in this cohort, with 12 of the 18 counsellees (66.7%) testing positive for it."
rs80359688,22638694,Hereditary Breast And Ovarian Cancer Syndrome,South Africa,South Africa,"Afrikaner, Coloured",TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,CYP2D6 genotyping and use of antidepressants in breast cancer patients: test development for clinical application.,22638694,2013,DisGeNET,rs80359688,SNV,,,,,,
rs80359277,27446417,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the,27446417,2016,DisGeNET,rs80359277,SNV,,,,,,
rs80359180,22034289,Hereditary Breast And Ovarian Cancer Syndrome,Nigeria,West Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs80359180,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs749980674,22034289,"Neoplastic Syndromes, Hereditary",Nigeria,West Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs749980674,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80359180,22034289,"Neoplastic Syndromes, Hereditary",Nigeria,West Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs80359180,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80359644,22034289,"Neoplastic Syndromes, Hereditary",Nigeria,West Africa,NS,FALSE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patients.,22034289,2012,DisGeNET,rs80359644,SNV,,,,,,"Complete sequence analysis of all BRCA1 and BRCA2 exons and intron-exon boundaries for 434 Nigerian breast cancer patients from the University College Hospital in Ibadan, Nigeria"
rs80359688,23885733,Hereditary Breast And Ovarian Cancer Syndrome,South Africa,South Africa,Xhosa,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Implementation of a breast cancer genetic service in South Africa - lessons learned.,23885733,2013,DisGeNET,rs80359688,SNV,,,,,,
rs80359535,23885733,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,Xhosa,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Implementation of a breast cancer genetic service in South Africa - lessons learned.,23885733,2013,DisGeNET,rs80359535,SNV,,,,,,
rs80359688,23885733,"Neoplastic Syndromes, Hereditary",South Africa,South Africa,Xhosa,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Implementation of a breast cancer genetic service in South Africa - lessons learned.,23885733,2013,DisGeNET,rs80359688,SNV,,,,,,
rs149330893,25320599,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Novel nonsense mutation of BRCA2 gene in a Moroccan man with familial breast cancer.,25320599,2015,DisGeNET,rs149330893,SNV,,,,,,
rs80359473,17020472,"Breast-Ovarian Cancer, Familial, Susceptibility To, 2",North Africa,North Africa,NS,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews.,17020472,2007,DisGeNET,rs80359473,SNV,,,,,,
rs80359473,17020472,Hereditary Breast And Ovarian Cancer Syndrome,North Africa,North Africa,Jewish,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews.,17020472,2007,DisGeNET,rs80359473,SNV,,,,,,
rs80359473,17020472,"Neoplastic Syndromes, Hereditary",North Africa,North Africa,Jewish,TRUE,NS,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,The P1812A and P25T BRCA1 and the 5164del4 BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews.,17020472,2007,DisGeNET,rs80359473,SNV,,,,,,
rs80359527,23697973,Hereditary Breast And Ovarian Cancer Syndrome,"Algeria, Morocco, Tunisia",North Africa,NS,TRUE,1.45E-10,BRCA2,,BRCA2,BRCA2 DNA repair associated,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries.,23697973,2012,DisGeNET,rs80359527,SNV,,,,,,
rs11571658,11359068,"Breast-Ovarian Cancer, Familial, Susceptibility To, 2",Mauritius,East Africa,NS,FALSE,NS,BRCA2,,BRCA2,breast cancer gene 2,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation analysis of a Mauritian hereditary breast cancer family reveals the BRCA2 6503deITT mutation previously found to recur in different ethnic populations.,11359068,2001,DisGeNET,rs11571658,SNV,,,,,,variant not found in the paper
rs11571658,11359068,"Neoplastic Syndromes, Hereditary",Mauritius,East Africa,NS,FALSE,NS,BRCA2,,BRCA2,breast cancer gene 2,13,P51587,"Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Mutation analysis of a Mauritian hereditary breast cancer family reveals the BRCA2 6503deITT mutation previously found to recur in different ethnic populations.,11359068,2001,DisGeNET,rs11571658,SNV,,,,,,variant not found in the paper
rs397514357,19757147,Biotinidase Deficiency,Somali,West Africa,NS,FALSE,NS,BTD,,BTD,biotinidase,3,P43251,"The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota.,19757147,2013,DisGeNET,rs397514357,SNV,,,,,,"All four Somali patients have the P497S mutation, with one of the four being homozygous for the mutation. The three compound heterozygotes all have a novel mutation (P142T) and two of them have another change (Y428Y) that has never been described."
rs397507173,20083419,Biotinidase Deficiency,"Morocco, Austria, India, Spain",North Africa,NS,TRUE,NS,BTD,,BTD,biotinidase,3,P43251,"The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC).,20083419,2010,DisGeNET,rs397507173,SNV,,,,,,"The study report patients with biochemically proven biotinidase deficiency. Patients were recruited from Austria, India, Morocco and Spain. Patients detected through neonatal screening were asymptomatic at the time of diagnosis. This mutation is not studied for Moroccon patients."
rs397514386,20083419,Biotinidase Deficiency,"Morocco, Austria, India, Spain",North Africa,NS,TRUE,NS,BTD,,BTD,biotinidase,3,P43251,"The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC).,20083419,2010,DisGeNET,rs397514386,SNV,,,,,,
rs397514398,20083419,Biotinidase Deficiency,"Morocco, Austria, India, Spain",North Africa,NS,TRUE,NS,BTD,,BTD,biotinidase,3,P43251,"The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC).,20083419,2010,DisGeNET,rs397514398,SNV,,,,,,
rs397514411,20083419,Biotinidase Deficiency,"Morocco, Austria, India, Spain",North Africa,NS,TRUE,NS,BTD,,BTD,biotinidase,3,P43251,"The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC).,20083419,2010,DisGeNET,rs397514411,SNV,,,,,,
rs397514414,20083419,Biotinidase Deficiency,"Morocco, Austria, India, Spain",North Africa,NS,TRUE,NS,BTD,,BTD,biotinidase,3,P43251,"The protein encoded by this gene functions to recycle protein-bound biotin by cleaving biocytin (biotin-epsilon-lysine), a normal product of carboxylase degradation, resulting in regeneration of free biotin. The encoded protein has also been shown to have biotinyl transferase activity. Mutations in this gene are associated with biotinidase deficiency. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC).,20083419,2010,DisGeNET,rs397514414,SNV,,,,,,
rs376103979,20039086,Neurodegeneration With Brain Iron Accumulation 4,Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19.,20039086,2010,DisGeNET,rs376103979,SNV,,,,,,
rs376103979,20039086,"Spastic Paraplegia 43, Autosomal Recessive",Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia and amyotrophy associated with a novel locus on chromosome 19.,20039086,2010,DisGeNET,rs376103979,SNV,,,,,,
rs376103979,23857908,Neurodegeneration With Brain Iron Accumulation (Nbia),Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs376103979,SNV,,,,,,
rs749785672,23857908,Neurodegeneration With Brain Iron Accumulation (Nbia),Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs749785672,SNV,,,,,,
rs760318047,23857908,Neurodegeneration With Brain Iron Accumulation (Nbia),Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs760318047,SNV,,,,,,
rs376103979,23857908,Neurodegeneration With Brain Iron Accumulation 4,Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs376103979,SNV,,,,,,
rs398122409,23857908,Neurodegeneration With Brain Iron Accumulation 4,Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs398122409,SNV,,,,,,
rs515726205,23857908,Neurodegeneration With Brain Iron Accumulation 4,Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs515726205,SNV,,,,,,
rs376103979,23857908,"Spastic Paraplegia 43, Autosomal Recessive",Mali,West Africa,NS,FALSE,NS,C19orf12,,C19orf12,chromosome 19 open reading frame 12,19,Q9NSK7,"This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12.,23857908,2014,DisGeNET,rs376103979,SNV,,,,,,
rs121964921,9218625,Complement Component 7 Deficiency,Morocco,North Africa,NS,FALSE,NS,C7,,C7,complement C7,5,P10643,"This gene encodes a serum glycoprotein that forms a membrane attack complex together with complement components C5b, C6, C8, and C9 as part of the terminal complement pathway of the innate immune system. The protein encoded by this gene contains a cholesterol-dependent cytolysin/membrane attack complex/perforin-like (CDC/MACPF) domain and belongs to a large family of structurally related molecules that form pores involved in host immunity and bacterial pathogenesis. This protein initiates membrane attack complex formation by binding the C5b-C6 subcomplex and inserts into the phospholipid bilayer, serving as a membrane anchor. Mutations in this gene are associated with a rare disorder called C7 deficiency. [provided by RefSeq, Nov 2016].",22/11/2021,PubMed,Molecular bases of C7 deficiency: three different defects.,9218625,1997,DisGeNET,rs121964921,SNV,,,,,,cannot have a full access to the article
rs104894559,15295099,Retinitis Pigmentosa,South Africa,South Africa,NS,FALSE,> 0.05,CA4,,CA4,carbonic anhydrase 4 ,17,P22748,"Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. This gene encodes a glycosylphosphatidyl-inositol-anchored membrane isozyme expressed on the luminal surfaces of pulmonary (and certain other) capillaries and proximal renal tubules. Its exact function is not known; however, it may have a role in inherited renal abnormalities of bicarbonate transport. ",22/11/2021,PubMed,Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17.,15295099,2004,DisGeNET,rs104894559,SNV,,,,,,
rs339097,20200517,Allele G is associated with increased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,0.03,CALU,,CALU,calumenin,7,O43852,"The product of this gene is a calcium-binding protein localized in the endoplasmic reticulum (ER) and it is involved in such ER functions as protein folding and sorting. This protein belongs to a family of multiple EF-hand proteins (CERC) that include reticulocalbin, ERC-55, and Cab45 and the product of this gene. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.,20200517,2010,PharmGKB,637879876,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 194 African Americans. Allele G is associated with increased dose of warfarin.
rs339097,20200517,Allele G is associated with increased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,0.03,CALU,,CALU,calumenin,7,O43852,"The product of this gene is a calcium-binding protein localized in the endoplasmic reticulum (ER) and it is involved in such ER functions as protein folding and sorting. This protein belongs to a family of multiple EF-hand proteins (CERC) that include reticulocalbin, ERC-55, and Cab45 and the product of this gene. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose requirements in African Americans.,20200517,2010,PharmGKB,637879876,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 194 African Americans. Allele G is associated with increased dose of warfarin.
rs339097,21228733,Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.,Egypt,North Africa,NS,FALSE,0.04,CALU,,CALU,calumenin,7,O43852,"The product of this gene is a calcium-binding protein localized in the endoplasmic reticulum (ER) and it is involved in such ER functions as protein folding and sorting. This protein belongs to a family of multiple EF-hand proteins (CERC) that include reticulocalbin, ERC-55, and Cab45 and the product of this gene. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864550,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA. A p value of 0.04 was given for dose-genotype association, but the authors stated that this association did not reach significanc in multiple regression testing (p = 0.066), and that was likely due to insufficient power."
rs339097,21228733,Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.,Egypt,North Africa,NS,FALSE,0.04,CALU,,CALU,calumenin,7,O43852,"The product of this gene is a calcium-binding protein localized in the endoplasmic reticulum (ER) and it is involved in such ER functions as protein folding and sorting. This protein belongs to a family of multiple EF-hand proteins (CERC) that include reticulocalbin, ERC-55, and Cab45 and the product of this gene. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864550,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA. A p value of 0.04 was given for dose-genotype association, but the authors stated that this association did not reach significanc in multiple regression testing (p = 0.066), and that was likely due to insufficient power."
rs1043550,29479633,Allele G is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele A.,Tunisia,North Africa,NS,FALSE,0.009,CALU,,CALU,calumenin,7,O43852,"The product of this gene is a calcium-binding protein localized in the endoplasmic reticulum (ER) and it is involved in such ER functions as protein folding and sorting. This protein belongs to a family of multiple EF-hand proteins (CERC) that include reticulocalbin, ERC-55, and Cab45 and the product of this gene. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.,29479633,2018,PharmGKB,1449188291,SNV,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,Patients with the AA genotype may require a lower dose of acenocoumarol as compared to patients with the AG or GG genotypes. Other clinical and genetic factors may also affect dose of acenocoumarol.
rs3842570,20470430,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.007,CAPN10,,CAPN10,calpain 10,2,Q9HC96,"Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.,20470430,2010,DisGeNET,rs3842570,SNV,,,,,,MAF was similar between patients and controls.
rs3792267,20470430,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.359,CAPN10,,CAPN10,calpain 10,2,Q9HC96,"Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.,20470430,2010,DisGeNET,rs3792267,SNV,,,,,,MAF was similar between patients and controls.
rs5030952,20470430,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.673,CAPN10,,CAPN10,calpain 10,2,Q9HC96,"Calpains represent a ubiquitous, well-conserved family of calcium-dependent cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large catalytic subunit has four domains: domain I, the N-terminal regulatory domain that is processed upon calpain activation; domain II, the protease domain; domain III, a linker domain of unknown function; and domain IV, the calmodulin-like calcium-binding domain. This gene encodes a large subunit. It is an atypical calpain in that it lacks the calmodulin-like calcium-binding domain and instead has a divergent C-terminal domain. It is similar in organization to calpains 5 and 6. This gene is associated with type 2 or non-insulin-dependent diabetes mellitus (NIDDM), and is located within the NIDDM1 region. Multiple alternative transcript variants have been described for this gene. [provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.,20470430,2010,DisGeNET,rs5030952,SNV,,,,,,MAF was similar between patients and controls.
rs374665929,22158424,Limb-Girdle Muscular Dystrophy Type 2A,Tunisia,North Africa,NS,FALSE,NS,CAPN3,,CAPN3,calpain 3,15,P20807,"Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CAPN3 mRNA processing alteration caused by splicing mutation associated with novel genomic rearrangement of Alu elements.,22158424,2012,DisGeNET,rs374665929,SNV,,,,,,
rs375495026,12730724,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,CAPN3,,CAPN3,calpain 3,15,P20807,"Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.,12730724,2003,DisGeNET,rs375495026,SNV,,,,,,
rs875989900,12730724,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,CAPN3,,CAPN3,calpain 3,15,P20807,"Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.,12730724,2003,DisGeNET,rs875989900,SNV,,,,,,
rs375624435,26358359,Psoriasis,Tunisia,North Africa,NS,FALSE,< 0.001,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs375624435,SNV,,,,,,Variant reported in Tunisian patient with psoriasis.
rs375624435,26358359,Psoriasis 2,Tunisia,North Africa,NS,FALSE,< 0.001,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs375624435,SNV,,,,,,Variant reported in Tunisian patient with psoriasis.
rs762364495,26358359,Psoriasis 2,Tunisia,North Africa,NS,FALSE,< 0.001,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs762364495,SNV,,,,,,Variant reported in Tunisian patient with psoriasis.
rs200731780,26358359,Psoriasis 2,Tunisia,North Africa,NS,FALSE,< 0.01,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs200731780,SNV,,,,,,
rs200790561,26358359,Psoriasis 2,Tunisia,North Africa,NS,FALSE,< 0.05,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs200790561,SNV,,,,,,Variant reported in Tunisian patient with psoriasis.
rs200790561,26358359,Psoriasis,"Tunisia, Europe",North Africa,NS,TRUE,< 0.05,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs200790561,SNV,,,,,,
rs281875215,26358359,Psoriasis,Tunisia,North Africa,NS,FALSE,NS,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs281875215,SNV,,,,,,Variant reported in Tunisian patient with psoriasis.
rs146214639,26358359,Psoriasis 2,Tunisia,North Africa,NS,FALSE,NS,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.,26358359,2016,DisGeNET,rs146214639,SNV,,,,,,
rs281875215,23013406,Psoriasis,Tunisia,North Africa,NS,FALSE,NS,CARD14,,CARD14,caspase recruitment domain family member 14,17,Q9BXL6,"This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families.,23013406,2013,DisGeNET,rs281875215,SNV,,,,,,Provide confirmatory evidence for a novel psoriasis locus at chromosome 2p12 and reveal a psoriasis family with a mutation at PSORS2.
rs398122363,9835960,"Candidiasis, Familial, 2",Algeria,North Africa,NS,FALSE,NS,CARD9,,CARD9,caspase recruitment domain family member 9,9,Q9H257,"The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,[Dermatophytic disease: exuberant hyperkeratosis with cutaneous horns].,9835960,1998,DisGeNET,rs398122363,SNV,,,,,,
rs398122363,24131138,"Candidiasis, Familial, 2","Algeria, Morocco, Tunisia",North Africa,NS,TRUE,NS,CARD9,,CARD9,caspase recruitment domain family member 9,9,Q9H257,"The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Deep dermatophytosis and inherited CARD9 deficiency.,24131138,2013,DisGeNET,rs398122363,SNV,,,,,,
rs398122364,24131138,"Candidiasis, Familial, 2","Algeria, Morocco, Tunisia",North Africa,NS,TRUE,NS,CARD9,,CARD9,caspase recruitment domain family member 9,9,Q9H257,"The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Deep dermatophytosis and inherited CARD9 deficiency.,24131138,2013,DisGeNET,rs398122364,SNV,,,,,,
rs398122363,25702837,Meningoencephalitis,Morocco,North Africa,NS,FALSE,NS,CARD9,,CARD9,caspase recruitment domain family member 9,9,Q9H257,"The protein encoded by this gene is a member of the CARD protein family, which is defined by the presence of a characteristic caspase-associated recruitment domain (CARD). CARD is a protein interaction domain known to participate in activation or suppression of CARD containing members of the caspase family, and thus plays an important regulatory role in cell apoptosis. This protein was identified by its selective association with the CARD domain of BCL10, a postive regulator of apoptosis and NF-kappaB activation, and is thought to function as a molecular scaffold for the assembly of a BCL10 signaling complex that activates NF-kappaB. Several alternatively spliced transcript variants have been observed, but their full-length nature is not clearly defined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both.",25702837,2015,DisGeNET,rs398122363,SNV,,,,,,Variant was described in patient from Morocco.
rs13281615,22910930,Breast Carcinoma,Tunisia,North Africa,NS,FALSE,0.03,CASC21,,CASC21,cancer susceptibility 21,8,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs13281615,SNV,,,,,,G vs. A allele was found to be significantly associated with breast cancer in Tunisians
rs13281615,22910930,Malignant Neoplasm Of Breast,Tunisia,North Africa,NS,FALSE,0.03,CASC21,,CASC21,cancer susceptibility 21,8,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs13281615,SNV,,,,,,G vs. A allele was found to be significantly associated with breast cancer in Tunisians
rs13281615,22910930,Breast Carcinoma,Tunisia,North Africa,NS,FALSE,0.03,CASC8,,CASC8,cancer susceptibility 8,8,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs13281615,SNV,,,,,,G vs. A allele was found to be significantly associated with breast cancer in Tunisians
rs13281615,22910930,Malignant Neoplasm Of Breast,Tunisia,North Africa,NS,FALSE,0.03,CASC8,,CASC8,cancer susceptibility 8,8,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs13281615,SNV,,,,,,G vs. A allele was found to be significantly associated with breast cancer in Tunisians
rs398123151,21517828,"Hyperhomocysteinemia, Thrombotic, Cbs-Related",Sudan,East Africa,NS,TRUE,NS,CBS,,CBS,cystathionine beta-synthase,21,P35520,"The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016].",22/11/2021,PubMed,Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria.,21517828,2013,DisGeNET,rs398123151,SNV,,,,,,"In the Sudanese family, the p.Thr257Met mutation in the CBS gene, previously described in Italian and Spanish patients, was found."
rs758236584,21517828,"Hyperhomocysteinemia, Thrombotic, Cbs-Related",Sudan,East Africa,NS,TRUE,NS,CBS,,CBS,cystathionine beta-synthase,21,P35520,"The protein encoded by this gene acts as a homotetramer to catalyze the conversion of homocysteine to cystathionine, the first step in the transsulfuration pathway. The encoded protein is allosterically activated by adenosyl-methionine and uses pyridoxal phosphate as a cofactor. Defects in this gene can cause cystathionine beta-synthase deficiency (CBSD), which can lead to homocystinuria. This gene is a major contributor to cellular hydrogen sulfide production. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2016].",22/11/2021,PubMed,Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria.,21517828,2013,DisGeNET,rs758236584,SNV,,,,,,
rs869025342,26358778,"Hypotonia, Infantile, With Psychomotor Retardation",Ethiopia,East Africa,NS,FALSE,NS,CCDC174,,CCDC174,coiled-coil domain containing 174,3,Q6PII3,"The protein encoded by this gene is found in the nucleus, where it interacts with eukaryotic translation initiation factor 4A, isoform 3. The encoded protein appears to be a part of the exon junction complex, which is involved in RNA processing, translation, and nonsense-mediated mRNA decay. A mutation in this gene has been associated with infantile hypotonia with psychomotor retardation. [provided by RefSeq, Mar 2016].",22/11/2021,PubMed,"CDC174, a novel component of the exon junction complex whose mutation underlies a syndrome of hypotonia and psychomotor developmental delay.",26358778,2016,DisGeNET,rs869025342,SNV,,,,,,
rs3917887,26626202,"Tuberculosis, Spinal",Algeria,North Africa,Arab/Berber,FALSE,NS,CCL2,,CCL2,chemokine ligand 2,17,P13500,"This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Chemokines are a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of N-terminal cysteine residues of the mature peptide. This chemokine is a member of the CC subfamily which is characterized by two adjacent cysteine residues. This cytokine displays chemotactic activity for monocytes and basophils but not for neutrophils or eosinophils. It has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. It binds to chemokine receptors CCR2 and CCR4. Elevated expression of the encoded protein is associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ",22/11/2021,PubMed,Functional polymorphisms of Monocyte Chemoattractant Protein-1 gene and Pott's disease risk.,26626202,2016,DisGeNET,rs3917887,SNV,,,,,,
rs1799864,12325020,Acquired Immunodeficiency Syndrome,South Africa,South Africa,NS,FALSE,0.00000065,CCR2,,CCR2,C-C motif chemokine receptor 2,3,P41597,"The protein encoded by this gene is a receptor for monocyte chemoattractant protein-1, a chemokine which specifically mediates monocyte chemotaxis. Monocyte chemoattractant protein-1 is involved in monocyte infiltration in inflammatory diseases such as rheumatoid arthritis as well as in the inflammatory response against tumors. The encoded protein mediates agonist-dependent calcium mobilization and inhibition of adenylyl cyclase. This protein can also be a coreceptor with CD4 for HIV-1 infection. This gene is located in the chemokine receptor gene cluster region of chromosome 3.",22/11/2021,PubMed,Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay.,12325020,2002,DisGeNET,rs1799864,SNV,,,,,,
rs757366142,12325020,Acquired Immunodeficiency Syndrome,South Africa,South Africa,NS,FALSE,0.00000493,CCR2,,CCR2,C-C motif chemokine receptor 2,3,P41597,"The protein encoded by this gene is a receptor for monocyte chemoattractant protein-1, a chemokine which specifically mediates monocyte chemotaxis. Monocyte chemoattractant protein-1 is involved in monocyte infiltration in inflammatory diseases such as rheumatoid arthritis as well as in the inflammatory response against tumors. The encoded protein mediates agonist-dependent calcium mobilization and inhibition of adenylyl cyclase. This protein can also be a coreceptor with CD4 for HIV-1 infection. This gene is located in the chemokine receptor gene cluster region of chromosome 3.",22/11/2021,PubMed,Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay.,12325020,2002,DisGeNET,rs757366142,SNV,,,,,,
rs333,9132277,"West Nile Virus, Susceptibility To (Finding)","Africa, America, Asia, Europe",Africa,NS,TRUE,> 0.05,CCR5,,CCR5,C-C motif chemokine receptor 5,3,P51681,"This gene encodes a member of the beta chemokine receptor family, which is predicted to be a seven transmembrane protein similar to G protein-coupled receptors. This protein is expressed by T cells and macrophages, and is known to be an important co-receptor for macrophage-tropic virus, including HIV, to enter host cells. Defective alleles of this gene have been associated with the HIV infection resistance. The ligands of this receptor include monocyte chemoattractant protein 2 (MCP-2), macrophage inflammatory protein 1 alpha (MIP-1 alpha), macrophage inflammatory protein 1 beta (MIP-1 beta) and regulated on activation normal T expressed and secreted protein (RANTES). Expression of this gene was also detected in a promyeloblastic cell line, suggesting that this protein may play a role in granulocyte lineage proliferation and differentiation. This gene is located at the chemokine receptor gene cluster region. An allelic polymorphism in this gene results in both functional and non-functional alleles; the reference genome represents the functional allele. Two transcript variants encoding the same protein have been found for this gene. ",22/11/2021,PubMed,"Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.",9132277,1997,DisGeNET,rs333,SNV,,,,,,
rs118203986,16399879,"Neuropathy, Hereditary Sensory, With Spastic Paraplegia, Autosomal Recessive",Morocco,North Africa,NS,FALSE,NS,CCT5,Genetic variability study,CCT5,chaperonin containing TCP1 subunit 5,5,P48643,"The protein encoded by this gene is a molecular chaperone that is a member of the chaperonin containing TCP1 complex (CCT), also known as the TCP1 ring complex (TRiC). This complex consists of two identical stacked rings, each containing eight different proteins. Unfolded polypeptides enter the central cavity of the complex and are folded in an ATP-dependent manner. The complex folds various proteins, including actin and tubulin. Mutations in this gene cause hereditary sensory and autonomic neuropathy with spastic paraplegia (HSNSP). Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 5 and 13. [provided by RefSeq, Apr 2015].",22/11/2021,PubMed,Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia.,16399879,2006,DisGeNET,rs118203986,SNV,,,,,,The H147R was identified at homozygous state in 4 members from a Moroccon consanuineous family with autosomal recessive mutilating sensory neuropathy with spastic paraplegia.
rs6940729,26519441,Homocysteine Measurement,"Nigeria, USA",West Africa / African American/Afro-Caribbean,"African American, Yoruba",TRUE,NS,CD2AP,,CD2AP,CD2 associated protein,6,Q9Y5K6,"This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians.,26519441,2016,DisGeNET,rs6940729,SNV,,,,,,
rs777112652,27259055,"Deafness, Autosomal Recessive 105",Mauritania,North Africa,NS,FALSE,NS,CDC14A,,CDC14A,cell division cycle 14A,1,Q9UNH5,"The protein encoded by this gene is a member of the dual specificity protein tyrosine phosphatase family. It is highly similar to Saccharomyces cerevisiae Cdc14, a protein tyrosine phosphatase involved in the exit of cell mitosis and initiation of DNA replication, suggesting a role in cell cycle control. This protein has been shown to interact with, and dephosphorylate tumor suppressor protein p53, and is thought to regulate the function of p53. Alternative splicing of this gene results in several transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mutations in CDC14A, Encoding a Protein Phosphatase Involved in Hair Cell Ciliogenesis, Cause Autosomal-Recessive Severe to Profound Deafness.",27259055,2017,DisGeNET,rs777112652,SNV,,,,,,
rs876661408,27259055,"Deafness, Autosomal Recessive 105",Mauritania,North Africa,NS,FALSE,NS,CDC14A,,CDC14A,cell division cycle 14A,1,Q9UNH5,"The protein encoded by this gene is a member of the dual specificity protein tyrosine phosphatase family. It is highly similar to Saccharomyces cerevisiae Cdc14, a protein tyrosine phosphatase involved in the exit of cell mitosis and initiation of DNA replication, suggesting a role in cell cycle control. This protein has been shown to interact with, and dephosphorylate tumor suppressor protein p53, and is thought to regulate the function of p53. Alternative splicing of this gene results in several transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mutations in CDC14A, Encoding a Protein Phosphatase Involved in Hair Cell Ciliogenesis, Cause Autosomal-Recessive Severe to Profound Deafness.",27259055,2017,DisGeNET,rs876661408,SNV,,,,,,
rs9940464,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-6,CDH13,,CDH13,cadherin 13,16,P55290,"This gene encodes a member of the cadherin superfamily. The encoded protein is localized to the surface of the cell membrane and is anchored by a GPI moiety, rather than by a transmembrane domain. The protein lacks the cytoplasmic domain characteristic of other cadherins, and so is not thought to be a cell-cell adhesion glycoprotein. This protein acts as a negative regulator of axon growth during neural differentiation. It also protects vascular endothelial cells from apoptosis due to oxidative stress, and is associated with resistance to atherosclerosis. The gene is hypermethylated in many types of cancer. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, May 2011].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,,SNV,,,,,,NA
rs398122971,22887808,"Microcephaly, Primary Autosomal Recessive, 3",Somali,East Africa,NS,FALSE,NS,CDK5RAP2,,CDK5RAP2,CDK5 regulatory subunit associated protein 2,9,Q96SN8,"This gene encodes a regulator of CDK5 (cyclin-dependent kinase 5) activity. The protein encoded by this gene is localized to the centrosome and Golgi complex, interacts with CDK5R1 and pericentrin (PCNT), plays a role in centriole engagement and microtubule nucleation, and has been linked to primary microcephaly and Alzheimer's disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2013].",22/11/2021,PubMed,A novel nonsense CDK5RAP2 mutation in a Somali child with primary microcephaly and sensorineural hearing loss.,22887808,2013,DisGeNET,rs398122971,SNV,,,,,,
rs7756992,24898818,"Diabetes Mellitus, Non-Insulin-Dependent",Morocco,North Africa,NS,FALSE,0.18,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,"Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.",24898818,2015,DisGeNET,rs7756992,SNV,,,,,,"A caseâ€“control study of 250 unrelated Moroccon diabetic patients and 250 healthy controls, using TaqMan allelic discrimination assays to genotype the three SNPs and meta-analysis to investigate the  association between the polymorphisms and diabetes in Arab populations. The results showed a significant diabetes association only with the variant rs4402960 of the IGF2BP2 gene under additive 2 (GG vs. TT; p = 0.009) and recessive (TT vs. GG?GT; p = 0.003)
models."
rs7756992,24636221,Diabetic Nephropathy,Tunisia,North Africa,NS,FALSE,0.001,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs7756992,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs7756992,24636221,Diabetes,Tunisia,North Africa,NS,FALSE,NS,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs7756992,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs7756992,24636221,Diabetes Mellitus,Tunisia,North Africa,NS,FALSE,NS,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs7756992,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs7756992,24636221,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,NS,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs7756992,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs7756992,24636221,Hypertensive Disease,Tunisia,North Africa,NS,FALSE,NS,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs7756992,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs7756992,18461161,"Diabetes Mellitus, Non-Insulin-Dependent",Morocco,North Africa,NS,FALSE,0.25,CDKAL1,,CDKAL1,CDK5 regulatory subunit associated protein 1 like 1,6,Q5VV42,"The protein encoded by this gene is a member of the methylthiotransferase family. The function of this gene is not known. Genome-wide association studies have linked single nucleotide polymorphisms in an intron of this gene with susceptibilty to type 2 diabetes. [provided by RefSeq, May 2010].",22/11/2021,PubMed,Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.,18461161,2008,DisGeNET,rs7756992,SNV,,,,,,
rs104894099,12700603,Melanoma,"Morocco, Tunisia",North Africa,NS,TRUE,NS,CDKN2A,"Genetic variability study,Functional analysis",CDKN2A,cyclin dependent kinase inhibitor 2A,9,"['P42771', 'Q8N726']","This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012].",22/11/2021,PubMed,"A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.",12700603,2003,DisGeNET,rs104894099,SNV,,,,,,"Variant identified in mixed origin families (Morrocan -Jewish, Tunisia-Jewish). Jewish ancestry linked to inheritance of the variant. "
rs104894099,12700603,Melanoma-Pancreatic Cancer Syndrome,"Morocco, Tunisia",North Africa,NS,TRUE,NS,CDKN2A,"Genetic variability study,Functional analysis",CDKN2A,cyclin dependent kinase inhibitor 2A,9,"['P42771', 'Q8N726']","This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012].",22/11/2021,PubMed,"A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.",12700603,2003,DisGeNET,rs104894099,SNV,,,,,,"Variant identified in mixed origin families (Morrocan -Jewish, Tunisia-Jewish). Jewish ancestry linked to inheritance of the variant. "
rs104894099,12700603,"Melanoma, Cutaneous Malignant, Susceptibility To, 2","Morocco, Tunisia",North Africa,NS,TRUE,NS,CDKN2A,"Genetic variability study,Functional analysis",CDKN2A,cyclin dependent kinase inhibitor 2A,9,"['P42771', 'Q8N726']","This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012].",22/11/2021,PubMed,"A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.",12700603,2003,DisGeNET,rs104894099,SNV,,,,,,"Variant identified in mixed origin families (Morrocan -Jewish, Tunisia-Jewish). Jewish ancestry linked to inheritance of the variant. "
rs104894099,12700603,"Neoplastic Syndromes, Hereditary","Morocco, Tunisia",North Africa,NS,TRUE,NS,CDKN2A,"Genetic variability study,Functional analysis",CDKN2A,cyclin dependent kinase inhibitor 2A,9,"['P42771', 'Q8N726']","This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012].",22/11/2021,PubMed,"A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.",12700603,2003,DisGeNET,rs104894099,SNV,,,,,,"Variant identified in mixed origin families (Morrocan -Jewish, Tunisia-Jewish). Jewish ancestry linked to inheritance of the variant. "
rs6008813,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,4.34E-07,CELSR1,Association,CELSR1,cadherin EGF LAG seven-pass G-type receptor 1,22,Q9NYQ6,"The protein encoded by this gene is a member of the flamingo subfamily, part of the cadherin superfamily. The flamingo subfamily consists of nonclassic-type cadherins; a subpopulation that does not interact with catenins. The flamingo cadherins are located at the plasma membrane and have nine cadherin domains, seven epidermal growth factor-like repeats and two laminin A G-type repeats in their ectodomain. They also have seven transmembrane domains, a characteristic unique to this subfamily. It is postulated that these proteins are receptors involved in contact-mediated communication, with cadherin domains acting as homophilic binding regions and the EGF-like domains involved in cell adhesion and receptor-ligand interactions. This particular member is a developmentally regulated, neural-specific gene which plays an unspecified role in early embryogenesis. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs6008813,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs200024180,19243074,"Epilepsy, Progressive Myoclonic, 8",Algeria,North Africa,NS,FALSE,< 0.01 - 1.0,CERS1,,CERS1,ceramide synthase 1,19,P27544,"This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1.",22/11/2021,PubMed,Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment.,19243074,2009,DisGeNET,rs200024180,SNV,,,,,,
rs587776996,23754960,"Ichthyosis, Congenital, Autosomal Recessive 9",Tunisia,North Africa,NS,FALSE,0.04,CERS3,,CERS3,ceramide synthase 3,15,Q8IU89,"This gene is a member of the ceramide synthase family of genes. The ceramide synthase enzymes regulate sphingolipid synthesis by catalyzing the formation of ceramides from sphingoid base and acyl-coA substrates. This family member is involved in the synthesis of ceramides with ultra-long-chain acyl moieties (ULC-Cers), important to the epidermis in its role in creating a protective barrier from the environment. The protein encoded by this gene has also been implicated in modification of the lipid structures required for spermatogenesis. Mutations in this gene have been associated with male fertility defects, and epidermal defects, including ichthyosis. Alternative splicing results in multiple transcript variants encoding different isoforms. ",22/11/2021,PubMed,Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans.,23754960,2013,DisGeNET,rs587776996,SNV,,,,,,
rs3785161,26915813,Allele C is not associated with response to trandolapril in people with Hypertension as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,0.096,CES1P1,,CES1P1,carboxylesterase 1 pseudogene 1,16,Q9UKY3,"This gene is a member of the carboxylesterase (CES) gene family. The family members are responsible for the hydrolysis or transesterification of various xenobiotics, such as cocaine and heroin, and endogenous substrates with ester, thioester, or amide bonds. They may participate in fatty acyl and cholesterol ester metabolism, and may play a role in the blood-brain barrier system. This gene does not encode a protein and the sequence is similar to the CES1 gene, so represents a pseudogene of the CES1 gene. [provided by RefSeq, Jun 2010].",22/11/2021,PubMed,CES1P1 variant -816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.,26915813,2017,PharmGKB,1447979801,SNV,trandolapril,DB00519,Approved,"For the treatment of mild to moderate hypertension, as an adjunct in the treatment of congestive heart failure (CHF), to improve survival following myocardial infarction (MI) in individuals who are hemodynamically stable and demonstrate symptoms of left ventricular systolic dysfunction or signs of CHF within a few days following acute MI, and to slow progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy.","(2S,3aR,7aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid",rs3785161 is assigned to âˆ’816A>C in the CES1P1 gene in this study and not associated with response to trandolapril in people with Hypertensionsion
rs6439153,27236921,Pneumococcal Bacteraemia,Kenya,East Africa,NS,FALSE,NS,CFAP92,,CFAP92,cilia and flagella associated protein 92 (putative),3,Q9ULG3,Gene function information is missing for this gene,22/11/2021,PubMed,Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.,27236921,2017,DisGeNET,rs6439153,SNV,,,,,,SNP not found in the specified article
rs1061170,16865697,Age Related Macular Degeneration,"Somali, USA",East Africa / African American/Afro-Caribbean,NS,TRUE,NS,CFH,Genetic variability study,CFH,complement factor H,1,P08603,"This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011].",22/11/2021,PubMed,Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His.,16865697,2006,DisGeNET,rs1061170,SNV,,,,,,The study includes 75 African-Americans and 128 Somalis sampled with other multi-ethnic individuals
rs1061170,16865697,Glycogen Storage Disease Type Ii,"Somali, USA",East Africa / African American/Afro-Caribbean,NS,TRUE,NS,CFH,Genetic variability study,CFH,complement factor H,1,P08603,"This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011].",22/11/2021,PubMed,Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His.,16865697,2006,DisGeNET,rs1061170,SNV,,,,,,The study includes 75 African-Americans and 128 Somalis sampled with other multi-ethnic individuals.
rs1061170,18766990,Age Related Macular Degeneration,South Africa,South Africa,Xhosa,FALSE,NS,CFH,,CFH,complement factor H,1,P08603,"This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011].",22/11/2021,PubMed,The frequency of the H402 allele of CFH and its involvement with age-related maculopathy in an aged Black African Xhosa population.,18766990,2008,DisGeNET,rs1061170,SNV,,,,,,No association with disease have been done only allele and genotype counts and percentages of the CFH Y402H variant in the group of 114 Black South African individuals were evaluated.
rs1061170,23306536,Age Related Macular Degeneration,Tunisia,North Africa,NS,FALSE,2.62E-16,CFH,Genetic variability study,CFH,complement factor H,1,P08603,"This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011].",22/11/2021,PubMed,Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population.,23306536,2013,DisGeNET,rs1061170,SNV,,,,,,The frequency of the CFH 402H allele was significantly higher in AMD patients than in controls. The p-value reports on the difference of the CFH 402H allele frequency between the patient and control groups.
rs202179988,20880762,Congenital Bilateral Aplasia Of Vas Deferens,Morocco,North Africa,NS,FALSE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,[R74W;R1070W;D1270N]: a new complex allele responsible for cystic fibrosis.,20880762,2011,DisGeNET,rs202179988,SNV,,,,,,Observed 1 Moroccon cystic fibrosis patient.
rs202179988,20880762,Cystic Fibrosis,Morocco,North Africa,NS,FALSE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,[R74W;R1070W;D1270N]: a new complex allele responsible for cystic fibrosis.,20880762,2011,DisGeNET,rs202179988,SNV,,,,,,Observed 1 Moroccon cystic fibrosis patient.
rs75549581,9950364,Cystic Fibrosis,Sub-Saharan Africa,Sub-Saharan Africa,"Nguni,Zulu,Xhosa,Ndebele,Swazi,Sotho,Tswana,Pedi,Tsonga,,Shangaan,Venda,Pygmies,Ubangian speakers",TRUE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis carrier frequencies in populations of African origin.,9950364,1999,DisGeNET,rs75549581,SNV,,,,,,
rs201124247,9259197,Cystic Fibrosis,"Algeria, Morocco, Tunisia, Europe",North Africa,NS,TRUE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium.,9259197,2000,DisGeNET,rs201124247,SNV,,,,,,Study investigated the frequency of established cystic fibrosis mutations in various populations.
rs397508604,9259197,Cystic Fibrosis,"Algeria, Morocco, Tunisia, Europe",North Africa,NS,TRUE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium.,9259197,2000,DisGeNET,rs397508604,SNV,,,,,,Study investigated the frequency of established cystic fibrosis mutations in various populations.
rs78655421,9259197,Cystic Fibrosis,"Algeria, Morocco, Tunisia, Europe",North Africa,NS,TRUE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium.,9259197,2000,DisGeNET,rs78655421,SNV,,,,,,Study investigated the frequency of established cystic fibrosis mutations in various populations.
rs75549581,15025720,Cystic Fibrosis,"Cameroon, Senegal, French Guiana",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Novel CFTR mutations in black cystic fibrosis patients.,15025720,2004,DisGeNET,rs75549581,SNV,,,,,,
rs397508700,9222768,Cystic Fibrosis,Algeria,North Africa,Berber/Arab,TRUE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient.,9222768,2000,DisGeNET,rs397508700,SNV,,,,,,"Cystic fibrosis (CF) is a common autosomal recessive genetic disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This study report a novel mutation p.Ala141Asp (rs397508700), identified in a 14-year-old Algerian girl diagnosed with CF at 4 years of age, based on clinical observations and elevated sweat electrolyte levels. The patient has recurrent respiratory infections with Pseudomonas aeruginosa but no digestive symptom."
rs80034486,15357568,Cystic Fibrosis,Egypt,North Africa,NS,FALSE,NS,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Pseudo-Bartter's syndrome in an Egyptian infant with cystic fibrosis mutation N1303K.,15357568,2004,DisGeNET,rs80034486,SNV,,,,,,
rs113993959,19715466,Cystic Fibrosis,Tunisia,North Africa,NS,FALSE,0.000000636,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.,19715466,2009,DisGeNET,rs113993959,SNV,,,,,,
rs374946172,19715466,Cystic Fibrosis,Tunisia,North Africa,NS,FALSE,0.003,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.,19715466,2009,DisGeNET,rs374946172,SNV,,,,,,
rs397508538,19715466,Cystic Fibrosis,Tunisia,North Africa,NS,FALSE,0.04,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.,19715466,2009,DisGeNET,rs397508538,SNV,,,,,,
rs77010898,19715466,Cystic Fibrosis,Tunisia,North Africa,NS,FALSE,< 0.05,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.,19715466,2009,DisGeNET,rs77010898,SNV,,,,,,
rs79850223,19715466,Cystic Fibrosis,Tunisia,North Africa,NS,FALSE,1.45E-10,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.,19715466,2009,DisGeNET,rs79850223,SNV,,,,,,
rs80034486,19715466,Cystic Fibrosis,Tunisia,North Africa,NS,FALSE,1.45E-10,CFTR,,CFTR,CF transmembrane conductance regulator,7,P13569,"This gene encodes a member of the ATP-binding cassette (ABC) transporter superfamily. The encoded protein functions as a chloride channel, making it unique among members of this protein family, and controls ion and water secretion and absorption in epithelial tissues. Channel activation is mediated by cycles of regulatory domain phosphorylation, ATP-binding by the nucleotide-binding domains, and ATP hydrolysis. Mutations in this gene cause cystic fibrosis, the most common lethal genetic disorder in populations of Northern European descent. The most frequently occurring mutation in cystic fibrosis, DeltaF508, results in impaired folding and trafficking of the encoded protein. Multiple pseudogenes have been identified in the human genome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.,19715466,2009,DisGeNET,rs80034486,SNV,,,,,,
rs871606,23087401,Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,0.06,CHIC2,,CHIC2,cysteine rich hydrophobic domain 2,4,Q9UKJ5,"This gene encodes a member of the CHIC family of proteins. The encoded protein contains a cysteine-rich hydrophobic (CHIC) motif, and is localized to vesicular structures and the plasma membrane. This gene is associated with some cases of acute myeloid leukemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491521,SNV,atenolol,DB00335,Approved,1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis.3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,rs871606 near CHIC2 was marginally associated with DBP response to atenolol monotherapy in African Americans.
rs871606,23087401,Allele T is not associated with response to atenolol in people with Hypertension as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,0.06,CHIC2,,CHIC2,cysteine rich hydrophobic domain 2,4,Q9UKJ5,"This gene encodes a member of the CHIC family of proteins. The encoded protein contains a cysteine-rich hydrophobic (CHIC) motif, and is localized to vesicular structures and the plasma membrane. This gene is associated with some cases of acute myeloid leukemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491521,SNV,atenolol,DB00335,Approved,Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,rs871606 near CHIC2 was marginally associated with DBP response to atenolol monotherapy in African Americans.
rs773526895,19064877,"Myasthenic Syndrome, Congenital, Associated With Acetylcholine Receptor Deficiency","Algeria, Libya, Morocco, Tunisia",North Africa,NS,TRUE,NS,CHRNE,,CHRNE,cholinergic receptor nicotinic epsilon subunit,17,Q04844,"Acetylcholine receptors at mature mammalian neuromuscular junctions are pentameric protein complexes composed of four subunits in the ratio of two alpha subunits to one beta, one epsilon, and one delta subunit. The acetylcholine receptor changes subunit composition shortly after birth when the epsilon subunit replaces the gamma subunit seen in embryonic receptors. Mutations in the epsilon subunit are associated with congenital myasthenic syndrome. [provided by RefSeq, Sep 2009].",22/11/2021,PubMed,The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa.,19064877,2009,DisGeNET,rs773526895,SNV,,,,,,
rs414171,20484391,"Bacteremia, Susceptibility To, 2","Gambia, Kenya, Malawi, Hong Kong, Vietnam",East Africa / West Africa,NS,TRUE,NS,CISH,,CISH,cytokine inducible SH2 containing protein,3,Q9NSE2,"The protein encoded by this gene contains a SH2 domain and a SOCS box domain. The protein thus belongs to the cytokine-induced STAT inhibitor (CIS), also known as suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by IL2, IL3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein has been shown to be involved in the inactivation of the erythropoietin receptor. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,CISH and susceptibility to infectious diseases.,20484391,2010,DisGeNET,rs414171,SNV,,,,,,"Tested for an association between CISH polymor-phisms and susceptibility to major infectious diseases (bacteremia, tuberculosis, and severe malaria) in blood samples from 8402 persons in Gambia, Hong Kong, Kenya, Malawi, and Vietnam."
rs414171,20484391,"Malaria, Susceptibility To (Finding)","Gambia, Kenya, Malawi, Hong Kong, Vietnam",East Africa / West Africa,NS,TRUE,NS,CISH,,CISH,cytokine inducible SH2 containing protein,3,Q9NSE2,"The protein encoded by this gene contains a SH2 domain and a SOCS box domain. The protein thus belongs to the cytokine-induced STAT inhibitor (CIS), also known as suppressor of cytokine signaling (SOCS) or STAT-induced STAT inhibitor (SSI), protein family. CIS family members are known to be cytokine-inducible negative regulators of cytokine signaling. The expression of this gene can be induced by IL2, IL3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein has been shown to be involved in the inactivation of the erythropoietin receptor. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,CISH and susceptibility to infectious diseases.,20484391,2010,DisGeNET,rs414171,SNV,,,,,,"Tested for an association between CISH polymor-phisms and susceptibility to major infectious diseases (bacteremia, tuberculosis, and severe malaria) in blood samples from 8402 persons in Gambia, Hong Kong, Kenya, Malawi, and Vietnam."
rs864309516,15521008,"Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",Morocco,North Africa,NS,FALSE,NS,CLDN1,,CLDN1,claudin 1,3,O95832,"Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. Loss of function mutations result in neonatal ichthyosis-sclerosing cholangitis syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease.,15521008,2004,DisGeNET,rs864309516,SNV,,,,,,
rs864309516,12164927,"Ichthyosis, Leukocyte Vacuoles, Alopecia, And Sclerosing Cholangitis",Morocco,North Africa,NS,FALSE,< 0.001,CLDN1,,CLDN1,claudin 1,3,O95832,"Tight junctions represent one mode of cell-to-cell adhesion in epithelial or endothelial cell sheets, forming continuous seals around cells and serving as a physical barrier to prevent solutes and water from passing freely through the paracellular space. These junctions are comprised of sets of continuous networking strands in the outwardly facing cytoplasmic leaflet, with complementary grooves in the inwardly facing extracytoplasmic leaflet. The protein encoded by this gene, a member of the claudin family, is an integral membrane protein and a component of tight junction strands. Loss of function mutations result in neonatal ichthyosis-sclerosing cholangitis syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygosity mapping of a locus for a novel syndromic ichthyosis to chromosome 3q27-q28.,12164927,2002,DisGeNET,rs864309516,SNV,,,,,,
rs398122387,23518707,"Epilepsy, Familial Adult Myoclonic, 5",Egypt,North Africa,NS,FALSE,NS,CNTN2,,CNTN2,contactin 2,1,Q02246,"This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,Autosomal recessive cortical myoclonic tremor and epilepsy: association with a mutation in the potassium channel associated gene CNTN2.,23518707,2013,DisGeNET,rs398122387,SNV,,,,,,
rs387906959,23430903,"Congenital Disorder Of Glycosylation, Type Iil",Morocco,North Africa,NS,FALSE,NS,COG6,,COG6,component of oligomeric golgi complex 6,13,Q9Y2V7,"This gene encodes a subunit of the conserved oligomeric Golgi complex that is required for maintaining normal structure and activity of the Golgi apparatus. The encoded protein is organized with conserved oligomeric Golgi complex components 5, 7 and 8 into a sub-complex referred to as lobe B. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2009].",22/11/2021,PubMed,"Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype.",23430903,2013,DisGeNET,rs387906959,SNV,,,,,,"Sequencing of the COG subunit genes revealed a homozygous mutation (c.G1646T)( rs387906959) in COG6 leading to amino acid exchange p.G549V in the COG6 protein. , The studied patients presented with mutation c.G1646T ( . This mutation produces instability of mRNA rather than a degradation of mutated protein speed of mRNA and contribute to the interindividual phenotypical variation assoiciated in children patient with hyposialylation."
rs606231410,25633957,"Deafness, Autosomal Recessive 53",Tunisia,North Africa,NS,FALSE,NS,COL11A2,,COL11A2,collagen type XI alpha 2 chain,6,P13942,"This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009].",22/11/2021,PubMed,Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53.,25633957,2015,DisGeNET,rs606231410,SNV,,,,,,"COL11A2 mutations, c.109G > T (p.Ala37Ser) and c.2662C > A (p.Pro888Thr)"
rs864309523,25633957,"Deafness, Autosomal Recessive 53",Tunisia,North Africa,NS,FALSE,NS,COL11A2,,COL11A2,collagen type XI alpha 2 chain,6,P13942,"This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009].",22/11/2021,PubMed,Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53.,25633957,2015,DisGeNET,rs864309523,SNV,,,,,,"COL11A2 mutations, c.109G > T (p.Ala37Ser) and c.2662C > A (p.Pro888Thr)"
rs606231410,25633957,Nonsyndromic Deafness,Tunisia,North Africa,NS,FALSE,NS,COL11A2,,COL11A2,collagen type XI alpha 2 chain,6,P13942,"This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009].",22/11/2021,PubMed,Novel mutations confirm that COL11A2 is responsible for autosomal recessive non-syndromic hearing loss DFNB53.,25633957,2015,DisGeNET,rs606231410,SNV,,,,,,"COL11A2 mutations, c.109G > T (p.Ala37Ser) and c.2662C > A (p.Pro888Thr)"
rs797044915,16637051,"Genetic Diseases, Inborn",Egypt,North Africa,NS,FALSE,NS,COL11A2,,COL11A2,collagen type XI alpha 2 chain,6,P13942,"This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009].",22/11/2021,PubMed,Oto-spondylo-megaepiphyseal dysplasia (OSMED): clinical and radiological findings in sibs homozygous for premature stop codon mutation in the COL11A2 gene.,16637051,2006,DisGeNET,rs797044915,SNV,,,,,,
rs72656330,8100856,"Osteogenesis Imperfecta, Recessive Perinatal Lethal",South Africa,South Africa,NS,FALSE,NS,COL1A1,,COL1A1,collagen type I alpha 1 chain,17,P02452,"This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008].",22/11/2021,PubMed,"Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible.",8100856,1993,DisGeNET,rs72656330,SNV,,,,,,COLlAl and COL1A2 genes in the article
rs72658200,3995789,Osteogenesis Imperfecta Type Iii (Disorder),South Africa,South Africa,NS,FALSE,NS,COL1A2,,COL1A2,collagen type I alpha 2 chain,7,P08123,"This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008].",22/11/2021,PubMed,On the paradoxically high relative prevalence of osteogenesis imperfecta type III in the black population of South Africa.,3995789,1985,DisGeNET,rs72658200,SNV,,,,,,
rs2104772,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,0.017,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs2104772,SNV,,,,,,
rs1330363,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,0.02,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs1330363,SNV,,,,,,
rs1249744,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,NS,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs1249744,SNV,,,,,,Not associeted with Achilles Tendinopathy
rs13321,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,NS,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs13321,SNV,,,,,,Not associeted with Achilles Tendinopathy ; The GCA haplotype (rs946053-rs13321-rs2104772) occurred significantly more frequently in TEN participants compared to CON (27% vs. 18%; p Â¼ 0.019)
rs4143245,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,NS,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs4143245,SNV,,,,,,Not associeted with Achilles Tendinopathy ; The GCA haplotype (rs946053-rs13321-rs2104772) occurred significantly more frequently in TEN participants compared to CON (27% vs. 18%; p=0.019)
rs753085,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,NS,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs753085,SNV,,,,,,Not associeted with Achilles Tendinopathy
rs946053,23192621,Disorder Of Achilles Tendon,"South Africa, Australia",South Africa,NS,TRUE,NS,COL27A1,,COL27A1,collagen type XXVII alpha 1 chain,9,Q8IZC6,"This gene encodes a member of the fibrillar collagen family, and plays a role during the calcification of cartilage and the transition of cartilage to bone. The encoded protein product is a preproprotein. It includes an N-terminal signal peptide, which is followed by an N-terminal propetide, mature peptide and a C-terminal propeptide. The N-terminal propeptide contains thrombospondin N-terminal-like and laminin G-like domains. The mature peptide is a major triple-helical region. The C-terminal propeptide, also known as COLFI domain, plays crucial roles in tissue growth and repair. Mutations in this gene cause Steel syndrome. Alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been determined. ",22/11/2021,PubMed,Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations.,23192621,2013,DisGeNET,rs946053,SNV,,,,,,The GCA haplotype (rs946053-rs13321-rs2104772) occurred significantly more frequently in TEN participants compared to CON (27% vs. 18%; p =0.019)
rs121912931,16909383,Stickler Syndrome (Disorder),Morocco,North Africa,NS,FALSE,NS,COL9A1,,COL9A1,collagen type IX alpha 1 chain,6,P20849,"This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.,16909383,2006,DisGeNET,rs121912931,SNV,,,,,,COL9A1 is the fourth identified gene that can cause Stickler syndrome.
rs121912931,16909383,"Stickler Syndrome, Type 1",Morocco,North Africa,NS,FALSE,NS,COL9A1,,COL9A1,collagen type IX alpha 1 chain,6,P20849,"This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.,16909383,2006,DisGeNET,rs121912931,SNV,,,,,,COL9A1 is the fourth identified gene that can cause Stickler syndrome.
rs121912931,16909383,"Stickler Syndrome, Type Iv",Morocco,North Africa,NS,FALSE,NS,COL9A1,,COL9A1,collagen type IX alpha 1 chain,6,P20849,"This gene encodes one of the three alpha chains of type IX collagen, which is a minor (5-20%) collagen component of hyaline cartilage. Type IX collagen is usually found in tissues containing type II collagen, a fibrillar collagen. Studies in knockout mice have shown that synthesis of the alpha 1 chain is essential for assembly of type IX collagen molecules, a heterotrimeric molecule, and that lack of type IX collagen is associated with early onset osteoarthritis. Mutations in this gene are associated with osteoarthritis in humans, with multiple epiphyseal dysplasia, 6, a form of chondrodysplasia, and with Stickler syndrome, a disease characterized by ophthalmic, orofacial, articular, and auditory defects. Two transcript variants that encode different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene.,16909383,2006,DisGeNET,rs121912931,SNV,,,,,,COL9A1 is the fourth identified gene that can cause Stickler syndrome.
rs4680,29259946,Allele G is not associated with dose of morphine in people with Pain as compared to allele A.,Tunisia,North Africa,NS,FALSE,NS,COMT,,COMT,catechol-O-methyltransferase,22,P21964,"Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008].",22/11/2021,PubMed,Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment.,29259946,2017,PharmGKB,1449182349,SNV,morphine,DB00295,"Approved, Investigational","Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse.","(4R,4aR,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",rs4680 is assigned to 158A>G allele in the COMT gene in this study and is not associated with dose of morphine in people with Pain.
rs737865,16876132,Genotype AA is associated with decreased response to bupropion in smokers as compared to genotypes AG + GG.,USA,African American/Afro-Caribbean,African American,FALSE,0.05,COMT,,COMT,catechol-O-methyltransferase,22,P21964,"Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008].",22/11/2021,PubMed,Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence.,16876132,2007,PharmGKB,981419313,SNV,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,rs737865 is assigned to COMT gene in this study and associated with a lower response rate to bupropion
rs61738009,21922598,Febrile Convulsions,"Morocco, Europe",North Africa,NS,TRUE,0.03,CPA6,,CPA6,carboxypeptidase A10,8,Q8N4T4,"The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome.",22/11/2021,PubMed,Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy.,21922598,2012,DisGeNET,rs61738009,SNV,,,,,,
rs114402678,21922598,"Febrile Seizures, Familial, 11","Morocco, Europe",North Africa,NS,TRUE,0.00000077,CPA6,,CPA6,carboxypeptidase A6,8,Q8N4T0,"The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome.",22/11/2021,PubMed,Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy.,21922598,2012,DisGeNET,rs114402678,SNV,,,,,,
rs61738009,21922598,"Epilepsies, Partial","Morocco, Europe",North Africa,NS,TRUE,0.03,CPA6,,CPA6,carboxypeptidase A7,8,Q8N4T1,"The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome.",22/11/2021,PubMed,Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy.,21922598,2012,DisGeNET,rs61738009,SNV,,,,,,
rs61738009,21922598,"Epilepsy, Familial Temporal Lobe, 5","Morocco, Europe",North Africa,NS,TRUE,0.03,CPA6,,CPA6,carboxypeptidase A8,8,Q8N4T2,"The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome.",22/11/2021,PubMed,Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy.,21922598,2012,DisGeNET,rs61738009,SNV,,,,,,
rs61738009,21922598,"Epilepsy, Temporal Lobe","Morocco, Europe",North Africa,NS,TRUE,0.03,CPA6,,CPA6,carboxypeptidase A9,8,Q8N4T3,"The gene encodes a member of the peptidase M14 family of metallocarboxypeptidases. The encoded preproprotein is proteolytically processed to generate the mature enzyme, which catalyzes the release of large hydrophobic C-terminal amino acids. This enzyme has functions ranging from digestion of food to selective biosynthesis of neuroendocrine peptides. Mutations in this gene may be linked to epilepsy and febrile seizures, and a translocation t(6;8)(q26;q13) involving this gene has been associated with Duane retraction syndrome.",22/11/2021,PubMed,Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy.,21922598,2012,DisGeNET,rs61738009,SNV,,,,,,
rs398123015,23332917,"Spastic Paraplegia 46, Autosomal Recessive",Tunisia,North Africa,NS,FALSE,NS,CREB3,,CREB3,cAMP responsive element binding protein 3,9,O43889,"This gene encodes a transcription factor that is a member of the leucine zipper family of DNA binding proteins. This protein binds to the cAMP-response element and regulates cell proliferation. The protein interacts with host cell factor C1, which also associates with the herpes simplex virus (HSV) protein VP16 that induces transcription of HSV immediate-early genes. This protein and VP16 both bind to the same site on host cell factor C1. It is thought that the interaction between this protein and host cell factor C1 plays a role in the establishment of latency during HSV infection. This protein also plays a role in leukocyte migration, tumor suppression, and endoplasmic reticulum stress-associated protein degradation. Additional transcript variants have been identified, but their biological validity has not been determined.[provided by RefSeq, Nov 2009].",22/11/2021,PubMed,Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity.,23332917,2013,DisGeNET,rs398123015,SNV,,,,,,
rs387907333,21955071,Osteogenesis Imperfecta Type Vii,Egypt,North Africa,NS,FALSE,NS,CRTAP,,CRTAP,cartilage associated protein,3,O75718,"The protein encoded by this gene is similar to the chicken and mouse CRTAP genes. The encoded protein is a scaffolding protein that may influence the activity of at least one member of the cytohesin/ARNO family in response to specific cellular stimuli. Defects in this gene are associated with osteogenesis imperfecta, a connective tissue disorder characterized by bone fragility and low bone mass. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.,21955071,2013,DisGeNET,rs387907333,SNV,,,,,,
rs28931605,12676897,"Cataract, Congenital, Cerulean Type, 3",Morocco,North Africa,NS,FALSE,NS,CRYGD,,CRYGD,crystallin gamma D,2,P07320,"Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts.,12676897,2003,DisGeNET,rs28931605,SNV,,,,,,
rs28931605,12676897,"Cataract, Punctate, Progressive Juvenile-Onset",Morocco,North Africa,NS,FALSE,NS,CRYGD,,CRYGD,crystallin gamma D,2,P07320,"Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts.,12676897,2003,DisGeNET,rs28931605,SNV,,,,,,
rs28931605,12676897,Cerulean cataract,Morocco,North Africa,NS,FALSE,NS,CRYGD,,CRYGD,crystallin gamma D,2,P07320,"Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts.,12676897,2003,DisGeNET,rs28931605,SNV,,,,,,
rs28931605,12676897,Nonnuclear Polymorphic Congenital Cataract,Morocco,North Africa,NS,FALSE,NS,CRYGD,,CRYGD,crystallin gamma D,2,P07320,"Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. Four gamma-crystallin genes (gamma-A through gamma-D) and three pseudogenes (gamma-E, gamma-F, gamma-G) are tandemly organized in a genomic segment as a gene cluster. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts.,12676897,2003,DisGeNET,rs28931605,SNV,,,,,,
rs147739031,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,9.96E-07,CSMD1,Association,CSMD1,CUB and Sushi multiple domains 1,8,Q96PZ7,"Predicted to act upstream of or within several processes, including learning or memory; mammary gland branching involved in pregnancy; and reproductive structure development. Predicted to be integral component of membrane. ",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs147739031,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs73505850,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,6.67E-07,CSMD1,Association,CSMD1,CUB and Sushi multiple domains 1,8,Q96PZ7,"Predicted to act upstream of or within several processes, including learning or memory; mammary gland branching involved in pregnancy; and reproductive structure development. Predicted to be integral component of membrane. ",22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs73505850,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the additive model."
rs74315443,9012407,Unverricht-Lundborg Syndrome,"North Africa, Europe",North Africa,NS,TRUE,NS,CSTB,,CSTB,cystatin B,21,P04080,"The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and kininogens. This gene encodes a stefin that functions as an intracellular thiol protease inhibitor. The protein is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. The protein is thought to play a role in protecting against the proteases leaking from lysosomes. Evidence indicates that mutations in this gene are responsible for the primary defects in patients with progressive myoclonic epilepsy (EPM1). One type of mutation responsible for EPM1 is the expansion in the promoter region of this gene of a CCCCGCCCCGCG repeat from 2-3 copies to 30-78 copies. [provided by RefSeq, Jul 2016].",22/11/2021,PubMed,"Identification of mutations in cystatin B, the gene responsible for the Unverricht-Lundborg type of progressive myoclonus epilepsy (EPM1).",9012407,1997,DisGeNET,rs74315443,SNV,,,,,,
rs231775,23829277,"Lymphoma, Non-Hodgkin",Egypt,North Africa,NS,FALSE,0.01,CTLA4,,CTLA4,cytotoxic T-lymphocyte associated protein 4,2,P16410,"This gene is a member of the immunoglobulin superfamily and encodes a protein which transmits an inhibitory signal to T cells. The protein contains a V domain, a transmembrane domain, and a cytoplasmic tail. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. The membrane-bound isoform functions as a homodimer interconnected by a disulfide bond, while the soluble isoform functions as a monomer. Mutations in this gene have been associated with insulin-dependent diabetes mellitus, Graves disease, Hashimoto thyroiditis, celiac disease, systemic lupus erythematosus, thyroid-associated orbitopathy, and other autoimmune diseases. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Association of cytotoxic T-lymphocyte antigen 4 genetic polymorphism, hepatitis C viral infection and B-cell non-Hodgkin lymphoma: an Egyptian study.",23829277,2014,DisGeNET,rs231775,SNV,,,,,,
rs375952052,25326109,"Cystinosis, Benign, Nonnephropathic",South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,CTNS,,CTNS,"cystinosin, lysosomal cystine transporter",17,O60931,"This gene encodes a seven-transmembrane domain protein that functions to transport cystine out of lysosomes. Its activity is driven by the H+ electrochemical gradient of the lysosomal membrane. Mutations in this gene cause cystinosis, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009].",22/11/2021,PubMed,Common mutation causes cystinosis in the majority of black South African patients.,25326109,2015,DisGeNET,rs375952052,SNV,,,,,,Xhosa-speaking black South Africans and seven were Cape Coloureds (mixed race).
rs375952052,25326109,Juvenile Nephropathic Cystinosis (Disorder),South Africa,South Africa,"Xhosa,Coloured",TRUE,NS,CTNS,,CTNS,"cystinosin, lysosomal cystine transporter",17,O60931,"This gene encodes a seven-transmembrane domain protein that functions to transport cystine out of lysosomes. Its activity is driven by the H+ electrochemical gradient of the lysosomal membrane. Mutations in this gene cause cystinosis, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009].",22/11/2021,PubMed,Common mutation causes cystinosis in the majority of black South African patients.,25326109,2015,DisGeNET,rs375952052,SNV,,,,,,Xhosa-speaking black South Africans and seven were Cape Coloureds (mixed race).
rs1044703733,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,0.919,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs1044703733,SNV,,,,,,
rs104894215,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,> 0.05,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs104894215,SNV,,,,,,
rs104894216,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,> 0.05,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs104894216,SNV,,,,,,
rs217086,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,0.017,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs217086,SNV,,,,,,
rs587777532,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,0.04,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs587777532,SNV,,,,,,
rs587777533,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,0.04,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs587777533,SNV,,,,,,
rs587777534,11886537,Papillon-Lefevre Disease,"Algeria, Morocco, Europe",North Africa,NS,TRUE,0.04,CTSC,,CTSC,cathepsin C,11,P53634,"This gene encodes a member of the peptidase C1 family and lysosomal cysteine proteinase that appears to be a central coordinator for activation of many serine proteinases in cells of the immune system. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate heavy and light chains that form a disulfide-linked dimer. A portion of the propeptide acts as an intramolecular chaperone for the folding and stabilization of the mature enzyme. This enzyme requires chloride ions for activity and can degrade glucagon. Defects in the encoded protein have been shown to be a cause of Papillon-Lefevre syndrome, an autosomal recessive disorder characterized by palmoplantar keratosis and periodontitis. ",22/11/2021,PubMed,"Novel point mutations, deletions, and polymorphisms in the cathepsin C gene in nine families from Europe and North Africa with Papillon-Lef√®vre syndrome.",11886537,2001,DisGeNET,rs587777534,SNV,,,,,,
rs763059810,12325020,Acquired Immunodeficiency Syndrome,South Africa,South Africa,NS,FALSE,0.008,CXCR4,,CXCR4,C-X-C motif chemokine receptor 4,2,P61073,"This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane regions and is located on the cell surface. It acts with the CD4 protein to support HIV entry into cells and is also highly expressed in breast cancer cells. Mutations in this gene have been associated with WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.",22/11/2021,PubMed,Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay.,12325020,2002,DisGeNET,rs763059810,SNV,,,,,,
rs28934586,2022736,11-Beta-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.,2022736,1991,DisGeNET,rs28934586,SNV,,,,,,
rs28934586,2022736,Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.,2022736,1991,DisGeNET,rs28934586,SNV,,,,,,
rs28934586,8530633,11-Beta-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Absence of steroid biosynthetic defects in heterozygote individuals for classic 11 beta-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene.,8530633,1995,DisGeNET,rs28934586,SNV,,,,,,
rs28934586,8530633,Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Absence of steroid biosynthetic defects in heterozygote individuals for classic 11 beta-hydroxylase deficiency due to a R448H mutation in the CYP11B1 gene.,8530633,1995,DisGeNET,rs28934586,SNV,,,,,,
rs28934586,7049883,Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency,"Morocco, Tunisia, Turkey",North Africa,NS,TRUE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.,7049883,1982,DisGeNET,rs28934586,SNV,,,,,,
rs28934586,16030166,Deficiency Of Monooxygenase,Morocco,North Africa,Jewish,FALSE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews.,16030166,2005,DisGeNET,rs28934586,SNV,,,,,,
rs28934586,16030166,Congenital Adrenal Hyperplasia Due To 11-Beta-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP11B1,,CYP11B1,cytochrome P450 family 11 subfamily B member 1,8,P15538,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the mitochondrial inner membrane and is involved in the conversion of progesterone to cortisol in the adrenal cortex. Mutations in this gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews.,16030166,2005,DisGeNET,rs28934586,SNV,,,,,,
rs762551,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AA + AC.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.2734,CYP1A2,,CYP1A2,cytochrome P450 family 1 subfamily A member 2,15,P05177,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680695,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs45564134,26779253,Allele G is not associated with concentrations of efavirenz in people with HIV as compared to genotypes G/del + del/del.,South Africa,South Africa,NS,FALSE,0.8789,CYP1A2,,CYP1A2,cytochrome P450 family 1 subfamily A member 2,15,P05177,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680719,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP1A2*1K,12920202,CYP1A2 *1K is associated with decreased metabolism of caffeine in healthy individuals.,Ethiopia,East Africa,NS,FALSE,< 0.02,CYP1A2,,CYP1A2,cytochrome P450 family 1 subfamily A member 2,15,P05177,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.,12920202,2003,PharmGKB,827698390,Star allele,caffeine,DB00201,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione",
rs762551,26348712,Genotype CC is associated with increased response to nevirapine in people with HIV as compared to genotypes AA + AC.,Zimbabwe,South Africa,Shona,FALSE,0.012,CYP1A2,,CYP1A2,cytochrome P450 family 1 subfamily A member 2,15,P05177,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.,26348712,2016,PharmGKB,1448110413,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP1A2 g.-163C>A(rs762551)
rs28936700,12372064,"Glaucoma 3, Primary Congenital, A",Morocco,North Africa,NS,FALSE,NS,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco.,12372064,2003,DisGeNET,rs28936700,SNV,,,,,,
rs28936700,12372064,Primary Congenital Glaucoma,Morocco,North Africa,NS,FALSE,NS,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel frameshift founder mutation in the cytochrome P450 1B1 (CYP1B1) gene is associated with primary congenital glaucoma in Morocco.,12372064,2003,DisGeNET,rs28936700,SNV,,,,,,
rs4986888,11854439,"Glaucoma 3, Primary Congenital, A",Ethiopia,East Africa,NS,FALSE,NS,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.,11854439,2002,DisGeNET,rs4986888,SNV,,,,,,
rs4986888,11854439,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)",Ethiopia,East Africa,NS,FALSE,NS,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.,11854439,2002,DisGeNET,rs4986888,SNV,,,,,,
rs4986888,11854439,"Glaucoma, Primary Open Angle, Juvenile-Onset",Ethiopia,East Africa,NS,FALSE,NS,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.,11854439,2002,DisGeNET,rs4986888,SNV,,,,,,
rs4986888,11854439,Hydrophthalmos,Ethiopia,East Africa,NS,FALSE,NS,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.,11854439,2002,DisGeNET,rs4986888,SNV,,,,,,
rs104893628,14635112,"Glaucoma 3, Primary Congenital, A","Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893628,SNV,,,,,,
rs104893628,14635112,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)","Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893628,SNV,,,,,,
rs104893628,14635112,"Glaucoma, Primary Open Angle, Juvenile-Onset","Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893628,SNV,,,,,,
rs104893628,14635112,Hydrophthalmos,"Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893628,SNV,,,,,,
rs104893629,14635112,"Glaucoma 3, Primary Congenital, A","Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893629,SNV,,,,,,
rs104893629,14635112,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)","Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893629,SNV,,,,,,
rs104893629,14635112,"Glaucoma, Primary Open Angle, Juvenile-Onset","Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893629,SNV,,,,,,
rs104893629,14635112,Hydrophthalmos,"Algeria, Europe",North Africa,NS,TRUE,> 0.05,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs104893629,SNV,,,,,,
rs148542782,14635112,"Glaucoma 3, Primary Congenital, A","Algeria, Europe",North Africa,NS,TRUE,0.000000996,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs148542782,SNV,,,,,,
rs148542782,14635112,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)","Algeria, Europe",North Africa,NS,TRUE,0.000000996,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs148542782,SNV,,,,,,
rs148542782,14635112,"Glaucoma, Primary Open Angle, Juvenile-Onset","Algeria, Europe",North Africa,NS,TRUE,0.000000996,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs148542782,SNV,,,,,,
rs148542782,14635112,Hydrophthalmos,"Algeria, Europe",North Africa,NS,TRUE,0.000000996,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs148542782,SNV,,,,,,
rs55989760,14635112,"Glaucoma 3, Primary Congenital, A","Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs55989760,SNV,,,,,,
rs55989760,14635112,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)","Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs55989760,SNV,,,,,,
rs55989760,14635112,"Glaucoma, Primary Open Angle, Juvenile-Onset","Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs55989760,SNV,,,,,,
rs55989760,14635112,Hydrophthalmos,"Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs55989760,SNV,,,,,,
rs57865060,14635112,"Glaucoma 3, Primary Congenital, A","Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs57865060,SNV,,,,,,
rs57865060,14635112,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)","Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs57865060,SNV,,,,,,
rs57865060,14635112,"Glaucoma, Primary Open Angle, Juvenile-Onset","Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs57865060,SNV,,,,,,
rs57865060,14635112,Hydrophthalmos,"Algeria, Europe",North Africa,NS,TRUE,0.04,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs57865060,SNV,,,,,,
rs72549378,14635112,"Glaucoma 3, Primary Congenital, A","Algeria, Europe",North Africa,NS,TRUE,6.82E-08,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs72549378,SNV,,,,,,
rs72549378,14635112,"Glaucoma, Primary Open Angle, Adult-Onset (Disorder)","Algeria, Europe",North Africa,NS,TRUE,6.82E-08,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs72549378,SNV,,,,,,
rs72549378,14635112,"Glaucoma, Primary Open Angle, Juvenile-Onset","Algeria, Europe",North Africa,NS,TRUE,6.82E-08,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs72549378,SNV,,,,,,
rs72549378,14635112,Hydrophthalmos,"Algeria, Europe",North Africa,NS,TRUE,6.82E-08,CYP1B1,,CYP1B1,cytochrome P450 family 1 subfamily B member 1,2,Q16678,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The enzyme encoded by this gene localizes to the endoplasmic reticulum and metabolizes procarcinogens such as polycyclic aromatic hydrocarbons and 17beta-estradiol. Mutations in this gene have been associated with primary congenital glaucoma; therefore it is thought that the enzyme also metabolizes a signaling molecule involved in eye development, possibly a steroid. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.,14635112,2003,DisGeNET,rs72549378,SNV,,,,,,
rs7755898,18973462,21-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation.,18973462,2009,DisGeNET,rs7755898,SNV,,,,,,
rs6475,18973462,Chronic Active Hepatitis,Morocco,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation.,18973462,2009,DisGeNET,rs6475,SNV,,,,,,
rs7755898,18973462,Chronic Active Hepatitis,Morocco,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation.,18973462,2009,DisGeNET,rs7755898,SNV,,,,,,
rs7755898,18973462,Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation.,18973462,2009,DisGeNET,rs7755898,SNV,,,,,,
rs7755898,21532487,21-Hydroxylase Deficiency,Morocco,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Detection of a frequent duplicated CYP21A2 gene carrying a Q318X mutation in a general population with quantitative PCR methods.,21532487,2011,DisGeNET,rs7755898,SNV,,,,,,
rs7755898,14715874,21-Hydroxylase Deficiency,Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs7755898,SNV,,,,,,
rs7755898,14715874,Chronic Active Hepatitis,Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs7755898,SNV,,,,,,
rs6475,14715874,Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency,Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs6475,SNV,,,,,,
rs759736443,14715874,Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency,Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs759736443,SNV,,,,,,
rs7755898,14715874,Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency,Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs7755898,SNV,,,,,,
rs7769409,14715874,Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency,Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs7769409,SNV,,,,,,
rs6475,14715874,"Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs6475,SNV,,,,,,
rs759736443,14715874,"Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs759736443,SNV,,,,,,
rs7769409,14715874,"Hyperandrogenism, Nonclassic Type, Due To 21-Hydroxylase Deficiency",Tunisia,North Africa,NS,FALSE,NS,CYP21A2,,CYP21A2,cytochrome P450 family 21 subfamily A member 2,6,P08686,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation.,14715874,2004,DisGeNET,rs7769409,SNV,,,,,,
rs397515353,8514861,"Xanthomatosis, Cerebrotendinous",Morocco,North Africa,Jewish,FALSE,NS,CYP27A1,,CYP27A1,cytochrome P450 family 27 subfamily A member 1,2,Q02318,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.,8514861,1993,DisGeNET,rs397515353,SNV,,,,,,
rs397515354,8514861,"Xanthomatosis, Cerebrotendinous",Morocco,North Africa,Jewish,FALSE,NS,CYP27A1,,CYP27A1,cytochrome P450 family 27 subfamily A member 1,2,Q02318,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.,8514861,1993,DisGeNET,rs397515354,SNV,,,,,,
rs587778812,8514861,"Xanthomatosis, Cerebrotendinous",Morocco,North Africa,Jewish,FALSE,NS,CYP27A1,,CYP27A1,cytochrome P450 family 27 subfamily A member 1,2,Q02318,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.,8514861,1993,DisGeNET,rs587778812,SNV,,,,,,
rs121908102,8014582,"Xanthomatosis, Cerebrotendinous",Morocco,North Africa,Jewish,TRUE,NS,CYP27A1,Genetic variability study,CYP27A1,cytochrome P450 family 27 subfamily A member 1,2,Q02318,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein oxidizes cholesterol intermediates as part of the bile synthesis pathway. Since the conversion of cholesterol to bile acids is the major route for removing cholesterol from the body, this protein is important for overall cholesterol homeostasis. Mutations in this gene cause cerebrotendinous xanthomatosis, a rare autosomal recessive lipid storage disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular genetics of cerebrotendinous xanthomatosis in Jews of north African origin.,8014582,1994,DisGeNET,rs121908102,SNV,,,,,,"Two mutations were shown to cause CTX in four Jewish families of Moroccon origin. An additional mutant allele, found in a Jewish family of Algerian origin is characterized. Sequence analysis revealed a C to T transition at cDNA position 1037 which predicted a threonine to methionine substitution at residue 306 (designated T306M). It is highly suggestive, but not definitive, that this transition is the mutation causing CTX. A search for additional cases from Jewish families of North African extraction identified five new families including 10 cases. The three sterol 27-hydroxylase gene mutations account for all 10 CTX families and their presence may suggest the existence of positive selective forces that lead to an increased prevalence of this relatively rare disease in Jewish from North Africa."
rs28399454,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.15,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680725,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399433,19659438,Genotype AC is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.,Haiti,African American/Afro-Caribbean,NS,FALSE,0.0187,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.",19659438,2009,PharmGKB,827704966,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2A6*2,19238117,CYP2A6 *2 is associated with decreased metabolism of efavirenz in people with HIV.,USA,African American/Afro-Caribbean,NS,TRUE,0.06,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function.,19238117,2009,PharmGKB,827803602,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*6,24497997,CYP2B6 *6 is associated with metabolism of efavirenz in people with HIV.,Uganda,East Africa,NS,FALSE,< 0.0001,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.,24497997,2014,PharmGKB,1183944291,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399433,24729586,Allele C is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,0.004,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.,24729586,2015,PharmGKB,1184467517,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2A6*17,15993850,CYP2A6 *17/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.,15993850,2005,PharmGKB,827827648,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*1A,15993850,CYP2A6 *17/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.,15993850,2005,PharmGKB,827827648,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*20,15993850,CYP2A6 *17/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.,15993850,2005,PharmGKB,827827648,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*1A,15993850,CYP2A6 *1A/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.,15993850,2005,PharmGKB,827827639,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*20,15993850,CYP2A6 *1A/*20 is associated with decreased metabolism of nicotine in healthy individuals as compared to CYP2A6 *1A/*1A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.,15993850,2005,PharmGKB,827827639,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*1A,17267622,CYP2A6 *1X2B is associated with increased metabolism of nicotine as compared to CYP2A6 *1A.,USA,African American/Afro-Caribbean,African American,FALSE,> 0.05,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel duplication type of CYP2A6 gene in African-American population.,17267622,2007,PharmGKB,827827796,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*1X2B,17267622,CYP2A6 *1X2B is associated with increased metabolism of nicotine as compared to CYP2A6 *1A.,USA,African American/Afro-Caribbean,African American,FALSE,> 0.05,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel duplication type of CYP2A6 gene in African-American population.,17267622,2007,PharmGKB,827827796,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*17,27035242,CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.,27035242,2017,PharmGKB,1447982613,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*26,27035242,CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.,27035242,2017,PharmGKB,1447982613,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*4A,27035242,CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.,27035242,2017,PharmGKB,1447982613,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
CYP2A6*9,27035242,CYP2A6 *4A/*17 + *9/*26 are associated with decreased metabolism of nicotine.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2A6,,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.,27035242,2017,PharmGKB,1447982613,Star allele,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,
rs140471703,24305170,Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC.,Canada,African American/Afro-Caribbean,NS,FALSE,< 0.001,CYP2A6,Association,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.,24305170,2014,PharmGKB,1183701955,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,This is an in vitro functional study from 32 African-American individuals with low CYP2A6 activity. CYP2A6*41 (R265Q) corresponds to c.794G>A (rs140471703-T) and shows lower nicotine metabolism
rs143690364,24305170,Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC.,Canada,African American/Afro-Caribbean,NS,FALSE,< 0.001,CYP2A6,Association,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.,24305170,2014,PharmGKB,1183701959,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,This is an in vitro functional study from 32 African-American individuals with low CYP2A6 activity. CYP2A6*39 (V68M) corresponds to c.202G>A (rs143690364-T) and shows lower nicotine metabolism.
rs376817657,24305170,Genotypes CT + TT is associated with decreased metabolism of nicotine as compared to genotype CC.,Canada,African American/Afro-Caribbean,NS,FALSE,< 0.001,CYP2A6,Association,CYP2A6,cytochrome P450 family 2 subfamily A member 6,19,P11509,"This gene, CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.,24305170,2014,PharmGKB,1183701942,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,This is an in vitro functional study from 32 African-American individuals with low CYP2A6 activity. CYP2A6*44 (E390K) corresponds to c.1168G>A (rs376817657-T) and shows lower nicotine metabolism.
CYP2B6*1,19916993,CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.",19916993,2010,PharmGKB,1448995884,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*11,19916993,CYP2B6 *11 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.",19916993,2010,PharmGKB,1448995884,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*6,19916993,CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.",19916993,2010,PharmGKB,1448995871,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*1,19916993,CYP2B6 *6 is associated with decreased clearance of efavirenz in healthy individuals as compared to CYP2B6 *1/*1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single-dose efavirenz population pharmacokinetics in Ugandans.",19916993,2010,PharmGKB,1448995871,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs4803419,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.0045,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680740,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one","Patients with HIV and the CC genotype may have lower plasma concentrations of efavirenz as compared to patients with the CT or TT genotypes. However, other studies have failed to find this association. Other clinical and genetic factors may also influence plasma concentrations of efavirenz in patients with HIV. This annotation only covers the pharmacokinetic relationship between rs4803419 and efavirenz and does not include evidence about clinical outcomes."
rs1042389,26779253,Genotype TT is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CC + CT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.0065,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680819,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs35303484,26779253,Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AG + GG.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.7802,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680733,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Patients with the AA genotype and HIV who are treated with efavirenz may have decreased efavirenz plasma concentrations as compared to patients with the GG genotype. 
rs28399499,26779253,Genotype CC is associated with increased concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680778,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs2279343,26779253,Allele G is associated with increased concentrations of efavirenz in people with HIV as compared to allele A.,South Africa,South Africa,NS,FALSE,< 0.05,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680752,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,26779253,Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G.,South Africa,South Africa,NS,FALSE,< 0.05,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680746,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Genotype TT is associated with increased plasma concentration of efavirenz in people with HIV Infections as compared to genotypes GG + GT.
rs3745274,26779253,Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G.,South Africa,South Africa,NS,FALSE,< 0.05,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1446905193,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Genotype TT is associated with increased plasma concentration of efavirenz in people with HIV Infections as compared to genotypes GG + GT.
rs3745274,28481785,Genotypes GT + TT are associated with decreased resistance to efavirenz in people with HIV as compared to genotype GG.,Botswana,South Africa,NS,FALSE,0.06,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Brief Report: CYP2B6 516G>T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana.,28481785,2017,PharmGKB,1448617505,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYPB2B6 516G>T (rs3745274)
rs3745274,26831894,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,"South Africa, Zimbabwe",South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.,26831894,2016,PharmGKB,1448997257,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 c.516G/T (rs3745274)
rs3745274,26831894,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,"South Africa, Zimbabwe",South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.,26831894,2016,PharmGKB,1448663995,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 c.516G/T (rs3745274)
rs3745274,26831894,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,"South Africa, Zimbabwe",South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.,26831894,2016,PharmGKB,1448997108,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 c.516G/T (rs3745274)
CYP2B6*6,27045425,CYP2B6 *6 is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to CYP2B6 *1.,Uganda,East Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.,27045425,2017,PharmGKB,1447984366,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*1,27045425,CYP2B6 *6 is associated with increased trough concentration of efavirenz in people with HIV and Tuberculosis as compared to CYP2B6 *1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 genotype-based efavirenz dose recommendations during rifampicin-based antituberculosis cotreatment for a sub-Saharan Africa population.,27045425,2017,PharmGKB,1447984366,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,25303294,Genotypes GT + TT is associated with concentrations of efavirenz in people with HIV as compared to genotype GG.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.",25303294,2015,PharmGKB,1185234900,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Patients with the GT genotype and HIV infection may have increased plasma concentrations and decreased clearance of efavirenz as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's exposure to efavirenz.This annotation only covers the pharmacokinetic relationship between rs3745274 and efavirenz and does not include evidence about clinical outcomes.
rs35303484,25303294,Allele G is associated with concentrations of efavirenz in people with HIV as compared to allele A.,Uganda,East Africa,NS,FALSE,< 0.05,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.",25303294,2015,PharmGKB,1185234929,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Patients with the GG genotype and HIV who are treated with efavirenz may have increased efavirenz plasma concentrations as compared to patients with the AA genotype. Evidence is conflicting as to this association. Other genetic and clinical factors may also influence a patient's metabolism of efavirenz.
rs28399499,28692529,Genotypes CC + CT is associated with decreased clearance of efavirenz in people with HIV as compared to genotype TT.,Botswana,South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.,28692529,2018,PharmGKB,1448636182,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 983Tâ†’C (rs28399499)
rs3745274,28692529,Genotypes GT + TT is associated with decreased clearance of efavirenz in people with HIV as compared to genotype GG.,Botswana,South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 genotypes and early efavirenz-based HIV treatment outcomes in Botswana.,28692529,2018,PharmGKB,1448636173,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 516Gâ†’T(rs3745274)
rs3745274,28816644,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,South Africa,South Africa,NS,FALSE,0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.,28816644,2018,PharmGKB,1448997257,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,28816644,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,South Africa,South Africa,NS,FALSE,0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.,28816644,2018,PharmGKB,1448663995,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,28816644,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,South Africa,South Africa,NS,FALSE,0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.,28816644,2018,PharmGKB,1448997108,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399499,28816644,Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT.,South Africa,South Africa,NS,FALSE,0.411,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.,28816644,2018,PharmGKB,1448997264,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 c.983T>C (rs28399499) 24 months Post Efavirenz-Based Antiretroviral Therapy Initiation
rs28399499,28816644,Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT.,South Africa,South Africa,NS,FALSE,0.411,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.,28816644,2018,PharmGKB,1448665545,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 c.983T>C (rs28399499) 24 months Post Efavirenz-Based Antiretroviral Therapy Initiation
rs2279343,28816644,Allele G is not associated with increased concentrations of efavirenz in children with HIV as compared to allele A.,South Africa,South Africa,NS,FALSE,0.589,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study.,28816644,2018,PharmGKB,1448665077,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 c.785A>G (rs2279343) 24 months Post Efavirenz-Based Antiretroviral Therapy Initiation
rs36118214,19659438,Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.,Haiti,African American/Afro-Caribbean,NS,FALSE,0.0008,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.",19659438,2009,PharmGKB,1184471413,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,19659438,Allele T (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele G (assigned as extensive metabolizer phenotype) .,Haiti,African American/Afro-Caribbean,NS,FALSE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.",19659438,2009,PharmGKB,1184471369,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,19659438,Genotype TT (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotype GG (assigned as extensive metabolizer phenotype) .,Haiti,African American/Afro-Caribbean,NS,FALSE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.",19659438,2009,PharmGKB,1184471312,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399499,19659438,Allele C (assigned as poor metabolizer phenotype) is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to allele T (assigned as extensive metabolizer phenotype) .,Haiti,African American/Afro-Caribbean,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.",19659438,2009,PharmGKB,1184471365,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,19704172,Genotypes GT + TT are associated with increased concentrations of efavirenz as compared to genotype GG.,South Africa,South Africa,NS,FALSE,0.016,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.,19704172,2009,PharmGKB,1448997483,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 516G>T  (rs3745274)
rs3745274,18057928,Genotype TT is associated with increased concentrations of efavirenz in people with HIV as compared to genotypes GG + GT.,Zimbabwe,South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe.,18057928,2008,PharmGKB,1448997691,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6516Gâ†’T(*6) (rs3745274)
rs28399499,16495778,Allele C is associated with decreased metabolism of efavirenz in people with HIV.,Sub-Saharan Africa,Sub-Saharan Africa,NS,FALSE,0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.,16495778,2006,PharmGKB,769170863,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399499,16495778,Allele C is associated with decreased metabolism of efavirenz in people with HIV.,Sub-Saharan Africa,Sub-Saharan Africa,NS,FALSE,0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.,16495778,2006,PharmGKB,1184988315,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,22057858,Genotype TT is associated with decreased clearance of efavirenz in children with HIV Infections as compared to genotype GG.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children.,22057858,2012,PharmGKB,1184512470,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one","Patients with the TT genotype may have an increased risk for efavirenz-induced side effects, including sleep- and central nervous system-related side effects, as compared to patients with the GG genotype. Other genetic and clinical factors may also influence a patient's risk for toxicity."
CYP2B6*1,23734829,CYP2B6 *6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.,23734829,2014,PharmGKB,1448997246,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*6,23734829,CYP2B6 *6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.,23734829,2014,PharmGKB,1448997246,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,25831219,Genotypes GT + TT is associated with increased concentrations of efavirenz in people with HIV as compared to genotype GG.,Ethiopia,East Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Is there a need to increase the dose of efavirenz during concomitant rifampicin-based antituberculosis therapy in sub-Saharan Africa? The HIV-TB pharmagene study.,25831219,2016,PharmGKB,1448997218,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6*6 (c.516G>T rs3745274)
rs3745274,25974723,Genotypes GT + TT are associated with increased concentrations of efavirenz in people with HIV as compared to genotype GG.,Ethiopia,East Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients.,25974723,2016,PharmGKB,1448993691,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6  516 G>T (rs3745274)
CYP2B6*6,20881953,CYP2B6 *6/*6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.,South Africa,South Africa,NS,FALSE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients.,20881953,2010,PharmGKB,1448995859,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*1,20881953,CYP2B6 *6/*6 is associated with increased concentrations of efavirenz in people with HIV as compared to CYP2B6 *1/*1.,South Africa,South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Long-term efavirenz autoinduction and its effect on plasma exposure in HIV patients.,20881953,2010,PharmGKB,1448995859,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs2279343,22481606,Genotypes AG + GG are associated with increased concentrations of efavirenz in children with HIV as compared to genotype AA.,Rwanda,Central Africa,NS,FALSE,0.01,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms.",22481606,2012,PharmGKB,1448997270,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6785Aâ†’G (rs2279343)
rs28399499,22481606,Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT.,Rwanda,Central Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms.",22481606,2012,PharmGKB,1448997264,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6983Tâ†’C (rs28399499)
rs28399499,22481606,Genotype CT is associated with increased concentrations of efavirenz in children with HIV as compared to genotype TT.,Rwanda,Central Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms.",22481606,2012,PharmGKB,1448665545,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6983Tâ†’C (rs28399499)
rs3745274,22481606,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,Rwanda,Central Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms.",22481606,2012,PharmGKB,1448997257,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6516Gâ†’T(rs3745274)
rs3745274,22481606,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,Rwanda,Central Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms.",22481606,2012,PharmGKB,1448663995,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6516Gâ†’T(rs3745274)
rs3745274,22481606,Genotypes GT + TT are associated with increased concentrations of efavirenz in children with HIV as compared to genotype GG.,Rwanda,Central Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mid-dosing interval efavirenz plasma concentrations in HIV-1-infected children in Rwanda: treatment efficacy, tolerability, adherence, and the influence of CYP2B6 polymorphisms.",22481606,2012,PharmGKB,1448997108,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6516Gâ†’T(rs3745274)
CYP2B6*6,24497997,CYP2B6 *1/*1 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.,Uganda,East Africa,NS,FALSE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.,24497997,2014,PharmGKB,1183764170,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*6,24497997,CYP2B6 *1/*6 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.,Uganda,East Africa,NS,FALSE,< 0.0001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.,24497997,2014,PharmGKB,1183771932,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*1,24497997,CYP2B6 *1/*1 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.,24497997,2014,PharmGKB,1183764170,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2B6*1,24497997,CYP2B6 *1/*6 is associated with increased metabolism of efavirenz in people with HIV as compared to CYP2B6 *6/*6.,Uganda,East Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.,24497997,2014,PharmGKB,1183771932,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399499,25611810,Allele C is associated with increased concentrations of efavirenz in people with HIV as compared to allele T.,South Africa,South Africa,NS,FALSE,0.002,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.,25611810,2016,PharmGKB,1446905210,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs4803419,25611810,Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele C.,South Africa,South Africa,NS,FALSE,0.04,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.,25611810,2016,PharmGKB,1446905219,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,25611810,Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G.,South Africa,South Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.,25611810,2016,PharmGKB,1447680746,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,25611810,Allele T is associated with increased concentrations of efavirenz in people with HIV as compared to allele G.,South Africa,South Africa,NS,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.,25611810,2016,PharmGKB,1446905193,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,28187506,Genotypes GT + TT are associated with increased concentrations of efavirenz in women with HIV as compared to genotype GG.,Uganda,East Africa,NS,FALSE,0.021,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.,28187506,2017,PharmGKB,1448684688,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",CYP2B6 516G>T (rs3745274)
CYP2B6*1,20952418,CYP2B6 *1/*18 is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988346,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Ugandan populations included Bantu and Nilotic populations
CYP2B6*18,20952418,CYP2B6 *1/*18 is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988346,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Ugandan populations included Bantu and Nilotic populations
CYP2B6*1,20952418,CYP2B6 *1/*9 is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988354,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Ugandan populations included Bantu and Nilotic populations
CYP2B6*9,20952418,CYP2B6 *1/*9 is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988354,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Ugandan populations included Bantu and Nilotic populations
CYP2B6*6,20952418,CYP2B6 *6/*6 is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,NS,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988338,Star allele,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",Ugandan populations included Bantu and Nilotic populations
rs28399499,20952418,Allele C is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,"Ugandan Nilotic, Ugandan Bantu",TRUE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,769170863,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28399499,20952418,Allele C is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,"Ugandan Nilotic, Ugandan Bantu",TRUE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988315,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3745274,20952418,Allele T is associated with decreased metabolism of efavirenz in people with HIV.,"Uganda, Zimbabwe",East Africa / South Africa,"Ugandan Nilotic,Ugandan Bantu",TRUE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Tribal ethnicity and CYP2B6 genetics in Ugandan and Zimbabwean populations in the UK: implications for efavirenz dosing in HIV infection.,20952418,2011,PharmGKB,1184988306,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs4803419,28187506,Genotype CT is associated with decreased concentrations of levonorgestrel in women with HIV as compared to genotype CC.,Uganda,East Africa,NS,FALSE,0.058,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.,28187506,2017,PharmGKB,1448684682,SNV,levonorgestrel,DB00367,"Approved, Investigational","Emergency contraception: Levonorgestrel, in the single-agent emergency contraceptive form, is indicated for the prevention of pregnancy after the confirmed or suspected failure of contraception methods or following unprotected intercourse. It is distributed by prescription for patients under 17, and over the counter for those above this age. This levonorgestrel-only form of contraception is not indicated for regular contraception and must be taken as soon as possible within 72 hours after intercourse. It has shown a lower efficacy when it is used off label within 96 hours. Long-term contraception or nonemergency contraception: In addition to the above indication in emergency contraception, levonorgestrel is combined with other contraceptives in contraceptive formulations designed for regular use, for example with ethinyl estradiol. It is used in various hormone-releasing intrauterine devices for long-term contraception ranging for a duration of 3-5 years. Product labeling for Mirena specifically mentions that it is recommended in women who have had at least 1 child. A subdermal implant is also available for the prevention of pregnancy for up to 5 years. Hormone therapy and off-label uses: Levonorgestrel is prescribed in combination with estradiol as hormone therapy during menopause to manage vasomotor symptoms and to prevent osteoporosis.24Off-label, levonorgestrel may be used to treat menorrhagia, endometrial hyperplasia, and endometriosis.","(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",CYP2B6 15582C>T (rs4803419)
rs3745274,28187506,Genotypes GT + TT are associated with decreased concentrations of levonorgestrel in women with HIV as compared to genotype GG.,Uganda,East Africa,NS,FALSE,0.115,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.,28187506,2017,PharmGKB,1448684673,SNV,levonorgestrel,DB00367,"Approved, Investigational","Emergency contraception: Levonorgestrel, in the single-agent emergency contraceptive form, is indicated for the prevention of pregnancy after the confirmed or suspected failure of contraception methods or following unprotected intercourse. It is distributed by prescription for patients under 17, and over the counter for those above this age. This levonorgestrel-only form of contraception is not indicated for regular contraception and must be taken as soon as possible within 72 hours after intercourse. It has shown a lower efficacy when it is used off label within 96 hours. Long-term contraception or nonemergency contraception: In addition to the above indication in emergency contraception, levonorgestrel is combined with other contraceptives in contraceptive formulations designed for regular use, for example with ethinyl estradiol. It is used in various hormone-releasing intrauterine devices for long-term contraception ranging for a duration of 3-5 years. Product labeling for Mirena specifically mentions that it is recommended in women who have had at least 1 child. A subdermal implant is also available for the prevention of pregnancy for up to 5 years. Hormone therapy and off-label uses: Levonorgestrel is prescribed in combination with estradiol as hormone therapy during menopause to manage vasomotor symptoms and to prevent osteoporosis.24Off-label, levonorgestrel may be used to treat menorrhagia, endometrial hyperplasia, and endometriosis.","(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one",CYP2B6 516G>T (rs3745274)
rs3745274,26348712,Genotype TT is associated with increased concentrations of nevirapine in people with HIV as compared to genotypes GG + GT.,Zimbabwe,South Africa,Shona,FALSE,< 0.001,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.,26348712,2016,PharmGKB,1448110402,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2B6c.516G>T(rs3745274)
rs3745274,22111602,Genotypes GT + TT are associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG.,Malawi,East Africa,NS,FALSE,0.31,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823670,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2B6 516G>T (Q172H; rs3745274)
rs28399499,24217698,Genotype CT is associated with decreased clearance of nevirapine in people with HIV as compared to genotype TT.,Malawi,East Africa,NS,FALSE,< 0.01,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.,24217698,2014,PharmGKB,1296598953,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2B6c.983T>C
rs3745274,24217698,Genotypes GT + TT is associated with decreased clearance of nevirapine in people with HIV as compared to genotype GG.,Malawi,East Africa,NS,FALSE,< 0.01,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Population pharmacokinetic and pharmacogenetic analysis of nevirapine in hypersensitive and tolerant HIV-infected patients from Malawi.,24217698,2014,PharmGKB,1296598965,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2B6c.516G>T
rs28399499,27195527,Allele C is associated with increased concentrations of nevirapine in women as compared to allele T.,Nigeria,West Africa,NS,FALSE,0.012,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study.,27195527,2017,PharmGKB,1448108791,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2B6983 T>C (rs28399499)
rs3745274,27195527,Allele T is associated with increased concentrations of nevirapine in women as compared to allele G.,Nigeria,West Africa,NS,FALSE,0.098,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pregnancy affects nevirapine pharmacokinetics: evidence from a CYP2B6 genotype-guided observational study.,27195527,2017,PharmGKB,1448108757,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2B6516 G>T (rs3745274)
rs28399499,28673292,Allele C is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T.,Tanzania,East Africa,NS,FALSE,0.605,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003516,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol","CYP2B6*18 (c.983T4C, rs28399499)"
rs28399499,28673292,Allele C is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele T.,Tanzania,East Africa,NS,FALSE,0.605,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003652,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol","CYP2B6*18 (c.983T4C, rs28399499)"
rs3745274,28673292,Allele T is not associated with concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele G.,Tanzania,East Africa,NS,FALSE,0.676,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003506,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol","CYP2B6*6 (c.516G4T, rs3745274)"
rs3745274,28673292,Allele T is not associated with response to lumefantrine in women with Malaria and Pregnancy as compared to allele G.,Tanzania,East Africa,NS,FALSE,0.676,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003645,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol","CYP2B6*6 (c.516G4T, rs3745274)"
CYP2B6*18,23149928,CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,0.01,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403153,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*6,23149928,CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,0.01,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403153,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*22,23149928,CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,0.46,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403153,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*5,23149928,CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,0.91,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403153,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*4,23149928,CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403153,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*1,23149928,CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403174,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*18,23149928,CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403174,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*22,23149928,CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403174,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*4,23149928,CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403174,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*5,23149928,CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403174,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*6,23149928,CYP2B6 *6/*6 + *6/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403174,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2B6*1,23149928,CYP2B6 *1/*6 + *1/*18 is associated with decreased metabolism of bupropion in people with Tobacco Use Disorder as compared to CYP2B6 *1/*1 + *1/*4 + *1/*5 + *1/*22 + *22/*22.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2B6,,CYP2B6,cytochrome P450 family 2 subfamily B member 6,19,P20813,"This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2B6 and bupropion's smoking-cessation pharmacology: the role of hydroxybupropion.,23149928,2013,PharmGKB,1445403153,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2C19*1,25120580,CYP2C19 *1/*17 is associated with decreased concentrations of voriconazole.,Cameroon,Central Africa,NS,FALSE,NS,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity.,25120580,2014,PharmGKB,1444828163,Star allele,voriconazole,DB00582,"Approved, Investigational","For the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.","(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol",
CYP2C19*17,25120580,CYP2C19 *1/*17 is associated with decreased concentrations of voriconazole.,Cameroon,West Africa,NS,FALSE,NS,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity.,25120580,2014,PharmGKB,1444828163,Star allele,voriconazole,DB00582,"Approved, Investigational","For the treatment of esophageal candidiasis, invasive pulmonary aspergillosis, and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp.","(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol",
rs4244285,16267764,Genotype AA is associated with decreased metabolism of nelfinavir in people with HIV Infections as compared to genotype GG.,"USA, Italy",African American/Afro-Caribbean,NS,TRUE,< 0.001,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.,16267764,2006,PharmGKB,827695410,SNV,nelfinavir,DB00220,Approved,Used in combination with other antiviral drugs in the treatment of HIV in both adults and children.,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide",Patients with the AA genotype and pancreatic cancer or HIV may have decreased metabolism and increased concentrations of nelfinavir as compared to patients with the GG genotype. Other genetic and clinical factors may also influence metabolism and concentration of nelfinavir.
CYP2C19*1,25187485,CYP2C19 *2 + *17 are not associated with response to bupropion in people with Tobacco Use Disorder as compared to CYP2C19 *1.,USA,African American/Afro-Caribbean,"African American, Asian, Caucasian",TRUE,NS,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.,25187485,2015,PharmGKB,1184985821,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
CYP2C19*17,25187485,CYP2C19 *2 + *17 are not associated with response to bupropion in people with Tobacco Use Disorder as compared to CYP2C19 *1.,USA,African American/Afro-Caribbean,"African American, Asian, Caucasian",TRUE,NS,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.,25187485,2015,PharmGKB,1184985821,Star allele,bupropion,DB01156,Approved,"Bupropion is indicated for the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation. When used in combination with naltrexone as the marketed product Contrave, bupropion is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obese) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). Bupropion is also used off-label as a first-line treatment in patients with ADHD and comorbid bipolar disorder when used as an adjunct to mood stabilizers.",2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,
rs12248560,16413245,Genotype TT is associated with increased metabolism of mephenytoin in people with no disease as compared to genotype CC.,Ethiopia,East Africa,NS,FALSE,0.013,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.,16413245,2006,PharmGKB,655387719,SNV,mephenytoin,DB00532,"Approved, Investigational, Withdrawn",For the treatment of refractory partial epilepsy,"5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione",Patients with the TT genotype who are treated with mephenytoin may require an increased dose as compared to patients with the CC genotype.
rs11188072,16413245,Genotype TT is associated with increased metabolism of mephenytoin in people with no disease as compared to genotype CC.,Ethiopia,East Africa,NS,FALSE,0.013,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.,16413245,2006,PharmGKB,655387714,SNV,mephenytoin,DB00532,"Approved, Investigational, Withdrawn",For the treatment of refractory partial epilepsy,"5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione",Patients with the CC genotype who are treated with mephenytoin may require a decreased dose as compared to patients with the TT genotype.
rs12248560,16413245,Genotype TT is associated with increased metabolism of omeprazole in people with no disease as compared to genotype CC.,Ethiopia,East Africa,NS,FALSE,0.013,CYP2C19,,CYP2C19,cytochrome P450 family 2 subfamily C member 19,10,P33261,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, omeprazole, diazepam and some barbiturates. Polymorphism within this gene is associated with variable ability to metabolize mephenytoin, known as the poor metabolizer and extensive metabolizer phenotypes. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.,16413245,2006,PharmGKB,655387718,SNV,omeprazole,DB00338,"Approved, Investigational","Omeprazole, according to the FDA label Label is a proton pump inhibitor (PPI) used for the following purposes: Treatment of active duodenal ulcer in adults. Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults. Treatment of active benign gastric ulcer in adults. Treatment of symptomatic gastroesophageal reflux disease (GERD) in patients 1 year of age and older Treatment of erosive esophagitis (EE) due to acid-mediated GERD in patients 1 month of age and older. Maintenance of healing of EE due to acid-mediated GERD in patients 1 year of age and older. Pathologic hypersecretory conditions in adults.","6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole","Patients with the TT genotype who are treated with mephenytoin may require an increased dose as compared to patients with the CC genotype. Other genetic factors, including other CYP2C19 alleles *17 rs12248560, *2 rs4244285,*3 rs4986893, and clinical factors may also influence a patient's required dose and should be taken into consideration."
CYP2C8*2,18779360,No differences between CYP2C8 genotypes with regard to amodiaquine efficacy or safety were evident.,Ghana,West Africa,NS,FALSE,> 0.05,CYP2C8,,CYP2C8,cytochrome P450 family 2 subfamily C member 8cytochrome P450 family 2 subfamily C member 8,10,P10632,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize many xenobiotics, including the anticonvulsive drug mephenytoin, benzo(a)pyrene, 7-ethyoxycoumarin, and the anti-cancer drug taxol. This gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. Several transcript variants encoding a few different isoforms have been found for this gene.",22/11/2021,PubMed,Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.,18779360,2008,PharmGKB,TBD,Star allele,amodiaquine,DB00613,"Approved, Investigational",For treatment of acute malarial attacks in non-immune subjects.,4-[(7-chloroquinolin-4-yl)amino]-2-[(diethylamino)methyl]phenol,
rs707265,26779253,Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AG + GG.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.7919,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680801,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
CYP2C9*5,15289788,CYP2C9 *1/*5 + *5/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,0.01,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1133417241,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*6,15289788,CYP2C9 *1/*5 + *5/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,0.01,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1133417241,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*6,15289788,CYP2C9 *1/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,0.01,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1134049001,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*8,15289788,CYP2C9 *1/*8 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,0.01,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1134736215,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*11,15289788,CYP2C9 *1/*11 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1134807206,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*1,15289788,CYP2C9 *1/*11 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1134807206,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*1,15289788,CYP2C9 *1/*5 + *5/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1133417241,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*1,15289788,CYP2C9 *1/*6 is associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1134049001,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
CYP2C9*1,15289788,CYP2C9 *1/*8 is not associated with decreased metabolism of losartan in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.",15289788,2004,PharmGKB,1134736215,Star allele,losartan,DB00678,Approved,"Losartan is indicated to treat hypertension in patients older than 6 years, reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage), and to treat diabetic nephropathy with elevated serum creatinine and proteinuria in patients with type 2 diabetes and hypertension. Losartan with hydrochlorothiazide is indicated to treat hypertension and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy (though this benefit may not extend to patients with African heritage).","[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol",
rs9332131,28685643,Allele del is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.,28685643,2018,PharmGKB,1449005482,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs933213 is assigned to CYP2C9*6 and is a null allele associated with decreased dose of warfarin in Pulmonary Embolism.
rs9332131,28685643,Allele del is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.,28685643,2018,PharmGKB,1449005482,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs933213 is assigned to CYP2C9*6 and is a null allele associated with decreased dose of warfarin in Pulmonary Embolism.
rs28371686,28685643,Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.,28685643,2018,PharmGKB,1449005488,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"rs57527516 is a retired alias for rs28371686. In the study, the authors did not use  rs28371686 but the rs28371683 which have not been used in PhamGKB. It is also assigned to CYP2C9*5 that leads to a substitution Asp360Glu. Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C ."
rs28371686,28685643,Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.,28685643,2018,PharmGKB,1449005488,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"rs57527516 is a retired alias for rs28371686. In the study, the authors did not use  rs28371686 but the rs28371683 which have not been used in PhamGKB. It is also assigned to CYP2C9*5 that leads to a substitution Asp360Glu. Allele G is associated with decreased dose of warfarin in Pulmonary Embolism as compared to allele C ."
CYP2C9*6,15094935,CYP2C9 *6/*6 is associated with decreased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2C9 genetic polymorphisms and warfarin.,15094935,2004,PharmGKB,1183701586,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,15094935,CYP2C9 *6/*6 is associated with decreased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2C9 genetic polymorphisms and warfarin.,15094935,2004,PharmGKB,1183701586,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs202201137,30518301,Allele G is associated with decreased dose of warfarin.,Puerto Rico,African American/Afro-Caribbean,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements.",30518301,2020,PharmGKB,1450180271,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports a single patient. rs202201137 is a transition A>G resulting in the amino acid substitution  p.Asn457Ser associated to decreased dose of warfarin. rs202201137 belongs to the CYP2C9*61 haplotype.
rs202201137,30518301,Allele G is associated with decreased dose of warfarin.,Puerto Rico,African American/Afro-Caribbean,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements.",30518301,2020,PharmGKB,1450180271,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports a single patient. rs202201137 is a transition A>G resulting in the amino acid substitution  p.Asn457Ser associated to decreased dose of warfarin. rs202201137 belongs to the CYP2C9*61 haplotype.
CYP2C9*1,19663669,CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1183700910,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,19663669,CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1183700910,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,19663669,CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1183700910,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,19663669,CYP2C9 *8/*8 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1183700910,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*9,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*9,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1 + *1/*8 + *1/*9 + *9/*9.,Sudan,East Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510278,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,21590310,CYP2C9 *2 + *6 + *5 + *11 is associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,Sudan,East Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Evaluation of the effects of VKORC1 polymorphisms and haplotypes, CYP2C9 genotypes, and clinical factors on warfarin response in Sudanese patients.",21590310,2012,PharmGKB,1184510263,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,25712185,CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.,25712185,2015,PharmGKB,1444695840,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,25712185,CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.,25712185,2015,PharmGKB,1444695840,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,25712185,CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.,25712185,2015,PharmGKB,1444695840,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,25712185,CYP2C9 *1/*8 + *8/*8 are associated with decreased clearance of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Factors influencing pharmacokinetics of warfarin in African-Americans: implications for pharmacogenetic dosing algorithms.,25712185,2015,PharmGKB,1444695840,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs7900194,20072124,Allele A is associated with decreased dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431781,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs7900194 is assigned to CYP2C9*8 in the study and is associated to decreased dose of warfarin.
rs7900194,20072124,Allele A is associated with decreased dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431781,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs7900194 is assigned to CYP2C9*8 in the study and is associated to decreased dose of warfarin.
rs7900194,20072124,Allele A is associated with decreased dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864548,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs7900194 is assigned to CYP2C9*8 in the study and is associated to decreased dose of warfarin.
rs7900194,20072124,Allele A is associated with decreased dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864548,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs7900194 is assigned to CYP2C9*8 in the study and is associated to decreased dose of warfarin.
rs1057910,20072124,Allele C is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037860,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*3 in the study. Allele C is associated with decreased dose of warfarin as compared to allele A.
rs1057910,20072124,Allele C is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037860,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*3 in the study. Allele C is associated with decreased dose of warfarin as compared to allele A.
rs1057910,20072124,Allele C is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864562,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*3 in the study. Allele C is associated with decreased dose of warfarin as compared to allele A.
rs1057910,20072124,Allele C is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864562,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*3 in the study. Allele C is associated with decreased dose of warfarin as compared to allele A.
rs28371686,20072124,Allele G is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431793,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs28371686 is assigned to CYP2C9*5 in the study and is associated to decreased dose of warfarin.
rs28371686,20072124,Allele G is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431793,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs28371686 is assigned to CYP2C9*5 in the study and is associated to decreased dose of warfarin.
rs28371686,20072124,Allele G is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864554,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs28371686 is assigned to CYP2C9*5 in the study and is associated to decreased dose of warfarin.
rs28371686,20072124,Allele G is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864554,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs28371686 is assigned to CYP2C9*5 in the study and is associated to decreased dose of warfarin.
rs1799853,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037879,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*2 in the study. Allele T is associated with decreased dose of warfarin as compared to allele C.
rs1799853,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037879,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*2 in the study. Allele T is associated with decreased dose of warfarin as compared to allele C.
rs1799853,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864546,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*2 in the study. Allele T is associated with decreased dose of warfarin as compared to allele C.
rs1799853,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,827864546,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs1057910 is described as CYP2C9*2 in the study. Allele T is associated with decreased dose of warfarin as compared to allele C.
rs28371685,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431789,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs28371685 is assigned to CYP2C9*11 in the study and is associated to decreased dose of warfarin.
rs28371685,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431789,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs28371685 is assigned to CYP2C9*11 in the study and is associated to decreased dose of warfarin.
rs9332131,20072124,Genotype DEL is associated with decreased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431785,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs9332131 is described as a null alelle CYP2C9*6 in the study and is  is associated with decreased dose of warfarin.
rs9332131,20072124,Genotype DEL is associated with decreased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,608431785,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs9332131 is described as a null alelle CYP2C9*6 in the study and is  is associated with decreased dose of warfarin.
rs7900194,21228733,Allele A is associated with decreased dose of warfarin as compared to allele G.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,608431781,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. This SNP defines CYP2C9*8 by PharmGKB. Allele A is associated with decreased dose of warfarin as compared to allele G. The p-value is reported for the genotype *1/*8.
rs7900194,21228733,Allele A is associated with decreased dose of warfarin as compared to allele G.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,608431781,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. This SNP defines CYP2C9*8 by PharmGKB. Allele A is associated with decreased dose of warfarin as compared to allele G. The p-value is reported for the genotype *1/*8.
rs7900194,21228733,Allele A is associated with decreased dose of warfarin as compared to allele G.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864548,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. This SNP defines CYP2C9*8 by PharmGKB. Allele A is associated with decreased dose of warfarin as compared to allele G. The p-value is reported for the genotype *1/*8.
rs7900194,21228733,Allele A is associated with decreased dose of warfarin as compared to allele G.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864548,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. This SNP defines CYP2C9*8 by PharmGKB. Allele A is associated with decreased dose of warfarin as compared to allele G. The p-value is reported for the genotype *1/*8.
rs1057910,21228733,Allele C is associated with decreased dose of warfarin as compared to allele A.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,982037860,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. This SNP defines CYP2C9*3 by PharmGKB. Allele C is associated with decreased dose of warfarin as compared to allele A. The p-value is reported for the genotypes *1/*3, *2/*3 and *3/*3."
rs1057910,21228733,Allele C is associated with decreased dose of warfarin as compared to allele A.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,982037860,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. This SNP defines CYP2C9*3 by PharmGKB. Allele C is associated with decreased dose of warfarin as compared to allele A. The p-value is reported for the genotypes *1/*3, *2/*3 and *3/*3."
rs1057910,21228733,Allele C is associated with decreased dose of warfarin as compared to allele A.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864562,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. This SNP defines CYP2C9*3 by PharmGKB. Allele C is associated with decreased dose of warfarin as compared to allele A. The p-value is reported for the genotypes *1/*3, *2/*3 and *3/*3."
rs1057910,21228733,Allele C is associated with decreased dose of warfarin as compared to allele A.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864562,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. This SNP defines CYP2C9*3 by PharmGKB. Allele C is associated with decreased dose of warfarin as compared to allele A. The p-value is reported for the genotypes *1/*3, *2/*3 and *3/*3."
rs28371686,21228733,Allele G is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,608431793,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. The RS ID was assigned by PharmGKB defining CYP2C9*5. Allele G is associated with decreased dose of warfarin as compared to allele C. The p-value is reported for the genotype *1/*5, *5/*5."
rs28371686,21228733,Allele G is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,608431793,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. The RS ID was assigned by PharmGKB defining CYP2C9*5. Allele G is associated with decreased dose of warfarin as compared to allele C. The p-value is reported for the genotype *1/*5, *5/*5."
rs28371686,21228733,Allele G is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864554,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. The RS ID was assigned by PharmGKB defining CYP2C9*5. Allele G is associated with decreased dose of warfarin as compared to allele C. The p-value is reported for the genotype *1/*5, *5/*5."
rs28371686,21228733,Allele G is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864554,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. The RS ID was assigned by PharmGKB defining CYP2C9*5. Allele G is associated with decreased dose of warfarin as compared to allele C. The p-value is reported for the genotype *1/*5, *5/*5."
rs1799853,21228733,Allele T is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,982037879,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. PharmGKB defines the SNP as CYP2C9*2. It corresponds to Arg144Cys substitution. Allele T is associated to decreased dose of warfarin compared to allele C. The p-value is reported for the genotypes *2/*2, *1/*2 and *2/*3."
rs1799853,21228733,Allele T is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,982037879,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. PharmGKB defines the SNP as CYP2C9*2. It corresponds to Arg144Cys substitution. Allele T is associated to decreased dose of warfarin compared to allele C. The p-value is reported for the genotypes *2/*2, *1/*2 and *2/*3."
rs1799853,21228733,Allele T is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864546,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. PharmGKB defines the SNP as CYP2C9*2. It corresponds to Arg144Cys substitution. Allele T is associated to decreased dose of warfarin compared to allele C. The p-value is reported for the genotypes *2/*2, *1/*2 and *2/*3."
rs1799853,21228733,Allele T is associated with decreased dose of warfarin as compared to allele C.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864546,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on 195 cases from Egypt. PharmGKB defines the SNP as CYP2C9*2. It corresponds to Arg144Cys substitution. Allele T is associated to decreased dose of warfarin compared to allele C. The p-value is reported for the genotypes *2/*2, *1/*2 and *2/*3."
rs56165452,21228733,Genotype CT is associated with decreased dose of warfarin as compared to genotype TT.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,982034970,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. This SNP defines CYP2C9*4 by PharmGKB. Genotype CT is associated with decreased dose of warfarin as compared to genotype TT. The p-value is reported for the genotypes *1/*4.
rs56165452,21228733,Genotype CT is associated with decreased dose of warfarin as compared to genotype TT.,Egypt,North Africa,NS,FALSE,0.0028,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,982034970,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. This SNP defines CYP2C9*4 by PharmGKB. Genotype CT is associated with decreased dose of warfarin as compared to genotype TT. The p-value is reported for the genotypes *1/*4.
rs12777823,28686080,Allele A is associated with dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,1.66E-07,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.,28686080,2018,PharmGKB,1448636878,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"A total of 1680 patients were included in this study. Among them, 539 are African-Americans. The rs12777823 corresponds to Sequence Position Deletion Insertion (SPDI) locus (NC_000010.11:94645744:G:A). rs12777823 is located on CYP2C gene cluster that includes the CYP2C9, CYP2C8, CYP2C18, and CYP2C19 genes. SNP rs12777823 was significantly associated with warfarin dose in African-Americans."
rs12777823,28686080,Allele A is associated with dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,1.66E-07,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.,28686080,2018,PharmGKB,1448636878,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"A total of 1680 patients were included in this study. Among them, 539 are African-Americans. The rs12777823 corresponds to Sequence Position Deletion Insertion (SPDI) locus (NC_000010.11:94645744:G:A). rs12777823 is located on CYP2C gene cluster that includes the CYP2C9, CYP2C8, CYP2C18, and CYP2C19 genes. SNP rs12777823 was significantly associated with warfarin dose in African-Americans."
CYP2C9*1,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,18466099,CYP2C9 *2 + *3 + *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.0001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519652,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*10,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*10,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,19802360,CYP2C9 *11 + *2 + *3 + *5 + *6 is associated with decreased dose of warfarin as compared to CYP2C9 *1.,USA,African American/Afro-Caribbean,African American,FALSE,0.59,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.,19802360,2007,PharmGKB,1183701419,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*8,28135054,CYP2C9 *2 + *3 + *5 + *8 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573256,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs7089580,25499099,Genotype AT is associated with increased clearance of warfarin as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.,25499099,2015,PharmGKB,1444608101,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Carriers of the minor allele (A/T or T/T) show higher mRNA expression of CYP2C9 in liver compared to A/A.
rs7089580,25499099,Genotype AT is associated with increased clearance of warfarin as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.,25499099,2015,PharmGKB,1444608101,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Carriers of the minor allele (A/T or T/T) show higher mRNA expression of CYP2C9 in liver compared to A/A.
rs7089580,25499099,Genotype AT is associated with increased dose of warfarin as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.04,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.,25499099,2015,PharmGKB,1444608095,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Carriers of the minor allele T show higher oral clearance of warfarin compared to wild type homozygotes.
rs7089580,25499099,Genotype AT is associated with increased dose of warfarin as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.04,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel single nucleotide polymorphism in CYP2C9 is associated with changes in warfarin clearance and CYP2C9 expression levels in African Americans.,25499099,2015,PharmGKB,1444608095,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Carriers of the minor allele T show higher oral clearance of warfarin compared to wild type homozygotes.
CYP2C9*11,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*5,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*6,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.11,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,26024874,CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.68,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296627,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,26024874,CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.68,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296627,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,26024874,CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296671,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,26024874,CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296671,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,26024874,CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296627,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,26024874,CYP2C9 *1/*2 + *2/*2 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296627,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,26024874,CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296671,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,26024874,CYP2C9 *1/*3 + *3/*3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296671,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*1,26024874,CYP2C9 *5 + *6 + *11 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296737,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs7089580,21270790,Allele T is associated with increased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,0.035,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.,21270790,2011,PharmGKB,769245708,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Assciated with increased dose of warfarin.
rs7089580,21270790,Allele T is associated with increased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,0.035,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.,21270790,2011,PharmGKB,769245708,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Assciated with increased dose of warfarin.
CYP2C9*1,17324110,CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.81,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.,17324110,2007,PharmGKB,1447520623,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,There was no apparent differences in warfarin dose requirements or anticoagulation control based on CYP2C9 genotype in Africanâ€“Americans.
CYP2C9*1,17324110,CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,0.81,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.,17324110,2007,PharmGKB,1447520623,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,There was no apparent differences in warfarin dose requirements or anticoagulation control based on CYP2C9 genotype in Africanâ€“Americans.
CYP2C9*2,17324110,CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.,17324110,2007,PharmGKB,1447520623,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*2,17324110,CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.,17324110,2007,PharmGKB,1447520623,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,17324110,CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.,17324110,2007,PharmGKB,1447520623,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,17324110,CYP2C9 *2 + *3 are associated with decreased dose of warfarin as compared to CYP2C9 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.,17324110,2007,PharmGKB,1447520623,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*3,22854539,CYP2C9 and VKORC1 variant allele/genotype were significantly associated with the daily warfarin dose.,Oman,Africa,NS,TRUE,< 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.,22854539,2012,PharmGKB,TBD,Star allele,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs12777823,25461246,rs12777823 associated with warfarin dose requirements.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans.,25461246,2015,PharmGKB,TBD,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
CYP2C9*11,21811894,CYP2C9 *11 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,981940175,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*5,21811894,CYP2C9 *5 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,981940181,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*6,21811894,CYP2C9 *6 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,981940169,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*8,21811894,CYP2C9 *8 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,981940163,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*9,21811894,CYP2C9 *9 is not associated with increased response to acenocoumarol as compared to CYP2C9 *1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,981940156,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,21811894,CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,1444706610,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*11,21811894,CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,1444706610,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*5,21811894,CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,1444706610,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*8,21811894,CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,1444706610,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*9,21811894,CYP2C9 *9/*11 + *5/*8 are associated with decreased metabolism of acenocoumarol in healthy individuals as compared to CYP2C9 *1/*1.,Benin,West Africa,NS,FALSE,> 0.05,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Acenocoumarol sensitivity and pharmacokinetic characterization of CYP2C9 *5/*8,*8/*11,*9/*11 and VKORC1*2 in black African healthy Beninese subjects.",21811894,2013,PharmGKB,1444706610,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*3,29479633,"CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",Tunisia,North Africa,NS,FALSE,0.008,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.,29479633,2018,PharmGKB,1449188274,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*2,29479633,CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.,Tunisia,North Africa,NS,FALSE,0.013,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.,29479633,2018,PharmGKB,1449188252,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,29479633,CYP2C9 *2 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation as compared to CYP2C9 *1.,Tunisia,North Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.,29479633,2018,PharmGKB,1449188252,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,29479633,"CYP2C9 *3 is associated with decreased dose of acenocoumarol in people with Atrial Fibrillation, Atrial Flutter or Venous Thrombosis as compared to CYP2C9 *1.",Tunisia,North Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.,29479633,2018,PharmGKB,1449188274,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*2,22486182,CYP2C9 *1/*2 is not associated with dose of acenocoumarol.,Morocco,North Africa,NS,FALSE,0.0082,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010090,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*3,22486182,CYP2C9 *1/*3 is not associated with dose of acenocoumarol.,Morocco,North Africa,NS,FALSE,0.0082,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010097,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,22486182,CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.,Morocco,North Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010010,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,22486182,CYP2C9 *1/*1 is associated with increased dose of acenocoumarol.,Morocco,North Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010082,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,22486182,CYP2C9 *1/*2 is not associated with dose of acenocoumarol.,Morocco,North Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010090,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
CYP2C9*1,22486182,CYP2C9 *1/*3 is not associated with dose of acenocoumarol.,Morocco,North Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010097,Star allele,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,
rs28371685,16220110,Allele T is associated with increased metabolism of phenytoin in people with no disease as compared to genotype CC.,Benin,West Africa,NS,FALSE,0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.",16220110,2006,PharmGKB,769249040,SNV,phenytoin,DB00252,Approved,"For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.","5,5-diphenylimidazolidine-2,4-dione","As measured by urinary excretion of its major metabolite, S-enantiomer of 5-(4-hydroxyphenyl)-5-phenylhydantoin (p-HPPH). Statistics given for trend with various PM allele vs *1*1. [stat_test: ANOVA]"
rs9332131,16220110,Genotype DEL is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype AA.,Benin,West Africa,NS,FALSE,0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.",16220110,2006,PharmGKB,769249041,SNV,phenytoin,DB00252,Approved,"For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.","5,5-diphenylimidazolidine-2,4-dione","As measured by urinary excretion of its major metabolite, S-enantiomer of 5-(4-hydroxyphenyl)-5-phenylhydantoin (p-HPPH). Statistics given for trend with various PM allele vs *1*1. [stat_test: ANOVA]"
rs28371686,16220110,Allele G is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype CC.,Benin,West Africa,NS,FALSE,< 0.001,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.",16220110,2006,PharmGKB,769249016,SNV,phenytoin,DB00252,Approved,"For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.","5,5-diphenylimidazolidine-2,4-dione","One hundred and nine subjects were included in the study. The RS ID was assigned by PharmGKB defining CYP2C9*5. Genotypes *1/*5, *5/*6, *5/*8  show a significant decrease in Urinary excretion of 5-(4-hydroxyphenyl)-5-phenylhydantoin compared to *1/*1."
rs7900194,16220110,Allele A is associated with decreased metabolism of phenytoin in people with no disease as compared to genotype GG.,Benin,West Africa,NS,FALSE,NS,CYP2C9,,CYP2C9,cytochrome P450 family 2 subfamily C member 9,10,P11712,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population.",16220110,2006,PharmGKB,769249039,SNV,phenytoin,DB00252,Approved,"For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery.","5,5-diphenylimidazolidine-2,4-dione","One hundred and nine subjects were included in the study.  The RS ID was assigned by PharmGKB defining CYP2C9*8. Genotypes*1/*8, *8/*9, *8/*11, *5/*8  show a significant decrease in Urinary excretion of 5-(4-hydroxyphenyl)-5-phenylhydantoin compared to *1/*1."
CYP2D6*101,23394389,CYP2D6 *2/*101 is associated with decreased metabolism of dextromethorphan in healthy individuals.,Trinidad,African American/Afro-Caribbean,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.,23394389,2013,PharmGKB,1184989087,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*2,23394389,CYP2D6 *2/*101 is associated with decreased metabolism of dextromethorphan in healthy individuals.,Trinidad,African American/Afro-Caribbean,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.,23394389,2013,PharmGKB,1184989087,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*100,23394389,CYP2D6 *5/*100 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,Trinidad,African American/Afro-Caribbean,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.,23394389,2013,PharmGKB,1184989053,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*5,23394389,CYP2D6 *5/*100 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,Trinidad,African American/Afro-Caribbean,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants.,23394389,2013,PharmGKB,1184989053,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*2,16415111,CYP2D6 *2/*36 (assigned as extensive metabolizer phenotype) is not associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.,16415111,2006,PharmGKB,1446897151,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*36,16415111,CYP2D6 *2/*36 (assigned as extensive metabolizer phenotype) is not associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.,16415111,2006,PharmGKB,1446897151,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*36,16415111,CYP2D6 *4/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.,16415111,2006,PharmGKB,1446897132,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*4,16415111,CYP2D6 *4/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.,16415111,2006,PharmGKB,1446897132,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*36,16415111,CYP2D6 *4xN/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.,16415111,2006,PharmGKB,1446897141,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*4xN,16415111,CYP2D6 *4xN/*36 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.,16415111,2006,PharmGKB,1446897141,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*40,12811367,CYP2D6 *40/*42 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,"Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects.",12811367,2003,PharmGKB,1184757143,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*42,12811367,CYP2D6 *40/*42 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,"Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects.",12811367,2003,PharmGKB,1184757143,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*4xN,17392730,CYP2D6 *4xN/*56 is associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,"Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.",17392730,2007,PharmGKB,1184986040,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*56,17392730,CYP2D6 *4xN/*56 is associated with decreased metabolism of dextromethorphan.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,"Identification and characterization of CYP2D6*56B, an allele associated with the poor metabolizer phenotype.",17392730,2007,PharmGKB,1184986040,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*1,11823760,CYP2D6 *29/*29 is associated with decreased metabolism of dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.,Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756941,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*2,11823760,CYP2D6 *29/*29 is associated with decreased metabolism of dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.,Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756941,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*29,11823760,CYP2D6 *29/*29 is associated with decreased metabolism of dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.,Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756941,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*1,12152006,CYP2D6 *17 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757110,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*17,12152006,CYP2D6 *17 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757110,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*1,12152006,CYP2D6 *29 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757117,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*29,12152006,CYP2D6 *29 is associated with decreased metabolism of dextromethorphan in healthy individuals as compared to CYP2D6 *1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757117,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*3,12152006,CYP2D6 *3/*4xN (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184986056,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*4xN,12152006,CYP2D6 *3/*4xN (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184986056,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*4,12152006,CYP2D6 *6/*40 + *4/*40 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757079,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*40,12152006,CYP2D6 *6/*40 + *4/*40 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757079,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*6,12152006,CYP2D6 *6/*40 + *4/*40 (assigned as poor metabolizers phenotype) is associated with decreased metabolism of dextromethorphan in healthy individuals.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.,12152006,2002,PharmGKB,1184757079,Star allele,dextromethorphan,DB00514,Approved,For treatment and relief of dry cough.,"(4bS,8aR,9S)-3-Methoxy-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene",
CYP2D6*1,11823760,CYP2D6 *29/*29 is associated with decreased metabolism of codeine or debrisoquine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.,Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756952,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*2,11823760,CYP2D6 *29/*29 is associated with decreased metabolism of codeine or debrisoquine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.,Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756952,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*29,11823760,CYP2D6 *29/*29 is associated with decreased metabolism of codeine or debrisoquine in healthy individuals as compared to CYP2D6 *1/*1 + *1/*2.,Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756952,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*1,11823760,"CYP2D6 *5/*17 is associated with decreased metabolism of codeine, debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *17/*17 + *1/*1.",Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756913,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol","Authors described Tanzanians as ""black Tanzanians'."
CYP2D6*17,11823760,"CYP2D6 *5/*17 is associated with decreased metabolism of codeine, debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *17/*17 + *1/*1.",Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756913,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*5,11823760,"CYP2D6 *5/*17 is associated with decreased metabolism of codeine, debrisoquine, dextromethorphan or metoprolol in healthy individuals as compared to CYP2D6 *17/*17 + *1/*1.",Tanzania,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The African-specific CYP2D617 allele encodes an enzyme with changed substrate specificity.,11823760,2002,PharmGKB,1184756913,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*1,17517247,"CYP2D6 *17 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046931,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*17,17517247,"CYP2D6 *17 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046931,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*1,17517247,"CYP2D6 *4 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046905,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*4,17517247,"CYP2D6 *4 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046905,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*1,17517247,"CYP2D6 *40 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046937,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*40,17517247,"CYP2D6 *40 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046937,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*1,17517247,"CYP2D6 *5 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046919,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*5,17517247,"CYP2D6 *5 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046919,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*1,17517247,"CYP2D6 *6 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046925,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*6,17517247,"CYP2D6 *6 is associated with decreased response to codeine in children with Anemia, Sickle Cell as compared to CYP2D6 *1.",USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis.,17517247,2007,PharmGKB,982046925,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*17,19357842,"CYP2D6 *17 is associated with decreased metabolism of codeine in people with Anemia, Sickle Cell.",USA,African American/Afro-Caribbean,African American,FALSE,0.16,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease.,19357842,2009,PharmGKB,1447963867,Star allele,codeine,DB00318,"Approved,Illicit","Codeine sulfate is a form of this drug that is commonly used. It is available in tablet form Label and indicated for the relief of mild to moderately severe pain, where the use of an opioid analgesic is appropriate Label. The solution form is used by itself or combined in a syrup with other drugs and is used as a cough suppressant in adults aged 18 and above.","(5alpha,6alpha)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol",
CYP2D6*17,8971426,CYP2D6*17 is associated with diminished debrisoquine hydroxylase activity,Zimbabwe,South Africa,Shona,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity.,8971426,1996,PharmGKB,TBD,Star allele,debrisoquine,DB04840,"Approved, Investigational","For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.","1,2,3,4-tetrahydroisoquinoline-2-carboximidamide",
CYP2D6*17,9918137,CYP2D6*17 associated with higher average metabolic ratios among African-Americans compared with Caucasians.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,CYP2D6 phenotype-genotype relationships in African-Americans and Caucasians in Los Angeles.,9918137,1998,PharmGKB,TBD,Star allele,debrisoquine,DB04840,"Approved, Investigational","For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.","1,2,3,4-tetrahydroisoquinoline-2-carboximidamide",
CYP2D6*29,11470994,CYP2D6*29 associated with decreased debrisoquine hydroxylation activity.,Tanzania,East Africa,NS,FALSE,< 0.01,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity.,11470994,2001,PharmGKB,TBD,Star allele,debrisoquine,DB04840,"Approved, Investigational","For the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypertension.","1,2,3,4-tetrahydroisoquinoline-2-carboximidamide",
rs28371706,22111602,Genotypes AA + AG are associated with decreased clearance of nevirapine in children with HIV as compared to genotype GG.,Malawi,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823698,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP2D6*17 (rs28371706)
CYP2D6*1,29555325,"CYP2D6*1 allele (wild type) frequency was significantly greater than CYP2D6*DUP, CYP2D6*4 and CYP2D6*10 alleles in both chronically tramadol-treated and control groups.",Egypt,North Africa,NS,FALSE,< 0.05,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.,29555325,2018,PharmGKB,TBD,Star allele,tramadol,DB00193,"Approved, Investigational",Tramadol is approved for the management of moderate to severe pain in adults.,2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol,
CYP2D6*2,20837591,CYP2D6 *2/*41 is associated with increased concentrations of hydrocodone.,Somali,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.,20837591,2010,PharmGKB,1449189944,Star allele,hydrocodone,DB00956,"Approved, Illicit, Investigational","Hydrocodone is indicated for the management of acute pain, sometimes in combination with acetaminophen or ibuprofen, as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.","4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6-one",
CYP2D6*41,20837591,CYP2D6 *2/*41 is associated with increased concentrations of hydrocodone.,Somali,East Africa,NS,FALSE,NS,CYP2D6,,CYP2D6,cytochrome P450 family 2 subfamily D member 6,22,P10635,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.,20837591,2010,PharmGKB,1449189944,Star allele,hydrocodone,DB00956,"Approved, Illicit, Investigational","Hydrocodone is indicated for the management of acute pain, sometimes in combination with acetaminophen or ibuprofen, as well as the symptomatic treatment of the common cold and allergic rhinitis in combination with decongestants, antihistamines, and expectorants.","4,5alpha-epoxy-3-methoxy-17-methylmorphinan-6-one",
rs61495246,10969262,"Vitamin D Hydroxylation-Deficient Rickets, Type 1B",Nigeria,West Africa,NS,FALSE,NS,CYP2R1,,CYP2R1,cytochrome P450 family 2 subfamily R member 1,11,Q6VVX0,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Case-control study of factors associated with nutritional rickets in Nigerian children.,10969262,2000,DisGeNET,rs61495246,SNV,,,,,,
rs61495246,25942481,"Vitamin D Hydroxylation-Deficient Rickets, Type 1B",Nigeria,West Africa,NS,FALSE,NS,CYP2R1,,CYP2R1,cytochrome P450 family 2 subfamily R member 1,11,Q6VVX0,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This enzyme is a microsomal vitamin D hydroxylase that converts vitamin D into the active ligand for the vitamin D receptor. A mutation in this gene has been associated with selective 25-hydroxyvitamin D deficiency. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency.,25942481,2015,DisGeNET,rs61495246,SNV,,,,,,
rs2242480,29318894,Allele T is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,1.91E-08,CYP3A4,Association,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.,29318894,2018,PharmGKB,1449163561,SNV,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",The study involves 363 African-American kidney allograft recipients. Subjects received tacrolimus for maintenance immunosuppression. The p-value reports the association between the rs2242480 SNP (1*G) and the longitudinal dose-normalized tacrolimus trough concentrations in the African-American cohort.
rs4646437,29318894,Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,8.86E-08,CYP3A4,Association,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.,29318894,2018,PharmGKB,1449163570,SNV,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",The study involves 363 African-American kidney allograft recipients. Subjects received tacrolimus for maintenance immunosuppression. The p-value reports the association between the rs4646437 SNP and the longitudinal dose-normalized tacrolimus trough concentrations in the African-American cohort.
CYP3A4*1,26615671,CYP3A4 *1/*1B is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A4 *1/*1.,Tunisia,North Africa,NS,FALSE,< 0.0001,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.,26615671,2016,PharmGKB,1447674678,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A4*1B,26615671,CYP3A4 *1/*1B is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A4 *1/*1.,Tunisia,North Africa,NS,FALSE,< 0.0001,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.,26615671,2016,PharmGKB,1447674678,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A4*22,25051018,CYP3A4 *1/*22 + *22/*22 is associated with concentrations of simvastatin as compared to CYP3A4 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.01,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort.,25051018,2015,PharmGKB,1184746928,Star allele,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
CYP3A4*1,25051018,CYP3A4 *1/*22 + *22/*22 is associated with concentrations of simvastatin as compared to CYP3A4 *1/*1.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort.,25051018,2015,PharmGKB,1184746928,Star allele,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
CYP3A4*1,29450233,CYP3A4 *1/*1B is associated with increased dose of buprenorphine in people with Opioid-Related Disorders.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach.,29450233,2018,PharmGKB,1449170970,Star allele,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",
CYP3A4*1B,29450233,CYP3A4 *1/*1B is associated with increased dose of buprenorphine in people with Opioid-Related Disorders.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Pharmacogenomics-guided policy in opioid use disorder (OUD) management: An ethnically-diverse case-based approach.,29450233,2018,PharmGKB,1449170970,Star allele,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",
rs2740574,27142945,Genotypes CT + TT is not associated with concentrations of lopinavir in people with HIV as compared to genotype CC.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,CYP3A4,Association,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986082,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs2740574-G and lopinavir plasma concentration.
rs4646437,25240575,Genotypes AG + GG is associated with increased dose-adjusted trough concentrations of cyclosporine in people with Kidney Transplantation as compared to genotype AA.,Egypt,North Africa,NS,FALSE,0.009,CYP3A4,Association,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.,25240575,2016,PharmGKB,1185012200,SNV,cyclosporine,DB00091,"Approved, Investigational","Cyclosporine is officially approved for different conditions listed below: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. For this indication, it can be used concomitantly with azathioprine and corticosteroids. Treatment of patients with severe active, rheumatoid arthritis when the patient no longer responds to methotrexate. Concomitantly with methotrexate for the treatment of patients with severe active rheumatoid arthritis when patients do not respond to methotrexate treatment alone. Treatment of adult nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. Its ophthalmic solution is indicated to increase tear production in patients with keratoconjunctivitis sicca in patients from 4 years old. Prevention of graft rejection following bone marrow transplantation and in the treatment of graft-versus-host disease (GVHD). Treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis in adults and children. Away from all this approved and reviewed indications, cyclosporine is commonly used on dermatology for the treatment of various inflammatory skin conditions such as atopic dermatitis, blistering disorders, and connective tissue diseases.","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",Fifty Egyptian renal transplant recipients and under cyclosporin therapy were recruited for the study. Patients carrying the rs4646437C>T in either homozygous or heterozygous forms show a significant difference in daily dose requirement of cyclosporin. The p-value presented in the table was calculated 9 months after the transplantation.
rs4646437,25240575,Genotypes AG + GG is associated with increased response to cyclosporine in people with Kidney Transplantation as compared to genotype AA.,Egypt,North Africa,NS,FALSE,< 0.009,CYP3A4,Association,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.,25240575,2016,PharmGKB,1185012251,SNV,cyclosporine,DB00091,"Approved, Investigational","Cyclosporine is officially approved for different conditions listed below: Prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. For this indication, it can be used concomitantly with azathioprine and corticosteroids. Treatment of patients with severe active, rheumatoid arthritis when the patient no longer responds to methotrexate. Concomitantly with methotrexate for the treatment of patients with severe active rheumatoid arthritis when patients do not respond to methotrexate treatment alone. Treatment of adult nonimmunocompromised patients with severe, recalcitrant, plaque psoriasis that have failed to respond to at least one systemic therapy or when systemic therapies are not tolerated or contraindicated. Its ophthalmic solution is indicated to increase tear production in patients with keratoconjunctivitis sicca in patients from 4 years old. Prevention of graft rejection following bone marrow transplantation and in the treatment of graft-versus-host disease (GVHD). Treatment of steroid dependent and steroid-resistant nephrotic syndrome due to glomerular diseases such as minimal change nephropathy, focal and segmental glomerulosclerosis or membranous glomerulonephritis in adults and children. Away from all this approved and reviewed indications, cyclosporine is commonly used on dermatology for the treatment of various inflammatory skin conditions such as atopic dermatitis, blistering disorders, and connective tissue diseases.","(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone",Fifty Egyptian renal transplant recipients and under cyclosporin therapy were recruited for the study. Patients carrying the rs4646437C>T in either homozygous or heterozygous forms show a significant difference in dose-adjusted C0 levels. The p-value presented in the table was calculated 9 months after the transplantation.
rs2740574,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,South Africa,South Africa,NS,FALSE,0.872,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680825,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",This SNP was not associated with virologic response. Not significant at a Bonferroni-corrected P value threshold of p=0.0007 (n=76 SNPs were examined by univariate analysis).
rs2740574,22111602,Genotype CC is not associated with decreased clearance of nevirapine in people with HIV as compared to genotypes CT + TT.,Malawi,East Africa,NS,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823747,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",CYP3A4*1B (rs2740574)
rs2740574,28673292,Allele C is associated with increased concentrations of lumefantrine in women with Malaria and Pregnancy as compared to allele T.,Tanzania,East Africa,NS,FALSE,0.018,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003545,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol","CYP3A4*1B (âˆ’392A>G, rs2740574)"
rs2246709,19907160,Genotypes AG + GG are associated with increased response to amlodipine in people with Hypertension as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,TRUE,0.01,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,769169820,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate",CYP3A4 T16090C
rs2740574,19907160,Genotypes CT + TT are not associated with response to amlodipine in women with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,TRUE,0.016,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,982043679,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","the study suggests that blood pressure response to amlodipine among high-risk African- Americans appears to be determined by CYP3A4 genotypes, and sex specificity may be an important consideration"
rs2740574,19907160,Genotypes CT + TT are associated with increased response to amlodipine in women with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,TRUE,0.44,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,982043591,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate",CYP3A4 Aâ€“392G
rs2246709,19907160,Genotypes AG + GG are not associated with response to amlodipine in men with Hypertension as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,982043687,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","the study suggests that blood pressure response to amlodipine among high-risk African- Americans appears to be determined by CYP3A4 genotypes, and sex specificity may be an important consideration"
rs2246709,19907160,Genotypes AG + GG are not associated with response to amlodipine in people with Hypertension as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,982043709,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","the study suggests that blood pressure response to amlodipine among high-risk African- Americans appears to be determined by CYP3A4 genotypes, and sex specificity may be an important consideration"
rs2246709,19907160,Genotypes AG + GG are not associated with response to amlodipine in women with Hypertension as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,982043698,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","the study suggests that blood pressure response to amlodipine among high-risk African- Americans appears to be determined by CYP3A4 genotypes, and sex specificity may be an important consideration"
rs2740574,19907160,Genotypes CT + TT are not associated with response to amlodipine in men with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,CYP3A4 and CYP3A5 polymorphisms and blood pressure response to amlodipine among African-American men and women with early hypertensive renal disease.,19907160,2010,PharmGKB,982043660,SNV,amlodipine,DB00381,Approved,"Amlodipine may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of the following conditions Label: Hypertension, Coronary artery disease, Chronic stable angina, Vasospastic angina (Prinzmetalâ€™s or Variant angina). Angiographically documented coronary artery disease in patients without heart failure or an ejection fraction < 40%.","3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate","the study suggests that blood pressure response to amlodipine among high-risk African- Americans appears to be determined by CYP3A4 genotypes, and sex specificity may be an important consideration"
rs2740574,23252947,Genotype TT is associated with increased clearance of carbamazepine in people with Epilepsy as compared to genotypes CC + CT.,USA,African American/Afro-Caribbean,African American,TRUE,0.027,CYP3A4,,CYP3A4,cytochrome P450 family 3 subfamily A member 4,7,P08684,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501734,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine","rs2740574, (A>G), The CYP3A4*1B SNP was significantly associated with CBZ clearance"
rs4646450,29318894,Allele A is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,4.91E-07,CYP3A5,Association,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.,29318894,2018,PharmGKB,1449163533,SNV,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",The study involves 363 African-American kidney allograft recipients. Subjects received tacrolimus for maintenance immunosuppression. The p-value reports the association between the rs4646450 SNP and the longitudinal dose-normalized tacrolimus trough concentrations in the African-American cohort.
CYP3A5*3A,26667830,CYP3A5 *3A + *6 + *7 are associated with decreased clearance of tacrolimus in people with Kidney Transplantation.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.,26667830,2017,PharmGKB,1448267244,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*6,26667830,CYP3A5 *3A + *6 + *7 are associated with decreased clearance of tacrolimus in people with Kidney Transplantation.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.,26667830,2017,PharmGKB,1448267244,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*7,26667830,CYP3A5 *3A + *6 + *7 are associated with decreased clearance of tacrolimus in people with Kidney Transplantation.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.,26667830,2017,PharmGKB,1448267244,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*1A,29161757,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.,29161757,2019,PharmGKB,1449183103,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*3A,29161757,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.,29161757,2019,PharmGKB,1449183103,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*6,29161757,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.,29161757,2019,PharmGKB,1449183103,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*7,29161757,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 + *1A/*7 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *3A/*7 + *6/*6 + *6/*7 + *7/*7.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Impact of CYP3A5 genomic variances on clinical outcomes among African American kidney transplant recipients.,29161757,2019,PharmGKB,1449183103,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*1A,26615671,CYP3A5 *1A/*1A + *1A/*3A is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A.,Tunisia,North Africa,NS,FALSE,< 0.005,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.,26615671,2016,PharmGKB,1447674691,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*3A,26615671,CYP3A5 *1A/*1A + *1A/*3A is associated with decreased dose-adjusted trough concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A.,Tunisia,North Africa,NS,FALSE,< 0.005,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.,26615671,2016,PharmGKB,1447674691,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*1A,29162334,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449170428,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*3A,29162334,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449170428,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*6,29162334,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased concentrations of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449170428,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*1A,29162334,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449171185,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*3A,29162334,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449171185,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*6,29162334,CYP3A5 *1A/*1A + *1A/*3A + *1A/*6 is associated with increased dose of tacrolimus in people with Kidney Transplantation as compared to CYP3A5 *3A/*3A + *3A/*6 + *6/*6.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients.",29162334,2019,PharmGKB,1449171185,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*3,21206424,CYP3A5*3 (rs776746) was the top variant associated with tacrolimus troughs.,USA,African American/Afro-Caribbean,African American,TRUE,2.4x10−33,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Novel polymorphisms associated with tacrolimus trough concentrations: results from a multicenter kidney transplant consortium.,21206424,2011,PharmGKB,TBD,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
CYP3A5*3,22304537,The tacrolimus daily requirements for heterozygous patients (CYP3A5*3/*1) were higher compared with homozygous patients (CYP3A5*3/*3) ,Morocco,North Africa,NS,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Frequencies of CYP3A5*1/*3 variants in a Moroccan population and effect on tacrolimus daily dose requirements in renal transplant patients.,22304537,2012,PharmGKB,TBD,Star allele,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",
rs17161788,18727922,Genotype TT is associated with decreased response to atorvastatin in people with Hypercholesterolemia as compared to genotypes CC + CT.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia.,18727922,2009,PharmGKB,982044239,SNV,atorvastatin,DB01076,Approved,"Atorvastatin is approved for the treatment of several types of dyslipidemias including: Primary hyperlipidemia and mixed dyslipidemia in adults, Hypertriglyceridemia, Primary dysbetalipoproteinemia, Homozygous familial hypercholesterolemia, Heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications. Dyslipidemia is defined as an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis. Atorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles. Atorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors, and in patients with type 2 diabetes without coronary heart disease but multiple risk factors. Atorvastatin can also be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid",rs17161788 is assigned to CYP3A5*1D allele in the CYP3A5 gene in this study and is associated with decreased response to atorvastatin in people with Hypercholesterolemia in non-African
rs2740574,28673292,Allele T is associated with decreased response to lumefantrine in women with Malaria and Pregnancy as compared to allele C.,Tanzania,East Africa,NS,FALSE,0.018,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women.,28673292,2018,PharmGKB,1449003637,SNV,lumefantrine,DB06708,Approved,"Lumefantrine and artemether combination therapy is indicated for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum, including malaria acquired in chloroquine-resistant areas. May also be used to treat uncomplicated malaria when the Plasmodium species has not been identified. Indicated for use in adults and children greater than 5 kg.","2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl]ethan-1-ol","CYP3A4*1B (âˆ’392A>G, rs2740574)"
CYP3A5*3A,23252947,CYP3A5 *3A/*3A is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to CYP3A5 *1A/*1A + *1A/*3A.,USA,African American/Afro-Caribbean,"African American, Caucasian",TRUE,0.037,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501747,Star allele,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",
CYP3A5*1A,23252947,CYP3A5 *3A/*3A is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to CYP3A5 *1A/*1A + *1A/*3A.,USA,African American/Afro-Caribbean,"African American, Caucasian",TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501747,Star allele,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",
CYP3A5*1A,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998561,Star allele,,,,,,
CYP3A5*3A,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998561,Star allele,,,,,,
CYP3A5*6,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998561,Star allele,,,,,,
CYP3A5*7,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998561,Star allele,,,,,,
CYP3A5*1A,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998461,Star allele,,,,,,
CYP3A5*3A,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998461,Star allele,,,,,,
CYP3A5*6,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998461,Star allele,,,,,,
CYP3A5*7,19710077,CYP3A5 *3A + *6 + *7 are associated with decreased metabolism of atazanavir in healthy individuals as compared to CYP3A5 *1A.,USA,African American/Afro-Caribbean,African American,TRUE,NS,CYP3A5,,CYP3A5,cytochrome P450 family 3 subfamily A member 5,7,P20815,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The encoded protein metabolizes drugs as well as the steroid hormones testosterone and progesterone. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Two pseudogenes of this gene have been identified within this cluster on chromosome 7. Expression of this gene is widely variable among populations, and a single nucleotide polymorphism that affects transcript splicing has been associated with susceptibility to hypertensions. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.,19710077,2009,PharmGKB,1184998461,Star allele,,,,,,
rs2257401,29318894,Allele C is associated with trough concentration of tacrolimus in people with Kidney Transplantation and Transplantation as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,0.015,CYP3A7,Association,CYP3A7,cytochrome P450 family 3 subfamily A member 7,7,P24462,"This gene encodes a member of the cytochrome P450 superfamily of enzymes, which participate in drug metabolism and the synthesis of cholesterol, steroids and other lipids. This enzyme hydroxylates testosterone and dehydroepiandrosterone 3-sulphate, which is involved in the formation of estriol during pregnancy. This gene is part of a cluster of related genes on chromosome 7q21.1. Naturally-occurring readthrough transcription occurs between this gene and the downstream CYP3A51P pseudogene and is represented by GeneID:100861540. [provided by RefSeq, Jan 2015].",22/11/2021,PubMed,Attempted validation of 44 reported SNPs associated with tacrolimus troughs in a cohort of kidney allograft recipients.,29318894,2018,PharmGKB,1449163553,SNV,tacrolimus,DB00864,"Approved, Investigational","For use after allogenic organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It was given FDA approval in 1994 for use in liver transplantation. Since then, this indication has expanded to kidney, heart, small bowel, pancreas, lung, trachea, skin, cornea, and limb transplants. It has also been used in a topical preparation in the treatment of severe atopic dermatitis.","(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.0â?´,â?¹]octacos-18-ene-2,3,10,16-tetrone",The study involves 363 African-American kidney allograft recipients. Subjects received tacrolimus for maintenance immunosuppression. The p-value reports the association between the rs2257401 SNP (*2) and the longitudinal dose-normalized tacrolimus trough concentrations in the African-American cohort.
CYP4F2*3,30506689,The CYP4F2*3 polymorphism was consistently associated with an increase in mean coumarin dose.,"Africa, America, Asia, Europe ",Africa / African American/Afro-Caribbean,NS,TRUE,< 0.05,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.",30506689,2019,PharmGKB,TBD,Star allele,coumarin,DB04665,Experimental,Not Available,2H-chromen-2-one,
rs2108622,20072124,Allele T is not associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037942,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs2108622 correspond to the amino acid substitution V433M. It is not clear from the study if the substitution in heterozygote or homozygote states is associated with decreased dse of warfarin.
rs2108622,20072124,Allele T is not associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037942,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs2108622 correspond to the amino acid substitution V433M. It is not clear from the study if the substitution in heterozygote or homozygote states is associated with decreased dse of warfarin.
rs2108622,21228733,Allele C is not associated with decreased dose of warfarin as compared to allele T.,Egypt,North Africa,NS,FALSE,0.31,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864558,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Allele C is not associated with decreased dose of warfarin as compared to allele T.
rs2108622,21228733,Allele C is not associated with decreased dose of warfarin as compared to allele T.,Egypt,North Africa,NS,FALSE,0.31,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864558,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Allele C is not associated with decreased dose of warfarin as compared to allele T.
rs2108622,27938396,"Genotypes CT + TT is not associated with increased dose of warfarin in people with Atrial Fibrillation, Cardiomyopathies, heart valve replacement, Peripheral Vascular Diseases, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",Ghana,West Africa,NS,FALSE,0.128,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.,27938396,2017,PharmGKB,1448602262,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 116 Ghanian patients receiving stable warfarin doses. The  rs2108622 T allele was genotyped corresponding to CYP4F2*3. No significant variation has been noticed for warfarin doses for both the TT and CT genotypes compared to CC genotype. The p-value is reported for the TT genotype.
rs2108622,27938396,"Genotypes CT + TT is not associated with increased dose of warfarin in people with Atrial Fibrillation, Cardiomyopathies, heart valve replacement, Peripheral Vascular Diseases, Pulmonary Embolism and Venous Thrombosis as compared to genotype CC.",Ghana,West Africa,NS,FALSE,0.128,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population.,27938396,2017,PharmGKB,1448602262,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 116 Ghanian patients receiving stable warfarin doses. The  rs2108622 T allele was genotyped corresponding to CYP4F2*3. No significant variation has been noticed for warfarin doses for both the TT and CT genotypes compared to CC genotype. The p-value is reported for the TT genotype.
rs2108622,26024874,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.76,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296694,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. rs2108622; A allele was evaluated but found no significant dose changes in the African American cohort in contrast to European Americans from the same study. 
rs2108622,26024874,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.76,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296694,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. rs2108622; A allele was evaluated but found no significant dose changes in the African American cohort in contrast to European Americans from the same study. 
rs2108622,26024874,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.76,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1447952609,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. rs2108622; A allele was evaluated but found no significant dose changes in the African American cohort in contrast to European Americans from the same study. 
rs2108622,26024874,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.76,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1447952609,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. rs2108622; A allele was evaluated but found no significant dose changes in the African American cohort in contrast to European Americans from the same study. 
rs2108622,26877068,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.73,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.,26877068,2016,PharmGKB,1445296694,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on CYP4F2*3 correspondings to rs2108622 T allele. The cohort includes 531 African Americans. Patients carrying the *3 may have increased warfarin dosage requirements as compared to patients with *1/*1 or *1/*3. However, this wasn't found to be significant with a p-value of 0.73 and 0.75 respectively for *3/*3 and *1/*3 compared to *1/*1 in the African American group. "
rs2108622,26877068,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.73,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.,26877068,2016,PharmGKB,1445296694,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on CYP4F2*3 correspondings to rs2108622 T allele. The cohort includes 531 African Americans. Patients carrying the *3 may have increased warfarin dosage requirements as compared to patients with *1/*1 or *1/*3. However, this wasn't found to be significant with a p-value of 0.73 and 0.75 respectively for *3/*3 and *1/*3 compared to *1/*1 in the African American group. "
rs2108622,26877068,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.73,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.,26877068,2016,PharmGKB,1447952609,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on CYP4F2*3 correspondings to rs2108622 T allele. The cohort includes 531 African Americans. Patients carrying the *3 may have increased warfarin dosage requirements as compared to patients with *1/*1 or *1/*3. However, this wasn't found to be significant with a p-value of 0.73 and 0.75 respectively for *3/*3 and *1/*3 compared to *1/*1 in the African American group. "
rs2108622,26877068,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.73,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race-Specific Influence of CYP4F2 on Dose and Risk of Hemorrhage Among Warfarin Users.,26877068,2016,PharmGKB,1447952609,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study reports on CYP4F2*3 correspondings to rs2108622 T allele. The cohort includes 531 African Americans. Patients carrying the *3 may have increased warfarin dosage requirements as compared to patients with *1/*1 or *1/*3. However, this wasn't found to be significant with a p-value of 0.73 and 0.75 respectively for *3/*3 and *1/*3 compared to *1/*1 in the African American group. "
rs2108622,29479633,Allele T is associated with increased dose of acenocoumarol in people with Atrial Fibrillation as compared to allele C.,Morocco,North Africa,NS,FALSE,0.028,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.,29479633,2018,PharmGKB,1449188284,SNV,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,Patients with the TT genotype required significantly higher weekly maintenance doses of acenocoumarol compared to CT heterozygotes.
rs2108622,22486182,Genotype TT is associated with increased dose of acenocoumarol as compared to genotype CT.,Morocco,North Africa,NS,FALSE,0.76,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010017,SNV,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.
rs2108622,22486182,Genotype TT is not associated with dose of acenocoumarol as compared to genotype CC.,Morocco,North Africa,NS,FALSE,NS,CYP4F2,,CYP4F2,cytochrome P450 family 4 subfamily F member 2,19,P78329,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010056,SNV,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,No significant difference was seen between the daily dose for CYP4F2 wildtype patients and the daily dose for CYP4F2 variant carriers.
rs118091316,16436457,"Ichthyosis, Lamellar, 3","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118091316,SNV,,,,,,
rs118091316,16436457,"Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118091316,SNV,,,,,,
rs118203935,16436457,"Ichthyosis, Lamellar, 3","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118203935,SNV,,,,,,
rs118203935,16436457,"Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118203935,SNV,,,,,,
rs118203936,16436457,"Ichthyosis, Lamellar, 3","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118203936,SNV,,,,,,
rs118203936,16436457,"Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118203936,SNV,,,,,,
rs118203937,16436457,"Ichthyosis, Lamellar, 3","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118203937,SNV,,,,,,
rs118203937,16436457,"Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive","Algeria, Europe",North Africa,NS,TRUE,0,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs118203937,SNV,,,,,,
rs201129618,16436457,"Ichthyosis, Lamellar, 3","Algeria, Europe",North Africa,NS,TRUE,< 0.05,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs201129618,SNV,,,,,,
rs201129618,16436457,"Ichthyosis, Nonlamellar And Nonerythrodermic, Congenital, Autosomal Recessive","Algeria, Europe",North Africa,NS,TRUE,< 0.05,CYP4F22,,CYP4F22,cytochrome P450 family 4 subfamily F member 22,19,Q6NT55,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This gene is part of a cluster of cytochrome P450 genes on chromosome 19 and encodes an enzyme thought to play a role in the 12(R)-lipoxygenase pathway. Mutations in this gene are the cause of ichthyosis lamellar type 3.",22/11/2021,PubMed,Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3.,16436457,2006,DisGeNET,rs201129618,SNV,,,,,,
rs121908611,7987300,"Spastic Paraplegia 5A, Autosomal Recessive (Disorder)",Tunisia,North Africa,NS,FALSE,NS,CYP7B1,Linkage,CYP7B1,cytochrome P450 family 7 subfamily B member 1,8,O75881,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016].",22/11/2021,PubMed,Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity.,7987300,1994,DisGeNET,rs121908611,SNV,,,,,,"Genetic linkage analysis established the linkage of the autosomal recessive (RFSP) locus to chromosome 8 markers, D8S260,  D8S166,  D8S285, PLAT,  and D8S279 in four Tunisian family."
rs121908614,7987300,"Spastic Paraplegia 5A, Autosomal Recessive (Disorder)",Tunisia,North Africa,NS,FALSE,NS,CYP7B1,Linkage,CYP7B1,cytochrome P450 family 7 subfamily B member 1,8,O75881,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway of extrahepatic tissues, which converts cholesterol to bile acids. This enzyme likely plays a minor role in total bile acid synthesis, but may also be involved in the development of atherosclerosis, neurosteroid metabolism and sex hormone synthesis. Mutations in this gene have been associated with hereditary spastic paraplegia (SPG5 or HSP), an autosomal recessive disorder. [provided by RefSeq, Apr 2016].",22/11/2021,PubMed,Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity.,7987300,1994,DisGeNET,rs121908614,SNV,,,,,,"Genetic linkage analysis established the linkage of the autosomal recessive (RFSP) locus to chromosome 8 markers, D8S260,  D8S166,  D8S285, PLAT,  and D8S279 in four Tunisian family."
rs797045023,24052401,"Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 9",Libya,North Africa,NS,FALSE,NS,DAG1,,DAG1,dystroglycan 1,3,Q14118,"This gene encodes dystroglycan, a central component of dystrophin-glycoprotein complex that links the extracellular matrix and the cytoskeleton in the skeletal muscle. The encoded preproprotein undergoes O- and N-glycosylation, and proteolytic processing to generate alpha and beta subunits. Certain mutations in this gene are known to cause distinct forms of muscular dystrophy. Alternative splicing results in multiple transcript variants, all encoding the same protein. [provided by RefSeq, Nov 2015].",22/11/2021,PubMed,Homozygous dystroglycan mutation associated with a novel muscle-eye-brain disease-like phenotype with multicystic leucodystrophy.,24052401,2014,DisGeNET,rs797045023,SNV,,,,,,
rs794729665,25601850,"Deafness, Autosomal Recessive 66",Tunisia,North Africa,NS,FALSE,NS,DCDC2,,DCDC2,doublecortin domain containing 2,6,Q9UHG0,"This gene encodes a doublecortin domain-containing family member. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization. This family member is thought to function in neuronal migration where it may affect the signaling of primary cilia. Mutations in this gene have been associated with reading disability (RD) type 2, also referred to as developmental dyslexia. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2013].",22/11/2021,PubMed,"A missense mutation in DCDC2 causes human recessive deafness DFNB66, likely by interfering with sensory hair cell and supporting cell cilia length regulation.",25601850,2015,DisGeNET,rs794729665,SNV,,,,,,
rs794729665,25601850,Nonsyndromic Deafness,Tunisia,North Africa,NS,FALSE,NS,DCDC2,,DCDC2,doublecortin domain containing 2,6,Q9UHG0,"This gene encodes a doublecortin domain-containing family member. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization. This family member is thought to function in neuronal migration where it may affect the signaling of primary cilia. Mutations in this gene have been associated with reading disability (RD) type 2, also referred to as developmental dyslexia. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2013].",22/11/2021,PubMed,"A missense mutation in DCDC2 causes human recessive deafness DFNB66, likely by interfering with sensory hair cell and supporting cell cilia length regulation.",25601850,2015,DisGeNET,rs794729665,SNV,,,,,,
rs794729665,16244493,"Deafness, Autosomal Recessive 66",Tunisia,North Africa,NS,FALSE,NS,DCDC2,,DCDC2,doublecortin domain containing 2,6,Q9UHG0,"This gene encodes a doublecortin domain-containing family member. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization. This family member is thought to function in neuronal migration where it may affect the signaling of primary cilia. Mutations in this gene have been associated with reading disability (RD) type 2, also referred to as developmental dyslexia. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2013].",22/11/2021,PubMed,"A novel autosomal recessive non-syndromic deafness locus, DFNB66, maps to chromosome 6p21.2-22.3 in a large Tunisian consanguineous family.",16244493,2006,DisGeNET,rs794729665,SNV,,,,,,
rs121964990,23478190,"Genetic Diseases, Inborn",Algeria,North Africa,NS,FALSE,NS,DLD,,DLD,dihydrolipoamide dehydrogenase,7,P09622,"This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, the encoded protein functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome.,23478190,2013,DisGeNET,rs121964990,SNV,,,,,,Pathogenic mutation detected in Algerian family with DLD deficiency
rs121964990,23478190,"Lactic Acidosis, Congenital Infantile, Due To Lad Deficiency",Algeria,North Africa,NS,FALSE,NS,DLD,,DLD,dihydrolipoamide dehydrogenase,7,P09622,"This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, the encoded protein functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome.,23478190,2013,DisGeNET,rs121964990,SNV,,,,,,"Biochemical investigation (lactate, pyruvate, aminoacids in plasma, organic acids in urine) was normal in the investigated family"
rs121964990,23478190,NAdh Cytochrome B5 Reductase Deficiency,Algeria,North Africa,NS,FALSE,NS,DLD,,DLD,dihydrolipoamide dehydrogenase,7,P09622,"This gene encodes a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, the encoded protein functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome.,23478190,2013,DisGeNET,rs121964990,SNV,,,,,,Pyruvate dehydrogenase activity was reduced to 70% in skin fibroblasts of patients.
rs756614404,22522442,"Spinal Muscular Atrophy, Distal, Autosomal Recessive, 5",Morocco,North Africa,Jewish,FALSE,NS,DNAJB2,,DNAJB2,DnaJ heat shock protein family (Hsp40) member B2,2,P25686,"This gene is almost exclusively expressed in the brain, mainly in the neuronal layers. It encodes a protein that shows sequence similarity to bacterial DnaJ protein and the yeast homologs. In bacteria, this protein is implicated in protein folding and protein complex dissociation. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation.,22522442,2012,DisGeNET,rs756614404,SNV,,,,,,
rs387907571,24218364,"Parkinson Disease, Late-Onset","Tunisia, Canada, Norway, Taiwan, USA",North Africa,NS,TRUE,NS,DNAJC13,,DNAJC13,DnaJ heat shock protein family (Hsp40) member C13,3,O75165,"This gene encodes a member of the Dnaj protein family whose members act as co-chaperones of a partner heat-shock protein by binding to the latter and stimulating ATP hydrolysis. The encoded protein associates with the heat-shock protein Hsc70 and plays a role in clathrin-mediated endocytosis. It may also be involved in post-endocytic transport mechanisms via its associations with other proteins, including the sorting nexin SNX1. Mutations in this gene are associated with Parkinson's disease. [provided by RefSeq, Jun 2016].",22/11/2021,PubMed,DNAJC13 mutations in Parkinson disease.,24218364,2014,DisGeNET,rs387907571,SNV,,,,,,
rs2269879,22440088,Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.29,DOT1L,Association,DOT1L,DOT1 like histone lysine methyltransferase,19,Q8TEK3,"The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.,22440088,2012,PharmGKB,981239001,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",The P-value was calculated for diastolic blood pressure response to hydrochlorothiazide.
rs2269879,22440088,Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.73,DOT1L,Association,DOT1L,DOT1 like histone lysine methyltransferase,19,Q8TEK3,"The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.,22440088,2012,PharmGKB,981239001,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",The P-value was calculated for systolic blood pressure response to hydrochlorothiazide.
rs2269879,22440088,Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.29,DOT1L,Association,DOT1L,DOT1 like histone lysine methyltransferase,19,Q8TEK3,"The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.,22440088,2012,PharmGKB,981239001,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",The P-value was calculated for diastolic blood pressure response to hydrochlorothiazide.
rs2269879,22440088,Genotypes CT + TT are not associated with increased response to hydrochlorothiazide in people with Hypertension as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.73,DOT1L,Association,DOT1L,DOT1 like histone lysine methyltransferase,19,Q8TEK3,"The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.,22440088,2012,PharmGKB,981239001,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",The P-value was calculated for systolic blood pressure response to hydrochlorothiazide.
rs265976,17092969,Genotype GT is associated with decreased response to clozapine in people with Schizophrenia as compared to genotypes GG + TT.,Canada,African American/Afro-Caribbean,NS,FALSE,0.033,DRD1,,DRD1,dopamine receptor D1,5,P21728,"This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.,17092969,2008,PharmGKB,982025734,SNV,clozapine,DB00363,Approved,For use in patients with treatment-resistant schizophrenia.,"8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine","In the African American sample, individual marker analysis identified the rs265976 SNP to be associated with response. Patients with the heterozygote 1/2 genotype were significantly more likely to be non-responders (p= 0.033) as well as have poorer response in terms of positive symptoms (p = 0.027) compared with patients having the other two genotypes."
rs265981,17092969,Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.,Canada,African American/Afro-Caribbean,NS,FALSE,NS,DRD1,,DRD1,dopamine receptor D1,5,P21728,"This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.,17092969,2008,PharmGKB,982025895,SNV,clozapine,DB00363,Approved,For use in patients with treatment-resistant schizophrenia.,"8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",
rs686,17092969,Allele A is not associated with response to clozapine in people with Schizophrenia as compared to allele G.,Canada,African American/Afro-Caribbean,NS,FALSE,NS,DRD1,,DRD1,dopamine receptor D1,5,P21728,"This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.,17092969,2008,PharmGKB,982025903,SNV,clozapine,DB00363,Approved,For use in patients with treatment-resistant schizophrenia.,"8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",
rs4532,17092969,Allele C is not associated with response to clozapine in people with Schizophrenia as compared to allele T.,Canada,African American/Afro-Caribbean,NS,FALSE,NS,DRD1,,DRD1,dopamine receptor D1,5,P21728,"This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association study of four dopamine D1 receptor gene polymorphisms and clozapine treatment response.,17092969,2008,PharmGKB,982025774,SNV,clozapine,DB00363,Approved,For use in patients with treatment-resistant schizophrenia.,"8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",No allelic association was observed between rs4532 polymorphism and antipsychotic drug response as indicated by pooled O.R. and its 95% C.I. (1.17 [0.90â€“1.52])
rs1799732,28673279,Genotype G/del is associated with decreased response to aripiprazole in people with schizoaffective disorder.,USA,African American/Afro-Caribbean,African American,FALSE,NS,DRD2,,DRD2,dopamine receptor D2,11,P14416,"This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing.",22/11/2021,PubMed,Pharmacogenetic evaluation to assess breakthrough psychosis with aripiprazole long-acting injection: a case report.,28673279,2017,PharmGKB,1449140243,SNV,aripiprazole,DB01238,"Approved, Investigational","Aripiprazole is indicated for manic and mixed episodes associated with bipolar I disorder, irritability associated with autism spectrum disorder, treatment of schizophrenia, treatment of Tourette's disorder, and as an adjunctive treatment of major depressive disorder. An injectable formulation of aripiprazole is indicated for agitation associated with schizophrenia or bipolar mania.","7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one",
rs1125394,15830237,Genotype DEL is not associated with increased response to clozapine in people with Schizophrenia as compared to allele G.,Canada,African American/Afro-Caribbean,NS,FALSE,0.029,DRD2,,DRD2,dopamine receptor D2,11,P14416,"This gene encodes the D2 subtype of the dopamine receptor. This G-protein coupled receptor inhibits adenylyl cyclase activity. A missense mutation in this gene causes myoclonus dystonia; other mutations have been associated with schizophrenia. Alternative splicing of this gene results in two transcript variants encoding different isoforms. A third variant has been described, but it has not been determined whether this form is normal or due to aberrant splicing. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.,15830237,2006,DisGeNET,rs1125394,SNV,,,,,,
rs267606776,16575393,Hypotrichosis 6,"Morocco, Iran, Iraq",North Africa,Jewish,TRUE,0.001,DSG4,,DSG4,desmoglein 4,18,Q86SJ6,"This gene encodes a member of the desmoglein subgroup of desmosomal cadherins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a transmembrane component of desmosomes and may play a role in cell-cell adhesion in epithelial cells. Mutations in the gene are associated with localized autosomal recessive hypotrichosis and monilethrix, characterized by impaired hair growth. [provided by RefSeq, May 2016].",22/11/2021,PubMed,An autosomal recessive form of monilethrix is caused by mutations in DSG4: clinical overlap with localized autosomal recessive hypotrichosis.,16575393,2006,DisGeNET,rs267606776,SNV,,,,,,"12 Jewish families from Iraq, Iran, and Morocco."
rs267606777,16575393,Hypotrichosis 6,"Morocco, Iran, Iraq",North Africa,Jewish,TRUE,NS,DSG4,,DSG4,desmoglein 4,18,Q86SJ6,"This gene encodes a member of the desmoglein subgroup of desmosomal cadherins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a transmembrane component of desmosomes and may play a role in cell-cell adhesion in epithelial cells. Mutations in the gene are associated with localized autosomal recessive hypotrichosis and monilethrix, characterized by impaired hair growth. [provided by RefSeq, May 2016].",22/11/2021,PubMed,An autosomal recessive form of monilethrix is caused by mutations in DSG4: clinical overlap with localized autosomal recessive hypotrichosis.,16575393,2006,DisGeNET,rs267606777,SNV,,,,,,"12 Jewish families from Iraq, Iran, and Morocco."
rs909706,19369910,Genotype TC is associated with increased response to haloperidol in people with Schizophrenia as compared to genotype CC.,USA,African American/Afro-Caribbean,NS,TRUE,0.027,DTNBP1,,DTNBP1,dystrobrevin binding protein 1,6,Q96EV8,"This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.,19369910,2009,PharmGKB,608178665,SNV,haloperidol,DB00502,Approved,"Haloperidol is indicated for a number of conditions including for the treatment of schizophrenia, for the manifestations of psychotic disorders, for the control of tics and vocal utterances of Touretteâ€™s Disorder in children and adults, for treatment of severe behavior problems in children of combative, explosive hyperexcitability (which cannot be accounted for by immediate provocation). Haloperidol is also indicated in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability, and poor frustration tolerance. Haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics",4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,"Allele A of marker rs909706 (P1583) have better response to haloperidol (0.007< or =p< or =0.080) in European-Americans, African-Americans."
rs742105,19369910,Genotypes TT + CT are associated with increased response to clozapine in people with Schizophrenia as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,TRUE,0.005,DTNBP1,,DTNBP1,dystrobrevin binding protein 1,6,Q96EV8,"This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. A similar protein in mouse is a component of a protein complex termed biogenesis of lysosome-related organelles complex 1 (BLOC-1), and binds to alpha- and beta-dystrobrevins, which are components of the dystrophin-associated protein complex (DPC). Mutations in this gene are associated with Hermansky-Pudlak syndrome type 7. This gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.,19369910,2009,PharmGKB,699642395,SNV,clozapine,DB00363,Approved,For use in patients with treatment-resistant schizophrenia.,"8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",Genotypewise analysis showed that the AA subjects with the genotypes C/T+T/T of rs742105 had better response to clozapine than those with genotype C/C of rs742105.
rs881152,20673984,Allele G is not associated with increased response to salbutamol in people with Asthma as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,0.936,DUSP1,Association,DUSP1,dual specificity phosphatase 1,5,P28562,"The protein encoded by this gene is a phosphatase with dual specificity for tyrosine and threonine. The encoded protein can dephosphorylate MAP kinase MAPK1/ERK2, which results in its involvement in several cellular processes. This protein appears to play an important role in the human cellular response to environmental stress as well as in the negative regulation of cellular proliferation. Finally, the encoded protein can make some solid tumors resistant to both chemotherapy and radiotherapy, making it a target for cancer therapy. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.,20673984,2010,PharmGKB,769174165,SNV,salbutamol,DB01001,Approved,"Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known to induce bronchospasm.",4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,"The study includes 176 African-Americans (Study of African American, Asthma, Genes and Environments). The individuals presented Asthma history. The presented p-value reports on the significance level of the forced expiratory volume at one second (FEV1) to evaluate the association with bronchodilator responsiveness with the genotype. The genotype rs881152 did not appear to modify the relationship between Inhaled corticosteroids use and bronchodilator responsiveness in the African-American cohort but not in the ethnically diverse cohort. The p-value reported here is from model 1 but models 2 and 3 also show non-significant levels with values of 0.722 and 0.432 respectively. "
rs137853025,19442771,Saldino-Noonan Syndrome,Morocco,North Africa,NS,FALSE,NS,DYNC2H1,,DYNC2H1,dynein cytoplasmic 2 heavy chain 1,11,Q8NCM8,"This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,"DYNC2H1 mutations cause asphyxiating thoracic dystrophy and short rib-polydactyly syndrome, type III.",19442771,2009,DisGeNET,rs137853025,SNV,,,,,,SNP not found in the specified article
rs869025563,15327549,Lipoid Proteinosis Of Urbach And Wiethe,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,ECM1,,ECM1,extracellular matrix protein 1,1,Q16610,"This gene encodes a soluble protein that is involved in endochondral bone formation, angiogenesis, and tumor biology. It also interacts with a variety of extracellular and structural proteins, contributing to the maintenance of skin integrity and homeostasis. Mutations in this gene are associated with lipoid proteinosis disorder (also known as hyalinosis cutis et mucosae or Urbach-Wiethe disease) that is characterized by generalized thickening of skin, mucosae and certain viscera. Alternatively spliced transcript variants encoding distinct isoforms have been described for this gene. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,"Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa.",15327549,2004,DisGeNET,rs869025563,SNV,,,,,,
rs121908116,17354266,"Ectodermal Dysplasia 11A, Hypohidrotic/Hair/Tooth Type, Autosomal Dominant",Morocco,North Africa,NS,FALSE,NS,EDARADD,"Genetic variability study,Functional analysis",EDARADD,EDAR associated death domain,1,Q8WWZ3,"This gene was identified by its association with ectodermal dysplasia, a genetic disorder characterized by defective development of hair, teeth, and eccrine sweat glands. The protein encoded by this gene is a death domain-containing protein, and is found to interact with EDAR, a death domain receptor known to be required for the development of hair, teeth and other ectodermal derivatives. This protein and EDAR are coexpressed in epithelial cells during the formation of hair follicles and teeth. Through its interaction with EDAR, this protein acts as an adaptor, and links the receptor to downstream signaling pathways. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus.,17354266,2007,DisGeNET,rs121908116,SNV,,,,,,"Novel missense mutation in the EDARADD gene (c.335T4G, p.Leu112Arg). Thus, the EDARADD gene accounts for both recessive and dominant EDA. EDAR is activated by its ligand, ectodysplasin, and uses EDARADD to build an intracellular complex and activate nuclear factor kappa B (NF-kB)."
rs74315309,17354266,"Ectodermal Dysplasia 11B, Hypohidrotic/Hair/Tooth Type, Autosomal Recessive",Morocco,North Africa,NS,FALSE,NS,EDARADD,"Genetic variability study,Functional analysis",EDARADD,EDAR associated death domain,1,Q8WWZ3,"This gene was identified by its association with ectodermal dysplasia, a genetic disorder characterized by defective development of hair, teeth, and eccrine sweat glands. The protein encoded by this gene is a death domain-containing protein, and is found to interact with EDAR, a death domain receptor known to be required for the development of hair, teeth and other ectodermal derivatives. This protein and EDAR are coexpressed in epithelial cells during the formation of hair follicles and teeth. Through its interaction with EDAR, this protein acts as an adaptor, and links the receptor to downstream signaling pathways. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus.,17354266,2007,DisGeNET,rs74315309,SNV,,,,,,"Novel missense mutation in the EDARADD gene (c.335T4G, p.Leu112Arg). Thus, the EDARADD gene accounts for both recessive and dominant EDA. EDAR is activated by its ligand, ectodysplasin, and uses EDARADD to build an intracellular complex and activate nuclear factor kappa B (NF-kB)."
rs121908116,17354266,"Ectodermal Dysplasia 3, Anhidrotic",Morocco,North Africa,NS,FALSE,NS,EDARADD,"Genetic variability study,Functional analysis",EDARADD,EDAR associated death domain,1,Q8WWZ3,"This gene was identified by its association with ectodermal dysplasia, a genetic disorder characterized by defective development of hair, teeth, and eccrine sweat glands. The protein encoded by this gene is a death domain-containing protein, and is found to interact with EDAR, a death domain receptor known to be required for the development of hair, teeth and other ectodermal derivatives. This protein and EDAR are coexpressed in epithelial cells during the formation of hair follicles and teeth. Through its interaction with EDAR, this protein acts as an adaptor, and links the receptor to downstream signaling pathways. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus.,17354266,2007,DisGeNET,rs121908116,SNV,,,,,,"Novel missense mutation in the EDARADD gene (c.335T4G, p.Leu112Arg). Thus, the EDARADD gene accounts for both recessive and dominant EDA. EDAR is activated by its ligand, ectodysplasin, and uses EDARADD to build an intracellular complex and activate nuclear factor kappa B (NF-kB)."
rs5333,30672385,Genotypes CC + TC is associated with increased resistance to prednisone in children with Nephrotic Syndrome as compared to genotype TT.,Egypt,North Africa,NS,TRUE,0.228,EDNRA,,EDNRA,endothelin receptor type A,4,P25101,"This gene encodes the receptor for endothelin-1, a peptide that plays a role in potent and long-lasting vasoconstriction. This receptor associates with guanine-nucleotide-binding (G) proteins, and this coupling activates a phosphatidylinositol-calcium second messenger system. Polymorphisms in this gene have been linked to migraine headache resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Association of endothelin receptor type A rs5333 gene polymorphism with steroid response in Egyptian children with idiopathic nephrotic syndrome.,30672385,2020,DisGeNET,rs5333,SNV,,,,,,"No significant association between risk of hypertension in INS patients and (TC, CC) genotypes of rs5333 polymorphism of EDNRA gene."
rs112176450,24080171,Parkinson Disease,South Africa,South Africa,NS,FALSE,NS,EIF4G1,Genetic variability study,EIF4G1,eukaryotic translation initiation factor 4 gamma 1,3,Q04637,"The protein encoded by this gene is a component of the multi-subunit protein complex EIF4F. This complex facilitates the recruitment of mRNA to the ribosome, which is a rate-limiting step during the initiation phase of protein synthesis. The recognition of the mRNA cap and the ATP-dependent unwinding of 5'-terminal secondary structure is catalyzed by factors in this complex. The subunit encoded by this gene is a large scaffolding protein that contains binding sites for other members of the EIF4F complex. A domain at its N-terminus can also interact with the poly(A)-binding protein, which may mediate the circularization of mRNA during translation. Alternative splicing results in multiple transcript variants, some of which are derived from alternative promoter usage. [provided by RefSeq, Aug 2010].",22/11/2021,PubMed,EIF4G1 R1205H and VPS35 D620N mutations are rare in Parkinson's disease from South Africa.,24080171,2014,DisGeNET,rs112176450,SNV,,,,,,418 PD patients and 528 controls of various South African ethnic groups. The R1205H variant was not found suggesting that it is not a common cause of PD in South African patients.
rs6942726,20400458,Body Height,"Nigeria, USA",West Africa / African American/Afro-Caribbean,African American,TRUE,0.0098,ELMO1,,ELMO1,engulfment and cell motility 1,7,Q92556,"This gene encodes a member of the engulfment and cell motility protein family. These proteins interact with dedicator of cytokinesis proteins to promote phagocytosis and cell migration. Increased expression of this gene and dedicator of cytokinesis 1 may promote glioma cell invasion, and single nucleotide polymorphisms in this gene may be associated with diabetic nephropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,Genome-wide association of anthropometric traits in African- and African-derived populations.,20400458,2010,DisGeNET,rs6942726,SNV,,,,,,This study contains the results of many other investigated SNPs/genes as well. Seperated by African American and Nigerian analysis.
rs6942726,20400458,Body Height,"Nigeria, USA",West Africa / African American/Afro-Caribbean,Igbo,TRUE,2.12E-05,ELMO1,,ELMO1,engulfment and cell motility 1,7,Q92556,"This gene encodes a member of the engulfment and cell motility protein family. These proteins interact with dedicator of cytokinesis proteins to promote phagocytosis and cell migration. Increased expression of this gene and dedicator of cytokinesis 1 may promote glioma cell invasion, and single nucleotide polymorphisms in this gene may be associated with diabetic nephropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013].",22/11/2021,PubMed,Genome-wide association of anthropometric traits in African- and African-derived populations.,20400458,2010,DisGeNET,rs6942726,SNV,,,,,,This study contains the results of many other investigated SNPs/genes as well. Seperated by African American and Nigerian analysis.
rs1044498,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,0.939,ENPP1,,ENPP1,ectonucleotide pyrophosphatase/phosphodiesterase 1,6,P22413,"This gene is a member of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) family. The encoded protein is a type II transmembrane glycoprotein comprising two identical disulfide-bonded subunits. This protein has broad specificity and cleaves a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds of nucleotides and nucleotide sugars. This protein may function to hydrolyze nucleoside 5' triphosphates to their corresponding monophosphates and may also hydrolyze diadenosine polyphosphates. Mutations in this gene have been associated with 'idiopathic' infantile arterial calcification, ossification of the posterior longitudinal ligament of the spine (OPLL), and insulin resistance. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs1044498,SNV,,,,,,"In both Lebanese and Tunisians, ENPP1 rs1044498 (P = 0.231 and P = 0.939, respectively) and MLXIPL (P = 0.284 and P = 0.984, respectively) were not associated with T2DM."
rs121917734,2386772,"Spherocytosis, Type 5",Tunisia,North Africa,NS,FALSE,NS,EPB42,,EPB42,erythrocyte membrane protein band 4.2,15,P16452,"Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A haemolytic syndrome associated with the complete absence of red cell membrane protein 4.2 in two Tunisian siblings.,2386772,1990,DisGeNET,rs121917734,SNV,,,,,,The absence of red cell membrane protein 4.2 failed to relate closely to hereditary elliptocytosis or to hereditary spherocytosis.
rs121917734,7772513,"Spherocytosis, Type 5",Tunisia,North Africa,NS,FALSE,NS,EPB42,,EPB42,erythrocyte membrane protein band 4.2,15,P16452,"Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia.,7772513,1995,DisGeNET,rs121917734,SNV,,,,,,This study infer that the nearly total absence of protein 4.2 in the Tunisian patients results from imbalance between destruction and synthesis of mutated protein 4.2 prior to its binding to the membrane.
rs1051740,23252947,Genotype TT is associated with decreased metabolism of carbamazepine in people with Epilepsy as compared to genotypes CC + CT.,USA,African American/Afro-Caribbean,African American,FALSE,0.026,EPHX1,Association,EPHX1,epoxide hydrolase 1,1,P07099,"Epoxide hydrolase is a critical biotransformation enzyme that converts epoxides from the degradation of aromatic compounds to trans-dihydrodiols which can be conjugated and excreted from the body. Epoxide hydrolase functions in both the activation and detoxification of epoxides. Mutations in this gene cause preeclampsia, epoxide hydrolase deficiency or increased epoxide hydrolase activity. Alternatively spliced transcript variants encoding the same protein have been found for this gene.[provided by RefSeq, Dec 2008].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501753,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",African-American patients homozygous for the lower EPHX1 activity allele (TT) demonstrated a lower CBZ-diol:CBZ-E ratio at 2h as compared with patients with at least one C (His) allele. The p-value is reported for both  CC + CT vs TT.
rs587777691,24741995,"Deafness, Autosomal Recessive 102",Algeria,North Africa,NS,FALSE,NS,EPS8,,EPS8,epidermal growth factor receptor pathway substrate 8,12,Q12929,"This gene encodes a member of the EPS8 family. This protein contains one PH domain and one SH3 domain. It functions as part of the EGFR pathway, though its exact role has not been determined. Highly similar proteins in other organisms are involved in the transduction of signals from Ras to Rac and growth factor-mediated actin remodeling. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"EPS8, encoding an actin-binding protein of cochlear hair cell stereocilia, is a new causal gene for autosomal recessive profound deafness.",24741995,2014,DisGeNET,rs587777691,SNV,,,,,,
rs13181,25311495,Leukemia,Tunisia,North Africa,NS,FALSE,0.248,ERCC2,,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19,P18074,"The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,"Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.",25311495,2016,DisGeNET,rs13181,SNV,,,,,,rs13181 may be protective against Chronic myeloid leukemia and acute-myeloid leukemia development
rs13181,21426550,Bladder Neoplasm,Tunisia,North Africa,NS,FALSE,NS,ERCC2,,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19,P18074,"The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs13181,SNV,,,,,,rs13181 was not implicated in the bladder cancer occurrence
rs13181,21426550,Carcinoma Of Bladder,Tunisia,North Africa,NS,FALSE,NS,ERCC2,,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19,P18074,"The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs13181,SNV,,,,,,rs13181 was not implicated in the Carcinoma Of Bladder occurrence
rs13181,21426550,Malignant Neoplasm Of Urinary Bladder,Tunisia,North Africa,NS,FALSE,NS,ERCC2,,ERCC2,"ERCC excision repair 2, TFIIH core complex helicase subunit",19,P18074,"The nucleotide excision repair pathway is a mechanism to repair damage to DNA. The protein encoded by this gene is involved in transcription-coupled nucleotide excision repair and is an integral member of the basal transcription factor BTF2/TFIIH complex. The gene product has ATP-dependent DNA helicase activity and belongs to the RAD3/XPD subfamily of helicases. Defects in this gene can result in three different disorders, the cancer-prone syndrome xeroderma pigmentosum complementation group D, trichothiodystrophy, and Cockayne syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs13181,SNV,,,,,,rs13181 was not implicated in the Malignant Neoplasm Of Urinary Bladder occurrence
rs17655,25311495,Leukemia,Tunisia,North Africa,NS,FALSE,NS,ERCC5,,ERCC5,"ERCC excision repair 5, endonuclease",13,P28715,"This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,"Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.",25311495,2016,DisGeNET,rs17655,SNV,,,,,,no significant differences in genotypes frequencies were observed for rs17655 between patients and controls.
rs17655,21426550,Bladder Neoplasm,Tunisia,North Africa,NS,FALSE,NS,ERCC5,,ERCC5,"ERCC excision repair 5, endonuclease",13,P28715,"This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs17655,SNV,,,,,,rs17655 was not implicated in the bladder cancer occurrence
rs17655,21426550,Carcinoma Of Bladder,Tunisia,North Africa,NS,FALSE,NS,ERCC5,,ERCC5,"ERCC excision repair 5, endonuclease",13,P28715,"This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs17655,SNV,,,,,,rs17655 was not implicated in the Carcinoma Of Bladder occurrence
rs17655,21426550,Malignant Neoplasm Of Urinary Bladder,Tunisia,North Africa,NS,FALSE,NS,ERCC5,,ERCC5,"ERCC excision repair 5, endonuclease",13,P28715,"This gene encodes a single-strand specific DNA endonuclease that makes the 3' incision in DNA excision repair following UV-induced damage. The protein may also function in other cellular processes, including RNA polymerase II transcription, and transcription-coupled DNA repair. Mutations in this gene cause xeroderma pigmentosum complementation group G (XP-G), which is also referred to as xeroderma pigmentosum VII (XP7), a skin disorder characterized by hypersensitivity to UV light and increased susceptibility for skin cancer development following UV exposure. Some patients also develop Cockayne syndrome, which is characterized by severe growth defects, cognitive disability, and cachexia. Read-through transcription exists between this gene and the neighboring upstream BIVM (basic, immunoglobulin-like variable motif containing) gene. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs17655,SNV,,,,,,rs17655 was not implicated in the Malignant Neoplasm Of Urinary Bladder occurrence
rs1131692059,27754803,Estrogen Resistance,Algeria,North Africa,NS,FALSE,NS,ESR1,Genetic variability study,ESR1,estrogen receptor 1,6,P03372,"This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Familial Multiplicity of Estrogen Insensitivity Associated With a Loss-of-Function ESR1 Mutation.,27754803,2017,DisGeNET,rs1131692059,SNV,,,,,,The mutation was identified in 3 siblings from one consanguineous family.
rs121964931,8883260,Factor Vii Deficiency,Morocco,North Africa,NS,FALSE,NS,F7,,F7,coagulation factor VII,13,P08709,"This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond. In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa. Defects in this gene can cause coagulopathy. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews.",8883260,1996,DisGeNET,rs121964931,SNV,,,,,,cannot have a full access to the article
rs17233141,11091222,Estren-Dameshek Variant Of Fanconi Anemia,Morocco,North Africa,Jewish,FALSE,NS,FANCA,,FANCA,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.,11091222,2001,DisGeNET,rs17233141,SNV,,,,,,"Identified 4 ethnic-specific mutations: 2172-2173insG (exon 24), the first Moroccon mutation; 4275delT (exon 43), the second Moroccon mutation; 890-893del (exon 10), the Tunisian mutation; and 2574C>G (S858R), the Indian mutation."
rs17233141,11091222,Estren-Dameshek Variant Of Fanconi Pancytopenia,Morocco,North Africa,Jewish,FALSE,NS,FANCA,,FANCA,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.,11091222,2001,DisGeNET,rs17233141,SNV,,,,,,"Identified 4 ethnic-specific mutations: 2172-2173insG (exon 24), the first Moroccon mutation; 4275delT (exon 43), the second Moroccon mutation; 890-893del (exon 10), the Tunisian mutation; and 2574C>G (S858R), the Indian mutation."
rs17233141,11091222,"Fanconi Anemia, Complementation Group A (Disorder)","Morocco, Tunisia, India",North Africa,NS,TRUE,NS,FANCA,,FANCA,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Fanconi anaemia group A (FANCA) mutations in Israeli non-Ashkenazi Jewish patients.,11091222,2001,DisGeNET,rs17233141,SNV,,,,,,"Identified 4 ethnic-specific mutations: 2172-2173insG (exon 24), the first Moroccon mutation; 4275delT (exon 43), the second Moroccon mutation; 890-893del (exon 10), the Tunisian mutation; and 2574C>G (S858R), the Indian mutation."
rs121907930,12827451,"Fanconi Anemia, Complementation Group A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,FANCA,Genetic variability study,FANCA,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.,12827451,2003,DisGeNET,rs121907930,SNV,,,,,,The W171X mutation was identified in a consanguineous Tunisian family.
rs587776570,12827451,"Fanconi Anemia, Complementation Group A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,FANCA,Genetic variability study,FANCA,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations.,12827451,2003,DisGeNET,rs587776570,SNV,,,,,,The 1606delT in exon 17 of the FANCA gene was identified in a Tunisian patient.
rs149277003,10210316,Estren-Dameshek Variant Of Fanconi Pancytopenia,"Algeria, Morocco, Iraq",North Africa,NS,TRUE,0.000000996,FANCA,,FANCA,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.",10210316,1999,DisGeNET,rs149277003,SNV,,,,,,
rs104886457,8844212,"Fanconi Anemia, Complementation Group C","South Africa, Asia, Europe",South Africa,NS,TRUE,> 0.05,FANCC,,FANCC,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel mutations and polymorphisms in the Fanconi anemia group C gene.,8844212,1996,DisGeNET,rs104886457,SNV,,,,,,
rs104886457,8844212,"Neoplastic Syndromes, Hereditary","South Africa, Asia, Europe",South Africa,NS,TRUE,> 0.05,FANCC,,FANCC,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel mutations and polymorphisms in the Fanconi anemia group C gene.,8844212,1996,DisGeNET,rs104886457,SNV,,,,,,
rs121917784,8844212,"Fanconi Anemia, Complementation Group C","South Africa, Asia, Europe",South Africa,NS,TRUE,< 0.05,FANCC,,FANCC,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel mutations and polymorphisms in the Fanconi anemia group C gene.,8844212,1996,DisGeNET,rs121917784,SNV,,,,,,
rs121917785,8844212,"Fanconi Anemia, Complementation Group C","South Africa, Asia, Europe",South Africa,NS,TRUE,< 0.05,FANCC,,FANCC,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel mutations and polymorphisms in the Fanconi anemia group C gene.,8844212,1996,DisGeNET,rs121917785,SNV,,,,,,
rs377294947,8844212,"Fanconi Anemia, Complementation Group C","South Africa, Asia, Europe",South Africa,NS,TRUE,0.003,FANCC,,FANCC,FA complementation group A,16,O15360,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel mutations and polymorphisms in the Fanconi anemia group C gene.,8844212,1996,DisGeNET,rs377294947,SNV,,,,,,
rs587776640,15657175,Fanconi Anemia,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,FANCG,,FANCG,FA complementation group G,9,O15287,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A common Fanconi anemia mutation in black populations of sub-Saharan Africa.,15657175,2005,DisGeNET,rs587776640,SNV,,,,,,FANCGgene (c.637_643delTACCGCC)
rs587776640,15657175,Fanconi Anemia Complementation Group G,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,FANCG,,FANCG,FA complementation group G,9,O15287,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A common Fanconi anemia mutation in black populations of sub-Saharan Africa.,15657175,2005,DisGeNET,rs587776640,SNV,,,,,,
rs587776640,15657175,"Fanconi Anemia, Complementation Group A (Disorder)",Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,FANCG,,FANCG,FA complementation group G,9,O15287,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A common Fanconi anemia mutation in black populations of sub-Saharan Africa.,15657175,2005,DisGeNET,rs587776640,SNV,,,,,,
rs587776640,11126723,Fanconi Anemia Complementation Group G,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,FANCG,,FANCG,FA complementation group G,9,O15287,"The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group G. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Phylogenetic relationships of human populations in sub-Saharan Africa.,11126723,2001,DisGeNET,rs587776640,SNV,,,,,,"Data from the GM/KM system showed a genetic homogeneity of the Bantu populations, with some exceptions, supporting the possibility of a common origin of these peoples."
rs5030738,23049979,Malaria,Ghana,West Africa,NS,FALSE,NS,FCGR3B,,FCGR3B,Fc gamma receptor IIIb,1,O75015,"The protein encoded by this gene is a low affinity receptor for the Fc region of gamma immunoglobulins (IgG). The encoded protein acts as a monomer and can bind either monomeric or aggregated IgG. This gene may function to capture immune complexes in the peripheral circulation. Several transcript variants encoding different isoforms have been found for this gene. A highly-similar gene encoding a related protein is also found on chromosome 1. [provided by RefSeq, Aug 2012].",22/11/2021,PubMed,Fc Î³ receptor IIIB (FcÎ³RIIIB) polymorphisms are associated with clinical malaria in Ghanaian children.,23049979,2013,DisGeNET,rs5030738,SNV,,,,,,
rs121918292,12668616,Poikiloderma Of Kindler,Senegal,West Africa,NS,FALSE,NS,FERMT1,,FERMT1,FERM domain containing kindlin 1,20,Q9BQL6,"This gene encodes a member of the fermitin family, and contains a FERM domain and a pleckstrin homology domain. The encoded protein is involved in integrin signaling and linkage of the actin cytoskeleton to the extracellular matrix. Mutations in this gene have been linked to Kindler syndrome. [provided by RefSeq, Dec 2009].",22/11/2021,PubMed,Identification of mutations in a new gene encoding a FERM family protein with a pleckstrin homology domain in Kindler syndrome.,12668616,2004,DisGeNET,rs121918292,SNV,,,,,,This point mutation 787C>T (Q263X) in exon 6 was present in Senegalese family.
rs1960669,28045923,Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,NS,FGF2,,FGF2,fibroblast growth factor 2,4,P09038,"The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995800,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs1960669 is assigned to FGF2 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs281860303,21306635,"Deafness, Congenital, With Inner Ear Agenesis, Microtia, And Microdontia",Somalia,East Africa,NS,FALSE,< 0.05,FGF3,,FGF3,fibroblast growth factor 3,11,P11487,"The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities and are involved in a variety of biological processes including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This gene was identified by its similarity with mouse fgf3/int-2, a proto-oncogene activated in virally induced mammary tumors in the mouse. Frequent amplification of this gene has been found in human tumors, which may be important for neoplastic transformation and tumor progression. Studies of the similar genes in mouse and chicken suggested the role in inner ear formation.",22/11/2021,PubMed,Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome.,21306635,2011,DisGeNET,rs281860303,SNV,,,,,,
rs2981582,22910930,Neoplasm Metastasis,Tunisia,North Africa,NS,FALSE,0.00002,FGFR2,,FGFR2,fibroblast growth factor receptor 2,10,P21802,"The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs2981582,SNV,,,,,,"This SNP is associated with increased risk of distant metastasis , AG p-value = 0.004 , AA p-value = 0.00006 , A allele p-value = 0.00002"
rs1219648,22910930,Breast Carcinoma,Tunisia,North Africa,NS,FALSE,1.00E-03,FGFR2,,FGFR2,fibroblast growth factor receptor 2,10,P21802,"The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs1219648,SNV,,,,,,G vs. A allele was found to be significantly associated with breast cancer in Tunisians ;
rs1219648,22910930,Malignant Neoplasm Of Breast,Tunisia,North Africa,NS,FALSE,1.00E-04,FGFR2,,FGFR2,fibroblast growth factor receptor 2,10,P21802,"The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs1219648,SNV,,,,,,G vs. A allele was found to be significantly associated with breast cancer in Tunisians
rs2981582,22910930,Breast Carcinoma,Tunisia,North Africa,NS,FALSE,3.00E-06,FGFR2,,FGFR2,fibroblast growth factor receptor 2,10,P21802,"The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs2981582,SNV,,,,,,A vs. G  allele was found to be significantly associated with breast cancer in Tunisians
rs2981582,22910930,Malignant Neoplasm Of Breast,Tunisia,North Africa,NS,FALSE,3.00E-07,FGFR2,,FGFR2,fibroblast growth factor receptor 2,10,P21802,"The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs2981582,SNV,,,,,,A vs. G  allele was found to be significantly associated with breast cancer in Tunisians
rs587777716,18758830,"Polymicrogyria, Bilateral Occipital",Morocco,North Africa,NS,FALSE,NS,FIG4,,FIG4,FIG4 phosphoinositide 5-phosphatase,6,Q92562,"The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A locus for bilateral occipital polymicrogyria maps to chromosome 6q16-q22.,18758830,2009,DisGeNET,rs587777716,SNV,,,,,,
rs377357931,24598713,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,0.003,FIG4,,FIG4,FIG4 phosphoinositide 5-phosphatase,6,Q92562,"The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria.,24598713,2014,DisGeNET,rs377357931,SNV,,,,,,
rs587777716,24598713,"Polymicrogyria, Bilateral Occipital",Morocco,North Africa,NS,FALSE,0.04,FIG4,,FIG4,FIG4 phosphoinositide 5-phosphatase,6,Q92562,"The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria.,24598713,2014,DisGeNET,rs587777716,SNV,,,,,,
rs587777716,24598713,"Polymicrogyria, Bilateral Temporooccipital",Morocco,North Africa,NS,FALSE,0.04,FIG4,,FIG4,FIG4 phosphoinositide 5-phosphatase,6,Q92562,"The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria.,24598713,2014,DisGeNET,rs587777716,SNV,,,,,,
rs747768373,24598713,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,> 0.05,FIG4,,FIG4,FIG4 phosphoinositide 5-phosphatase,6,Q92562,"The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria.,24598713,2014,DisGeNET,rs747768373,SNV,,,,,,
rs28937903,23420653,"Muscular Dystrophy, Limb-Girdle, Type 2I",Morocco,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Elevated serum creatine kinase and small cerebellum prompt diagnosis of congenital muscular dystrophy due to FKRP mutations.,23420653,2014,DisGeNET,rs28937903,SNV,,,,,,
rs28937903,23420653,Walker-Warburg Congenital Muscular Dystrophy,Morocco,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Elevated serum creatine kinase and small cerebellum prompt diagnosis of congenital muscular dystrophy due to FKRP mutations.,23420653,2014,DisGeNET,rs28937903,SNV,,,,,,
rs104894682,12707439,"Muscular Dystrophy, Limb-Girdle, Type 2I",Tunisia,North Africa,NS,FALSE,NS,FKRP,"Genetic variability study,Functional analysis",FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Fukutin-related protein gene mutated in the original kindred limb-girdle MD 2I.,12707439,2004,DisGeNET,rs104894682,SNV,,,,,,This family includes 13 patients. All are related and originally from the same geographic region in southeast Tunisia
rs28937903,14652796,"Muscular Dystrophy, Congenital, 1C",Tunisia,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.,14652796,2004,DisGeNET,rs28937903,SNV,,,,,,
rs28937904,14652796,"Muscular Dystrophy, Congenital, 1C",Tunisia,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.,14652796,2004,DisGeNET,rs28937904,SNV,,,,,,
rs28937903,14652796,"Muscular Dystrophy, Limb-Girdle, Type 2I",Tunisia,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.,14652796,2004,DisGeNET,rs28937903,SNV,,,,,,
rs28937903,14652796,Walker-Warburg Congenital Muscular Dystrophy,Tunisia,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families.,14652796,2004,DisGeNET,rs28937903,SNV,,,,,,
rs28937903,18671187,"Muscular Dystrophy, Congenital, 1C",Tunisia,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations.,18671187,2008,DisGeNET,rs28937903,SNV,,,,,,
rs28937903,18671187,Walker-Warburg Congenital Muscular Dystrophy,Tunisia,North Africa,NS,FALSE,NS,FKRP,,FKRP,fukutin related protein,19,Q9H9S5,"This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Variable cardiac involvement in Tunisian siblings harboring FKRP gene mutations.,18671187,2008,DisGeNET,rs28937903,SNV,,,,,,
rs2266782,28178031,Allele G is not associated with metabolism of cotinine in people with Tobacco Use Disorder as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,0.42,FMO3,Association,FMO3,flavin containing dimethylaniline monoxygenase 3,1,P31513,"Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. The human FMO gene family is composed of 5 genes and multiple pseudogenes. FMO members have distinct developmental- and tissue-specific expression patterns. The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals. This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry. This transmembrane protein localizes to the endoplasmic reticulum of many tissues. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor. In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.[provided by RefSeq, Jan 2016].",22/11/2021,PubMed,"Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.",28178031,2017,PharmGKB,1448602091,SNV,cotinine,NA,NA,Cotinine is an alkaloid found in tobacco and is also the predominant metabolite of nicotine.,(5S)-1-methyl-5-(3-pyridyl)pyrrolidin-2-one,The study includes 60 African-American individuals smokers who received a simultaneous intravenous infusion of deuterium-labeled nicotine and cotinine.
rs2266782,28178031,Allele G is not associated with metabolism of nicotine in people with Tobacco Use Disorder as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,0.645,FMO3,Association,FMO3,flavin containing dimethylaniline monoxygenase 3,1,P31513,"Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. The human FMO gene family is composed of 5 genes and multiple pseudogenes. FMO members have distinct developmental- and tissue-specific expression patterns. The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals. This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry. This transmembrane protein localizes to the endoplasmic reticulum of many tissues. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor. In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.[provided by RefSeq, Jan 2016].",22/11/2021,PubMed,"Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.",28178031,2017,PharmGKB,1448602097,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,The study includes 60 African-American individuals smokers who received a simultaneous intravenous infusion of deuterium-labeled nicotine and cotinine.
rs2266782,24448396,"Genotypes AA + AG is associated with decreased metabolism of nicotine in CYP2A6 reduced, but not normal, metabolizers as compared to genotype GG.",Canada,African American/Afro-Caribbean,NS,FALSE,0.07,FMO3,Association,FMO3,flavin containing dimethylaniline monoxygenase 3,1,P31513,"Flavin-containing monooxygenases (FMO) are an important class of drug-metabolizing enzymes that catalyze the NADPH-dependent oxygenation of various nitrogen-,sulfur-, and phosphorous-containing xenobiotics such as therapeutic drugs, dietary compounds, pesticides, and other foreign compounds. The human FMO gene family is composed of 5 genes and multiple pseudogenes. FMO members have distinct developmental- and tissue-specific expression patterns. The expression of this FMO3 gene, the major FMO expressed in adult liver, can vary up to 20-fold between individuals. This inter-individual variation in FMO3 expression levels is likely to have significant effects on the rate at which xenobiotics are metabolised and, therefore, is of considerable interest to the pharmaceutical industry. This transmembrane protein localizes to the endoplasmic reticulum of many tissues. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. Mutations in this gene cause the disorder trimethylaminuria (TMAu) which is characterized by the accumulation and excretion of unmetabolized trimethylamine and a distinctive body odor. In healthy individuals, trimethylamine is primarily converted to the non odorous trimethylamine N-oxide.[provided by RefSeq, Jan 2016].",22/11/2021,PubMed,"Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.",24448396,2014,PharmGKB,1183703319,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,"In reduced CYP2A6 metabolizers, there was a trend toward higher nicotine AUC in the FMO3 GA/AA vs. GG group with NM_006894.6:c.472G>A  leading to E158K substitution."
rs16980091,30100615,Allele T is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele C.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.042,FOXA3,,FOXA3,forkhead box A3,19,P55318,"This gene encodes a member of the forkhead class of DNA-binding proteins. These hepatocyte nuclear factors are transcriptional activators for liver-specific transcripts such as albumin and transthyretin, and they also interact with chromatin. Similar family members in mice have roles in the regulation of metabolism and in the differentiation of the pancreas and liver. The crystal structure of a similar protein in rat has been resolved. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733152,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Variants associated with high rosuvastatin Cmax (Cmaxâ€‰>â€‰20â€‰ng/ml)
rs7856096,25079360,Allele G is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,1.82E-08,FPGS,,FPGS,folylpolyglutamate synthase,9,Q05932,"This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.,25079360,2014,PharmGKB,1184512419,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"360 African American patients are included in a discovery cohort receiving warfarin. rs7856096 is upstream of exon 2 of the folylpolyglutamate synthase gene (FPGS), which encodes a mitochondrial enzyme involved in folate sequestration. rs7856096, was significantly associated with warfarin dose."
rs7856096,25079360,Allele G is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,1.82E-08,FPGS,,FPGS,folylpolyglutamate synthase,9,Q05932,"This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.,25079360,2014,PharmGKB,1184512419,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"360 African American patients are included in a discovery cohort receiving warfarin. rs7856096 is upstream of exon 2 of the folylpolyglutamate synthase gene (FPGS), which encodes a mitochondrial enzyme involved in folate sequestration. rs7856096, was significantly associated with warfarin dose."
rs7856096,25079360,Allele G is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,1.82E-08,FPGS,,FPGS,folylpolyglutamate synthase,9,Q05932,"This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.,25079360,2014,PharmGKB,1184512426,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"360 African American patients are included in a discovery cohort receiving warfarin. rs7856096 is upstream of exon 2 of the folylpolyglutamate synthase gene (FPGS), which encodes a mitochondrial enzyme involved in folate sequestration. rs7856096, was significantly associated with warfarin dose."
rs7856096,25079360,Allele G is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,1.82E-08,FPGS,,FPGS,folylpolyglutamate synthase,9,Q05932,"This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Genetic variant in folate homeostasis is associated with lower warfarin dose in African Americans.,25079360,2014,PharmGKB,1184512426,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"360 African American patients are included in a discovery cohort receiving warfarin. rs7856096 is upstream of exon 2 of the folylpolyglutamate synthase gene (FPGS), which encodes a mitochondrial enzyme involved in folate sequestration. rs7856096, was significantly associated with warfarin dose."
rs7856096,26751406,Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG.,Egypt,North Africa,NS,FALSE,0.86,FPGS,,FPGS,folylpolyglutamate synthase,9,Q05932,"This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,"Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.",26751406,2016,PharmGKB,1447677830,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study includes 204 Egyptians genotyped for rs4889606 G allele. There was a significant association between the AA, AG, and GG genotypes for warfarin dose variation. "
rs7856096,26751406,Genotype AA is not associated with dose of warfarin as compared to genotypes AG + GG.,Egypt,North Africa,NS,FALSE,0.86,FPGS,,FPGS,folylpolyglutamate synthase,9,Q05932,"This gene encodes the folylpolyglutamate synthetase enzyme. This enzyme has a central role in establishing and maintaining both cytosolic and mitochondrial folylpolyglutamate concentrations and, therefore, is essential for folate homeostasis and the survival of proliferating cells. This enzyme catalyzes the ATP-dependent addition of glutamate moieties to folate and folate derivatives. Alternative splicing results in transcript variants encoding different isoforms. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,"Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.",26751406,2016,PharmGKB,1447677830,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study includes 204 Egyptians genotyped for rs4889606 G allele. There was a significant association between the AA, AG, and GG genotypes for warfarin dose variation. "
rs121912609,19732862,Bifid Nose With Or Without Anorectal And Renal Anomalies,Egypt,North Africa,NS,FALSE,NS,FREM1,,FREM1,FRAS1 related extracellular matrix 1,9,Q5H8C1,"This gene encodes a basement membrane protein that may play a role in craniofacial and renal development. Mutations in this gene have been associated with bifid nose with or without anorectal and renal anomalies. Alternatively spliced transcript variants encoding different isoforms have been described. PubMed ID 19940113 describes one such variant that initiates transcription within a distinct, internal exon; the resulting shorter isoform (named Toll-like/interleukin-1 receptor regulator, TILRR) is suggested to be a co-receptor of the interleukin 1 receptor family and may regulate receptor function and Toll-like receptor/interleukin 1 receptor signal transduction, contributing to the control of inflammatory response activation. [provided by RefSeq, Apr 2011].",22/11/2021,PubMed,"FREM1 mutations cause bifid nose, renal agenesis, and anorectal malformations syndrome.",19732862,2009,DisGeNET,rs121912609,SNV,,,,,,"Candidate-gene analysis revealed homozygous frameshift and missense mutations in FREM1, which encodes an extracellular matrix component of basement membranes."
rs121912610,19732862,Bifid Nose With Or Without Anorectal And Renal Anomalies,Egypt,North Africa,NS,FALSE,NS,FREM1,,FREM1,FRAS1 related extracellular matrix 1,9,Q5H8C1,"This gene encodes a basement membrane protein that may play a role in craniofacial and renal development. Mutations in this gene have been associated with bifid nose with or without anorectal and renal anomalies. Alternatively spliced transcript variants encoding different isoforms have been described. PubMed ID 19940113 describes one such variant that initiates transcription within a distinct, internal exon; the resulting shorter isoform (named Toll-like/interleukin-1 receptor regulator, TILRR) is suggested to be a co-receptor of the interleukin 1 receptor family and may regulate receptor function and Toll-like receptor/interleukin 1 receptor signal transduction, contributing to the control of inflammatory response activation. [provided by RefSeq, Apr 2011].",22/11/2021,PubMed,"FREM1 mutations cause bifid nose, renal agenesis, and anorectal malformations syndrome.",19732862,2009,DisGeNET,rs121912610,SNV,,,,,,"Candidate-gene analysis revealed homozygous frameshift and missense mutations in FREM1, which encodes an extracellular matrix component of basement membranes."
rs186873296,26416757,Malaria,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,9.50E-11,FREM3,,FREM3,FRAS1 related extracellular matrix 3,4,P0C091,This gene encodes an integral membrane protein containing numerous CSPG (chondroitin sulfate proteoglycan element) repeats and Calx-beta domains. The protein belongs to the family of FRAS1/FREM extracellular matrix proteins and may play a role cell adhesion.,22/11/2021,PubMed,A novel locus of resistance to severe malaria in a region of ancient balancing selection.,26416757,2016,DisGeNET,rs186873296,SNV,,,,,,"Odds ratio = 5 0.67, 95% CI = 0.60-0.76"
rs114169033,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,6.67E-07,FRG1-DT,Association,FRG1-DT,FRG1 divergent transcript,4,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs114169033,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the additive model."
rs8057044,26700404,Hypertensive Disease,Tunisia,North Africa,NS,FALSE,0.019,FTO,,FTO,FTO alpha-ketoglutarate dependent dioxygenase,16,Q9C0B1,"This gene is a nuclear protein of the AlkB related non-haem iron and 2-oxoglutarate-dependent oxygenase superfamily but the exact physiological function of this gene is not known. Other non-heme iron enzymes function to reverse alkylated DNA and RNA damage by oxidative demethylation. Studies in mice and humans indicate a role in nervous and cardiovascular systems and a strong association with body mass index, obesity risk, and type 2 diabetes. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Association of genetic variants in the FTO gene with metabolic syndrome: A case-control study in the Tunisian population.,26700404,2016,DisGeNET,rs8057044,SNV,,,,,,
rs80358195,8504303,Fucosidase Deficiency Disease,"Algeria, USA",North Africa,NS,TRUE,NS,FUCA1,,FUCA1,alpha-L-fucosidase 1,1,P04066,"The protein encoded by this gene is a lysosomal enzyme involved in the degradation of fucose-containing glycoproteins and glycolipids. Mutations in this gene are associated with fucosidosis (FUCA1D), which is an autosomal recessive lysosomal storage disease. A pseudogene of this locus is present on chr 2.[provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Fucosidosis: four new mutations and a new polymorphism.,8504303,1993,DisGeNET,rs80358195,SNV,,,,,,
rs601338,22237057,Infection Caused By Helicobacter Pylori,"West Africa, Europe",West Africa,NS,TRUE,NS,FUT2,,FUT2,fucosyltransferase 2,19,Q10981,"The protein encoded by this gene is a Golgi stack membrane protein that is involved in the creation of a precursor of the H antigen, which is required for the final step in the soluble A and B antigen synthesis pathway. This gene is one of two encoding the galactoside 2-L-fucosyltransferase enzyme. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Helicobacter pylori serologic status has no influence on the association between fucosyltransferase 2 polymorphism (FUT2 461 G->A) and vitamin B-12 in Europe and West Africa.,22237057,2012,DisGeNET,rs601338,SNV,,,,,,
rs1801175,18008183,Glycogen Storage Disease Type I,Tunisia,North Africa,NS,FALSE,NS,G6PC1,,G6PC1,glucose-6-phosphatase catalytic subunit 1,17,P35575,"Glucose-6-phosphatase (G6Pase) is a multi-subunit integral membrane protein of the endoplasmic reticulum that is composed of a catalytic subunit and transporters for G6P, inorganic phosphate, and glucose. This gene (G6PC) is one of the three glucose-6-phosphatase catalytic-subunit-encoding genes in human: G6PC, G6PC2 and G6PC3. Glucose-6-phosphatase catalyzes the hydrolysis of D-glucose 6-phosphate to D-glucose and orthophosphate and is a key enzyme in glucose homeostasis, functioning in gluconeogenesis and glycogenolysis. Mutations in this gene cause glycogen storage disease type I (GSD1). This disease, also known as von Gierke disease, is a metabolic disorder characterized by severe hypoglycemia associated with the accumulation of glycogen and fat in the liver and kidneys.[provided by RefSeq, Feb 2011].",22/11/2021,PubMed,Mutation spectrum of glycogen storage disease type Ia in Tunisia: implication for molecular diagnosis.,18008183,2008,DisGeNET,rs1801175,SNV,,,,,,"The R83C mutation was found to be the major cause of GSD Ia, accounting for 24 of 36 mutant alleles (66.6%)."
rs750470654,18008183,Glycogen Storage Disease Type I,Tunisia,North Africa,NS,FALSE,NS,G6PC1,,G6PC1,glucose-6-phosphatase catalytic subunit 1,17,P35575,"Glucose-6-phosphatase (G6Pase) is a multi-subunit integral membrane protein of the endoplasmic reticulum that is composed of a catalytic subunit and transporters for G6P, inorganic phosphate, and glucose. This gene (G6PC) is one of the three glucose-6-phosphatase catalytic-subunit-encoding genes in human: G6PC, G6PC2 and G6PC3. Glucose-6-phosphatase catalyzes the hydrolysis of D-glucose 6-phosphate to D-glucose and orthophosphate and is a key enzyme in glucose homeostasis, functioning in gluconeogenesis and glycogenolysis. Mutations in this gene cause glycogen storage disease type I (GSD1). This disease, also known as von Gierke disease, is a metabolic disorder characterized by severe hypoglycemia associated with the accumulation of glycogen and fat in the liver and kidneys.[provided by RefSeq, Feb 2011].",22/11/2021,PubMed,Mutation spectrum of glycogen storage disease type Ia in Tunisia: implication for molecular diagnosis.,18008183,2008,DisGeNET,rs750470654,SNV,,,,,,The R170Q mutation was the second most frequent mutation; it accounts for 10 of 36 mutant alleles (27.7%).
rs137852347,11112389,"Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency",Ethiopia,East Africa,NS,FALSE,NS,G6PD,,G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A new exon 9 glucose-6-phosphate dehydrogenase mutation (G6PD ""Rehovot"") in a Jewish Ethiopian family with variable phenotypes.",11112389,2001,DisGeNET,rs137852347,SNV,,,,,,rs137852347 was associated in hereditary nonspherocytic hemolytic anemia case with severe congenital neutropenia
rs1050829,24934404,Anemia,Cameroon,West Africa,NS,FALSE,0.005,G6PD,Association,G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.,24934404,2015,DisGeNET,rs1050829,SNV,,,,,,"A total of 971 cases and 891 controls were enrolled into the study. Study involved malaria diagnosed children (aged 1 month to 13 years) admitted in nine health facilities in the Centre, Littoral and South West regions of Cameroon."
rs1050828,24934404,Anemia,Cameroon,West Africa,NS,FALSE,0.009,G6PD,Association,G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.,24934404,2015,DisGeNET,rs1050828,SNV,,,,,,"A total of 971 cases and 891 controls were enrolled into the study. Study involved malaria diagnosed children (aged 1 month to 13 years) admitted in nine health facilities in the Centre, Littoral and South West regions of Cameroon."
rs1050828,19789650,Deficiency Of Glucose-6-Phosphate Dehydrogenase,Uganda,East Africa,NS,FALSE,NS,G6PD,"Association,Functional analysis",G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.,19789650,2010,DisGeNET,rs1050828,SNV,,,,,,"A total of 600 individuals, consisting of 289 females and 311 males, were tested for G6PD enzyme activity. G6PD-deficient females were significantly protected against uncomplicated malaria, but this protection was only seen when G6PD deficiency is described using enzyme activity. "
rs1050828,12524354,"Anemia, Nonspherocytic Hemolytic, Due To G6Pd Deficiency","Africa, America, Asia, Europe",Africa,NS,TRUE,< 0.017,G6PD,,G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Nucleotide variability at G6pd and the signature of malarial selection in humans.,12524354,2002,DisGeNET,rs1050828,SNV,,,,,,
rs1050828,23146719,Cataract,Sudan,North Africa,NS,FALSE,< 0.05,G6PD,,G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan.,23146719,2013,DisGeNET,rs1050828,SNV,,,,,,
rs1050829,23146719,Cataract,Sudan,North Africa,NS,FALSE,< 0.05,G6PD,,G6PD,glucose-6-phosphate dehydrogenase,X,P11413,"This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan.,23146719,2013,DisGeNET,rs1050829,SNV,,,,,,
rs111033690,19418241,Classical Galactosemia,Nigeria,West Africa,NS,FALSE,NS,GALT,Genetic variability study,GALT,galactose-1-phosphate uridylyltransferase,9,P07902,"Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Negative screening tests in classical galactosaemia caused by S135L homozygosity.,19418241,2009,DisGeNET,rs111033690,SNV,,,,,,Pathogenic/likely pathogenic mutation identified in a 16-month-old Irish-born child of Nigerian origin.
rs111033690,12350230,Classical Galactosemia,South Africa,South Africa,"AfriKaner,Coloured",FALSE,NS,GALT,Genetic variability study,GALT,galactose-1-phosphate uridylyltransferase,9,P07902,"Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,The clinical and molecular spectrum of galactosemia in patients from the Cape Town region of South Africa.,12350230,2003,DisGeNET,rs111033690,SNV,,,,,,Pathogenic/likely pathogenic mutation identified in black negroid and mixed patients with galactosemia
rs111033690,10070616,Classical Galactosemia,South Africa,South Africa,NS,FALSE,NS,GALT,Genetic variability study,GALT,galactose-1-phosphate uridylyltransferase,9,P07902,"Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,The molecular basis of transferase galactosaemia in South African negroids.,10070616,1999,DisGeNET,rs111033690,SNV,,,,,,Pathogenic/likelypathogenic mutation identified in negroid and caucasoid individuals . This mutation is a major cause of galactosaemia as it was found in about 91% of the negroid galactosaemics investigated. The low frequencies of the S135L allele in caucasoids and its high frequencies in negroid African and in African American galactosaemics suggests that this mutation originated in Africa.
rs759581558,2153943,"Genetic Diseases, Inborn",Tunisia,North Africa,NS,FALSE,NS,GAN,,GAN,gigaxonin,16,Q9H2C0,"This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Giant axonal neuropathy with inherited multisystem degeneration in a Tunisian kindred.,2153943,1990,DisGeNET,rs759581558,SNV,,,,,,
rs119485093,2153943,Giant Axonal Neuropathy 1,Tunisia,North Africa,NS,FALSE,NS,GAN,,GAN,gigaxonin,16,Q9H2C0,"This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Giant axonal neuropathy with inherited multisystem degeneration in a Tunisian kindred.,2153943,1990,DisGeNET,rs119485093,SNV,,,,,,
rs119485092,11053687,Giant Axonal Neuropathy 1,Algeria,North Africa,NS,FALSE,0,GAN,,GAN,gigaxonin,16,Q9H2C0,"This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Charcot-Marie-Tooth 2-like presentation of an Algerian family with giant axonal neuropathy.,11053687,2000,DisGeNET,rs119485092,SNV,,,,,,
rs759581558,11053687,"Genetic Diseases, Inborn",Algeria,North Africa,NS,FALSE,0.008,GAN,,GAN,gigaxonin,16,Q9H2C0,"This gene encodes a member of the cytoskeletal BTB/kelch (Broad-Complex, Tramtrack and Bric a brac) repeat family. The encoded protein plays a role in neurofilament architecture and is involved in mediating the ubiquitination and degradation of some proteins. Defects in this gene are a cause of giant axonal neuropathy (GAN). [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Charcot-Marie-Tooth 2-like presentation of an Algerian family with giant axonal neuropathy.,11053687,2000,DisGeNET,rs759581558,SNV,,,,,,
rs3824662,27684731,Childhood Acute Lymphoblastic Leukemia,Egypt,North Africa,NS,FALSE,0.015,GATA3,,GATA3,GATA binding protein 3,10,P23771,"This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact.,27684731,2018,DisGeNET,rs3824662,SNV,,,,,,
rs3824662,27684731,Acute Lymphocytic Leukemia,Egypt,North Africa,NS,FALSE,NS,GATA3,,GATA3,GATA binding protein 3,10,P23771,"This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact.,27684731,2018,DisGeNET,rs3824662,SNV,,,,,,
rs3824662,27684731,Adult Acute Lymphocytic Leukemia,Egypt,North Africa,NS,FALSE,NS,GATA3,,GATA3,GATA binding protein 3,10,P23771,"This gene encodes a protein which belongs to the GATA family of transcription factors. The protein contains two GATA-type zinc fingers and is an important regulator of T-cell development and plays an important role in endothelial cell biology. Defects in this gene are the cause of hypoparathyroidism with sensorineural deafness and renal dysplasia. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact.,27684731,2018,DisGeNET,rs3824662,SNV,,,,,,
rs364897,21056933,Gaucher Disease,Morocco,North Africa,NS,FALSE,NS,GBA,,GBA,glucosylceramidase beta,1,P04062,"This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,A monozygotic twin pair with highly discordant Gaucher phenotypes.,21056933,2011,DisGeNET,rs364897,SNV,,,,,,
rs80356769,8937765,"Gaucher Disease, Type 1",South Africa,South Africa,"Jewish, Afrikaner, Coloured",FALSE,NS,GBA,,GBA,glucosylceramidase beta,1,P04062,"This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,The molecular characterization of Gaucher disease in South Africa.,8937765,1996,DisGeNET,rs80356769,SNV,,,,,,
rs76763715,8937765,"Gaucher Disease, Type 1",South Africa,South Africa,"Jewish, Afrikaner, Coloured",FALSE,NS,GBA,,GBA,glucosylceramidase beta,1,P04062,"This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,The molecular characterization of Gaucher disease in South Africa.,8937765,1996,DisGeNET,rs76763715,SNV,,,,,,
rs398123012,20593214,"Spastic Paraplegia 46, Autosomal Recessive",Tunisia,North Africa,NS,FALSE,NS,GBA2,,GBA2,glucosylceramidase beta 2,9,Q9HCG7,"This gene encodes a microsomal beta-glucosidase that catalyzes the hydrolysis of bile acid 3-O-glucosides as endogenous compounds. Studies to determine subcellular localization of this protein in the liver indicated that the enzyme was mainly enriched in the microsomal fraction where it appeared to be confined to the endoplasmic reticulum. This putative transmembrane protein is thought to play a role in carbohydrate transport and metabolism. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A new locus (SPG46) maps to 9p21.2-q21.12 in a Tunisian family with a complicated autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum.,20593214,2011,DisGeNET,rs398123012,SNV,,,,,,
rs398123014,23332917,"Spastic Paraplegia 46, Autosomal Recessive",Tunisia,North Africa,NS,FALSE,NS,GBA2,,GBA2,glucosylceramidase beta 2,9,Q9HCG7,"This gene encodes a microsomal beta-glucosidase that catalyzes the hydrolysis of bile acid 3-O-glucosides as endogenous compounds. Studies to determine subcellular localization of this protein in the liver indicated that the enzyme was mainly enriched in the microsomal fraction where it appeared to be confined to the endoplasmic reticulum. This putative transmembrane protein is thought to play a role in carbohydrate transport and metabolism. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity.,23332917,2013,DisGeNET,rs398123014,SNV,,,,,,Two nonsense mutations (c.363C>A [p.Tyr121(âˆ—)] and c.1018C>T [p.Arg340(âˆ—)]) and a substitution (c.2618G>A [p.Arg873His]) were identified.
rs121434371,20732827,"Glutaric Aciduria, Type 1",South Africa,South Africa,NS,FALSE,NS,GCDH,Genetic variability study,GCDH,glutaryl-CoA dehydrogenase,19,Q92947,"The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013].",22/11/2021,PubMed,Glutaric aciduria type 1 in South Africa-high incidence of glutaryl-CoA dehydrogenase deficiency in black South Africans.,20732827,2011,DisGeNET,rs121434371,SNV,,,,,,The mutation A293T was found at the homozygous state in 11 unrelated patients with glutaric Aciduria type 1.
rs104894075,11743579,"Charcot-Marie-Tooth Disease, Type 4A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.,11743579,2002,DisGeNET,rs104894075,SNV,,,,,,Associated with Charcot Marie Tooth 4A
rs104894076,11743579,"Charcot-Marie-Tooth Disease, Type 4A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.,11743579,2002,DisGeNET,rs104894076,SNV,,,,,,Associated with Charcot Marie Tooth 4A
rs121908112,11743579,"Charcot-Marie-Tooth Disease, Type 4A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.,11743579,2002,DisGeNET,rs121908112,SNV,,,,,,Associated with Charcot Marie Tooth 4A
rs104894075,11743579,"Charcot-Marie-Tooth Disease, Axonal, Type 2K",Tunisia,North Africa,NS,FALSE,NS,GDAP1,Genetic variability study,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.,11743579,2002,DisGeNET,rs104894075,SNV,,,,,,Variant identified in Tunisian families with high prevalence of CMTD.
rs104894075,11743579,"Charcot-Marie-Tooth Disease, Type 4A, Axonal Form",Tunisia,North Africa,NS,FALSE,NS,GDAP1,Genetic variability study,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.,11743579,2002,DisGeNET,rs104894075,SNV,,,,,,Variant identified in Tunisian families with high prevalence of CMTD.
rs104894075,12707075,Charcot-Marie-Tooth Disease,Morocco,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.,12707075,2003,DisGeNET,rs104894075,SNV,,,,,,"Associated with Charcot-Marie-Tooth Disease, Axonal, Type 2K"
rs104894075,12707075,"Charcot-Marie-Tooth Disease, Axonal, Type 2K",Morocco,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.,12707075,2003,DisGeNET,rs104894075,SNV,,,,,,"Associated with Charcot-Marie-Tooth Disease, Axonal, Type 2K"
rs104894075,12707075,"Charcot-Marie-Tooth Disease, Type 4A (Disorder)",Morocco,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.,12707075,2003,DisGeNET,rs104894075,SNV,,,,,,"Associated with Charcot-Marie-Tooth Disease, Axonal, Type 2K"
rs104894075,12707075,"Charcot-Marie-Tooth Disease, Type 4A, Axonal Form",Morocco,North Africa,NS,FALSE,NS,GDAP1,,GDAP1,ganglioside induced differentiation associated protein 1,8,Q8TB36,"This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012].",22/11/2021,PubMed,Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.,12707075,2003,DisGeNET,rs104894075,SNV,,,,,,"Associated with Charcot-Marie-Tooth Disease, Axonal, Type 2K"
rs200024180,19243074,"Epilepsy, Progressive Myoclonic, 8",Algeria,North Africa,NS,FALSE,< 0.01 - 1.0,GDF1,,GDF1,growth differentiation factor 1,19,P27539,This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations.,22/11/2021,PubMed,Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment.,19243074,2009,DisGeNET,rs200024180,SNV,,,,,,
rs121908192,26018198,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,0,GFER,,GFER,"growth factor, augmenter of liver regeneration",16,P55789,"The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. ",22/11/2021,PubMed,Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature.,26018198,2016,DisGeNET,rs121908192,SNV,,,,,,
rs373135339,26018198,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,0.085,GFER,,GFER,"growth factor, augmenter of liver regeneration",16,P55789,"The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. ",22/11/2021,PubMed,Adrenal Insufficiency in Mitochondrial Disease: A Rare Case of GFER-Related Mitochondrial Encephalomyopathy and Review of the Literature.,26018198,2016,DisGeNET,rs373135339,SNV,,,,,,
rs121908192,28155230,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,0,GFER,,GFER,"growth factor, augmenter of liver regeneration",16,P55789,"The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. ",22/11/2021,PubMed,Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data.,28155230,2017,DisGeNET,rs121908192,SNV,,,,,,
rs373135339,28155230,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,0.085,GFER,,GFER,"growth factor, augmenter of liver regeneration",16,P55789,"The hepatotrophic factor designated augmenter of liver regeneration (ALR) is thought to be one of the factors responsible for the extraordinary regenerative capacity of mammalian liver. It has also been called hepatic regenerative stimulation substance (HSS). The gene resides on chromosome 16 in the interval containing the locus for polycystic kidney disease (PKD1). The putative gene product is 42% similar to the scERV1 protein of yeast. The yeast scERV1 gene had been found to be essential for oxidative phosphorylation, the maintenance of mitochondrial genomes, and the cell division cycle. The human gene is both the structural and functional homolog of the yeast scERV1 gene. ",22/11/2021,PubMed,Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data.,28155230,2017,DisGeNET,rs373135339,SNV,,,,,,
rs201322234,8664562,"Myasthenic Syndrome, Congenital, 12",Libya,North Africa,NS,FALSE,< 0.05,GFPT1,,GFPT1,glutamine--fructose-6-phosphate transaminase 1,2,Q06210,This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. ,22/11/2021,PubMed,An autosomal-recessive congenital myasthenic syndrome with tubular aggregates in a Libyan family.,8664562,1996,DisGeNET,rs201322234,SNV,,,,,,
rs12714145,26751406,Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.,Egypt,North Africa,NS,FALSE,0.24,GGCX,,GGCX,gamma-glutamyl carboxylase,2,P38435,"This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.",26751406,2016,PharmGKB,1447677818,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study includes 204 Egyptians genotyped for the rs12714145 T allele. There was a significant association between the CC, CT, and TT genotypes for warfarin dose variation. "
rs12714145,26751406,Genotype CC is not associated with dose of warfarin as compared to genotypes CT + TT.,Egypt,North Africa,NS,FALSE,0.24,GGCX,,GGCX,gamma-glutamyl carboxylase,2,P38435,"This gene encodes an integral membrane protein of the rough endoplasmic reticulum that carboxylates glutamate residues of vitamin K-dependent proteins to gamma carboxyl glutamate, a modification that is required for their activity. The vitamin K-dependent protein substrates have a propeptide that binds the enzyme, with carbon dioxide, dioxide, and reduced vitamin K acting as co-substrates. Vitamin K-dependent proteins affect a number of physiologic processes including blood coagulation, prevention of vascular calcification, and inflammation. Allelic variants of this gene have been associated with pseudoxanthoma elasticum-like disorder with associated multiple coagulation factor deficiency. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.",26751406,2016,PharmGKB,1447677818,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study includes 204 Egyptians genotyped for the rs12714145 T allele. There was a significant association between the CC, CT, and TT genotypes for warfarin dose variation. "
rs71640277,8530604,"Isolated Growth Hormone Deficiency, Type Ii",South Africa,South Africa,NS,FALSE,NS,GH1,,GH1,growth hormone 1,17,P01241,"The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency--a clinical research center study.,8530604,2001,DisGeNET,rs71640277,SNV,,,,,,
rs121909358,8488849,Laron Syndrome,South Africa,South Africa,NS,TRUE,NS,GHR,Genetic variability study,GHR,growth hormone receptor,5,P10912,"This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011].",22/11/2021,PubMed,Diverse growth hormone receptor gene mutations in Laron syndrome.,8488849,1993,DisGeNET,rs121909358,SNV,,,,,,"Laron syndrome is caused by diverse GHR gene mutations, including deletions, RNA processing defects, translational stop codons, and missense codons."
rs121909363,8488849,Laron Syndrome,South Africa,South Africa,NS,TRUE,NS,GHR,Genetic variability study,GHR,growth hormone receptor,5,P10912,"This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011].",22/11/2021,PubMed,Diverse growth hormone receptor gene mutations in Laron syndrome.,8488849,1993,DisGeNET,rs121909363,SNV,,,,,,"Laron syndrome is caused by diverse GHR gene mutations, including deletions, RNA processing defects, translational stop codons, and missense codons."
rs730880281,8488849,Laron Syndrome,South Africa,South Africa,NS,TRUE,NS,GHR,Genetic variability study,GHR,growth hormone receptor,5,P10912,"This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011].",22/11/2021,PubMed,Diverse growth hormone receptor gene mutations in Laron syndrome.,8488849,1993,DisGeNET,rs730880281,SNV,,,,,,"Laron syndrome is caused by diverse GHR gene mutations, including deletions, RNA processing defects, translational stop codons, and missense codons."
rs116074753,19250854,Parkinson Disease,"Egypt, Europe",North Africa,NS,TRUE,0.0006,GIGYF2,,GIGYF2,GRB10 interacting GYF protein 2 ,2,Q6Y7W6,"This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.,19250854,2009,DisGeNET,rs116074753,SNV,,,,,,
rs72554080,19250854,Parkinson Disease,"Egypt, Europe",North Africa,NS,TRUE,6.82E-08,GIGYF2,,GIGYF2,GRB10 interacting GYF protein 2 ,2,Q6Y7W6,"This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.,19250854,2009,DisGeNET,rs72554080,SNV,,,,,,
rs72554080,19250854,"Parkinson Disease 11, Autosomal Dominant","Egypt, Europe",North Africa,NS,TRUE,6.82E-08,GIGYF2,,GIGYF2,GRB10 interacting GYF protein 2 ,2,Q6Y7W6,"This gene contains CAG trinucleotide repeats and encodes a protein containing several stretches of polyglutamine residues. The encoded protein may be involved in the regulation of tyrosine kinase receptor signaling. This gene is located in a chromosomal region that was genetically linked to Parkinson disease type 11, and mutations in this gene were thought to be causative for this disease. However, more recent studies in different populations have been unable to replicate this association. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.,19250854,2009,DisGeNET,rs72554080,SNV,,,,,,
rs104894401,23856378,"Deafness, Autosomal Dominant 3A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Compound heterozygosity for dominant and recessive GJB2 mutations in a Tunisian family and association with successful cochlear implant outcome.,23856378,2014,DisGeNET,rs104894401,SNV,,,,,,Dominant mutations in GJB2 associated with hearing loss
rs104894401,23856378,"Deafness, Autosomal Recessive 1A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Compound heterozygosity for dominant and recessive GJB2 mutations in a Tunisian family and association with successful cochlear implant outcome.,23856378,2014,DisGeNET,rs104894401,SNV,,,,,,Dominant mutations in GJB2 associated with hearing loss
rs80338948,9471561,"Deafness, Autosomal Recessive 1A (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Connexin 26 R143W mutation associated with recessive nonsyndromic sensorineural deafness in Africa.,9471561,1998,DisGeNET,rs80338948,SNV,,,,,,
rs104894402,9856479,"Deafness, Autosomal Dominant 3A (Disorder)",Egypt,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma.,9856479,1998,DisGeNET,rs104894402,SNV,,,,,,Associated with which autosomal dominant deafness 3A
rs28931594,23924173,Keratitis-ichthyosis-deafness (KID) syndrome,Cameroon,West Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Heterozygous p.Asp50Asn mutation in the GJB2 gene in two Cameroonian patients with keratitis-ichthyosis-deafness (KID) syndrome.,23924173,2013,DisGeNET,rs28931594,SNV,,,,,,
rs72474224,14722929,"Deafness, Autosomal Recessive 1A (Disorder)","Kenya, Sudan",East Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants.,14722929,2004,DisGeNET,rs72474224,SNV,,,,,,
rs72474224,14722929,"Deafness, Digenic, Gjb2/Gjb3 (Disorder)","Kenya, Sudan",East Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants.,14722929,2004,DisGeNET,rs72474224,SNV,,,,,,
rs72474224,14722929,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)","Kenya, Sudan",East Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Low frequency of deafness-associated GJB2 variants in Kenya and Sudan and novel GJB2 variants.,14722929,2004,DisGeNET,rs72474224,SNV,,,,,,
rs80338939,19375528,"Deafness, Autosomal Recessive 1A (Disorder)",Algeria,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Molecular screening of deafness in Algeria: high genetic heterogeneity involving DFNB1 and the Usher loci, DFNB2/USH1B, DFNB12/USH1D and DFNB23/USH1F.",19375528,2009,DisGeNET,rs80338939,SNV,,,,,,Non-syndromic deafness within 50 families and 9 sporadic cases from Algeria is described.
rs80338939,19375528,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)",Algeria,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Molecular screening of deafness in Algeria: high genetic heterogeneity involving DFNB1 and the Usher loci, DFNB2/USH1B, DFNB12/USH1D and DFNB23/USH1F.",19375528,2009,DisGeNET,rs80338939,SNV,,,,,,Non-syndromic deafness within 50 families and 9 sporadic cases from Algeria is described.
rs80338948,15954104,"Deafness, Autosomal Recessive 1A (Disorder)",Egypt,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Mutation analysis of the GJB2 (connexin 26) gene in Egypt.,15954104,2006,DisGeNET,rs80338948,SNV,,,,,,
rs104894398,11439000,"Deafness, Autosomal Recessive 1A (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs104894398,SNV,,,,,,
rs568612627,11439000,"Deafness, Autosomal Recessive 1A (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs568612627,SNV,,,,,,Associated with profound sensorineural hearing impairment
rs80338950,11439000,"Deafness, Autosomal Dominant 3A (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs80338950,SNV,,,,,,"Substantial evidence indicates that another novel mutation, R184Q, is dominant. A family study revealed thathearing loss co-segregated with heterozygosity for R184Q"
rs80338948,11439000,"Deafness, Autosomal Recessive 1A (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs80338948,SNV,,,,,,"R143W was greatly predominant also in other parts of the country, contributing 90% to all GJB2 mutations seen."
rs568612627,11439000,"Deafness, Digenic, Gjb2/Gjb3 (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs568612627,SNV,,,,,,"Two apparently unrelated individuals and a sibling of one of them were homozygous for V178A, suggesting that V178A is another recessive cause forhearing loss."
rs80338948,11439000,"Deafness, Digenic, Gjb2/Gjb3 (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs80338948,SNV,,,,,,"R143W was greatly predominant also in other parts of the country, contributing 90% to all GJB2 mutations seen."
rs568612627,11439000,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs568612627,SNV,,,,,,"Two apparently unrelated individuals and a sibling of one of them were homozygous for V178A, suggesting that V178A is another recessive cause forhearing loss."
rs80338948,11439000,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)",Ghana,West Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana.,11439000,2002,DisGeNET,rs80338948,SNV,,,,,,"R143W was greatly predominant also in other parts of the country, contributing 90% to all GJB2 mutations seen."
rs80338950,9336442,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338950,SNV,,,,,,Associated with Prelingual Deafness
rs886037849,9336442,Mutilating Keratoderma,Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs886037849,SNV,,,,,,Not specified in the study but associated with Mutilating keratoderma
rs104894398,9336442,"Deafness, Autosomal Recessive 1A (Disorder)","Tunisia, France, New Zealand, UK",North Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs104894398,SNV,,,,,,"Identified in a single Tunisian family, normal hearing parents were found to be heterozygous for the mutation. This family is from the south of Tunisia."
rs80338939,9336442,"Deafness, Autosomal Recessive 1A (Disorder)","Tunisia, France, New Zealand, UK",North Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338939,SNV,,,,,,"Identified in four Tunisian families, this mutation is referred to as the 30delG mutation. These are families from the North and South of Tunisia."
rs80338939,9336442,"Ichthyosis, Hystrix-Like, With Deafness",Tunisia,North Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338939,SNV,,,,,,"Identified in four Tunisian families, this mutation is referred to as the 30delG mutation. These are families from the North and South of Tunisia."
rs80338939,9336442,"Knuckle Pads, Leuconychia And Sensorineural Deafness",Tunisia,North Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338939,SNV,,,,,,"Identified in four Tunisian families, this mutation is referred to as the 30delG mutation. These are families from the North and South of Tunisia."
rs80338939,9336442,Mutilating Keratoderma,Tunisia,North Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338939,SNV,,,,,,"Identified in four Tunisian families, this mutation is referred to as the 30delG mutation. These are families from the North and South of Tunisia."
rs80338939,9336442,Palmoplantar Keratoderma With Deafness,Tunisia,North Africa,NS,FALSE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338939,SNV,,,,,,"Identified in four Tunisian families, this mutation is referred to as the 30delG mutation. These are families from the North and South of Tunisia."
rs80338939,9336442,"Deafness, Autosomal Dominant 3A (Disorder)","Tunisia, France, New Zealand, UK",North Africa,NS,TRUE,NS,GJB2,Genetic variability study,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Prelingual deafness: high prevalence of a 30delG mutation in the connexin 26 gene.,9336442,1997,DisGeNET,rs80338939,SNV,,,,,,"Identified in four Tunisian families, this mutation is referred to as the 30delG mutation. These are families from the North and South of Tunisia."
rs104894398,22429511,"Deafness, Autosomal Recessive 1A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Segregation of a new mutation in SLC26A4 and p.E47X mutation in GJB2 within a consanguineous Tunisian family affected with Pendred syndrome.,22429511,2012,DisGeNET,rs104894398,SNV,,,,,,"Associated with Deafness, Autosomal Recessive 1A "
rs779018464,23680645,"Deafness, Autosomal Dominant 3A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs779018464,SNV,,,,,,
rs72474224,23680645,"Deafness, Autosomal Recessive 1A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs72474224,SNV,,,,,,
rs779018464,23680645,"Deafness, Autosomal Recessive 1A (Disorder)",Tunisia,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs779018464,SNV,,,,,,
rs72474224,23680645,"Deafness, Digenic, Gjb2/Gjb3 (Disorder)",Morocco,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs72474224,SNV,,,,,,
rs779018464,23680645,"Deafness, Digenic, Gjb2/Gjb3 (Disorder)",Morocco,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs779018464,SNV,,,,,,
rs72474224,23680645,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)",Morocco,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs72474224,SNV,,,,,,
rs779018464,23680645,"Deafness, Digenic, Gjb2/Gjb6 (Disorder)",Morocco,North Africa,NS,FALSE,NS,GJB2,,GJB2,gap junction protein beta 2,13,P29033,"This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Update of the spectrum of GJB2 gene mutations in Tunisian families with autosomal recessive nonsyndromic hearing loss.,23680645,2013,DisGeNET,rs779018464,SNV,,,,,,
rs73043340,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,3.76E-07,GLB1,Association,GLB1,galactosidase beta 1,3,P16278 ,"This gene encodes a member of the glycosyl hydrolase 35 family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature lysosomal enzyme. This enzyme catalyzes the hydrolysis of a terminal beta-linked galactose residue from ganglioside substrates and other glycoconjugates. Mutations in this gene may result in GM1-gangliosidosis and Morquio B syndrome. ",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs73043340,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs1537415,25682733,Acute Periodontitis,Sudan,East Africa,NS,FALSE,0.0295,GLT6D1,,GLT6D1,glycosyltransferase 6 domain containing 1,9,Q7Z4J2,"The GT6 glycosyltransferases gene family, which includes the ABO blood group (ABO; MIM 110300) and GLT6D1, shows a complex evolution pattern, with multiple events of gain and loss in different mammal species. In humans, the ABO gene is considered the sole functional member, although the O allele is null and is fixed in certain populations (summary by Casals et al. (2009) [PubMed 19218399]).[supplied by OMIM, Jan 2011].",22/11/2021,PubMed,Replication of the association of GLT6D1 with aggressive periodontitis in a Sudanese population.,25682733,2016,DisGeNET,rs1537415,SNV,,,,,,
rs1537415,25682733,"Periodontitis, Juvenile",Sudan,East Africa,NS,TRUE,< 0.05,GLT6D1,,GLT6D1,glycosyltransferase 6 domain containing 1,9,Q7Z4J2,"The GT6 glycosyltransferases gene family, which includes the ABO blood group (ABO; MIM 110300) and GLT6D1, shows a complex evolution pattern, with multiple events of gain and loss in different mammal species. In humans, the ABO gene is considered the sole functional member, although the O allele is null and is fixed in certain populations (summary by Casals et al. (2009) [PubMed 19218399]).[supplied by OMIM, Jan 2011].",22/11/2021,PubMed,Replication of the association of GLT6D1 with aggressive periodontitis in a Sudanese population.,25682733,2016,DisGeNET,rs1537415,SNV,,,,,,"The association strengthened to OR=1.56 (95% CI 1.15-2.16), p=0.0042 when the controls were supplemented with data from the Hap map for the Yoruba in Ibadan (n=147) and remained significant (p=0.013) after correction for multiple testing. "
rs5443,25306451,The GNB3 TT genotype was associated with greater therapeutic effect.,USA,African American/Afro-Caribbean,African American,FALSE,> 0.05,GNB3,,GNB3,G protein subunit beta 3,12,P16520,"Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit which belongs to the WD repeat G protein beta family. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. A single-nucleotide polymorphism (C825T) in this gene is associated with essential hypertension and obesity. This polymorphism is also associated with the occurrence of the splice variant GNB3-s, which appears to have increased activity. GNB3-s is an example of alternative splicing caused by a nucleotide change outside of the splice donor and acceptor sites. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. ",22/11/2021,PubMed,G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.,25306451,2014,PharmGKB,TBD,SNV,isosorbide dinitrate,DB00883,"Approved, Investigational",For the prevention of angina pectoris due to coronary artery disease.,"(3R,3aS,6S,6aS)-6-(nitrooxy)-hexahydrofuro[3,2-b]furan-3-yl nitrate",
rs5443,25306451,The GNB3 TT genotype was associated with greater therapeutic effect.,USA,African American/Afro-Caribbean,African American,FALSE,> 0.05,GNB3,,GNB3,G protein subunit beta 3,12,P16520,"Heterotrimeric guanine nucleotide-binding proteins (G proteins), which integrate signals between receptors and effector proteins, are composed of an alpha, a beta, and a gamma subunit. These subunits are encoded by families of related genes. This gene encodes a beta subunit which belongs to the WD repeat G protein beta family. Beta subunits are important regulators of alpha subunits, as well as of certain signal transduction receptors and effectors. A single-nucleotide polymorphism (C825T) in this gene is associated with essential hypertension and obesity. This polymorphism is also associated with the occurrence of the splice variant GNB3-s, which appears to have increased activity. GNB3-s is an example of alternative splicing caused by a nucleotide change outside of the splice donor and acceptor sites. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. ",23/11/2021,PubMed,G-protein beta-3 subunit genotype predicts enhanced benefit of fixed-dose isosorbide dinitrate and hydralazine: results of A-HeFT.,25306451,2014,PharmGKB,TBD,SNV,hydralazine,DB01275,Approved,Hydralazine is indicated alone or adjunct to standard therapy to treat essential hypertension. A combination product with isosorbide dinitrate is indicated as an adjunct therapy in the treatment of heart failure.,1-hydrazinylphthalazine,
rs748949603,20300792,"Inclusion Body Myopathy, Autosomal Recessive",Egypt,North Africa,NS,FALSE,NS,GNE,,GNE,glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase,9,Q9Y223,"The protein encoded by this gene is a bifunctional enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. It is a rate-limiting enzyme in the sialic acid biosynthetic pathway. Sialic acid modification of cell surface molecules is crucial for their function in many biologic processes, including cell adhesion and signal transduction. Differential sialylation of cell surface molecules is also implicated in the tumorigenicity and metastatic behavior of malignant cells. Mutations in this gene are associated with sialuria, autosomal recessive inclusion body myopathy, and Nonaka myopathy. Alternative splicing of this gene results in transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The spectrum of GNE mutations: allelic heterogeneity for a common phenotype.,20300792,2010,DisGeNET,rs748949603,SNV,,,,,,
rs797044857,28886269,"Genetic Diseases, Inborn",Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,GRHL3,,GRHL3,grainyhead like transcription factor 3,1,Q8TE85,"This gene encodes a member of the grainyhead family of transcription factors. The encoded protein may function as a transcription factor during development, and has been shown to stimulate migration of endothelial cells. Multiple transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Loss-of-Function GRHL3 Variants Detected in African Patients with Isolated Cleft Palate.,28886269,2018,DisGeNET,rs797044857,SNV,,,,,,
rs11146020,21332319,Genotypes CC + CG are not associated with increased response to clozapine in people with Schizophrenia as compared to genotype GG.,Canada,African American/Afro-Caribbean,NS,FALSE,0.551,GRIN1,,GRIN1,glutamate ionotropic receptor NMDA type subunit 1,9,Q05586,"The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor channel superfamily which are heteromeric protein complexes with multiple subunits arranged to form a ligand-gated ion channel. These subunits play a key role in the plasticity of synapses, which is believed to underlie memory and learning. Cell-specific factors are thought to control expression of different isoforms, possibly contributing to the functional diversity of the subunits. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Gene-gene interaction analyses between NMDA receptor subunit and dopamine receptor gene variants and clozapine response.,21332319,2011,PharmGKB,827789188,SNV,clozapine,DB00363,Approved,For use in patients with treatment-resistant schizophrenia.,"8-Chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",Patients with the CC genotype and Schizophrenia may have a decreased response to clozapine compared to patients with a CT or TT genotype. Other genetic and clinical factors may also influence a patient's response to clozapine.
rs1801058,19119263,Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC.,USA,African American/Afro-Caribbean,NS,FALSE,0.04,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864109,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,Significant relationship between A486V (rs1801058) and blood pressure response in Usual MAP (102â€“107 mm Hg)
rs1024323,19119263,Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.05,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864047,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,Association between A142V (rs1024323)and blood pressure response in Usual MAP (102â€“107 mm Hg)
rs1024323,19119263,Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.05,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864069,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,
rs2960306,19119263,Genotypes GT + TT are associated with decreased response to metoprolol in men with hypertensive nephrosclerosis.,USA,African American/Afro-Caribbean,NS,FALSE,0.11,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864080,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,Reaching a target MAP of 107 mm Hg by R65L (rs2960306)was not significant
rs1801058,19119263,Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.,USA,African American/Afro-Caribbean,NS,FALSE,< 0.001,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864092,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,Strong relationship between A486V and blood pressure response among men in Low MAP (â‰¤92 mm Hg)
rs2960306,19119263,Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.,USA,African American/Afro-Caribbean,NS,FALSE,NS,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864125,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol,There were no other significant relationships between GRK4 variants and blood pressure response among men and women randomized to a low MAP
rs1801058,19119263,Genotype CT is associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype CC.,USA,African American/Afro-Caribbean,NS,FALSE,0.04,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864109,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,Significant relationship between A486V (rs1801058) and blood pressure response in Usual MAP (102â€“107 mm Hg)
rs1024323,19119263,Genotype CC is associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.05,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864047,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,Association between A142V (rs1024323)and blood pressure response in Usual MAP (102â€“107 mm Hg)
rs1024323,19119263,Genotype CC is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.05,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864069,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,
rs2960306,19119263,Genotypes GT + TT are associated with decreased response to metoprolol in men with hypertensive nephrosclerosis.,USA,African American/Afro-Caribbean,NS,FALSE,0.11,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864080,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,Reaching a target MAP of 107 mm Hg by R65L (rs2960306)was not significant
rs1801058,19119263,Genotype CT is not associated with decreased response to metoprolol in men with hypertensive nephrosclerosis as compared to genotype CC.,USA,African American/Afro-Caribbean,NS,FALSE,< 0.001,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864092,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,Strong relationship between A486V and blood pressure response among men in Low MAP (â‰¤92 mm Hg)
rs2960306,19119263,Genotype TT is not associated with decreased response to metoprolol in women with hypertensive nephrosclerosis as compared to genotype GG.,USA,African American/Afro-Caribbean,NS,FALSE,NS,GRK4,,GRK4,G protein-coupled receptor kinase 4,4,P32298,"This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating its deactivation. This gene has been linked to both genetic and acquired hypertension. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2013].",22/11/2021,PubMed,G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.,19119263,2009,PharmGKB,827864125,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,There were no other significant relationships between GRK4 variants and blood pressure response among men and women randomized to a low MAP
rs2230345,18425130,Polymorphism inhibits beta-adrenergic receptor signaling,USA,African American/Afro-Caribbean,African American,TRUE,NS,GRK5,,GRK5,G protein-coupled receptor kinase 5,,P34947,This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating their deactivation. It has also been shown to play a role in regulating the motility of polymorphonuclear leukocytes (PMNs).,22/11/2021,PubMed,A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.,18425130,2008,PharmGKB,TBD,SNV,carvedilol,DB01136,"Approved, Investigational","Carvedilol is indicated to treat mild to severe heart failure, left ventricular dysfunction after myocardial infarction with ventricular ejection fraction ≤40%, or hypertension.",1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol,
rs2230345,18425130,Polymorphism inhibits beta-adrenergic receptor signaling,USA,African American/Afro-Caribbean,African American,TRUE,NS,GRK5,,GRK5,G protein-coupled receptor kinase 5,,P34947,This gene encodes a member of the guanine nucleotide-binding protein (G protein)-coupled receptor kinase subfamily of the Ser/Thr protein kinase family. The protein phosphorylates the activated forms of G protein-coupled receptors thus initiating their deactivation. It has also been shown to play a role in regulating the motility of polymorphonuclear leukocytes (PMNs).,22/11/2021,PubMed,A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.,18425130,2008,PharmGKB,TBD,SNV,metoprolol,DB00264,"Approved, Investigational","Metoprolol is indicated for the treatment of angina, heart failure, myocardial infarction, atrial fibrillation, atrial flutter and hypertension. Some off-label uses of metoprolol include supraventricular tachycardia and thyroid storm. All the indications of metoprolol are part of cardiovascular diseases. These conditions correspond to a number of diseases that involve the function of the heart and blood vessels. The underlying causes of these conditions are variable and can be due to genetic disposition, lifestyle decisions such as smoking, obesity, diet, and lack of exercise, and comorbidity with other conditions such as diabetes. The cardiovascular diseases are the leading cause of death on a global scale.",1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol,
rs114246623,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,7.70E-07,GRM7,Association,GRM7,glutamate metabotropic receptor 7,3,Q14831,"L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs114246623,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs532063800,23146719,Cataract,Sudan,North Africa,NS,FALSE,0.007,H6PD,,H6PD,hexose-6-phosphate dehydrogenase,1,O95479,"There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. ",22/11/2021,PubMed,Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan.,23146719,2013,DisGeNET,rs532063800,SNV,,,,,,
rs543287988,23146719,Cataract,Sudan,North Africa,NS,FALSE,0.011,H6PD,,H6PD,hexose-6-phosphate dehydrogenase,1,O95479,"There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. ",22/11/2021,PubMed,Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan.,23146719,2013,DisGeNET,rs543287988,SNV,,,,,,
rs749808170,23146719,Cataract,Sudan,North Africa,NS,FALSE,> 0.05,H6PD,,H6PD,hexose-6-phosphate dehydrogenase,1,O95479,"There are 2 forms of glucose-6-phosphate dehydrogenase. G form is X-linked and H form, encoded by this gene, is autosomally linked. This H form shows activity with other hexose-6-phosphates, especially galactose-6-phosphate, whereas the G form is specific for glucose-6-phosphate. Both forms are present in most tissues, but H form is not found in red cells. ",22/11/2021,PubMed,Analysis of the genetic variants of glucose-6-phosphate dehydrogenase in inhabitants of the 4th Nile cataract region in Sudan.,23146719,2013,DisGeNET,rs749808170,SNV,,,,,,
rs7706544,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,1.94E-07,HARS1,Association,HARS1,histidyl-tRNA synthetase 1,5,P12081,"Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene is a cytoplasmic enzyme which belongs to the class II family of aminoacyl-tRNA synthetases. The enzyme is responsible for the synthesis of histidyl-transfer RNA, which is essential for the incorporation of histidine into proteins. The gene is located in a head-to-head orientation with HARSL on chromosome five, where the homologous genes share a bidirectional promoter. The gene product is a frequent target of autoantibodies in the human autoimmune disease polymyositis/dermatomyositis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs7706544,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs281864819,15481894,Alpha-Thalassemia,Tunisia,North Africa,NS,FALSE,< 0.05,HBA2,,HBA2,hemoglobin subunit alpha 2,16,P69905,"The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported.",22/11/2021,PubMed,A novel alpha-thalassemia nonsense mutation in codon 23 of the alpha2-globin gene (GAG-->TAG) in a Tunisian family.,15481894,2004,DisGeNET,rs281864819,SNV,,,,,,
rs33943001,2283297,Beta Thalassemia,Egypt,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A new beta-thalassemia mutation produced by a single nucleotide substitution in the conserved dinucleotide sequence of the IVS-I consensus acceptor site (AG----AA).,2283297,1990,DisGeNET,rs33943001,SNV,,,,,,"A G+A substitution was found at position 130 of the IVS-I which alters the conserved dinucleotide AG present in the consensus a c c e p t o r sequence, thus producing a beta-thalassemia."
rs33971440,2283297,Beta Thalassemia,Egypt,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A new beta-thalassemia mutation produced by a single nucleotide substitution in the conserved dinucleotide sequence of the IVS-I consensus acceptor site (AG----AA).,2283297,1990,DisGeNET,rs33971440,SNV,,,,,,IVS-1-1 (G-A) mutation gave negative results.
rs33956879,2393712,Beta Thalassemia,Algeria,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A new mutation at IVS1 nt 2(T----A), in beta-thalassemia from Algeria.",2393712,1990,DisGeNET,rs33956879,SNV,,,,,,The thalassemic chromosomes on which we have actually determined a mutation carried a T C transition at position 2 in IVSI.
rs63749819,2393712,Beta^0^ Thalassemia,Algeria,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A new mutation at IVS1 nt 2(T----A), in beta-thalassemia from Algeria.",2393712,1990,DisGeNET,rs63749819,SNV,,,,,,Thalassemic mutation was observed in the DNA of a patient carried a deletion of A in codon 6 (GAG -GG).
rs334,1376298,"Anemia, Sickle Cell",Cameroon,West Africa,Eton,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel sickle cell mutation of yet another origin in Africa: the Cameroon type.,1376298,1992,DisGeNET,rs334,SNV,,,,,,"This gene is in linkage disequilibrium with a novel 13-globin gene cluster haplotype, designated here as the ""Cameroon haplotype"". the homozygous individuals all belong to the Eton ethnic group."
rs334,1376298,Beta Thalassemia,Cameroon,West Africa,Eton,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel sickle cell mutation of yet another origin in Africa: the Cameroon type.,1376298,1992,DisGeNET,rs334,SNV,,,,,,"This gene is in linkage disequilibrium with a novel 13-globin gene cluster haplotype, designated here as the ""Cameroon haplotype"". the homozygous individuals all belong to the Eton ethnic group."
rs334,24312262,severe malarial anaemia (SMA),Cameroon,West Africa,NS,FALSE,7.11E-08,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs334,SNV,,,,,,SMA individuals were more likely to develop malaria infection.
rs334,24312262,Sickle Cell Trait,Cameroon,West Africa,NS,FALSE,8.56E-07,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs334,SNV,,,,,,Sickle celled individuals were more likely to develop malaria infection.
rs334,24312262,Malaria,Cameroon,West Africa,NS,FALSE,3.08E-05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs334,SNV,,,,,,The rs334 variant was significantly associated with protection from malaria infection in heterozygotes in the semi-bantu.
rs334,24312262,Anemia,Cameroon,West Africa,NS,FALSE,0.004,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs334,SNV,,,,,,Carriage of the sickle cell trait was associated with protection from anaemia.
rs33915217,3021139,Beta Thalassemia,Algeria,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Beta thalassemia due to a novel mutation in IVS 1 sequence donor site consensus sequence creating a restriction site.,3021139,1986,DisGeNET,rs33915217,SNV,,,,,,"Novel G>A transition, was located at IVS 1 nucleotide 5 within the donor splice site consensus sequence."
rs33915217,1917531,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Beta-thalassemia, HB S-beta-thalassemia and sickle cell anemia among Tunisians.",1917531,1991,DisGeNET,rs33915217,SNV,,,,,,IVS-1-5 (G>A) mutation cause a Bo-thalassemia o r a severe B+-thalassemia.
rs33980857,1917531,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Beta-thalassemia, HB S-beta-thalassemia and sickle cell anemia among Tunisians.",1917531,1991,DisGeNET,rs33980857,SNV,,,,,,(T>A) at position -30 mutation cause a Bo-thalassemia o r a severe B+-thalassemia.
rs334,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,1.30E-28,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs334,SNV,,,,,,
rs334,22895189,Malaria,Ghana,West Africa,NS,FALSE,1.40E-38,HBB,Association,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide association study indicates two novel resistance loci for severe malaria.,22895189,2012,DisGeNET,rs334,SNV,,,,,,OR=0.11 in Combined Ghanaian groups (heterozygous advantage).
rs372091,22895189,Malaria,Ghana,West Africa,NS,FALSE,1.10E-14,HBB,Association,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide association study indicates two novel resistance loci for severe malaria.,22895189,2012,DisGeNET,rs372091,SNV,,,,,,OR=0.44 in Combined Ghanaian groups (heterozygous advantage).
rs63749819,17486495,Beta Thalassemia,Morocco,North Africa,NS,FALSE,< 1E-5,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genotypic correlation between six common beta-thalassemia mutations and the XmnI polymorphism in the Moroccan population.,17486495,2007,DisGeNET,rs63749819,SNV,,,,,,
rs334,18048408,"Anemia, Sickle Cell",Burkina Faso,West Africa,Mossi,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Haemoglobin S and haemoglobin C: 'quick but costly' versus 'slow but gratis' genetic adaptations to Plasmodium falciparum malaria.,18048408,2008,DisGeNET,rs334,SNV,,,,,,
rs334,20552021,Sickle Cell Trait/ Trachoma,Gambia,West Africa,Mandinka,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.,20552021,2010,DisGeNET,rs334,SNV,,,,,,
rs334,22625666,Beta Thalassemia,Mauritania,West Africa,"Moors,Pulhars, Soninkés,Wolofs",FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Hb S [Î²6(A3)Gluâ†’Val, GAG>GTG] and Î²-globin gene cluster haplotype distribution in Mauritania.",22625666,2012,DisGeNET,rs334,SNV,,,,,,5.71% of the Mauritanian population carry the Hb S variant with the highest incidence was found in the Mauritanian Black Africans (10.69%) where it reached 20.87% in the Soninkés subethnic group. While it was lower (3.37%) in the black Moors.
rs33931746,18976160,Beta Thalassemia,Morocco,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular basis of beta-thalassemia in Morocco: possible origins of the molecular heterogeneity.,18976160,2009,DisGeNET,rs33931746,SNV,,,,,,
rs334,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,8.59E-13,HBB,Association,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs334,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the heterozygous model."
rs33930165,23297836,Beta Thalassemia,USA,African American/Afro-Caribbean,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"The clinical and laboratory spectrum of Hb C [Î²6(A3)Gluâ†’Lys, GAG>AAG] disease.",23297836,2013,DisGeNET,rs33930165,SNV,,,,,,Ã¾ Hb C/Î² -thal patients had Hb and MCV values similar to those of Hb CC disease but both indices were lower in patients with Hb C/Î²0-thal
rs33945777,3422218,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,NS,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The peculiar spectrum of beta-thalassemia genes in Tunisia.,3422218,1988,DisGeNET,rs33945777,SNV,,,,,,Oligonucleotide specific for beta-thal mutations at IVS-2 nt 1.
rs334,2579336,"Anemia, Sickle Cell","Benin, Senegal",West Africa,NS,TRUE,7.11E-08,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.,2579336,1985,DisGeNET,rs334,SNV,,,,,,
rs334,2891298,"Anemia, Sickle Cell",South Africa,South Africa,NS,FALSE,7.11E-08,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Globin gene-associated restriction-fragment-length polymorphisms in southern African peoples.,2891298,1987,DisGeNET,rs334,SNV,,,,,,
rs334,2898142,"Anemia, Sickle Cell","Benin, Congo, Senegal",Central Africa / West Africa,NS,TRUE,7.11E-08,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Structural analysis of the 5' flanking region of the beta-globin gene in African sickle cell anemia patients: further evidence for three origins of the sickle cell mutation in Africa.,2898142,1988,DisGeNET,rs334,SNV,,,,,,
rs35424040,3114175,Beta-Knossos-Thalassemia,Egypt,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Hemoglobin Knossos [alpha 2 beta 2(27)(B9)Ala----Ser] in Egypt.,3114175,1987,DisGeNET,rs35424040,SNV,,,,,,
rs35424040,3114175,Beta+ Thalassemia,Egypt,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Hemoglobin Knossos [alpha 2 beta 2(27)(B9)Ala----Ser] in Egypt.,3114175,1987,DisGeNET,rs35424040,SNV,,,,,,
rs334,6268660,"Anemia, Sickle Cell",Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,1.81E-09,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Sickle gene. Its origin and diffusion from West Africa.,6268660,1981,DisGeNET,rs334,SNV,,,,,,
rs35424040,6469698,Beta-Knossos-Thalassemia,Algeria,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Two new cases of heterozygosity for hemoglobin Knossos alpha 2 beta 2 27 Ala----Ser detected in the French West Indies and Algeria.,6469698,1984,DisGeNET,rs35424040,SNV,,,,,,
rs35424040,6469698,Beta+ Thalassemia,Algeria,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Two new cases of heterozygosity for hemoglobin Knossos alpha 2 beta 2 27 Ala----Ser detected in the French West Indies and Algeria.,6469698,1984,DisGeNET,rs35424040,SNV,,,,,,
rs334,6584911,"Anemia, Sickle Cell",Africa,Africa,NS,TRUE,1.81E-09,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa.,6584911,1984,DisGeNET,rs334,SNV,,,,,,
rs35424040,6668188,Beta-Knossos-Thalassemia,Algeria,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Silent beta-thalassemia associated with Hb Knossos beta 27 (B9) Ala replaced by Ser in Algeria.,6668188,1983,DisGeNET,rs35424040,SNV,,,,,,
rs35424040,6668188,Beta+ Thalassemia,Algeria,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Silent beta-thalassemia associated with Hb Knossos beta 27 (B9) Ala replaced by Ser in Algeria.,6668188,1983,DisGeNET,rs35424040,SNV,,,,,,
rs33930165,11001883,Beta Thalassemia,Mali,West Africa,NS,FALSE,0.01,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S.",11001883,2000,DisGeNET,rs33930165,SNV,,,,,,
rs36015961,11001883,Beta Thalassemia,Mali,West Africa,NS,FALSE,0.03,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S.",11001883,2000,DisGeNET,rs36015961,SNV,,,,,,
rs33950507,12850492,Beta+ Thalassemia,"Africa, America, Asia, Europe",Africa,NS,TRUE,0.01,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.,12850492,2019,DisGeNET,rs33950507,SNV,,,,,,
rs33950507,12850492,Hemoglobin E/Beta Thalassemia Disease,"Africa, America, Asia, Europe",Africa,NS,TRUE,0.01,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.,12850492,2019,DisGeNET,rs33950507,SNV,,,,,,
rs33931746,14734204,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,0.01,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical and molecular aspects of haemoglobinopathies in Tunisia.,14734204,2004,DisGeNET,rs33931746,SNV,,,,,,
rs34218908,14734204,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,0.00000115,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical and molecular aspects of haemoglobinopathies in Tunisia.,14734204,2004,DisGeNET,rs34218908,SNV,,,,,,
rs63751208,14734204,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,< 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical and molecular aspects of haemoglobinopathies in Tunisia.,14734204,2004,DisGeNET,rs63751208,SNV,,,,,,
rs35894115,16987798,Beta Thalassemia,Tunisia,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Detection of two rare beta-thalassemia alleles found in the Tunisian population: codon 47 (+A) and codons 106/107 (+G).,16987798,2006,DisGeNET,rs35894115,SNV,,,,,,
rs35894115,19205970,Beta Thalassemia,Algeria,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular heterogeneity of beta-thalassemia in Algeria: how to face up to a major health problem.,19205970,2009,DisGeNET,rs35894115,SNV,,,,,,
rs35894115,20113284,Beta Thalassemia,"Algeria, Morocco, Tunisia",North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Hemoglobinopathies in North Africa: a review.,20113284,2010,DisGeNET,rs35894115,SNV,,,,,,
rs34889882,25617386,Beta Thalassemia,Egypt,North Africa,NS,FALSE,> 0.05,HBB,,HBB,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,√ü-Globin Mutations in Egyptian Patients With √ü-Thalassemia.,25617386,2015,DisGeNET,rs34889882,SNV,,,,,,
rs34809449,10335983,Fetal Hemoglobin Quantitative Trait Locus 1,Algeria,North Africa,NS,FALSE,< 0.001,HBG2,,HBG2,hemoglobin subunit beta,11,P68871,"The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel C-->A transversion within the distal CCAAT motif of the Ggamma-globin gene in the Algerian Ggammabeta+-hereditary persistence of fetal hemoglobin.,10335983,1999,DisGeNET,rs34809449,SNV,,,,,,
rs753780877,26153217,"Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation",Morocco,North Africa,NS,FALSE,NS,HERC1,,HERC1,HECT and RLD domain containing E3 ubiquitin protein ligase family member 1,15,Q15751,"This gen encodes a member of the HERC protein family. This protein stimulates guanine nucleotide exchange on ARF1 and Rab proteins. This protein may be involved in membrane transport processes. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,"A nonsense variant in HERC1 is associated with intellectual disability, megalencephaly, thick corpus callosum and cerebellar atrophy.",26153217,2016,DisGeNET,rs753780877,SNV,,,,,,
rs121907960,1322637,Tay-Sachs Disease,Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.,1322637,1992,DisGeNET,rs121907960,SNV,,,,,,"An in-frame deletion of one of the two adjacent phenylalanine codons at position 304 or 305 (AF304/305) in one HEXA allele ; Also identified two additional mutations within exon 5 of the HEXA gene that account for the remaining TSD alleles in the patient and carriers. One of the mutations is a novel C-to-G transversion, resulting in a replacement of Tyr180 by a stop codon. The other mutation is a G-to-A transition resulting in an Arg170-to-Gln substitution."
rs121907969,1322637,Tay-Sachs Disease,Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Identification and rapid detection of three Tay-Sachs mutations in the Moroccan Jewish population.,1322637,1992,DisGeNET,rs121907969,SNV,,,,,,"An in-frame deletion of one of the two adjacent phenylalanine codons at position 304 or 305 (AF304/305) in one HEXA allele ; Also identified two additional mutations within exon 5 of the HEXA gene that account for the remaining TSD alleles in the patient and carriers. One of the mutations is a novel C-to-G transversion, resulting in a replacement of Tyr180 by a stop codon. The other mutation is a G-to-A transition resulting in an Arg170-to-Gln substitution."
rs121907952,9338583,"Gm2-Gangliosidosis, Adult Chronic Type",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,The E482K mutation was identified in one patient with Tay-Sachs diseases.
rs121907957,9338583,"Gm2-Gangliosidosis, Adult Chronic Type",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907952,9338583,"Gm2-Gangliosidosis, Variant B1",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,The E482K mutation was identified in one patient with Tay-Sachs diseases.
rs121907957,9338583,"Gm2-Gangliosidosis, Variant B1",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907952,9338583,"Hexosaminidase A Deficiency, Adult Type",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,The E482K mutation was identified in one patient with Tay-Sachs diseases.
rs121907957,9338583,"Hexosaminidase A Deficiency, Adult Type",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907952,9338583,Tay-Sachs Disease,Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,The E482K mutation was identified in one patient with Tay-Sachs diseases.
rs121907957,9338583,Tay-Sachs Disease,Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907952,9338583,"Tay-Sachs Disease, Juvenile",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907957,9338583,"Tay-Sachs Disease, Juvenile",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907952,9338583,"Tay-Sachs Disease, Pseudo-Ab Variant",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907957,9338583,"Tay-Sachs Disease, Pseudo-Ab Variant",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907952,9338583,"Tay-Sachs Disease, Variant B1",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907952,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907957,9338583,"Tay-Sachs Disease, Variant B1",Morocco,North Africa,Jewish,FALSE,NS,HEXA,Genetic variability study,HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease and HEXA mutations among Moroccan Jews.,9338583,2000,DisGeNET,rs121907957,SNV,,,,,,"Known and new mutations were screened in HEXA gene, four additional mutations were found. One of them is a novel, IVS5-2(A->G) substitution, resulting in exon skipping, and it was found only among enzyme-defined carriers. The seven HEXA identified mutations among Moroccon Jewish are: DF304/305, R170Q, IVS-2(A->G), Y180X, E482K, 1278+TATC, and IVS12+1(G->C)."
rs121907960,1825014,Tay-Sachs Disease,Morocco,North Africa,Jewish,FALSE,NS,HEXA,"Genetic variability study,Functional analysis",HEXA,hexosaminidase subunit alpha,15,P06865,"This gene encodes a member of the glycosyl hydrolase 20 family of proteins. The encoded preproprotein is proteolytically processed to generate the alpha subunit of the lysosomal enzyme beta-hexosaminidase. This enzyme, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene lead to an accumulation of GM2 ganglioside in neurons, the underlying cause of neurodegenerative disorders termed the GM2 gangliosidoses, including Tay-Sachs disease (GM2-gangliosidosis type I). Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.,1825014,1991,DisGeNET,rs121907960,SNV,,,,,,"An in-frame deletion of one of the two adjacent phenylalanine codons that are present at positions 304 and 305 in the a-subunit sequence. The mutation impairs the subunit assembly of 0-hexosaminidase A, resulting in an absence of enzyme activity."
rs1800562,12568299,"Hemochromatosis, Type 1",South Africa,South Africa,NS,FALSE,NS,HFE,,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Frequencies of the hereditary hemochromatosis allele in different populations. Comparison of previous phenotypic methods and novel genotypic methods.,12568299,2003,DisGeNET,rs1800562,SNV,,,,,,Allele frequency is 5.8%.
rs1800562,10401000,Hereditary Hemochromatosis,South Africa,South Africa,Khoisan,FALSE,0.005,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs1800562,SNV,,,,,,"Mutation with conflicting interpretations of pathogenicity in ClinVar identified in Khoisan individual, The mutant allele frequency of the C282Y mutation was found to be significantly lower in 73 apparently unrelated VP patients with the R59W mutation than in 102 controls drawn from the same population (P = 0.005)."
rs28934595,10401000,"Hemochromatosis, Type 1",South Africa,South Africa,Afrikaner,FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs28934595,SNV,,,,,,"Pathogenic mutation identified in patients from south Africa with hereditary Hemochromatosis (Caucasian), Mutation Q127H was detected in exon 3 of the HFE gene together with mutation H63D in an apparently severely affected patient previously shown to carry the protoporphyrinogen oxidase (PPOX) gene mutation R59W"
rs28934595,10401000,Hereditary Hemochromatosis,South Africa,South Africa,Afrikaner,FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs28934595,SNV,,,,,,"Pathogenic mutation identified in patients from south Africa with hereditary Hemochromatosis (Caucasian), Mutation Q127H was detected in exon 3 of the HFE gene together with mutation H63D in an apparently severely affected patient previously shown to carry the protoporphyrinogen oxidase (PPOX) gene mutation R59W"
rs28934595,10401000,Variegate Porphyria,South Africa,South Africa,Afrikaner,FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs28934595,SNV,,,,,,"Pathogenic mutation identified in patients from south Africa with hereditary Hemochromatosis (Caucasian), Mutation Q127H was detected in exon 3 of the HFE gene together with mutation H63D in an apparently severely affected patient previously shown to carry the protoporphyrinogen oxidase (PPOX) gene mutation R59W"
rs111033558,10401000,"Hemochromatosis, Type 1",South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs111033558,SNV,,,,,,Pathogenic mutation identified in patient from South Africa with hereditary Hemochromatosis (Caucasian).
rs111033558,10401000,Hereditary Hemochromatosis,South Africa,South Africa,"Afrikaner, Coloured",FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs111033558,SNV,,,,,,Pathogenic mutation identified in patient from South Africa with hereditary Hemochromatosis (Caucasian).
rs1799945,10401000,Hereditary Hemochromatosis,South Africa,South Africa,Khoisan,FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs1799945,SNV,,,,,,Mutation with conflicting interpretations of pathogenicity in ClinVar identified in Khoisan individual. Mutation Q127H was detected in exon 3 of the HFE gene together with mutation H63D in an apparently severely affected patient previously shown to carry the protoporphyrinogen oxidase (PPOX) gene mutation R59W.
rs1799945,10401000,Variegate Porphyria,South Africa,South Africa,Khoisan,FALSE,NS,HFE,Genetic variability study,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. At least nine alternatively spliced variants have been described for this gene. Additional variants have been found but their full-length nature has not been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs1799945,SNV,,,,,,Mutation with conflicting interpretations of pathogenicity in ClinVar identified in Khoisan individual. Mutation Q127H was detected in exon 3 of the HFE gene together with mutation H63D in an apparently severely affected patient previously shown to carry the protoporphyrinogen oxidase ( PPOX ) gene mutation R59W
rs1800562,17490902,Iron Overload,"South Africa, Swaziland, Zimbabwe, UK, USA",South Africa / African American/Afro-Caribbean,NS,TRUE,> 0.05,HFE,,HFE,homeostatic iron regulator,6,Q30201,"The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta2-microglobulin (beta2M). It is thought that this protein functions to regulate iron absorption by regulating the interaction of the transferrin receptor with transferrin. The iron storage disorder, hereditary haemochromatosis, is a recessive genetic disorder that results from defects in this gene. ",22/11/2021,PubMed,SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.,17490902,2018,DisGeNET,rs1800562,SNV,,,,,,
rs1049246177,23430897,Alkaptonuria,"Algeria, Europe, Asia",North Africa,NS,TRUE,NS,HGD,Genetic variability study,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database.",23430897,2013,DisGeNET,rs1049246177,SNV,,,,,,The mutation was identified in one Algerian patient and segregates in family from father. The mutation (c.130C>T) causes the substitution L44F.
rs374473331,23430897,Alkaptonuria,"Algeria, Europe, Asia",North Africa,NS,TRUE,NS,HGD,Genetic variability study,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database.",23430897,2013,DisGeNET,rs374473331,SNV,,,,,,The mutation was identified in one Algerian patient and segregates in family from father. The mutation (c.368G>C) causes the substitution G123A.
rs544956641,16085442,Alkaptonuria,Algeria,North Africa,NS,FALSE,NS,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.",16085442,2006,DisGeNET,rs544956641,SNV,,,,,,
rs786204422,16085442,Alkaptonuria,Algeria,North Africa,NS,FALSE,NS,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.",16085442,2006,DisGeNET,rs786204422,SNV,,,,,,
rs786204662,16085442,Alkaptonuria,Algeria,North Africa,NS,FALSE,NS,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.",16085442,2006,DisGeNET,rs786204662,SNV,,,,,,
rs1057516362,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,0.028,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs1057516362,SNV,,,,,,
rs120074173,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,0,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs120074173,SNV,,,,,,
rs373921680,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,0.003,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs373921680,SNV,,,,,,
rs397515518,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,0.04,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs397515518,SNV,,,,,,
rs562853291,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,0.04,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs562853291,SNV,,,,,,
rs767201131,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,< 0.05,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs767201131,SNV,,,,,,
rs775274569,9529363,Alkaptonuria,"Algeria, Europe",North Africa,NS,TRUE,8.39E-09,HGD,,HGD,"homogentisate 1,2-dioxygenase",3,Q93099,"This gene encodes the enzyme homogentisate 1,2 dioxygenase. This enzyme is involved in the catabolism of the amino acids tyrosine and phenylalanine. Mutations in this gene are the cause of the autosomal recessive metabolism disorder alkaptonuria.[provided by RefSeq, May 2010].",22/11/2021,PubMed,"Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.",9529363,1998,DisGeNET,rs775274569,SNV,,,,,,
rs121908285,20825431,MPS IIIC,"Morocco, Argentina, Spain",North Africa,NS,TRUE,NS,HGSNAT,"Genetic variability study,Functional Analysis",HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8,Q68CP4,"This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.,20825431,2013,DisGeNET,rs121908285,SNV,,,,,,"All mutant alleles were identified and comprised nine distinct mutant alleles, seven of which were novel, including four missense mutations (p.A54V, p.L113P, p.G424V and p.L445P) and three splicing mutations due to two point mutations (c.633+1G>A and c.1378-1G>A) and an intronic deletion (c.821-31_821-13del). Furthermore, a new single nucleotide polymorphism (SNP) (c.564-98T>C) were found. The two most frequent changes were the previously described c.372-2A>G and c.234+1G>A mutations."
rs121908286,20825431,MPS IIIC,"Morocco, Argentina, Spain",North Africa,NS,TRUE,NS,HGSNAT,"Genetic variability study,Functional Analysis",HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8,Q68CP4,"This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.,20825431,2013,DisGeNET,rs121908286,SNV,,,,,,"All mutant alleles were identified and comprised nine distinct mutant alleles, seven of which were novel, including four missense mutations (p.A54V, p.L113P, p.G424V and p.L445P) and three splicing mutations due to two point mutations (c.633+1G>A and c.1378-1G>A) and an intronic deletion (c.821-31_821-13del). Furthermore, a new single nucleotide polymorphism (SNP) (c.564-98T>C) were found. The two most frequent changes were the previously described c.372-2A>G and c.234+1G>A mutations."
rs483352896,20825431,MPS IIIC,"Morocco, Argentina, Spain",North Africa,NS,TRUE,NS,HGSNAT,"Genetic variability study,Functional Analysis",HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8,Q68CP4,"This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.,20825431,2013,DisGeNET,rs483352896,SNV,,,,,,"All mutant alleles were identified and comprised nine distinct mutant alleles, seven of which were novel, including four missense mutations (p.A54V, p.L113P, p.G424V and p.L445P) and three splicing mutations due to two point mutations (c.633+1G>A and c.1378-1G>A) and an intronic deletion (c.821-31_821-13del). Furthermore, a new single nucleotide polymorphism (SNP) (c.564-98T>C) were found. The two most frequent changes were the previously described c.372-2A>G and c.234+1G>A mutations."
rs483352908,20825431,MPS IIIC,"Morocco, Argentina, Spain",North Africa,NS,TRUE,NS,HGSNAT,"Genetic variability study,Functional Analysis",HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8,Q68CP4,"This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.,20825431,2013,DisGeNET,rs483352908,SNV,,,,,,"All mutant alleles were identified and comprised nine distinct mutant alleles, seven of which were novel, including four missense mutations (p.A54V, p.L113P, p.G424V and p.L445P) and three splicing mutations due to two point mutations (c.633+1G>A and c.1378-1G>A) and an intronic deletion (c.821-31_821-13del). Furthermore, a new single nucleotide polymorphism (SNP) (c.564-98T>C) were found. The two most frequent changes were the previously described c.372-2A>G and c.234+1G>A mutations."
rs483352896,20825431,Mucopolysaccharidosis Iii,"Morocco, Argentina, Spain",North Africa,NS,TRUE,NS,HGSNAT,"Genetic variability study,Functional Analysis",HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8,Q68CP4,"This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.,20825431,2013,DisGeNET,rs483352896,SNV,,,,,,"All mutant alleles were identified and comprised nine distinct mutant alleles, seven of which were novel, including four missense mutations (p.A54V, p.L113P, p.G424V and p.L445P) and three splicing mutations due to two point mutations (c.633+1G>A and c.1378-1G>A) and an intronic deletion (c.821-31_821-13del). Furthermore, a new single nucleotide polymorphism (SNP) (c.564-98T>C) were found. The two most frequent changes were the previously described c.372-2A>G and c.234+1G>A mutations."
rs483352908,20825431,Retinitis Pigmentosa 73,"Morocco, Argentina, Spain",North Africa,NS,TRUE,NS,HGSNAT,"Genetic variability study,Functional Analysis",HGSNAT,heparan-alpha-glucosaminide N-acetyltransferase,8,Q68CP4,"This gene encodes a lysosomal acetyltransferase, which is one of several enzymes involved in the lysosomal degradation of heparin sulfate. Mutations in this gene are associated with Sanfilippo syndrome C, one type of the lysosomal storage disease mucopolysaccaridosis III, which results from impaired degradation of heparan sulfate. [provided by RefSeq, Jan 2009].",22/11/2021,PubMed,Molecular analysis of Sanfilippo syndrome type C in Spain: seven novel HGSNAT mutations and characterization of the mutant alleles.,20825431,2013,DisGeNET,rs483352908,SNV,,,,,,"All mutant alleles were identified and comprised nine distinct mutant alleles, seven of which were novel, including four missense mutations (p.A54V, p.L113P, p.G424V and p.L445P) and three splicing mutations due to two point mutations (c.633+1G>A and c.1378-1G>A) and an intronic deletion (c.821-31_821-13del). Furthermore, a new single nucleotide polymorphism (SNP) (c.564-98T>C) were found. The two most frequent changes were the previously described c.372-2A>G and c.234+1G>A mutations."
HLA-A01,23360626,HLA-A01 allele was associated with sustained virological response.,Egypt,North Africa,NS,FALSE,0.02,HLA-A,,HLA-A,"major histocompatibility complex, class I, A",6,P04439,"HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.",23/11/2021,PubMed,Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.,23360626,2013,PharmGKB,TBD,Star allele,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
HLA-A01,23360626,HLA-A01 allele was associated with sustained virological response.,Egypt,North Africa,NS,FALSE,0.02,HLA-A,,HLA-A,"major histocompatibility complex, class I, A",6,P04439,"HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.",22/11/2021,PubMed,Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.,23360626,2013,PharmGKB,TBD,Star allele,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
HLA-B38 ,23360626,HLA-B38 can predict non response to therapy.,Egypt,North Africa,NS,FALSE,0.009,HLA-B,,HLA-B,"major histocompatibility complex, class I, B",6,P01889,"HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008].",25/11/2021,PubMed,Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.,23360626,2013,PharmGKB,TBD,Star allele,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
HLA-B38 ,23360626,HLA-B38 can predict non response to therapy.,Egypt,North Africa,NS,FALSE,0.009,HLA-B,,HLA-B,"major histocompatibility complex, class I, B",6,P01889,"HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008].",24/11/2021,PubMed,Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.,23360626,2013,PharmGKB,TBD,Star allele,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs34213790,28062682,HIV Infections,"Malawi, Mozambique, Uganda","East Africa, South Africa",NS,TRUE,1.15E-06,HLA-B,,HLA-B,"major histocompatibility complex, class I, B",6,P01889,"HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.,28062682,2017,DisGeNET,rs34213790,SNV,,,,,,
rs5010528,28062682,Stevens-Johnson Syndrome,"Malawi, Mozambique, Uganda","East Africa, South Africa",NS,TRUE,0.006,HLA-C,,HLA-C,"major histocompatibility complex, class I, C",6,P10321,"HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.,28062682,2017,DisGeNET,rs5010528,SNV,,,,,,rs5010528 in the HLA-C locus)is association with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)SJS/TEN in the replication cohort.
rs5010528,28062682,Toxic Epidermal Necrolysis,"Malawi, Mozambique, Uganda","East Africa, South Africa",NS,TRUE,0.006,HLA-C,,HLA-C,"major histocompatibility complex, class I, C",6,P10321,"HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.,28062682,2017,DisGeNET,rs5010528,SNV,,,,,,rs5010528 in the HLA-C locus)is association with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)SJS/TEN in the replication cohort.
rs5010528,28062682,HIV Infections,"Malawi, Mozambique, Uganda","East Africa, South Africa",NS,TRUE,NS,HLA-C,,HLA-C,"major histocompatibility complex, class I, C",6,P10321,"HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.,28062682,2017,DisGeNET,rs5010528,SNV,,,,,,
rs189159450,9463797,Acute Intermittent Porphyria,South Africa,South Africa,NS,FALSE,NS,HMBS,,HMBS,hydroxymethylbilane synthase,11,P08397,"This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria.,9463797,2000,DisGeNET,rs189159450,SNV,,,,,,
rs189159450,9463797,Hydroxymethylbilane Synthase Deficiency,South Africa,South Africa,NS,FALSE,NS,HMBS,,HMBS,hydroxymethylbilane synthase,11,P08397,"This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of two novel mutations in the hydroxymethylbilane synthase gene in three patients from two unrelated families with acute intermittent porphyria.,9463797,2000,DisGeNET,rs189159450,SNV,,,,,,
rs118204094,11030413,Acute Intermittent Porphyria,"Algeria, Cameroon, Mali, Morocco, Guadeloupe, Martinique, West Indies",North Africa / West Africa / African American/Afro-Caribbean,NS,TRUE,NS,HMBS,Genetic variability study,HMBS,hydroxymethylbilane synthase,11,P08397,"This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms.,11030413,2001,DisGeNET,rs118204094,SNV,,,,,,"Seven apparently unrelated acute intermittent prophyria patients (4 Africans: 1 from south Algeria, 1 from Cameroon, 1 from Mali, 1 from south Morocco; 3 Afro-Caribbeans from the French West Indies: 2 from Guadeloupe, and 1 from Martinique) were studied. The R116W mutation was present in the Afro-Caribbeans patient from the French West Indies."
rs118204094,11030413,Chester-Type Porphyria,"Algeria, Cameroon, Mali, Morocco, Guadeloupe, Martinique, West Indies",North Africa / West Africa / African American/Afro-Caribbean,NS,TRUE,NS,HMBS,Genetic variability study,HMBS,hydroxymethylbilane synthase,11,P08397,"This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms.,11030413,2001,DisGeNET,rs118204094,SNV,,,,,,"Seven apparently unrelated acute intermittent prophyria patients (4 Africans: 1 from south Algeria, 1 from Cameroon, 1 from Mali, 1 from south Morocco; 3 Afro-Caribbeans from the French West Indies: 2 from Guadeloupe, and 1 from Martinique) were studied. The R116W mutation was present in the Afro-Caribbeans patient from the French West Indies."
rs118204094,11030413,Hydroxymethylbilane Synthase Deficiency,"Algeria, Cameroon, Mali, Morocco, Guadeloupe, Martinique, West Indies",North Africa / West Africa / African American/Afro-Caribbean,NS,TRUE,NS,HMBS,Genetic variability study,HMBS,hydroxymethylbilane synthase,11,P08397,"This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms.,11030413,2001,DisGeNET,rs118204094,SNV,,,,,,"Seven apparently unrelated acute intermittent prophyria patients (4 Africans: 1 from south Algeria, 1 from Cameroon, 1 from Mali, 1 from south Morocco; 3 Afro-Caribbeans from the French West Indies: 2 from Guadeloupe, and 1 from Martinique) were studied. The R116W mutation was present in the Afro-Caribbeans patient from the French West Indies."
rs118204094,11030413,"Porphyria, Acute Intermittent, Nonerythroid Variant","Algeria, Cameroon, Mali, Morocco, Guadeloupe, Martinique, West Indies",North Africa / West Africa / African American/Afro-Caribbean,NS,TRUE,NS,HMBS,Genetic variability study,HMBS,hydroxymethylbilane synthase,11,P08397,"This gene encodes a member of the hydroxymethylbilane synthase superfamily. The encoded protein is the third enzyme of the heme biosynthetic pathway and catalyzes the head to tail condensation of four porphobilinogen molecules into the linear hydroxymethylbilane. Mutations in this gene are associated with the autosomal dominant disease acute intermittent porphyria. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms.,11030413,2001,DisGeNET,rs118204094,SNV,,,,,,"Seven apparently unrelated acute intermittent prophyria patients (4 Africans: 1 from south Algeria, 1 from Cameroon, 1 from Mali, 1 from south Morocco; 3 Afro-Caribbeans from the French West Indies: 2 from Guadeloupe, and 1 from Martinique) were studied. The R116W mutation was present in the Afro-Caribbeans patient from the French West Indies."
rs879255520,25986072,"Macular Degeneration, Age-Related, 1",Tunisia,North Africa,Jewish,FALSE,NS,HMCN1,,HMCN1,hemicentin 1,1,Q96RW7,"This gene encodes a large extracellular member of the immunoglobulin superfamily. A similar protein in C. elegans forms long, fine tracks at specific extracellular sites that are involved in many processes such as stabilization of the germline syncytium, anchorage of mechanosensory neurons to the epidermis, and organization of hemidesmosomes in the epidermis. Mutations in this gene may be associated with age-related macular degeneration. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Rare genetic variants in Tunisian Jewish patients suffering from age-related macular degeneration.,25986072,2016,DisGeNET,rs879255520,SNV,,,,,,
rs3846663,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.05,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",27/11/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs6453131,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.004,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",28/11/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs3761738,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.72,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",29/11/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs3761739,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.13,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",30/11/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs10038095,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.02,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",01/12/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs17238484,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.18,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",02/12/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs3846662,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.25,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",03/12/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs4629571,18332269,HMGCR gene polymorphisms are associated with reduced plasma LDL-C and LDL-C response to simvastatin.,USA,African American/Afro-Caribbean,African American,TRUE,0.73,HMGCR,,HMGCR,3-hydroxy-3-methylglutaryl-CoA reductase,5,P04035,"HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. ",04/12/2021,PubMed,Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment,18332269,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs7979473,22939635,C-Reactive Protein Measurement,USA,African American/Afro-Caribbean,NS,TRUE,1.45E-10,HNF1A,,HNF1A,HNF1 homeobox A,12,P20823,"The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015].",22/11/2021,PubMed,Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.,22939635,2012,DisGeNET,rs7979473,SNV,,,,,,Minor allele A/Major allele G
rs2259816,22939635,C-Reactive Protein Measurement,USA,African American/Afro-Caribbean,NS,TRUE,3.00E-10,HNF1A,,HNF1A,HNF1 homeobox A,12,P20823,"The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015].",22/11/2021,PubMed,Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.,22939635,2012,DisGeNET,rs2259816,SNV,,,,,,Minor allele T/Major allele G
rs3212207,30100615,Allele C is associated with increased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.01,HNF4A,,HNF4A,hepatocyte nuclear factor 4 alpha,20,P41235,"The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733134,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Variants associated with high rosuvastatin Cmax (Cmaxâ€‰>â€‰20â€‰ng/ml)
rs104894517,14999562,Anhaptoglobinemia,Ghana,West Africa,NS,FALSE,NS,HP,Genetic variability study,HP,haptoglobin,16,P00738,"This gene encodes a preproprotein, which is processed to yield both alpha and beta chains, which subsequently combine as a tetramer to produce haptoglobin. Haptoglobin functions to bind free plasma hemoglobin, which allows degradative enzymes to gain access to the hemoglobin, while at the same time preventing loss of iron through the kidneys and protecting the kidneys from damage by hemoglobin. Mutations in this gene and/or its regulatory regions cause ahaptoglobinemia or hypohaptoglobinemia. This gene has also been linked to diabetic nephropathy, the incidence of coronary artery disease in type 1 diabetes, Crohn's disease, inflammatory disease behavior, primary sclerosing cholangitis, susceptibility to idiopathic Parkinson's disease, and a reduced incidence of Plasmodium falciparum malaria. The protein encoded also exhibits antimicrobial activity against bacteria. A similar duplicated gene is located next to this gene on chromosome 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014].",22/11/2021,PubMed,A novel I247T missense mutation in the haptoglobin 2 beta-chain decreases the expression of the protein and is associated with ahaptoglobinemia.,14999562,2004,DisGeNET,rs104894517,SNV,,,,,,Mutation in one ahaptoglobinemic individual out of nine ahaptoglobinemic and eight hypohaptoglobinemic subjects
rs104894517,14999562,Hypohaptoglobinemia (Disorder),Ghana,West Africa,NS,FALSE,NS,HP,Genetic variability study,HP,haptoglobin,16,P00738,"This gene encodes a preproprotein, which is processed to yield both alpha and beta chains, which subsequently combine as a tetramer to produce haptoglobin. Haptoglobin functions to bind free plasma hemoglobin, which allows degradative enzymes to gain access to the hemoglobin, while at the same time preventing loss of iron through the kidneys and protecting the kidneys from damage by hemoglobin. Mutations in this gene and/or its regulatory regions cause ahaptoglobinemia or hypohaptoglobinemia. This gene has also been linked to diabetic nephropathy, the incidence of coronary artery disease in type 1 diabetes, Crohn's disease, inflammatory disease behavior, primary sclerosing cholangitis, susceptibility to idiopathic Parkinson's disease, and a reduced incidence of Plasmodium falciparum malaria. The protein encoded also exhibits antimicrobial activity against bacteria. A similar duplicated gene is located next to this gene on chromosome 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014].",22/11/2021,PubMed,A novel I247T missense mutation in the haptoglobin 2 beta-chain decreases the expression of the protein and is associated with ahaptoglobinemia.,14999562,2004,DisGeNET,rs104894517,SNV,,,,,,Mutation in one ahaptoglobinemic individual out of nine ahaptoglobinemic and eight hypohaptoglobinemic subjects
rs104894517,14616769,Anhaptoglobinemia,Ghana,West Africa,NS,FALSE,NS,HP,,HP,haptoglobin,16,P00738,"This gene encodes a preproprotein, which is processed to yield both alpha and beta chains, which subsequently combine as a tetramer to produce haptoglobin. Haptoglobin functions to bind free plasma hemoglobin, which allows degradative enzymes to gain access to the hemoglobin, while at the same time preventing loss of iron through the kidneys and protecting the kidneys from damage by hemoglobin. Mutations in this gene and/or its regulatory regions cause ahaptoglobinemia or hypohaptoglobinemia. This gene has also been linked to diabetic nephropathy, the incidence of coronary artery disease in type 1 diabetes, Crohn's disease, inflammatory disease behavior, primary sclerosing cholangitis, susceptibility to idiopathic Parkinson's disease, and a reduced incidence of Plasmodium falciparum malaria. The protein encoded also exhibits antimicrobial activity against bacteria. A similar duplicated gene is located next to this gene on chromosome 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014].",22/11/2021,PubMed,"A-61C and C-101G Hp gene promoter polymorphisms are, respectively, associated with ahaptoglobinaemia and hypohaptoglobinaemia in Ghana.",14616769,2004,DisGeNET,rs104894517,SNV,,,,,,
rs5470,20552021,Sickle Cell Trait/ Trachoma,Gambia,West Africa,Mandinka,FALSE,NS,HP,,HP,haptoglobin,16,P00738,"This gene encodes a preproprotein, which is processed to yield both alpha and beta chains, which subsequently combine as a tetramer to produce haptoglobin. Haptoglobin functions to bind free plasma hemoglobin, which allows degradative enzymes to gain access to the hemoglobin, while at the same time preventing loss of iron through the kidneys and protecting the kidneys from damage by hemoglobin. Mutations in this gene and/or its regulatory regions cause ahaptoglobinemia or hypohaptoglobinemia. This gene has also been linked to diabetic nephropathy, the incidence of coronary artery disease in type 1 diabetes, Crohn's disease, inflammatory disease behavior, primary sclerosing cholangitis, susceptibility to idiopathic Parkinson's disease, and a reduced incidence of Plasmodium falciparum malaria. The protein encoded also exhibits antimicrobial activity against bacteria. A similar duplicated gene is located next to this gene on chromosome 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014].",22/11/2021,PubMed,Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.,20552021,2010,DisGeNET,rs5470,SNV,,,,,,"The variant allele of the -101C-G promoter SNP, was associated with a two-fold increased risk of active trachoma in boys, but with a non-significantly decreased risk in girls."
rs5471,20552021,Sickle Cell Trait/ Trachoma,Gambia,West Africa,Mandinka,FALSE,NS,HP,,HP,haptoglobin,16,P00738,"This gene encodes a preproprotein, which is processed to yield both alpha and beta chains, which subsequently combine as a tetramer to produce haptoglobin. Haptoglobin functions to bind free plasma hemoglobin, which allows degradative enzymes to gain access to the hemoglobin, while at the same time preventing loss of iron through the kidneys and protecting the kidneys from damage by hemoglobin. Mutations in this gene and/or its regulatory regions cause ahaptoglobinemia or hypohaptoglobinemia. This gene has also been linked to diabetic nephropathy, the incidence of coronary artery disease in type 1 diabetes, Crohn's disease, inflammatory disease behavior, primary sclerosing cholangitis, susceptibility to idiopathic Parkinson's disease, and a reduced incidence of Plasmodium falciparum malaria. The protein encoded also exhibits antimicrobial activity against bacteria. A similar duplicated gene is located next to this gene on chromosome 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2014].",22/11/2021,PubMed,Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.,20552021,2010,DisGeNET,rs5471,SNV,,,,,,"The variant allele of the -101C-G promoter SNP, was associated with a two-fold increased risk of active trachoma in boys, but with a non-significantly decreased risk in girls."
rs747724352,26545797,17-Hydroxysteroid Dehydrogenase Deficiency,Tunisia,North Africa,NS,FALSE,NS,HSD17B3,,HSD17B3,hydroxysteroid 17-beta dehydrogenase 3,9,P37058,"This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone.  It preferentially uses NADP as cofactor.  Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Biochemical analyses and molecular modeling explain the functional loss of 17Î²-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development.",26545797,2016,DisGeNET,rs747724352,SNV,,,,,,
rs747724352,26545797,"46, XY Disorders Of Sex Development",Tunisia,North Africa,NS,FALSE,NS,HSD17B3,,HSD17B3,hydroxysteroid 17-beta dehydrogenase 3,9,P37058,"This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone.  It preferentially uses NADP as cofactor.  Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Biochemical analyses and molecular modeling explain the functional loss of 17Î²-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development.",26545797,2016,DisGeNET,rs747724352,SNV,,,,,,
rs747724352,26545797,Polycystic Ovarian Disease Due To 17-Ketosteroid Reductase Deficiency,Tunisia,North Africa,NS,FALSE,NS,HSD17B3,,HSD17B3,hydroxysteroid 17-beta dehydrogenase 3,9,P37058,"This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone.  It preferentially uses NADP as cofactor.  Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Biochemical analyses and molecular modeling explain the functional loss of 17Î²-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY Disorders of Sex Development.",26545797,2016,DisGeNET,rs747724352,SNV,,,,,,
rs76665058,23158458,Study reveals associations between functional HTR2A variants and depression severity or citalopram response.,USA,African American/Afro-Caribbean,African American,TRUE,< 0.05,HTR2A,,HTR2A,5-hydroxytryptamine receptor 2A,14,P28223,"This gene encodes one of the receptors for serotonin, a neurotransmitter with many roles. Mutations in this gene are associated with susceptibility to schizophrenia and obsessive-compulsive disorder, and are also associated with response to the antidepressant citalopram in patients with major depressive disorder (MDD). MDD patients who also have a mutation in intron 2 of this gene show a significantly reduced response to citalopram as this antidepressant downregulates expression of this gene. Multiple transcript variants encoding different isoforms have been found for this gene.",22/11/2021,PubMed,Multiple regulatory variants modulate expression of 5-hydroxytryptamine 2A receptors in human cortex.,23158458,2013,PharmGKB,TBD,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",
rs5491,9861406,"Malaria, Cerebral, Susceptibility To (Finding)",Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,< 0.001,ICAM1,,ICAM1,intercellular adhesion molecule 1,19,P05362,"This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population.",9861406,1998,DisGeNET,rs5491,SNV,,,,,,
rs5491,23609612,"Malaria, Cerebral, Susceptibility To (Finding)",Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,< 0.001,ICAM1,,ICAM1,intercellular adhesion molecule 1,19,P05362,"This gene encodes a cell surface glycoprotein which is typically expressed on endothelial cells and cells of the immune system. It binds to integrins of type CD11a / CD18, or CD11b / CD18 and is also exploited by Rhinovirus as a receptor. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Patterns of nucleotide and haplotype diversity at ICAM-1 across global human populations with varying levels of malaria exposure.,23609612,2013,DisGeNET,rs5491,SNV,,,,,,
rs121965022,8477267,Pfaundler-Hurler Syndrome,Lybia,North Africa,NS,FALSE,NS,IDUA,,IDUA,alpha-L-iduronidase,4,P35475,"This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A deletion/insertion mutation in the IDUA gene in a Libyan Jewish patient with Hurler syndrome (mucopolysaccharidosis IH).,8477267,1993,DisGeNET,rs121965022,SNV,,,,,,"Pathogenic mutation detected in Lybian Jewish patient with Hurler syndrome
phenotype"
rs121965021,16435195,Pfaundler-Hurler Syndrome,Tunisia,North Africa,NS,FALSE,NS,IDUA,,IDUA,alpha-L-iduronidase,4,P35475,"This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mucopolysaccharidosis I: Alpha-L-Iduronidase mutations in three Tunisian families.,16435195,2006,DisGeNET,rs121965021,SNV,,,,,,"Pathogenic mutation detected in Tunisian patients with Hurlerâ€“Scheie
phenotype 
phenotype"
rs756572099,16435195,Pfaundler-Hurler Syndrome,Tunisia,North Africa,NS,FALSE,NS,IDUA,,IDUA,alpha-L-iduronidase,4,P35475,"This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mucopolysaccharidosis I: Alpha-L-Iduronidase mutations in three Tunisian families.,16435195,2006,DisGeNET,rs756572099,SNV,,,,,,"Pathogenic mutation detected in Tunisian patients with Hurler phenotype
phenotype"
rs121965021,10738517,Pfaundler-Hurler Syndrome,Morocco,North Africa,NS,FALSE,NS,IDUA,,IDUA,alpha-L-iduronidase,4,P35475,"This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mucopolysaccharidosis type I: characterization of a common mutation that causes Hurler syndrome in Moroccan subjects.,10738517,2000,DisGeNET,rs121965021,SNV,,,,,,Pathogenic mutation detected in Moroccan patients with MPS I
rs387907012,22991235,"Microcephaly, Epilepsy, And Diabetes Syndrome",Egypt,North Africa,NS,FALSE,NS,IER3IP1,,IER3IP1,immediate early response 3 interacting protein 1,18,Q9Y5U9,"This gene encodes a small protein that is localized to the endoplasmic reticulum (ER) and may play a role in the ER stress response by mediating cell differentiation and apoptosis. Transcription of this gene is regulated by tumor necrosis factor alpha and specificity protein 1 (Sp1). Mutations in this gene may play a role in microcephaly, epilepsy, and diabetes syndrome (MEDS), and a pseudogene of this gene is located on the long arm of chromosome 12. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,"A homozygous IER3IP1 mutation causes microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (MEDS).",22991235,2013,DisGeNET,rs387907012,SNV,,,,,,"Epilepsy, Microcephaly and permanent neonatal diabetes syndrome revealed homozygous missense mutations in the immediate early response three interacting protein 1 gene (IER3IP1), an ER stress response protein that mediates cell differentiation. Patients having this mutations had elevated apoptosis of the cerebral cortex and pancreatic beta cells, which was hypothesized to be the result of dysfunctional cellular differentiation under â€˜â€˜stressâ€™â€™ stimuli"
rs2229207,16757563,"Hepatitis B Virus, Susceptibility To",Gambia,West Africa,NS,FALSE,< 0.05,IFNAR2,,IFNAR2,interferon alpha and beta receptor subunit 2,21,P48551,"The protein encoded by this gene is a type I membrane protein that forms one of the two chains of a receptor for interferons alpha and beta. Binding and activation of the receptor stimulates Janus protein kinases, which in turn phosphorylate several proteins, including STAT1 and STAT2. The protein belongs to the type II cytokine receptor family. Mutations in this gene are associated with Immunodeficiency 45. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence.,16757563,2006,DisGeNET,rs2229207,SNV,,,,,,
rs752113778,22708048,Immunodeficiency 27A,Egypt,North Africa,NS,FALSE,NS,IFNGR1,,IFNGR1,interferon gamma receptor 1,6,P15260,"This gene (IFNGR1) encodes the ligand-binding chain (alpha) of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. A genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection. In addition, defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease, also known as familial disseminated atypical mycobacterial infection. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mendelian susceptibility to mycobacterial disease in egyptian children.,22708048,2012,DisGeNET,rs752113778,SNV,,,,,,
rs387907107,21378380,Cranioectodermal Dysplasia 3,Morocco,North Africa,NS,FALSE,NS,IFT43,,IFT43,intraflagellar transport 43,14,Q96FT9,"This gene encodes a subunit of the intraflagellar transport complex A (IFT-A). IFT-A is a multiprotein complex that plays an important role in cilia assembly and maintenance by mediating retrograde ciliary transport. Mutations in this gene are a cause of cranioectodermal dysplasia-3 (CED3), also known as Sensenbrenner syndrome. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,C14ORF179 encoding IFT43 is mutated in Sensenbrenner syndrome.,21378380,2011,DisGeNET,rs387907107,SNV,,,,,,
rs4402960,24898818,"Diabetes Mellitus, Non-Insulin-Dependent",Morocco,North Africa,NS,FALSE,0.009,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"Association analysis of IGF2BP2, KCNJ11, and CDKAL1 polymorphisms with type 2 diabetes mellitus in a Moroccan population: a case-control study and meta-analysis.",24898818,2015,DisGeNET,rs4402960,SNV,,,,,,"A caseâ€“control study of 250 unrelated Moroccon diabetic patients and 250 healthy controls, using TaqMan allelic discrimination assays to genotype the three SNPs and meta-analysis to investigate the  association between the polymorphisms and diabetes in Arab populations. The results showed a significant diabetes association only with the variant rs4402960 of the IGF2BP2 gene under additive 2 (GG vs. TT; p = 0.009) and recessive (TT vs. GG?GT; p = 0.003)
models."
rs4402960,24636221,Overweight,Tunisia,North Africa,NS,FALSE,< 0.0001,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs4402960,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs4402960,24636221,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,< 1E-4,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs4402960,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs4402960,24636221,Hypertensive Disease,Tunisia,North Africa,NS,FALSE,< 1E-4,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs4402960,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs4402960,24636221,Obesity,Tunisia,North Africa,NS,FALSE,< 1E-4,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.",24636221,2015,DisGeNET,rs4402960,SNV,,,,,,A case-control association study including 200 Type 2 diabetes Tunisian patients (World Health Organization criteria) and 208 controls (age â‰¥40; fasting plasma glucose <6.1 mmol/L; without first degree family history of diabetes) has been performed.
rs1470579,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,0.45,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs1470579,SNV,,,,,,"IGF2BP2 rs1470579, KCNJ11 rs5219, PPARÎ³ rs1801282 and SLC30A8 rs13266634 displayed various associations with T2DM in the study populations."
rs1470579,18461161,"Diabetes Mellitus, Non-Insulin-Dependent",Morocco,North Africa,NS,FALSE,0.22,IGF2BP2,,IGF2BP2,insulin like growth factor 2 mRNA binding protein 2,3,Q9Y6M1,"This gene encodes a protein that binds the 5' UTR of insulin-like growth factor 2 (IGF2) mRNA and regulates its translation. It plays an important role in metabolism and variation in this gene is associated with susceptibility to diabetes. Alternative splicing and promoter usage results in multiple transcript variants. Related pseudogenes are found on several chromosomes. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.,18461161,2008,DisGeNET,rs1470579,SNV,,,,,,
rs115338764,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,1.98E-07,IK,Association,IK,IK cytokine,5,Q13123,"The protein encoded by this gene was identified by its RED repeat, a stretch of repeated arginine, glutamic acid and aspartic acid residues. The protein localizes to discrete dots within the nucleus, excluding the nucleolus. Its function is unknown. This gene maps to chromosome 5; however, a pseudogene may exist on chromosome 2. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs115338764,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs1800872,23790189,Tuberculosis,Sudan,East Africa,NS,FALSE,< 0.01,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population.,23790189,2013,DisGeNET,,SNV,,,,,,NA
rs1800871,26076679,Cervical Cancer,Tunisia,North Africa,NS,TRUE,0.028,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.,26076679,2016,DisGeNET,rs1800871,SNV,,,,,,"Specific IL-10 variants (rs3024490, rs1800872, and rs1800871) and haplotype (GTCCA and TGATG) may contribute to the development of cervical cancer among Tunisian women."
rs1800872,26076679,Cervical Cancer,Tunisia,North Africa,NS,TRUE,0.037,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.,26076679,2016,DisGeNET,rs1800872,SNV,,,,,,
rs1800871,26076679,Cervix Carcinoma,Tunisia,North Africa,NS,FALSE,NS,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.,26076679,2016,DisGeNET,rs1800871,SNV,,,,,,
rs1800872,26076679,Cervix Carcinoma,Tunisia,North Africa,NS,FALSE,NS,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.,26076679,2016,DisGeNET,rs1800872,SNV,,,,,,
rs1800871,26076679,Malignant Tumor Of Cervix,Tunisia,North Africa,NS,FALSE,NS,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.,26076679,2016,DisGeNET,rs1800871,SNV,,,,,,
rs1800872,26076679,Malignant Tumor Of Cervix,Tunisia,North Africa,NS,FALSE,NS,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,IL-10 gene promoter and intron polymorphisms as genetic biomarkers of cervical cancer susceptibility among Tunisians.,26076679,2016,DisGeNET,rs1800872,SNV,,,,,,
rs1800872,23790189,Tuberculosis,Sudan,East Africa,NS,TRUE,< 0.0001,IL10,,IL10,interleukin 10,1,P22301,"The protein encoded by this gene is a cytokine produced primarily by monocytes and to a lesser extent by lymphocytes. This cytokine has pleiotropic effects in immunoregulation and inflammation. It down-regulates the expression of Th1 cytokines, MHC class II Ags, and costimulatory molecules on macrophages. It also enhances B cell survival, proliferation, and antibody production. This cytokine can block NF-kappa B activity, and is involved in the regulation of the JAK-STAT signaling pathway. Knockout studies in mice suggested the function of this cytokine as an essential immunoregulator in the intestinal tract. Mutations in this gene are associated with an increased susceptibility to HIV-1 infection and rheumatoid arthritis. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population.,23790189,2013,DisGeNET,rs1800872,SNV,,,,,,There were significant differences in allele distribution for CCL5 -28 C/G (rs 2280788) and IL-10 -592 A/C (rs1800872) in patients with tuberculosis compared with healthy controls.
rs786201006,24127073,Immunodeficiency 29,Tunisia,North Africa,NS,FALSE,NS,IL12B,,IL12B,interleukin 12B,5,P29460,"This gene encodes a subunit of interleukin 12, a cytokine that acts on T and natural killer cells, and has a broad array of biological activities. Interleukin 12 is a disulfide-linked heterodimer composed of the 40 kD cytokine receptor like subunit encoded by this gene, and a 35 kD subunit encoded by IL12A. This cytokine is expressed by activated macrophages that serve as an essential inducer of Th1 cells development. This cytokine has been found to be important for sustaining a sufficient number of memory/effector Th1 cells to mediate long-term protection to an intracellular pathogen. Overexpression of this gene was observed in the central nervous system of patients with multiple sclerosis (MS), suggesting a role of this cytokine in the pathogenesis of the disease. The promoter polymorphism of this gene has been reported to be associated with the severity of atopic and non-atopic asthma in children. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients.",24127073,2014,DisGeNET,rs786201006,SNV,,,,,,
rs20541,25406098,Psoriasis,Egypt,North Africa,NS,FALSE,0.0506,IL13,Association,IL13,interleukin 13,5,P35225,"This gene encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort.,25406098,2016,DisGeNET,rs20541,SNV,,,,,,132 recruited patients.
rs10519612,24689757,Acute Lymphocytic Leukemia,Egypt,North Africa,NS,FALSE,0.025,IL15,Association,IL15,interleukin 15,4,P40933,"The protein encoded by this gene is a cytokine that regulates T and natural killer cell activation and proliferation. This cytokine and interleukine 2 share many biological activities. They are found to bind common hematopoietin receptor subunits, and may compete for the same receptor, and thus negatively regulate each other's activity. The number of CD8+ memory cells is shown to be controlled by a balance between this cytokine and IL2. This cytokine induces the activation of JAK kinases, as well as the phosphorylation and activation of transcription activators STAT3, STAT5, and STAT6. Studies of the mouse counterpart suggested that this cytokine may increase the expression of apoptosis inhibitor BCL2L1/BCL-x(L), possibly through the transcription activation activity of STAT6, and thus prevent apoptosis. Alternatively spliced transcript variants of this gene have been reported. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,Influence of interleukin-15 polymorphism on the survival of adult patients with acute lymphoblastic leukemia in Egypt.,24689757,2015,DisGeNET,rs10519612,SNV,,,,,,The study included 164 adult patients with acute lymphoblastic leukemia and 158 healthy subjects as a control group. The rs10519612 CC genotype frequency was significantly higher in Acute Lymphocytic Leukemia cases than in controls.
rs2397084,26515887,Lupus Erythematosus,Egypt,North Africa,NS,FALSE,> 0.05,IL17F,,IL17F,interleukin 17F,6,Q96PD4,"The protein encoded by this gene is a cytokine that shares sequence similarity with IL17. This cytokine is expressed by activated T cells, and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM_CSF. This cytokine is also found to inhibit the angiogenesis of endothelial cells and induce endothelial cells to produce IL2, TGFB1/TGFB, and monocyte chemoattractant protein-1. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis.",26515887,2016,DisGeNET,rs2397084,SNV,,,,,,
rs763780,26515887,Lupus Erythematosus,Egypt,North Africa,NS,FALSE,> 0.05,IL17F,,IL17F,interleukin 17F,6,Q96PD4,"The protein encoded by this gene is a cytokine that shares sequence similarity with IL17. This cytokine is expressed by activated T cells, and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM_CSF. This cytokine is also found to inhibit the angiogenesis of endothelial cells and induce endothelial cells to produce IL2, TGFB1/TGFB, and monocyte chemoattractant protein-1. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Interleukin-17A rs2275913, Interleukin-17F rs763780 and rs2397084 gene polymorphisms as possible risk factors in Juvenile lupus and lupus related nephritis.",26515887,2016,DisGeNET,rs763780,SNV,,,,,,
rs708567,24312262,Malaria,Cameroon,West Africa,NS,FALSE,0.01,IL17RC,,IL17RC,interleukin 17 receptor C,3,Q8NAC3,"This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs708567,SNV,,,,,,The rs708567 GA individuals were associated with protection from uncomplicated malaria.
rs708567,24312262,Anemia,Cameroon,West Africa,NS,FALSE,NS,IL17RC,,IL17RC,interleukin 17 receptor C,3,Q8NAC3,"This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs708567,SNV,,,,,,
rs708567,24312262,Sickle Cell Trait,Cameroon,West Africa,NS,FALSE,NS,IL17RC,,IL17RC,interleukin 17 receptor C,3,Q8NAC3,"This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs708567,SNV,,,,,,
rs6780995,24312262,Hyperpyrexia,Cameroon,West Africa,NS,FALSE,0.002,IL17RD,,IL17RD,interleukin 17 receptor D,3,Q8NFM7,"This gene encodes a membrane protein belonging to the interleukin-17 receptor (IL-17R) protein family. The encoded protein is a component of the interleukin-17 receptor signaling complex, and the interaction between this protein and IL-17R does not require the interleukin. The gene product also affects fibroblast growth factor signaling, inhibiting or stimulating growth through MAPK/ERK signaling. Alternate splicing generates multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs6780995,SNV,,,,,,The rs6780995 variant strongly associated with increased risk of hyperpyrexia.
rs6780995,24312262,Anemia,Cameroon,West Africa,NS,FALSE,NS,IL17RD,,IL17RD,interleukin 17 receptor D,3,Q8NFM7,"This gene encodes a membrane protein belonging to the interleukin-17 receptor (IL-17R) protein family. The encoded protein is a component of the interleukin-17 receptor signaling complex, and the interaction between this protein and IL-17R does not require the interleukin. The gene product also affects fibroblast growth factor signaling, inhibiting or stimulating growth through MAPK/ERK signaling. Alternate splicing generates multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs6780995,SNV,,,,,,
rs6780995,24312262,Sickle Cell Trait,Cameroon,West Africa,NS,FALSE,NS,IL17RD,,IL17RD,interleukin 17 receptor D,3,Q8NFM7,"This gene encodes a membrane protein belonging to the interleukin-17 receptor (IL-17R) protein family. The encoded protein is a component of the interleukin-17 receptor signaling complex, and the interaction between this protein and IL-17R does not require the interleukin. The gene product also affects fibroblast growth factor signaling, inhibiting or stimulating growth through MAPK/ERK signaling. Alternate splicing generates multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Association of cytokine and Toll-like receptor gene polymorphisms with severe malaria in three regions of Cameroon.,24312262,2014,DisGeNET,rs6780995,SNV,,,,,,
rs11209026,25259511,Crohn Disease,Puerto Rico,African American/Afro-Caribbean,NS,FALSE,0.00038,IL23R,Association,IL23R,interleukin 23 receptor,1,Q5VWK5,"The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.,25259511,2015,DisGeNET,rs11209026,SNV,,,,,,No additional information on the cohort origin is available. It is assumed that the population of Puerto Rico is a mixed one with african ancestry contribution.
rs11209026,25666505,Inflammatory Bowel Diseases,Egypt,North Africa,NS,FALSE,0.003,IL23R,Association,IL23R,interleukin 23 receptor,1,Q5VWK5,"The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.,25666505,2015,DisGeNET,rs11209026,SNV,,,,,,"92 HVC Eyptian patients, 100 controls with no liver diseases. The associations between IL23R polymorphism and HCC patients is evident for recessive model of inheritance as there was significant difference between HCV without HCC patients with controls."
rs11209026,25666505,Inflammatory Bowel Diseases,Egypt,North Africa,NS,FALSE,< 0.001,IL23R,Association,IL23R,interleukin 23 receptor,1,Q5VWK5,"The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.,25666505,2015,DisGeNET,rs11209026,SNV,,,,,,"192 HVC Eyptian patients, 100 controls with no liver diseases. The associations between IL23R polymorphism and HCC  patients is evident for recessive model of inheritance as there was significant difference between HCV with HCC patients with controls."
rs7517847,28452232,Liver Carcinoma,Egypt,North Africa,NS,FALSE,NS,IL23R,,IL23R,interleukin 23 receptor,1,Q5VWK5,"The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma.,28452232,2017,DisGeNET,rs7517847,SNV,,,,,,The frequency of the IL-23 R (rs7517847) G and LEP (rs7799039) G alleles were significantly higher among HCC patients compared to controls (p = .004 and .02) and the polymorphisms were associated with an increased risk but not affecting the clinical presentation of HCC among Egyptian patients
rs7517847,28452232,Malignant Neoplasms,Egypt,North Africa,NS,FALSE,NS,IL23R,,IL23R,interleukin 23 receptor,1,Q5VWK5,"The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma.,28452232,2017,DisGeNET,rs7517847,SNV,,,,,,The frequency of the IL-23 R (rs7517847) G and LEP (rs7799039) G alleles were significantly higher among HCC patients compared to controls (p = .004 and .02) and the polymorphisms were associated with an increased risk but not affecting the clinical presentation of HCC among Egyptian patients
rs11209026,25406098,Psoriasis,Egypt,North Africa,NS,FALSE,0.2,IL23R,Association,IL23R,interleukin 23 receptor,1,Q5VWK5,"The protein encoded by this gene is a subunit of the receptor for IL23A/IL23. This protein pairs with the receptor molecule IL12RB1/IL12Rbeta1, and both are required for IL23A signaling. This protein associates constitutively with Janus kinase 2 (JAK2), and also binds to transcription activator STAT3 in a ligand-dependent manner. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort.,25406098,2016,DisGeNET,rs11209026,SNV,,,,,,132 recruited patients.
rs12979860,20176026,No association was found between rs12979860 genotype and treatment response.,USA,African American/Afro-Caribbean,African American,TRUE,> 0.05,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.,20176026,2010,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs8099917,24102823,"In chronic hepatitis C genotype 4 patients, favourable genotypes of both SNPs of IL28B are valuable for predicting sustained virological responses. ",Egypt,North Africa,NS,FALSE,0.027,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.,24102823,2014,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs8099917,24102823,"In chronic hepatitis C genotype 4 patients, favourable genotypes of both SNPs of IL28B are valuable for predicting sustained virological responses. ",Egypt,North Africa,NS,FALSE,0.027,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.,24102823,2014,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs12979860,25393304,"Prediction of sustained virologic response with high accuracy (71-96%) was possible in genotype 1, 2, 3 and 4 infected patients who received PEG-IFN/ribavirin combination therapy by selection of beneficial IL28B rs12979860 C/C and/or ss469415590 TT/TT genotypes.","Egypt, Germany",North Africa,NS,TRUE,< 0.001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.,25393304,2014,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs12979860,25958342,IL-28B rs12979860 SNP can be a good parameter for the prediction of treatment success in patients with chronic hepatitis C before initiation of antiviral therapy in Morocco.,Morocco,North Africa,NS,FALSE,< 0.001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.,25958342,2015,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs8099917,26003758,IL28B genotype is a significant pre-treatment predictor of response to PEG-IFN/RBV in HCV infected Egyptian patients,Egypt,North Africa,NS,FALSE,0.004,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients.,26003758,2015,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs12979860,26902034,The IL28B rs12979860 SNP is the strongest predictor of sustained virological response among Egyptian patients infected with HCV-4.,Egypt,North Africa,NS,FALSE,< 0.0001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Interleukin 28B Polymorphism Predicts Treatment Outcome Among Egyptian Patients Infected With HCV Genotype 4.,26902034,2015,PharmGKB,TBD,SNV,ribavirin,DB00811,Approved,Indicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates.,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide",
rs12979860,20176026,No association was found between rs12979860 genotype and treatment response.,USA,African American/Afro-Caribbean,African American,TRUE,> 0.05,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin.,20176026,2010,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs12979860,24102823,"In chronic hepatitis C genotype 4 patients, favourable genotypes of both SNPs of IL28B are valuable for predicting sustained virological responses. ",Egypt,North Africa,NS,FALSE,0.001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.,24102823,2014,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs12979860,24102823,"In chronic hepatitis C genotype 4 patients, favourable genotypes of both SNPs of IL28B are valuable for predicting sustained virological responses. ",Egypt,North Africa,NS,FALSE,0.001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4.,24102823,2014,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs12979860,25393304,"Prediction of sustained virologic response with high accuracy (71-96%) was possible in genotype 1, 2, 3 and 4 infected patients who received PEG-IFN/ribavirin combination therapy by selection of beneficial IL28B rs12979860 C/C and/or ss469415590 TT/TT genotypes.","Egypt, Germany",North Africa,NS,TRUE,< 0.001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.,25393304,2014,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs12979860,25958342,IL-28B rs12979860 SNP can be a good parameter for the prediction of treatment success in patients with chronic hepatitis C before initiation of antiviral therapy in Morocco.,Morocco,North Africa,NS,FALSE,< 0.001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.,25958342,2015,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs8099917,26003758,IL28B genotype is a significant pre-treatment predictor of response to PEG-IFN/RBV in HCV infected Egyptian patients,Egypt,North Africa,NS,FALSE,0.004,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Assessment of interleukin 28B genotype as a predictor of response to combined therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients.,26003758,2015,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs368234815,26186989,rs368234815 is the primary IL28B region polymorphism for impaired HCV clearance.,USA,African American/Afro-Caribbean,African American,TRUE,0.003,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.,26186989,2015,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs12979860,26902034,The IL28B rs12979860 SNP is the strongest predictor of sustained virological response among Egyptian patients infected with HCV-4.,Egypt,North Africa,NS,FALSE,< 0.0001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Interleukin 28B Polymorphism Predicts Treatment Outcome Among Egyptian Patients Infected With HCV Genotype 4.,26902034,2015,PharmGKB,TBD,SNV,peginterferon alfa-2a,DB00008,"Approved, Investigational",Peginterferon alfa-2a is indicated for the treatment of HCV in combination with other antiviral drugs in patients over 5 years of age with compensated liver disease. May be used as a monotherapy in patients with contraindications to or significant intolerance to other anti-viral therapies.,NA,
rs12979860,23358556,Liver Diseases,Morocco,North Africa,NS,FALSE,0.0532,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.,23358556,2013,DisGeNET,rs12979860,SNV,,,,,,"Patients with advanced liver disease carried the rs12979860-
 T/T genotype more frequently than patients with mild chronic hepatitis C"
rs12979860,23358556,"Hepatitis C, Chronic",Morocco,North Africa,NS,FALSE,0.00001,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.,23358556,2013,DisGeNET,rs12979860,SNV,,,,,,Individuals with clearance were 4.69 times more likely to have the C/C genotype for rs12979860 polymorphism
rs12979860,21951981,Liver Diseases,"Egypt, Sub-Saharan Africa","North Africa, Sub-Saharan Africa",NS,TRUE,0.0008,IL28B,,IL28B,interleukin 28B,19,Q8IZI9,"This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA).",22/11/2021,PubMed,IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C.,21951981,2012,DisGeNET,rs12979860,SNV,,,,,,Better chronic hepatitis C treatment response rate of the C allele of the IL28B gene SNP rs12979860 was shwn but no significant relationship was found between rs12979860 and the severity of the disease.
rs387906914,21848462,Acrodermatitis Continua Of Hallopeau,Tunisia,North Africa,NS,FALSE,NS,IL36RN,,IL36RN,interleukin 36 receptor antagonist,2,Q9UBH0,"The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine was shown to specifically inhibit the activation of NF-kappaB induced by interleukin 1 family, member 6 (IL1F6). This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. Two alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.,21848462,2011,DisGeNET,rs387906914,SNV,,,,,,"The rs387906914 or IL36RN known as interleukin-1F5, an antagonist of three cytokines belonging to the interleukin-1 family â€” interleukin-36Î±, interleukin-36Î², and interleukin-36Î³ (also known as interleukin-1F6, interleukin-1F8, and interleukin-1F9, respectively). These cytokines activate several proinflammatory signaling pathways, such as the nuclear factor-ÎºB and mitogen-activated protein kinase pathways. The interleukin-36Ra antagonist and the three agonists interleukin-36Î±, interleukin-36Î², and interleukin-36Î³, as well as interleukin-1RL2, are highly expressed in epithelial tissues such as the skin, trachea, and esophagus.20 Moreover, we have shown that the expression of interleukin-36Î³ agonist can be strongly induced in keratinocytes after treatment with immunostimulating agents such as interleukin-1Î² and poly(I:C). These data suggest that this pathway may play a role in the innate immune response to pathogens."
rs387906914,21848462,Generalized Pustular Psoriasis,Tunisia,North Africa,NS,FALSE,NS,IL36RN,,IL36RN,interleukin 36 receptor antagonist,2,Q9UBH0,"The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine was shown to specifically inhibit the activation of NF-kappaB induced by interleukin 1 family, member 6 (IL1F6). This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. Two alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.,21848462,2011,DisGeNET,rs387906914,SNV,,,,,,"Significant linkage to an interval of 1.2 megabases on chromosome
2q13-q14.1 and a homozygous missense mutation in IL36RN (rs387906914), encoding an interleukin-36â€“receptor antagonist (interleukin-36Ra), an antiinflammatory cytokine. This mutation predicts the substitution of a proline residue for leucine at amino acid position 27 (L27P). Homology-based structural modeling of human interleukin-36Ra
suggests that the proline at position 27 affects both the stability of interleukin-36Ra
and its interaction with its receptor, interleukin-1 receptorâ€“like 2 (interleukin-1 receptorâ€“related protein 2). Aberrant interleukin-36Ra structure and function lead to unregulated secretion of inflammatory cytokines and generalized pustular psoriasis.
inflammatory cytokines and generalized pustular psoriasis. "
rs1801275,21497535,Rheumatoid Arthritis,Egypt,North Africa,NS,TRUE,0.04,IL4R,,IL4R,interleukin 4 receptor,16,P24394,"This gene encodes the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE production. The encoded protein also can bind interleukin 4 to promote differentiation of Th2 cells. A soluble form of the encoded protein can be produced by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitus, asthma, or eczema. Polymorphisms in this gene are also associated with resistance to human immunodeficiency virus type-1 infection. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Association of interleukin-4 receptor gene polymorphisms with rheumatoid arthritis in Egyptian female patients.,21497535,2012,DisGeNET,rs1801275,SNV,,,,,,"The frequencies of IL-4R Q576R genotype were significantly decreased in patients with erosive RA compared to patients with nonerosive RA (31.6% versus 48.2%, OR: 2.7, 95% CI: 1-7.7, P: 0.04)."
rs689,25256132,Diabetes,Egypt,North Africa,NS,FALSE,< 0.05,INS,,INS,insulin,11,P01308,"This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.,25256132,2015,DisGeNET,rs689,SNV,,,,,,
rs689,25256132,Diabetes Mellitus,Egypt,North Africa,NS,FALSE,< 0.05,INS,,INS,insulin,11,P01308,"This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.,25256132,2015,DisGeNET,rs689,SNV,,,,,,
rs886037750,26691667,Rabson-Mendenhall Syndrome,Libya,North Africa,NS,FALSE,NS,INSR,,INSR,insulin receptor,19,P06213,"This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015].",22/11/2021,PubMed,A novel homozygous missense mutation in the insulin receptor gene results in an atypical presentation of Rabson-Mendenhall syndrome.,26691667,2016,DisGeNET,rs886037750,SNV,,,,,,Paper describes the results for single child.
rs2004640,18752149,Rheumatoid Arthritis,Tunisia,North Africa,NS,FALSE,0.01,IRF5,,IRF5,interferon regulatory factor 5,7,Q13568,"This gene encodes a member of the interferon regulatory factor (IRF) family, a group of transcription factors with diverse roles, including virus-mediated activation of interferon, and modulation of cell growth, differentiation, apoptosis, and immune system activity. Members of the IRF family are characterized by a conserved N-terminal DNA-binding domain containing tryptophan (W) repeats. Alternative promoter use and alternative splicing result in multiple transcript variants, and a 30-nt indel polymorphism (SNP rs60344245) can result in loss of a 10-aa segment. [provided by RefSeq, Dec 2016].",22/11/2021,PubMed,Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population.,18752149,2008,DisGeNET,rs2004640,SNV,,,,,,
rs1127354,28480960,Anemia,Egypt,North Africa,NS,FALSE,0.004,ITPA,Association,ITPA,inosine triphosphatase,20,Q9BY32,"This gene encodes an inosine triphosphate pyrophosphohydrolase. The encoded protein hydrolyzes inosine triphosphate and deoxyinosine triphosphate to the monophosphate nucleotide and diphosphate. This protein, which is a member of the HAM1 NTPase protein family, is found in the cytoplasm and acts as a homodimer. Defects in the encoded protein can result in inosine triphosphate pyrophosphorylase deficiency which causes an accumulation of ITP in red blood cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.,28480960,2018,DisGeNET,rs1127354,SNV,,,,,,97 Egyptian HCV infected patients; 71 males and 26 females treated with pegylated-interferon (PEG-INF) /RBV therapy. The homozygous wild type genotype (CC) was associated with a hemoglobin reduction at week 4.
rs1127354,28480960,"Hepatitis C, Chronic",Egypt,North Africa,NS,FALSE,0.492,ITPA,Association,ITPA,inosine triphosphatase,20,Q9BY32,"This gene encodes an inosine triphosphate pyrophosphohydrolase. The encoded protein hydrolyzes inosine triphosphate and deoxyinosine triphosphate to the monophosphate nucleotide and diphosphate. This protein, which is a member of the HAM1 NTPase protein family, is found in the cytoplasm and acts as a homodimer. Defects in the encoded protein can result in inosine triphosphate pyrophosphorylase deficiency which causes an accumulation of ITP in red blood cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C.,28480960,2018,DisGeNET,rs1127354,SNV,,,,,,97 Egyptian HCV infected patients; 71 males and 26 females treated with pegylated-interferon (PEG-INF) /RBV therapy. No association with sustained virological response was observed.
rs1127354,28543275,Anemia,Egypt,North Africa,NS,FALSE,0.019,ITPA,Association,ITPA,inosine triphosphatase,20,Q9BY32,"This gene encodes an inosine triphosphate pyrophosphohydrolase. The encoded protein hydrolyzes inosine triphosphate and deoxyinosine triphosphate to the monophosphate nucleotide and diphosphate. This protein, which is a member of the HAM1 NTPase protein family, is found in the cytoplasm and acts as a homodimer. Defects in the encoded protein can result in inosine triphosphate pyrophosphorylase deficiency which causes an accumulation of ITP in red blood cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012].",22/11/2021,PubMed,The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients.,28543275,2018,DisGeNET,rs1127354,SNV,,,,,,123 treatment naive adult Egyptian patients with chronic hepatitis C were recruited.  The ITPA rs1127354 polymorphism was significantly related to delta Hb levels at week 8 of treatment. The median value of Hb reduction in ITPA rs1127354 CA/AA was -1.1 g/dL (IQR: -2.15 to 0.2 g/dL) compared with the CC group where the reduction was -2.1 g/dL (IQR: -3.25 to -1.1 g/dL).
rs142761835,22350545,Isovaleryl-Coa Dehydrogenase Deficiency,South Africa,South Africa,NS,FALSE,NS,IVD,,IVD,isovaleryl-CoA dehydrogenase,15,P26440,"Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial matrix enzyme that catalyzes the third step in leucine catabolism. The genetic deficiency of IVD results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Clinical variability of isovaleric acidemia in a genetically homogeneous population.,22350545,2013,DisGeNET,rs142761835,SNV,,,,,,This article describes this rs as a mutation
rs77375493,27468853,Idiopathic Pulmonary Arterial Hypertension,Egypt,North Africa,NS,FALSE,> 0.05,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.,27468853,2017,DisGeNET,rs77375493,SNV,,,,,,
rs77375493,27468853,Polycythemia Vera,Egypt,North Africa,NS,FALSE,> 0.05,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.,27468853,2017,DisGeNET,rs77375493,SNV,,,,,,
rs77375493,27468853,Primary Myelofibrosis,Egypt,North Africa,NS,FALSE,> 0.05,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.,27468853,2017,DisGeNET,rs77375493,SNV,,,,,,
rs77375493,27468853,"Thrombocythemia, Essential",Egypt,North Africa,NS,FALSE,> 0.05,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.,27468853,2017,DisGeNET,rs77375493,SNV,,,,,,
rs77375493,19939582,Polycythemia Vera,Morocco,North Africa,NS,FALSE,NS,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,"JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.",19939582,2011,DisGeNET,rs77375493,SNV,,,,,,
rs77375493,26617890,Polycythemia Vera,Egypt,North Africa,NS,FALSE,NS,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.,26617890,2016,DisGeNET,rs77375493,SNV,,,,,,
rs77375493,26617890,Primary Myelofibrosis,Egypt,North Africa,NS,FALSE,NS,JAK2,,JAK2,Janus kinase 2,9,O60674,"This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients.,26617890,2016,DisGeNET,rs77375493,SNV,,,,,,
rs5219,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,8.00E-04,KCNJ11,,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11,Q14654,"Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs5219,SNV,,,,,,"IGF2BP2 rs1470579, KCNJ11 rs5219, PPARÎ³ rs1801282 and SLC30A8 rs13266634 displayed various associations with T2DM in the study populations."
rs5219,19368707,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.006,KCNJ11,,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11,Q14654,"Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.,19368707,2009,DisGeNET,rs5219,SNV,,,,,,
rs5219,24332549,"Diabetes Mellitus, Non-Insulin-Dependent",Mauritania,West Africa,NS,FALSE,0.026,KCNJ11,,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11,Q14654,"Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population.,24332549,2015,DisGeNET,rs5219,SNV,,,,,,
rs5219,24332549,"Diabetes Mellitus, Non-Insulin-Dependent",Mauritania,West Africa,NS,TRUE,0.793,KCNJ11,,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11,Q14654,"Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,E23K variant in KCNJ11 gene is associated with susceptibility to type 2 diabetes in the Mauritanian population.,24332549,2015,DisGeNET,rs5219,SNV,,,,,,
rs5219,25165692,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,TRUE,0.007,KCNJ11,,KCNJ11,potassium inwardly rectifying channel subfamily J member 11,11,Q14654,"Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins and is found associated with the sulfonylurea receptor SUR. Mutations in this gene are a cause of familial persistent hyperinsulinemic hypoglycemia of infancy (PHHI), an autosomal recessive disorder characterized by unregulated insulin secretion. Defects in this gene may also contribute to autosomal dominant non-insulin-dependent diabetes mellitus type II (NIDDM), transient neonatal diabetes mellitus type 3 (TNDM3), and permanent neonatal diabetes mellitus (PNDM). Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Evidence for association of the E23K variant of KCNJ11 gene with type 2 diabetes in Tunisian population: population-based study and meta-analysis.,25165692,2015,DisGeNET,rs5219,SNV,,,,,,
rs2237892,23107108,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,FALSE,0.014,KCNQ1,,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11,P51787,"This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Lack of association between genetic polymorphisms within KCNQ1 locus and type 2 diabetes in Tunisian Arabs.,23107108,2013,DisGeNET,rs2237892,SNV,,,,,,
rs2237896,23107108,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,FALSE,NS,KCNQ1,,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11,P51787,"This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Lack of association between genetic polymorphisms within KCNQ1 locus and type 2 diabetes in Tunisian Arabs.,23107108,2013,DisGeNET,rs2237896,SNV,,,,,,Not significant.
rs12720459,16246960,Romano-Ward Syndrome,South Africa,South Africa,NS,FALSE,< 0.001,KCNQ1,,KCNQ1,potassium voltage-gated channel subfamily Q member 1,11,P51787,"This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population.,16246960,2006,DisGeNET,rs12720459,SNV,,,,,,rs12720459 was associated the unusual clinical severity Congenital Long-QT Syndrome
rs267607199,17455289,"Epilepsy, Progressive Myoclonic 3",Morocco,North Africa,NS,FALSE,NS,KCTD7,,KCTD7,potassium channel tetramerization domain containing 7,7,Q96MP8,"This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011].",22/11/2021,PubMed,Mutation of a potassium channel-related gene in progressive myoclonic epilepsy.,17455289,2007,DisGeNET,rs267607199,SNV,,,,,,Observed 1 large consanguineous Moroccon family.
rs200652879,17455289,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,NS,KCTD7,,KCTD7,potassium channel tetramerization domain containing 7,7,Q96MP8,"This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011].",22/11/2021,PubMed,Mutation of a potassium channel-related gene in progressive myoclonic epilepsy.,17455289,2007,DisGeNET,rs200652879,SNV,,,,,,Observed 1 large consanguineous Moroccon family.
rs387907259,16434418,"Spastic Paraplegia 30, Autosomal Recessive (Disorder)","Algeria, Tunisia, Czech Republic, France ",North Africa,NS,TRUE,NS,KIF1A,,KIF1A,kinesin family member 1A,2,Q12756,"The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3.,16434418,2006,DisGeNET,rs387907259,SNV,,,,,,
rs587777197,24319291,"Ataxia, Spastic, 2, Autosomal Recessive (Disorder)",Morocco,North Africa,NS,TRUE,NS,KIF1C,,KIF1C,kinesin family member 1C,17,O43896,"The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014].",22/11/2021,PubMed,KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction.,24319291,2014,DisGeNET,rs587777197,SNV,,,,,,
rs587777198,24319291,"Ataxia, Spastic, 2, Autosomal Recessive (Disorder)",Morocco,North Africa,NS,TRUE,NS,KIF1C,,KIF1C,kinesin family member 1C,17,O43896,"The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014].",22/11/2021,PubMed,KIF1C mutations in two families with hereditary spastic paraparesis and cerebellar dysfunction.,24319291,2014,DisGeNET,rs587777198,SNV,,,,,,
rs781752990,9066878,"Genetic Diseases, Inborn",Algeria,North Africa,NS,FALSE,NS,KIF7,,KIF7,kinesin family member 7,15,Q2M1P5,"This gene encodes a cilia-associated protein belonging to the kinesin family. This protein plays a role in the sonic hedgehog (SHH) signaling pathway through the regulation of GLI transcription factors. It functions as a negative regulator of the SHH pathway by preventing inappropriate activation of GLI2 in the absence of ligand, and as a positive regulator by preventing the processing of GLI3 into its repressor form. Mutations in this gene have been associated with various ciliopathies. [provided by RefSeq, Oct 2011].",22/11/2021,PubMed,Acrocallosal syndrome in an Algerian boy born to consanguineous parents: review of the literature and further delineation of the syndrome.,9066878,2000,DisGeNET,rs781752990,SNV,,,,,,
rs121434514,15883926,Shprintzen-Goldberg Syndrome,Morocco,North Africa,NS,FALSE,NS,KIFBP,Linkage,KIFBP,kinesin family binding protein,10,Q96EK5,"This gene encodes a kinesin family member 1 binding protein that is characterized by two tetratrico peptide repeats. The encoded protein localizes to the mitochondria and may be involved in regulating transport of the mitochondria. Mutations in this gene are associated with Goldberg-Shprintzen megacolon syndrome. [provided by RefSeq, Mar 2010].",22/11/2021,PubMed,Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems.,15883926,2005,DisGeNET,rs121434514,SNV,,,,,,The R90X was found at homozygous state in a consanguineous Moroccon family.
rs121913684,9450866,Piebaldism,South Africa,South Africa,Xhosa,FALSE,NS,KIT,,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4,P10721,"This gene encodes a receptor tyrosine kinase. This gene was initially identified as a homolog of the feline sarcoma viral oncogene v-kit and is often referred to as proto-oncogene c-Kit. The canonical form of this glycosylated transmembrane protein has an N-terminal extracellular region with five immunoglobulin-like domains, a transmembrane region, and an intracellular tyrosine kinase domain at the C-terminus. Upon activation by its cytokine ligand, stem cell factor (SCF), this protein phosphorylates multiple intracellular proteins that play a role in in the proliferation, differentiation, migration and apoptosis of many cell types and thereby plays an important role in hematopoiesis, stem cell maintenance, gametogenesis, melanogenesis, and in mast cell development, migration and function. This protein can be a membrane-bound or soluble protein. Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Piebaldism with deafness: molecular evidence for an expanded syndrome.,9450866,2000,DisGeNET,rs121913684,SNV,,,,,,The occurrence of sensorineural deafness in the patient extends considerably the phenotypic range of piebaldism due to KITgene mutation in humans and tightens the clinical similarity between piebaldism and the various forms of Waardenburg syndrome.
rs121913684,9450866,Piebaldism With Sensorineural Deafness,South Africa,South Africa,Xhosa,FALSE,NS,KIT,,KIT,"KIT proto-oncogene, receptor tyrosine kinase",4,P10721,"This gene encodes a receptor tyrosine kinase. This gene was initially identified as a homolog of the feline sarcoma viral oncogene v-kit and is often referred to as proto-oncogene c-Kit. The canonical form of this glycosylated transmembrane protein has an N-terminal extracellular region with five immunoglobulin-like domains, a transmembrane region, and an intracellular tyrosine kinase domain at the C-terminus. Upon activation by its cytokine ligand, stem cell factor (SCF), this protein phosphorylates multiple intracellular proteins that play a role in in the proliferation, differentiation, migration and apoptosis of many cell types and thereby plays an important role in hematopoiesis, stem cell maintenance, gametogenesis, melanogenesis, and in mast cell development, migration and function. This protein can be a membrane-bound or soluble protein. Mutations in this gene are associated with gastrointestinal stromal tumors, mast cell disease, acute myelogenous leukemia, and piebaldism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2020].",22/11/2021,PubMed,Piebaldism with deafness: molecular evidence for an expanded syndrome.,9450866,2000,DisGeNET,rs121913684,SNV,,,,,,The occurrence of sensorineural deafness in the patient extends considerably the phenotypic range of piebaldism due to KITgene mutation in humans and tightens the clinical similarity between piebaldism and the various forms of Waardenburg syndrome.
rs2967790,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,5.85E-07,KLHL3,Association,KLHL3,kelch like family member 3,5,Q9UH77,"This gene is ubiquitously expressed and encodes a full-length protein which has an N-terminal BTB domain followed by a BACK domain and six kelch-like repeats in the C-terminus. These kelch-like repeats promote substrate ubiquitination of bound proteins via interaction of the BTB domain with the CUL3 (cullin 3) component of a cullin-RING E3 ubiquitin ligase (CRL) complex. Muatations in this gene cause pseudohypoaldosteronism type IID (PHA2D); a rare Mendelian syndrome featuring hypertension, hyperkalaemia and metabolic acidosis. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs2967790,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the additive model."
rs758188096,27528495,Nemaline Myopathy 8,Morocco,North Africa,NS,FALSE,NS,KLHL40,,KLHL40,kelch like family member 40,3,Q2TBA0,"This gene encodes a protein containing a BACK domain, a BTB/POZ domain, and 5 Kelch repeats, however, its exact function is not known. The gene and the multi-domain protein structure are conserved across different taxa, including primates, rodents, chicken and zebrafish. [provided by RefSeq, Dec 2012].",22/11/2021,PubMed,Mild clinical presentation in KLHL40-related nemaline myopathy (NEM 8).,27528495,2018,DisGeNET,rs758188096,SNV,,,,,,
rs763915472,26626498,"Microcephaly 4, Primary, Autosomal Recessive","Egypt, Japan",North Africa,NS,FALSE,NS,KNL1,,KNL1,kinetochore scaffold 1,15,Q8NG31,"The protein encoded by this gene is a component of the multiprotein assembly that is required for creation of kinetochore-microtubule attachments and chromosome segregation. The encoded protein functions as a scaffold for proteins that influence the spindle assembly checkpoint during the eukaryotic cell cycle and it interacts with at least five different kinetochore proteins and two checkpoint kinases. In adults, this gene is predominantly expressed in normal testes, various cancer cell lines and primary tumors from other tissues and is ubiquitously expressed in fetal tissues. This gene was originally identified as a fusion partner with the mixed-lineage leukemia (MLL) gene in t(11;15)(q23;q14). Mutations in this gene cause autosomal recessive primary microcephaly-4 (MCPH4). Alternative splicing results in multiple transcript variants encoding different isoforms. Additional splice variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jan 2013].",22/11/2021,PubMed,Refining the phenotype associated with CASC5 mutation.,26626498,2016,DisGeNET,rs763915472,SNV,,,,,,
rs763915472,22983954,"Microcephaly 4, Primary, Autosomal Recessive",Morocco,North Africa,NS,FALSE,> 0.05,KNL1,,KNL1,kinetochore scaffold 1,15,Q8NG31,"The protein encoded by this gene is a component of the multiprotein assembly that is required for creation of kinetochore-microtubule attachments and chromosome segregation. The encoded protein functions as a scaffold for proteins that influence the spindle assembly checkpoint during the eukaryotic cell cycle and it interacts with at least five different kinetochore proteins and two checkpoint kinases. In adults, this gene is predominantly expressed in normal testes, various cancer cell lines and primary tumors from other tissues and is ubiquitously expressed in fetal tissues. This gene was originally identified as a fusion partner with the mixed-lineage leukemia (MLL) gene in t(11;15)(q23;q14). Mutations in this gene cause autosomal recessive primary microcephaly-4 (MCPH4). Alternative splicing results in multiple transcript variants encoding different isoforms. Additional splice variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jan 2013].",22/11/2021,PubMed,Kinetochore KMN network gene CASC5 mutated in primary microcephaly.,22983954,2012,DisGeNET,rs763915472,SNV,,,,,,
rs11554495,17039343,Malignant Neoplasm Of Pancreas,"Cameroon, Ethiopia, Europe",East Africa / West Africa,NS,TRUE,0.0006,KRT8,,KRT8,keratin 8,12,P05787,This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene.,22/11/2021,PubMed,Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.,17039343,2006,DisGeNET,rs11554495,SNV,,,,,,
rs11554495,17039343,Pancreatic Carcinoma,"Cameroon, Ethiopia, Europe",East Africa / West Africa,NS,TRUE,0.0006,KRT8,,KRT8,keratin 8,12,P05787,This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene.,22/11/2021,PubMed,Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.,17039343,2006,DisGeNET,rs11554495,SNV,,,,,,
rs11554495,17039343,Pancreatitis,"Cameroon, Ethiopia, Europe",East Africa / West Africa,NS,TRUE,0.0006,KRT8,,KRT8,keratin 8,12,P05787,This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene.,22/11/2021,PubMed,Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.,17039343,2006,DisGeNET,rs11554495,SNV,,,,,,
rs57749775,17039343,Pancreatitis,"Cameroon, Ethiopia, Europe",East Africa / West Africa,NS,TRUE,0.04,KRT8,,KRT8,keratin 8,12,P05787,This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene.,22/11/2021,PubMed,Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.,17039343,2006,DisGeNET,rs57749775,SNV,,,,,,
rs57749775,17039343,"Pancreatitis, Chronic","Cameroon, Ethiopia, Europe",East Africa / West Africa,NS,TRUE,0.04,KRT8,,KRT8,keratin 8,12,P05787,This gene is a member of the type II keratin family clustered on the long arm of chromosome 12. Type I and type II keratins heteropolymerize to form intermediate-sized filaments in the cytoplasm of epithelial cells. The product of this gene typically dimerizes with keratin 18 to form an intermediate filament in simple single-layered epithelial cells. This protein plays a role in maintaining cellular structural integrity and also functions in signal transduction and cellular differentiation. Mutations in this gene cause cryptogenic cirrhosis. Alternatively spliced transcript variants have been found for this gene.,22/11/2021,PubMed,Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer.,17039343,2006,DisGeNET,rs57749775,SNV,,,,,,
rs14158,20413733,LDLR haplotype 5 (LDLR L5) was associated with smaller simvastatin-induced reductions in low-density lipoprotein cholesterol.,USA,African American/Afro-Caribbean,African American,TRUE,0.0002,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.,20413733,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs5742911,20413733,LDLR haplotype 5 (LDLR L5) was associated with smaller simvastatin-induced reductions in low-density lipoprotein cholesterol.,USA,African American/Afro-Caribbean,African American,TRUE,0.0002,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",23/11/2021,PubMed,Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.,20413733,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs17249057,20413733,LDLR haplotype 5 (LDLR L5) was associated with smaller simvastatin-induced reductions in low-density lipoprotein cholesterol.,USA,African American/Afro-Caribbean,African American,TRUE,0.0002,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",24/11/2021,PubMed,Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.,20413733,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs2738467,20413733,LDLR haplotype 5 (LDLR L5) was associated with smaller simvastatin-induced reductions in low-density lipoprotein cholesterol.,USA,African American/Afro-Caribbean,African American,TRUE,0.0002,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",25/11/2021,PubMed,Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.,20413733,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs7254521,20413733,LDLR haplotype 5 (LDLR L5) was associated with smaller simvastatin-induced reductions in low-density lipoprotein cholesterol.,USA,African American/Afro-Caribbean,African American,TRUE,0.0002,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",26/11/2021,PubMed,Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.,20413733,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs1433099,20413733,LDLR haplotype 5 (LDLR L5) was associated with smaller simvastatin-induced reductions in low-density lipoprotein cholesterol.,USA,African American/Afro-Caribbean,African American,TRUE,0.0002,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",27/11/2021,PubMed,Combined influence of LDLR and HMGCR sequence variation on lipid-lowering response to simvastatin.,20413733,2010,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs121908028,2352257,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,Genetic variability study,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,An exon 4 mutation identified in the majority of South African familial hypercholesterolaemics.,2352257,1990,DisGeNET,rs121908028,SNV,,,,,,Detection of a point mutation in DNA from two Afrikaner FH homozygotes. A cytosine to guanine base substitution at nucleotide position 681 of the LDL receptor cDNA results in an amino acid change from aspartic acid to glutamic acid at residue 206 in the cysteine rich ligand binding domain of the LDL receptor.
rs875989907,12414836,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemia.,12414836,2002,DisGeNET,rs875989907,SNV,,,,,,
rs879254526,12414836,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemia.,12414836,2002,DisGeNET,rs879254526,SNV,,,,,,
rs121908024,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs121908024,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs121908028,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs121908028,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs121908029,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs121908029,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs121908030,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs121908030,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs28941776,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs28941776,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs28942081,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs28942081,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs387906301,3263645,"Hypercholesterolemia, Familial",South Africa,South Africa,Xhosa,FALSE,NS,LDLR,Functional analysis,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Deletion in the first cysteine-rich repeat of low density lipoprotein receptor impairs its transport but not lipoprotein binding in fibroblasts from a subject with familial hypercholesterolemia.,3263645,1988,DisGeNET,rs387906301,SNV,,,,,,"A mutation in LDLR gene represented as deletion of six base pairs that removes two amino acids, aspartic acid and glycine, from the first cysteine-rich ligand binding repeat."
rs879255174,22417841,"Hypercholesterolemia, Familial",Algeria,North Africa,NS,FALSE,< 0.05,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.,22417841,2012,DisGeNET,rs879255174,SNV,,,,,,
rs139361635,9727745,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Familial hypercholesterolemia: potential diagnostic value of mutation screening in a pediatric population of South Africa.,9727745,1998,DisGeNET,rs139361635,SNV,,,,,,SNP not found in the specified article
rs139361635,9727745,Hyperlipoproteinemia Type Iia,South Africa,South Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Familial hypercholesterolemia: potential diagnostic value of mutation screening in a pediatric population of South Africa.,9727745,1998,DisGeNET,rs139361635,SNV,,,,,,SNP not found in the specified article
rs879254919,11257256,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,"Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families.",11257256,2001,DisGeNET,rs879254919,SNV,,,,,,Region of Souassi in Tunisia.
rs746091400,10422804,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry.,10422804,1999,DisGeNET,rs746091400,SNV,,,,,,
rs879254496,10422804,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry.,10422804,1999,DisGeNET,rs879254496,SNV,,,,,,
rs879254630,10422804,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry.,10422804,1999,DisGeNET,rs879254630,SNV,,,,,,
rs879254809,10422804,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry.,10422804,1999,DisGeNET,rs879254809,SNV,,,,,,
rs28942084,1464748,"Hypercholesterolemia, Familial",South Africa,South Africa,Indian,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian origin.,1464748,1992,DisGeNET,rs28942084,SNV,,,,,,Relatively high incidence of FH among Indians in South Africa.
rs28942084,1464748,Hyperlipoproteinemia Type Iia,South Africa,South Africa,Indian,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Identification and properties of the proline664-leucine mutant LDL receptor in South Africans of Indian origin.,1464748,1992,DisGeNET,rs28942084,SNV,,,,,,
rs121908033,1757095,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,Genetic variability study,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areas.,1757095,1991,DisGeNET,rs121908033,SNV,,,,,,"South African Afrikaners were screened for the presence of three point mutations in the low density lipoprotein receptor gene; The prevalence and distribution of the mutations were compared in 27 unrelated homozygous and 79 unrelated heterozygous FH Afrikaner patients from two regions in South Africa, the Transvaal and Cape Provinces. The relative distribution of the three mutations was similar in the two regions, with the FH1 mutation being the most prevalent (66%), followed by the FH2 mutation (27%) and the FH3 mutation (7%)."
rs730880131,20144596,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.,20144596,2010,DisGeNET,rs730880131,SNV,,,,,,
rs730882096,20144596,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.,20144596,2010,DisGeNET,rs730882096,SNV,,,,,,
rs777640882,20144596,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.,20144596,2010,DisGeNET,rs777640882,SNV,,,,,,
rs879255213,20144596,"Hypercholesterolemia, Familial",Tunisia,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.,20144596,2010,DisGeNET,rs879255213,SNV,,,,,,
rs754676104,16806138,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco.,16806138,2006,DisGeNET,rs754676104,SNV,,,,,,
rs755667663,16806138,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco.,16806138,2006,DisGeNET,rs755667663,SNV,,,,,,
rs879254467,16806138,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco.,16806138,2006,DisGeNET,rs879254467,SNV,,,,,,
rs879254554,16806138,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco.,16806138,2006,DisGeNET,rs879254554,SNV,,,,,,
rs879255003,16806138,"Hypercholesterolemia, Familial",Morocco,North Africa,NS,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutational heterogeneity in low-density lipoprotein receptor gene related to familial hypercholesterolemia in Morocco.,16806138,2006,DisGeNET,rs879255003,SNV,,,,,,
rs387906301,10882754,"Hypercholesterolemia, Familial",South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs387906301,SNV,,,,,,SNP not found in the specified article
rs879254554,10882754,"Hypercholesterolemia, Familial",South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs879254554,SNV,,,,,,SNP not found in the specified article
rs137943601,10882754,Hyperlipoproteinemia Type Iia,South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs137943601,SNV,,,,,,SNP not found in the specified article
rs201573863,10882754,Hyperlipoproteinemia Type Iia,South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs201573863,SNV,,,,,,SNP not found in the specified article
rs5928,10882754,Hyperlipoproteinemia Type Iia,South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs5928,SNV,,,,,,SNP not found in the specified article
rs137943601,10882754,Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2,South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs137943601,SNV,,,,,,SNP not found in the specified article
rs201573863,10882754,Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2,South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs201573863,SNV,,,,,,SNP not found in the specified article
rs5928,10882754,Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2,South Africa,South Africa,"Xhosa,Swazi,Zulu,Sotho,Pedi,Tswana",FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia.,10882754,2000,DisGeNET,rs5928,SNV,,,,,,SNP not found in the specified article
rs371482223,7903269,Hyperlipoproteinemia Type Iia,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.,7903269,1993,DisGeNET,rs371482223,SNV,,,,,,
rs28942078,7903269,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.,7903269,1993,DisGeNET,rs28942078,SNV,,,,,,
rs371482223,7903269,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population.,7903269,1993,DisGeNET,rs371482223,SNV,,,,,,
rs121908028,1952806,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,Genetic variability study,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners.,1952806,1991,DisGeNET,rs121908028,SNV,,,,,,"Three different point mutations were recently identified in South African familial hypercholesterolaemics.It has been shown that a common mutation at the 3'-end of exon 4 (base 681) of the LDL receptor gene is present in about 70% of alleles, while the mutations in exons 9 (base 1285) and 4 (base 523) of the gene are present in about 20 and 10% respectively of the genes studied."
rs28942078,1952806,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,Genetic variability study,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,The molecular basis and diagnosis of familial hypercholesterolaemia in South African Afrikaners.,1952806,1991,DisGeNET,rs28942078,SNV,,,,,,"Three different point mutations were recently identified in South African familial hypercholesterolaemics.It has been shown that a common mutation at the 3'-end of exon 4 (base 681) of the LDL receptor gene is present in about 70% of alleles, while the mutations in exons 9 (base 1285) and 4 (base 523) of the gene are present in about 20 and 10% respectively of the genes studied."
rs121908028,2569482,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs121908028,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs28942078,2569482,"Hypercholesterolemia, Familial",South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs28942078,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs121908028,2569482,Hyperlipoproteinemia Type Iia,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs121908028,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs121908033,2569482,Hyperlipoproteinemia Type Iia,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs121908033,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs28942078,2569482,Hyperlipoproteinemia Type Iia,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs28942078,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs121908028,2569482,Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs121908028,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs121908033,2569482,Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs121908033,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs28942078,2569482,Low Density Lipoprotein Cholesterol Level Quantitative Trait Locus 2,South Africa,South Africa,Afrikaner,FALSE,NS,LDLR,"Genetic variability study,Functional analysis",LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.,2569482,1989,DisGeNET,rs28942078,SNV,,,,,,Two mutations that together makeup > 95% of the mutant LDL receptor genes represented. Both mutations were basepair substitutions that result in single-amino acid changes. these mutations will predominate in the Afrikaner population and high frequency of FH is due to a founder effect.
rs121908027,1867200,"Hypercholesterolemia, Familial","South Africa, Israel",South Africa,NS,TRUE,0,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.,1867200,1991,DisGeNET,rs121908027,SNV,,,,,,
rs121908028,9664576,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,0,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.,9664576,1998,DisGeNET,rs121908028,SNV,,,,,,
rs121908030,9664576,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,0,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.,9664576,1998,DisGeNET,rs121908030,SNV,,,,,,
rs370860696,9664576,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,0.03,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.,9664576,1998,DisGeNET,rs370860696,SNV,,,,,,
rs879254594,9664576,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,< 0.05,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.,9664576,1998,DisGeNET,rs879254594,SNV,,,,,,
rs879254867,9664576,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,< 0.05,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.,9664576,1998,DisGeNET,rs879254867,SNV,,,,,,
rs879255135,9664576,"Hypercholesterolemia, Familial",South Africa,South Africa,NS,FALSE,< 0.05,LDLR,,LDLR,low density lipoprotein receptor,19,P01130,"The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010].",22/11/2021,PubMed,Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.,9664576,1998,DisGeNET,rs879255135,SNV,,,,,,
rs1805096,22939635,C-Reactive Protein Measurement,USA,African American/Afro-Caribbean,NS,TRUE,2.20E-09,LEPR,,LEPR,leptin receptor,1,P48357,"The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010].",22/11/2021,PubMed,Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.,22939635,2012,DisGeNET,rs1805096,SNV,,,,,,Minor allele A/Major allele G
rs1805096,20304616,Obesity,Tunisia,North Africa,NS,TRUE,0.21,LEPR,,LEPR,leptin receptor,1,P48357,"The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010].",22/11/2021,PubMed,The G3057A LEPR polymorphism is associated with obesity in Tunisian women.,20304616,2011,DisGeNET,rs1805096,SNV,,,,,,No significant differences in genotype frequencies were observed between obese patients and controls.
rs62589000,20304616,Obesity,Tunisia,North Africa,NS,TRUE,0.21,LEPR,,LEPR,leptin receptor,1,P48357,"The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010].",22/11/2021,PubMed,The G3057A LEPR polymorphism is associated with obesity in Tunisian women.,20304616,2011,DisGeNET,rs62589000,SNV,,,,,,No significant differences in genotype frequencies were observed between obese patients and controls.
rs11335470,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,2.52E-07,LINC00944,Association,LINC00944,uncharacterized LINC00944,12,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs11335470,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the heterozygous model."
rs4842407,28388302,Drug-Induced Liver Disease,Ethiopia,East Africa,NS,FALSE,0.00000053,lincRNA,,lincRNA,NA,NA,NA,NA,22/11/2021,PubMed,Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.,28388302,2017,DisGeNET,rs4842407,SNV,,,,,,
rs4842407,28388302,HIV Infections,Ethiopia,East Africa,NS,FALSE,0.00000053,lincRNA,,lincRNA,NA,NA,NA,NA,22/11/2021,PubMed,Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.,28388302,2017,DisGeNET,rs4842407,SNV,,,,,,
rs4842407,28388302,Tuberculosis,Ethiopia,East Africa,NS,FALSE,0.00000053,lincRNA,,lincRNA,NA,NA,NA,NA,22/11/2021,PubMed,Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs.,28388302,2017,DisGeNET,rs4842407,SNV,,,,,,
rs57077886,10441578,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,A locus for an axonal form of autosomal recessive Charcot-Marie-Tooth disease maps to chromosome 1q21.2-q21.3.,10441578,2000,DisGeNET,rs57077886,SNV,,,,,,Autosomal Recessive Charcot-Marie-Tooth Disease Maps to Chromosome 1q21.2-q21.3 in large consanguineous Moroccon ARCMT2 family with nine affected sibs
rs58596362,22991222,Progeria,Morocco,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,An inherited LMNA gene mutation in atypical Progeria syndrome.,22991222,2013,DisGeNET,rs58596362,SNV,,,,,,
rs59885338,17347251,"Charcot-Marie-Tooth Disease, Type 2B1",Morocco,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.,17347251,2007,DisGeNET,rs59885338,SNV,,,,,,
rs59885338,17347251,Hereditary Motor And Sensory-Neuropathy Type Ii,Morocco,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.,17347251,2007,DisGeNET,rs59885338,SNV,,,,,,
rs59885338,11799477,"Charcot-Marie-Tooth Disease, Type 2B1",Algeria,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,"Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse.",11799477,2002,DisGeNET,rs59885338,SNV,,,,,,
rs59885338,14607793,Charcot-Marie-Tooth Disease,Algeria,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.,14607793,2004,DisGeNET,rs59885338,SNV,,,,,,
rs59885338,14607793,"Charcot-Marie-Tooth Disease, Type 2B1",Algeria,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.,14607793,2004,DisGeNET,rs59885338,SNV,,,,,,
rs57077886,14607793,"Genetic Diseases, Inborn",Algeria,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.,14607793,2004,DisGeNET,rs57077886,SNV,,,,,,
rs59885338,14607793,Hereditary Motor And Sensory-Neuropathy Type Ii,Algeria,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Phenotypic variability in autosomal recessive axonal Charcot-Marie-Tooth disease due to the R298C mutation in lamin A/C.,14607793,2004,DisGeNET,rs59885338,SNV,,,,,,
rs59885338,12467734,Charcot-Marie-Tooth Disease,Algeria,North Africa,NS,FALSE,NS,LMNA,,LMNA,lamin A/C,1,P02545,"The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in Lamin A/C gene.,12467734,2003,DisGeNET,rs59885338,SNV,,,,,,
rs62477096,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,6.63E-07,LOC101928283,Association,LOC101928283,uncharacterized LOC101928283,7,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs62477096,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs6965492,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,6.92E-07,LOC101928283,Association,LOC101928283,uncharacterized LOC101928283,7,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs6965492,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs10905371,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,2.77E-07,LOC105376397,Association,LOC105376397,uncharacterized LOC105376397,10,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs10905371,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs7896254,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,3.27E-07,LOC105376397,Association,LOC105376397,uncharacterized LOC105376397,10,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs7896254,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs10905374,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,4.43E-07,LOC105376397,Association,LOC105376397,uncharacterized LOC105376397,10,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs10905374,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs7096374,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,5.16E-07,LOC105376397,Association,LOC105376397,uncharacterized LOC105376397,10,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs7096374,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs1417402,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,5.00E-07,LOC105378806,,LOC105378806,uncharacterized LOC105378806,1,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs1417402,SNV,,,,,,
rs2185710,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,5.95E-08,LOC107986636,Association,LOC107986636,uncharacterized LOC107986636,6,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs2185710,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs140817150,27236921,Pneumococcal Bacteraemia,Kenya,East Africa,NS,FALSE,7.25E-09,LOC107986770,,LOC107986770,uncharacterized LOC107986770,7,No Uniprot record,Gene function information is missing for this gene,22/11/2021,PubMed,Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.,27236921,2017,DisGeNET,rs140817150,SNV,,,,,,Peak association with Bactermia was observed at rs140817150
rs3825942,18421074,Exfoliation Syndrome,Ghana,West Africa,NS,FALSE,0.217,LOXL1,Association,LOXL1,lysyl oxidase like 1,15,Q08397,"This gene encodes a member of the lysyl oxidase family of proteins. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyzes the first step in the formation of crosslinks in collagen and elastin. The encoded preproprotein is proteolytically processed to generate the mature enzyme. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. Mutations in this gene are associated with exfoliation syndrome. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.,18421074,2008,DisGeNET,rs3825942,SNV,,,,,,"The study reports on a Ghanian population with primary open angle glaucoma (controls n=138, cases n = 170). "
rs1048661,18421074,Exfoliation Syndrome,USA,African American/Afro-Caribbean,African American,FALSE,0.245,LOXL1,Association,LOXL1,lysyl oxidase like 1,15,Q08397,"This gene encodes a member of the lysyl oxidase family of proteins. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyzes the first step in the formation of crosslinks in collagen and elastin. The encoded preproprotein is proteolytically processed to generate the mature enzyme. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. Mutations in this gene are associated with exfoliation syndrome. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.,18421074,2008,DisGeNET,rs1048661,SNV,,,,,,"The study reports on an African-American population with primary open angle glaucoma (controls n=97, cases n = 193). "
rs3825942,18421074,Exfoliation Syndrome,USA,African American/Afro-Caribbean,African American,FALSE,0.617,LOXL1,Association,LOXL1,lysyl oxidase like 1,15,Q08397,"This gene encodes a member of the lysyl oxidase family of proteins. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyzes the first step in the formation of crosslinks in collagen and elastin. The encoded preproprotein is proteolytically processed to generate the mature enzyme. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. Mutations in this gene are associated with exfoliation syndrome. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.,18421074,2008,DisGeNET,rs3825942,SNV,,,,,,"The study reports on an African-American population with primary open angle glaucoma (controls n=97, cases n = 193). "
rs1048661,18421074,Exfoliation Syndrome,Ghana,West Africa,NS,FALSE,0.764,LOXL1,Association,LOXL1,lysyl oxidase like 1,15,Q08397,"This gene encodes a member of the lysyl oxidase family of proteins. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyzes the first step in the formation of crosslinks in collagen and elastin. The encoded preproprotein is proteolytically processed to generate the mature enzyme. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. Mutations in this gene are associated with exfoliation syndrome. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Lack of association between LOXL1 variants and primary open-angle glaucoma in three different populations.,18421074,2008,DisGeNET,rs1048661,SNV,,,,,,"The study reports on a Ghanian population with primary open angle glaucoma (controls n=138, cases n = 170). "
rs3825942,20431720,Exfoliation Syndrome,South Africa,South Africa,NS,FALSE,5.20E-13,LOXL1,,LOXL1,lysyl oxidase like 1,15,Q08397,"This gene encodes a member of the lysyl oxidase family of proteins. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyzes the first step in the formation of crosslinks in collagen and elastin. The encoded preproprotein is proteolytically processed to generate the mature enzyme. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. Mutations in this gene are associated with exfoliation syndrome. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population.,20431720,2010,DisGeNET,rs3825942,SNV,,,,,,The allele frequencies of both rs3825942 and rs1048661 differed significantly between the XFG and control subjects from South Africa.
rs1048661,20431720,Exfoliation Syndrome,South Africa,South Africa,NS,FALSE,1.70E-05,LOXL1,,LOXL1,lysyl oxidase like 1,15,Q08397,"This gene encodes a member of the lysyl oxidase family of proteins. The prototypic member of the family is essential to the biogenesis of connective tissue, encoding an extracellular copper-dependent amine oxidase that catalyzes the first step in the formation of crosslinks in collagen and elastin. The encoded preproprotein is proteolytically processed to generate the mature enzyme. A highly conserved amino acid sequence at the C-terminus end appears to be sufficient for amine oxidase activity, suggesting that each family member may retain this function. The N-terminus is poorly conserved and may impart additional roles in developmental regulation, senescence, tumor suppression, cell growth control, and chemotaxis to each member of the family. Mutations in this gene are associated with exfoliation syndrome. [provided by RefSeq, Jan 2016].",22/11/2021,PubMed,Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population.,20431720,2010,DisGeNET,rs1048661,SNV,,,,,,The allele frequencies of both rs3825942 and rs1048661 differed significantly between the XFG and control subjects from South Africa.
rs3798220,26302166,Coronary Artery Disease,"Gabon, Egypt, South Africa",North Africa / South Africa / West Africa,NS,TRUE,0.034,LPA,,LPA,lipoprotein(a),3,P08519,"The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence. ",22/11/2021,PubMed,Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.,26302166,2015,DisGeNET,rs3798220,SNV,,,,,,
rs11313667,26729753,LRRC15 rs11313667 was validated for systolic BP response to β-blocker therapy with 3-group meta-analysis,USA,African American/Afro-Caribbean,African American,TRUE,7.2×10(-8),LRRC15,,LRRC15,leucine rich repeat containing 15,,Q8TF66,Enables collagen binding activity; fibronectin binding activity; and laminin binding activity. Involved in negative regulation of protein localization to plasma membrane; positive regulation of cell migration; and receptor-mediated virion attachment to host cell. Located in extracellular exosome. Colocalizes with collagen-containing extracellular matrix. ,22/11/2021,PubMed,Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to √ü-Blockers in Hypertensive African Americans.,26729753,2016,PharmGKB,TBD,SNV,atenolol,DB00335,Approved,Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,
rs34637584,22056842,Parkinson Disease,Tunisia,North Africa,NS,FALSE,NS,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Cognitive dysfunction in Tunisian LRRK2 associated Parkinson's disease.,22056842,2012,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,25330418,"Genetic Diseases, Inborn",Tunisia,North Africa,Berber,TRUE,NS,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Disease penetrance of late-onset parkinsonism: a meta-analysis.,25330418,2015,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,16240353,Parkinson Disease,"Algeria, Morocco, Tunisia, Europe",North Africa,NS,TRUE,NS,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,G2019S LRRK2 mutation in French and North African families with Parkinson's disease.,16240353,2006,DisGeNET,rs34637584,SNV,,,,,,G2019S mutation in the LRRK2 gene appears to represent a significant cause of autosomal dominant PD in North Africa with a frequency of 41%.
rs34637584,21699405,Parkinson Disease,Egypt,North Africa,NS,FALSE,0.004,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.,21699405,2012,DisGeNET,rs34637584,SNV,,,,,,"Among PD patients, carriers of the G2019S mutation had significantly  higher UPDRS motor score and a higher score for resting tremor than  noncarriers (p=0.019 and p=0.004, respectively)."
rs55739947,20144646,Parkinsonian Disorders,Tunisia,North Africa,NS,FALSE,0.04,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Heterodimerization of Lrrk1-Lrrk2: Implications for LRRK2-associated Parkinson disease.,20144646,2010,DisGeNET,rs55739947,SNV,,,,,,Evidence of a possible association with protection from PD was observed.
rs34637584,19357115,"Parkinson Disease, Familial, Type 1","North Africa, Europe",North Africa,NS,TRUE,NS,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease.,19357115,2009,DisGeNET,rs34637584,SNV,,,,,,The Mutation in the leucine-rich-repeat kinase 2 (LRRK2) gene have been identified in families with autosomal dominant Parkinsons disease (ADPD) with a frenquency of (43%) in North Africa.
rs34637584,17115391,Parkinson Disease,Tunisia,North Africa,NS,FALSE,NS,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.,17115391,2007,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,16966502,Parkinson Disease,"Algeria, Morocco, Tunisia, USA",North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.,16966502,2006,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,16966502,Parkinson Disease 8 (Disorder),"Algeria, Morocco, Tunisia, USA",North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.,16966502,2006,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,17433753,Parkinson Disease,"Tunisia, USA, Europe, Middle East",North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.",17433753,2008,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,17440812,Parkinson Disease,"North Africa, Asia, Europe",North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.,17440812,2007,DisGeNET,rs34637584,SNV,,,,,,
rs34778348,17440812,Parkinson Disease,"North Africa, Asia, Europe",North Africa,NS,TRUE,< 0.001,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease.,17440812,2007,DisGeNET,rs34778348,SNV,,,,,,
rs34637584,17596714,Parkinson Disease,"Algeria, France",North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease.,17596714,2007,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,17881276,Parkinson Disease,North Africa,North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An analysis of genetic studies of Parkinson's disease in Africa.,17881276,2008,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,18539535,Parkinson Disease,Tunisia,North Africa,NS,FALSE,0.85,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.,18539535,2008,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,19412725,Parkinson Disease,"Morocco, Iraq",North Africa,NS,TRUE,0.000001,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.",19412725,2009,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,19945510,Parkinson Disease,Tunisia,North Africa,NS,FALSE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Glucocerebrosidase mutations are not a common risk factor for Parkinson disease in North Africa.,19945510,2010,DisGeNET,rs34637584,SNV,,,,,,
rs33949390,20082991,"Parkinson Disease, Familial, Type 1","North Africa, Asia",North Africa,NS,TRUE,0.01,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical features of LRRK2 parkinsonism.,20082991,2009,DisGeNET,rs33949390,SNV,,,,,,
rs34778348,20082991,"Parkinson Disease, Familial, Type 1","North Africa, Asia",North Africa,NS,TRUE,< 0.001,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical features of LRRK2 parkinsonism.,20082991,2009,DisGeNET,rs34778348,SNV,,,,,,
rs35870237,20082991,"Parkinson Disease, Familial, Type 1","North Africa, Asia",North Africa,NS,TRUE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical features of LRRK2 parkinsonism.,20082991,2009,DisGeNET,rs35870237,SNV,,,,,,
rs34637584,20413974,Parkinson Disease,North Africa,North Africa,NS,TRUE,0.061,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,LRRK2 G2019S in the North African population: a review.,20413974,2010,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,20721913,Parkinson Disease,Tunisia,North Africa,NS,FALSE,0.061,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa.,20721913,2010,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,20933457,Parkinson Disease,Algeria,North Africa,NS,FALSE,< 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort.,20933457,2010,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,20933457,Parkinsonian Disorders,Algeria,North Africa,NS,FALSE,< 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,LRRK2 G2019S mutation in Parkinson's disease: a neuropsychological and neuropsychiatric study in a large Algerian cohort.,20933457,2010,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,24355527,Neurodegenerative Disorders,Tunisia,North Africa,NS,FALSE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.,24355527,2014,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,24355527,Parkinson Disease,Tunisia,North Africa,NS,FALSE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.,24355527,2014,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,24355527,Parkinsonian Disorders,Tunisia,North Africa,NS,FALSE,> 0.05,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.,24355527,2014,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,25487881,Parkinson Disease,Tunisia,North Africa,NS,FALSE,< 0.001,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.,25487881,2015,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,28683740,Familial (Fpah),Tunisia,North Africa,NS,FALSE,< 0.001,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.,28683740,2017,DisGeNET,rs34637584,SNV,,,,,,
rs34637584,28683740,Sporadic Parkinson Disease,Tunisia,North Africa,NS,FALSE,< 0.001,LRRK2,,LRRK2,leucine rich repeat kinase 2,12,Q5S007,"This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort.,28683740,2017,DisGeNET,rs34637584,SNV,,,,,,
rs62015197,25676789,Uric Acid Measurement (Procedure),USA,African American/Afro-Caribbean,African American,TRUE,8.30E-07,MAPK6,,MAPK6,mitogen-activated protein kinase 6,15,Q16659,"The protein encoded by this gene is a member of the Ser/Thr protein kinase family, and is most closely related to mitogen-activated protein kinases (MAP kinases). MAP kinases also known as extracellular signal-regulated kinases (ERKs), are activated through protein phosphorylation cascades and act as integration points for multiple biochemical signals. This kinase is localized in the nucleus, and has been reported to be activated in fibroblasts upon treatment with serum or phorbol esters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs62015197,SNV,,,,,,Association results in all subjects after imputation
rs864309717,19182162,"Skin Creases, Congenital Symmetric Circumferential, 2",Tunisia,North Africa,NS,FALSE,< 0.05,MAPRE2,,MAPRE2,microtubule associated protein RP/EB family member 2,18,Q15555,The protein encoded by this gene shares significant homology to the adenomatous polyposis coli (APC) protein-binding EB1 gene family. This protein is a microtubule-associated protein that is necessary for spindle symmetry during mitosis. It is thought to play a role in the tumorigenesis of colorectal cancers and the proliferative control of normal cells. Alternative splicing of this gene results in multiple transcript variants. ,22/11/2021,PubMed,Multiple congenital anomalies/mental retardation syndrome with multiple circumferential skin creases: a new syndrome?,19182162,2009,DisGeNET,rs864309717,SNV,,,,,,
rs63751438,12722177,Frontotemporal Dementia,Algeria,North Africa,NS,FALSE,< 0.05,MAPT,,MAPT,microtubule associated protein tau,17,P10636,"This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. ",22/11/2021,PubMed,Phenotypic presentation of frontotemporal dementia with Parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin.,12722177,2003,DisGeNET,rs63751438,SNV,,,,,,
rs56392418,17252003,Masp2 Deficiency,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,MASP2,,MASP2,MBL associated serine protease 2,1,O00187,"This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016].",22/11/2021,PubMed,Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms.,17252003,2007,DisGeNET,rs56392418,SNV,,,,,,
rs72550870,17252003,Masp2 Deficiency,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,MASP2,,MASP2,MBL associated serine protease 2,1,O00187,"This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016].",22/11/2021,PubMed,Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms.,17252003,2007,DisGeNET,rs72550870,SNV,,,,,,
rs1800450,1304173,Mannose-Binding Protein Deficiency,"Ghana, UK, China",West Africa,NS,TRUE,< 0.0001,MBL2,,MBL2,mannose binding lectin 2,10,P11226,"This gene encodes the soluble mannose-binding lectin or mannose-binding protein found in serum. The protein encoded belongs to the collectin family and is an important element in the innate immune system. The protein recognizes and binds to mannose and N-acetylglucosamine on many microorganisms, including bacteria, yeast, and viruses including influenza virus, HIV and SARS-CoV. This binding activates the classical complement pathway. Deficiencies of this gene have been associated with susceptibility to autoimmune and infectious diseases. [provided by RefSeq, Jun 2020].",22/11/2021,PubMed,High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene.,1304173,1992,DisGeNET,rs1800450,SNV,,,,,,"In the Gambians, the codon 57 mutation, frequency of the mutant gene 0.29 in adults and 0.23 in newborns. The codon 54 mutation was very rare (frequency 0.003). The codon 54 mutation was frequent in both a British Caucasian and a Hong Kong Chinese population (frequency of the mutant gene 0.17 and 0.11 respectively). The reported p value is calculated for the gambian population."
rs747681609,26788538,Obesity,South Africa,South Africa,"Afrikaner,Indian,Coloured",FALSE,NS,MC4R,,MC4R,melanocortin 4 receptor,18,P32245,"The protein encoded by this gene is a membrane-bound receptor and member of the melanocortin receptor family. The encoded protein interacts with adrenocorticotropic and MSH hormones and is mediated by G proteins. This is an intronless gene. Defects in this gene are a cause of autosomal dominant obesity. [provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Allelic variants of the Melanocortin 4 receptor (MC4R) gene in a South African study group.,26788538,2016,DisGeNET,rs747681609,SNV,,,,,,
rs78289603,20491958,"Factor V And Factor Viii, Combined Deficiency Of, 2",Tunisia,North Africa,NS,FALSE,NS,MCFD2,,MCFD2,"multiple coagulation factor deficiency 2, ER cargo receptor complex subunit",2,Q8NI22,"This gene encodes a soluble luminal protein with two calmodulin-like EF-hand motifs at its C-terminus. This protein forms a complex with LMAN1 (lectin mannose binding protein 1; also known as ERGIC-53) that facilitates the transport of coagulation factors V (FV) and VIII (FVIII) from the endoplasmic reticulum to the Golgi apparatus via an endoplasmic reticulum Golgi intermediate compartment (ERGIC). Mutations in this gene cause combined deficiency of FV and FVIII (F5F8D); a rare autosomal recessive bleeding disorder characterized by mild to moderate bleeding and coordinate reduction in plasma FV and FVIII levels. This protein has also been shown to maintain stem cell potential in adult central nervous system and is a marker for testicular germ cell tumors. The 3' UTR of this gene contains a transposon-like human repeat element named 'THE 1'. A processed RNA pseudogene of this gene is on chromosome 6p22.1. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2016].",22/11/2021,PubMed,Molecular analysis in two Tunisian families with combined factor V and factor VIII deficiency.,20491958,2011,DisGeNET,rs78289603,SNV,,,,,,
rs41525747,17159977,Lactase Persistence,"Kenya, Sudan, Tanzania",East Africa,NS,TRUE,0.0007,MCM6,,MCM6,minichromosome maintenance complex component 6,2,Q14566,"The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are essential for the initiation of eukaryotic genome replication. The hexameric protein complex formed by the MCM proteins is a key component of the pre-replication complex (pre_RC) and may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. The MCM complex consisting of this protein and MCM2, 4 and 7 proteins possesses DNA helicase activity, and may act as a DNA unwinding enzyme. The phosphorylation of the complex by CDC2 kinase reduces the helicase activity, suggesting a role in the regulation of DNA replication. Single nucleotide polymorphisms in the intron regions of this gene are associated with differential transcriptional activation of the promoter of the neighboring lactase gene and, thereby, influence lactose intolerance in early adulthood. [provided by RefSeq, May 2012].",22/11/2021,PubMed,Convergent adaptation of human lactase persistence in Africa and Europe.,17159977,2007,DisGeNET,rs41525747,SNV,,,,,,
rs41525747,17159977,Lactase Persistence,"Kenya, Sudan, Tanzania",East Africa,NS,TRUE,0.0043,MCM6,,MCM6,minichromosome maintenance complex component 6,2,Q14566,"The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are essential for the initiation of eukaryotic genome replication. The hexameric protein complex formed by the MCM proteins is a key component of the pre-replication complex (pre_RC) and may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. The MCM complex consisting of this protein and MCM2, 4 and 7 proteins possesses DNA helicase activity, and may act as a DNA unwinding enzyme. The phosphorylation of the complex by CDC2 kinase reduces the helicase activity, suggesting a role in the regulation of DNA replication. Single nucleotide polymorphisms in the intron regions of this gene are associated with differential transcriptional activation of the promoter of the neighboring lactase gene and, thereby, influence lactose intolerance in early adulthood. [provided by RefSeq, May 2012].",22/11/2021,PubMed,Convergent adaptation of human lactase persistence in Africa and Europe.,17159977,2007,DisGeNET,rs41525747,SNV,,,,,,
rs41380347,17159977,Lactase Persistence,"Kenya, Sudan, Tanzania",East Africa,NS,TRUE,0.0302,MCM6,,MCM6,minichromosome maintenance complex component 6,2,Q14566,"The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are essential for the initiation of eukaryotic genome replication. The hexameric protein complex formed by the MCM proteins is a key component of the pre-replication complex (pre_RC) and may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. The MCM complex consisting of this protein and MCM2, 4 and 7 proteins possesses DNA helicase activity, and may act as a DNA unwinding enzyme. The phosphorylation of the complex by CDC2 kinase reduces the helicase activity, suggesting a role in the regulation of DNA replication. Single nucleotide polymorphisms in the intron regions of this gene are associated with differential transcriptional activation of the promoter of the neighboring lactase gene and, thereby, influence lactose intolerance in early adulthood. [provided by RefSeq, May 2012].",22/11/2021,PubMed,Convergent adaptation of human lactase persistence in Africa and Europe.,17159977,2007,DisGeNET,rs41380347,SNV,,,,,,
rs145946881,17159977,Lactase Persistence,"Kenya, Sudanese, Tanzania",North Africa,Beja,TRUE,0.0869,MCM6,,MCM6,minichromosome maintenance complex component 6,2,Q14566,"The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are essential for the initiation of eukaryotic genome replication. The hexameric protein complex formed by the MCM proteins is a key component of the pre-replication complex (pre_RC) and may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. The MCM complex consisting of this protein and MCM2, 4 and 7 proteins possesses DNA helicase activity, and may act as a DNA unwinding enzyme. The phosphorylation of the complex by CDC2 kinase reduces the helicase activity, suggesting a role in the regulation of DNA replication. Single nucleotide polymorphisms in the intron regions of this gene are associated with differential transcriptional activation of the promoter of the neighboring lactase gene and, thereby, influence lactose intolerance in early adulthood. [provided by RefSeq, May 2012].",22/11/2021,PubMed,Convergent adaptation of human lactase persistence in Africa and Europe.,17159977,2007,DisGeNET,rs145946881,SNV,,,,,,
rs4988235,15106124,Lactase Persistence,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,MCM6,,MCM6,minichromosome maintenance complex component 6,2,Q14566,"The protein encoded by this gene is one of the highly conserved mini-chromosome maintenance proteins (MCM) that are essential for the initiation of eukaryotic genome replication. The hexameric protein complex formed by the MCM proteins is a key component of the pre-replication complex (pre_RC) and may be involved in the formation of replication forks and in the recruitment of other DNA replication related proteins. The MCM complex consisting of this protein and MCM2, 4 and 7 proteins possesses DNA helicase activity, and may act as a DNA unwinding enzyme. The phosphorylation of the complex by CDC2 kinase reduces the helicase activity, suggesting a role in the regulation of DNA replication. Single nucleotide polymorphisms in the intron regions of this gene are associated with differential transcriptional activation of the promoter of the neighboring lactase gene and, thereby, influence lactose intolerance in early adulthood. [provided by RefSeq, May 2012].",22/11/2021,PubMed,The T allele of a single-nucleotide polymorphism 13.9 kb upstream of the lactase gene (LCT) (C-13.9kbT) does not predict or cause the lactase-persistence phenotype in Africans.,15106124,2004,DisGeNET,rs4988235,SNV,,,,,,
rs28934906,20631224,Rett Syndrome,Tunisia,North Africa,NS,FALSE,NS,MECP2,,MECP2,methyl-CpG binding protein 2,X,P51608,"DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015].",22/11/2021,PubMed,Mutational analysis of the MECP2 gene in Tunisian patients with Rett syndrome: a novel double mutation.,20631224,2011,DisGeNET,rs28934906,SNV,,,,,,
rs61752717,21294448,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterisation of the disease.,21294448,2011,DisGeNET,rs61752717,SNV,,,,,,
rs61752717,21294448,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Analysis of common MEFV mutations in Egyptian patients with familial Mediterranean fever: molecular characterisation of the disease.,21294448,2011,DisGeNET,rs61752717,SNV,,,,,,
rs104895091,17592559,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,Genetic variability study,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical and molecular diagnosis of Familial Mediterranean Fever in Egyptian children.,17592559,2007,DisGeNET,rs104895091,SNV,,,,,,"Patients (66 Egyptian cases, 37 males and 29 females) had been referred from healthcenters and hospitals of the Delta region, Egypt."
rs104895091,17592559,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,Genetic variability study,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Clinical and molecular diagnosis of Familial Mediterranean Fever in Egyptian children.,17592559,2007,DisGeNET,rs104895091,SNV,,,,,,"Patients (66 Egyptian cases, 37 males and 29 females) had been referred from healthcenters and hospitals of the Delta region, Egypt."
rs3743930,20151816,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,MEFV gene mutations in Egyptian patients with familial Mediterranean fever.,20151816,2010,DisGeNET,rs3743930,SNV,,,,,,
rs3743930,20151816,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,MEFV gene mutations in Egyptian patients with familial Mediterranean fever.,20151816,2010,DisGeNET,rs3743930,SNV,,,,,,
rs61752717,20151816,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,MEFV gene mutations in Egyptian patients with familial Mediterranean fever.,20151816,2010,DisGeNET,rs61752717,SNV,,,,,,
rs61752717,20151816,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,"MEFV innate immuity regulator, pyrin",16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,MEFV gene mutations in Egyptian patients with familial Mediterranean fever.,20151816,2010,DisGeNET,rs61752717,SNV,,,,,,
rs28940579,24862656,Systemic Onset Juvenile Chronic Arthritis,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,MEFV Innate Immunity Regulator,16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,MEFV mutations in Egyptian children with systemic-onset juvenile idiopathic arthritis.,24862656,2015,DisGeNET,rs28940579,SNV,,,,,,
rs28940579,19777236,Familial Mediterranean Fever,Egypt,North Africa,NS,FALSE,NS,MEFV,,MEFV,MEFV Innate Immunity Regulator,16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations.,19777236,2010,DisGeNET,rs28940579,SNV,,,,,,
rs28940578,27956278,Familial Mediterranean Fever,Morocco,North Africa,NS,FALSE,NS,MEFV,,MEFV,MEFV Innate Immunity Regulator,16,O15553,"This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever.,27956278,2017,DisGeNET,rs28940578,SNV,,,,,,
rs387907314,22180149,Retinitis Pigmentosa 38 (Disorder),South Africa,North Africa,NS,FALSE,NS,MERTK,,MERTK,"MER proto-oncogene, tyrosine kinase",2,Q12866,"This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa.,22180149,2012,DisGeNET,rs387907314,SNV,,,,,,
rs371956016,17301963,"Genetic Diseases, Inborn",Morocco,North Africa,NS,FALSE,NS,MERTK,Genetic variability study,MERTK,"MER proto-oncogene, tyrosine kinase",2,Q12866,"This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction.,17301963,2007,DisGeNET,rs371956016,SNV,,,,,,A novel homozygous donor splice site mutation found in all affected children with e hearing loss and retinal degeneration.
rs371956016,17301963,Retinitis Pigmentosa 38 (Disorder),South Africa,North Africa,NS,FALSE,NS,MERTK,Genetic variability study,MERTK,"MER proto-oncogene, tyrosine kinase",2,Q12866,"This gene is a member of the MER/AXL/TYRO3 receptor kinase family and encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type (immunoglobulin-like) domains, and one tyrosine kinase domain. Mutations in this gene have been associated with disruption of the retinal pigment epithelium (RPE) phagocytosis pathway and onset of autosomal recessive retinitis pigmentosa (RP). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction.,17301963,2007,DisGeNET,rs371956016,SNV,,,,,,A novel homozygous donor splice site mutation found in all affected children with e hearing loss and retinal degeneration.
rs2401027,20400458,Body Mass Index,"Nigeria, USA",West Africa / African American/Afro-Caribbean,African American,TRUE,0.0014,METTL25,,METTL25,methyltransferase like 25,12,Q8N6Q8,Predicted to enable methyltransferase activity. Predicted to be involved in methylation.,22/11/2021,PubMed,Genome-wide association of anthropometric traits in African- and African-derived populations.,20400458,2010,DisGeNET,rs2401027,SNV,,,,,,This study contains the results of many other investigated SNPs/genes as well. Seperated by African American and Nigerian analysis.
rs2401027,20400458,Body Mass Index,"Nigeria, USA",West Africa / African American/Afro-Caribbean,Igbo,TRUE,2.80E-05,METTL25,,METTL25,methyltransferase like 25,12,Q8N6Q8,Predicted to enable methyltransferase activity. Predicted to be involved in methylation.,22/11/2021,PubMed,Genome-wide association of anthropometric traits in African- and African-derived populations.,20400458,2010,DisGeNET,rs2401027,SNV,,,,,,This study contains the results of many other investigated SNPs/genes as well. Seperated by African American and Nigerian analysis.
rs118203978,18850119,"Ceroid Lipofuscinosis, Neuronal, 7",Egypt,North Africa,NS,TRUE,NS,MFSD8,Genetic variability study,MFSD8,major facilitator superfamily domain containing 8,4,Q8NHS3,"This gene encodes a ubiquitous integral membrane protein that contains a transporter domain and a major facilitator superfamily (MFS) domain. Other members of the major facilitator superfamily transport small solutes through chemiosmotic ion gradients. The substrate transported by this protein is unknown. The protein likely localizes to lysosomal membranes. Mutations in this gene are correlated with a variant form of late infantile-onset neuronal ceroid lipofuscinoses (vLINCL). [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis.,18850119,2009,DisGeNET,rs118203978,SNV,,,,,,The p.Y121C mutation was found at homozygous state in the 5 affected sibs from a consanguineous family. The parents were heterozygous. The mutation was absent in 50 Egyptian and 200 Austrian controls.
rs11614913,27043015,Chronic Obstructive Airway Disease,Egypt,North Africa,NS,FALSE,NS,MIR196A2,,MIR196A2,microRNA 196a-2,12,No Uniprot record,"microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009].",22/11/2021,PubMed,Association of MicroRNA-196a2 Variant with Response to Short-Acting Î²2-Agonist in COPD: An Egyptian Pilot Study.,27043015,2016,DisGeNET,rs11614913,SNV,,,,,,Genotyping of the MIR-196a2 rs11614913 (C/T) polymorphism revealed no significant difference between COPD patients and controls under all genetic association models
rs1057516766,19168821,Megalencephalic Leukoencephalopathy With Subcortical Cysts,Tunisia,North Africa,NS,FALSE,NS,MLC1,Genetic variability study,MLC1,modulator of VRAC current 1,22,Q15049,"The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Megalencephalic leukoencephalopathy with subcortical cysts in a Tunisian boy.,19168821,2009,DisGeNET,rs1057516766,SNV,,,,,,Pathogenic/likely pathogenic mutation identified in 2-year-old Tunisian boy with Megalencephalic leukoencephalopathy with subcortical cysts.
rs121908345,12189496,Megalencephalic Leukoencephalopathy With Subcortical Cysts,Libya,North Africa,Jewish,FALSE,NS,MLC1,Genetic variability study,MLC1,modulator of VRAC current 1,22,Q15049,"The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews.,12189496,2002,DisGeNET,rs121908345,SNV,,,,,,"Screening of 200 normal Libyan Jewish individuals for the p.G59E mutation, revealed a carrier rate of 1/40 compared with an expected carrier rate of 1/81"
rs80358241,12189496,Megalencephalic Leukoencephalopathy With Subcortical Cysts,Libya,North Africa,Jewish,FALSE,NS,MLC1,Genetic variability study,MLC1,modulator of VRAC current 1,22,Q15049,"The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews.,12189496,2002,DisGeNET,rs80358241,SNV,,,,,,"Screening of 200 normal Libyan Jewish individuals for the p.G59E mutation, revealed a carrier rate of 1/40 compared with an expected carrier rate of 1/81"
rs80358242,12189496,Megalencephalic Leukoencephalopathy With Subcortical Cysts,Libya,North Africa,Jewish,FALSE,NS,MLC1,Genetic variability study,MLC1,modulator of VRAC current 1,22,Q15049,"The function of this gene product is unknown; however, homology to other proteins suggests that it may be an integral membrane transporter. Mutations in this gene have been associated with megalencephalic leukoencephalopathy with subcortical cysts, an autosomal recessive neurological disorder. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Megalencephalic leukoencephalopathy with subcortical cysts; a founder effect in Israeli patients and a higher than expected carrier rate among Libyan Jews.,12189496,2002,DisGeNET,rs80358242,SNV,,,,,,"Three novel mutations (p.G59E, p.P92S, and 134_136insC) WERE described in seven MLC families. One of these mutations, p.G59E, was found in the vast majority of MLC patients in Israel. Screening of 200 normal Libyan Jewish individuals for the p.G59E mutation, revealed a carrier rate of 1/40 compared with an expected carrier rate of 1/81"
rs7800944,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,0.984,MLXIPL,,MLXIPL,MLX interacting protein like,7,Q9NP71,"This gene encodes a basic helix-loop-helix leucine zipper transcription factor of the Myc/Max/Mad superfamily. This protein forms a heterodimeric complex and binds and activates, in a glucose-dependent manner, carbohydrate response element (ChoRE) motifs in the promoters of triglyceride synthesis genes. The gene is deleted in Williams-Beuren syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at chromosome 7q11.23. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs7800944,SNV,,,,,,"In both Lebanese and Tunisians, ENPP1 rs1044498 (P = 0.231 and P = 0.939, respectively) and MLXIPL (P = 0.284 and P = 0.984, respectively) were not associated with T2DM."
rs12788102,23717212,Malaria,Gambia,West Africa,NS,FALSE,1.90E-16,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs12788102,SNV,,,,,,rs12788102 was associated with severe malaria 5including cerebral malaria and severe malarial anaemia) with the lowest meta-analysis P value across Gambia
rs1594812,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-10,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs1594812,SNV,,,,,,
rs17227978,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-11,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs17227978,SNV,,,,,,
rs17228092,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-12,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs17228092,SNV,,,,,,
rs17228176,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-13,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs17228176,SNV,,,,,,
rs17228183,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-14,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs17228183,SNV,,,,,,
rs12789492,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-6,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs12789492,SNV,,,,,,
rs17325567,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-6,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs17325567,SNV,,,,,,
rs12801757,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-7,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs12801757,SNV,,,,,,
rs12806476,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-8,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs12806476,SNV,,,,,,
rs12808215,23717212,Malaria,"Gambia, Kenya, Malawi",East Africa / South Africa / West Africa,NS,TRUE,< 1E-9,MMP26,,MMP26,matrix metallopeptidase 26,11,Q9NRE1,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016].",22/11/2021,PubMed,Imputation-based meta-analysis of severe malaria in three African populations.,23717212,2013,DisGeNET,rs12808215,SNV,,,,,,
rs17577,28045923,Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,NS,MMP9,,MMP9,matrix metallopeptidase 9,20,P14780,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995822,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs2274756 was merged into rs17577 and is assigned to MMP9 in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs2236416,28045923,Allele G is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,NS,MMP9,,MMP9,matrix metallopeptidase 9,20,P14780,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995815,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs2236416 is assigned to MMP9 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs2274755,28045923,Allele T is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,NS,MMP9,,MMP9,matrix metallopeptidase 9,20,P14780,"Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995807,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs2274755 is assigned to MMP9 gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs121918257,25750861,Methylmalonic Aciduria Due To Methylmalonyl-Coa Mutase Deficiency,Egypt,North Africa,NS,FALSE,NS,MMUT,,MMUT,methylmalonyl-CoA mutase,6,P22033,"This gene encodes the mitochondrial enzyme methylmalonyl Coenzyme A mutase. In humans, the product of this gene is a vitamin B12-dependent enzyme which catalyzes the isomerization of methylmalonyl-CoA to succinyl-CoA, while in other species this enzyme may have different functions. Mutations in this gene may lead to various types of methylmalonic aciduria.",22/11/2021,PubMed,Mutation analysis of methylmalonyl CoA mutase gene exon 2 in Egyptian families: Identification of 25 novel allelic variants.,25750861,2015,DisGeNET,rs121918257,SNV,,,,,,This variant was described among Egyptian patient with Methylmalonic aciduria.
rs12076902,23087401,Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,0.02,MOV10,,MOV10,Mov10 RISC complex RNA helicase,1,Q9HCE1,"Enables 5'-3' RNA helicase activity and RNA binding activity. Involved in defense response to virus; negative regulation of transposition, RNA-mediated; and posttranscriptional regulation of gene expression. Located in P-body and cytosol. Implicated in hypertension.",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491537,SNV,atenolol,DB00335,Approved,1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis.3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,"In African Americans, rs12076902 was found to be nominally associated with BP response to atenolol."
rs12076902,23087401,Allele A is not associated with response to atenolol in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,0.02,MOV10,,MOV10,Mov10 RISC complex RNA helicase,1,Q9HCE1,"Enables 5'-3' RNA helicase activity and RNA binding activity. Involved in defense response to virus; negative regulation of transposition, RNA-mediated; and posttranscriptional regulation of gene expression. Located in P-body and cytosol. Implicated in hypertension.",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491537,SNV,atenolol,DB00335,Approved,Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,"In African Americans, rs12076902 was found to be nominally associated with BP response to atenolol."
rs12069113,23087401,Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T.,USA,African American/Afro-Caribbean,NS,FALSE,0.042,MOV10,,MOV10,Mov10 RISC complex RNA helicase,1,Q9HCE1,"Enables 5'-3' RNA helicase activity and RNA binding activity. Involved in defense response to virus; negative regulation of transposition, RNA-mediated; and posttranscriptional regulation of gene expression. Located in P-body and cytosol. Implicated in hypertension.",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491533,SNV,atenolol,DB00335,Approved,1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis.3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,"In African Americans, rs12069113 was found to be nominally associated with BP response to atenolol."
rs12069113,23087401,Allele C is not associated with response to atenolol in people with Hypertension as compared to allele T.,USA,African American/Afro-Caribbean,NS,FALSE,0.042,MOV10,,MOV10,Mov10 RISC complex RNA helicase,1,Q9HCE1,"Enables 5'-3' RNA helicase activity and RNA binding activity. Involved in defense response to virus; negative regulation of transposition, RNA-mediated; and posttranscriptional regulation of gene expression. Located in P-body and cytosol. Implicated in hypertension.",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491533,SNV,atenolol,DB00335,Approved,Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,"In African Americans, rs12069113 was found to be nominally associated with BP response to atenolol."
rs63749991,21311894,"Neoplastic Syndromes, Hereditary",Tunisia,North Africa,NS,FALSE,NS,MSH2,,MSH2,mutS homolog 2,2,P43246,"This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012].",22/11/2021,PubMed,Lynch syndrome in Tunisia: first description of clinical features and germline mutations.,21311894,2011,DisGeNET,rs63749991,SNV,,,,,,
rs63751453,21311894,Hereditary Nonpolyposis Colorectal Cancer,Tunisia,North Africa,NS,FALSE,NS,MSH3,,MSH3,mutS homolog 3,5,P20585,"The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011].",22/11/2021,PubMed,Lynch syndrome in Tunisia: first description of clinical features and germline mutations.,21311894,2011,DisGeNET,rs63751453,SNV,,,,,,
rs587776437,20525945,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-ATP6,,MT-ATP6,mitochondrially encoded ATP synthase membrane subunit 6,MT,P00846,"Contributes to proton-transporting ATP synthase activity, rotational mechanism. Involved in mitochondrial ATP synthesis coupled proton transport. Part of mitochondrial proton-transporting ATP synthase complex. Implicated in Leber hereditary optic neuropathy; NARP syndrome; Parkinson's disease; multiple sclerosis; and systemic lupus erythematosus. ",22/11/2021,PubMed,Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene.,20525945,2011,DisGeNET,rs587776437,SNV,,,,,,
rs370471013,19349200,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-CO1,,MT-CO1,mitochondrially encoded cytochrome c oxidase I,MT,P00395,"Contributes to cytochrome-c oxidase activity. Predicted to be involved in electron transport coupled proton transport and mitochondrial electron transport, cytochrome c to oxygen. Part of mitochondrial respiratory chain complex III and mitochondrial respiratory chain complex IV. ",22/11/2021,PubMed,Two new mutations in the MT-TW gene leading to the disruption of the secondary structure of the tRNA(Trp) in patients with Leigh syndrome.,19349200,2009,DisGeNET,rs370471013,SNV,,,,,,
rs587776435,19349200,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-CO1,,MT-CO1,mitochondrially encoded cytochrome c oxidase I,MT,P00395,"Contributes to cytochrome-c oxidase activity. Predicted to be involved in electron transport coupled proton transport and mitochondrial electron transport, cytochrome c to oxygen. Part of mitochondrial respiratory chain complex III and mitochondrial respiratory chain complex IV. ",22/11/2021,PubMed,Two new mutations in the MT-TW gene leading to the disruption of the secondary structure of the tRNA(Trp) in patients with Leigh syndrome.,19349200,2009,DisGeNET,rs587776435,SNV,,,,,,
rs587776437,20525945,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-CO3,,MT-CO3,mitochondrially encoded cytochrome c oxidase III,MT,P00414,Predicted to enable electron transfer activity and oxidoreduction-driven active transmembrane transporter activity. Involved in respiratory chain complex IV assembly. Part of respiratory chain complex IV. Implicated in MELAS syndrome. ,22/11/2021,PubMed,Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene.,20525945,2011,DisGeNET,rs587776437,SNV,,,,,,
rs199476104,10072046,"Optic Atrophy, Hereditary, Leber","Tunisia, Italy",North Africa,NS,TRUE,NS,MT-CYB,,MT-CYB,mitochondrially encoded cytochrome b,MT,P00156,"Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including electron transport coupled proton transport; response to cobalamin; and response to glucagon. Located in mitochondrion. Implicated in ovarian carcinoma and urinary bladder cancer.",22/11/2021,PubMed,Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy.,10072046,1999,DisGeNET,rs199476104,SNV,,,,,,"8 Italian participants, 1 Tunisian participant. Mitochondrial DNA investigated."
rs199476134,12509511,"Optic Atrophy, Hereditary, Leber","Africa, Asia, Europe",Africa,NS,TRUE,NS,MT-CYB,,MT-CYB,mitochondrially encoded cytochrome b,MT,P00156,"Predicted to enable metal ion binding activity. Predicted to be involved in several processes, including electron transport coupled proton transport; response to cobalamin; and response to glucagon. Located in mitochondrion. Implicated in ovarian carcinoma and urinary bladder cancer.",22/11/2021,PubMed,Natural selection shaped regional mtDNA variation in humans.,12509511,2003,DisGeNET,rs199476134,SNV,,,,,,Mitochondrial DNA investigated.
rs587776437,20525945,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-ND3,,MT-ND3,mitochondrially encoded NADH dehydrogenase 3,MT,P03897,"Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone. Part of mitochondrial respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; Leigh disease; and Parkinson's disease.",22/11/2021,PubMed,Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene.,20525945,2011,DisGeNET,rs587776437,SNV,,,,,,
rs587776437,20525945,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-ND4,,MT-ND4,mitochondrially encoded NADH dehydrogenase 4,MT,"P03905	","Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Part of mitochondrial respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; Parkinson's disease; macular degeneration; and schizophrenia. Biomarker of Alzheimer's disease. ",22/11/2021,PubMed,Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene.,20525945,2011,DisGeNET,rs587776437,SNV,,,,,,
rs587776437,20525945,Leigh Disease,Tunisia,North Africa,NS,FALSE,NS,MT-ND4L,,MT-ND4L,mitochondrially encoded NADH dehydrogenase 4L,MT,P03901,Predicted to enable NADH dehydrogenase (ubiquinone) activity. Predicted to be located in mitochondrial inner membrane. Implicated in Leber hereditary optic neuropathy and diabetes mellitus.,22/11/2021,PubMed,Molecular-clinical correlation in a family with a novel heteroplasmic Leigh syndrome missense mutation in the mitochondrial cytochrome c oxidase III gene.,20525945,2011,DisGeNET,rs587776437,SNV,,,,,,
rs1801133,21644011,Genotypes AA + AG is associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to genotype GG.,Egypt,North Africa,NS,FALSE,0.01,MTHFR,,MTHFR,methylenetetrahydrofolate reductase,1,P42898,"The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.,21644011,2013,PharmGKB,1446898629,SNV,methotrexate,DB00563,Approved,"Methotrexate oral solution is indicated for pediatric acute lymphoblastic leukemia and pediatric polyarticular juvenile idiopathic arthritis. Methotrexate injections for subcutaneous use are indicated for severe active rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and severe, recalcitrant, disabling psoriasis. Other formulations are indicated to treat gestational choriocarcinoma, chorioadenoma destruens, hydatiform mole, breast cancer, epidermoid cancer of the head and neck, advanced mycosis fungoides, lung cancer, and advanced non-Hodgkin's lymphoma. It is also used in the maintenance of acute lymphocytic leukemia. Methotrexate is also given before treatment with leucovorin to prolong relapse-free survival following surgical removal of a tumour in non-metastatic osteosarcoma.","(2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid",C677T is assigned to MTHFR gene in this study and it's associated with increased exposure to methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma
rs1801133,28215593,Rheumatoid Arthritis,Egypt,North Africa,NS,FALSE,0.011,MTHFR,Association,MTHFR,methylenetetrahydrofolate reductase,1,P42898,"The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis.,28215593,2017,DisGeNET,rs1801133,SNV,,,,,,"Subjects with the TT genotype were significantly more likely to develop Rheumatoid Arthritis (OR = 2.9, 95% CI = 1.2 - 7.3, P = 0.011). Rheumatoid arthritis patients carrying minor T allele were significantly more likely to develop atherosclerosis compared with those carrying the C allele (OR = 4.6, 95% CI = 2.8 - 7.8, P Ë‚ 0.001)."
rs587780078,21443744,Colon Carcinoma,"Algeria, Morocco, Tunisia, Portugal",North Africa,NS,TRUE,< 0.0001,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,Frequent mutation in North African patients with MUTYH-associated polyposis.,21443744,2013,DisGeNET,rs587780078,SNV,,,,,,
rs587780078,22744763,Colon Carcinoma,Tunisia,North Africa,NS,FALSE,NS,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.,22744763,2013,DisGeNET,rs587780078,SNV,,,,,,
rs36053993,22744763,"Colorectal Adenomatous Polyposis, Autosomal Recessive",Tunisia,North Africa,NS,FALSE,NS,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.,22744763,2013,DisGeNET,rs36053993,SNV,,,,,,
rs587780078,22744763,"Colorectal Adenomatous Polyposis, Autosomal Recessive",Tunisia,North Africa,NS,FALSE,NS,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.,22744763,2013,DisGeNET,rs587780078,SNV,,,,,,
rs36053993,22744763,"Neoplastic Syndromes, Hereditary",Tunisia,North Africa,NS,FALSE,NS,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.,22744763,2013,DisGeNET,rs36053993,SNV,,,,,,
rs587780078,22744763,"Neoplastic Syndromes, Hereditary",Tunisia,North Africa,NS,FALSE,NS,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.,22744763,2013,DisGeNET,rs587780078,SNV,,,,,,
rs36053993,22744763,Stomach Neoplasms,Tunisia,North Africa,NS,FALSE,NS,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.,22744763,2013,DisGeNET,rs36053993,SNV,,,,,,
rs34612342,22266422,"Colorectal Adenomatous Polyposis, Autosomal Recessive",Morocco,North Africa,NS,FALSE,0.1,MUTYH,,MUTYH,mutY DNA glycosylase,1,Q9UIF7,"This gene encodes a DNA glycosylase involved in oxidative DNA damage repair. The enzyme excises adenine bases from the DNA backbone at sites where adenine is inappropriately paired with guanine, cytosine, or 8-oxo-7,8-dihydroguanine, a major oxidatively damaged DNA lesion. The protein is localized to the nucleus and mitochondria. This gene product is thought to play a role in signaling apoptosis by the introduction of single-strand breaks following oxidative damage. Mutations in this gene result in heritable predisposition to colorectal cancer, termed MUTYH-associated polyposis (MAP). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2017].",22/11/2021,PubMed,The first mutations in the MYH gene reported in Moroccan colon cancer patients.,22266422,2012,DisGeNET,rs34612342,SNV,,,,,,
rs367947846,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,MYBPC3,,MYBPC3,myosin binding protein C3,11,Q14896,"MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3, the cardiac isoform, is expressed exclussively in heart muscle. Regulatory phosphorylation of the cardiac isoform in vivo by cAMP-dependent protein kinase (PKA) upon adrenergic stimulation may be linked to modulation of cardiac contraction. Mutations in MYBPC3 are one cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs367947846,SNV,,,,,,Nonsense mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs387907267,23233322,Hypertrophic Cardiomyopathy,Egypt,North Africa,NS,FALSE,NS,MYBPC3,,MYBPC3,myosin binding protein C3,11,Q14896,"MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3, the cardiac isoform, is expressed exclussively in heart muscle. Regulatory phosphorylation of the cardiac isoform in vivo by cAMP-dependent protein kinase (PKA) upon adrenergic stimulation may be linked to modulation of cardiac contraction. Mutations in MYBPC3 are one cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs387907267,SNV,,,,,,Pathogenic mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs397516074,23233322,Hypertrophic Cardiomyopathy,Egypt,North Africa,NS,FALSE,NS,MYBPC3,,MYBPC3,myosin binding protein C3,11,Q14896,"MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3, the cardiac isoform, is expressed exclussively in heart muscle. Regulatory phosphorylation of the cardiac isoform in vivo by cAMP-dependent protein kinase (PKA) upon adrenergic stimulation may be linked to modulation of cardiac contraction. Mutations in MYBPC3 are one cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs397516074,SNV,,,,,,Pathogenic/Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs397516127,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs397516127,SNV,,,,,,Pathogenic mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs397516127,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs397516127,SNV,,,,,,Pathogenic mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs397516127,23233322,Hypertrophic Cardiomyopathy,Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs397516127,SNV,,,,,,Pathogenic mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs397516127,23233322,Hypertrophic Cardiomyopathy,Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs397516127,SNV,,,,,,Pathogenic mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs3218713,23233322,"Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)",Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs3218713,SNV,,,,,,Pathogenic/Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs3218716,23233322,"Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)",Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs3218716,SNV,,,,,,Pathogenic/Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs3218713,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs3218713,SNV,,,,,,Pathogenic/Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs3218716,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs3218716,SNV,,,,,,Pathogenic/Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs3218716,23233322,Hypertrophic Cardiomyopathy,Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs3218716,SNV,,,,,,Pathogenic/Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs371898076,23233322,Hypertrophic Cardiomyopathy,Egypt,North Africa,NS,FALSE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs371898076,SNV,,,,,,Pathogenic mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs2754158,8751444,Asymmetric Septal Hypertrophy,"Morocco, Spain",North Africa,NS,TRUE,< 0.05,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.,8751444,1996,DisGeNET,rs2754158,SNV,,,,,,
rs2754158,8751444,"Cardiomyopathy, Familial Hypertrophic, 1 (Disorder)","Morocco, Spain",North Africa,NS,TRUE,< 0.05,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.,8751444,1996,DisGeNET,rs2754158,SNV,,,,,,
rs2754158,8751444,"Cardiomyopathy, Hypertrophic, Familial","Morocco, Spain",North Africa,NS,TRUE,< 0.05,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.,8751444,1996,DisGeNET,rs2754158,SNV,,,,,,
rs2754158,8751444,Idiopathic Hypertrophic Subaortic Stenosis,"Morocco, Spain",North Africa,NS,TRUE,< 0.05,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.,8751444,1996,DisGeNET,rs2754158,SNV,,,,,,
rs121964857,16938236,Hypertrophic Cardiomyopathy,"Morocco, Spain",North Africa,NS,TRUE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,[Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene].,16938236,2006,DisGeNET,rs121964857,SNV,,,,,,
rs1057519899,16938236,Hypertrophic Cardiomyopathy,"Morocco, Spain",North Africa,NS,TRUE,NS,MYH7,,MYH7,myosin heavy chain 7,14,P12883,"Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing early-onset distal myopathy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,[Hypertrophic cardiomyopathy: infrequent mutation of the cardiac beta-myosin heavy-chain gene].,16938236,2006,DisGeNET,rs1057519899,SNV,,,,,,
rs727504409,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,MYH8,,MYH8,myosin heavy chain 8,17,P13535,"Myosins are actin-based motor proteins that function in the generation of mechanical force in eukaryotic cells. Muscle myosins are heterohexamers composed of 2 myosin heavy chains and 2 pairs of nonidentical myosin light chains. This gene encodes a member of the class II or conventional myosin heavy chains, and functions in skeletal muscle contraction. This gene is predominantly expressed in fetal skeletal muscle. This gene is found in a cluster of myosin heavy chain genes on chromosome 17. A mutation in this gene results in trismus-pseudocamptodactyly syndrome. [provided by RefSeq, Sep 2009].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs727504409,SNV,,,,,,Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs886037762,27440999,"Usher Syndrome, Type I",Tunisia,North Africa,NS,FALSE,NS,MYO7A,,MYO7A,myosin VIIA,11,Q13402,"This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic analysis of Tunisian families with Usher syndrome type 1: toward improving early molecular diagnosis.,27440999,2018,DisGeNET,rs886037762,SNV,,,,,,SNP not found in the specified article
rs377267777,25798947,"Usher Syndrome, Type I",Tunisia,North Africa,NS,FALSE,NS,MYO7A,,MYO7A,myosin VIIA,11,Q13402,"This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.,25798947,2015,DisGeNET,rs377267777,SNV,,,,,,
rs377267777,25798947,"Usher Syndrome, Type I, French Variety, Formerly",Tunisia,North Africa,NS,FALSE,NS,MYO7A,,MYO7A,myosin VIIA,11,Q13402,"This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.,25798947,2015,DisGeNET,rs377267777,SNV,,,,,,
rs377267777,25798947,"Usher Syndrome, Type Ia, Formerly",Tunisia,North Africa,NS,FALSE,NS,MYO7A,,MYO7A,myosin VIIA,11,Q13402,"This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.,25798947,2015,DisGeNET,rs377267777,SNV,,,,,,
rs377267777,25798947,"Usher Syndrome, Type Ib (Disorder)",Tunisia,North Africa,NS,FALSE,NS,MYO7A,,MYO7A,myosin VIIA,11,Q13402,"This gene is a member of the myosin gene family. Myosins are mechanochemical proteins characterized by the presence of a motor domain, an actin-binding domain, a neck domain that interacts with other proteins, and a tail domain that serves as an anchor. This gene encodes an unconventional myosin with a very short tail. Defects in this gene are associated with the mouse shaker-1 phenotype and the human Usher syndrome 1B which are characterized by deafness, reduced vestibular function, and (in human) retinal degeneration. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Whole exome sequencing identifies mutations in Usher syndrome genes in profoundly deaf Tunisian patients.,25798947,2015,DisGeNET,rs377267777,SNV,,,,,,
rs3003172,20400458,Body Mass Index,"Nigeria, USA",West Africa,Igbo,TRUE,3.01E-05,MYT1,,MYT1,myelin transcription factor 1,20,Q01538,"The protein encoded by this gene is a member of a family of neural specific, zinc finger-containing DNA-binding proteins. The protein binds to the promoter regions of proteolipid proteins of the central nervous system and plays a role in the developing nervous system. ",22/11/2021,PubMed,Genome-wide association of anthropometric traits in African- and African-derived populations.,20400458,2010,DisGeNET,rs3003172,SNV,,,,,,This study contains the results of many other investigated SNPs/genes as well. Seperated by African American and Nigerian analysis.
rs3003172,20400458,Body Mass Index,"Nigeria, USA",West Africa / African American/Afro-Caribbean,African American,TRUE,0.0069,MYT1,,MYT1,myelin transcription factor 1,20,Q01538,"The protein encoded by this gene is a member of a family of neural specific, zinc finger-containing DNA-binding proteins. The protein binds to the promoter regions of proteolipid proteins of the central nervous system and plays a role in the developing nervous system. ",22/11/2021,PubMed,Genome-wide association of anthropometric traits in African- and African-derived populations.,20400458,2010,DisGeNET,rs3003172,SNV,,,,,,This study contains the results of many other investigated SNPs/genes as well. Seperated by African American and Nigerian analysis.
rs144312179,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,6.24E-07,NALF1,Association,NALF1,NALCN channel auxiliary factor 1,13,B1AL88,"Predicted to contribute to stretch-activated, cation-selective, calcium channel activity. Predicted to be involved in calcium ion import across plasma membrane. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. ",22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs144312179,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the additive model."
rs587776650,16544999,Nijmegen Breakage Syndrome,"Morocco, Italy",North Africa,NS,TRUE,0.04,NBN,,NBN,nibrin,8,O60934,"Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation.",22/11/2021,PubMed,Screening of Nijmegen breakage syndrome 1 mutations in four unrelated families by polymerase chain reaction using sequence-specific primers.,16544999,2006,DisGeNET,rs587776650,SNV,,,,,,
rs267606689,19542079,Leigh Disease,Morocco,North Africa,NS,FALSE,NS,NDUFAF5,,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,20,Q5TEU4,"The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes a mitochondrial protein that is associated with the matrix face of the mitochondrial inner membrane and is required for complex I assembly. A mutation in this gene results in mitochondrial complex I deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome.,19542079,2010,DisGeNET,rs267606689,SNV,,,,,,"A consanguineous Moroccon family with Leigh syndrome comprise 11 children, three of which are affected."
rs267606689,19542079,Mitochondrial Complex I Deficiency,Morocco,North Africa,NS,FALSE,NS,NDUFAF5,,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,20,Q5TEU4,"The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes a mitochondrial protein that is associated with the matrix face of the mitochondrial inner membrane and is required for complex I assembly. A mutation in this gene results in mitochondrial complex I deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Defective complex I assembly due to C20orf7 mutations as a new cause of Leigh syndrome.,19542079,2010,DisGeNET,rs267606689,SNV,,,,,,"A consanguineous Moroccon family with Leigh syndrome comprise 11 children, three of which are affected."
rs118203929,18940309,Mitochondrial Complex I Deficiency,Egypt,North Africa,NS,FALSE,NS,NDUFAF5,,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,20,Q5TEU4,"The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes a mitochondrial protein that is associated with the matrix face of the mitochondrial inner membrane and is required for complex I assembly. A mutation in this gene results in mitochondrial complex I deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease.,18940309,2008,DisGeNET,rs118203929,SNV,,,,,,
rs267606689,18940309,Mitochondrial Complex I Deficiency,Egypt,North Africa,NS,FALSE,NS,NDUFAF5,,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,20,Q5TEU4,"The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes a mitochondrial protein that is associated with the matrix face of the mitochondrial inner membrane and is required for complex I assembly. A mutation in this gene results in mitochondrial complex I deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease.,18940309,2008,DisGeNET,rs267606689,SNV,,,,,,
rs118203929,18940309,NAdh:Q(1) Oxidoreductase Deficiency,Egypt,North Africa,NS,FALSE,NS,NDUFAF5,,NDUFAF5,NADH:ubiquinone oxidoreductase complex assembly factor 5,20,Q5TEU4,"The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes a mitochondrial protein that is associated with the matrix face of the mitochondrial inner membrane and is required for complex I assembly. A mutation in this gene results in mitochondrial complex I deficiency. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease.,18940309,2008,DisGeNET,rs118203929,SNV,,,,,,
rs267606991,20691405,Ectodermal Dysplasia-Syndactyly Syndrome 1,Algeria,North Africa,NS,FALSE,NS,NECTIN4,,NECTIN4,nectin cell adhesion molecule 4,1,Q96NY8,"This gene encodes a member of the nectin family. The encoded protein contains two immunoglobulin-like (Ig-like) C2-type domains and one Ig-like V-type domain. It is involved in cell adhesion through trans-homophilic and -heterophilic interactions. It is a single-pass type I membrane protein. The soluble form is produced by proteolytic cleavage at the cell surface by the metalloproteinase ADAM17/TACE. The secreted form is found in both breast tumor cell lines and breast tumor patients. Mutations in this gene are the cause of ectodermal dysplasia-syndactyly syndrome type 1, an autosomal recessive disorder. Alternatively spliced transcript variants have been found but the full-length nature of the variant has not been determined.[provided by RefSeq, Jan 2011].",22/11/2021,PubMed,"Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome.",20691405,2010,DisGeNET,rs267606991,SNV,,,,,,
rs267606992,20691405,Ectodermal Dysplasia-Syndactyly Syndrome 1,Algeria,North Africa,NS,FALSE,NS,NECTIN4,,NECTIN4,nectin cell adhesion molecule 4,1,Q96NY8,"This gene encodes a member of the nectin family. The encoded protein contains two immunoglobulin-like (Ig-like) C2-type domains and one Ig-like V-type domain. It is involved in cell adhesion through trans-homophilic and -heterophilic interactions. It is a single-pass type I membrane protein. The soluble form is produced by proteolytic cleavage at the cell surface by the metalloproteinase ADAM17/TACE. The secreted form is found in both breast tumor cell lines and breast tumor patients. Mutations in this gene are the cause of ectodermal dysplasia-syndactyly syndrome type 1, an autosomal recessive disorder. Alternatively spliced transcript variants have been found but the full-length nature of the variant has not been determined.[provided by RefSeq, Jan 2011].",22/11/2021,PubMed,"Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome.",20691405,2010,DisGeNET,rs267606992,SNV,,,,,,
rs730880260,20691405,Ectodermal Dysplasia-Syndactyly Syndrome 1,Algeria,North Africa,NS,FALSE,NS,NECTIN4,,NECTIN4,nectin cell adhesion molecule 4,1,Q96NY8,"This gene encodes a member of the nectin family. The encoded protein contains two immunoglobulin-like (Ig-like) C2-type domains and one Ig-like V-type domain. It is involved in cell adhesion through trans-homophilic and -heterophilic interactions. It is a single-pass type I membrane protein. The soluble form is produced by proteolytic cleavage at the cell surface by the metalloproteinase ADAM17/TACE. The secreted form is found in both breast tumor cell lines and breast tumor patients. Mutations in this gene are the cause of ectodermal dysplasia-syndactyly syndrome type 1, an autosomal recessive disorder. Alternatively spliced transcript variants have been found but the full-length nature of the variant has not been determined.[provided by RefSeq, Jan 2011].",22/11/2021,PubMed,"Mutations in PVRL4, encoding cell adhesion molecule nectin-4, cause ectodermal dysplasia-syndactyly syndrome.",20691405,2010,DisGeNET,rs730880260,SNV,,,,,,
rs1008899,23353631,Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981747509,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",
rs1008899,23353631,Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981747509,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",
rs292449,23353631,Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981741019,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",
rs292449,23353631,Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981741019,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",
rs4149601,23353631,Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981732098,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide",
rs1008899,23353631,Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981747509,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",
rs1008899,23353631,Allele A is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981747509,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",
rs292449,23353631,Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981741019,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",
rs292449,23353631,Allele C is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981741019,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",
rs4149601,23353631,Allele G is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,NS,NEDD4L,,NEDD4L,NEDD4 like E3 ubiquitin protein ligase,18,Q96PU5,"This gene encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases. HECT domain E3 ubiquitin ligases transfer ubiquitin from E2 ubiquitin-conjugating enzymes to protein substrates, thus targeting specific proteins for lysosomal degradation. The encoded protein mediates the ubiquitination of multiple target substrates and plays a critical role in epithelial sodium transport by regulating the cell surface expression of the epithelial sodium channel, ENaC. Single nucleotide polymorphisms in this gene may be associated with essential hypertension. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,Association of variants in NEDD4L with blood pressure response and adverse cardiovascular outcomes in hypertensive patients treated with thiazide diuretics.,23353631,2013,PharmGKB,981732098,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide",
rs6021191,25987655,Acute Lymphocytic Leukemia,"Africa, America, Asia, Europe",Africa,NS,TRUE,0.000000041,NFATC2,,NFATC2,"nuclear factor of activated T cells 2	",20,Q13469,"This gene is a member of the nuclear factor of activated T cells (NFAT) family. The product of this gene is a DNA-binding protein with a REL-homology region (RHR) and an NFAT-homology region (NHR). This protein is present in the cytosol and only translocates to the nucleus upon T cell receptor (TCR) stimulation, where it becomes a member of the nuclear factors of activated T cells transcription complex. This complex plays a central role in inducing gene transcription during the immune response. Alternate transcriptional splice variants encoding different isoforms have been characterized. ",22/11/2021,PubMed,Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.,25987655,2015,DisGeNET,rs6021191,SNV,,,,,,
rs6021191,25987655,Precursor Cell Lymphoblastic Leukemia Lymphoma,"Africa, America, Asia, Europe",Africa,NS,TRUE,0.000000041,NFATC2,,NFATC2,"nuclear factor of activated T cells 2	",20,Q13469,"This gene is a member of the nuclear factor of activated T cells (NFAT) family. The product of this gene is a DNA-binding protein with a REL-homology region (RHR) and an NFAT-homology region (NHR). This protein is present in the cytosol and only translocates to the nucleus upon T cell receptor (TCR) stimulation, where it becomes a member of the nuclear factors of activated T cells transcription complex. This complex plays a central role in inducing gene transcription during the immune response. Alternate transcriptional splice variants encoding different isoforms have been characterized. ",22/11/2021,PubMed,Genome-wide analysis links NFATC2 with asparaginase hypersensitivity.,25987655,2015,DisGeNET,rs6021191,SNV,,,,,,
rs199422217,15317751,"Ichthyosiform Erythroderma, Congenital","Algeria, Colombia, Syria, Turkey",North Africa,NS,TRUE,NS,NIPAL4,,NIPAL4,NIPA like domain containing 4,5,Q0D2K0,"This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis.,15317751,2005,DisGeNET,rs199422217,SNV,,,,,,
rs199422216,15317751,"Ichthyosis, Congenital, Autosomal Recessive 6","Algeria, Colombia, Syria, Turkey",North Africa,NS,TRUE,NS,NIPAL4,,NIPAL4,NIPA like domain containing 4,5,Q0D2K0,"This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis.,15317751,2005,DisGeNET,rs199422216,SNV,,,,,,
rs199422217,15317751,"Ichthyosis, Congenital, Autosomal Recessive 6","Algeria, Colombia, Syria, Turkey",North Africa,NS,TRUE,NS,NIPAL4,,NIPAL4,NIPA like domain containing 4,5,Q0D2K0,"This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis.,15317751,2005,DisGeNET,rs199422217,SNV,,,,,,
rs375688767,15317751,"Ichthyosis, Congenital, Autosomal Recessive 6","Algeria, Colombia, Syria, Turkey",North Africa,NS,TRUE,NS,NIPAL4,,NIPAL4,NIPA like domain containing 4,5,Q0D2K0,"This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis.,15317751,2005,DisGeNET,rs375688767,SNV,,,,,,
rs775903553,15317751,"Ichthyosis, Congenital, Autosomal Recessive 6","Algeria, Colombia, Syria, Turkey",North Africa,NS,TRUE,NS,NIPAL4,,NIPAL4,NIPA like domain containing 4,5,Q0D2K0,"This gene likely encodes a membrane receptor. Mutations in this gene have been associated with autosomal recessive congenital ichthyosis. [provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis.,15317751,2005,DisGeNET,rs775903553,SNV,,,,,,
rs180177478,17284928,Familial Cold Urticaria,Ethiopia,East Africa,Jewish,FALSE,NS,NLRP3,,NLRP3,NLR family pyrin domain containing 3,1,Q96P20,"This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin.",17284928,2007,DisGeNET,rs180177478,SNV,,,,,,The mutation was shown to affect a highly conserved residue of the protein and to segregate with the disease throughout the extended family.
rs121908150,11992256,Familial Cold Urticaria,"Algeria, England, France",North Africa,NS,TRUE,NS,NLRP3,"Genetic variability study,Linkage",NLRP3,NLR family pyrin domain containing 3,1,Q96P20,"This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.,11992256,2002,DisGeNET,rs121908150,SNV,,,,,,"Identified NLPR3 (alias CIAS1) mutations, all locatedin exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France,England, and Algeria. Five mutationsâ€”namely, R260W, D303N, T348M, A439T, and G569Râ€”were novel. sequences allowed to identify four SNPs located in exon 3 of the NLPR3 gene. These SNPs are localized on the third base of codons 219 (C/T), 242 (A/G), 260 (A/G), and 434 (C/T), and they do not modify the encoded amino acid"
rs121908150,11992256,Muckle-Wells Syndrome,"Algeria, England, France",North Africa,NS,TRUE,NS,NLRP3,"Genetic variability study,Linkage",NLRP3,NLR family pyrin domain containing 3,1,Q96P20,"This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.,11992256,2002,DisGeNET,rs121908150,SNV,,,,,,"Identified CIAS1 mutations, all locatedin exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France,England, and Algeria. Five mutationsâ€”namely, R260W, D303N, T348M, A439T, and G569Râ€”were novel. sequences allowed to identify four SNPs located in exon 3 of the CIAS1 gene. These SNPs are localized on the third base of codons 219 (C/T), 242 (A/G), 260 (A/G), and 434 (C/T), and they do not modify the encoded amino acid"
rs121908151,11992256,Muckle-Wells Syndrome,"Algeria, England, France",North Africa,NS,TRUE,NS,NLRP3,"Genetic variability study,Linkage",NLRP3,NLR family pyrin domain containing 3,1,Q96P20,"This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.,11992256,2002,DisGeNET,rs121908151,SNV,,,,,,"Identified CIAS1 mutations, all locatedin exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France,England, and Algeria. Five mutationsâ€”namely, R260W, D303N, T348M, A439T, and G569Râ€”were novel. sequences allowed to identify four SNPs located in exon 3 of the CIAS1 gene. These SNPs are localized on the third base of codons 219 (C/T), 242 (A/G), 260 (A/G), and 434 (C/T), and they do not modify the encoded amino acid"
rs180177430,11992256,Muckle-Wells Syndrome,"Algeria, England, France",North Africa,NS,TRUE,NS,NLRP3,"Genetic variability study,Linkage",NLRP3,NLR family pyrin domain containing 3,1,Q96P20,"This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes.,11992256,2002,DisGeNET,rs180177430,SNV,,,,,,"Identified CIAS1 mutations, all locatedin exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France,England, and Algeria. Five mutationsâ€”namely, R260W, D303N, T348M, A439T, and G569Râ€”were novel. sequences allowed to identify four SNPs located in exon 3 of the CIAS1 gene. These SNPs are localized on the third base of codons 219 (C/T), 242 (A/G), 260 (A/G), and 434 (C/T), and they do not modify the encoded amino acid"
rs104895506,19054016,Gestational Trophoblastic Disease,Morocco,North Africa,NS,FALSE,NS,NLRP7,Genetic variability study,NLRP7,NLR family pyrin domain containing 7,19,Q8WX94,"This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous NLRP7 mutations in a Moroccan woman with recurrent reproductive failure.,19054016,2009,DisGeNET,rs104895506,SNV,,,,,,This is the first patient (A report on one woman) with North-African origin. Mutation screening of NLRP7 could be proposed more systematically in women with recurrent pathological pregnancy outcomes of unknown origin.
rs606231234,21623199,Complete Hydatidiform Mole,Tunisia,North Africa,NS,FALSE,NS,NLRP7,,NLRP7,NLR family pyrin domain containing 7,19,Q8WX94,"This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Screening for NLRP7 mutations in familial and sporadic recurrent hydatidiform moles: report of 2 Tunisian families.,21623199,2011,DisGeNET,rs606231234,SNV,,,,,,
rs886039789,27129361,Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency,Algeria,North Africa,NS,FALSE,NS,NNT,,NNT,nicotinamide nucleotide transhydrogenase,5,Q13423,"This gene encodes an integral protein of the inner mitochondrial membrane. The enzyme couples hydride transfer between NAD(H) and NADP(+) to proton translocation across the inner mitochondrial membrane. Under most physiological conditions, the enzyme uses energy from the mitochondrial proton gradient to produce high concentrations of NADPH. The resulting NADPH is used for biosynthesis and in free radical detoxification. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.",27129361,2017,DisGeNET,rs886039789,SNV,,,,,,
rs886039790,27129361,Glucocorticoid Deficiency 4 With Or Without Mineralocorticoid Deficiency,Algeria,North Africa,NS,FALSE,NS,NNT,,NNT,nicotinamide nucleotide transhydrogenase,5,Q13423,"This gene encodes an integral protein of the inner mitochondrial membrane. The enzyme couples hydride transfer between NAD(H) and NADP(+) to proton translocation across the inner mitochondrial membrane. Under most physiological conditions, the enzyme uses energy from the mitochondrial proton gradient to produce high concentrations of NADPH. The resulting NADPH is used for biosynthesis and in free radical detoxification. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,"NNT mutations: a cause of primary adrenal insufficiency, oxidative stress and extra-adrenal defects.",27129361,2017,DisGeNET,rs886039790,SNV,,,,,,
rs17313265,25259511,Crohn Disease,Puerto Rico,African American/Afro-Caribbean,African American,TRUE,9.36E-06,NOD2,Association,NOD2,nucleotide binding oligomerization domain containing 2,16,Q9HC29,"This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014].",22/11/2021,PubMed,Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico.,25259511,2015,DisGeNET,rs17313265,SNV,,,,,,No additional information on the cohort origin is available. It is assumed that the population of Puerto Rico is a mixed one with african ancestry contribution.
rs2066844,15712650,Crohn Disease,Tunisia,North Africa,NS,FALSE,NS,NOD2,,NOD2,nucleotide binding oligomerization domain containing 2,16,Q9HC29,"This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014].",22/11/2021,PubMed,CARD15/NOD2 in a Tunisian population with Crohn's disease.,15712650,2005,DisGeNET,rs2066844,SNV,,,,,,No association between NOD2 and Crohn Disease observed in the study.
rs2066845,26167078,Crohn Disease,Algeria,North Africa,NS,FALSE,NS,NOD2,,NOD2,nucleotide binding oligomerization domain containing 2,16,Q9HC29,"This gene is a member of the Nod1/Apaf-1 family and encodes a protein with two caspase recruitment (CARD) domains and six leucine-rich repeats (LRRs). The protein is primarily expressed in the peripheral blood leukocytes. It plays a role in the immune response to intracellular bacterial lipopolysaccharides (LPS) by recognizing the muramyl dipeptide (MDP) derived from them and activating the NFKB protein. Mutations in this gene have been associated with Crohn disease and Blau syndrome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jun 2014].",22/11/2021,PubMed,NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.,26167078,2016,DisGeNET,rs2066845,SNV,,,,,,"""three NOD2 variants showed a significant association with CD but did not reach statistical significance"""
rs17728971,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,6.50E-07,Non-genic,,Non-genic,NA,14,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs17728971,SNV,,,,,,
rs6572335,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,9.30E-07,Non-genic,,Non-genic,NA,14,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs6572335,SNV,,,,,,
rs2057178,22306650,Tuberculosis,"Gambia, Ghana, Indonesia, Russian",West Africa,NS,TRUE,4.87E-04,Non-genic,Association,Non-genic,NA,11,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Common variants at 11p13 are associated with susceptibility to tuberculosis.,22306650,2012,DisGeNET,rs2057178,SNV,,,,,,The study reports on 1329 TB cases and 1847 controls genotyped using Affymetrix SNP Array 6.0.
rs7918885,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,1.29E-07,Non genic,Association,Non-genic,NA,10,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs7918885,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs1799983,24095258,Myocardial Infarction,Tunisia,North Africa,Arab,FALSE,< 0.001,NOS3,,NOS3,nitric oxide synthase 3,7,P29474,"Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016].",22/11/2021,PubMed,Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.,24095258,2014,DisGeNET,rs1799983,SNV,,,,,,"The authors defined the cohort as ""Tunisian Arab descendents who resided in Tunisia and all were from North Tunisia"". "
rs2070744,24095258,Myocardial Infarction,Tunisia,North Africa,Arab,FALSE,< 0.001,NOS3,,NOS3,nitric oxide synthase 3,7,P29474,"Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. Nitric oxide is synthesized from L-arginine by nitric oxide synthases. Variations in this gene are associated with susceptibility to coronary spasm. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Oct 2016].",22/11/2021,PubMed,Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.,24095258,2014,DisGeNET,rs2070744,SNV,,,,,,"The authors defined the cohort as ""Tunisian Arab descendents who resided in Tunisia and all were from North Tunisia"". "
rs11694,11567215,"Niemann-Pick Disease, Type C2","Algeria, Europe",North Africa,NS,TRUE,0,NPC2,,NPC2,"NPC intracellular cholesterol rransporter 2	",14,P61916,"This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. ",22/11/2021,PubMed,Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.,11567215,2001,DisGeNET,rs11694,SNV,,,,,,
rs80358260,11567215,"Niemann-Pick Disease, Type C2","Algeria, Europe",North Africa,NS,TRUE,1.45E-10,NPC2,,NPC2,"NPC intracellular cholesterol rransporter 2	",14,P61916,"This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. ",22/11/2021,PubMed,Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.,11567215,2001,DisGeNET,rs80358260,SNV,,,,,,
rs80358266,11567215,"Niemann-Pick Disease, Type C2","Algeria, Europe",North Africa,NS,TRUE,1.45E-10,NPC2,,NPC2,"NPC intracellular cholesterol rransporter 2	",14,P61916,"This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. ",22/11/2021,PubMed,Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.,11567215,2001,DisGeNET,rs80358266,SNV,,,,,,
rs80358268,11567215,"Niemann-Pick Disease, Type C2","Algeria, Europe",North Africa,NS,TRUE,1.45E-10,NPC2,,NPC2,"NPC intracellular cholesterol rransporter 2	",14,P61916,"This gene encodes a protein containing a lipid recognition domain. The encoded protein may function in regulating the transport of cholesterol through the late endosomal/lysosomal system. Mutations in this gene have been associated with Niemann-Pick disease, type C2 and frontal lobe atrophy. ",22/11/2021,PubMed,Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.,11567215,2001,DisGeNET,rs80358268,SNV,,,,,,
rs387907373,21739173,X-Linked Adrenal Hypoplasia,Congo,Central Africa,NS,FALSE,NS,NR0B1,,NR0B1,nuclear receptor subfamily 0 group B member 1,X,P51843,"This gene encodes a protein that contains a DNA-binding domain. The encoded protein acts as a dominant-negative regulator of transcription which is mediated by the retinoic acid receptor. This protein also functions as an anti-testis gene by acting antagonistically to Sry. Mutations in this gene result in both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,X-linked adrenal hypoplasia congenita: a novel DAX1 missense mutation and challenges for clinical diagnosis in Africa.,21739173,2012,DisGeNET,rs387907373,SNV,,,,,,
rs12721616,30100615,Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele C.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.01,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733085,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmaxâ€‰<â€‰7â€‰ng/ml)
rs1054191,26779253,Genotype GG is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AA + AG.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.1553,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680871,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3814057,26779253,Genotype AA is not associated with concentrations of efavirenz in people with HIV as compared to genotypes AC + CC.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.3185,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680877,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs1054190,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.7802,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680865,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs3732360,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.9843,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680859,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs1523130,22111602,Genotypes CC + CT are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype TT.,Malawi,East Africa,NS,FALSE,NS,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823838,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",NR1I2 44477T>C (rs1523130)
rs2472677,22111602,Genotypes CT + TT are not associated with decreased clearance of nevirapine in people with HIV as compared to genotype CC.,Malawi,East Africa,NS,FALSE,NS,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823858,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",NR1I2 63396C>T (rs2472677)
rs3842689,22111602,Genotypes GAGAAG/DEL + DEL/DEL are associated with increased clearance of nevirapine in people with HIV as compared to genotype GAGAAG/GAGAAG.,Malawi,East Africa,NS,FALSE,NS,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians.,22111602,2012,PharmGKB,827823690,SNV,nevirapine,DB00238,Approved,For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.,"11-cyclopropyl-4-methyl-5,11-dihydro-6H- dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one",NR1I2 6-bp indel (rs3842689)
rs3814055,23252947,Allele T is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,0.04,NR1I2,Association,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501880,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",The association is reported for clearance measures in epilepsy patients receiving carbamazepine treatment for allele rs3814055 (C>T) in 30 African-Americans.
rs1523130,26892777,Genotype CC (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes CT + TT.,"South Africa, USA, Peru",South Africa / African American/Afro-Caribbean,NS,TRUE,0.65,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).,26892777,2017,PharmGKB,1447947686,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs2472677,26892777,Genotype CT (assigned as deficiency phenotype) is associated with decreased concentrations of atazanavir in people with HIV as compared to genotypes CC + TT.,"South Africa, USA, Peru",South Africa / African American/Afro-Caribbean,NS,TRUE,0.89,NR1I2,,NR1I2,nuclear receptor subfamily 1 group I member 2,3,O75469,"This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).,26892777,2017,PharmGKB,1447947668,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs2502815,23173844,Genotype AA is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype GG.,South Africa,South Africa,NS,FALSE,0.424,NR1I3,,NR1I3,nuclear receptor subfamily 1 group I member 3,1,Q14994,"This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.,23173844,2013,PharmGKB,1184512552,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",NR1I3 rs2502815T/T
rs3003596,23173844,Genotype GG is associated with increased metabolism of efavirenz in people with HIV Infections as compared to genotype AA.,South Africa,South Africa,NS,FALSE,0.424,NR1I3,,NR1I3,nuclear receptor subfamily 1 group I member 3,1,Q14994,"This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.,23173844,2013,PharmGKB,1184512504,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",NR1I3rs3003596C/C
rs2307424,23173844,Genotype GG is not associated with metabolism of efavirenz in people with HIV Infections as compared to genotype AG.,South Africa,South Africa,NS,FALSE,0.424,NR1I3,,NR1I3,nuclear receptor subfamily 1 group I member 3,1,Q14994,"This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,PXR and CAR single nucleotide polymorphisms influence plasma efavirenz levels in South African HIV/AIDS patients.,23173844,2013,PharmGKB,1184512556,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",NR1I3 rs2307424C>T
rs398122810,19250380,Hsan Type Iv,Morocco,North Africa,Jewish,FALSE,NS,NTRK1,,NTRK1,neurotrophic receptor tyrosine kinase 1,1,P04629,"This gene encodes a member of the neurotrophic tyrosine kinase receptor (NTKR) family. This kinase is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. The presence of this kinase leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in this gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, cognitive disability and cancer. Alternate transcriptional splice variants of this gene have been found, but only three have been characterized to date. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Skoura - a genetic island for congenital insensitivity to pain and anhidrosis among Moroccan Jews, as determined by a novel mutation in the NTRK1 gene.",19250380,2009,DisGeNET,rs398122810,SNV,,,,,,
rs121918167,10649493,"Albinism, Oculocutaneous",South Africa,South Africa,NS,FALSE,NS,OCA2,,OCA2,OCA2 melanosomal transmembrane protein,15,Q04671,"This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.,10649493,2000,DisGeNET,rs121918167,SNV,,,,,,Pathogenic variant described in patient with Oculocutaneous albinism. 
rs533478642,10649493,"Albinism, Oculocutaneous",South Africa,South Africa,NS,FALSE,NS,OCA2,,OCA2,OCA2 melanosomal transmembrane protein,15,Q04671,"This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.,10649493,2000,DisGeNET,rs533478642,SNV,,,,,,Pathogenic variant described in patient with Oculocutaneous albinism. 
rs577826548,10649493,"Albinism, Oculocutaneous",South Africa,South Africa,NS,FALSE,NS,OCA2,,OCA2,OCA2 melanosomal transmembrane protein,15,Q04671,"This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.,10649493,2000,DisGeNET,rs577826548,SNV,,,,,,Pathogenic variant described in patient with Oculocutaneous albinism. 
rs34731820,10649493,"Albinism, Oculocutaneous","South Africa, Zambia",South Africa,NS,TRUE,NS,OCA2,,OCA2,OCA2 melanosomal transmembrane protein,15,Q04671,"This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.,10649493,2000,DisGeNET,rs34731820,SNV,,,,,,Pathogenic variant described in patient with Oculocutaneous albinism. 
rs121918168,10649493,Brown Oculocutaneous Albinism,"South Africa, Zambia",South Africa,NS,TRUE,NS,OCA2,,OCA2,OCA2 melanosomal transmembrane protein,15,Q04671,"This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.,10649493,2000,DisGeNET,rs121918168,SNV,,,,,,
rs121918168,10649493,Oculocutaneous Albinism Type 2,"South Africa, Zambia",South Africa,NS,TRUE,NS,OCA2,,OCA2,OCA2 melanosomal transmembrane protein,15,Q04671,"This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].",22/11/2021,PubMed,Identification of P gene mutations in individuals with oculocutaneous albinism in sub-Saharan Africa.,10649493,2000,DisGeNET,rs121918168,SNV,,,,,,Pathogenic variant described in patient with Oculocutaneous albinism type 2.
rs678849,23612435,Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.008,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449753059,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs678849 is assigned to OPRD1 gene in this study and it's associated with decreased response to buprenorphine in African-Americans with Opioid-Related Disorder
rs678849,23612435,Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.008,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157145,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs678849 is assigned to OPRD1 gene in this study and it's associated with decreased response to buprenorphine in African-Americans with Opioid-Related Disorder
rs529520,23612435,Allele C is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,0.28,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157166,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs529520 is assigned to OPRD1 gene in this study and not associated with response to buprenorphine in African-Americans with Opioid-Related Disorder
rs2234918,23612435,Allele T is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,0.76,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157181,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs2234918 is assigned to (G307G) in the OPRD1 gene in this study and not associated with response to buprenorphine in African-Americans with Opioid-Related Disorder
rs581111,23612435,Allele G is not associated with response to buprenorphine in people with Opioid-Related Disorders as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,0.84,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157174,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs581111 is assigned to OPRD1 gene in this study and not associated with response to buprenorphine in African-Americans with Opioid-Related Disorder
rs678849,30368523,Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.021,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioidÂ use disorder.,30368523,2018,PharmGKB,1449753059,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs678849 is assigned to OPRD1 gene in this study and it's associated with decreased response to buprenorphine in African-Americans with Opioid-Related Disorder
rs678849,30368523,Genotype CC is associated with decreased response to buprenorphine in people with Opioid-Related Disorders as compared to genotypes CT + TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.021,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioidÂ use disorder.,30368523,2018,PharmGKB,1449157145,SNV,buprenorphine,DB00921,"Approved, Illicit, Investigational","For the treatment of moderate to severe pain, peri-operative analgesia, and opioid dependence.","(2S)-2-[(5R,6R,7R,14S)-17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol",rs678849 is assigned to OPRD1 gene in this study and it's associated with decreased response to buprenorphine in African-Americans with Opioid-Related Disorder
rs678849,23612435,Genotype CC is associated with increased response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.001,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157237,SNV,methadone,DB00333,Approved,"Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.","6-(dimethylamino)-4,4-diphenylheptan-3-one",rs678849 is assigned to the OPRD1 gene in this study and itâ€™s associated with increased response to methadone in African-Americans with Opioid-Related Disorder
rs2234918,23612435,Allele T is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,0.07,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157271,SNV,methadone,DB00333,Approved,"Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.","6-(dimethylamino)-4,4-diphenylheptan-3-one",rs2234918 is assigned to OPRD1 gene in this study and not associated with response to methadone in African-Americans with Opioid-Related Disorder
rs581111,23612435,Allele G is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,0.17,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157264,SNV,methadone,DB00333,Approved,"Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.","6-(dimethylamino)-4,4-diphenylheptan-3-one",rs581111 is assigned to OPRD1 gene in this study and not associated with response to methadone in African-Americans with Opioid-Related Disorder
rs529520,23612435,Allele C is not associated with response to methadone in people with Opioid-Related Disorders as compared to allele A.,USA,African American/Afro-Caribbean,NS,FALSE,NS,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.,23612435,2014,PharmGKB,1449157257,SNV,methadone,DB00333,Approved,"Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.","6-(dimethylamino)-4,4-diphenylheptan-3-one",rs529520 is assigned to OPRD1 gene in this study and not associated with response to methadone in African-Americans with Opioid-Related Disorder
rs678849,30368523,Genotype CC is not associated with response to methadone in people with Opioid-Related Disorders as compared to genotypes CT + TT.,USA,African American/Afro-Caribbean,NS,FALSE,0.087,OPRD1,,OPRD1,opioid receptor delta 1,1,P41143,"Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Is intrinsic component of plasma membrane. ",22/11/2021,PubMed,Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioidÂ use disorder.,30368523,2018,PharmGKB,1449753070,SNV,methadone,DB00333,Approved,"Methadone is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatment options are inadequate. It's recommended that use is reserved for use in patients for whom alternative treatment options (eg, nonopioid analgesics, opioid combination products) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. Methadone is also indicated for detoxification treatment of opioid addiction (heroin or other morphine-like drugs), and for maintenance substitution treatment for opioid dependence in adults in conjunction with appropriate social and medical services.","6-(dimethylamino)-4,4-diphenylheptan-3-one",rs678849 is assigned to OPRD1 gene in this study and not associated with response to methadone in African-Americans with Opioid-Related Disorder
rs1051660,29259946,Allele A is associated with decreased dose of morphine in people with Pain as compared to allele C.,Tunisia,North Africa,NS,FALSE,0.02,OPRM1,,OPRM1,opioid receptor mu 1,6,P35372,"This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013].",22/11/2021,PubMed,Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment.,29259946,2017,PharmGKB,1449182301,SNV,morphine,DB00295,"Approved, Investigational","Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse.","(4R,4aR,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",rs1051660 is assigned to 36 G>T allele in the OPRM1 gene in this study and is not associated with bone metastasis in cancer patients
rs17174629,29259946,Allele G is not associated with dose of morphine in people with Pain as compared to allele A.,Tunisia,North Africa,NS,FALSE,NS,OPRM1,,OPRM1,opioid receptor mu 1,6,P35372,"This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013].",22/11/2021,PubMed,Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment.,29259946,2017,PharmGKB,1449182316,SNV,morphine,DB00295,"Approved, Investigational","Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse.","(4R,4aR,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",rs17174629 is assigned to âˆ’1320 A>G allele in the OPRM1 gene in this study and is not associated with dose of morphine in people with Pain
rs1799971,29259946,Allele G is not associated with dose of morphine in people with Pain as compared to allele A.,Tunisia,North Africa,NS,FALSE,NS,OPRM1,,OPRM1,opioid receptor mu 1,6,P35372,"This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013].",22/11/2021,PubMed,Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment.,29259946,2017,PharmGKB,1449182322,SNV,morphine,DB00295,"Approved, Investigational","Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse.","(4R,4aR,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",rs1799971 is assigned to 118 A>G allele in the OPRM1 gene in this study and is not associated with dose of morphine in people with Pain
rs1799972,29259946,Allele T is not associated with dose of morphine in people with Pain as compared to allele C.,Tunisia,North Africa,NS,FALSE,NS,OPRM1,,OPRM1,opioid receptor mu 1,6,P35372,"This gene encodes one of at least three opioid receptors in humans; the mu opioid receptor (MOR). The MOR is the principal target of endogenous opioid peptides and opioid analgesic agents such as beta-endorphin and enkephalins. The MOR also has an important role in dependence to other drugs of abuse, such as nicotine, cocaine, and alcohol via its modulation of the dopamine system. The NM_001008503.2:c.118A>G allele has been associated with opioid and alcohol addiction and variations in pain sensitivity but evidence for it having a causal role is conflicting. Multiple transcript variants encoding different isoforms have been found for this gene. Though the canonical MOR belongs to the superfamily of 7-transmembrane-spanning G-protein-coupled receptors some isoforms of this gene have only 6 transmembrane domains. [provided by RefSeq, Oct 2013].",22/11/2021,PubMed,Genetic Analysis of Mu and Kappa Opioid Receptor and COMT Enzyme in Cancer Pain Tunisian Patients Under Opioid Treatment.,29259946,2017,PharmGKB,1449182334,SNV,morphine,DB00295,"Approved, Investigational","Morphine is used for the management of chronic moderate-to-severe pain. Opioids, including morphine, can manage pain effectively when used for a short amount of time. The use of opioids for longer periods needs to be monitored as they can develop a physical dependence, addiction disorder and drug abuse.","(4R,4aR,7S,7aR,12bS)-3-Methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol",rs1799972 is assigned to 17C>T allele in the OPRM1 gene in this study and is not associated with dose of morphine in people with Pain
rs773429181,17301963,Auditory Neuropathy Spectrum Disorder,Morocco,North Africa,NS,TRUE,NS,OTOF,Genetic variability study,OTOF,otoferlin,2,Q9HC10,"Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction.,17301963,2007,DisGeNET,rs773429181,SNV,,,,,,The rs773429181 is a missens variant on the OTOF gene whereas the paper report on 2 other variants on 2 other different genes (DBNF59 and MERTK).
rs2046934,28261502,Allele G is associated with resistance to clopidogrel in people with Acute coronary syndrome as compared to allele A.,Morocco,North Africa,NS,FALSE,< 0.05,P2RY12,,P2RY12,purinergic receptor P2Y12,3,Q9H244,"The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013].",22/11/2021,PubMed,Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?,28261502,2017,PharmGKB,1448604375,SNV,clopidogrel,DB00758,Approved,"Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease.","methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate",rs2046934 is assigned to T744C in the P2Y12 gene in this study and it's associated with resistance to clopidogrel in people with Acute coronary syndrome
rs72659351,22281939,"Osteogenesis Imperfecta, Type Viii","Ghana, Nigeria, USA",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,P3H1,,P3H1,prolyl 3-hydroxylase 1,1,Q32P28,"This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta.,22281939,2012,DisGeNET,rs72659351,SNV,,,,,,
rs72659348,17277775,"Osteogenesis Imperfecta, Type Viii","Ghana, Nigeria, USA, Pakistan",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,P3H1,,P3H1,prolyl 3-hydroxylase 1,1,Q32P28,"This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.,17277775,2007,DisGeNET,rs72659348,SNV,,,,,,
rs72659351,17277775,"Osteogenesis Imperfecta, Type Viii","Ghana, Nigeria, USA, Pakistan",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,P3H1,,P3H1,prolyl 3-hydroxylase 1,1,Q32P28,"This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.,17277775,2007,DisGeNET,rs72659351,SNV,,,,,,
rs72659354,17277775,"Osteogenesis Imperfecta, Type Viii","Ghana, Nigeria, USA, Pakistan",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,P3H1,,P3H1,prolyl 3-hydroxylase 1,1,Q32P28,"This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.,17277775,2007,DisGeNET,rs72659354,SNV,,,,,,
rs72659355,17277775,"Osteogenesis Imperfecta, Type Viii","Ghana, Nigeria, USA, Pakistan",West Africa / African American/Afro-Caribbean,NS,TRUE,NS,P3H1,,P3H1,prolyl 3-hydroxylase 1,1,Q32P28,"This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.,17277775,2007,DisGeNET,rs72659355,SNV,,,,,,
rs62508646,8095248,Phenylketonurias,"Morocco, Tunisia",North Africa,NS,TRUE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.",8095248,1993,DisGeNET,rs62508646,SNV,,,,,,
rs62508646,8095248,Classical Phenylketonuria,"Morocco, Tunisia",North Africa,NS,TRUE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in north African Jews with phenylketonuria.",8095248,1993,DisGeNET,rs62508646,SNV,,,,,,
rs5030845,10196714,Phenylketonurias,Egypt,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Haplotypes and mutations of the PAH locus in Egyptian families with PKU.,10196714,1999,DisGeNET,rs5030845,SNV,,,,,,
rs62508698,2564729,Classical Phenylketonuria,Algeria,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency.,2564729,1989,DisGeNET,rs62508698,SNV,,,,,,
rs62508698,2564729,"Hyperphenylalaninemia, Non-Pku Mild",Tunisia,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency.,2564729,1989,DisGeNET,rs62508698,SNV,,,,,,
rs62508698,2564729,"Phenylketonuria, Maternal",Algeria,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency.,2564729,1989,DisGeNET,rs62508698,SNV,,,,,,
rs62508698,2564729,Phenylketonurias,Algeria,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency.,2564729,1989,DisGeNET,rs62508698,SNV,,,,,,
rs62508734,2564729,Phenylketonurias,Algeria,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency.,2564729,1989,DisGeNET,rs62508734,SNV,,,,,,
rs199475575,19786003,Phenylketonurias,Morocco,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Mutation analysis of phenylketonuria patients from Morocco: high prevalence of mutation G352fsdelG and detection of a novel mutation p.K85X.,19786003,2010,DisGeNET,rs199475575,SNV,,,,,,
rs62516094,19786003,Phenylketonurias,Morocco,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Mutation analysis of phenylketonuria patients from Morocco: high prevalence of mutation G352fsdelG and detection of a novel mutation p.K85X.,19786003,2010,DisGeNET,rs62516094,SNV,,,,,,20 unrelated Moroccon families; 7 PKU patients.
rs199475579,8682503,Phenylketonurias,Egypt,North Africa,NS,FALSE,NS,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Preliminary studies on the molecular basis of hyperphenylalaninemia in Egypt.,8682503,1996,DisGeNET,rs199475579,SNV,,,,,,56 Egyptian hyperphenylalaninemic patients. Phenylketonuria can result in severe hyperphenylalaninemia.
rs5030847,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,< 0.05,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs5030847,SNV,,,,,,
rs5030851,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,< 0.05,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs5030851,SNV,,,,,,
rs5030853,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,< 0.05,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs5030853,SNV,,,,,,
rs5030857,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,< 0.05,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs5030857,SNV,,,,,,
rs62508646,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,0.000000663,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs62508646,SNV,,,,,,
rs62508730,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,0.000000663,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs62508730,SNV,,,,,,
rs62516146,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,0.000000663,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs62516146,SNV,,,,,,
rs62642937,18294361,Hyperphenylalaninaemia,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,0.000000663,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs62642937,SNV,,,,,,
rs62642937,18294361,Phenylketonurias,"Tunisia, Israel, Yemen",North Africa,NS,TRUE,0.000000663,PAH,,PAH,phenylalanine hydroxylase,12,P00439,"This gene encodes a member of the biopterin-dependent aromatic amino acid hydroxylase protein family. The encoded phenylalanine hydroxylase enzyme hydroxylates phenylalanine to tyrosine and is the rate-limiting step in phenylalanine catabolism. Deficiency of this enzyme activity results in the autosomal recessive disorder phenylketonuria. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A mutation analysis of the phenylalanine hydroxylase (PAH) gene in the Israeli population.,18294361,2008,DisGeNET,rs62642937,SNV,,,,,,
rs587776416,27624329,"Breast Cancer, Familial",Nigeria,West Africa,NS,FALSE,NS,PALB2,,PALB2,partner and localizer of BRCA2,16,Q86YC2,"This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2.,27624329,2017,DisGeNET,rs587776416,SNV,,,,,,The Nigerian carrier had different alleles at all 7 STR markers.
rs137853003,27440999,"Usher Syndrome, Type If",Tunisia,North Africa,NS,FALSE,NS,PCDH15,,PCDH15,protocadherin related 15,10,Q96QU1,"This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008].",22/11/2021,PubMed,Genetic analysis of Tunisian families with Usher syndrome type 1: toward improving early molecular diagnosis.,27440999,2018,DisGeNET,rs137853003,SNV,,,,,,mutation is expected to result in the absence of synthesized protein due to mRNA nonsense mediated deca
rs113425597,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,6.36E-07,PCDHA1,Association,PCDHA1,protocadherin alpha 1,5,Q9Y5I3,"This gene is a member of the protocadherin alpha gene cluster, one of three related gene clusters tandemly linked on chromosome five that demonstrate an unusual genomic organization similar to that of B-cell and T-cell receptor gene clusters. The alpha gene cluster is composed of 15 cadherin superfamily genes related to the mouse CNR genes and consists of 13 highly similar and 2 more distantly related coding sequences. The tandem array of 15 N-terminal exons, or variable exons, are followed by downstream C-terminal exons, or constant exons, which are shared by all genes in the cluster. The large, uninterrupted N-terminal exons each encode six cadherin ectodomains while the C-terminal exons encode the cytoplasmic domain. These neural cadherin-like cell adhesion proteins are integral plasma membrane proteins that most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been observed and additional variants have been suggested but their full-length nature has yet to be determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs113425597,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs6880234,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,7.49E-07,PCDHA7,Association,PCDHA7,protocadherin alpha 7,5,Q9UN72,"This gene is a member of the protocadherin alpha gene cluster, one of three related gene clusters tandemly linked on chromosome five that demonstrate an unusual genomic organization similar to that of B-cell and T-cell receptor gene clusters. The alpha gene cluster is composed of 15 cadherin superfamily genes related to the mouse CNR genes and consists of 13 highly similar and 2 more distantly related coding sequences. The tandem array of 15 N-terminal exons, or variable exons, are followed by downstream C-terminal exons, or constant exons, which are shared by all genes in the cluster. The large, uninterrupted N-terminal exons each encode six cadherin ectodomains while the C-terminal exons encode the cytoplasmic domain. These neural cadherin-like cell adhesion proteins are integral plasma membrane proteins that most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been observed and additional variants have been suggested but their full-length nature has yet to be determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs6880234,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs61749035,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,7.50E-07,PCDHGA1,Association,PCDHGA1,"protocadherin gamma subfamily A, 1",5,Q9Y5H4,"This gene is a member of the protocadherin gamma gene cluster, one of three related clusters tandemly linked on chromosome five. These gene clusters have an immunoglobulin-like organization, suggesting that a novel mechanism may be involved in their regulation and expression. The gamma gene cluster includes 22 genes divided into 3 subfamilies. Subfamily A contains 12 genes, subfamily B contains 7 genes and 2 pseudogenes, and the more distantly related subfamily C contains 3 genes. The tandem array of 22 large, variable region exons are followed by a constant region, containing 3 exons shared by all genes in the cluster. Each variable region exon encodes the extracellular region, which includes 6 cadherin ectodomains and a transmembrane region. The constant region exons encode the common cytoplasmic region. These neural cadherin-like cell adhesion proteins most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been described for the gamma cluster genes. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs61749035,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs11591147,26902539,"One LOF variant, rs11591147 (p.R46L) was significantly associated with LDL-C response to statin.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.,26902539,2017,PharmGKB,TBD,SNV,lovastatin,DB00227,"Approved, Investigational","Lovastatin is indicated to reduce the risk of myocardial infarction, unstable angina, and the need for coronary revascularization procedures in individuals without symptomatic cardiovascular disease, average to moderately elevated total-C and LDL-C, and below average HDL-C. It is indicated as an intervention alternative in individuals presenting dyslipidemia at risk of developing atherosclerotic vascular disease. The administration of this agent should be accompanied by the implementation of a fat and cholesterol-restricted diet.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate",
rs11591147,26902539,"One LOF variant, rs11591147 (p.R46L) was significantly associated with LDL-C response to statin.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.,26902539,2017,PharmGKB,TBD,SNV,simvastatin,DB00641,Approved,"Simvastatin is indicated for the treatment of hyperlipidemia to reduce elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDLâ€‘C), apolipoprotein B (Apo B), and triglycerides (TG), and to increase high-density lipoprotein cholesterol (HDL-C).This includes the treatment of primary hyperlipidemia (Fredrickson type IIa, heterozygous familial and nonfamilial), mixed dyslipidemia (Fredrickson type IIb), hypertriglyceridemia (Fredrickson type IV hyperlipidemia), primary dysbetalipoproteinemia (Fredrickson type III hyperlipidemia), homozygous familial hypercholesterolemia (HoFH) as an adjunct to other lipid-lowering treatments, as well as adolescent patients with Heterozygous Familial Hypercholesterolemia (HeFH). Simvastatin is also indicated to reduce the risk of cardiovascular morbidity and mortality including myocardial infarction, stroke, and the need for revascularization procedures. It is primarily used in patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate",
rs11591147,26902539,"One LOF variant, rs11591147 (p.R46L) was significantly associated with LDL-C response to statin.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.,26902539,2017,PharmGKB,TBD,SNV,pravastatin,DB00175,Approved,"Pravastatin is indicated for primary prevention of coronary events hypercholesterolemic patients without clinical evidence of coronary heart disease. Its use includes the reduction of risk on myocardial infarction, undergoing myocardial revascularization procedures and cardiovascular mortality.","(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid",
rs11591147,26902539,"One LOF variant, rs11591147 (p.R46L) was significantly associated with LDL-C response to statin.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.,26902539,2017,PharmGKB,TBD,SNV,atorvastatin,DB01076,Approved,"Atorvastatin is approved for the treatment of several types of dyslipidemias including: Primary hyperlipidemia and mixed dyslipidemia in adults, Hypertriglyceridemia, Primary dysbetalipoproteinemia, Homozygous familial hypercholesterolemia, Heterozygous familial hypercholesterolemia in adolescent patients with failed dietary modifications. Dyslipidemia is defined as an elevation of plasma cholesterol, triglycerides or both as well as to the presence of low levels of high-density lipoprotein. This condition represents an increased risk for the development of atherosclerosis. Atorvastatin is indicated, in combination with dietary modifications, to prevent cardiovascular events in patients with cardiac risk factors and/or abnormal lipid profiles. Atorvastatin can be used as a preventive agent for myocardial infarction, stroke, revascularization, and angina, in patients without coronary heart disease but with multiple risk factors, and in patients with type 2 diabetes without coronary heart disease but multiple risk factors. Atorvastatin can also be used as a preventive agent for non-fatal myocardial infarction, fatal and non-fatal stroke, revascularization procedures, hospitalization for congestive heart failure and angina in patients with coronary heart disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid",
rs11591147,26902539,"One LOF variant, rs11591147 (p.R46L) was significantly associated with LDL-C response to statin.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.,26902539,2017,PharmGKB,TBD,SNV,fluvastatin,DB01095,Approved,"To be used as an adjunct to dietary therapy to prevent cardiovascular events. May be used as secondary prevention in patients with coronary heart disease (CHD) to reduce the risk of requiring coronary revascularization procedures, for reducing progression of coronary atherosclerosis in hypercholesterolemic patients with CHD, and for the treatment of primary hypercholesterolemia and mixed dyslidipidemia.","(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid",
rs11591147,26902539,"One LOF variant, rs11591147 (p.R46L) was significantly associated with LDL-C response to statin.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.,26902539,2017,PharmGKB,TBD,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",
rs28942111,17765244,Hyperlipoproteinemia Type Iia,South Africa,South Africa,NS,FALSE,NS,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa.,17765244,2008,DisGeNET,rs28942111,SNV,,,,,,South African patient revealed the presence of a T/A mutation translating into the previously reported S127R substitution associated with FH.
rs505151,29447211,Malaria,Mali,West Africa,NS,FALSE,0.035,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children.,29447211,2018,DisGeNET,rs505151,SNV,,,,,,
rs505151,29447211,Malaria,Mali,West Africa,NS,FALSE,NS,PCSK9,,PCSK9,proprotein convertase subtilisin/kexin type 9,1,Q8NBP7,"This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].",22/11/2021,PubMed,Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children.,29447211,2018,DisGeNET,rs505151,SNV,,,,,,
rs121918583,10234513,Retinitis Pigmentosa 40 (Disorder),Tunisia,North Africa,NS,FALSE,NS,PDE6B,Linkage,PDE6B,phosphodiesterase 6B,4,P35913,"Photon absorption triggers a signaling cascade in rod photoreceptors that activates cGMP phosphodiesterase (PDE), resulting in the rapid hydrolysis of cGMP, closure of cGMP-gated cation channels, and hyperpolarization of the cell. PDE is a peripheral membrane heterotrimeric enzyme made up of alpha, beta, and gamma subunits. This gene encodes the beta subunit. Mutations in this gene result in retinitis pigmentosa and autosomal dominant congenital stationary night blindness. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009].",22/11/2021,PubMed,"A novel locus for Usher syndrome type II, USH2B, maps to chromosome 3 at p23-24.2.",10234513,1999,DisGeNET,rs121918583,SNV,,,,,,"Through linkage analysis, this study demonstrated that the gene responsible for Usher type II syndrome in a Tunisian consanguineous family maps to chromosome 3 at position p23-24.2, thus providing definitive evidence for the genetic heterogeneity of the syndrome."
rs121918583,18854872,Retinitis Pigmentosa 40 (Disorder),Tunisia,North Africa,NS,FALSE,NS,PDE6B,,PDE6B,phosphodiesterase 6B,4,P35913,"Photon absorption triggers a signaling cascade in rod photoreceptors that activates cGMP phosphodiesterase (PDE), resulting in the rapid hydrolysis of cGMP, closure of cGMP-gated cation channels, and hyperpolarization of the cell. PDE is a peripheral membrane heterotrimeric enzyme made up of alpha, beta, and gamma subunits. This gene encodes the beta subunit. Mutations in this gene result in retinitis pigmentosa and autosomal dominant congenital stationary night blindness. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009].",22/11/2021,PubMed,Identification of two new mutations in the GPR98 and the PDE6B genes segregating in a Tunisian family.,18854872,2009,DisGeNET,rs121918583,SNV,,,,,,"Linkage analysis disclosed the cosegregation of the USH2 phenotype with the USH2C locus markers, D5S428 and D5S618, whereas the ARRP perfectly segregates with PDE6B flanking markers D4S3360 and D4S2930."
rs773876922,23108490,Spinocerebellar Ataxia 23,"Egypt, Greece, India, UK",North Africa,NS,TRUE,NS,PDYN,,PDYN,prodynorphin,20,P01213,"The protein encoded by this gene is a preproprotein that is proteolytically processed to form the secreted opioid peptides beta-neoendorphin, dynorphin, leu-enkephalin, rimorphin, and leumorphin. These peptides are ligands for the kappa-type of opioid receptor. Dynorphin is involved in modulating responses to several psychoactive substances, including cocaine. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2010].",22/11/2021,PubMed,The frequency of spinocerebellar ataxia type 23 in a UK population.,23108490,2013,DisGeNET,rs773876922,SNV,,,,,,
rs267608247,26593283,"Genetic Diseases, Inborn",Egypt,North Africa,NS,FALSE,NS,PEX6,,PEX6,peroxisomal biogenesis factor 6,6,Q13608,"This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015].",22/11/2021,PubMed,PEX6 is Expressed in Photoreceptor Cilia and Mutated in Deafblindness with Enamel Dysplasia and Microcephaly.,26593283,2016,DisGeNET,rs267608247,SNV,,,,,,
rs61753219,26593283,"Genetic Diseases, Inborn",Egypt,North Africa,NS,FALSE,NS,PEX6,,PEX6,peroxisomal biogenesis factor 6,6,Q13608,"This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015].",22/11/2021,PubMed,PEX6 is Expressed in Photoreceptor Cilia and Mutated in Deafblindness with Enamel Dysplasia and Microcephaly.,26593283,2016,DisGeNET,rs61753219,SNV,,,,,,
rs267608260,24698316,Immunodeficiency 23,Tunisia,North Africa,NS,FALSE,NS,PGM3,,PGM3,phosphoglucomutase 3,6,O95394,"This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.,24698316,2014,DisGeNET,rs267608260,SNV,,,,,,Identified two sequence variants in PGM3 (ENSP00000424874/PGM3-001/NP_056414).
rs267608261,24698316,Immunodeficiency 23,Tunisia,North Africa,NS,FALSE,NS,PGM3,,PGM3,phosphoglucomutase 3,6,O95394,"This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.,24698316,2014,DisGeNET,rs267608261,SNV,,,,,,Identified two sequence variants in PGM3 (ENSP00000424874/PGM3-001/NP_056414).
rs587777416,24698316,Immunodeficiency 23,Tunisia,North Africa,NS,FALSE,NS,PGM3,,PGM3,phosphoglucomutase 3,6,O95394,"This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.,24698316,2014,DisGeNET,rs587777416,SNV,,,,,,Identified two sequence variants in PGM3 (ENSP00000424874/PGM3-001/NP_056414).
rs267608259,24698316,Job Syndrome,Tunisia,North Africa,NS,TRUE,NS,PGM3,,PGM3,phosphoglucomutase 3,6,O95394,"This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.,24698316,2014,DisGeNET,rs267608259,SNV,,,,,,Identified two sequence variants in PGM3 (ENSP00000424874/PGM3-001/NP_056414).
rs267608260,24698316,Job Syndrome,Tunisia,North Africa,NS,TRUE,NS,PGM3,,PGM3,phosphoglucomutase 3,6,O95394,"This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.,24698316,2014,DisGeNET,rs267608260,SNV,,,,,,Identified two sequence variants in PGM3 (ENSP00000424874/PGM3-001/NP_056414).
rs267608261,24698316,Job Syndrome,Tunisia,North Africa,NS,TRUE,NS,PGM3,,PGM3,phosphoglucomutase 3,6,O95394,"This gene encodes a member of the phosphohexose mutase family. The encoded protein mediates both glycogen formation and utilization by catalyzing the interconversion of glucose-1-phosphate and glucose-6-phosphate. A non-synonymous single nucleotide polymorphism in this gene may play a role in resistance to diabetic nephropathy and neuropathy. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.,24698316,2014,DisGeNET,rs267608261,SNV,,,,,,Identified two sequence variants in PGM3 (ENSP00000424874/PGM3-001/NP_056414).
rs1057519425,27843126,"Arthrogryposis, Distal, With Impaired Proprioception And Touch","Libya, Asia",North Africa,NS,TRUE,0.028,PIEZO2,,PIEZO2,"piezo type mechanosensitive ion channel component 2	",18,Q9H5I5,"The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. ",22/11/2021,PubMed,"Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis.",27843126,2016,DisGeNET,rs1057519425,SNV,,,,,,
rs1057519626,27843126,"Arthrogryposis, Distal, With Impaired Proprioception And Touch","Libya, Asia",North Africa,NS,TRUE,0.028,PIEZO2,,PIEZO2,"piezo type mechanosensitive ion channel component 2	",18,Q9H5I5,"The protein encoded by this gene contains more than thirty transmembrane domains and likely functions as part of mechanically-activated (MA) cation channels. These channels serve to connect mechanical forces to biological signals. The encoded protein quickly adapts MA currents in somatosensory neurons. Defects in this gene are a cause of type 5 distal arthrogryposis. Several alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. ",22/11/2021,PubMed,"Biallelic Loss of Proprioception-Related PIEZO2 Causes Muscular Atrophy with Perinatal Respiratory Distress, Arthrogryposis, and Scoliosis.",27843126,2016,DisGeNET,rs1057519626,SNV,,,,,,
rs372392424,26996948,"Mental Retardation, Autosomal Recessive 53","Egypt, Japan",North Africa,NS,TRUE,NS,PIGG,,PIGG,phosphatidylinositol glycan anchor biosynthesis class G,4,Q5H8A4,"This gene encodes an enzyme involved in glycosylphosphatidylinositol-anchor biosynthesis. The encoded protein, which is localized to the endoplasmic reticulum, is involved in transferring ethanoloamine phosphate to mannose 2 of glycosylphosphatidylinositol species H7 to form species H8. Allelic variants of this gene have been associated with intellectual disability, hypotonia, and early-onset seizures. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.,26996948,2016,DisGeNET,rs372392424,SNV,,,,,,
rs869320772,26996948,"Mental Retardation, Autosomal Recessive 53","Egypt, Japan",North Africa,NS,TRUE,NS,PIGG,,PIGG,phosphatidylinositol glycan anchor biosynthesis class G,4,Q5H8A4,"This gene encodes an enzyme involved in glycosylphosphatidylinositol-anchor biosynthesis. The encoded protein, which is localized to the endoplasmic reticulum, is involved in transferring ethanoloamine phosphate to mannose 2 of glycosylphosphatidylinositol species H7 to form species H8. Allelic variants of this gene have been associated with intellectual disability, hypotonia, and early-onset seizures. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.,26996948,2016,DisGeNET,rs869320772,SNV,,,,,,
rs869320773,26996948,"Mental Retardation, Autosomal Recessive 53","Egypt, Japan",North Africa,NS,TRUE,NS,PIGG,,PIGG,phosphatidylinositol glycan anchor biosynthesis class G,4,Q5H8A4,"This gene encodes an enzyme involved in glycosylphosphatidylinositol-anchor biosynthesis. The encoded protein, which is localized to the endoplasmic reticulum, is involved in transferring ethanoloamine phosphate to mannose 2 of glycosylphosphatidylinositol species H7 to form species H8. Allelic variants of this gene have been associated with intellectual disability, hypotonia, and early-onset seizures. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,Pathogenic Variants in PIGG Cause Intellectual Disability with Seizures and Hypotonia.,26996948,2016,DisGeNET,rs869320773,SNV,,,,,,
rs74315360,16966503,"Parkinson Disease 6, Autosomal Recessive Early-Onset",Sudan,East Africa,NS,FALSE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1.,16966503,2006,DisGeNET,rs74315360,SNV,,,,,,
rs74315360,16966503,"Parkinson Disease 6, Late-Onset, Susceptibility To",Sudan,East Africa,NS,FALSE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1.,16966503,2006,DisGeNET,rs74315360,SNV,,,,,,
rs573931674,16401616,"Parkinson Disease 6, Autosomal Recessive Early-Onset","North Africa, Europe",North Africa,NS,TRUE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.,16401616,2006,DisGeNET,rs573931674,SNV,,,,,,
rs573931674,16401616,"Parkinson Disease 6, Late-Onset, Susceptibility To","North Africa, Europe",North Africa,NS,TRUE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa.,16401616,2006,DisGeNET,rs573931674,SNV,,,,,,
rs45539432,18685134,"Parkinson Disease 6, Autosomal Recessive Early-Onset",Tunisia,North Africa,NS,FALSE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,PINK1 mutations and parkinsonism.,18685134,2008,DisGeNET,rs45539432,SNV,,,,,,
rs45467995,18685134,Parkinsonian Disorders,Tunisia,North Africa,NS,FALSE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,PINK1 mutations and parkinsonism.,18685134,2008,DisGeNET,rs45467995,SNV,,,,,,
rs45539432,18685134,Parkinsonian Disorders,Tunisia,North Africa,NS,FALSE,NS,PINK1,,PINK1,PTEN induced kinase 1,1,Q9BXM7,"This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,PINK1 mutations and parkinsonism.,18685134,2008,DisGeNET,rs45539432,SNV,,,,,,
rs148617572,26721323,Autosomal Recessive Polycystic Kidney Disease,Egypt,North Africa,NS,FALSE,NS,PKHD1,,PKHD1,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,6,P08F94,"The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Ashkenazi founder mutation in the PKHD1 gene.,26721323,2016,DisGeNET,rs148617572,SNV,,,,,,
rs398124484,26721323,Autosomal Recessive Polycystic Kidney Disease,Morocco,North Africa,NS,TRUE,NS,PKHD1,,PKHD1,PKHD1 ciliary IPT domain containing fibrocystin/polyductin,6,P08F94,"The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An Ashkenazi founder mutation in the PKHD1 gene.,26721323,2016,DisGeNET,rs398124484,SNV,,,,,,
rs118204089,9886305,Deficiency Of Pyruvate Kinase,Guinea,West Africa,NS,FALSE,NS,PKLR,Genetic variability study,PKLR,pyruvate kinase L/R,1,P30613,"The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A new sickle cell disease phenotype associating Hb S trait, severe pyruvate kinase deficiency (PK Conakry), and an alpha2 globin gene variant (Hb Conakry).",9886305,1999,DisGeNET,rs118204089,SNV,,,,,,"The S130Y mutation in the PKLR gene was reported in one Guinean women with episodes of marked anemia, repeated typical metaphyseal painful crises, hemosiderosis, and pyruvate kinase deficiency. The S130Y mutation was referred as 'PK Conakry'. In addition, the patient carried a new haemoglobin variant, Hb Conakry [a80(F1) Leu ->Val], which seemed to have a mild effect. "
rs116100695,28133914,Deficiency Of Pyruvate Kinase,Tunisia,North Africa,NS,FALSE,0,PKLR,,PKLR,pyruvate kinase L/R,1,P30613,"The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene.",22/11/2021,PubMed,Molecular basis of pyruvate kinase deficiency among Tunisians: description of new mutations affecting coding and noncoding regions in the PKLR gene.,28133914,2017,DisGeNET,rs116100695,SNV,,,,,,
rs193922674,19880068,Arrhythmogenic Right Ventricular Dysplasia,South Africa,South Africa,NS,TRUE,NS,PKP2,,PKP2,plakophilin 2,12,Q99959,"This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene product may regulate the signaling activity of beta-catenin. Two alternately spliced transcripts encoding two protein isoforms have been identified. A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.",19880068,2010,DisGeNET,rs193922674,SNV,,,,,,
rs397516986,19880068,Arrhythmogenic Right Ventricular Dysplasia,South Africa,South Africa,NS,TRUE,NS,PKP2,,PKP2,plakophilin 2,12,Q99959,"This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene product may regulate the signaling activity of beta-catenin. Two alternately spliced transcripts encoding two protein isoforms have been identified. A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.",19880068,2010,DisGeNET,rs397516986,SNV,,,,,,
rs397517021,19880068,Arrhythmogenic Right Ventricular Dysplasia,South Africa,South Africa,NS,TRUE,NS,PKP2,,PKP2,plakophilin 2,12,Q99959,"This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene product may regulate the signaling activity of beta-catenin. Two alternately spliced transcripts encoding two protein isoforms have been identified. A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.",19880068,2010,DisGeNET,rs397517021,SNV,,,,,,
rs727504432,19880068,Arrhythmogenic Right Ventricular Dysplasia,South Africa,South Africa,NS,TRUE,NS,PKP2,,PKP2,plakophilin 2,12,Q99959,"This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene product may regulate the signaling activity of beta-catenin. Two alternately spliced transcripts encoding two protein isoforms have been identified. A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.",19880068,2010,DisGeNET,rs727504432,SNV,,,,,,
rs727504786,19880068,Arrhythmogenic Right Ventricular Dysplasia,South Africa,South Africa,NS,TRUE,NS,PKP2,,PKP2,plakophilin 2,12,Q99959,"This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene product may regulate the signaling activity of beta-catenin. Two alternately spliced transcripts encoding two protein isoforms have been identified. A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.",19880068,2010,DisGeNET,rs727504786,SNV,,,,,,
rs766209297,19880068,Arrhythmogenic Right Ventricular Dysplasia,South Africa,South Africa,NS,TRUE,NS,PKP2,,PKP2,plakophilin 2,12,Q99959,"This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This gene product may regulate the signaling activity of beta-catenin. Two alternately spliced transcripts encoding two protein isoforms have been identified. A processed pseudogene with high similarity to this locus has been mapped to chromosome 12p13. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the arrhythmogenic right ventricular cardiomyopathy registry of South Africa.",19880068,2010,DisGeNET,rs766209297,SNV,,,,,,
rs111033559,26917049,"Cardiomyopathy, Familial Idiopathic",South Africa,South Africa,Afrikaner,FALSE,NS,PLN,Genetic variability study,PLN,phospholamban,6,P26678,"The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016].",22/11/2021,PubMed,"Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies.",26917049,2017,DisGeNET,rs111033559,SNV,,,,,,Pathogenic mutation identified in a south African proband of European descent with severe DCM 5 dilated cardiomyopathy
rs738409,24269995,Hepatitis C,Morocco,North Africa,NS,FALSE,0.004,PNPLA3,,PNPLA3,patatin like phospholipase domain containing 3,22,Q9NST1,"The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.,24269995,2015,DisGeNET,rs738409,SNV,,,,,,"Variation at rs738409 was not associated with significant changes in resolution rate of hepatitis C. By contrast, M/M genotype, present at higher frequencies (22.8%) in HCC patients than in patients with chronic hepatitis C (8.5%, P = 0.004) or control individuals (9.1%, P = 0.005) was associated with a 3-fold increase of liver cancer risk."
rs738409,24269995,"Hepatitis C, Chronic",Morocco,North Africa,NS,FALSE,0.004,PNPLA3,,PNPLA3,patatin like phospholipase domain containing 3,22,Q9NST1,"The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.,24269995,2015,DisGeNET,rs738409,SNV,,,,,,"Variation at rs738409 was not associated with significant changes in resolution rate of hepatitis C. By contrast, M/M genotype, present at higher frequencies (22.8%) in HCC patients than in patients with chronic hepatitis C (8.5%, P = 0.004) or control individuals (9.1%, P = 0.005) was associated with a 3-fold increase of liver cancer risk."
rs738409,24269995,Liver And Intrahepatic Biliary Tract Carcinoma,Morocco,North Africa,NS,FALSE,0.004,PNPLA3,,PNPLA3,patatin like phospholipase domain containing 3,22,Q9NST1,"The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.,24269995,2015,DisGeNET,rs738409,SNV,,,,,,"Variation at rs738409 was not associated with significant changes in resolution rate of hepatitis C. By contrast, M/M genotype, present at higher frequencies (22.8%) in HCC patients than in patients with chronic hepatitis C (8.5%, P = 0.004) or control individuals (9.1%, P = 0.005) was associated with a 3-fold increase of liver cancer risk."
rs738409,24269995,Malignant Neoplasm Of Liver,Morocco,North Africa,NS,FALSE,0.004,PNPLA3,,PNPLA3,patatin like phospholipase domain containing 3,22,Q9NST1,"The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.,24269995,2015,DisGeNET,rs738409,SNV,,,,,,"Variation at rs738409 was not associated with significant changes in resolution rate of hepatitis C. By contrast, M/M genotype, present at higher frequencies (22.8%) in HCC patients than in patients with chronic hepatitis C (8.5%, P = 0.004) or control individuals (9.1%, P = 0.005) was associated with a 3-fold increase of liver cancer risk."
rs738409,24269995,Liver Carcinoma,"Morocco, Tunisia",North Africa,NS,TRUE,0.004,PNPLA3,,PNPLA3,patatin like phospholipase domain containing 3,22,Q9NST1,"The protein encoded by this gene is a triacylglycerol lipase that mediates triacylglycerol hydrolysis in adipocytes. The encoded protein, which appears to be membrane bound, may be involved in the balance of energy usage/storage in adipocytes. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The adiponutrin I148M variant is a risk factor for HCV-associated liver cancer in North-African patients.,24269995,2015,DisGeNET,rs738409,SNV,,,,,,"Variation at rs738409 was not associated with significant changes in resolution rate of hepatitis C. By contrast, M/M genotype, present at higher frequencies (22.8%) in HCC patients than in patients with chronic hepatitis C (8.5%, P = 0.004) or control individuals (9.1%, P = 0.005) was associated with a 3-fold increase of liver cancer risk."
rs488069,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,7.60E-07,POMGNT2,,POMGNT2,"protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)",3,Q8NAT1,"This gene encodes a protein with glycosyltransferase activity although its function is not currently known. [provided by RefSeq, Sep 2012].",22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs488069,SNV,,,,,,
rs662,21783258,Bipolar I Disorder,Tunisia,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene.,21783258,2013,DisGeNET,rs662,SNV,,,,,,
rs854560,21783258,Bipolar I Disorder,Tunisia,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between bipolar I disorder and the L55M and Q192R polymorphisms of the paraoxonase 1 (PON1) gene.,21783258,2013,DisGeNET,rs854560,SNV,,,,,,
rs662,28185016,Antiphospholipid Syndrome,Egypt,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.,28185016,2018,DisGeNET,rs662,SNV,,,,,,
rs854560,28185016,Antiphospholipid Syndrome,Egypt,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.,28185016,2018,DisGeNET,rs854560,SNV,,,,,,
rs662,28185016,"Lupus Erythematosus, Systemic",Egypt,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.,28185016,2018,DisGeNET,rs662,SNV,,,,,,
rs854560,28185016,"Lupus Erythematosus, Systemic",Egypt,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.,28185016,2018,DisGeNET,rs854560,SNV,,,,,,
rs662,28185016,"Polyendocrinopathies, Autoimmune",Egypt,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.,28185016,2018,DisGeNET,rs662,SNV,,,,,,
rs854560,28185016,"Polyendocrinopathies, Autoimmune",Egypt,North Africa,NS,FALSE,NS,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.,28185016,2018,DisGeNET,rs854560,SNV,,,,,,
rs854560,21229382,Breast Carcinoma,Egypt,North Africa,NS,FALSE,< 0.001,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.,21229382,2011,DisGeNET,rs854560,SNV,,,,,,
rs854560,21229382,Malignant Neoplasm Of Breast,Egypt,North Africa,NS,FALSE,< 0.001,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.,21229382,2011,DisGeNET,rs854560,SNV,,,,,,
rs662,21229382,Breast Carcinoma,Egypt,North Africa,NS,FALSE,< 0.05,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.,21229382,2011,DisGeNET,rs662,SNV,,,,,,
rs662,21229382,Malignant Neoplasm Of Breast,Egypt,North Africa,NS,FALSE,< 0.05,PON1,,PON1,paraoxonase 1,7,P27169,"This gene encodes a member of the paraoxonase family of enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.,21229382,2011,DisGeNET,rs662,SNV,,,,,,
rs1057868,24448396,"Genotypes CT + TT is associated with increased metabolism of nicotine in CYP2A6 normal, but not reduced, metabolizers as compared to genotype CC.",Canada,African American/Afro-Caribbean,NS,FALSE,0.03,POR,Association,POR,cytochrome p450 oxidoreductase,7,P16435,"This gene encodes an endoplasmic reticulum membrane oxidoreductase that is essential for multiple metabolic processes, including reactions catalyzed by cytochrome P450 proteins for metabolism of steroid hormones, drugs and xenobiotics. The encoded protein has a flavin adenine dinucleotide (FAD)-binding domain and a flavodoxin-like domain which bind two cofactors, FAD and FMN, that allow it to donate electrons directly from NADPH to all microsomal P450 enzymes. Mutations in this gene cause a complex set of disorders, including apparent combined P450C17 and P450C21 deficiency, amenorrhea and disordered steroidogenesis, congenital adrenal hyperplasia and Antley-Bixler syndrome, that resemble those caused by defects in steroid metabolizing enzymes such as aromatase, 21-hydroxylase, and 17 alpha-hydroxylase. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,"Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.",24448396,2014,PharmGKB,1183703328,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,"In normal CYP2A6 metabolizers, 3HC/COT was higher in the POR CT/TT relative to CC group with NM_001367562.1:c.1508C>T leads to A503V substitution."
rs1801282,17434720,"Diabetes Mellitus, Non-Insulin-Dependent","Ethiopia, Benin, Ecuador and Italy",East Africa / West Africa,NS,TRUE,1,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits.,17434720,2007,DisGeNET,rs1801282,SNV,,,,,,
rs1805192,17434720,"Diabetes Mellitus, Non-Insulin-Dependent","Ethiopia, Benin, Ecuador and Italy",East Africa / West Africa,NS,TRUE,NS,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits.,17434720,2007,DisGeNET,rs1805192,SNV,,,,,,
rs1801282,18250615,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.044,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Association of the peroxisome proliferator-activated receptor-gamma2 Pro12Ala but not the C1431T gene variants with lower body mass index in Type 2 diabetes.,18250615,2008,DisGeNET,rs1801282,SNV,,,,,,The variant results in the substitution Pro12Ala. Pro12Ala is associated with normal (BMI<25.0) but not with overweight/obesity among T2DM patients.
rs1801282,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,0.159,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs1801282,SNV,,,,,,"IGF2BP2 rs1470579, KCNJ11 rs5219, PPARÎ³ rs1801282 and SLC30A8 rs13266634 displayed various associations with T2DM in the study populations."
rs1801282,18657335,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,TRUE,> 0.05,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population.,18657335,2008,DisGeNET,rs1801282,SNV,,,,,,"The results support that the genetic variation at ENPP1-K121Q predisposes to T2D in the Tunisian population after adjustment on gender, age and BMI status (OR = 1.55, 95%CI [1.11-2.16], p = 0.007)."
rs1805192,18657335,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,TRUE,NS,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Effect of ENPP1/PC-1-K121Q and PPARgamma-Pro12Ala polymorphisms on the genetic susceptibility to T2D in the Tunisian population.,18657335,2008,DisGeNET,rs1805192,SNV,,,,,,"The results support that the genetic variation at ENPP1-K121Q predisposes to T2D in the Tunisian population after adjustment on gender, age and BMI status (OR = 1.55, 95%CI [1.11-2.16], p = 0.007)."
rs1801282,24447396,"Diabetes Mellitus, Non-Insulin-Dependent",South Africa,South Africa,"Black Africans, Caucasian, Asians",TRUE,0.012,PPARG,,PPARG,peroxisome proliferator activated receptor gamma,3,P37231,"This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa.,24447396,2014,DisGeNET,rs1801282,SNV,,,,,,Genotype frequencies were 10.4% (PPARG Pro12Ala) and 7.7% (IRS1 Gly972Arg).
rs121918324,8673113,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria.,8673113,1996,DisGeNET,rs121918324,SNV,,,,,,
rs121918324,8673113,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria.,8673113,1996,DisGeNET,rs121918324,SNV,,,,,,Number of patients was not mentioned in the paper. The variant was described in patients with Variegate Porphyria.
rs121918324,8673113,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria.,8673113,1996,DisGeNET,rs121918324,SNV,,,,,,
rs121918324,21910705,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Extended haplotype studies in South African and Dutch variegate porphyria families carrying the recurrent p.R59W mutation confirm a common ancestry.,21910705,2012,DisGeNET,rs121918324,SNV,,,,,,Patient from South Africa had the mutation R59W which is associated with homozygous Variegate porphyria.
rs121918324,10870850,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs121918324,SNV,,,,,,Two unrelated probands from South Africa had the common R59W mutation which is associated with Variegate porphyria.
rs767419411,10870850,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs767419411,SNV,,,,,,Patient from South Africa had the mutation Arg138Gln which is associated with homozygous Variegate porphyria.
rs900431442,10870850,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs900431442,SNV,,,,,,Patient from South Africa had the mutation Y348C which is associated with homozygous Variegate porphyria.
rs121918324,10870850,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs121918324,SNV,,,,,,Two unrelated probands from South Africa had the common R59W mutation which is associated with Variegate porphyria.
rs767419411,10870850,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs767419411,SNV,,,,,,
rs900431442,10870850,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs900431442,SNV,,,,,,
rs121918324,10870850,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs121918324,SNV,,,,,,Two unrelated probands from South Africa had the common R59W mutation which is associated with Variegate porphyria.
rs767419411,10870850,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs767419411,SNV,,,,,,
rs900431442,10870850,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Homozygous variegate porphyria in South Africa: genotypic analysis in two cases.,10870850,2000,DisGeNET,rs900431442,SNV,,,,,,Patient from South Africa had the mutation Y348C which is associated with homozygous Variegate porphyria.
rs769452432,11350188,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria.,11350188,2001,DisGeNET,rs769452432,SNV,,,,,,
rs769452432,11350188,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria.,11350188,2001,DisGeNET,rs769452432,SNV,,,,,,
rs769452432,11350188,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria.,11350188,2001,DisGeNET,rs769452432,SNV,,,,,,
rs121918324,8817334,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918324,SNV,,,,,,Mutations described among variegate porphyria patients from SA with founder effect.
rs121918325,8817334,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918325,SNV,,,,,,
rs121918326,8817334,"Porphyria, South African Type",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918326,SNV,,,,,,
rs121918324,8817334,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918324,SNV,,,,,,Mutations described among variegate porphyria patients from SA with founder effect.
rs121918325,8817334,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918325,SNV,,,,,,
rs121918326,8817334,Variegate Porphyria,South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918326,SNV,,,,,,
rs121918324,8817334,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918324,SNV,,,,,,Mutations described among variegate porphyria patients from SA with founder effect.
rs121918325,8817334,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918325,SNV,,,,,,
rs121918326,8817334,"Variegate Porphyria, Homozygous Variant",South Africa,South Africa,NS,FALSE,NS,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Identification of three mutations and associated haplotypes in the protoporphyrinogen oxidase gene in South African families with variegate porphyria.,8817334,1996,DisGeNET,rs121918326,SNV,,,,,,
rs121918324,10401000,Variegate Porphyria,South Africa,South Africa,Afrikaner,FALSE,0.005,PPOX,Genetic variability study,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spectrum of mutations in the HFE gene implicated in haemochromatosis and porphyria.,10401000,2000,DisGeNET,rs121918324,SNV,,,,,,Pathogenic mutation identified in patients from South Africa with Variegate Porphyria (Caucasian). The mutant allele frequency of the C282Y mutation was found to be significantly lower in 73 apparently unrelated VP patients with the R59W mutation than in 102 controls drawn from the same population (P = 0.005).
rs121918324,8290408,Variegate Porphyria,South Africa,South Africa,NS,FALSE,> 0.05,PPOX,,PPOX,protoporphyrinogen oxidase,1,P50336,"This gene encodes the penultimate enzyme of heme biosynthesis, which catalyzes the 6-electron oxidation of protoporphyrinogen IX to form protoporphyrin IX. Mutations in this gene cause variegate porphyria, an autosomal dominant disorder of heme metabolism resulting from a deficiency in protoporphyrinogen oxidase, an enzyme located on the inner mitochondrial membrane. Alternatively spliced transcript variants encoding the same protein have been identified. ",22/11/2021,PubMed,Homozygous variegate porphyria: an evolving clinical syndrome.,8290408,1993,DisGeNET,rs121918324,SNV,,,,,,
rs28933385,10889050,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Age and origin of the PRNP E200K mutation causing familial Creutzfeldt-Jacob disease in Libyan Jews.,10889050,2000,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,10889050,Fatal Familial Insomnia,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Age and origin of the PRNP E200K mutation causing familial Creutzfeldt-Jacob disease in Libyan Jews.,10889050,2000,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,10889050,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Age and origin of the PRNP E200K mutation causing familial Creutzfeldt-Jacob disease in Libyan Jews.,10889050,2000,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,10090891,Prion Diseases,"Libya, Tunisia, Europe",North Africa,Jewish,TRUE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Ancestral origins and worldwide distribution of the PRNP 200K mutation causing familial Creutzfeldt-Jakob disease.,10090891,2001,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8529127,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene.,8529127,1995,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8529127,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene.,8529127,1995,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,25522698,"Creutzfeldt-Jakob Disease, Familial",Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD.,25522698,2016,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,9279329,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews.,9279329,1997,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,9279329,Fatal Familial Insomnia,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews.,9279329,1997,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,9279329,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Familial Creutzfeldt-Jakob disease. Codon 200 prion disease in Libyan Jews.,9279329,1997,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,1798423,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews.,1798423,1991,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,1798423,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Genetic and environmental factors determining the development of Creutzfeldt-Jakob disease in Libyan Jews.,1798423,1991,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8564843,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease.,8564843,1996,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8564843,"Creutzfeldt-Jakob Disease, Familial",Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease.,8564843,1996,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8564843,Other Creutzfeldt-Jakob Disease,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease.,8564843,1996,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8105682,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD).,8105682,1993,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,8105682,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD).,8105682,1993,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,7913755,Creutzfeldt-Jakob Disease,Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.,7913755,1994,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,7913755,"Creutzfeldt-Jakob Disease, Familial",Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.,7913755,1994,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,2008182,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease.,2008182,1991,DisGeNET,rs28933385,SNV,,,,,,
rs1799990,12815603,Creutzfeldt-Jakob Disease,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Prion susceptibility and protective alleles exhibit marked geographic differences.,12815603,2003,DisGeNET,rs1799990,SNV,,,,,,"The (385A>G : M129V) susceptibility allele was found at high frequencies in Old World populations, very high in the Pacific (~81%) and up to 93% in Central and East Asia, but at a low frequency (~30%) in Native Americans."
rs1800014,12815603,Creutzfeldt-Jakob Disease,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Prion susceptibility and protective alleles exhibit marked geographic differences.,12815603,2003,DisGeNET,rs1800014,SNV,,,,,,The protective 219L allele was not identified in the Sub-Saharan African cohort. 219L allele is restricted to Asian and Pacific populations.
rs1799990,12815603,Fatal Familial Insomnia,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Prion susceptibility and protective alleles exhibit marked geographic differences.,12815603,2003,DisGeNET,rs1799990,SNV,,,,,,(385A>G: M129V) is related to susceptibility to prion diseases. 129M and 129V are in similar frequencies in sub-Saharan Africa.
rs1800014,12815603,Fatal Familial Insomnia,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Prion susceptibility and protective alleles exhibit marked geographic differences.,12815603,2003,DisGeNET,rs1800014,SNV,,,,,,The protective 219L allele was restricted to Asian and Pacific populations.
rs28933385,1351274,Prion Diseases,Libya,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Transmission of spongiform encephalopathy from a familial Creutzfeldt-Jakob disease patient of Jewish Libyan origin carrying the PRNP codon 200 mutation.,1351274,2001,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,26806765,"Creutzfeldt-Jakob Disease, Familial",Lybia,North Africa,Jewish,FALSE,NS,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Unusual presentations in patients with E200K familial Creutzfeldt-Jakob disease.,26806765,2016,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,1684755,Creutzfeldt-Jakob Disease,"Libya, Tunisia, Europe",North Africa,NS,TRUE,< 0.05,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families.,1684755,1991,DisGeNET,rs28933385,SNV,,,,,,
rs28933385,1684755,Fatal Familial Insomnia,"Libya, Tunisia, Europe",North Africa,NS,TRUE,< 0.05,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families.,1684755,1991,DisGeNET,rs28933385,SNV,,,,,,
rs11538758,10526198,Prion Diseases,Morocco,North Africa,NS,FALSE,0.000000198,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease.,10526198,1999,DisGeNET,rs11538758,SNV,,,,,,
rs74315407,10526198,Creutzfeldt-Jakob Disease,Morocco,North Africa,NS,FALSE,1.07E-23,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease.,10526198,1999,DisGeNET,rs74315407,SNV,,,,,,
rs74315407,10526198,Prion Diseases,Morocco,North Africa,NS,FALSE,1.07E-23,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,Mutation at codon 210 (V210I) of the prion protein gene in a North African patient with Creutzfeldt-Jakob disease.,10526198,1999,DisGeNET,rs74315407,SNV,,,,,,
rs28933385,15366237,Huntington Disease-Like 1,Libya,North Africa,NS,FALSE,< 0.05,PRNP,,PRNP,prion protein,20,"['P04156', 'F7VJQ1']","The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally similar protein to the one encoded by this gene. Mutations in the repeat region as well as elsewhere in this gene have been associated with Creutzfeldt-Jakob disease, fatal familial insomnia, Gerstmann-Straussler disease, Huntington disease-like 1, and kuru. An overlapping open reading frame has been found for this gene that encodes a smaller, structurally unrelated protein, AltPrp. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014].",22/11/2021,PubMed,"[Creutzfeldt-Jakob encephalopathy with mutation E200K. Report of a ""sporadic"" case].",15366237,2004,DisGeNET,rs28933385,SNV,,,,,,
rs121917843,15531542,Dwarfism,Tunisia,North Africa,NS,FALSE,NS,PROP1,,PROP1,PROP paired-like homeobox 1,5,O75360,"This gene encodes a paired-like homeodomain transcription factor in the developing pituitary gland. Expression occurs prior to and is required for expression of pou domain transcription factor 1, which is responsible for pituitary development and hormone expression. Mutations in this gene have been associated with combined pituitary hormone deficiency-2 as well as deficiencies in luteinizing hormone, follicle-stimulating hormone, growth hormone, prolactin, and thyroid-stimulating hormone. [provided by RefSeq, Sep 2011].",22/11/2021,PubMed,A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.,15531542,2004,DisGeNET,rs121917843,SNV,,,,,,"The report in this study showed the deleterious effect of the recessive R73C mutation that affects a hot spot of the PROP1 gene and was associated with severe dwarfism, a lack of spontaneous puberty, and a high incidence of early onset of corticotroph deficiency."
rs121917843,15531542,Panhypopituitarism,Tunisia,North Africa,NS,FALSE,NS,PROP1,,PROP1,PROP paired-like homeobox 1,5,O75360,"This gene encodes a paired-like homeodomain transcription factor in the developing pituitary gland. Expression occurs prior to and is required for expression of pou domain transcription factor 1, which is responsible for pituitary development and hormone expression. Mutations in this gene have been associated with combined pituitary hormone deficiency-2 as well as deficiencies in luteinizing hormone, follicle-stimulating hormone, growth hormone, prolactin, and thyroid-stimulating hormone. [provided by RefSeq, Sep 2011].",22/11/2021,PubMed,A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.,15531542,2004,DisGeNET,rs121917843,SNV,,,,,,"The report in this study showed the deleterious effect of the recessive R73C mutation that affects a hot spot of the PROP1 gene and was associated with severe dwarfism, a lack of spontaneous puberty, and a high incidence of early onset of corticotroph deficiency."
rs121917843,15531542,Pituitary Dwarfism Type 3,Tunisia,North Africa,NS,FALSE,NS,PROP1,,PROP1,PROP paired-like homeobox 1,5,O75360,"This gene encodes a paired-like homeodomain transcription factor in the developing pituitary gland. Expression occurs prior to and is required for expression of pou domain transcription factor 1, which is responsible for pituitary development and hormone expression. Mutations in this gene have been associated with combined pituitary hormone deficiency-2 as well as deficiencies in luteinizing hormone, follicle-stimulating hormone, growth hormone, prolactin, and thyroid-stimulating hormone. [provided by RefSeq, Sep 2011].",22/11/2021,PubMed,A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies.,15531542,2004,DisGeNET,rs121917843,SNV,,,,,,"The report in this study showed the deleterious effect of the recessive R73C mutation that affects a hot spot of the PROP1 gene and was associated with severe dwarfism, a lack of spontaneous puberty, and a high incidence of early onset of corticotroph deficiency."
rs121917839,14614227,Pituitary Dwarfism Type 3,Morocco,North Africa,Jewish,FALSE,NS,PROP1,,PROP1,PROP paired-like homeobox 1,5,O75360,"This gene encodes a paired-like homeodomain transcription factor in the developing pituitary gland. Expression occurs prior to and is required for expression of pou domain transcription factor 1, which is responsible for pituitary development and hormone expression. Mutations in this gene have been associated with combined pituitary hormone deficiency-2 as well as deficiencies in luteinizing hormone, follicle-stimulating hormone, growth hormone, prolactin, and thyroid-stimulating hormone. [provided by RefSeq, Sep 2011].",22/11/2021,PubMed,PROP-1 gene mutation (R120C) causing combined pituitary hormone deficiencies with variable clinical course in eight siblings of one Jewish Moroccan family.,14614227,2004,DisGeNET,rs121917839,SNV,,,,,,"The combined  pituitary  hormonedeficiencies (CPHD) in the study family, caused by an R120C mutation, was characterized by clinical phenotypic variability in terms of the severity of hormonal deficiencies and the time of their development."
rs1046089,19039607,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",FALSE,< 0.00001,PRRC2A,Association,PRRC2A,proline rich coiled-coil 2A,6,P48634,"A cluster of genes, BAT1-BAT5, has been localized in the vicinity of the genes for TNF alpha and TNF beta. These genes are all within the human major histocompatibility complex class III region. This gene has microsatellite repeats which are associated with the age-at-onset of insulin-dependent diabetes mellitus (IDDM) and possibly thought to be involved with the inflammatory process of pancreatic beta-cell destruction during the development of IDDM. This gene is also a candidate gene for the development of rheumatoid arthritis. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2010].",22/11/2021,PubMed,A genetic association study in the Gambia using tagging polymorphisms in the major histocompatibility complex class III region implicates a HLA-B associated transcript 2 polymorphism in severe malaria susceptibility.,19039607,2009,DisGeNET,rs1046089,SNV,,,,,,"The study reports on 1535 severe malaria Gambian patients. BAT2 is an alias for PRRC2A. The rs1046089 SNP may have haplotypic associations with the contiguous AIF1(i), AIF1(ii) and BAT2(i) polymorphisms. "
rs730882064,19526372,"Microphthalmia, Isolated 6",Tunisia,North Africa,NS,FALSE,NS,PRSS56,,PRSS56,serine protease 56,2,P0CW18,"This gene encodes a protein that contains a peptidase S1 domain and possesses trypsin-like serine protease activity. The encoded protein may play a role in eye development, and mutations in this gene are a cause of autosomal recessive posterior microphthalmos. [provided by RefSeq, Dec 2011].",22/11/2021,PubMed,A genome-wide linkage scan in Tunisian families identifies a novel locus for non-syndromic posterior microphthalmia to chromosome 2q37.1.,19526372,2009,DisGeNET,rs730882064,SNV,,,,,,
rs267606990,25337068,Noonan Syndrome,Tunisia,North Africa,NS,FALSE,NS,PTPN11,,PTPN11,protein tyrosine phosphatase non-receptor type 11,12,Q06124,"The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016].",22/11/2021,PubMed,Clinical and Molecular Findings of Tunisian Patients with RASopathies.,25337068,2014,DisGeNET,rs267606990,SNV,,,,,,
rs28933386,20979190,Noonan Syndrome,Morocco,North Africa,NS,FALSE,NS,PTPN11,,PTPN11,protein tyrosine phosphatase non-receptor type 11,12,Q06124,"The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016].",22/11/2021,PubMed,Germinal mosaicism in Noonan syndrome: A family with two affected siblings of normal parents.,20979190,2011,DisGeNET,rs28933386,SNV,,,,,,
rs2476601,20101775,Inflammatory Bowel Diseases,Tunisia,North Africa,NS,FALSE,0.00001,PTPN22,,PTPN22,protein tyrosine phosphatase non-receptor type 22,1,Q9Y2R2,"This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Lymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia.,20101775,2010,DisGeNET,rs2476601,SNV,,,,,,
rs2476601,25256132,Diabetes,Egypt,North Africa,NS,FALSE,> 0.05,PTPN22,,PTPN22,protein tyrosine phosphatase non-receptor type 22,1,Q9Y2R2,"This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.,25256132,2015,DisGeNET,rs2476601,SNV,,,,,,
rs2476601,25256132,Diabetes Mellitus,Egypt,North Africa,NS,FALSE,> 0.05,PTPN22,,PTPN22,protein tyrosine phosphatase non-receptor type 22,1,Q9Y2R2,"This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.,25256132,2015,DisGeNET,rs2476601,SNV,,,,,,
rs2476601,25256132,"Diabetes Mellitus, Insulin-Dependent",Egypt,North Africa,NS,FALSE,> 0.05,PTPN22,,PTPN22,protein tyrosine phosphatase non-receptor type 22,1,Q9Y2R2,"This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.,25256132,2015,DisGeNET,rs2476601,SNV,,,,,,
rs2476601,19343596,Rheumatoid Arthritis,Tunisia,North Africa,NS,FALSE,> 0.05,PTPN22,,PTPN22,protein tyrosine phosphatase non-receptor type 22,1,Q9Y2R2,"This gene encodes of member of the non-receptor class 4 subfamily of the protein-tyrosine phosphatase family. The encoded protein is a lymphoid-specific intracellular phosphatase that associates with the molecular adapter protein CBL and may be involved in regulating CBL function in the T-cell receptor signaling pathway. Mutations in this gene may be associated with a range of autoimmune disorders including Type 1 Diabetes, rheumatoid arthritis, systemic lupus erythematosus and Graves' disease. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population.,19343596,2009,DisGeNET,rs2476601,SNV,,,,,,
rs10739150,26425837,rs10739150 near PTPRD is associated with response to atenolol.,USA,African American/Afro-Caribbean,African American,TRUE,8.25E-10,PTPRD,,PTPRD,"protein tyrosine phosphatase receptor type D	",9,P23468,"The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an extracellular region, a single transmembrane segment and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this protein is composed of three Ig-like and eight fibronectin type III-like domains. Studies of the similar genes in chicken and fly suggest the role of this PTP is in promoting neurite growth, and regulating neurons axon guidance. Multiple alternatively spliced transcript variants of this gene have been reported. A related pseudogene has been identified on chromosome 5.",22/11/2021,PubMed,PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.,26425837,2015,PharmGKB,TBD,SNV,atenolol,DB00335,Approved,Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,
rs7633054,27236921,Bacteremia,Kenya,East Africa,NS,FALSE,NS,PTPRG,,PTPRG,protein tyrosine phosphatase receptor type G,3,P23470,"The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this PTP contains a carbonic anhydrase-like (CAH) domain, which is also found in the extracellular region of PTPRBETA/ZETA. This gene is located in a chromosomal region that is frequently deleted in renal cell carcinoma and lung carcinoma, thus is thought to be a candidate tumor suppressor gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.,27236921,2017,DisGeNET,rs7633054,SNV,,,,,,SNP not found in the specified article
rs281865414,20346435,"Deafness, Autosomal Recessive 84A",Tunisia,North Africa,NS,TRUE,NS,PTPRQ,,PTPRQ,protein tyrosine phosphatase receptor type Q,12,Q9UMZ3,"This locus encodes a member of the type III receptor-like protein-tyrosine phosphatase family. The encoded protein catalyzes the dephosphorylation of phosphotyrosine and phosphatidylinositol and plays roles in cellular proliferation and differentiation. Mutations at this locus have been linked to autosomal recessive deafness. [provided by RefSeq, Mar 2014].",22/11/2021,PubMed,Mutations in PTPRQ are a cause of autosomal-recessive nonsyndromic hearing impairment DFNB84 and associated with vestibular dysfunction.,20346435,2010,DisGeNET,rs281865414,SNV,,,,,,Position 2 in the reference protein sequence corresponds to position 1 in the paper.
rs114073621,17324573,Glycogen Storage Disease Type V,"Algeria, Tunisia, Europe",North Africa,NS,TRUE,0.000000636,PYGM,,PYGM,"glycogen phosphorylase, muscle associated	",11,P11217,"This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.,17324573,2007,DisGeNET,rs114073621,SNV,,,,,,
rs116987552,17324573,Glycogen Storage Disease Type V,"Algeria, Tunisia, Europe",North Africa,NS,TRUE,0,PYGM,,PYGM,"glycogen phosphorylase, muscle associated	",11,P11217,"This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.,17324573,2007,DisGeNET,rs116987552,SNV,,,,,,
rs119103259,17324573,Glycogen Storage Disease Type V,"Algeria, Tunisia, Europe",North Africa,NS,TRUE,0,PYGM,,PYGM,"glycogen phosphorylase, muscle associated	",11,P11217,"This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.,17324573,2007,DisGeNET,rs119103259,SNV,,,,,,
rs398124208,17324573,Glycogen Storage Disease Type V,"Algeria, Tunisia, Europe",North Africa,NS,TRUE,0.04,PYGM,,PYGM,"glycogen phosphorylase, muscle associated	",11,P11217,"This gene encodes a muscle enzyme involved in glycogenolysis. Highly similar enzymes encoded by different genes are found in liver and brain. Mutations in this gene are associated with McArdle disease (myophosphorylase deficiency), a glycogen storage disease of muscle. Alternative splicing results in multiple transcript variants.",22/11/2021,PubMed,Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation.,17324573,2007,DisGeNET,rs398124208,SNV,,,,,,
rs398123044,23746546,Retinitis Pigmentosa,Morocco,North Africa,Jewish,FALSE,NS,RAB28,,RAB28,"RAB28, member RAS oncogene family",4,P51157,"This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,"Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.",23746546,2013,DisGeNET,rs398123044,SNV,,,,,,
rs786200944,23746546,Retinitis Pigmentosa,Morocco,North Africa,Jewish,FALSE,NS,RAB28,,RAB28,"RAB28, member RAS oncogene family",4,P51157,"This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,"Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.",23746546,2013,DisGeNET,rs786200944,SNV,,,,,,
rs398123044,23746546,Cone-Rod Dystrophy 18,Morocco,North Africa,NS,FALSE,NS,RAB28,,RAB28,"RAB28, member RAS oncogene family",4,P51157,"This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,"Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.",23746546,2013,DisGeNET,rs398123044,SNV,,,,,,A homozygous nonsense mutation (c.409C>T [p.Arg137*]) was identified in a family of Moroccon Jewish descent with two siblings affected by arCRD.
rs751163782,23746546,Cone-Rod Dystrophy 18,Morocco,North Africa,NS,FALSE,NS,RAB28,,RAB28,"RAB28, member RAS oncogene family",4,P51157,"This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,"Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.",23746546,2013,DisGeNET,rs751163782,SNV,,,,,,
rs786200944,23746546,Cone-Rod Dystrophy 18,Morocco,North Africa,NS,FALSE,NS,RAB28,,RAB28,"RAB28, member RAS oncogene family",4,P51157,"This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,"Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.",23746546,2013,DisGeNET,rs786200944,SNV,,,,,,
rs875989778,23746546,Cone-Rod Dystrophy 18,Morocco,North Africa,NS,FALSE,NS,RAB28,,RAB28,"RAB28, member RAS oncogene family",4,P51157,"This gene encodes a member of the Rab subfamily of Ras-related small GTPases. The encoded protein may be involved in regulating intracellular trafficking. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 9 and X. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,"Mutations in RAB28, encoding a farnesylated small GTPase, are associated with autosomal-recessive cone-rod dystrophy.",23746546,2013,DisGeNET,rs875989778,SNV,,,,,,
rs137853052,18286824,Warburg Sjo Fledelius Syndrome,Egypt,North Africa,NS,FALSE,NS,RAB3GAP1,,RAB3GAP1,RAB3 GTPase activating protein catalytic subunit 1,2,Q15042,"This gene encodes the catalytic subunit of a Rab GTPase activating protein. The encoded protein forms a heterodimer with a non-catalytic subunit to specifically regulate the activity of members of the Rab3 subfamily of small G proteins. This protein mediates the hydrolysis of GTP bound Rab3 to the GDP bound form. Mutations in this gene are associated with Warburg micro syndrome. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Phenotypic variability in Micro syndrome: report of new cases.,18286824,2008,DisGeNET,rs137853052,SNV,,,,,,
rs137853293,25602518,Retinoblastoma,Tunisia,North Africa,NS,FALSE,NS,RB1,,RB1,RB transcriptional corepressor 1,13,P06400,"The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutation spectrum of RB1 gene in unilateral retinoblastoma cases from Tunisia and correlations with clinical features.,25602518,2015,DisGeNET,rs137853293,SNV,,,,,,SNP not found in the specified article
rs121913302,22219649,"Neoplastic Syndromes, Hereditary",Morocco,North Africa,NS,FALSE,NS,RB1,,RB1,RB transcriptional corepressor 1,13,P06400,"The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma.,22219649,2012,DisGeNET,rs121913302,SNV,,,,,,"This first report of RB1 gene screening in Moroccon patients with retinoblastoma shows a comparable mutational spectrum to those reported previously, which has evident importance for managing patients with retinoblastoma and their families."
rs121913301,22219649,Retinoblastoma,Morocco,North Africa,NS,FALSE,NS,RB1,,RB1,RB transcriptional corepressor 1,13,P06400,"The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma.,22219649,2012,DisGeNET,rs121913301,SNV,,,,,,"This first report of RB1 gene screening in  patients with retinoblastoma shows a comparable mutational spectrum to those reported previously, which has evident importance for managing patients with retinoblastoma and their families."
rs587776783,15776430,"Neoplastic Syndromes, Hereditary","Africa, America, Asia, Europe",Africa,NS,TRUE,0.04,RB1,,RB1,RB transcriptional corepressor 1,13,P06400,"The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Conservation of the RB1 gene in human and primates.,15776430,2005,DisGeNET,rs587776783,SNV,,,,,,
rs76262710,9259198,Familial Medullary Thyroid Carcinoma,Morocco,North Africa,Jewish,FALSE,NS,RET,,RET,ret proto-oncogene,10,P07949,"This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017].",22/11/2021,PubMed,Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.,9259198,2000,DisGeNET,rs76262710,SNV,,,,,,
rs76262710,9259198,Hirschsprung Disease,Morocco,North Africa,Jewish,FALSE,NS,RET,,RET,ret proto-oncogene,10,P07949,"This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017].",22/11/2021,PubMed,Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.,9259198,2000,DisGeNET,rs76262710,SNV,,,,,,
rs76262710,9259198,Medullary Carcinoma Of Thyroid,Morocco,North Africa,Jewish,FALSE,NS,RET,,RET,ret proto-oncogene,10,P07949,"This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017].",22/11/2021,PubMed,Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.,9259198,2000,DisGeNET,rs76262710,SNV,,,,,,
rs76262710,9259198,Pheochromocytoma,Morocco,North Africa,Jewish,FALSE,NS,RET,,RET,ret proto-oncogene,10,P07949,"This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017].",22/11/2021,PubMed,Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting.,9259198,2000,DisGeNET,rs76262710,SNV,,,,,,
rs2842030,17588543,Genotype GG is associated with increased response to risperidone in people with Schizophrenia as compared to genotypes TT + GT.,USA,African American/Afro-Caribbean,African American,TRUE,0.002,RGS4,,RGS4,regulator of G protein signaling 4,1,P49798,"Regulator of G protein signaling (RGS) family members are regulatory molecules that act as GTPase activating proteins (GAPs) for G alpha subunits of heterotrimeric G proteins. RGS proteins are able to deactivate G protein subunits of the Gi alpha, Go alpha and Gq alpha subtypes. They drive G proteins into their inactive GDP-bound forms. Regulator of G protein signaling 4 belongs to this family. All RGS proteins share a conserved 120-amino acid sequence termed the RGS domain. Regulator of G protein signaling 4 protein is 37% identical to RGS1 and 97% identical to rat Rgs4. This protein negatively regulate signaling upstream or at the level of the heterotrimeric G protein and is localized in the cytoplasm. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Ethnic stratification of the association of RGS4 variants with antipsychotic treatment response in schizophrenia.,17588543,2008,PharmGKB,608431255,SNV,risperidone,DB00734,"Approved, Investigational","Risperidone is indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with Bipolar I Disorder, and irritability associated with autistic disorder. Risperidone has additional indications through Health Canada for the short-term symptomatic management of aggression or psychotic symptoms in patients with severe dementia of the Alzheimer type unresponsive to nonpharmacological approaches. Risperidone is also used off-label for a number of conditions including as an adjunct to antidepressants in treatment-resistant depression.","3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one",rs2842030 is assigned to RGS4 gene in this study and it's associated with increased response to risperidone in African with Schizophrenia
rs6139258,28062682,Drug-Induced Liver Disease,"Malawi, Mozambique, Uganda","East Africa, South Africa",NS,TRUE,5.70E-07,RNF24,,RNF24,ring finger protein 24,20,Q9Y225,"This gene encodes an integral membrane protein that contains a RING-type zinc finger. The encoded protein may interact with multiple transient receptor potential cation channel subfamily C (TRPC) proteins and regulate the trafficking and insertion of these proteins into the plasma membrane. [provided by RefSeq, Mar 2016].",22/11/2021,PubMed,Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.,28062682,2017,DisGeNET,rs6139258,SNV,,,,,,The rs6139258 in the RNF24 locus is associated with nevirapine-induced Drug-induced liver injury (DILI).
rs6139258,28062682,HIV Infections,"Malawi, Mozambique, Uganda","East Africa, South Africa",NS,TRUE,NS,RNF24,,RNF24,ring finger protein 24,20,Q9Y225,"This gene encodes an integral membrane protein that contains a RING-type zinc finger. The encoded protein may interact with multiple transient receptor potential cation channel subfamily C (TRPC) proteins and regulate the trafficking and insertion of these proteins into the plasma membrane. [provided by RefSeq, Mar 2016].",22/11/2021,PubMed,Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.,28062682,2017,DisGeNET,rs6139258,SNV,,,,,,
rs878853326,16568030,"Genetic Diseases, Inborn",South Africa,South Africa,NS,FALSE,< 0.05,RP1,,RP1,"RP1 axonemal microtubule associated	",8,P56715,"This gene encodes a member of the doublecortin family. The protein encoded by this gene contains two doublecortin domains, which bind microtubules and regulate microtubule polymerization. The encoded protein is a photoreceptor microtubule-associated protein and is required for correct stacking of outer segment disc. This protein and the RP1L1 protein, another retinal-specific protein, play essential and synergistic roles in affecting photosensitivity and outer segment morphogenesis of rod photoreceptors. Because of its response to in vivo retinal oxygen levels, this protein was initially named ORP1 (oxygen-regulated protein-1). This protein was subsequently designated RP1 (retinitis pigmentosa 1) when it was found that mutations in this gene cause autosomal dominant retinitis pigmentosa. Mutations in this gene also cause autosomal recessive retinitis pigmentosa. Transcript variants resulted from an alternative promoter and alternative splicings have been found, which overlap the current reference sequence and has several exons upstream and downstream of the current reference sequence. However, the biological validity and full-length nature of some variants cannot be determined at this time.",22/11/2021,PubMed,Novel variants in the hotspot region of RP1 in South African patients with retinitis pigmentosa.,16568030,2006,DisGeNET,rs878853326,SNV,,,,,,
rs104894927,15032968,Retinitis Pigmentosa 2 (Disorder),South Africa,South Africa,NS,FALSE,NS,RP2,Genetic variability study,RP2,RP2 activator of ARL3 GTPase,X,O75695,"The RP2 locus has been implicated as one cause of X-linked retinitis pigmentosa. The predicted gene product shows homology with human cofactor C, a protein involved in the ultimate step of beta-tubulin folding. Progressive retinal degeneration may therefore be due to the accumulation of incorrectly-folded photoreceptor or neuron-specific tubulin isoforms followed by progressive cell death [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Arg120stop nonsense mutation in the RP2 gene: mutational hotspot and germ line mosaicism?,15032968,2004,DisGeNET,rs104894927,SNV,,,,,,"Genotype analysis has shown that the proband's unaffected brother carries the at-risk allele, but not the mutation. Thus, this is the first reported case of germ line mosaicism in a family with RP."
rs1042919,24024897,"RRM1 SNPs rs1042919 (which occurs in linkage disequilbrium with multiple other SNPs) and promoter SNP rs1561876 were associated with intracellular 1-β-D-arabinofuranosyl-CTP levels, response after remission induction therapy.","Nigeria, Europe",West Africa,Yoruba,TRUE,< 0.05,RRM1,,RRM1,"ribonucleotide reductase catalytic subunit M1	",4,P23921,"This gene encodes the large and catalytic subunit of ribonucleotide reductase, an enzyme essential for the conversion of ribonucleotides into deoxyribonucleotides. A pool of available deoxyribonucleotides is important for DNA replication during S phase of the cell cycle as well as multiple DNA repair processes. Alternative splicing results in multiple transcript variants. ",22/11/2021,PubMed,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.,24024897,2013,PharmGKB,TBD,SNV,cladribine,DB00242,"Approved, Investigational","For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.","(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol",
rs1561876,24024897,"RRM1 SNPs rs1042919 (which occurs in linkage disequilbrium with multiple other SNPs) and promoter SNP rs1561876 were associated with intracellular 1-β-D-arabinofuranosyl-CTP levels, response after remission induction therapy.","Nigeria, Europe",West Africa,Yoruba,TRUE,< 0.05,RRM1,,RRM1,"ribonucleotide reductase catalytic subunit M1	",4,P23921,"This gene encodes the large and catalytic subunit of ribonucleotide reductase, an enzyme essential for the conversion of ribonucleotides into deoxyribonucleotides. A pool of available deoxyribonucleotides is important for DNA replication during S phase of the cell cycle as well as multiple DNA repair processes. Alternative splicing results in multiple transcript variants. ",22/11/2021,PubMed,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.,24024897,2013,PharmGKB,TBD,SNV,cladribine,DB00242,"Approved, Investigational","For the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.","(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol",
rs1042919,24024897,"RRM1 SNPs rs1042919 (which occurs in linkage disequilbrium with multiple other SNPs) and promoter SNP rs1561876 were associated with intracellular 1-β-D-arabinofuranosyl-CTP levels, response after remission induction therapy.","Nigeria, Europe",West Africa,Yoruba,TRUE,< 0.05,RRM1,,RRM1,"ribonucleotide reductase catalytic subunit M1	",4,P23921,"This gene encodes the large and catalytic subunit of ribonucleotide reductase, an enzyme essential for the conversion of ribonucleotides into deoxyribonucleotides. A pool of available deoxyribonucleotides is important for DNA replication during S phase of the cell cycle as well as multiple DNA repair processes. Alternative splicing results in multiple transcript variants. ",22/11/2021,PubMed,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.,24024897,2013,PharmGKB,TBD,SNV,cytarabine,DB00987,"Approved, Investigational","For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.","4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
rs1561876,24024897,"RRM1 SNPs rs1042919 (which occurs in linkage disequilbrium with multiple other SNPs) and promoter SNP rs1561876 were associated with intracellular 1-β-D-arabinofuranosyl-CTP levels, response after remission induction therapy.","Nigeria, Europe",West Africa,Yoruba,TRUE,< 0.05,RRM1,,RRM1,"ribonucleotide reductase catalytic subunit M1	",4,P23921,"This gene encodes the large and catalytic subunit of ribonucleotide reductase, an enzyme essential for the conversion of ribonucleotides into deoxyribonucleotides. A pool of available deoxyribonucleotides is important for DNA replication during S phase of the cell cycle as well as multiple DNA repair processes. Alternative splicing results in multiple transcript variants. ",22/11/2021,PubMed,RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.,24024897,2013,PharmGKB,TBD,SNV,cytarabine,DB00987,"Approved, Investigational","For the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.","4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one",
rs542998,24934404,Hyperpyrexia,Cameroon,West Africa,NS,FALSE,0.011,RTN3,Association,RTN3,reticulon 3,11,O95197,"This gene belongs to the reticulon family of highly conserved genes that are preferentially expressed in neuroendocrine tissues. This family of proteins interact with, and modulate the activity of beta-amyloid converting enzyme 1 (BACE1), and the production of amyloid-beta. An increase in the expression of any reticulon protein substantially reduces the production of amyloid-beta, suggesting that reticulon proteins are negative modulators of BACE1 in cells. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, and pseudogenes of this gene are located on chromosomes 4 and 12. [provided by RefSeq, May 2012].",22/11/2021,PubMed,Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study.,24934404,2015,DisGeNET,rs542998,SNV,,,,,,"A total of 971 cases and 891 controls were enrolled into the study. Study involved malaria diagnosed children (aged 1 month to 13 years) admitted in nine health facilities in the Centre, Littoral and South West regions of Cameroon."
rs121918303,18073304,Cryptorchidism,"Egypt, Italy, Spain, Hungary",North Africa,NS,TRUE,NS,RXFP2,,RXFP2,relaxin family peptide receptor 2,13,Q8WXD0,"This gene encodes a member of the GPCR (G protein-coupled, 7-transmembrane receptor) family. Mutations in this gene are associated with cryptorchidism. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009].",22/11/2021,PubMed,The leucine-rich repeat-containing G protein-coupled receptor 8 gene T222P mutation does not cause cryptorchidism.,18073304,2008,DisGeNET,rs121918303,SNV,,,,,,The variant was described in  3 egyptian patients.
rs1805343,30100615,Allele A is associated with increased exposure to rosuvastatin in healthy individuals.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.001,RXRA,,RXRA,retinoid X receptor alpha,9,P19793,"Retinoid X receptors (RXRs) and retinoic acid receptors (RARs) are nuclear receptors that mediate the biological effects of retinoids by their involvement in retinoic acid-mediated gene activation. These receptors function as transcription factors by binding as homodimers or heterodimers to specific sequences in the promoters of target genes. The protein encoded by this gene is a member of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733142,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Variants associated with high rosuvastatin Cmax (Cmaxâ€‰>â€‰20â€‰ng/ml)
rs118192164,12112081,"Central Core Disease, Autosomal Recessive",Algeria,North Africa,NS,FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.",12112081,2002,DisGeNET,rs118192164,SNV,,,,,,
rs118192164,12112081,Central Core Myopathy (Disorder),Algeria,North Africa,NS,FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.",12112081,2002,DisGeNET,rs118192164,SNV,,,,,,
rs118192164,12112081,"Minicore Myopathy, Moderate, With Hand Involvement",Algeria,North Africa,NS,FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.",12112081,2002,DisGeNET,rs118192164,SNV,,,,,,
rs118192164,12112081,"Multicore Myopathy, Moderate, With Hand Involvement",Algeria,North Africa,NS,FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.",12112081,2002,DisGeNET,rs118192164,SNV,,,,,,
rs118192164,12112081,"Multiminicore Disease, Moderate, With Hand Involvement",Algeria,North Africa,NS,FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.",12112081,2002,DisGeNET,rs118192164,SNV,,,,,,
rs118192164,12112081,"Neuromuscular Disease, Congenital, With Uniform Type 1 Fiber (Disorder)",Algeria,North Africa,NS,FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A recessive form of central core disease, transiently presenting as multi-minicore disease, is associated with a homozygous mutation in the ryanodine receptor type 1 gene.",12112081,2002,DisGeNET,rs118192164,SNV,,,,,,
rs193922837,20839240,"Genetic Diseases, Inborn",South Africa,South Africa,"Afrikaner,Khoisan,Malay,Javanese Sumatran",FALSE,NS,RYR1,,RYR1,ryanodine receptor 1,19,P21817,"This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,RYR1 mutations are a common cause of congenital myopathies with central nuclei.,20839240,2010,DisGeNET,rs193922837,SNV,,,,,,
rs786204628,19529988,"Spastic Ataxia, Charlevoix-Saguenay Type",Tunisia,North Africa,NS,FALSE,NS,SACS,,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,A novel SACS gene mutation in a Tunisian family.,19529988,2010,DisGeNET,rs786204628,SNV,,,,,,
rs565203731,18569450,"Spastic Ataxia, Charlevoix-Saguenay Type",Tunisia,North Africa,NS,FALSE,NS,SACS,,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,Autosomal recessive ataxia caused by three distinct gene defects in a single consanguineous family.,18569450,2009,DisGeNET,rs565203731,SNV,,,,,,11 Tunisian patients belonging to the same large consanguineous family and sharing autosomal recessive ataxia phenotypes caused by three distinct gene defects.
rs565203731,26010040,"Spastic Ataxia, Charlevoix-Saguenay Type",Tunisia,North Africa,NS,FALSE,NS,SACS,,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,Comorbidity in the Tunisian population.,26010040,2016,DisGeNET,rs565203731,SNV,,,,,,Seventy-five disease associations have been reported among Tunisian families. This comorbidity could be individual or familial.
rs1057516689,12873855,"Genetic Diseases, Inborn",Tunisia,North Africa,NS,FALSE,NS,SACS,Linkage,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia.,12873855,2003,DisGeNET,rs1057516689,SNV,,,,,,Pathogenic/likely pathogenic mutation identified in Tunisian patient with autosomal recessive cerebellar ataxia.
rs774906736,12873855,"Genetic Diseases, Inborn",Tunisia,North Africa,NS,FALSE,NS,SACS,Linkage,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia.,12873855,2003,DisGeNET,rs774906736,SNV,,,,,,Pathogenic mutation identified in Tunisian patient with autosomal recessive cerebellar ataxia.
rs137853016,12873855,"Spastic Ataxia, Charlevoix-Saguenay Type",Tunisia,North Africa,NS,FALSE,NS,SACS,Linkage,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia.,12873855,2003,DisGeNET,rs137853016,SNV,,,,,,Pathogenic mutation identified in Tunisian patient with autosomal recessive cerebellar ataxia.
rs137853017,12873855,"Spastic Ataxia, Charlevoix-Saguenay Type",Tunisia,North Africa,NS,FALSE,NS,SACS,Linkage,SACS,sacsin molecular chaperone,13,Q9NZJ4,"This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that 'the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins' (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,Phenotypic features and genetic findings in sacsin-related autosomal recessive ataxia in Tunisia.,12873855,2003,DisGeNET,rs137853017,SNV,,,,,,Pathogenic mutation identified in Tunisian patient with autosomal recessive cerebellar ataxia.
rs137853125,17945526,Chylomicron Retention Disease,"Algeria, Europe",North Africa,NS,TRUE,> 0.05,SAR1B,,SAR1B,"secretion associated ras related GTPase 1B	",5,Q9Y6B6,"The protein encoded by this gene is a small GTPase that acts as a homodimer. The encoded protein is activated by the guanine nucleotide exchange factor PREB and is involved in protein transport from the endoplasmic reticulum to the Golgi. This protein is part of the COPII coat complex. Defects in this gene are a cause of chylomicron retention disease (CMRD), also known as Anderson disease (ANDD). Two transcript variants encoding the same protein have been found for this gene. ",22/11/2021,PubMed,Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein.,17945526,2008,DisGeNET,rs137853125,SNV,,,,,,
rs137853126,17945526,Chylomicron Retention Disease,"Algeria, Europe",North Africa,NS,TRUE,> 0.05,SAR1B,,SAR1B,"secretion associated ras related GTPase 1B	",5,Q9Y6B6,"The protein encoded by this gene is a small GTPase that acts as a homodimer. The encoded protein is activated by the guanine nucleotide exchange factor PREB and is involved in protein transport from the endoplasmic reticulum to the Golgi. This protein is part of the COPII coat complex. Defects in this gene are a cause of chylomicron retention disease (CMRD), also known as Anderson disease (ANDD). Two transcript variants encoding the same protein have been found for this gene. ",22/11/2021,PubMed,Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein.,17945526,2008,DisGeNET,rs137853126,SNV,,,,,,
rs28942109,17945526,Chylomicron Retention Disease,"Algeria, Europe",North Africa,NS,TRUE,0.022,SAR1B,,SAR1B,"secretion associated ras related GTPase 1B	",5,Q9Y6B6,"The protein encoded by this gene is a small GTPase that acts as a homodimer. The encoded protein is activated by the guanine nucleotide exchange factor PREB and is involved in protein transport from the endoplasmic reticulum to the Golgi. This protein is part of the COPII coat complex. Defects in this gene are a cause of chylomicron retention disease (CMRD), also known as Anderson disease (ANDD). Two transcript variants encoding the same protein have been found for this gene. ",22/11/2021,PubMed,Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein.,17945526,2008,DisGeNET,rs28942109,SNV,,,,,,
rs28942110,17945526,Chylomicron Retention Disease,"Algeria, Europe",North Africa,NS,TRUE,0.022,SAR1B,,SAR1B,"secretion associated ras related GTPase 1B	",5,Q9Y6B6,"The protein encoded by this gene is a small GTPase that acts as a homodimer. The encoded protein is activated by the guanine nucleotide exchange factor PREB and is involved in protein transport from the endoplasmic reticulum to the Golgi. This protein is part of the COPII coat complex. Defects in this gene are a cause of chylomicron retention disease (CMRD), also known as Anderson disease (ANDD). Two transcript variants encoding the same protein have been found for this gene. ",22/11/2021,PubMed,Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein.,17945526,2008,DisGeNET,rs28942110,SNV,,,,,,
rs587781245,25315659,Alopecia,Morocco,North Africa,NS,FALSE,NS,SASH1,,SASH1,SAM and SH3 domain containing 1,6,O94885,"This gene encodes a scaffold protein involved in the TLR4 signaling pathway that may stimulate cytokine production and endothelial cell migration in response to invading pathogens. The encoded protein has also been described as a potential tumor suppressor that may negatively regulate proliferation, apoptosis, and invasion of cancer cells, and reduced expression of this gene has been observed in multiple human cancers. Mutations in this gene may be associated with abnormal skin pigmentation in human patients. [provided by RefSeq, Oct 2016].",22/11/2021,PubMed,"Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma.",25315659,2016,DisGeNET,rs587781245,SNV,,,,,,
rs587781245,25315659,Palmoplantar Keratosis,Morocco,North Africa,NS,FALSE,NS,SASH1,,SASH1,SAM and SH3 domain containing 1,6,O94885,"This gene encodes a scaffold protein involved in the TLR4 signaling pathway that may stimulate cytokine production and endothelial cell migration in response to invading pathogens. The encoded protein has also been described as a potential tumor suppressor that may negatively regulate proliferation, apoptosis, and invasion of cancer cells, and reduced expression of this gene has been observed in multiple human cancers. Mutations in this gene may be associated with abnormal skin pigmentation in human patients. [provided by RefSeq, Oct 2016].",22/11/2021,PubMed,"Autosomal-recessive SASH1 variants associated with a new genodermatosis with pigmentation defects, palmoplantar keratoderma and skin carcinoma.",25315659,2016,DisGeNET,rs587781245,SNV,,,,,,
rs120074137,12687498,"Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma","Morocco, Tunisia",North Africa,NS,FALSE,NS,SBF2,,SBF2,SET binding factor 2,11,Q86WG5,"This gene encodes a pseudophosphatase and member of the myotubularin-related protein family. This gene maps within the CMT4B2 candidate region of chromosome 11p15 and mutations in this gene have been associated with Charcot-Marie-Tooth Disease, type 4B2. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.",12687498,2003,DisGeNET,rs120074137,SNV,,,,,,
rs120074138,12687498,"Charcot-Marie-Tooth Neuropathy, Type 4B2, With Early-Onset Glaucoma","Morocco, Tunisia",North Africa,NS,FALSE,NS,SBF2,,SBF2,SET binding factor 2,11,Q86WG5,"This gene encodes a pseudophosphatase and member of the myotubularin-related protein family. This gene maps within the CMT4B2 candidate region of chromosome 11p15 and mutations in this gene have been associated with Charcot-Marie-Tooth Disease, type 4B2. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma.",12687498,2003,DisGeNET,rs120074138,SNV,,,,,,
rs61759921,19017867,Bronchiectasis With Or Without Elevated Sweat Chloride 1,Rwanda,Central Africa,NS,FALSE,NS,SCNN1B,,SCNN1B,sodium channel epithelial 1 subunit beta,16,P51168,"Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the beta subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), and Liddle syndrome. [provided by RefSeq, Apr 2009].",22/11/2021,PubMed,Genetic analysis of Rwandan patients with cystic fibrosis-like symptoms: identification of novel cystic fibrosis transmembrane conductance regulator and epithelial sodium channel gene variants.,19017867,2009,DisGeNET,rs61759921,SNV,,,,,,
rs786203251,17376234,"Neoplastic Syndromes, Hereditary",USA,African American/Afro-Caribbean,"African American, Caucasian",TRUE,NS,SDHB,,SDHB,succinate dehydrogenase complex iron sulfur subunit B,1,P21912,"Complex II of the respiratory chain, which is specifically involved in the oxidation of succinate, carries electrons from FADH to CoQ. The complex is composed of four nuclear-encoded subunits and is localized in the mitochondrial inner membrane. The iron-sulfur subunit is highly conserved and contains three cysteine-rich clusters which may comprise the iron-sulfur centers of the enzyme. Sporadic and familial mutations in this gene result in paragangliomas and pheochromocytoma, and support a link between mitochondrial dysfunction and tumorigenesis. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA.,17376234,2007,DisGeNET,rs786203251,SNV,,,,,,
rs267607035,20920667,"Pontocerebellar Hypoplasia, Type 2D","Morocco, Iraq",North Africa,Jewish,FALSE,NS,SEPSECS,,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,4,Q9HD40,"The amino acid selenocysteine is the only amino acid that does not have its own tRNA synthetase. Instead, this amino acid is synthesized on its cognate tRNA in a three step process. The protein encoded by this gene catalyzes the third step in the process, the conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).[provided by RefSeq, Mar 2011].",22/11/2021,PubMed,Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.,20920667,2010,DisGeNET,rs267607035,SNV,,,,,,
rs267607036,20920667,"Pontocerebellar Hypoplasia, Type 2D","Morocco, Iraq",North Africa,Jewish,TRUE,NS,SEPSECS,,SEPSECS,Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase,4,Q9HD40,"The amino acid selenocysteine is the only amino acid that does not have its own tRNA synthetase. Instead, this amino acid is synthesized on its cognate tRNA in a three step process. The protein encoded by this gene catalyzes the third step in the process, the conversion of O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec).[provided by RefSeq, Mar 2011].",22/11/2021,PubMed,Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy.,20920667,2010,DisGeNET,rs267607036,SNV,,,,,,
rs61761869,11214903,Alpha 1-Antitrypsin Deficiency,"São Tomé and Príncipe, Portugal",West Africa,NS,TRUE,NS,SERPINA1,,SERPINA1,serpin family A member 1,14,P01009,"The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism.,11214903,2001,DisGeNET,rs61761869,SNV,,,,,,
rs61761869,19654085,Alpha 1-Antitrypsin Deficiency,Tunisia,North Africa,NS,FALSE,0.00000075,SERPINA1,,SERPINA1,serpin family A member 1,14,P01009,"The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,[Biochemical and molecular diagnosis of alpha 1 antitrypsin deficiency in a Tunisian family].,19654085,2009,DisGeNET,rs61761869,SNV,,,,,,
rs144666367,27476651,Peeling Skin Syndrome 5,Tunisia,North Africa,NS,FALSE,NS,SERPINB8,,SERPINB8,serpin family B member 8,18,P50452,"The protein encoded by this gene is a member of the ov-serpin family of serine protease inhibitors. The encoded protein is produced by platelets and can bind to and inhibit the function of furin, a serine protease involved in platelet functions. In addition, this protein has been found to enhance the mechanical stability of cell-cell adhesion in the skin, and defects in this gene have been associated with an autosomal-recessive form of exfoliative ichthyosis. [provided by RefSeq, Jan 2017].",22/11/2021,PubMed,Loss-of-Function Mutations in SERPINB8 Linked to Exfoliative Ichthyosis with Impaired Mechanical Stability of Intercellular Adhesions.,27476651,2017,DisGeNET,rs144666367,SNV,,,,,,This rs is described as c.850C>T (p.Arg284*
rs374612640,27476651,Peeling Skin Syndrome 5,Tunisia,North Africa,NS,FALSE,NS,SERPINB8,,SERPINB8,serpin family B member 8,18,P50452,"The protein encoded by this gene is a member of the ov-serpin family of serine protease inhibitors. The encoded protein is produced by platelets and can bind to and inhibit the function of furin, a serine protease involved in platelet functions. In addition, this protein has been found to enhance the mechanical stability of cell-cell adhesion in the skin, and defects in this gene have been associated with an autosomal-recessive form of exfoliative ichthyosis. [provided by RefSeq, Jan 2017].",22/11/2021,PubMed,Loss-of-Function Mutations in SERPINB8 Linked to Exfoliative Ichthyosis with Impaired Mechanical Stability of Intercellular Adhesions.,27476651,2017,DisGeNET,rs374612640,SNV,,,,,,"This rs is described as missense mutation, c.2T>C (p.Met1?),"
rs121909547,3775688,Antithrombin Iii Deficiency,Tunisia,North Africa,NS,FALSE,NS,SERPINC1,"Genetic variability study,Functional Analysis",SERPINC1,serpin family C member 1,1,P01008,"The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020].",22/11/2021,PubMed,Homozygous variant of antithrombin III: AT III Fontainebleau.,3775688,1986,DisGeNET,rs121909547,SNV,,,,,,
rs143570936,26934379,Alpha-Sarcoglycanopathies,Egypt,North Africa,NS,FALSE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Homozygous nonsense mutation in SGCA is a common cause of limb-girdle muscular dystrophy in Assiut, Egypt.",26934379,2017,DisGeNET,rs143570936,SNV,,,,,,This rs is described as NM_000023.2 c.739G>A
rs137852621,9153448,Alpha-Sarcoglycanopathies,"Tunisia, France",North Africa,NS,TRUE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.",9153448,1997,DisGeNET,rs137852621,SNV,,,,,,Associated with Muscular dystrophy
rs143570936,9153448,Alpha-Sarcoglycanopathies,"Tunisia, France",North Africa,NS,TRUE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.",9153448,1997,DisGeNET,rs143570936,SNV,,,,,,Associated with Muscular dystrophy
rs28933693,9153448,Alpha-Sarcoglycanopathies,"Tunisia, France",North Africa,NS,TRUE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.",9153448,1997,DisGeNET,rs28933693,SNV,,,,,,Associated with Muscular dystrophy
rs371675217,9153448,Alpha-Sarcoglycanopathies,"Tunisia, France",North Africa,NS,TRUE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,"Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy.",9153448,1997,DisGeNET,rs371675217,SNV,,,,,,Associated with Muscular dystrophy
rs137852621,7663524,Alpha-Sarcoglycanopathies,"Algeria, Morocco",North Africa,NS,FALSE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity.,7663524,1995,DisGeNET,rs137852621,SNV,,,,,,Associated with moderate phenotype of Muscular dystrophy
rs371675217,7663524,Alpha-Sarcoglycanopathies,"Algeria, Morocco",North Africa,NS,FALSE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity.,7663524,1995,DisGeNET,rs371675217,SNV,,,,,,Associated with mild phenotype of Muscular dystrophy
rs28933693,7663524,Alpha-Sarcoglycanopathies,Tunisia,North Africa,NS,TRUE,NS,SGCA,,SGCA,sarcoglycan alpha,17,Q16586,"This gene encodes a component of the dystrophin-glycoprotein complex (DGC), which is critical to the stability of muscle fiber membranes and to the linking of the actin cytoskeleton to the extracellular matrix. Its expression is thought to be restricted to striated muscle. Mutations in this gene result in type 2D autosomal recessive limb-girdle muscular dystrophy. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity.,7663524,1995,DisGeNET,rs28933693,SNV,,,,,,Associated with severe phenotype of Muscular dystrophy
rs104893869,9631401,"Limb-Girdle Muscular Dystrophy, Type 2E",Tunisia,North Africa,NS,FALSE,NS,SGCB,,SGCB,sarcoglycan beta,4,Q16585,"This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008].",22/11/2021,PubMed,LGMD 2E in Tunisia is caused by a homozygous missense mutation in beta-sarcoglycan exon 3.,9631401,1998,DisGeNET,rs104893869,SNV,,,,,,"Associated with limb-girdle muscular dystrophy, 2E"
rs786204786,24552312,Severe Autosomal Recessive Muscular Dystrophy Of Childhood - North African Type (Disorder),Morocco,North Africa,NS,FALSE,NS,SGCG,,SGCG,sarcoglycan gamma,13,Q13326,"This gene encodes gamma-sarcoglycan, one of several sarcolemmal transmembrane glycoproteins that interact with dystrophin. The dystrophin-glycoprotein complex (DGC) spans the sarcolemma and is comprised of dystrophin, syntrophin, alpha- and beta-dystroglycans and sarcoglycans. The DGC provides a structural link between the subsarcolemmal cytoskeleton and the extracellular matrix of muscle cells. Defects in the encoded protein can lead to early onset autosomal recessive muscular dystrophy, in particular limb-girdle muscular dystrophy, type 2C (LGMD2C). [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Carrier frequency of the c.525delT mutation in the SGCG gene and estimated prevalence of limb girdle muscular dystrophy type 2C among the Moroccan population.,24552312,2014,DisGeNET,rs786204786,SNV,,,,,,
rs770947426,21910976,Mucopolysaccharidosis Type Iiia,Tunisia,North Africa,NS,FALSE,NS,SGSH,,SGSH,N-sulfoglucosamine sulfohydrolase,17,P51688,"This gene encodes the enzyme sulfamidase; one of several enzymes involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with the lysosomal storage disease mucopolysaccaridosis IIIA, also known as Sanfilippo syndrome A, which results from impaired degradation of heparan sulfate. Transcripts of varying sizes have been reported but their biological validity has not been determined. [provided by RefSeq, Jun 2017].",22/11/2021,PubMed,"Molecular characterization of MPS IIIA, MPS IIIB and MPS IIIC in Tunisian patients.",21910976,2012,DisGeNET,rs770947426,SNV,,,,,,
rs3184504,23087401,Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,0.047,SH2B3,,SH2B3,SH2B adaptor protein 3,12,Q9UQQ2,"This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491528,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide","In African Americans treated with HCTZ, the C allele of rs3184504 SNP is associated with a slight increase in blood pressure"
rs3184504,23087401,Allele T is not associated with response to hydrochlorothiazide in people with Hypertension as compared to allele C.,USA,African American/Afro-Caribbean,NS,FALSE,0.047,SH2B3,,SH2B3,SH2B adaptor protein 3,12,Q9UQQ2,"This gene encodes a member of the SH2B adaptor family of proteins, which are involved in a range of signaling activities by growth factor and cytokine receptors. The encoded protein is a key negative regulator of cytokine signaling and plays a critical role in hematopoiesis. Mutations in this gene have been associated with susceptibility to celiac disease type 13 and susceptibility to insulin-dependent diabetes mellitus. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2014].",22/11/2021,PubMed,Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study.,23087401,2013,PharmGKB,1183491528,SNV,hydrochlorothiazide,DB00999,Approved,"Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy.10,11 Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.","6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide","In African Americans treated with HCTZ, the C allele of rs3184504 SNP is associated with a slight increase in blood pressure"
rs80338933,16924012,Charcot-Marie-Tooth Disease,Algeria,North Africa,NS,FALSE,NS,SH3TC2,,SH3TC2,SH3 domain and tetratricopeptide repeats 2,5,Q8TF17,"This gene encodes a protein with two N-terminal Src homology 3 (SH3) domains and 10 tetratricopeptide repeat (TPR) motifs, and is a member of a small gene family. The gene product has been proposed to be an adapter or docking molecule. Mutations in this gene result in autosomal recessive Charcot-Marie-Tooth disease type 4C, a childhood-onset neurodegenerative disease characterized by demyelination of motor and sensory neurons. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.,16924012,2006,DisGeNET,rs80338933,SNV,,,,,,
rs80338933,16924012,"Charcot-Marie-Tooth Disease, Type 4C",Algeria,North Africa,NS,FALSE,NS,SH3TC2,,SH3TC2,SH3 domain and tetratricopeptide repeats 2,5,Q8TF17,"This gene encodes a protein with two N-terminal Src homology 3 (SH3) domains and 10 tetratricopeptide repeat (TPR) motifs, and is a member of a small gene family. The gene product has been proposed to be an adapter or docking molecule. Mutations in this gene result in autosomal recessive Charcot-Marie-Tooth disease type 4C, a childhood-onset neurodegenerative disease characterized by demyelination of motor and sensory neurons. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.,16924012,2006,DisGeNET,rs80338933,SNV,,,,,,
rs80338933,16924012,"Mononeuropathy Of The Median Nerve, Mild","Algeria, Europe",North Africa,NS,TRUE,NS,SH3TC2,,SH3TC2,SH3 domain and tetratricopeptide repeats 2,5,Q8TF17,"This gene encodes a protein with two N-terminal Src homology 3 (SH3) domains and 10 tetratricopeptide repeat (TPR) motifs, and is a member of a small gene family. The gene product has been proposed to be an adapter or docking molecule. Mutations in this gene result in autosomal recessive Charcot-Marie-Tooth disease type 4C, a childhood-onset neurodegenerative disease characterized by demyelination of motor and sensory neurons. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.,16924012,2006,DisGeNET,rs80338933,SNV,,,,,,
rs797044960,21700001,"Deafness, Autosomal Dominant 23",Tunisia,North Africa,NS,FALSE,NS,SIX1,,SIX1,SIX homeobox 1,14,Q15475,"The protein encoded by this gene is a homeobox protein that is similar to the Drosophila 'sine oculis' gene product. This gene is found in a cluster of related genes on chromosome 14 and is thought to be involved in limb development. Defects in this gene are a cause of autosomal dominant deafness type 23 (DFNA23) and branchiootic syndrome type 3 (BOS3). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"A novel dominant mutation in SIX1, affecting a highly conserved residue, result in only auditory defects in humans.",21700001,2011,DisGeNET,rs797044960,SNV,,,,,,
rs56903885,30100615,Allele T is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.007,SLC10A1,,SLC10A1,solute carrier family 10 member 1,14,Q14973,"The protein encoded by this gene belongs to the sodium/bile acid cotransporter family, which are integral membrane glycoproteins that participate in the enterohepatic circulation of bile acids. Two homologous transporters are involved in the reabsorption of bile acids; the ileal sodium/bile acid cotransporter with an apical cell localization that absorbs bile acids from the intestinal lumen, bile duct and kidney, and the liver-specific sodium/bile acid cotransporter, represented by this protein, that is found in the basolateral membranes of hepatocytes. Bile acids are the catabolic product of cholesterol metabolism, hence this protein is important for cholesterol homeostasis. [provided by RefSeq, Oct 2011].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733079,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml)
rs17235409,16395392,"Buruli Ulcer, Susceptibility To",Ghana,West Africa,NS,FALSE,0.007,SLC11A1,,SLC11A1,solute carrier family 11 member 1,2,P49279,"This gene is a member of the solute carrier family 11 (proton-coupled divalent metal ion transporters) family and encodes a multi-pass membrane protein. The protein functions as a divalent transition metal (iron and manganese) transporter involved in iron metabolism and host resistance to certain pathogens. Mutations in this gene have been associated with susceptibility to infectious diseases such as tuberculosis and leprosy, and inflammatory diseases such as rheumatoid arthritis and Crohn disease. Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only one has been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.,16395392,2007,DisGeNET,rs17235409,SNV,,,,,,182 Buruli ulcer patients (102 with positive laboratory confirmation) and 191 healthy neighbourhood-matched controls in Ghana. The odds ratio of the GA genotype versus the GG genotype was 2.89 (95% confidence intervals (CI): 1.41-5.91)
rs363371,18797399,"Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",USA,African American/Afro-Caribbean,African American,FALSE,0.258,SLC18A2,,SLC18A2,solute carrier family 18 member A2,10,Q05940,"This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018].",22/11/2021,PubMed,Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.,18797399,2008,PharmGKB,1184749158,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",
rs929493,18797399,"Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele T.",USA,African American/Afro-Caribbean,African American,FALSE,0.3,SLC18A2,,SLC18A2,solute carrier family 18 member A2,10,Q05940,"This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018].",22/11/2021,PubMed,Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.,18797399,2008,PharmGKB,1184749196,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",rs929493 is assigned SLC18A2 gene in this study and is not associated with response to citalopram in people with Depressive Disorder.
rs363343,18797399,"Allele A is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele C.",USA,African American/Afro-Caribbean,African American,FALSE,> 0.1,SLC18A2,,SLC18A2,solute carrier family 18 member A2,10,Q05940,"This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018].",22/11/2021,PubMed,Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.,18797399,2008,PharmGKB,1184749190,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",
rs363390,18797399,"Allele C is not associated with response to citalopram in people with Depressive Disorder, Major as compared to allele G.",USA,African American/Afro-Caribbean,African American,FALSE,> 0.1,SLC18A2,,SLC18A2,solute carrier family 18 member A2,10,Q05940,"This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018].",22/11/2021,PubMed,Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.,18797399,2008,PharmGKB,1184749184,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",
rs713993048,23423671,Leigh Disease,Morocco,North Africa,NS,FALSE,NS,SLC19A3,,SLC19A3,solute carrier family 19 member 3,2,Q9BZV2,"This gene encodes a ubiquitously expressed transmembrane thiamine transporter that lacks folate transport activity. Mutations in this gene cause biotin-responsive basal ganglia disease (BBGD); a recessive disorder manifested in childhood that progresses to chronic encephalopathy, dystonia, quadriparesis, and death if untreated. Patients with BBGD have bilateral necrosis in the head of the caudate nucleus and in the putamen. Administration of high doses of biotin in the early progression of the disorder eliminates pathological symptoms while delayed treatment results in residual paraparesis, mild cognitive disability, or dystonia. Administration of thiamine is ineffective in the treatment of this disorder. Experiments have failed to show that this protein can transport biotin. Mutations in this gene also cause a Wernicke's-like encephalopathy.[provided by RefSeq, Jan 2010].",22/11/2021,PubMed,Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.,23423671,2013,DisGeNET,rs713993048,SNV,,,,,,
rs1426654,29025994,"Skin-Hair-Eye Pigmentation, Variation In, 4","Botswana, Ethiopia, Tanzania",East Africa / South Africa,NS,TRUE,5.00E-07,SLC24A5,,SLC24A5,solute carrier family 24 member 5,15,Q71RS6 ,This gene is a member of the potassium-dependent sodium/calcium exchanger family and encodes an intracellular membrane protein with 2 large hydrophilic loops and 2 sets of multiple transmembrane-spanning segments. Sequence variation in this gene has been associated with differences in skin pigmentation. ,22/11/2021,PubMed,Loci associated with skin pigmentation identified in African populations.,29025994,2018,DisGeNET,rs1426654,SNV,,,,,,is significantly associated with skin pigmentation in African populations
rs121918335,19780765,Early Myoclonic Encephalopathy,Algeria,North Africa,NS,FALSE,NS,SLC25A22,,SLC25A22,solute carrier family 25 member 22,11,Q9H936,"This gene encodes a mitochondrial glutamate carrier. Mutations in this gene are associated with early infantile epileptic encephalopathy. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Jul 2010].",22/11/2021,PubMed,Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts.,19780765,2009,DisGeNET,rs121918335,SNV,,,,,,Mutation was described in Algerian patient.
rs201279313,26729753,"African American participants heterozygous for SLC25A31 rs201279313 deletion versus wild-type genotype had better diastolic BP response to atenolol monotherapy, metoprolol monotherapy, and atenolol add-on therapy.",USA,African American/Afro-Caribbean,African American,TRUE,2.5×10(-8),SLC25A31,,SLC25A31,solute carrier family 25 member 31,4,Q9H0C2,"The protein encoded by this gene is a member of the ADP/ATP carrier family of proteins that exchange cytosolic ADP for matrix ATP in the mitochondria. Cells over-expressing this gene have been shown to display an anti-apoptotic phenotype. This protein is also thought to play a role in spermatogenesis, where it is believed to associate with a part of the flagellar cytoskeleton and with glycolytic enzymes. Male mice with mutations in the mouse ortholog of this gene are sterile and spermatocytes display an early meiotic arrest phenotype. Alternative splicing results in multiple transcript variants encoding different isoforms. ",22/11/2021,PubMed,Pharmacogenomic Genome-Wide Meta-Analysis of Blood Pressure Response to √ü-Blockers in Hypertensive African Americans.,26729753,2016,PharmGKB,TBD,SNV,atenolol,DB00335,Approved,Indicated for: 1) Management of hypertension alone and in combination with other antihypertensives. 2) Management of angina pectoris associated with coronary atherosclerosis. 3) Management of acute myocardial infarction in hemodynamically stable patients with a heart rate greater than 50 beats per minutes and a systolic blood pressure above 100 mmHg. Off-label uses include: 1) Secondary prevention of myocardial infarction. 2) Management of heart failure. 3) Management of atrial fibrillation. 4) Management of supraventricular tachycardia. 5) Management of ventricular arrythmias such as congenital long-QT and arrhythmogenic right ventricular cardiomyopathy. 6) Management of symptomatic thyrotoxicosis in combination with methimazole. 7) Prophylaxis of migraine headaches. 8) Management of alcohol withdrawal.,2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide,
rs111033307,10602116,Enlarged Vestibular Aqueduct,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,Genetic variability study,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation.,10602116,2000,DisGeNET,rs111033307,SNV,,,,,,This pathogenic mutation was identified in patients with profound congenital deafness (Pendred's Syndrome)
rs111033307,10602116,Pendred'S Syndrome,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,Genetic variability study,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Pendred syndrome: phenotypic variability in two families carrying the same PDS missense mutation.,10602116,2000,DisGeNET,rs111033307,SNV,,,,,,Pathogenic mutation identified in patients with profound congenital deafness (Pendred'S Syndrome).
rs201636911,22429511,Pendred'S Syndrome,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Segregation of a new mutation in SLC26A4 and p.E47X mutation in GJB2 within a consanguineous Tunisian family affected with Pendred syndrome.,22429511,2012,DisGeNET,rs201636911,SNV,,,,,,The paper discribe a c.451delG mutation on the SLC26A4 but the rs201636911 is a missense variant
rs201636911,22429511,Pendred'S Syndrome,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Segregation of a new mutation in SLC26A4 and p.E47X mutation in GJB2 within a consanguineous Tunisian family affected with Pendred syndrome.,22429511,2012,DisGeNET,rs201636911,SNV,,,,,,The paper discribe a c.451delG mutation on the SLC26A4 but the rs201636911 is a missense variant
rs111033307,20128824,Enlarged Vestibular Aqueduct,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,Genetic variability study,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Two missense mutations in SLC26A4 gene: a molecular and functional study.,20128824,2010,DisGeNET,rs111033307,SNV,,,,,,Pathogenic mutation identified in Tunisian patients with non syndromic hearing lost  and variable thyroid dysfunction.
rs111033307,20128824,Enlarged Vestibular Aqueduct,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,Genetic variability study,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Two missense mutations in SLC26A4 gene: a molecular and functional study.,20128824,2010,DisGeNET,rs111033307,SNV,,,,,,Pathogenic mutation identified in Tunisian patients with non syndromic hearing lost  and variable thyroid dysfunction.
rs111033307,20128824,Pendred'S Syndrome,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,Genetic variability study,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Two missense mutations in SLC26A4 gene: a molecular and functional study.,20128824,2010,DisGeNET,rs111033307,SNV,,,,,,Pathogenic mutation identified in Tunisian patients with non syndromic hearing lost  and variable thyroid dysfunction.
rs111033307,20128824,Pendred'S Syndrome,Tunisia,North Africa,NS,FALSE,NS,SLC26A4,Genetic variability study,SLC26A4,solute carrier family 26 member 4,7,O43511,"Mutations in this gene are associated with Pendred syndrome, the most common form of syndromic deafness, an autosomal-recessive disease. It is highly homologous to the SLC26A3 gene; they have similar genomic structures and this gene is located 3' of the SLC26A3 gene. The encoded protein has homology to sulfate transporters. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Two missense mutations in SLC26A4 gene: a molecular and functional study.,20128824,2010,DisGeNET,rs111033307,SNV,,,,,,Pathogenic mutation identified in Tunisian patients with non syndromic hearing lost  and variable thyroid dysfunction.
rs121912583,24894595,Histiocytosis With Joint Contractures And Sensorineural Deafness,Egypt,North Africa,NS,FALSE,NS,SLC29A3,,SLC29A3,solute carrier family 29 member 3,10,Q9BZD2,"This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010].",22/11/2021,PubMed,Novel homozygous SLC29A3 mutations among two unrelated Egyptian families with spectral features of H-syndrome.,24894595,2016,DisGeNET,rs121912583,SNV,,,,,,This study emphasized the inter- and intra-familial genetic heterogeneity among Egyptian patients with overlapping features of SLC29A3 disorders.
rs587776600,14569121,Arterial Tortuosity Syndrome,Morocco,North Africa,NS,FALSE,NS,SLC2A10,,SLC2A10,solute carrier family 2 member 10,20,O95528,"This gene encodes a member of the class III facilitative glucose transporter family. The encoded protein plays a role in regulation of glucose homeostasis. Mutations in this gene have been associated with arterial tortuosity syndrome.[provided by RefSeq, Dec 2009].",22/11/2021,PubMed,Homozygosity mapping of a gene for arterial tortuosity syndrome to chromosome 20q13.,14569121,2003,DisGeNET,rs587776600,SNV,,,,,,
rs13266634,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,1.60E-05,SLC30A8,,SLC30A8,solute carrier family 30 member 8,8,Q8IWU4,"The protein encoded by this gene is a zinc efflux transporter involved in the accumulation of zinc in intracellular vesicles. This gene is expressed at a high level only in the pancreas, particularly in islets of Langerhans. The encoded protein colocalizes with insulin in the secretory pathway granules of the insulin-secreting INS-1 cells. Allelic variants of this gene exist that confer susceptibility to diabetes mellitus, noninsulin-dependent (NIDDM). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2010].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs13266634,SNV,,,,,,"IGF2BP2 rs1470579, KCNJ11 rs5219, PPARÎ³ rs1801282 and SLC30A8 rs13266634 displayed various associations with T2DM in the study populations."
rs781897678,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,SLC35A2,,SLC35A2,solute carrier family 35 member A2,X,P78381,"This gene encodes a member of the nucleotide-sugar transporter family. The encoded protein is a multi-pass membrane protein. It transports UDP-galactose from the cytosol into Golgi vesicles, where it serves as a glycosyl donor for the generation of glycans. Mutations in this gene cause congenital disorder of glycosylation type IIm (CDG2M). Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Oct 2014].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs781897678,SNV,,,,,,
rs121434291,11254458,Acrodermatitis Enteropathica,"Egypt, Jordan",North Africa,NS,TRUE,0,SLC39A4,,SLC39A4,solute carrier family 39 member A4,8,Q6P5W5,This gene encodes a member of the zinc/iron-regulated transporter-like protein (ZIP) family. The encoded protein localizes to cell membranes and is required for zinc uptake in the intestine. Mutations in this gene result in acrodermatitis enteropathica. Multiple transcript variants encoding different isoforms have been found for this gene. ,22/11/2021,PubMed,Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3.,11254458,2001,DisGeNET,rs121434291,SNV,,,,,,
rs778210210,26637978,"Congenital Disorder Of Glycosylation, Type Iin",Egypt,North Africa,NS,FALSE,NS,SLC39A8,,SLC39A8,solute carrier family 39 member 8,4,Q9C0K1,"This gene encodes a member of the SLC39 family of solute-carrier genes, which show structural characteristics of zinc transporters. The encoded protein is glycosylated and found in the plasma membrane and mitochondria, and functions in the cellular import of zinc at the onset of inflammation. It is also thought to be the primary transporter of the toxic cation cadmium, which is found in cigarette smoke. Multiple transcript variants encoding different isoforms have been found for this gene. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8.,26637978,2016,DisGeNET,rs778210210,SNV,,,,,,
rs13107325,26006263,Schizophrenia,"Africa, Asia, Europe",Africa,NS,TRUE,0.0000027,SLC39A8,,SLC39A8,solute carrier family 39 member 8,4,Q9C0K1,"This gene encodes a member of the SLC39 family of solute-carrier genes, which show structural characteristics of zinc transporters. The encoded protein is glycosylated and found in the plasma membrane and mitochondria, and functions in the cellular import of zinc at the onset of inflammation. It is also thought to be the primary transporter of the toxic cation cadmium, which is found in cigarette smoke. Multiple transcript variants encoding different isoforms have been found for this gene. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Oct 2008].",22/11/2021,PubMed,Recent Positive Selection Drives the Expansion of a Schizophrenia Risk Nonsynonymous Variant at SLC39A8 in Europeans.,26006263,2016,DisGeNET,rs13107325,SNV,,,,,,
rs11568350,17490902,Iron Overload,"South Africa, Swaziland, Zimbabwe, UK, USA",South Africa / African American/Afro-Caribbean,NS,TRUE,0.0006,SLC40A1,,SLC40A1,solute carrier family 40 member A1,2,Q9NP59,The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). ,22/11/2021,PubMed,SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent.,17490902,2018,DisGeNET,rs11568350,SNV,,,,,,
rs368420430,22584997,"Hemochromatosis, Type 4",USA,African American/Afro-Caribbean,African American,FALSE,0.03,SLC40A1,,SLC40A1,solute carrier family 40 member A1,2,Q9NP59,The protein encoded by this gene is a cell membrane protein that may be involved in iron export from duodenal epithelial cells. Defects in this gene are a cause of hemochromatosis type 4 (HFE4). ,22/11/2021,PubMed,Mild iron overload in an African American man with SLC40A1 D270V.,22584997,2012,DisGeNET,rs368420430,SNV,,,,,,
rs25531,18618621,Allele C is not associated with response to citalopram in people with Depression as compared to allele T.,USA,African American/Afro-Caribbean,African American,FALSE,NS,SLC6A4,,SLC6A4,solute carrier family 6 member 4,17,P31645,"This gene encodes an integral membrane protein that transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons. The encoded protein terminates the action of serotonin and recycles it in a sodium-dependent manner. This protein is a target of psychomotor stimulants, such as amphetamines and cocaine, and is a member of the sodium:neurotransmitter symporter family. A repeat length polymorphism in the promoter of this gene has been shown to affect the rate of serotonin uptake. There have been conflicting results in the literature about the possible effect, if any, that this polymorphism may play in behavior and depression. [provided by RefSeq, May 2019].",22/11/2021,PubMed,SLC6A4 variation and citalopram response.,18618621,2009,PharmGKB,981477870,SNV,citalopram,DB00215,Approved,"For the treatment of depression, as indicated by the FDA label . Off-label indications include but are not limited to: treatment of sexual dysfunction, post-stroke behavioural changes, ethanol abuse, obsessive-compulsive disorder (OCD) in children, and diabetic neuropathy.","1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",They found no evidence of association between genotype at the rs25531 SNP and remission in any of the three ethnic groups
rs121908676,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs121908676,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients.  These mutant alleles were characterized and eight novel mutations were detected."
rs121908679,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs121908679,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833799,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833799,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833800,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833800,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833805,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833805,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833812,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833812,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833817,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833817,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833818,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833818,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs386833827,10631139,Lysinuric Protein Intolerance,"Tunisia, Italy, Japan",North Africa,NS,TRUE,NS,SLC7A7,Genetic variability study,SLC7A7,solute carrier family 7 member 7,14,Q9UM01,"The protein encoded by this gene is the light subunit of a cationic amino acid transporter. This sodium-independent transporter is formed when the light subunit encoded by this gene dimerizes with the heavy subunit transporter protein SLC3A2. This transporter is found in epithelial cell membranes where it transfers cationic and large neutral amino acids from the cell to the extracellular space. Defects in this gene are a cause of lysinuric protein intolerance (LPI). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance.,10631139,2000,DisGeNET,rs386833827,SNV,,,,,,"This study report the genomic structure of SLC7A7 gene and the results of the mutational analysis in Italian, Tunisian, and Japanese patients. These mutant alleles were characterized and eight novel mutations were detected."
rs121908479,11013083,Cystinuria,Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,Linkage,SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,Dating the origin of the V170M mutation causing non-type I cystinuria in Libyan Jews by linkage disequilibrium and physical mapping of the SLC7A9 gene.,11013083,2001,DisGeNET,rs121908479,SNV,,,,,,The age of the founder missense V170M mutation causing non-type I cystinuria in Jewish of Libyan ancestry is calculated to be approximately 14 to 15 generations or slightly more.
rs121908479,10471498,Cystinuria,Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908479,SNV,,,,,,"The Libyan Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908480,10471498,Cystinuria,Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908480,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908482,10471498,Cystinuria,Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908482,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908483,10471498,Cystinuria,Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908483,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs79389353,10471498,Cystinuria,Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs79389353,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908479,10471498,"Cystinuria, Type A",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908479,SNV,,,,,,"The Libyan Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908480,10471498,"Cystinuria, Type A",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908480,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908482,10471498,"Cystinuria, Type A",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908482,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908483,10471498,"Cystinuria, Type A",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908483,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs79389353,10471498,"Cystinuria, Type A",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs79389353,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908479,10471498,"Cystinuria, Type A-B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908479,SNV,,,,,,"The Libyan Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908480,10471498,"Cystinuria, Type A-B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908480,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908482,10471498,"Cystinuria, Type A-B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908482,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908483,10471498,"Cystinuria, Type A-B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908483,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs79389353,10471498,"Cystinuria, Type A-B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs79389353,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908479,10471498,"Cystinuria, Type B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908479,SNV,,,,,,"The Libyan Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908480,10471498,"Cystinuria, Type B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908480,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908482,10471498,"Cystinuria, Type B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908482,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs121908483,10471498,"Cystinuria, Type B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs121908483,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs79389353,10471498,"Cystinuria, Type B",Lybia,North Africa,Jewish,FALSE,NS,SLC7A9,"Genetic variability study,Functional Analysis",SLC7A9,solute carrier family 7 member 9,19,P82251,"This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].",22/11/2021,PubMed,"Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT.",10471498,2001,DisGeNET,rs79389353,SNV,,,,,,"The Libyan-Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes bo,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. Four missense mutations were identified (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients."
rs4149056,27142945,Allele C is not associated with concentrations of lopinavir in people with HIV.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986096,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149056 and lopinavir plasma concentration.
rs4149056,27142945,Allele C is not associated with concentrations of lopinavir in people with HIV.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986096,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149056 and lopinavir plasma concentration.
rs2306283,27142945,Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986111,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs2306283 and lopinavir plasma concentration.
rs2306283,27142945,Genotypes AA + AG is not associated with concentrations of lopinavir in people with HIV as compared to genotype GG.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986111,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs2306283 and lopinavir plasma concentration.
rs4149044,27142945,Genotypes AA + AT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986122,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149044 and lopinavir plasma concentration.
rs4149044,27142945,Genotypes AA + AT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986122,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149044 and lopinavir plasma concentration.
rs4149045,27142945,Genotypes AG + GG is not associated with concentrations of lopinavir in people with HIV as compared to genotype AA.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986129,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149045 and lopinavir plasma concentration.
rs4149045,27142945,Genotypes AG + GG is not associated with concentrations of lopinavir in people with HIV as compared to genotype AA.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986129,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149045 and lopinavir plasma concentration.
rs4149057,27142945,Genotypes CC + CT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986136,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149057 and lopinavir plasma concentration.
rs4149057,27142945,Genotypes CC + CT is not associated with concentrations of lopinavir in people with HIV as compared to genotype TT.,"Malawi, South Africa",East Africa / South Africa,Bantu,TRUE,> 0.05,SLCO1B1,Association,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.,27142945,2017,PharmGKB,1447986136,SNV,lopinavir,DB01601,Approved,Indicated in combination with other antiretroviral agents for the treatment of HIV-infection.,"(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide",The cohort of this study involved 86 (n = 86) Bantu African HIV-positive participants (black South Africans (n = 34) and Malawians (n = 52). No significant association was found between rs4149057 and lopinavir plasma concentration.
rs12305884,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733045,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs12305884,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733045,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs11045873,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733054,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs11045873,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele T.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733054,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs11045874,30100615,Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733062,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs11045874,30100615,Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733062,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs34671512,30100615,Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele A.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.016,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733067,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs34671512,30100615,Allele C is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele A.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.016,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733067,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs11045854,30100615,Allele A is associated with decreased exposure to rosuvastatin in healthy individuals as compared to allele G.,Zimbabwe,South Africa,"Kikuyu,Luo,Maasai,Hausa, Igbo,Yoruba,Zimbabwean San, Shona,Tanzanian mixed Bantu",FALSE,0.002,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,An African-specific profile of pharmacogene variants for rosuvastatin plasma variability: limited role for SLCO1B1 c.521T>C and ABCG2 c.421A>C.,30100615,2020,PharmGKB,1449733034,SNV,rosuvastatin,DB01098,Approved,"The FDA monograph states that rosuvastatin is indicated as an adjunct to diet in the treatment of triglyceridemia, Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia), and Homozygous Familial Hypercholesterolemia. The Health Canada monograph for rosuvastatin further specifies that rosuvastatin is indicated for the reduction of elevated total cholesterol (Total-C), LDL-C, ApoB, the Total-C/HDL-C ratio and triglycerides (TG) and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions when response to diet and exercise alone has been inadequate. It is also indicated for the prevention of major cardiovascular events (including risk of myocardial infarction, nonfatal stroke, and coronary artery revascularization) in adult patients without documented history of cardiovascular or cerebrovascular events, but with at least two conventional risk factors for cardiovascular disease. Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD. Statin-indicated conditions include diabetes mellitus, clinical atherosclerosis (including myocardial infarction, acute coronary syndromes, stable angina, documented coronary artery disease, stroke, trans ischemic attack (TIA), documented carotid disease, peripheral artery disease, and claudication), abdominal aortic aneurysm, chronic kidney disease, and severely elevated LDL-C levels.","(3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid",Significantly associated with reduced rosuvastatin Cmax (Cmax < 7 ng/ml).
rs4149056,26892777,Genotype CT (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotype TT.,"South Africa, USA, Peru",South Africa / African American/Afro-Caribbean,NS,TRUE,0.26,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).,26892777,2017,PharmGKB,1447947662,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs4149056,26892777,Genotype CT (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotype TT.,"South Africa, USA, Peru",South Africa / African American/Afro-Caribbean,NS,TRUE,0.26,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).,26892777,2017,PharmGKB,1447947662,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs2306283,26892777,Genotype GG (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes AA + AG.,"South Africa, USA, Peru",South Africa / African American/Afro-Caribbean,NS,TRUE,0.38,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).,26892777,2017,PharmGKB,1447947654,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs2306283,26892777,Genotype GG (assigned as deficiency phenotype) is not associated with concentrations of atazanavir in people with HIV as compared to genotypes AA + AG.,"South Africa, USA, Peru",South Africa / African American/Afro-Caribbean,NS,TRUE,0.38,SLCO1B1,,SLCO1B1,solute carrier organic anion transporter family member 1B1,12,Q9Y6L6,"This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of numerous endogenous compounds including bilirubin, 17-beta-glucuronosyl estradiol and leukotriene C4. This protein is also involved in the removal of drug compounds such as statins, bromosulfophthalein and rifampin from the blood into the hepatocytes. Polymorphisms in the gene encoding this protein are associated with impaired transporter function. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342).,26892777,2017,PharmGKB,1447947654,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs121908319,14674887,Meleda Disease,Tunisia,North Africa,NS,FALSE,NS,SLURP1,"Genetic variability study,Linkage",SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel missense mutation in the gene encoding SLURP-1 in patients with Mal de Meleda from northern Tunisia.,14674887,2004,DisGeNET,rs121908319,SNV,,,,,,"Haplotype analysis of markers CNG003, D8S1751 and D8S1836 revealed that all affected offspring were homozygous by descent for the three polymorphic markers. with a maximum lod score value, 3.22 confirmed the evidence for linkage to the ARS gene. Three different mutations were identified, the 82delT mutation previously described and two novel missense mutations"
rs121908320,14674887,Meleda Disease,Tunisia,North Africa,NS,FALSE,NS,SLURP1,"Genetic variability study,Linkage",SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel missense mutation in the gene encoding SLURP-1 in patients with Mal de Meleda from northern Tunisia.,14674887,2004,DisGeNET,rs121908320,SNV,,,,,,"Haplotype analysis of markers CNG003, D8S1751 and D8S1836 revealed that all affected offspring were homozygous by descent for the three polymorphic markers. with a maximum lod score value, 3.22 confirmed the evidence for linkage to the ARS gene. Three different mutations were identified, the 82delT mutation previously described and two novel missense mutations"
rs587776601,14674887,Meleda Disease,Tunisia,North Africa,NS,FALSE,NS,SLURP1,"Genetic variability study,Linkage",SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A novel missense mutation in the gene encoding SLURP-1 in patients with Mal de Meleda from northern Tunisia.,14674887,2004,DisGeNET,rs587776601,SNV,,,,,,"Haplotype analysis of markers CNG003, D8S1751 and D8S1836 revealed that all affected offspring were homozygous by descent for the three polymorphic markers. with a maximum lod score value, 3.22 confirmed the evidence for linkage to the ARS gene. Three different mutations were identified, the 82delT mutation previously described and two novel missense mutations"
rs28937888,9887370,Meleda Disease,Algeria,North Africa,NS,FALSE,NS,SLURP1,,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic linkage of Meleda disease to chromosome 8qter.,9887370,1999,DisGeNET,rs28937888,SNV,,,,,,
rs121908317,11285253,Meleda Disease,Algeria,North Africa,NS,FALSE,NS,SLURP1,Genetic variability study,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the gene encoding SLURP-1 in Mal de Meleda.,11285253,2001,DisGeNET,rs121908317,SNV,,,,,,"Three different homozygous mutations (a deletion, a non sens and a splice site mutation) were detected in  12 kindreds of Algerian origin from Croatia : CNG003, D8S1751, D8S1836, suggesting founder effects."
rs28937888,11285253,Meleda Disease,Algeria,North Africa,NS,FALSE,NS,SLURP1,Genetic variability study,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the gene encoding SLURP-1 in Mal de Meleda.,11285253,2001,DisGeNET,rs28937888,SNV,,,,,,"Three different homozygous mutations (a deletion, a non sens and a splice site mutation) were detected in  12 d 12 kindreds of Algerian origin from Croatia : CNG003, D8S1751, D8S1836, suggesting founder effects."
rs587776601,11285253,Meleda Disease,Algeria,North Africa,NS,FALSE,NS,SLURP1,Genetic variability study,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the gene encoding SLURP-1 in Mal de Meleda.,11285253,2001,DisGeNET,rs587776601,SNV,,,,,,"Three different homozygous mutations (a deletion, a non sens and a splice site mutation) were detected in  12 d 12 kindreds of Algerian origin from Croatia : CNG003, D8S1751, D8S1836, suggesting founder effects."
rs587776602,11285253,Meleda Disease,Algeria,North Africa,NS,FALSE,NS,SLURP1,Genetic variability study,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Mutations in the gene encoding SLURP-1 in Mal de Meleda.,11285253,2001,DisGeNET,rs587776602,SNV,,,,,,"Three different homozygous mutations (a deletion, a non sens and a splice site mutation) were detected in  12 d 12 kindreds of Algerian origin from Croatia : CNG003, D8S1751, D8S1836, suggesting founder effects."
rs121908320,24093092,Meleda Disease,Tunisia,North Africa,NS,FALSE,NS,SLURP1,Genetic variability study,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region.,24093092,2014,DisGeNET,rs121908320,SNV,,,,,,"SLURP1 gene revealed the existence of a nucleotide deletion, 82delT at homozygous state in the affected individuals. This frame shift variation is leading to a creation of a premature stop codon at amino acid position 32 within exon 2 and to the synthesis of a truncated protein."
rs587776601,24093092,Meleda Disease,Tunisia,North Africa,NS,FALSE,NS,SLURP1,Genetic variability study,SLURP1,secreted LY6/PLAUR domain containing 1,8,P55000,"The protein encoded by this gene is a member of the Ly6/uPAR family but lacks a GPI-anchoring signal sequence. It is thought that this secreted protein contains antitumor activity. Mutations in this gene have been associated with Mal de Meleda, a rare autosomal recessive skin disorder. This gene maps to the same chromosomal region as several members of the Ly6/uPAR family of glycoprotein receptors. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Particular Mal de Meleda phenotypes in Tunisia and mutations founder effect in the Mediterranean region.,24093092,2014,DisGeNET,rs587776601,SNV,,,,,,"SLURP1 gene revealed the existence of a nucleotide deletion, 82delT at homozygous state in the affected individuals. This frame shift variation is leading to a creation of a premature stop codon at amino acid position 32 within exon 2 and to the synthesis of a truncated protein."
rs4939827,26779637,Colon Carcinoma,Egypt,North Africa,NS,FALSE,0.16,SMAD7,,SMAD7,SMAD family member 7,18,O15105,"The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].",22/11/2021,PubMed,Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?,26779637,2017,DisGeNET,rs4939827,SNV,,,,,,"A study was carried out on 77 Egyptian CRC patients (male = 51 and female = 26), average age 51.3 Â± 11.9 (mean Â± SD), range 27â€“73 years"
rs4939827,26779637,Colorectal Cancer,Egypt,North Africa,NS,FALSE,0.16,SMAD7,,SMAD7,SMAD family member 7,18,O15105,"The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].",22/11/2021,PubMed,Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?,26779637,2017,DisGeNET,rs4939827,SNV,,,,,,
rs4939827,26779637,Rectal Carcinoma,Egypt,North Africa,NS,FALSE,0.87,SMAD7,,SMAD7,SMAD family member 7,18,O15105,"The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].",22/11/2021,PubMed,Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?,26779637,2017,DisGeNET,rs4939827,SNV,,,,,,
rs4939827,26779637,Colorectal Carcinoma,Egypt,North Africa,NS,FALSE,NS,SMAD7,,SMAD7,SMAD family member 7,18,O15105,"The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].",22/11/2021,PubMed,Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?,26779637,2017,DisGeNET,rs4939827,SNV,,,,,,
rs4939827,26779637,Malignant Tumor Of Colon,Egypt,North Africa,NS,FALSE,NS,SMAD7,,SMAD7,SMAD family member 7,18,O15105,"The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].",22/11/2021,PubMed,Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?,26779637,2017,DisGeNET,rs4939827,SNV,,,,,,
rs120074118,8225311,"Niemann-Pick Disease, Type A","Algeria, Morocco",North Africa,NS,FALSE,NS,SMPD1,,SMPD1,sphingomyelin phosphodiesterase 1,11,P17405,"The protein encoded by this gene is a lysosomal acid sphingomyelinase that converts sphingomyelin to ceramide. The encoded protein also has phospholipase C activity. Defects in this gene are a cause of Niemann-Pick disease type A (NPA) and Niemann-Pick disease type B (NPB). Multiple transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010].",22/11/2021,PubMed,Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa.,8225311,1993,DisGeNET,rs120074118,SNV,,,,,,
rs120074118,8225311,"Niemann-Pick Disease, Type B","Algeria, Morocco",North Africa,NS,FALSE,NS,SMPD1,,SMPD1,sphingomyelin phosphodiesterase 1,11,P17405,"The protein encoded by this gene is a lysosomal acid sphingomyelinase that converts sphingomyelin to ceramide. The encoded protein also has phospholipase C activity. Defects in this gene are a cause of Niemann-Pick disease type A (NPA) and Niemann-Pick disease type B (NPB). Multiple transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2010].",22/11/2021,PubMed,Deletion of arginine (608) in acid sphingomyelinase is the prevalent mutation among Niemann-Pick disease type B patients from northern Africa.,8225311,1993,DisGeNET,rs120074118,SNV,,,,,,
rs587776924,23246290,Hypotrichosis 11,"Tunisia, UK",North Africa,NS,TRUE,0.04,SNRPE,,SNRPE,"small nuclear ribonucleoprotein polypeptide E	",1,P62304,"The protein encoded by this gene is a core component of U small nuclear ribonucleoproteins, which are key components of the pre-mRNA processing spliceosome. The encoded protein plays a role in the 3' end processing of histone transcripts. This protein is one of the targets in the autoimmune disease systemic lupus erythematosus, and mutations in this gene have been associated with hypotrichosis. Several pseudogenes of this gene have been identified. ",22/11/2021,PubMed,"Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.",23246290,2013,DisGeNET,rs587776924,SNV,,,,,,
rs587776925,23246290,Hypotrichosis 11,"Tunisia, UK",North Africa,NS,TRUE,0.04,SNRPE,,SNRPE,"small nuclear ribonucleoprotein polypeptide E	",1,P62304,"The protein encoded by this gene is a core component of U small nuclear ribonucleoproteins, which are key components of the pre-mRNA processing spliceosome. The encoded protein plays a role in the 3' end processing of histone transcripts. This protein is one of the targets in the autoimmune disease systemic lupus erythematosus, and mutations in this gene have been associated with hypotrichosis. Several pseudogenes of this gene have been identified. ",22/11/2021,PubMed,"Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.",23246290,2013,DisGeNET,rs587776925,SNV,,,,,,
rs587776925,23246290,Hypotrichosis Simplex,"Tunisia, UK",North Africa,NS,TRUE,0.04,SNRPE,,SNRPE,"small nuclear ribonucleoprotein polypeptide E	",1,P62304,"The protein encoded by this gene is a core component of U small nuclear ribonucleoproteins, which are key components of the pre-mRNA processing spliceosome. The encoded protein plays a role in the 3' end processing of histone transcripts. This protein is one of the targets in the autoimmune disease systemic lupus erythematosus, and mutations in this gene have been associated with hypotrichosis. Several pseudogenes of this gene have been identified. ",22/11/2021,PubMed,"Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.",23246290,2013,DisGeNET,rs587776925,SNV,,,,,,
rs386134173,7920663,"Amyotrophic Lateral Sclerosis 2, Juvenile (Disorder)",Tunisia,North Africa,NS,FALSE,NS,SOD1,,SOD1,superoxide dismutase 1,21,P00441,"The protein encoded by this gene binds copper and zinc ions and is one of two isozymes responsible for destroying free superoxide radicals in the body. The encoded isozyme is a soluble cytoplasmic protein, acting as a homodimer to convert naturally-occuring but harmful superoxide radicals to molecular oxygen and hydrogen peroxide. The other isozyme is a mitochondrial protein. In addition, this protein contains an antimicrobial peptide that displays antibacterial, antifungal, and anti-MRSA activity against E. coli, E. faecalis, S. aureus, S. aureus MRSA LPV+, S. agalactiae, and yeast C. krusei. Mutations in this gene have been implicated as causes of familial amyotrophic lateral sclerosis. Rare transcript variants have been reported for this gene. [provided by RefSeq, Jul 2020].",22/11/2021,PubMed,Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35.,7920663,1994,DisGeNET,rs386134173,SNV,,,,,,
rs73208473,29315502,Allele A is associated with decreased exposure to atazanavir in women with HIV as compared to allele C.,USA,African American/Afro-Caribbean,African American,TRUE,8.04E-08,SORCS2,,SORCS2,sortilin related VPS10 domain containing receptor 2,4,Q96PQ0,"This gene encodes one family member of vacuolar protein sorting 10 (VPS10) domain-containing receptor proteins. The VPS10 domain name comes from the yeast carboxypeptidase Y sorting receptor Vps10 protein. Members of this gene family are large with many exons but the CDS lengths are usually less than 3700 nt. Very large introns typically separate the exons encoding the VPS10 domain; the remaining exons are separated by much smaller-sized introns. These genes are strongly expressed in the central nervous system. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair.,29315502,2019,PharmGKB,1450042840,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate","rs73208473 had an excellent imputation score (rsq= 0.973) and was in high LD with other directly measured SNPs showing strong association with ATV levels (r2= 0.86 across our entire multi-ethnic sample with rs73208470, association with ATV level p= 8.04x10âˆ’08)"
rs864622179,11087788,"Spastic Paraplegia 4, Autosomal Dominant",Tunisia,North Africa,NS,FALSE,NS,SPAST,,SPAST,spastin,2,Q9UBP0,"This gene encodes a member of the AAA (ATPases associated with a variety of cellular activities) protein family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. The use of alternative translational initiation sites in this gene results in a single transcript variant that can produce isoforms that differ in the length of their N-terminus and which thereby differ in the efficiency of their export from the nucleus to the cytoplasm. In addition, alternative splicing results in multiple transcript variants that encode isoforms that differ in other protein regions as well. One isoform of this gene has been shown to be a microtubule-severing enzyme that regulates microtubule abundance, mobility, and plus-end distribution. Mutations in this gene cause the most frequent form of autosomal dominant spastic paraplegia 4. [provided by RefSeq, May 2018].",22/11/2021,PubMed,Novel mutations in spastin gene and absence of correlation with age at onset of symptoms.,11087788,2001,DisGeNET,rs864622179,SNV,,,,,,Data in paper is for one family from Tunisia.
rs10192428,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,5.00E-07,SPATA3,,SPATA3,spermatogenesis associated 3,2,Q8NHX4,Predicted to be integral component of membrane. ,22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs10192428,SNV,,,,,,
rs1543061,19465909,Malaria,Gambia,West Africa,"Mandinka,Jola,Wolof,Fula",TRUE,9.60E-07,SPATA3,,SPATA3,spermatogenesis associated 3,2,Q8NHX4,Predicted to be integral component of membrane. ,22/11/2021,PubMed,Genome-wide and fine-resolution association analysis of malaria in West Africa.,19465909,2010,DisGeNET,rs1543061,SNV,,,,,,
rs312262728,20971220,"Spastic Paraplegia 11, Autosomal Recessive",Egypt,North Africa,NS,FALSE,NS,SPG11,,SPG11,"SPG11 vesicle trafficking associated, spatacsin",15,Q96JI7,"The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009].",22/11/2021,PubMed,Expanding the clinical spectrum of SPG11 gene mutations in recessive hereditary spastic paraplegia with thin corpus callosum.,20971220,2011,DisGeNET,rs312262728,SNV,,,,,,associated with Autosomal recessive hereditary spastic paraplegia with thin corpus callosum(ARHSP-TCC) in a consanguineous family from upper Egypt.
rs118203963,18332254,"Spastic Paraplegia 11, Autosomal Recessive",Tunisia,North Africa,Arab,FALSE,NS,SPG11,Genetic variability study,SPG11,"SPG11 vesicle trafficking associated, spatacsin",15,Q96JI7,"The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009].",22/11/2021,PubMed,"Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity.",18332254,2008,DisGeNET,rs118203963,SNV,,,,,,The R2034X mutation was reported in two Tunisian families with autosomal recessive spatic paraplegia 11.
rs312262720,18332254,"Spastic Paraplegia 11, Autosomal Recessive",Tunisia,North Africa,Arab,FALSE,NS,SPG11,Genetic variability study,SPG11,"SPG11 vesicle trafficking associated, spatacsin",15,Q96JI7,"The protein encoded by this gene is a potential transmembrane protein that is phosphorylated upon DNA damage. Defects in this gene are a cause of spastic paraplegia type 11 (SPG11). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009].",22/11/2021,PubMed,"Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity.",18332254,2008,DisGeNET,rs312262720,SNV,,,,,,The p.M245VfsX mutation was reported at homozygous state in affected members of 3 Tunisian families of Arab origin with spastic parapleagia 11.
rs61755320,16534102,Henoch-Schoenlein Purpura,Morocco,North Africa,NS,FALSE,NS,SPG7,,SPG7,"SPG7 matrix AAA peptidase subunit, paraplegin",16,Q9UQ90,"This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014].",22/11/2021,PubMed,Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia.,16534102,2006,DisGeNET,rs61755320,SNV,,,,,,
rs61755320,16534102,"Spastic Paraplegia 7, Autosomal Recessive",Morocco,North Africa,NS,FALSE,NS,SPG7,,SPG7,"SPG7 matrix AAA peptidase subunit, paraplegin",16,Q9UQ90,"This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Mar 2014].",22/11/2021,PubMed,Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia.,16534102,2006,DisGeNET,rs61755320,SNV,,,,,,
rs757679761,3126987,Elliptocytosis 2 (Disorder),"Benin, Burkina Faso, Ivory Coast, Togo",West Africa,NS,TRUE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,[Hereditary elliptocytosis in West Africa: frequency and repartition of spectrin variants].,3126987,1988,DisGeNET,rs757679761,SNV,,,,,,
rs121918643,8444470,Elliptocytosis 2 (Disorder),Morocco,North Africa,Moroccan,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,An alpha-spectrin mutation responsible for hereditary elliptocytosis associated in cis with the alpha v/41 polymorphism.,8444470,1993,DisGeNET,rs121918643,SNV,,,,,,Pathogenic mutation identified in a Moroccan family in both the heterozygous and homozygous states.
rs121918643,8444470,Hereditary Pyropoikilocytosis,Morocco,North Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,An alpha-spectrin mutation responsible for hereditary elliptocytosis associated in cis with the alpha v/41 polymorphism.,8444470,1993,DisGeNET,rs121918643,SNV,,,,,,Pathogenic mutation identified in a Moroccan family in both the heterozygous and homozygous states.
rs121918641,1679439,Elliptocytosis 2 (Disorder),Ghana,West Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.,1679439,1991,DisGeNET,rs121918641,SNV,,,,,,Mutation identified in in a black kindred from Ghana
rs121918641,1679439,Hereditary Pyropoikilocytosis,Ghana,West Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.,1679439,1991,DisGeNET,rs121918641,SNV,,,,,,Mutation identified in in a black kindred from Ghana
rs757679761,2567189,Elliptocytosis 2 (Disorder),"Algeria, Morocco",North Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Molecular basis of Sp alpha I/65 hereditary elliptocytosis in North Africa: insertion of a TTG triplet between codons 147 and 149 in the alpha-spectrin gene from five unrelated families.,2567189,1989,DisGeNET,rs757679761,SNV,,,,,,
rs121918641,2043465,Elliptocytosis 2 (Disorder),Tunisia,North Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Occurrence of the alpha I 22 Arg----His (CGT----CAT) spectrin mutation in Tunisia: potential association with severe elliptopoikilocytosis.,2043465,1991,DisGeNET,rs121918641,SNV,,,,,,Pathogenic mutation described in a Tunisian Family ( in father and his son)
rs121918641,2043465,Hereditary Pyropoikilocytosis,Tunisia,North Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Occurrence of the alpha I 22 Arg----His (CGT----CAT) spectrin mutation in Tunisia: potential association with severe elliptopoikilocytosis.,2043465,1991,DisGeNET,rs121918641,SNV,,,,,,Pathogenic mutation described in a Tunisian Family ( in father and his son)
rs7418956,1638030,Elliptocytosis 2 (Disorder),Tunisia,North Africa,NS,FALSE,NS,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Spectrin Jendouba: an alpha II/31 spectrin variant that is associated with elliptocytosis and carries a mutation distant from the dimer self-association site.,1638030,1992,DisGeNET,rs7418956,SNV,,,,,,
rs863223305,2895677,Elliptocytosis 2 (Disorder),Algeria,North Africa,NS,FALSE,< 0.05,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"Spectrin Oran (alpha II/21), a new spectrin variant concerning the alpha II domain and causing severe elliptocytosis in the homozygous state.",2895677,1988,DisGeNET,rs863223305,SNV,,,,,,
rs757147440,9192783,Hereditary Pyropoikilocytosis,Benin,West Africa,NS,FALSE,0.00000493,SPTA1,,SPTA1,"spectrin alpha, erythrocytic 1",1,P02549,"This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"Spectrin St Claude, a splicing mutation of the human alpha-spectrin gene associated with severe poikilocytic anemia.",9192783,1997,DisGeNET,rs757147440,SNV,,,,,,
rs769987150,23838597,"Genetic Diseases, Inborn",Egypt,North Africa,NS,FALSE,NS,SPTBN2,,SPTBN2,"spectrin beta, non-erythrocytic 2",11,O15020,"Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009].",22/11/2021,PubMed,Autosomal dominant SCA5 and autosomal recessive infantile SCA are allelic conditions resulting from SPTBN2 mutations.,23838597,2015,DisGeNET,rs769987150,SNV,,,,,,
rs6889768,24185611,Prostate Carcinoma,Ghana,West Africa,NS,FALSE,3.81E-07,SRA1,Association,SRA1,steroid receptor RNA activator 1,5,Q9HD15,"Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA. [provided by RefSeq, Mar 2012].",22/11/2021,PubMed,A genome-wide association study of prostate cancer in West African men.,24185611,2014,DisGeNET,rs6889768,SNV,,,,,,This is a GWAS study reporting on a cohort of 474 prostate cancer cases and 458 controls from Ghana.
rs764249635,22784038,Acute HIV Infection,South Africa,South Africa,NS,FALSE,NS,SRY,,SRY,sex determining region Y,Y,Q05066,"This intronless gene encodes a transcription factor that is a member of the high mobility group (HMG)-box family of DNA-binding proteins. This protein is the testis-determining factor (TDF), which initiates male sex determination. Mutations in this gene give rise to XY females with gonadal dysgenesis (Swyer syndrome); translocation of part of the Y chromosome containing this gene to the X chromosome causes XX male syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.,22784038,2012,DisGeNET,rs764249635,SNV,,,,,,
rs7574865,21418779,Rheumatoid Arthritis,Tunisia,North Africa,NS,FALSE,0.0014,STAT4,,STAT4,signal transducer and activator of transcription 4,2,Q14765,"The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is essential for mediating responses to IL12 in lymphocytes, and regulating the differentiation of T helper cells. Mutations in this gene may be associated with systemic lupus erythematosus and rheumatoid arthritis. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2011].",22/11/2021,PubMed,Signal transducer and activator of transcription and the risk of rheumatoid arthritis and thyroid autoimmune disorders.,21418779,2011,DisGeNET,rs7574865,SNV,,,,,,Genotypic association was found according to the absence of rheumatoid factor antibody (RF) (p=0.0014).
rs4889606,26751406,Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA.,Egypt,North Africa,NS,FALSE,0.0001,STX1B,,STX1B,syntaxin 1B,16,P61266,"The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015].",22/11/2021,PubMed,"Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.",26751406,2016,PharmGKB,1447677865,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study includes 204 Egyptians genotyped for rs4889606 G allele. STX1B rs4889606 was a significant determinant in univariate analysis (P = 0.0001). However, STX1B rs4889606 was in high linkage disequilibrium with VKORC1â€?1639 G>A, and was no longer significant after including VKORC1â€?1639 G>A in the regression model."
rs4889606,26751406,Genotypes AG + GG are associated with decreased dose of warfarin as compared to genotype AA.,Egypt,North Africa,NS,FALSE,0.0001,STX1B,,STX1B,syntaxin 1B,16,P61266,"The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015].",22/11/2021,PubMed,"Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians.",26751406,2016,PharmGKB,1447677865,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The study includes 204 Egyptians genotyped for rs4889606 G allele. STX1B rs4889606 was a significant determinant in univariate analysis (P = 0.0001). However, STX1B rs4889606 was in high linkage disequilibrium with VKORC1â€?1639 G>A, and was no longer significant after including VKORC1â€?1639 G>A in the regression model."
rs4889606,28135054,Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.0009,STX1B,,STX1B,syntaxin 1B,16,P61266,"The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573185,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The variant rs4889606 belongs to the STX1B gene. Carriers of the AG or GG genotypes requiring higher doses.   rs4889606 is a strong cis-eQTL for VKORC1. rs4889606 and VKORC1 -1639G>A rs9923231 were not in LD in either the discovery or replication cohorts.
rs4889606,28135054,Genotypes AG + GG are associated with increased dose of warfarin as compared to genotype AA.,USA,African American/Afro-Caribbean,African American,FALSE,0.0009,STX1B,,STX1B,syntaxin 1B,16,P61266,"The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573185,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The variant rs4889606 belongs to the STX1B gene. Carriers of the AG or GG genotypes requiring higher doses.   rs4889606 is a strong cis-eQTL for VKORC1.  rs4889606 and VKORC1 -1639G>A rs9923231 were not in LD in either the discovery or replication cohorts.
rs1411478,23415606,Parkinson Disease,Tunisia,North Africa,NS,FALSE,NS,STX6,,STX6,syntaxin 6,1,O43752,"Enables syntaxin binding activity. Involved in several processes, including Golgi ribbon formation; retrograde transport, endosome to Golgi; and vesicle fusion. Acts upstream of or within endocytic recycling. Located in several cellular components, including early endosome; perinuclear region of cytoplasm; and trans-Golgi network. Part of SNARE complex. ",22/11/2021,PubMed,STX6 rs1411478 is not associated with increased risk of Parkinson's disease.,23415606,2013,DisGeNET,rs1411478,SNV,,,,,,STX6 rs1411478 is not associated with increased risk of Parkinsonâ€™s disease
rs1411478,23415606,Progressive Supranuclear Palsy,Tunisia,North Africa,NS,FALSE,NS,STX6,,STX6,syntaxin 6,1,O43752,"Enables syntaxin binding activity. Involved in several processes, including Golgi ribbon formation; retrograde transport, endosome to Golgi; and vesicle fusion. Acts upstream of or within endocytic recycling. Located in several cellular components, including early endosome; perinuclear region of cytoplasm; and trans-Golgi network. Part of SNARE complex. ",22/11/2021,PubMed,STX6 rs1411478 is not associated with increased risk of Parkinson's disease.,23415606,2013,DisGeNET,rs1411478,SNV,,,,,,(rs1411478) reported to be associated with progressive supranuclear palsy (PSP) according to previous studies
rs7726475,21422096,Blood Pressure,"Nigeria, USA",West Africa / African American/Afro-Caribbean,African American,TRUE,1.00E-04,SUB1,,SUB1,SUB1 regulator of transcription,5,P53999,Enables identical protein binding activity; single-stranded DNA binding activity; and transcription coactivator activity. Involved in negative regulation of DNA metabolic process and regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of transcription regulator complex. ,22/11/2021,PubMed,Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: contributions from the CARe consortium.,21422096,2011,DisGeNET,rs7726475,SNV,,,,,,
rs7726475,21422096,Blood Pressure Finding,"Nigeria, USA",West Africa / African American/Afro-Caribbean,African American,TRUE,NS,SUB1,,SUB1,SUB1 regulator of transcription,5,P53999,Enables identical protein binding activity; single-stranded DNA binding activity; and transcription coactivator activity. Involved in negative regulation of DNA metabolic process and regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of transcription regulator complex. ,22/11/2021,PubMed,Combined admixture mapping and association analysis identifies a novel blood pressure genetic locus on 5p13: contributions from the CARe consortium.,21422096,2011,DisGeNET,rs7726475,SNV,,,,,,
rs9282861,28663312,Genotype TT is not associated with decreased metabolism of acetaminophen in healthy individuals as compared to genotypes CC + CT.,USA,African American/Afro-Caribbean,African American,TRUE,0.07,SULT1A1,,SULT1A1,sulfotransferase family 1A member 1,16,P50225,"Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. These cytosolic enzymes are different in their tissue distributions and substrate specificities. The gene structure (number and length of exons) is similar among family members. This gene encodes one of two phenol sulfotransferases with thermostable enzyme activity.  Multiple alternatively spliced variants that encode two isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.",28663312,2017,PharmGKB,1448639937,SNV,acetaminophen,DB00316,Approved,"In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms. Acetaminophen injection is indicated for: Management of mild to moderate pain, Management of moderate to severe pain with adjunctive opioid analgesics, Reduction of fever. Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children.",N-(4-hydroxyphenyl)acetamide,
rs137853300,9400791,"Fundus Dystrophy, Pseudoinflammatory, Of Sorsby","South Africa, Canada, USA",,NS,TRUE,> 0.05,SYN3,,SYN3,"synapsin III	",22,O14994,"This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. The protein encoded by this gene shares the synapsin family domain model, with domains A, C, and E exhibiting the highest degree of conservation. The protein contains a unique domain J, located between domains C and E. Based on this gene's localization to 22q12.3, a possible schizophrenia susceptibility locus, and the established neurobiological roles of the synapsins, this family member may represent a candidate gene for schizophrenia. The TIMP3 gene is located within an intron of this gene and is transcribed in the opposite direction. Alternative splicing of this gene results in multiple splice variants that encode different isoforms. ",22/11/2021,PubMed,Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation.,9400791,1997,DisGeNET,rs137853300,SNV,,,,,,
rs80358227,12107443,"Corneal Dystrophy, Lattice Type 3","Europe, Tunisia, USA, India",North Africa,NS,FALSE,NS,TACSTD2,,TACSTD2,tumor associated calcium signal transducer 2,1,P09758,"This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.[provided by RefSeq, Dec 2009].",22/11/2021,PubMed,Allelic and locus heterogeneity in autosomal recessive gelatinous drop-like corneal dystrophy.,12107443,2002,DisGeNET,rs80358227,SNV,,,,,,
rs80358226,12107443,"Corneal Dystrophy, Lattice Type 3","Europe, Tunisia, USA, India",North Africa,NS,TRUE,NS,TACSTD2,,TACSTD2,tumor associated calcium signal transducer 2,1,P09758,"This intronless gene encodes a carcinoma-associated antigen. This antigen is a cell surface receptor that transduces calcium signals. Mutations of this gene have been associated with gelatinous drop-like corneal dystrophy.[provided by RefSeq, Dec 2009].",22/11/2021,PubMed,Allelic and locus heterogeneity in autosomal recessive gelatinous drop-like corneal dystrophy.,12107443,2002,DisGeNET,rs80358226,SNV,,,,,,
rs767004810,26336027,Hypoparathyroidism-Retardation-Dysmorphism Syndrome,Morocco,North Africa,NS,FALSE,NS,TBCE,,TBCE,tubulin folding cofactor E,1,Q15813,"Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The Bedouin mutation c.155-166del of the TBCE gene in a patient with Sanjad-Sakati syndrome of Moroccan origin.,26336027,2016,DisGeNET,rs767004810,SNV,,,,,,Report on the first clinical and molecular description of a Moroccon patient with Sanjad-Sakati syndrome.
rs767004810,26336027,"Kenny-Caffey Syndrome, Type 1",Morocco,North Africa,NS,FALSE,NS,TBCE,,TBCE,tubulin folding cofactor E,1,Q15813,"Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The Bedouin mutation c.155-166del of the TBCE gene in a patient with Sanjad-Sakati syndrome of Moroccan origin.,26336027,2016,DisGeNET,rs767004810,SNV,,,,,,
rs199422114,17203301,Ghosal Hematodiaphyseal Syndrome,"Algeria, Tunisia",North Africa,NS,TRUE,NS,TBXAS1,,TBXAS1,thromboxane A synthase 1,7,P24557,"This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to thromboxane A2, a potent vasoconstrictor and inducer of platelet aggregation. The enzyme plays a role in several pathophysiological processes including hemostasis, cardiovascular disease, and stroke. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].",22/11/2021,PubMed,A gene responsible for Ghosal hemato-diaphyseal dysplasia maps to chromosome 7q33-34.,17203301,2007,DisGeNET,rs199422114,SNV,,,,,,
rs7903146,18443202,"Diabetes Mellitus, Non-Insulin-Dependent",USA,African American/Afro-Caribbean,African American,FALSE,1.59E-06,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.,18443202,2008,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,18443202,"Diabetes Mellitus, Non-Insulin-Dependent",USA,African American/Afro-Caribbean,African American,FALSE,1.59E-06,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.,18443202,2008,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,17470138,"Diabetes Mellitus, Non-Insulin-Dependent",Nigeria,West Africa,Bini,TRUE,0.152,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.,17470138,2007,DisGeNET,rs7903146,SNV,,,,,,"Admixed sample from mexico city ( European admixture, Native American , West African)"
rs7903146,17470138,"Diabetes Mellitus, Non-Insulin-Dependent",Nigeria,West Africa,Bini,TRUE,0.152,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.,17470138,2007,DisGeNET,rs7903146,SNV,,,,,,"Admixed sample from mexico city ( European admixture, Native American , West African)"
rs7903146,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,6.00E-06,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs7903146,SNV,,,,,,"TCF7L2 rs7903146 was markedly associated with T2DM in both the Lebanese [P = 4.6 Ã— 10âˆ’6, OR (95% CI): 1.38 (1.20â€“1.59)] and Tunisians [P = 6.0 Ã— 10âˆ’6, OR (95% CI): 1.36 (1.18â€“1.56)]."
rs7903146,22749234,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,TRUE,6.00E-06,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,"Contribution of common variants of ENPP1, IGF2BP2, KCNJ11, MLXIPL, PPARÎ³, SLC30A8 and TCF7L2 to the risk of type 2 diabetes in Lebanese and Tunisian Arabs.",22749234,2013,DisGeNET,rs7903146,SNV,,,,,,"TCF7L2 rs7903146 was markedly associated with T2DM in both the Lebanese [P = 4.6 Ã— 10âˆ’6, OR (95% CI): 1.38 (1.20â€“1.59)] and Tunisians [P = 6.0 Ã— 10âˆ’6, OR (95% CI): 1.36 (1.18â€“1.56)]."
rs7903146,19368707,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.006,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.,19368707,2009,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,19368707,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.006,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study.,19368707,2009,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,28420445,Obesity,Cameroon,West Africa,NS,FALSE,0.58,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study.,28420445,2017,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,28420445,Obesity,Cameroon,West Africa,NS,FALSE,0.58,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Investigation of the association between the TCF7L2 rs7903146 (C/T) gene polymorphism and obesity in a Cameroonian population: a pilot study.,28420445,2017,DisGeNET,rs7903146,SNV,,,,,,
rs12255372,24157263,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.6,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).,24157263,2014,DisGeNET,rs12255372,SNV,,,,,,MAF was comparable between PCOS cases and control subjects
rs12255372,24157263,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.6,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).,24157263,2014,DisGeNET,rs12255372,SNV,,,,,,MAF was comparable between PCOS cases and control subjects
rs4506565,24157263,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.61,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).,24157263,2014,DisGeNET,rs4506565,SNV,,,,,,MAF was comparable between PCOS cases and control subjects
rs4506565,24157263,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.61,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).,24157263,2014,DisGeNET,rs4506565,SNV,,,,,,MAF was comparable between PCOS cases and control subjects
rs7903146,19286335,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.2,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia.,19286335,2011,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,19286335,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,NS,FALSE,0.2,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,TCF7L2 is associated with type 2 diabetes in nonobese individuals from Tunisia.,19286335,2011,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,17476472,"Diabetes Mellitus, Non-Insulin-Dependent",Morocco,North Africa,NS,FALSE,2.90E-06,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis.,17476472,2007,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,17476472,"Diabetes Mellitus, Non-Insulin-Dependent",Morocco,North Africa,NS,FALSE,2.90E-06,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis.,17476472,2007,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,24059590,"Diabetes Mellitus, Non-Insulin-Dependent",Ghana,West Africa,NS,FALSE,0.014,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study.,24059590,2014,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,24059590,"Diabetes Mellitus, Non-Insulin-Dependent",Ghana,West Africa,NS,FALSE,0.014,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,The TCF7L2 rs7903146 (T) allele is associated with type 2 diabetes in urban Ghana: a hospital-based case-control study.,24059590,2014,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,25491720,"Diabetes Mellitus, Non-Insulin-Dependent",Algeria,North Africa,NS,FALSE,0.01,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,"The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population.",25491720,2015,DisGeNET,rs7903146,SNV,,,,,,
rs7903146,25491720,"Diabetes Mellitus, Non-Insulin-Dependent",Algeria,North Africa,NS,FALSE,0.01,TCF7L2,,TCF7L2,transcription factor 7 like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,"The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population.",25491720,2015,DisGeNET,rs7903146,SNV,,,,,,
rs12255372,17470138,"Diabetes Mellitus, Non-Insulin-Dependent",Nigeria,West Africa,Bini,TRUE,0.017,TCF7L2,,TCF7L2,transcription factor 7-like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association of TCF7L2 polymorphisms with type 2 diabetes in Mexico City.,17470138,2007,DisGeNET,rs12255372,SNV,,,,,,"Admixed sample from mexico city ( European admixture, Native American , West African)"
rs12255372,23142382,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,FALSE,1.10E-05,TCF7L2,,TCF7L2,transcription factor 7-like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects.,23142382,2013,DisGeNET,rs12255372,SNV,,,,,,Minor allele frequencies of rs12255372 was signficantly higher in cases.
rs7903146,23142382,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,FALSE,1.20E-06,TCF7L2,,TCF7L2,transcription factor 7-like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects.,23142382,2013,DisGeNET,rs7903146,SNV,,,,,,MAF was signficantly higer in cases.
rs4506565,23142382,"Diabetes Mellitus, Non-Insulin-Dependent",Tunisia,North Africa,Arab,FALSE,2.40E-08,TCF7L2,,TCF7L2,transcription factor 7-like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Transcription factor-7-like 2 gene variants are strongly associated with type 2 diabetes in Tunisian Arab subjects.,23142382,2013,DisGeNET,rs4506565,SNV,,,,,,MAF   was  signficantly higer in cases.
rs12255372,25678248,Polycystic Ovary Syndrome,"Tunisia, UK, China",North Africa,NS,TRUE,> 0.05,TCF7L2,,TCF7L2,transcription factor 7-like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis.,25678248,2015,DisGeNET,rs12255372,SNV,,,,,,
rs7903146,25678248,Polycystic Ovary Syndrome,"Tunisia, UK, China",North Africa,NS,TRUE,> 0.05,TCF7L2,,TCF7L2,transcription factor 7-like 2,10,Q9NQB0,"This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Association between rs7903146 and rs12255372 polymorphisms of transcription factor 7-like 2 gene and polycystic ovary syndrome: a systematic review and meta-analysis.,25678248,2015,DisGeNET,rs7903146,SNV,,,,,,
rs606231119,10518276,Transcolabamin Ii Deficiency,Morocco,North Africa,NS,FALSE,NS,TCN2,,TCN2,transcobalamin 2,22,P20062,"This gene encodes a member of the vitamin B12-binding protein family. This family of proteins, alternatively referred to as R binders, is expressed in various tissues and secretions. This plasma protein binds cobalamin and mediates the transport of cobalamin into cells. This protein and other mammalian cobalamin-binding proteins, such as transcobalamin I and gastric intrisic factor, may have evolved by duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010].",22/11/2021,PubMed,Transcobalamin II deficiency with methylmalonic aciduria in three sisters.,10518276,1999,DisGeNET,rs606231119,SNV,,,,,,absence of B12 detectable TC II by radioimmunoassay and by inability of cultured Ã?broblasts to synthesize TC II
rs1878468,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,8.98E-07,TENM3,Association,TENM3,teneurin transmembrane protein 3,4,Q9P273,"This gene encodes a large transmembrane protein that may be involved in the regulation of neuronal development. Mutation in this gene causes microphthalmia. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs1878468,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the heterozygous model."
rs121909211,15059726,Avellino Corneal Dystrophy,USA,African American/Afro-Caribbean,NS,FALSE,NS,TGFBI,Genetic variability study,TGFBI,transforming growth factor beta induced,5,Q15582,"This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An unusual clinical phenotype of Avellino corneal dystrophy associated with an Arg124His beta iG-H3 mutation in an African-American woman.,15059726,2004,DisGeNET,rs121909211,SNV,,,,,,This case reveals surface changes resembling vortex dystrophy and large granular deposits protruding through the anterior corneal surface.
rs201928238,15059726,Avellino Corneal Dystrophy,USA,African American/Afro-Caribbean,NS,FALSE,NS,TGFBI,Genetic variability study,TGFBI,transforming growth factor beta induced,5,Q15582,"This gene encodes an RGD-containing protein that binds to type I, II and IV collagens. The RGD motif is found in many extracellular matrix proteins modulating cell adhesion and serves as a ligand recognition sequence for several integrins. This protein plays a role in cell-collagen interactions and may be involved in endochondrial bone formation in cartilage. The protein is induced by transforming growth factor-beta and acts to inhibit cell adhesion. Mutations in this gene are associated with multiple types of corneal dystrophy. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,An unusual clinical phenotype of Avellino corneal dystrophy associated with an Arg124His beta iG-H3 mutation in an African-American woman.,15059726,2004,DisGeNET,rs201928238,SNV,,,,,,This case reveals surface changes resembling vortex dystrophy and large granular deposits protruding through the anterior corneal surface.
rs398122905,19241467,"Ichthyosiform Erythroderma, Congenital","Egypt, Morocco, South Africa, Tunisia, USA, Europe, Asia",North Africa / South Africa / African-American/Afro-Caribbean,NS,TRUE,NS,TGM1,,TGM1,transglutaminase 1,14,P22735,"The protein encoded by this gene is a membrane protein that catalyzes the addition of an alkyl group from an akylamine to a glutamine residue of a protein, forming an alkylglutamine in the protein. This protein alkylation leads to crosslinking of proteins and catenation of polyamines to proteins. This gene contains either one or two copies of a 22 nt repeat unit in its 3' UTR. Mutations in this gene have been associated with autosomal recessive lamellar ichthyosis (LI) and nonbullous congenital ichthyosiform erythroderma (NCIE). [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: summary of mutations (including 23 novel) and modeling of TGase-1.,19241467,2009,DisGeNET,rs398122905,SNV,,,,,,
rs606231276,19440220,"Peeling Skin Syndrome, Acral Type",Tunisia,North Africa,NS,FALSE,NS,TGM5,Genetic variability study,TGM5,transglutaminase 5,15,O43548,"This gene encodes a member of the transglutaminase family. The encoded protein catalyzes formation of protein cross-links between glutamine and lysine residues, often resulting in stabilization of protein assemblies. This reaction is calcium dependent. Mutations in this gene have been associated with acral peeling skin syndrome. [provided by RefSeq, Oct 2009].",22/11/2021,PubMed,A missense mutation in TGM5 causes acral peeling skin syndrome in a Tunisian family.,19440220,2009,DisGeNET,rs606231276,SNV,,,,,,This variant was found in 2 patients from the same family.
rs2057178,22306650,Tuberculosis,"Gambia, Ghana, Indonesia, Russian",West Africa,NS,TRUE,2.63E-09,THEM7P,Association,THEM7P,thioesterase superfamily member 7,11,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Common variants at 11p13 are associated with susceptibility to tuberculosis.,22306650,2012,DisGeNET,rs2057178,SNV,,,,,,The study reports on 1329 TB cases and 1847 controls genotyped using Affymetrix SNP Array 6.0.
rs11031728,22306650,Tuberculosis,"Gambia, Ghana, Indonesia, Russian",West Africa,NS,TRUE,5.25E-09,THEM7P,Association,THEM7P,thioesterase superfamily member 7,11,No Uniprot record,Gene function information are missing,22/11/2021,PubMed,Common variants at 11p13 are associated with susceptibility to tuberculosis.,22306650,2012,DisGeNET,rs11031728,SNV,,,,,,The study reports on 1329 TB cases and 1847 controls genotyped using Affymetrix SNP Array 6.0.
rs137853300,9400791,"Fundus Dystrophy, Pseudoinflammatory, Of Sorsby","South Africa, Canada, USA",,NS,TRUE,> 0.05,TIMP3,,TIMP3,"TIMP metallopeptidase inhibitor 3	",22,P35625,"This gene belongs to the TIMP gene family. The proteins encoded by this gene family are inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix (ECM). Expression of this gene is induced in response to mitogenic stimulation and this netrin domain-containing protein is localized to the ECM. Mutations in this gene have been associated with the autosomal dominant disorder Sorsby's fundus dystrophy. ",22/11/2021,PubMed,Sorsby fundus dystrophy: reevaluation of variable expressivity in patients carrying a TIMP3 founder mutation.,9400791,1997,DisGeNET,rs137853300,SNV,,,,,,
rs4833095,20478407,Anemia,Ghana,West Africa,NS,FALSE,NS,TLR1,,TLR1,toll like receptor 1,4,Q15399,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The toll-like receptor 1 variant S248N influences placental malaria.,20478407,2010,DisGeNET,rs4833095,SNV,,,,,,"The study was conducted from January 2000 to January 2001 in Agogo (pop. 30,000), Ghana, located in an area where malaria is hyper- to holoendemic."
rs4833095,20478407,Malaria,Ghana,West Africa,NS,FALSE,NS,TLR1,,TLR1,toll like receptor 1,4,Q15399,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,The toll-like receptor 1 variant S248N influences placental malaria.,20478407,2010,DisGeNET,rs4833095,SNV,,,,,,
rs4986790,16779724,Anemia,Ghana,West Africa,"Wolof,Mandinka,Fula,Serehuli,Jola",FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy.,16779724,2006,DisGeNET,rs4986790,SNV,,,,,,
rs4986791,23949880,Secondary Malignant Neoplasm Of Lymph Node,Tunisia,North Africa,NS,FALSE,0.001,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986791,SNV,,,,,,
rs4986791,23949880,Neoplasm Metastasis,Tunisia,North Africa,NS,FALSE,0.002,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986791,SNV,,,,,,"observed a positive link between D299G and T399I polymorphisms and CRC patients with lymph node (p =0.00024; p =0.0005, respectively) and metastasis (p =0.001; p =0.002, respectively)."
rs4986790,23949880,Colorectal Cancer,Tunisia,North Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986790,SNV,,,,,,Noted a significant association between T399I polymorphism and tumor differentiation (p =0.027) and tumor architecture (p = 0.02) in colorectal cancer (CRC) patients.
rs4986791,23949880,Colorectal Cancer,Tunisia,North Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986791,SNV,,,,,,
rs4986790,23949880,Colorectal Carcinoma,Tunisia,North Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986790,SNV,,,,,,
rs4986791,23949880,Colorectal Carcinoma,Tunisia,North Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986791,SNV,,,,,,
rs4986790,23949880,Neoplasm Metastasis,Tunisia,North Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986790,SNV,,,,,,
rs4986790,23949880,Secondary Malignant Neoplasm Of Lymph Node,Tunisia,North Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.,23949880,2014,DisGeNET,rs4986790,SNV,,,,,,"observed a positive link between D299G and T399I polymorphisms and CRC patients with lymph node (p =0.00024; p =0.0005, respectively) and metastasis (p =0.001; p =0.002, respectively)."
rs775910328,20478407,Anemia,Ghana,West Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,The toll-like receptor 1 variant S248N influences placental malaria.,20478407,2010,DisGeNET,rs775910328,SNV,,,,,,
rs775910328,20478407,Malaria,Ghana,West Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,The toll-like receptor 1 variant S248N influences placental malaria.,20478407,2010,DisGeNET,rs775910328,SNV,,,,,,
rs4986790,17545720,Active Tuberculosis,Tanzania,East Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania.,17545720,2007,DisGeNET,rs4986790,SNV,,,,,,A cohort of HIV-infected Tanzanian patients whether the Asp299Gly TLR4 polymorphism is associated with the development of active tuberculosis. A greater risk of developing active tuberculosis as well as a reduction in CD4 T-cell counts in patients with the Asp299Gly TLR4 polymorphism.
rs4986790,17545720,Tuberculosis,Tanzania,East Africa,NS,FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania.,17545720,2007,DisGeNET,rs4986790,SNV,,,,,,
rs4986790,15525557,Tuberculosis,Gambia,West Africa,"Wolof,Mandinka,Fula,Serehuli,Jola",FALSE,0.91,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.,15525557,2005,DisGeNET,rs4986790,SNV,,,,,,TLR4 Asp299Gly has no influence on monocyte LPS responses or susceptibility to TB in Gambians and could be an ancient neutral polymorphism.
rs4986790,15525557,"Tuberculosis, Pulmonary",Gambia,West Africa,"Wolof,Mandinka,Fula,Serehuli,Jola",FALSE,NS,TLR4,,TLR4,toll like receptor 4,9,O00206,"The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020].",22/11/2021,PubMed,The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.,15525557,2005,DisGeNET,rs4986790,SNV,,,,,,
rs121434508,22815638,Optic Atrophy 7 (Disorder),Morocco,North Africa,NS,FALSE,NS,TMEM126A,Linkage,TMEM126A,transmembrane protein 126A,11,Q9H061,"The protein encoded by this gene is a mitochondrial membrane protein of unknown function. Defects in this gene are a cause of optic atrophy type 7 (OPA7). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].",22/11/2021,PubMed,TMEM126A mutation in a Moroccan family with autosomal recessive optic atrophy.,22815638,2012,DisGeNET,rs121434508,SNV,,,,,,"In 3 affected sibs from a consanguineous Moroccon family with optic atrophy, the R55X identified was found at homozygous state while the unfacted parents were heterozygous. An unaffected sibling had transient loss of vision after exercise, i.e., Uhthoff's sign of optic neuropathy, and was found to be a heterozygous carrier of the mutation."
rs121434508,19327736,Optic Atrophy 7 (Disorder),"Morocco, Tunisia",North Africa,NS,TRUE,NS,TMEM126A,Genetic variability study,TMEM126A,transmembrane protein 126A,11,Q9H061,"The protein encoded by this gene is a mitochondrial membrane protein of unknown function. Defects in this gene are a cause of optic atrophy type 7 (OPA7). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].",22/11/2021,PubMed,"TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy.",19327736,2009,DisGeNET,rs121434508,SNV,,,,,,"In a multiplex consanguineous Algerian family with autosomal recessive optic atrophy, The mutation has been identified. The same mutation R55X was found in homozygosity in 3 additional autosomal recessive optic atrophy families of Maghrebian origin, 1 from Tunisia and 2 from Morocco."
rs137852999,11462234,"Deafness, Autosomal Recessive 10",Tunisia,North Africa,NS,FALSE,NS,TMPRSS3,,TMPRSS3,transmembrane serine protease 3,21,P57727,"This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012].",22/11/2021,PubMed,Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness.,11462234,2002,DisGeNET,rs137852999,SNV,,,,,,rs137852999 was responsible for two non-syndromic recessive deafness
rs28939084,11462234,"Deafness, Autosomal Recessive 10",Tunisia,North Africa,NS,FALSE,NS,TMPRSS3,,TMPRSS3,transmembrane serine protease 3,21,P57727,"This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012].",22/11/2021,PubMed,Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness.,11462234,2002,DisGeNET,rs28939084,SNV,,,,,,rs28939084 might alter the geometry of the active site loop and therefore affect the serine protease activity.
rs137852999,11462234,"Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8",Tunisia,North Africa,NS,FALSE,NS,TMPRSS3,,TMPRSS3,transmembrane serine protease 3,21,P57727,"This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012].",22/11/2021,PubMed,Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness.,11462234,2002,DisGeNET,rs137852999,SNV,,,,,,rs137852999 was responsible for two non-syndromic recessive deafness
rs28939084,11462234,"Deafness, Childhood-Onset Neurosensory, Autosomal Recessive 8",Tunisia,North Africa,NS,FALSE,NS,TMPRSS3,,TMPRSS3,transmembrane serine protease 3,21,P57727,"This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012].",22/11/2021,PubMed,Novel missense mutations of TMPRSS3 in two consanguineous Tunisian families with non-syndromic autosomal recessive deafness.,11462234,2002,DisGeNET,rs28939084,SNV,,,,,,
rs855791,24175968,Anemia,Rwanda,Central Africa,NS,FALSE,0.58,TMPRSS6,,TMPRSS6,transmembrane serine protease 6,22,Q8IU80,"The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,"Anaemia, iron deficiency and a common polymorphism of iron-regulation, TMPRSS6 rs855791, in Rwandan children.",24175968,2014,DisGeNET,rs855791,SNV,,,,,,
rs855791,26746433,Malaria,Nigeria,West Africa,NS,FALSE,NS,TMPRSS6,,TMPRSS6,transmembrane serine protease 6,22,Q8IU80,"The protein encoded by this gene is a type II transmembrane serine proteinase that is found attached to the cell surface. The encoded protein may be involved in matrix remodeling processes in the liver. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014].",22/11/2021,PubMed,Multiple sclerosis-like diagnosis as a complication of previously treated malaria in an iron and vitamin D deficient Nigerian patient.,26746433,2016,DisGeNET,rs855791,SNV,,,,,,
rs610604,25406098,Psoriasis,Egypt,North Africa,NS,FALSE,1.50E-03,TNFAIP3,Association,TNFAIP3,TNF alpha induced protein 3,6,P21580,"This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2012].",22/11/2021,PubMed,TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort.,25406098,2016,DisGeNET,rs610604,SNV,,,,,,"132 recruited patients; OR=1.71, 95% CI = 1.22 - 2.41."
rs6920220,21833526,Rheumatoid Arthritis,Tunisia,North Africa,NS,FALSE,0.35,TNFAIP3,,TNFAIP3,TNF alpha induced protein 3,6,P21580,"This gene was identified as a gene whose expression is rapidly induced by the tumor necrosis factor (TNF). The protein encoded by this gene is a zinc finger protein and ubiqitin-editing enzyme, and has been shown to inhibit NF-kappa B activation as well as TNF-mediated apoptosis. The encoded protein, which has both ubiquitin ligase and deubiquitinase activities, is involved in the cytokine-mediated immune and inflammatory responses. Several transcript variants encoding the same protein have been found for this gene. ",22/11/2021,PubMed,A Tunisian case-control association study of a 6q polymorphism in rheumatoid arthritis.,21833526,2012,DisGeNET,rs6920220,SNV,,,,,,
rs376923877,23233322,"Cardiomyopathy, Hypertrophic, Familial",Egypt,North Africa,NS,FALSE,NS,TNNT2,,TNNT2,"troponin T2, cardiac type",1,P45379,"The protein encoded by this gene is the tropomyosin-binding subunit of the troponin complex, which is located on the thin filament of striated muscles and regulates muscle contraction in response to alterations in intracellular calcium ion concentration. Mutations in this gene have been associated with familial hypertrophic cardiomyopathy as well as with dilated cardiomyopathy. Transcripts for this gene undergo alternative splicing that results in many tissue-specific isoforms, however, the full-length nature of some of these variants has not yet been determined. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.,23233322,2013,DisGeNET,rs376923877,SNV,,,,,,Likely pathogenicâ€‹ mutation detected in Egyptian hypertrophic cardiomyopathy (HCM) index patients
rs1160985,22939635,C-Reactive Protein Measurement,USA,African American/Afro-Caribbean,NS,TRUE,4.19E-13,TOMM40,,TOMM40,translocase of outer mitochondrial membrane 40,19,O96008,"The protein encoded by this gene is localized in the outer membrane of the mitochondria. It is the channel-forming subunit of the translocase of the mitochondrial outer membrane (TOM) complex that is essential for import of protein precursors into mitochondria. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.,22939635,2012,DisGeNET,rs1160985,SNV,,,,,,Minor allele C/Major allele T
rs8051542,22910930,Breast Carcinoma,Tunisia,North Africa,NS,FALSE,4.00E-04,TOX3,,TOX3,TOX high mobility group box family member 3,16,O15405,"The protein encoded by this gene contains an HMG-box, indicating that it may be involved in bending and unwinding of DNA and alteration of chromatin structure. The C-terminus of the encoded protein is glutamine-rich due to CAG repeats in the coding sequence. A minor allele of this gene has been implicated in an elevated risk of breast cancer. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs8051542,SNV,,,,,,T vs. C allele was found to be significantly associated with breast cancer in Tunisians
rs8051542,22910930,Malignant Neoplasm Of Breast,Tunisia,North Africa,NS,FALSE,4.00E-04,TOX3,,TOX3,TOX high mobility group box family member 3,16,O15405,"The protein encoded by this gene contains an HMG-box, indicating that it may be involved in bending and unwinding of DNA and alteration of chromatin structure. The C-terminus of the encoded protein is glutamine-rich due to CAG repeats in the coding sequence. A minor allele of this gene has been implicated in an elevated risk of breast cancer. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2009].",22/11/2021,PubMed,Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.,22910930,2013,DisGeNET,rs8051542,SNV,,,,,,T vs. C allele was found to be significantly associated with breast cancer in Tunisians
rs121912654,1672732,Liver Carcinoma,South Africa,South Africa,NS,FALSE,NS,TP53,,TP53,tumor protein p53,17,P04637,"This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016].",22/11/2021,PubMed,Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa.,1672732,1991,DisGeNET,rs121912654,SNV,,,,,,"Allelic detections from chromosome 17p and mutations of the p53 gene were found in 50% of primary HCCs from Southern Africa. The authors of the study refer to ""Southern African patients"" rather than the country."
rs1042522,25889455,Liver Carcinoma,"Morocco, Tunisia",North Africa,NS,TRUE,0.04,TP53,Association,TP53,tumor protein p53,17,P04637,"This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016].",22/11/2021,PubMed,TP53 R72P polymorphism modulates DNA methylation in hepatocellular carcinoma.,25889455,2016,DisGeNET,rs1042522,SNV,,,,,,45 Hepatocellular carcinoma patients have been investigated. The variant encodes for p.Arg72Pro mutation associated with the low methylation cluster.
rs11540654,20233677,"Breast Cancer, Familial",Tunisia,North Africa,NS,FALSE,0.0052,TP53,,TP53,tumor protein p53,17,P04637,"This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016].",22/11/2021,PubMed,"Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.",20233677,2010,DisGeNET,rs11540654,SNV,,,,,,
rs11540654,20233677,"Breast Carcinoma, Sporadic",Tunisia,North Africa,NS,FALSE,0.237,TP53,,TP53,tumor protein p53,17,P04637,"This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016].",22/11/2021,PubMed,"Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.",20233677,2010,DisGeNET,rs11540654,SNV,,,,,,
rs11540654,20233677,Malignant Neoplasm Of Breast,Tunisia,North Africa,NS,FALSE,0.237,TP53,,TP53,tumor protein p53,17,P04637,"This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016].",22/11/2021,PubMed,"Haplotype analysis of p53 polymorphisms: Arg72Pro, Ins16bp and G13964C in Tunisian patients with familial or sporadic breast cancer.",20233677,2010,DisGeNET,rs11540654,SNV,,,,,,
rs387906220,20170898,"Deafness, Autosomal Recessive 79",Morocco,North Africa,NS,FALSE,NS,TPRN,,TPRN,taperin,9,Q4KMQ1,"This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss.,20170898,2010,DisGeNET,rs387906220,SNV,,,,,,
rs387906221,20170898,"Deafness, Autosomal Recessive 79",Morocco,North Africa,NS,FALSE,NS,TPRN,,TPRN,taperin,9,Q4KMQ1,"This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss.,20170898,2010,DisGeNET,rs387906221,SNV,,,,,,
rs387906222,20170898,"Deafness, Autosomal Recessive 79",Morocco,North Africa,NS,FALSE,NS,TPRN,,TPRN,taperin,9,Q4KMQ1,"This locus encodes a sensory epithelial protein. It was defined by linkage analysis in three Pakistani families to lie between D9S1818 (centromeric) and D9SH6 (telomeric). Mutations at this locus have been associated with autosomal recessive deafness. [provided by RefSeq, Oct 2010].",22/11/2021,PubMed,Mutations in TPRN cause a progressive form of autosomal-recessive nonsyndromic hearing loss.,20170898,2010,DisGeNET,rs387906222,SNV,,,,,,
rs267607137,20004764,"Mental Retardation, Autosomal Recessive 13",Tunisia,North Africa,NS,FALSE,NS,TRAPPC9,,TRAPPC9,trafficking protein particle complex subunit 9,8,Q96Q05,"This gene encodes a protein that likely plays a role in NF-kappa-B signaling. Mutations in this gene have been associated with autosomal-recessive cognitive disability. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010].",22/11/2021,PubMed,Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation.,20004764,2010,DisGeNET,rs267607137,SNV,,,,,,Sequencing analysis revealed a nonsense variant (c.1708C>T [p.R570X]) within exon 9 of TRAPPC9.
rs7748513,22939635,C-Reactive Protein Measurement,USA,African American/Afro-Caribbean,NS,TRUE,8.39E-09,TREM2,,TREM2,triggering receptor expressed on myeloid cells 2,6,Q9NZC2,"This gene encodes a membrane protein that forms a receptor signaling complex with the TYRO protein tyrosine kinase binding protein. The encoded protein functions in immune response and may be involved in chronic inflammation by triggering the production of constitutive inflammatory cytokines. Defects in this gene are a cause of polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Nov 2012].",22/11/2021,PubMed,Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women.,22939635,2012,DisGeNET,rs7748513,SNV,,,,,,Minor allele G/Major allele A
rs9296359,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,1.21E-07,TREML4,Association,TREML4,triggering receptor expressed on myeloid cells like 4,6,Q6UXN2,Predicted to enable signaling receptor activity. Involved in positive regulation of toll-like receptor 7 signaling pathway. Predicted to be located in endoplasmic reticulum. Predicted to be active in cell surface. Predicted to colocalize with endosome membrane and lysosomal membrane. ,22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs9296359,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the heterozygous model."
rs267607142,897853,"Progressive Familial Heart Block, Type Ib",South Africa,South Africa,NS,FALSE,NS,TRPM4,,TRPM4,transient receptor potential cation channel subfamily M member 4,19,Q8TD43,"The protein encoded by this gene is a calcium-activated nonselective ion channel that mediates transport of monovalent cations across membranes, thereby depolarizing the membrane. The activity of the encoded protein increases with increasing intracellular calcium concentration, but this channel does not transport calcium. [provided by RefSeq, Mar 2016].",22/11/2021,PubMed,Progressive familial heart block--two types.,897853,1977,DisGeNET,rs267607142,SNV,,,,,,
rs121918670,11297590,"Hypothyroidism, Congenital, Nongoitrous, 4",Egypt,North Africa,NS,FALSE,NS,TSHB,,TSHB,thyroid stimulating hormone subunit beta,1,P01222,"The four human glycoprotein hormones chorionic gonadotropin (CG), luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH) are dimers consisting of alpha and beta subunits that are associated noncovalently. The alpha subunits of these hormones are identical, however, their beta chains are unique and confer biological specificity. Thyroid stimulating hormone functions in the control of thyroid structure and metabolism. The protein encoded by this gene is the beta subunit of thyroid stimulating hormone. Mutations in this gene are associated with congenital central and secondary hypothyroidism and Hashimoto's thyroiditis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013].",22/11/2021,PubMed,"Hyperplastic pituitary gland, high serum glycoprotein hormone alpha-subunit, and variable circulating thyrotropin (TSH) levels as hallmark of central hypothyroidism due to mutations of the TSH beta gene.",11297590,2001,DisGeNET,rs121918670,SNV,,,,,,"nonsense mutation of the TSHb gene (Q49X) reported in an Egyptian girl with ICH
 "
rs397515377,26068213,Ataxia With Vitamin E Deficiency,Algeria,North Africa,NS,FALSE,NS,TTPA,,TTPA,alpha tocopherol transfer protein,8,P49638,"This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,Molecular and clinical study of a cohort of 110 Algerian patients with autosomal recessive ataxia.,26068213,2015,DisGeNET,rs397515377,SNV,,,,,,
rs121917851,24369383,Ataxia With Vitamin E Deficiency,Tunisia,North Africa,NS,FALSE,NS,TTPA,,TTPA,alpha tocopherol transfer protein,8,P49638,"This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,"Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency.",24369383,2014,DisGeNET,rs121917851,SNV,,,,,,"The 744delA mutation represents the most common pathological mutation in Tunisia and worldwide, responsible for Ataxia with vitamin E deficiency."
rs397515377,24369383,Ataxia With Vitamin E Deficiency,Tunisia,North Africa,NS,FALSE,NS,TTPA,,TTPA,alpha tocopherol transfer protein,8,P49638,"This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,"Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency.",24369383,2014,DisGeNET,rs397515377,SNV,,,,,,"The 744delA mutation represents the most common pathological mutation in Tunisia and worldwide, responsible for Ataxia with vitamin E deficiency."
rs886040963,24369383,Ataxia With Vitamin E Deficiency,Tunisia,North Africa,NS,FALSE,NS,TTPA,,TTPA,alpha tocopherol transfer protein,8,P49638,"This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,"Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency.",24369383,2014,DisGeNET,rs886040963,SNV,,,,,,"The 744delA mutation represents the most common pathological mutation in Tunisia and worldwide, responsible for Ataxia with vitamin E deficiency."
rs886040964,24369383,Ataxia With Vitamin E Deficiency,Tunisia,North Africa,NS,FALSE,NS,TTPA,,TTPA,alpha tocopherol transfer protein,8,P49638,"This gene encodes a soluble protein that binds alpha-trocopherol, a form of vitamin E, with high selectivity and affinity. This protein plays an important role in regulating vitamin E levels in the body by transporting vitamin E between membrane vesicles and facilitating the secretion of vitamin E from hepatocytes to circulating lipoproteins. Mutations in this gene cause hereditary vitamin E deficiency (ataxia with vitamin E deficiency, AVED) and retinitis pigmentosa. [provided by RefSeq, Nov 2009].",22/11/2021,PubMed,"Molecular, clinical and peripheral neuropathy study of Tunisian patients with ataxia with vitamin E deficiency.",24369383,2014,DisGeNET,rs886040964,SNV,,,,,,"The 744delA mutation represents the most common pathological mutation in Tunisia and worldwide, responsible for Ataxia with vitamin E deficiency."
rs76992529,28102864,Heart Diseases,USA,African American/Afro-Caribbean,African Americans,FALSE,NS,TTR,,TTR,transthyretin,18,P02766,"This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.,28102864,2018,DisGeNET,rs76992529,SNV,,,,,,
rs76992529,28102864,Senile Cardiac Amyloidosis,USA,African American/Afro-Caribbean,African Americans,FALSE,NS,TTR,,TTR,transthyretin,18,P02766,"This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.,28102864,2018,DisGeNET,rs76992529,SNV,,,,,,
rs76992529,28102864,Cardiomyopathies,Sub-Saharan Africa,Sub-Saharan Africa / African American/Afro-Caribbean,NS,TRUE,NS,TTR,,TTR,transthyretin,18,P02766,"This gene encodes one of the three prealbumins, which include alpha-1-antitrypsin, transthyretin and orosomucoid. The encoded protein, transthyretin, is a homo-tetrameric carrier protein, which transports thyroid hormones in the plasma and cerebrospinal fluid. It is also involved in the transport of retinol (vitamin A) in the plasma by associating with retinol-binding protein. The protein may also be involved in other intracellular processes including proteolysis, nerve regeneration, autophagy and glucose homeostasis. Mutations in this gene are associated with amyloid deposition, predominantly affecting peripheral nerves or the heart, while a small percentage of the gene mutations are non-amyloidogenic. The mutations are implicated in the etiology of several diseases, including amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis and carpal tunnel syndrome. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.,28102864,2018,DisGeNET,rs76992529,SNV,,,,,,
rs141980901,17962469,Retinitis Pigmentosa 14,Algeria,North Africa,NS,FALSE,NS,TULP1,,TULP1,TUB like protein 1,6,O00294,"This gene encodes a member of the tubby-like gene family (TULPs). Members of this family have been identified in plants, vertebrates, and invertebrates. TULP proteins share a conserved C-terminal region of approximately 200 amino acid residues. The protein encoded by this gene is thought to play a role in the physiology of photoreceptors. Mutations in this gene are associated with recessive juvenile retinitis pigmentosa and Leber congenital amaurosis-15. [provided by RefSeq, Nov 2016].",22/11/2021,PubMed,Novel TULP1 mutation causing leber congenital amaurosis or early onset retinal degeneration.,17962469,2007,DisGeNET,rs141980901,SNV,,,,,,in this article the rs141980901 is described as A496T
rs145513733,8128955,"Albinism, Oculocutaneous, Type I, Temperature-Sensitive","Libya, Morocco, Tunisia, Israel",North Africa,NS,TRUE,0.00000135,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.,8128955,1994,DisGeNET,rs145513733,SNV,,,,,,
rs145513733,8128955,"Albinism, Oculocutaneous, Type Ib (Disorder)","Libya, Morocco, Tunisia, Israel",North Africa,NS,TRUE,0.00000135,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.,8128955,1994,DisGeNET,rs145513733,SNV,,,,,,
rs61753180,8128955,Oculocutaneous Albinism Type 1,"Libya, Morocco, Tunisia, Israel",North Africa,NS,TRUE,0.00000075,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.,8128955,1994,DisGeNET,rs61753180,SNV,,,,,,
rs61754375,8128955,Oculocutaneous Albinism Type 1,"Libya, Morocco, Tunisia, Israel",North Africa,NS,TRUE,0.00000075,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.,8128955,1994,DisGeNET,rs61754375,SNV,,,,,,
rs61754388,8128955,Oculocutaneous Albinism Type 1,"Libya, Morocco, Tunisia, Israel",North Africa,NS,TRUE,0.00000075,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.,8128955,1994,DisGeNET,rs61754388,SNV,,,,,,
rs104894313,18590551,"Genetic Diseases, Inborn",South Africa,South Africa,NS,FALSE,> 0.05,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Lack of adequate sun protection for children with oculocutaneous albinism in South Africa.,18590551,2008,DisGeNET,rs104894313,SNV,,,,,,
rs281865527,18590551,"Genetic Diseases, Inborn",South Africa,South Africa,NS,FALSE,< 0.05,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Lack of adequate sun protection for children with oculocutaneous albinism in South Africa.,18590551,2008,DisGeNET,rs281865527,SNV,,,,,,
rs28940876,18590551,"Genetic Diseases, Inborn",South Africa,South Africa,NS,FALSE,0.022,TYR,,TYR,tyrosinase,11,P14679,"The enzyme encoded by this gene catalyzes the first 2 steps, and at least 1 subsequent step, in the conversion of tyrosine to melanin. The enzyme has both tyrosine hydroxylase and dopa oxidase catalytic activities, and requires copper for function. Mutations in this gene result in oculocutaneous albinism, and nonpathologic polymorphisms result in skin pigmentation variation. The human genome contains a pseudogene similar to the 3' half of this gene. ",22/11/2021,PubMed,Lack of adequate sun protection for children with oculocutaneous albinism in South Africa.,18590551,2008,DisGeNET,rs28940876,SNV,,,,,,
rs796052130,2389793,"Hip Dysplasia, Beukes Type",South Africa,South Africa,Afrikaner,FALSE,NS,UFSP2,,UFSP2,UFM1 specific peptidase 2,4,Q9NUQ7,"This gene encodes a highly conserved cysteine protease. The protein cleaves two C-terminal residues from ubiquitin-fold modifier 1, a ubiquitin-like post-translational modifier protein. Activation of ubiquitin-fold modifier 1 by the encoded protein exposes a C-terminal glycine residue that allows interaction with other proteins and transfer to its target protein. An allelic variant of this gene has been associated with Beukes hip dysplasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016].",22/11/2021,PubMed,Beukes familial hip dysplasia: an autosomal dominant entity.,2389793,1990,DisGeNET,rs796052130,SNV,,,,,,
rs34650714,27798726,rs34650714 associated with a lower dose of allopurinol.,USA,African American/Afro-Caribbean,African American,TRUE,0.006,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.,27798726,2017,PharmGKB,TBD,SNV,allopurinol,DB00437,Approved,"Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.","1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one",
rs887829,29117017,Genotype CT is not associated with increased discontinuation of atazanavir as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,NS,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation.,29117017,2018,PharmGKB,1449154902,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs887829,29117017,Genotype TT is not associated with increased discontinuation of atazanavir as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,NS,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation.,29117017,2018,PharmGKB,1449154896,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs887829,26180834,Genotype TT is associated with increased discontinuation of atazanavir in people with HIV as compared to genotypes CC + CT.,USA,African American/Afro-Caribbean,African American,FALSE,NS,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia.,26180834,2015,PharmGKB,1445296945,SNV,atazanavir,DB01072,"Approved, Investigational","Used in combination with other antiretroviral agents for the treatment of HIV-1 infection, as well as postexposure prophylaxis of HIV infection in individuals who have had occupational or nonoccupational exposure to potentially infectious body fluids of a person known to be infected with HIV when that exposure represents a substantial risk for HIV transmission.","methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate",
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A1,,UGT1A1,UDP glucuronosyltransferase family 1 member A1,2,P22309,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A10,,UGT1A10,UDP glucuronosyltransferase family 1 member A10,2,Q9HAW8,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity on mycophenolic acid, coumarins, and quinolines. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A10,,UGT1A10,UDP glucuronosyltransferase family 1 member A10,2,Q9HAW8,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity on mycophenolic acid, coumarins, and quinolines. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A10,,UGT1A10,UDP glucuronosyltransferase family 1 member A10,2,Q9HAW8,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity on mycophenolic acid, coumarins, and quinolines. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A3,,UGT1A3,UDP glucuronosyltransferase family 1 member A3,2,P35503,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. Substrates of this enzyme include estrone, 2-hydroxyestrone, and metabolites of benzo alpha-pyrene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A3,,UGT1A3,UDP glucuronosyltransferase family 1 member A3,2,P35503,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. Substrates of this enzyme include estrone, 2-hydroxyestrone, and metabolites of benzo alpha-pyrene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A4,,UGT1A4,UDP glucuronosyltransferase family 1 member A4,2,P22310,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. This enzyme has some glucuronidase activity towards bilirubin, although is is more active on amines, steroids, and sapogenins. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A4,,UGT1A4,UDP glucuronosyltransferase family 1 member A4,2,P22310,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. This enzyme has some glucuronidase activity towards bilirubin, although is is more active on amines, steroids, and sapogenins. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A4,,UGT1A4,UDP glucuronosyltransferase family 1 member A4,2,P22310,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. This enzyme has some glucuronidase activity towards bilirubin, although is is more active on amines, steroids, and sapogenins. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A5,,UGT1A5,UDP glucuronosyltransferase family 1 member A5,2,P35504,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A5,,UGT1A5,UDP glucuronosyltransferase family 1 member A5,2,P35504,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A5,,UGT1A5,UDP glucuronosyltransferase family 1 member A5,2,P35504,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A6,,UGT1A6,UDP glucuronosyltransferase family 1 member A6,2,P19224,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenolic and planar compounds. Alternative splicing in the unique 5' end of this gene results in two transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A6,,UGT1A6,UDP glucuronosyltransferase family 1 member A6,2,P19224,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenolic and planar compounds. Alternative splicing in the unique 5' end of this gene results in two transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A6,,UGT1A6,UDP glucuronosyltransferase family 1 member A6,2,P19224,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenolic and planar compounds. Alternative splicing in the unique 5' end of this gene results in two transcript variants. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A7,,UGT1A7,UDP glucuronosyltransferase family 1 member A7,2,Q9HAW7,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has moderate glucuronidase activity with phenols. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A7,,UGT1A7,UDP glucuronosyltransferase family 1 member A7,2,Q9HAW7,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has moderate glucuronidase activity with phenols. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A7,,UGT1A7,UDP glucuronosyltransferase family 1 member A7,2,Q9HAW7,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has moderate glucuronidase activity with phenols. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A8,,UGT1A8,UDP glucuronosyltransferase family 1 member A8,2,Q9HAW9,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including coumarins, phenols, anthraquinones, flavones, and some opioids. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A8,,UGT1A8,UDP glucuronosyltransferase family 1 member A8,2,Q9HAW9,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including coumarins, phenols, anthraquinones, flavones, and some opioids. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A8,,UGT1A8,UDP glucuronosyltransferase family 1 member A8,2,Q9HAW9,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene has glucuronidase activity with many substrates including coumarins, phenols, anthraquinones, flavones, and some opioids. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs72551351,11968090,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A9,,UGT1A9,UDP glucuronosyltransferase family 1 member A9,2,O60656,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenols. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.,11968090,2002,DisGeNET,rs72551351,SNV,,,,,,
rs62625011,7989045,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A9,,UGT1A9,UDP glucuronosyltransferase family 1 member A9,2,O60656,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenols. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Genetic heterogeneity of Crigler-Najjar syndrome type I: a study of 14 cases.,7989045,1994,DisGeNET,rs62625011,SNV,,,,,,
rs72551351,12378576,"Crigler NAjjar Syndrome, Type 1",Tunisia,North Africa,NS,FALSE,NS,UGT1A9,,UGT1A9,UDP glucuronosyltransferase family 1 member A9,2,O60656,"This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The enzyme encoded by this gene is active on phenols. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP).,12378576,2002,DisGeNET,rs72551351,SNV,,,,,,
rs61750900,28178031,Genotype GG is not associated with metabolism of cotinine in people with Tobacco Use Disorder as compared to genotype GT.,USA,African American/Afro-Caribbean,African American,FALSE,0.76,UGT2B10,Association,UGT2B10,UDP glucuronosyltransferase family 2 member B10,4,P36537,Predicted to be involved in lipid metabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle. ,22/11/2021,PubMed,"Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.",28178031,2017,PharmGKB,1448602077,SNV,cotinine,NA,NA,Cotinine is an alkaloid found in tobacco and is also the predominant metabolite of nicotine.,(5S)-1-methyl-5-(3-pyridyl)pyrrolidin-2-one,The study includes 60 African-American individuals smokers who received a simultaneous intravenous infusion of deuterium-labeled nicotine and cotinine.
rs61750900,28178031,Genotype GG is not associated with metabolism of nicotine in people with Tobacco Use Disorder as compared to genotype GT.,USA,African American/Afro-Caribbean,African American,FALSE,0.65,UGT2B10,Association,UGT2B10,UDP glucuronosyltransferase family 2 member B10,4,P36537,Predicted to be involved in lipid metabolic process. Predicted to be located in endoplasmic reticulum membrane. Predicted to be integral component of membrane. Predicted to be active in intracellular membrane-bounded organelle. ,22/11/2021,PubMed,"Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.",28178031,2017,PharmGKB,1448602085,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,The study includes 60 African-American individuals smokers who received a simultaneous intravenous infusion of deuterium-labeled nicotine and cotinine.
rs1902023,28663312,Genotype AA is associated with increased metabolism of acetaminophen in healthy individuals as compared to genotypes AC + CC.,USA,African American/Afro-Caribbean,African American,TRUE,0.21,UGT2B15,,UGT2B15,UDP glucuronosyltransferase family 2 member B15,4,P54855,"This gene encodes a glycosyltransferase that is invovled in the metabolism and elimination of toxic compounts, both endogenous and of xenobiotic origin. This gene plays a role in the regulation of estrogens and androgens. This locus is present in a cluster of similar genes and pseudogenes on chromosome 4. [provided by RefSeq, Aug 2016].",22/11/2021,PubMed,"Race, Gender, and Genetic Polymorphism Contribute to Variability in Acetaminophen Pharmacokinetics, Metabolism, and Protein-Adduct Concentrations in Healthy African-American and European-American Volunteers.",28663312,2017,PharmGKB,1448639952,SNV,acetaminophen,DB00316,Approved,"In general, acetaminophen is used for the treatment of mild to moderate pain and reduction of fever. It is available over the counter in various forms, the most common being oral forms. Acetaminophen injection is indicated for: Management of mild to moderate pain, Management of moderate to severe pain with adjunctive opioid analgesics, Reduction of fever. Because of its low risk of causing allergic reactions, this drug can be administered in patients who are intolerant to salicylates and those with allergic tendencies, including bronchial asthmatics. Specific dosing guidelines should be followed when administering acetaminophen to children.",N-(4-hydroxyphenyl)acetamide,The results indicate that acetaminophen total clearance and partial metabolic clearance by glucuronidation and sulfation are similar in healthy adult African-Americans compared with European-Americans
rs7668258,26779253,Genotype CC is not associated with concentrations of efavirenz in people with HIV as compared to genotypes CT + TT.,Sub-Saharan Africa,Sub-Saharan Africa,NS,TRUE,0.2885,UGT2B7,,UGT2B7,UDP glucuronosyltransferase family 2 member B7,4,P16662,"The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017].",22/11/2021,PubMed,An Expanded Analysis of Pharmacogenetics Determinants of Efavirenz Response that Includes 3'-UTR Single Nucleotide Polymorphisms among Black South African HIV/AIDS Patients.,26779253,2016,PharmGKB,1447680853,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28365062,24729586,Genotype GG is associated with decreased metabolism of efavirenz in people with HIV Infections as compared to genotypes AA + AG.,USA,African American/Afro-Caribbean,African American,FALSE,0.025,UGT2B7,,UGT2B7,UDP glucuronosyltransferase family 2 member B7,4,P16662,"The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017].",22/11/2021,PubMed,Secondary metabolism pathway polymorphisms and plasma efavirenz concentrations in HIV-infected adults with CYP2B6 slow metabolizer genotypes.,24729586,2015,PharmGKB,1184467530,SNV,efavirenz,DB00625,"Approved, Investigational","(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one","(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one",
rs28365062,19628728,Allele G is associated with increased metabolism of zidovudine as compared to allele A.,Ghana,West Africa,NS,FALSE,0.029,UGT2B7,Association,UGT2B7,UDP glucuronosyltransferase family 2 member B7,4,P16662,"The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017].",22/11/2021,PubMed,Interindividual variability in pharmacokinetics of generic nucleoside reverse transcriptase inhibitors in TB/HIV-coinfected Ghanaian patients: UGT2B7*1c is associated with faster zidovudine clearance and glucuronidation.,19628728,2009,PharmGKB,769259039,SNV,zidovudine,DB00495,Approved,Used in combination with other antiretroviral agents for the treatment of human immunovirus (HIV) infections.,"3' Azido 2â€™,3' Dideoxythymidine","The study reports on 27 HIV/TB co-infected patients from Ghana. carriers of c.735A>G (UGT2B7*1c) appeared to have higher zidovudine concentrations with 57% lower mean AUC (P = 0.029, unpaired t-test), While UGT2B7*1a (reference) and UGT2B7*2 (c.802C>T) did not have significant differences as compared with non-carriers for any of the zidovudine pharmacokinetic parameters evaluated."
rs28365063,23252947,Genotype AA is associated with decreased clearance of carbamazepine in people with Epilepsy as compared to genotypes AG + GG.,USA,African American/Afro-Caribbean,African American,FALSE,0.004,UGT2B7,Association,UGT2B7,UDP glucuronosyltransferase family 2 member B7,4,P16662,"The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017].",22/11/2021,PubMed,Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.,23252947,2013,PharmGKB,981501889,SNV,carbamazepine,DB00564,"Approved, Investigational","Carbamazepine is indicated for the treatment of epilepsy and pain associated with true trigeminal neuralgia.16 In particular, carbamazepine has shown efficacy in treating mixed seizures, partial seizures with complex symptoms, and generalized tonic-clonic seizures. Carbamazepine is also indicated for the treatment of manic episodes and mixed manic-depressive episodes caused by bipolar I disorder.16 Some off-label, unapproved uses of carbamazepine include the treatment of alcohol withdrawal syndrome and restless leg syndrome. ","5-Carbamoyl-5H-dibenz(b,f)azepine",The association is reported for clearance measures in epilepsy patients receiving carbamazepine treatment for allele rs28365063 (A>G) in 30 African-Americans.
rs864321622,26708753,Encephalopathy Adverse Event,Egypt,North Africa,NS,FALSE,NS,UNC80,,UNC80,"unc-80 homolog, NALCN channel complex subunit",2,Q8N2C7,"The protein encoded by this gene is a component of a voltage-independent 'leak' ion-channel complex, in which it performs essential functions, such as serving as a bridge between two other components (sodium leak channel non-selective and UNC79) and as a scaffold for Src kinases. Leak channels play an importnat role in establishment and maintenance of resting membrane potentials in neurons. Mutations in this gene are associated with congenital infantile encephalopathy, intellectual disability and growth issues. [provided by RefSeq, Aug 2016].",22/11/2021,PubMed,"Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy.",26708753,2016,DisGeNET,rs864321622,SNV,,,,,,"Investigated 3 Saudi Arabian families, and 1 Egyptian family. Of the highlighted variants, rs864321622 is the only variant observed in the Egyptian family. "
rs864321622,26708753,"Hypotonia, Infantile, With Psychomotor Retardation And Characteristic Facies 2","Egypt, Saudi Arabia",North Africa,NS,TRUE,NS,UNC80,,UNC80,"unc-80 homolog, NALCN channel complex subunit",2,Q8N2C7,"The protein encoded by this gene is a component of a voltage-independent 'leak' ion-channel complex, in which it performs essential functions, such as serving as a bridge between two other components (sodium leak channel non-selective and UNC79) and as a scaffold for Src kinases. Leak channels play an importnat role in establishment and maintenance of resting membrane potentials in neurons. Mutations in this gene are associated with congenital infantile encephalopathy, intellectual disability and growth issues. [provided by RefSeq, Aug 2016].",22/11/2021,PubMed,"Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy.",26708753,2016,DisGeNET,rs864321622,SNV,,,,,,"Investigated 3 Saudi Arabian families, and 1 Egyptian family. Of the highlighted variants, rs864321622 is the only variant observed in the Egyptian family. "
rs121918057,21668429,Hepatoerythropoietic Porphyria,Equatorial Guinea,West Africa,NS,FALSE,NS,UROD,,UROD,uroporphyrinogen decarboxylase,1,P06132,"This gene encodes an enzyme in the heme biosynthetic pathway. This enzyme is responsible for catalyzing the conversion of uroporphyrinogen to coproporphyrinogen through the removal of four carboxymethyl side chains. Mutations and deficiency in this enzyme are known to cause familial porphyria cutanea tarda and hepatoerythropoetic porphyria.[provided by RefSeq, Aug 2010].",22/11/2021,PubMed,Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene.,21668429,2012,DisGeNET,rs121918057,SNV,,,,,,"This study presented a novel G170D missense mutation in homozygosity, and the results emphasized the complex relationship between the genetic defects and the biochemical phenotype in homozygous porphyria."
rs121918057,7706766,Familial Porphyria Cutanea Tarda,"Tunisia, Spain",North Africa,NS,TRUE,< 0.05,UROD,,UROD,uroporphyrinogen decarboxylase,1,P06132,"This gene encodes an enzyme in the heme biosynthetic pathway. This enzyme is responsible for catalyzing the conversion of uroporphyrinogen to coproporphyrinogen through the removal of four carboxymethyl side chains. Mutations and deficiency in this enzyme are known to cause familial porphyria cutanea tarda and hepatoerythropoetic porphyria.[provided by RefSeq, Aug 2010].",22/11/2021,PubMed,A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.,7706766,1995,DisGeNET,rs121918057,SNV,,,,,,
rs121918057,7706766,Hepatoerythropoietic Porphyria,"Tunisia, Spain",North Africa,NS,TRUE,< 0.05,UROD,,UROD,uroporphyrinogen decarboxylase,1,P06132,"This gene encodes an enzyme in the heme biosynthetic pathway. This enzyme is responsible for catalyzing the conversion of uroporphyrinogen to coproporphyrinogen through the removal of four carboxymethyl side chains. Mutations and deficiency in this enzyme are known to cause familial porphyria cutanea tarda and hepatoerythropoetic porphyria.[provided by RefSeq, Aug 2010].",22/11/2021,PubMed,A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.,7706766,1995,DisGeNET,rs121918057,SNV,,,,,,
rs121918057,7706766,Porphyria Cutanea Tarda,"Tunisia, Spain",North Africa,NS,TRUE,< 0.05,UROD,,UROD,uroporphyrinogen decarboxylase,1,P06132,"This gene encodes an enzyme in the heme biosynthetic pathway. This enzyme is responsible for catalyzing the conversion of uroporphyrinogen to coproporphyrinogen through the removal of four carboxymethyl side chains. Mutations and deficiency in this enzyme are known to cause familial porphyria cutanea tarda and hepatoerythropoetic porphyria.[provided by RefSeq, Aug 2010].",22/11/2021,PubMed,A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.,7706766,1995,DisGeNET,rs121918057,SNV,,,,,,
rs786205051,18925663,Poikiloderma With Neutropenia,Morocco,North Africa,NS,FALSE,0.956,USB1,,USB1,"U6 SnRNA biogenesis phosphodiesterase 1	",16,Q9BQ65,"This gene encodes a protein with several conserved domains, however, its exact function is not known. Mutations in this gene are associated with poikiloderma with neutropenia (PN), which shows phenotypic overlap with Rothmund-Thomson syndrome (RTS) caused by mutations in the RECQL4 gene. It is believed that this gene product interacts with RECQL4 protein via SMAD4 proteins, explaining the partial clinical overlap between PN and RTS. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.",22/11/2021,PubMed,"Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco.",18925663,2008,DisGeNET,rs786205051,SNV,,,,,,
rs876657624,27440999,"Usher Syndrome, Type Ic",Tunisia,North Africa,NS,FALSE,NS,USH1C,,USH1C,USH1 protein network component harmonin,11,Q9Y6N9,"This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009].",22/11/2021,PubMed,Genetic analysis of Tunisian families with Usher syndrome type 1: toward improving early molecular diagnosis.,27440999,2018,DisGeNET,rs876657624,SNV,,,,,,SNP not found in the specified article
rs80338903,11402400,"Usher Syndrome, Type Iia",South Africa,South Africa,NS,FALSE,NS,USH2A,,USH2A,usherin,1,O75445,"This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008].",22/11/2021,PubMed,A common ancestral origin of the frequent and widespread 2299delG USH2A mutation.,11402400,2001,DisGeNET,rs80338903,SNV,,,,,,Contains only 1 African participant - from South Africa.
rs373599651,10738000,"Usher Syndrome, Type Iia","Morocco, Iran",North Africa,NS,TRUE,0.003,USH2A,,USH2A,usherin,1,O75445,"This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008].",22/11/2021,PubMed,Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families.,10738000,2000,DisGeNET,rs373599651,SNV,,,,,,
rs397517963,10738000,"Usher Syndrome, Type Iia","Morocco, Iran",North Africa,NS,TRUE,0.04,USH2A,,USH2A,usherin,1,O75445,"This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008].",22/11/2021,PubMed,Three novel mutations and twelve polymorphisms identified in the USH2A gene in Israeli USH2 families.,10738000,2000,DisGeNET,rs397517963,SNV,,,,,,
rs387907252,22095910,Agenesis Of Corpus Callosum,Egypt,North Africa,NS,FALSE,NS,VAX1,,VAX1,ventral anterior homeobox 1,10,Q5SQQ9,"This gene encodes a homeo-domain containing protein from a class of homeobox transcription factors which are conserved in vertebrates. Genes of this family are involved in the regulation of body development and morphogenesis. The most conserved genes, called HOX genes are found in special gene clusters. This gene belongs to the VAX subfamily and lies in the vicinity of the EMX homeobox gene family. Another member of VAX family is located on chromosome 2. The encoded protein may play an important role in the development of anterior ventral forebrain and visual system. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans.",22095910,2012,DisGeNET,rs387907252,SNV,,,,,,"VAX1 mutation, c.453G>A and c.454C>A, that predicted p.Arg152Ser in a male with severe bilateral microphthalmia and small optic nerves, cleft lip and palate, corpus callosum agenesis, hippocampal malformations, and absence of the pineal gland. A similar phenotype to the patient of microphthalmia, agenesis of the corpus callosum, and cleft palate has also been observed in mice with loss of Vax1 function, making this the most likely mechanism."
rs387907252,22095910,"Microphthalmia, Syndromic 11",Egypt,North Africa,NS,FALSE,NS,VAX1,,VAX1,ventral anterior homeobox 1,10,Q5SQQ9,"This gene encodes a homeo-domain containing protein from a class of homeobox transcription factors which are conserved in vertebrates. Genes of this family are involved in the regulation of body development and morphogenesis. The most conserved genes, called HOX genes are found in special gene clusters. This gene belongs to the VAX subfamily and lies in the vicinity of the EMX homeobox gene family. Another member of VAX family is located on chromosome 2. The encoded protein may play an important role in the development of anterior ventral forebrain and visual system. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans.",22095910,2012,DisGeNET,rs387907252,SNV,,,,,,
rs387907252,22095910,Microphthalmos,Egypt,North Africa,NS,FALSE,NS,VAX1,,VAX1,ventral anterior homeobox 1,10,Q5SQQ9,"This gene encodes a homeo-domain containing protein from a class of homeobox transcription factors which are conserved in vertebrates. Genes of this family are involved in the regulation of body development and morphogenesis. The most conserved genes, called HOX genes are found in special gene clusters. This gene belongs to the VAX subfamily and lies in the vicinity of the EMX homeobox gene family. Another member of VAX family is located on chromosome 2. The encoded protein may play an important role in the development of anterior ventral forebrain and visual system. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,"VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: the first description of a VAX1 phenotype in humans.",22095910,2012,DisGeNET,rs387907252,SNV,,,,,,
rs833068,28045923,Allele A is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele G.,USA,African American/Afro-Caribbean,NS,FALSE,NS,VEGFA,,VEGFA,vascular endothelial growth factor A,6,P15692,"This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995829,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs833068 is assigned to VEGFA gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs833069,28045923,Allele C is not associated with response to bevacizumab in women with Breast Neoplasms as compared to allele T.,USA,African American/Afro-Caribbean,NS,FALSE,NS,VEGFA,,VEGFA,vascular endothelial growth factor A,6,P15692,"This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. The levels of VEGF are increased during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), thus promoting inflammation by facilitating recruitment of inflammatory cells, and by increasing the level of angiopoietin II (Ang II), one of two products of the SARS-CoV-2 binding target, angiotensin-converting enzyme 2 (ACE2). In turn, Ang II facilitates the elevation of VEGF, thus forming a vicious cycle in the release of inflammatory cytokines. [provided by RefSeq, Jun 2020].",22/11/2021,PubMed,"Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.",28045923,2017,PharmGKB,1448995836,SNV,bevacizumab,DB00112,"Approved, Investigational",As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer.,NA,rs833069 is assigned to VEGFA gene in this study and not associated with response to bevacizumab in women with Breast Neoplasms
rs9923231,28685643,Genotype GG is not associated with dose of warfarin in Pulmonary Embolism as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.,28685643,2018,PharmGKB,1449005494,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study describes the VKORC1 âˆ’1639GG genotype that was found to be insensitive to warfarin.
rs9923231,28685643,Genotype GG is not associated with dose of warfarin in Pulmonary Embolism as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Clinical effect of CYP2C9*5/*6 genotype on a patient's warfarin dose requirement.,28685643,2018,PharmGKB,1449005494,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study describes the VKORC1 âˆ’1639GG genotype that was found to be insensitive to warfarin.
rs72547529,19663669,Allele T is associated with increased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1445401050,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The variant is referred by g.1331G>A in the study's paper and reported with at frequency of 0.005 in a cohort of 300 healthy African-American individuals. The variant is associated with a warfarin resistant phenotype.
rs72547529,19663669,Allele T is associated with increased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1445401050,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The variant is referred by g.1331G>A in the study's paper and reported with at frequency of 0.005 in a cohort of 300 healthy African-American individuals. The variant is associated with a warfarin resistant phenotype.
rs72547529,19663669,Allele T is associated with increased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1445401057,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The variant is referred by g.1331G>A in the study's paper and reported with at frequency of 0.005 in a cohort of 300 healthy African-American individuals. The variant is associated with a warfarin resistant phenotype.
rs72547529,19663669,Allele T is associated with increased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1445401057,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The variant is referred by g.1331G>A in the study's paper and reported with at frequency of 0.005 in a cohort of 300 healthy African-American individuals. The variant is associated with a warfarin resistant phenotype.
rs72547529,19663669,Allele T is associated with increased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1445401065,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The variant is referred by g.1331G>A in the study's paper and reported with at frequency of 0.005 in a cohort of 300 healthy African-American individuals. The variant is associated with a warfarin resistant phenotype.
rs72547529,19663669,Allele T is associated with increased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,CYP2C9*8 is prevalent among African-Americans: implications for pharmacogenetic dosing.,19663669,2010,PharmGKB,1445401065,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The variant is referred by g.1331G>A in the study's paper and reported with at frequency of 0.005 in a cohort of 300 healthy African-American individuals. The variant is associated with a warfarin resistant phenotype.
rs9923231,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,0.002,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037894,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs9923231 is assigned to âˆ’1639G>A alle in VKORC1 gene
rs9923231,20072124,Allele T is associated with decreased dose of warfarin as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,0.002,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037894,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs9923231 is assigned to âˆ’1639G>A alle in VKORC1 gene
rs2884737,20072124,Allele C is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,0.027,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037919,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs2884737 is assigned to 497T>G allele in VKORC1 gene and is associated to lower doeses of warfarin
rs2884737,20072124,Allele C is associated with decreased dose of warfarin as compared to allele A.,USA,African American/Afro-Caribbean,African American,FALSE,0.027,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037919,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs2884737 is assigned to 497T>G allele in VKORC1 gene and is associated to lower doeses of warfarin
rs17880887,20072124,Allele T is not associated with decreased dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,0.119,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037888,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs17880887 is assigned to âˆ’4451C>A allele in VKORC1 gene and is not associated to lower dose of warfarin
rs17880887,20072124,Allele T is not associated with decreased dose of warfarin as compared to allele G.,USA,African American/Afro-Caribbean,African American,FALSE,0.119,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and clinical predictors of warfarin dose requirements in African Americans.,20072124,2010,PharmGKB,982037888,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,rs17880887 is assigned to âˆ’4451C>A allele in VKORC1 gene and is not associated to lower dose of warfarin
rs9923231,21228733,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,< 0.0001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864552,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.
rs9923231,21228733,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,< 0.0001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,827864552,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.
rs9923231,21228733,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,< 0.0001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,1445296652,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.
rs9923231,21228733,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,< 0.0001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,1445296652,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.
rs9923231,21228733,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,< 0.0001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,1448573250,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.
rs9923231,21228733,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,< 0.0001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients.,21228733,2011,PharmGKB,1448573250,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 195 cases from Egypt. Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.
rs8050894,18466099,Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.15,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519677,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes 273 African-American patients genotyped for 1542G/C (rs2359612) variant. Both GA and AA genotypes  did not have a significant influence on warfarin doses.
rs8050894,18466099,Genotypes CG + GG are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.15,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519677,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes 273 African-American patients genotyped for 1542G/C (rs2359612) variant. Both GA and AA genotypes  did not have a significant influence on warfarin doses.
rs7294,18466099,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.2,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519684,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes 273 African-American patients genotyped for 3730G/A (rs7294) variant. Both GA and AA genotypes  did not have a significant influence on warfarin doses.
rs7294,18466099,Genotypes CT + TT are associated with increased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.2,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519684,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes 273 African-American patients genotyped for 3730G/A (rs7294) variant. Both GA and AA genotypes  did not have a significant influence on warfarin doses.
rs2359612,18466099,Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.005,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519671,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes 273 African-American patients genotyped for 2255C/T (rs2359612) variant. Both CT and TT genotypes were associated with higher doeses of warfarin.
rs2359612,18466099,Genotypes AA + AG are associated with decreased dose of warfarin as compared to genotype GG.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.005,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.",18466099,2008,PharmGKB,1447519671,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes 273 African-American patients genotyped for 2255C/T (rs2359612) variant. Both CT and TT genotypes were associated with higher doeses of warfarin.
rs9923231,28135054,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,827864552,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The patients were genotyped for the  -1639G>A (rs9923231) variant. The allele is associated with lower doses of warfarin in both the discovey and the replication cohorts. The reported P value is for the dicovery cohort.
rs9923231,28135054,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,827864552,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The patients were genotyped for the  -1639G>A (rs9923231) variant. The allele is associated with lower doses of warfarin in both the discovey and the replication cohorts. The reported P value is for the dicovery cohort.
rs9923231,28135054,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1445296652,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The patients were genotyped for the  -1639G>A (rs9923231) variant. The allele is associated with lower doses of warfarin in both the discovey and the replication cohorts. The reported P value is for the dicovery cohort.
rs9923231,28135054,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1445296652,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The patients were genotyped for the  -1639G>A (rs9923231) variant. The allele is associated with lower doses of warfarin in both the discovey and the replication cohorts. The reported P value is for the dicovery cohort.
rs9923231,28135054,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573250,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The patients were genotyped for the  -1639G>A (rs9923231) variant. The allele is associated with lower doses of warfarin in both the discovey and the replication cohorts. The reported P value is for the dicovery cohort.
rs9923231,28135054,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans.,28135054,2018,PharmGKB,1448573250,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study includes African-American participants in a discovery (n = 306) and replication (n = 141) cohorts. The patients were genotyped for the  -1639G>A (rs9923231) variant. The allele is associated with lower doses of warfarin in both the discovey and the replication cohorts. The reported P value is for the dicovery cohort.
rs7200749,21635147,Allele A is associated with increased dose of warfarin as compared to allele G.,South Africa,South Africa,NS,FALSE,0.032,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.,21635147,2011,PharmGKB,1185002301,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 113 black urban women and 100 other black individuals representing the general population of South Africa with no distinction between ethnic groups. Allele A is associated with increased dose of warfarin as compared to allele G.
rs7200749,21635147,Allele A is associated with increased dose of warfarin as compared to allele G.,South Africa,South Africa,NS,FALSE,0.032,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.,21635147,2011,PharmGKB,1185002301,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 113 black urban women and 100 other black individuals representing the general population of South Africa with no distinction between ethnic groups. Allele A is associated with increased dose of warfarin as compared to allele G.
rs7294,21635147,Allele T is associated with increased dose of warfarin as compared to allele C.,South Africa,South Africa,NS,FALSE,0.032,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.,21635147,2011,PharmGKB,1185002294,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 113 black urban women and 100 other black individuals representing the general population of South Africa with no distinction between ethnic groups. Allele T is associated with increased dose of warfarin as compared to allele C.
rs7294,21635147,Allele T is associated with increased dose of warfarin as compared to allele C.,South Africa,South Africa,NS,FALSE,0.032,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.,21635147,2011,PharmGKB,1185002294,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports on 113 black urban women and 100 other black individuals representing the general population of South Africa with no distinction between ethnic groups. Allele T is associated with increased dose of warfarin as compared to allele C.
rs72547529,15630486,Allele T is associated with increased dose of warfarin as compared to allele C.,United Kingdom,African American/Afro-Caribbean,NS,TRUE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.,15630486,2005,PharmGKB,1445401050,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 820 subjects from UK of which one individual of Afro-Caribbean ancestry
rs72547529,15630486,Allele T is associated with increased dose of warfarin as compared to allele C.,United Kingdom,African American/Afro-Caribbean,NS,TRUE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.,15630486,2005,PharmGKB,1445401050,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 820 subjects from UK of which one individual of Afro-Caribbean ancestry
rs72547529,15630486,Allele T is associated with increased dose of warfarin as compared to allele C.,United Kingdom,African American/Afro-Caribbean,NS,TRUE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.,15630486,2005,PharmGKB,1445401057,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 820 subjects from UK of which one individual of Afro-Caribbean ancestry
rs72547529,15630486,Allele T is associated with increased dose of warfarin as compared to allele C.,United Kingdom,African American/Afro-Caribbean,NS,TRUE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.,15630486,2005,PharmGKB,1445401057,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 820 subjects from UK of which one individual of Afro-Caribbean ancestry
rs72547529,15630486,Allele T is associated with increased dose of warfarin as compared to allele C.,United Kingdom,African American/Afro-Caribbean,NS,TRUE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.,15630486,2005,PharmGKB,1445401065,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 820 subjects from UK of which one individual of Afro-Caribbean ancestry
rs72547529,15630486,Allele T is associated with increased dose of warfarin as compared to allele C.,United Kingdom,African American/Afro-Caribbean,NS,TRUE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.,15630486,2005,PharmGKB,1445401065,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 820 subjects from UK of which one individual of Afro-Caribbean ancestry
rs9923231,26024874,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,827864552,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. The TT and CT genotypes are associated with a significant dose decrease of warfarin.
rs9923231,26024874,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,827864552,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. The TT and CT genotypes are associated with a significant dose decrease of warfarin.
rs9923231,26024874,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296652,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. The TT and CT genotypes are associated with a significant dose decrease of warfarin.
rs9923231,26024874,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1445296652,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. The TT and CT genotypes are associated with a significant dose decrease of warfarin.
rs9923231,26024874,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1448573250,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. The TT and CT genotypes are associated with a significant dose decrease of warfarin.
rs9923231,26024874,Genotypes CT + TT are associated with decreased dose of warfarin as compared to genotype CC.,USA,African American/Afro-Caribbean,African American,FALSE,< 0.001,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Race influences warfarin dose changes associated with genetic factors.,26024874,2015,PharmGKB,1448573250,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study samples 595 African-Americans initiating warfarin with the target international normalized ratio of 2 to 3. The TT and CT genotypes are associated with a significant dose decrease of warfarin.
rs61162043,21270790,Allele G is associated with increased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,0.0041,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.,21270790,2011,PharmGKB,769245704,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Assciated with increased dose of warfarin.
rs61162043,21270790,Allele G is associated with increased dose of warfarin.,USA,African American/Afro-Caribbean,African American,FALSE,0.0041,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,The missing association: sequencing-based discovery of novel SNPs in VKORC1 and CYP2C9 that affect warfarin dose in African Americans.,21270790,2011,PharmGKB,769245704,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,Assciated with increased dose of warfarin.
rs61742245,23571513,Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,0.03,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians.,23571513,2014,PharmGKB,981862284,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study however focuses mainly on the Egyptian patients (n=206) taking chronic warfarin therapy and genotyped to reveal the NP_076869.1:p.Asp36Tyr protein mutation (corresponding to  NM_024006.6:c.106G>T ). Heterozygous carriers had a stable warfarin dose significantly higher than non-carriers.
rs61742245,23571513,Genotypes AA + AC are associated with increased dose of warfarin as compared to genotype CC.,Egypt,North Africa,NS,FALSE,0.03,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians.,23571513,2014,PharmGKB,981862284,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study however focuses mainly on the Egyptian patients (n=206) taking chronic warfarin therapy and genotyped to reveal the NP_076869.1:p.Asp36Tyr protein mutation (corresponding to  NM_024006.6:c.106G>T ). Heterozygous carriers had a stable warfarin dose significantly higher than non-carriers.
rs72547529,20615525,Allele T is associated with increased dose of warfarin as compared to allele C.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.,20615525,2010,PharmGKB,1445401050,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The total cohort of the study is 51 but only 11 of them are of African ancestry. Of the 11 patients on high doses of warfarin, sequencing of VKORC1 revealed a nonsynonymous VKORC1 V66M mutation in two warfarin resistant patients, both of African-descent."
rs72547529,20615525,Allele T is associated with increased dose of warfarin as compared to allele C.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.,20615525,2010,PharmGKB,1445401050,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The total cohort of the study is 51 but only 11 of them are of African ancestry. Of the 11 patients on high doses of warfarin, sequencing of VKORC1 revealed a nonsynonymous VKORC1 V66M mutation in two warfarin resistant patients, both of African-descent."
rs72547529,20615525,Allele T is associated with increased dose of warfarin as compared to allele C.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.,20615525,2010,PharmGKB,1445401057,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The total cohort of the study is 51 but only 11 of them are of African ancestry. Of the 11 patients on high doses of warfarin, sequencing of VKORC1 revealed a nonsynonymous VKORC1 V66M mutation in two warfarin resistant patients, both of African-descent."
rs72547529,20615525,Allele T is associated with increased dose of warfarin as compared to allele C.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.,20615525,2010,PharmGKB,1445401057,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The total cohort of the study is 51 but only 11 of them are of African ancestry. Of the 11 patients on high doses of warfarin, sequencing of VKORC1 revealed a nonsynonymous VKORC1 V66M mutation in two warfarin resistant patients, both of African-descent."
rs72547529,20615525,Allele T is associated with increased dose of warfarin as compared to allele C.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.,20615525,2010,PharmGKB,1445401065,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The total cohort of the study is 51 but only 11 of them are of African ancestry. Of the 11 patients on high doses of warfarin, sequencing of VKORC1 revealed a nonsynonymous VKORC1 V66M mutation in two warfarin resistant patients, both of African-descent."
rs72547529,20615525,Allele T is associated with increased dose of warfarin as compared to allele C.,Brazil,African American/Afro-Caribbean,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,VKORC1 V66M mutation in African Brazilian patients resistant to oral anticoagulant therapy.,20615525,2010,PharmGKB,1445401065,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,"The total cohort of the study is 51 but only 11 of them are of African ancestry. Of the 11 patients on high doses of warfarin, sequencing of VKORC1 revealed a nonsynonymous VKORC1 V66M mutation in two warfarin resistant patients, both of African-descent."
rs72547529,26513304,Allele T is associated with decreased response to warfarin as compared to allele C.,Tanzania,East Africa,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling.,26513304,2016,PharmGKB,1447520668,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports about a Tanzanian patient on warfarin dose (21 mg/day). The patient has the mutation NM_024006.6:c.196G>A in heterozygous form. The motation leads to the Val66Met substitution which results in a reduction of 80% of VKORC1 activity and very weak capacity of warfarin to bind to the protein (estimated by computational modeling).
rs72547529,26513304,Allele T is associated with decreased response to warfarin as compared to allele C.,Tanzania,East Africa,NS,FALSE,NS,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Warfarin resistance associated with genetic polymorphism of VKORC1: linking clinical response to molecular mechanism using computational modeling.,26513304,2016,PharmGKB,1447520668,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,The study reports about a Tanzanian patient on warfarin dose (21 mg/day). The patient has the mutation NM_024006.6:c.196G>A in heterozygous form. The motation leads to the Val66Met substitution which results in a reduction of 80% of VKORC1 activity and very weak capacity of warfarin to bind to the protein (estimated by computational modeling).
rs12777823,17110455,Asp36Tyr polymorphism predisposes to warfarin resistance,Ethiopa,East Africa,NS,TRUE,0.026,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance.,17110455,2007,PharmGKB,TBD,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs9923231,17329985,Polymorphism associated with lower warfarin maintenance dose requirements.,USA,African American/Afro-Caribbean,African American,TRUE,0.02,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Warfarin response and vitamin K epoxide reductase complex 1 in African Americans and Caucasians.,17329985,2007,PharmGKB,TBD,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs17886199,20716240,"in African Americans, the VKORC1 rs17886199 A-allele was associated with a lower warfarin dose.",USA,African American/Afro-Caribbean,African American,TRUE,0.002,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,New genetic variant that might improve warfarin dose prediction in African Americans.,20716240,2010,PharmGKB,TBD,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs9923231,22854539,CYP2C9 and VKORC1 variant allele/genotype were significantly associated with the daily warfarin dose.,Oman,Africa,NS,TRUE,< 0.05,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.,22854539,2012,PharmGKB,TBD,SNV,warfarin,DB00682,Approved,"Indicated for: 1) Prophylaxis and treatment of venous thromboembolism and related pulmonary embolism. 2) Prophylaxis and treatment of thromboembolism associated with atrial fibrillation. 3) Prophylaxis and treatment of thromboembolism associated with cardiac valve replacement. 4) Use as adjunct therapy to reduce mortality, recurrent myocardial infarction, and thromboembolic events post myocardial infarction. Off-label uses include: 1) Secondary prevention of stroke and transient ischemic attacks in patients with rheumatic mitral valve disease but without atrial fibrillation.",4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one,
rs9923231,22486182,Genotype CC is associated with increased dose of acenocoumarol as compared to genotype CT.,Morocco,North Africa,NS,FALSE,0.005,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010039,SNV,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,Patients with the CC genotype required significantly higher weekly maintenance doses of acenocoumarol compared to CT heterozygotes.
rs9923231,22486182,Genotype TT is not associated with dose of acenocoumarol as compared to genotype CT.,Morocco,North Africa,NS,FALSE,0.135,VKORC1,,VKORC1,vitamin K epoxide reductase complex subunit 1,16,Q9BQB6,"This gene encodes the catalytic subunit of the vitamin K epoxide reductase complex, which is responsible for the reduction of inactive vitamin K 2,3-epoxide to active vitamin K in the endoplasmic reticulum membrane. Vitamin K is a required co-factor for carboxylation of glutamic acid residues by vitamin K-dependent gamma-carboxylase in blood-clotting enzymes. Allelic variation in this gene is associated with vitamin k-dependent clotting factors combined deficiency of 2, and increased resistance or sensitivity to warfarin, an inhibitor of vitamin K epoxide reductase. Pseudogenes of this gene are located on chromosomes 1 and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015].",22/11/2021,PubMed,Influence of genetics and non-genetic factors on acenocoumarol maintenance dose requirement in Moroccan patients.,22486182,2013,PharmGKB,982010028,SNV,acenocoumarol,DB01418,"Approved, Investigational","For the treatment and prevention of thromboembolic diseases. More specifically, it is indicated for the prevention of cerebral embolism, deep vein thrombosis, pulmonary embolism, thromboembolism in infarction and transient ischemic attacks. It is used for the treatment of deep vein thrombosis and myocardial infarction.",4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one,Patients with the TT genotype did not require significantly different weekly maintenance doses of acenocoumarol compared to CT heterozygotes.
rs587777465,24577744,"Pontocerebellar Hypoplasia, Type 2E",Morocco,North Africa,Jewish,FALSE,NS,VPS53,,VPS53,VPS53 subunit of GARP complex,17,Q5VIR6,"This gene encodes a protein with sequence similarity to the yeast Vps53p protein. Vps53p is involved in retrograde vesicle trafficking in late Golgi. [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2).,24577744,2015,DisGeNET,rs587777465,SNV,,,,,,
rs587777466,24577744,"Pontocerebellar Hypoplasia, Type 2E",Morocco,North Africa,Jewish,FALSE,NS,VPS54,,VPS54,VPS54 subunit of GARP complex,2,Q9P1Q0,"This gene encodes for a protein that in yeast forms part of a trimeric vacuolar-protein-sorting complex that is required for retrograde transport of proteins from prevacuoles to the late Golgi compartment. As in yeast, mammalian Vps54 proteins contain a coiled-coil region and dileucine motifs. Alternative splicing results in multiple transcript variants encoding different isoforms [provided by RefSeq, Jul 2008].",22/11/2021,PubMed,VPS53 mutations cause progressive cerebello-cerebral atrophy type 2 (PCCA2).,24577744,2015,DisGeNET,rs587777466,SNV,,,,,,
rs869320674,15841483,"Deafness, Autosomal Recessive 31",Tunisia,North Africa,NS,FALSE,NS,WHRN,,WHRN,whirlin,9,Q9P202,"This gene is thought to function in the organization and stabilization of sterocilia elongation and actin cystoskeletal assembly, based on studies of the related mouse gene. Mutations in this gene have been associated with autosomal recessive non-syndromic deafness and Usher Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016].",22/11/2021,PubMed,Identification of a novel frameshift mutation in the DFNB31/WHRN gene in a Tunisian consanguineous family with hereditary non-syndromic recessive hearing loss.,15841483,2006,DisGeNET,rs869320674,SNV,,,,,,
rs1884725,27798726,rs1884725 associated with a lower dose of allopurinol.,USA,African American/Afro-Caribbean,African American,TRUE,0.033,XDH,,XDH,xanthine dehydrogenase,2,P47989,"Xanthine dehydrogenase belongs to the group of molybdenum-containing hydroxylases involved in the oxidative metabolism of purines. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Xanthine dehydrogenase can be converted to xanthine oxidase by reversible sulfhydryl oxidation or by irreversible proteolytic modification. Defects in xanthine dehydrogenase cause xanthinuria, may contribute to adult respiratory stress syndrome, and may potentiate influenza infection through an oxygen metabolite-dependent mechanism.",22/11/2021,PubMed,Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose.,27798726,2017,PharmGKB,TBD,SNV,allopurinol,DB00437,Approved,"Allopurinol is indicated in: 1) the management of patients with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy). 2) the management of patients with leukemia, lymphoma and malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels. Treatment with allopurinol should be discontinued when the potential for overproduction of uric acid is no longer present. 3) the management of patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. Therapy in such patients should be carefully assessed initially and reassessed periodically to determine in each case that treatment is beneficial and that the benefits outweigh the risks.","1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one",
rs104894132,8105686,"Xeroderma Pigmentosum, Group A",Tunisia,North Africa,NS,FALSE,NS,XPA,,XPA,"XPA, DNA damage recognition and repair factor",9,P23025,"This gene encodes a zinc finger protein plays a central role in nucleotide excision repair (NER), a specialized type of DNA repair. NER is responsible for repair of UV radiation-induced photoproducts and DNA adducts induced by chemical carcinogens and chemotherapeutic drugs. The encoded protein interacts with DNA and several NER proteins, acting as a scaffold to assemble the NER incision complex at sites of DNA damage. Mutations in this gene cause Xeroderma pigmentosum complementation group A (XP-A), an autosomal recessive skin disorder featuring hypersensitivity to sunlight and increased risk for skin cancer. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,High prevalence of the point mutation in exon 6 of the xeroderma pigmentosum group A-complementing (XPAC) gene in xeroderma pigmentosum group A patients in Tunisia.,8105686,1993,DisGeNET,rs104894132,SNV,,,,,,"Associated with Xeroderma Pigmentosum, Group A"
rs104894132,20199544,"Xeroderma Pigmentosum, Group A",Tunisia,North Africa,NS,FALSE,NS,XPA,,XPA,"XPA, DNA damage recognition and repair factor",9,P23025,"This gene encodes a zinc finger protein plays a central role in nucleotide excision repair (NER), a specialized type of DNA repair. NER is responsible for repair of UV radiation-induced photoproducts and DNA adducts induced by chemical carcinogens and chemotherapeutic drugs. The encoded protein interacts with DNA and several NER proteins, acting as a scaffold to assemble the NER incision complex at sites of DNA damage. Mutations in this gene cause Xeroderma pigmentosum complementation group A (XP-A), an autosomal recessive skin disorder featuring hypersensitivity to sunlight and increased risk for skin cancer. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.,20199544,2010,DisGeNET,rs104894132,SNV,,,,,,"Associated with Xeroderma Pigmentosum, Group A"
rs754532049,20054342,"Xeroderma Pigmentosum, Complementation Group C","Algeria, Morocco, Tunisia",North Africa,NS,TRUE,NS,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.,20054342,2010,DisGeNET,rs754532049,SNV,,,,,,
rs754532049,20463673,"Xeroderma Pigmentosum, Complementation Group C","Algeria, Morocco, Tunisia",North Africa,NS,TRUE,NS,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,Founder mutations in xeroderma pigmentosum.,20463673,2010,DisGeNET,rs754532049,SNV,,,,,,
rs754532049,19478817,"Xeroderma Pigmentosum, Complementation Group C",Tunisia,North Africa,NS,FALSE,NS,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,High frequency of the V548A fs X572 XPC mutation in Tunisia: implication for molecular diagnosis.,19478817,2010,DisGeNET,rs754532049,SNV,,,,,,
rs2228001,25311495,Leukemia,Tunisia,North Africa,NS,FALSE,0.0042,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.",25311495,2016,DisGeNET,rs2228001,SNV,,,,,,An increased risk of leukemia among subjects carrying the XPC 939Gln/Gln genotype was found
rs2228001,21426550,Bladder Neoplasm,Tunisia,North Africa,NS,FALSE,0.03,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs2228001,SNV,,,,,,rs2228001 was associated with developing bladder cancer compared to the control carrying the wild genotype
rs2228001,21426550,Carcinoma Of Bladder,Tunisia,North Africa,NS,FALSE,0.03,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs2228001,SNV,,,,,,rs2228001 was associated with developing bladder cancer compared to the control carrying the wild genotype
rs2228001,21426550,Malignant Neoplasm Of Urinary Bladder,Tunisia,North Africa,NS,FALSE,NS,XPC,,XPC,"XPC complex subunit, DNA damage recognition and repair factor",3,Q01831,"The protein encoded by this gene is a key component of the XPC complex, which plays an important role in the early steps of global genome nucleotide excision repair (NER). The encoded protein is important for damage sensing and DNA binding, and shows a preference for single-stranded DNA. Mutations in this gene or some other NER components can result in Xeroderma pigmentosum, a rare autosomal recessive disorder characterized by increased sensitivity to sunlight with the development of carcinomas at an early age. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2017].",22/11/2021,PubMed,"The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.",21426550,2011,DisGeNET,rs2228001,SNV,,,,,,no association between rs2228001polymorphism and tumors stage and grade.
rs118204050,18098276,"Spastic Paraplegia 15, Autosomal Recessive",Tunisia,North Africa,NS,FALSE,0,ZFYVE26,,ZFYVE26,"zinc finger FYVE-type containing 26	",14,Q68DK2,This gene encodes a protein which contains a FYVE zinc finger binding domain. The presence of this domain is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15.,22/11/2021,PubMed,Spastic paraplegia 15: linkage and clinical description of three Tunisian families.,18098276,2008,DisGeNET,rs118204050,SNV,,,,,,
rs7555340,25676789,Uric Acid Measurement (Procedure),USA,African American/Afro-Caribbean,African American,TRUE,3.90E-07,ZMYM6,,ZMYM6,zinc finger MYM-type containing 6,1,O95789,Predicted to enable DNA binding activity. Involved in cytoskeleton organization and regulation of cell morphogenesis. Predicted to be located in nucleus.,22/11/2021,PubMed,Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response.,25676789,2015,DisGeNET,rs7555340,SNV,,,,,,Association results in all subjects after imputation
rs185430475,28921760,Allele G is not associated with metabolism of nicotine as compared to allele C.,USA,African American/Afro-Caribbean,African American,FALSE,9.26E-07,ZNF536,Meta-analysis,ZNF536,zinc finger protein 536,19,O15090,"The protein encoded by this gene is a highly conserved zinc finger protein. The encoded protein is most abundant in brain, where it negatively regulates neuronal differentiation. [provided by RefSeq, Sep 2015].",22/11/2021,PubMed,Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.,28921760,2019,PharmGKB,1448996513,SNV,nicotine,DB00184,Approved,For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,The P-value is reported for a meta-analysis of African-American cohort; rs185430475 is a tagging SNP.
rs8109875,29381699,Malaria,Tanzania,East Africa,"Mzigua,Wasambaa,Wabondei,Mmbena,Mngoni,Pare,Mmkonde,Mgogo,Chagga,Other",TRUE,8.69E-07,ZNF536,Association,ZNF536,zinc finger protein 536,19,O15090,"The protein encoded by this gene is a highly conserved zinc finger protein. The encoded protein is most abundant in brain, where it negatively regulates neuronal differentiation. [provided by RefSeq, Sep 2015].",22/11/2021,PubMed,Novel genetic polymorphisms associated with severe malaria and under selective pressure in North-eastern Tanzania.,29381699,2018,DisGeNET,rs8109875,SNV,,,,,,"Investigated the following participants; 146 Mzigua,135 Wasambaa, 86 Wabondei, 23 Mmbena,18 Mngoni, 8 Pare, 8 Mmkonde, 8 Mgogo, 7 Chagga,10 Other. The p-value reported is for the recessive model."